cell_line_id,drug_id,response,predictions
DMS 273,9952709,2.373087309160908,2.461079573894493
NCI-H522,613000,2.2856040748624347,2.6337964206238142
YAPC,16038120,1.926562361021756,0.9249939447739451
NCI-H292,9935249,3.8808310590786,3.3315391463233937
SNU-449,navitoclax-gemcitabine (1-1 mol-mol),5.117951975418846,-1.237886504320444
NCI-H522,9908783,5.043768225694569,4.898205163484824
JM-1,11175137,0.9157477453434189,1.679060968636924
NCI-H522,5287620,-2.19230412457559,-2.041986860598845
MDA-MB-453,4917,2.8920757434762203,2.9997532661888044
DMS 273,135421197,2.3407622077730035,1.5411014116242034
SNU-449,BRD-K55473186,5.1406225681359174,4.334887926962465
SNU-61,4521392,3.90812104829802,4.049633407591818
G-401,9549297,1.736191202159007,2.0271978536028046
NCI-H146,89183176,1.451528120959232,3.091082257267536
LOU-NH91,5287620,-1.52867963951729,-1.6841464726386346
FTC-133,123631,3.8044847524269865,2.5588948291245597
KMRC-1,5291,3.811670367299954,3.5169573391530147
A-673,9823820,4.6435125645675095,3.108247506756525
FU-OV-1,168313047,2.3973799381416208,2.464678409108665
Panc 04.03,44462760,4.978463894781355,4.448086540911197
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272,3.1584639061323703
OPM-2,445091,3.996829176942573,3.841618377819387
ONS-76,5746,1.4703359849180313,1.16254149511846
NCI-H661,3025944,3.908905198351104,4.248385057814031
A4/Fukuda,107970,1.5574682195612295,2.0593371904112434
CAL-51,49850262,3.6300011952383584,3.899180681811472
NCI-H460,2858523,3.1665522277325575,3.123700256264357
G-401,6184667,2.5094508901292487,2.5977039432947056
NCI-H661,44607531,1.139733733680255,1.6457506636068018
SNU-81,6917907,-6.2756065511253185,-4.709365546658092
MSTO-211H,54678924,1.5146991125566602,2.4675454128391148
FTC-133,10127622,5.496386107928154,3.4590000593984627
EFO-27,11977753,-1.8189065225127747,-1.1330817398718016
SNU-61,selumetinib-decitabine (4-1 mol-mol),0.7791363138333649,2.0624824116114384
MSTO-211H,19582717,3.17062921236116,4.407550984703016
KMRC-1,53392493,3.2185750963739026,2.716404902589332
OPM-2,2749,1.7313419667612246,1.109262530858922
NCI-H460,5351362,3.0809857123464037,1.5940432966621898
SNU-449,56949517,4.374997906660537,4.4692706721044555
NCI-H146,1716436,1.8968095332546364,2.3435676270258217
MSTO-211H,9884685,-1.5007126123703023,0.8119979179631476
CA46,46926350,-5.311040218420036,-4.6096932332980085
BxPC-3,72193861,-0.2425633398981322,2.035939800025304
NCI-H522,24180719,4.104291025168841,3.3739184930844965
NCI-H292,16038120,0.8772093711483475,1.2525290104814593
NCI-H2171,11364421,-5.769988570724398,-3.4481919236292993
LOU-NH91,71304818,3.9209078908272703,2.6118321614599465
NCI-H2009,71466380,3.950405172838994,4.674405844233108
EFO-27,44607530,2.237032971856772,1.9828533908040444
CAL-51,3136844,4.799885860604426,4.483524856121214
MSTO-211H,9936388,-4.464575449065994,-0.7464887689955139
A2780,66577038,2.715796351675557,2.885561629206363
G-401,24779724,6.361263224396382,3.4435818077569165
OPM-2,5470400,-0.1217933569770787,-0.14529095343065065
HCC1143,36314,1.6197332159913502,-1.895073345318389
SW1463,54143018,1.6932952952144893,0.4321425055930592
JM-1,1317464,3.8125649173872938,2.802621849108604
DMS 273,46907787,0.4735517334159472,0.5364683749019961
MDA-MB-453,46843906,1.4379824902109608,3.0087495766916623
YAPC,6252,1.451992868069142,1.1414686839014268
MDA-MB-157,navitoclax-sorafenib (1-1 mol-mol),-1.4384143120917083,1.6711465028101926
CA46,46943432,1.2105530921386296,1.0528937407475905
NCI-H292,24785538,2.1095024536235374,1.8736316010591638
NCI-H292,3038522,3.811290582208577,3.3784175205455
NCI-H460,54454,2.7807551042334935,2.5979191372193036
NCI-H661,9911463,3.595935737335879,3.963263347272543
BT-549,4261,1.9217340769001163,1.9814681368216194
FTC-133,16013152,4.199465293191842,4.201029681773658
MDA-MB-453,54618305,5.448966988850886,3.745963601734532
LOU-NH91,56946209,-2.032751224257796,-3.9401169519180503
KMRC-1,16659841,4.161446951047465,3.7312392984829863
LXF 289,66577038,2.7615792990535937,3.01881579267099
A-673,2871966,-2.1375369153988597,0.042580341835417014
EFO-27,4788,6.204062284318603,5.756638146301668
FTC-133,5281321,-2.4880366458953196,-1.4276100672989498
JM-1,613753,2.4959303189076376,2.6859797880229115
CAL-51,168312962,1.4117577594763937,2.0341127174814
OPM-2,6450551,0.7106995413225735,1.3007176544276968
ONS-76,selumetinib-decitabine (4-1 mol-mol),-0.8020302824426914,2.9001214540163427
EFO-27,26596,4.577324640946523,-0.39996484259257054
LoVo,656346,0.766025679375412,0.7690993400577333
NCI-H522,4477,0.4448521837298123,0.43042130335659456
NCI-H727,9936388,1.6432072244848812,-0.7449426081130762
FTC-133,104842,-5.8581546696404,-2.4281882591037194
EFO-27,7326481,5.957065585898912,2.9552227107423765
NCI-H460,11222830,2.8861636193629323,1.7228094310494342
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245,3.5068633898650057
NCI-H460,54618771,1.6853262233131374,1.1994889088701177
JM-1,52947716,1.780956269613054,-3.4130705329316386
OPM-2,9444,2.5095115053941557,3.8594068562341453
NCI-H146,60700,-4.723399126949256,-1.030563562673572
BxPC-3,9911830,2.611582201474507,2.697790724591008
NCI-H146,16038120,1.7989248875403512,0.7258995020602065
LXF 289,51037431,5.679407317259089,3.10101881219496
HCC1143,44589607,1.260451666530297,3.101619318198471
CA46,5281321,-3.5082232289526663,-2.689632896112717
BxPC-3,3815108,3.682439325637505,2.9783556398078774
BT-549,ISOX-bortezomib (250-1 mol-mol),0.1826356805695565,0.9448942258928511
BxPC-3,3552672,2.73628551508051,2.8908976912346747
SCC-9,3081361,1.719146178558617,2.213503851891825
SCC-9,135875424,4.9754653396039314,4.184597573336576
LoVo,1716436,2.86184708699294,3.1145136587514144
MDA-MB-157,9884685,1.398372779004129,0.6189282966990001
NCI-H292,9911463,4.207043029649759,3.9484156082124797
G-401,54626689,4.421186382617726,4.390776992065689
NCI-H460,6917907,-4.956095121428261,-4.509510538876197
CA46,25062766,1.483751377697603,1.6453252595293626
LXF 289,44241473,4.688676931788039,5.021259704555793
EFO-27,71680916,4.9682795090816185,4.839141552750211
SW1463,11152667,-0.1903484351781526,-0.740288130230036
NCI-H292,73707398,0.96137499748578,1.43804303177689
NCI-H2009,16725315,3.943728055015544,4.466864826709059
SNU-61,135440466,2.760100648324382,2.2432603918646956
A2780,451668,4.676838081876032,1.6678762132082585
JM-1,46191454,-0.7072965876905944,0.1801999991738346
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.4267102020349025
SNU-449,2733526,4.280379959685792,3.9089675234093515
JM-1,10302451,3.097435274235228,2.688180985809458
DMS 273,tanespimycin-gemcitabine (1-1 mol-mol),-1.669434491650497,-1.1920137100818284
EFO-27,vorinostat-carboplatin (1-1 mol-mol),2.7861871023454077,3.3936557123633264
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.5194454726656543
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.3944639409742272
OPM-2,52912189,-3.1407059889083424,0.07809214136142166
SCC-9,9549297,5.273243325738832,2.7056722148967487
A-673,375860,-0.5094320760358009,-0.4107860091590689
SNU-449,15983966,0.8926749279922188,-1.043334526947678
SNU-449,135440466,2.7536019754154375,2.354803000566198
CA46,serdemetan-SCH-529074 (1-1 mol-mol),1.5485076626446956,1.3799629755884777
NCI-H522,73707398,0.7434005611154502,1.1176811832248637
NCI-H1623,72376,-0.6301176586270604,-1.6224283594885776
SCC-9,24901704,4.548877009949327,3.4716022018237136
HSC-4,448949,2.25928901468022,2.046254716035787
SCC-9,25102847,2.571358625043281,2.7275607179021812
FTC-133,135411,0.6572104898559208,0.7234895387778928
DMS 273,445643,4.452334519038606,3.7961999873071828
HSC-4,24771867,2.9499855440491243,2.9571485200913785
BxPC-3,2841722,6.186043735824486,4.431787207976253
MDA-MB-157,52947716,2.709287320485668,-1.0805736823500776
HSC-4,46224516,3.389129888163455,2.7103826070640995
NCI-H146,400769,-1.4971487301951925,-0.6140898509385552
LOU-NH91,387447,-3.4249375140388247,-4.1062426345573195
CA46,6610216,4.017162804005507,3.7527034315547514
LoVo,375860,-0.1162329718395109,-0.006817977323902742
FU-OV-1,9911830,2.8434321082933773,2.3387171335895376
LoVo,9840324,5.061772266378942,5.759166911497566
MSTO-211H,56649450,2.845391743702004,3.4500210409710736
HSC-4,9935249,3.700870290975298,3.3620934020962547
BT-549,44486219,4.179253703467884,4.537179628981299
SNU-449,24901704,3.9093934632949616,3.4251286025318564
FTC-133,44589607,3.1305768616958085,2.873025803357694
LOU-NH91,42642645,0.5799169530603235,1.0829280416355238
KYSE-70,51037431,6.2873914521382765,3.0664869187457624
KMRC-1,1566236,3.0378094444517645,2.5576025565158407
Panc 04.03,42642645,1.6619965718360328,1.1457502755108195
CAL-51,3689413,0.5709426612715743,-0.1439984468414681
NCI-H522,44487872,5.4176039717063915,4.5806360044366485
NCI-H2009,16722836,0.9347693241342916,1.8928301606923186
NCI-H522,11222830,1.4433136379668847,1.495500154590181
CA46,72193861,0.1338517787347367,0.13892601404230898
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403,0.08303311213370808
LoVo,119607,4.4096130331744865,5.103606519447115
MDA-MB-453,1566236,2.5975650319928434,2.1131752987523966
ONS-76,11152667,-0.1692604119623072,-0.7368365802468698
G-401,24748573,1.6686206591324024,1.4825710887136136
A2780,176870,3.0464675702719655,2.8879256282836594
NCI-H727,vorinostat-navitoclax (4-1 mol-mol),3.0192408076128823,1.3714853953236485
OPM-2,3385,3.5898560550490837,2.2356336592506683
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-1.2176149981396651
NOMO-1,53495165,-0.0338576092201104,-1.9357146641473393
LoVo,46191454,2.275591949439888,1.7428567847095804
A4/Fukuda,4096211,1.2598455852625392,1.2109069760839066
NCI-H522,25126798,3.91575296607237,3.744036720495288
FU-OV-1,135411,0.8541212220651947,0.7006336344810589
KYSE-70,10113978,1.960067513789881,3.3453894764600016
FU-OV-1,24856436,0.8416503079264269,0.628509994119485
A-498,10026128,4.231838396167064,3.90597544326344
JM-1,11626560,-0.1801568688824005,0.5779695842178457
NCI-H460,9911830,3.1326305509826824,2.746034043782737
A-673,9911830,1.9751375507094395,2.1004168914074928
Panc 04.03,71751553,4.683117627568525,4.5778741207358635
LXF 289,6450551,1.9915066986525345,2.91878828515295
NCI-H522,156414,0.937566519659893,1.2769788444898347
MDA-MB-453,6610355,3.820285868995436,4.4587227202494
FU-OV-1,46843906,0.6915308493256752,2.9906784770826804
NCI-H522,42642645,1.4297074042386375,0.3251708052083182
SCC-9,4917,3.683292695011318,3.017057153752067
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,1.1300196354414376
SBC-5,54649381,4.189343649803657,3.8758568455460165
NCI-H1623,6918837,-3.3974396350468674,-2.967573515875725
KMRC-1,10184653,1.755388017214173,0.6709859315101814
LXF 289,9967941,3.6599941581067057,3.774765869208287
FTC-133,57519531,1.7209799050566308,2.5874392477265546
NCI-H661,19582717,3.3132894226769056,4.315871502504629
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307,3.5683316780643675
LoVo,71466578,1.8530080227063717,4.536286609621581
NCI-H2009,46907787,0.5680124512944033,2.1912279470987155
DMS 273,49793307,-3.720971975288363,-3.706047358008121
NCI-H522,135659046,3.4944475458884012,3.5598744603777415
FTC-133,5351362,2.946320615286136,1.8479932207454923
JM-1,208908,1.8689748302954872,1.8574873136664458
Panc 04.03,216239,3.3806837686851923,2.4896590108877463
NOMO-1,71466445,1.8310961714544176,2.2266986038970598
NCI-H522,71680916,3.6078643166976896,4.378475781486217
EFO-27,2126,5.846579140474247,4.73163021694411
ONS-76,5284616,3.539643222518188,2.273280502964886
SCC-9,16736978,3.1048488109971664,1.971896986542408
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485,-4.024461808387466
A4/Fukuda,23582824,-0.7377224087572002,0.7403559260236261
NCI-H661,53325874,4.390083123893945,4.689509447933367
SNU-61,4096211,1.05462843518756,1.7041501934530776
CAL-51,675434,4.354107922133551,4.568692677435534
NOMO-1,11175137,1.3676050257567425,1.7127740057948202
NCI-H2171,5335621,4.282845813975702,4.230220521769931
SNU-449,11647372,1.9881649315547345,1.4096166338394827
NCI-H522,3503,2.0960599148243557,1.9371178786008847
NCI-H2171,52947716,1.4567314464455066,-1.8717382767309536
NOMO-1,5291,3.5817896511091862,3.259267973716822
NCI-H522,46843906,2.3044802452603967,2.346717857112587
OPM-2,11494412,0.3054873199299708,0.4982061792043625
A-673,53495165,-1.305348317827654,-1.190872742026479
KYSE-70,54618771,1.1170424016733127,1.511997107371775
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.384748606098871
SCC-9,3062316,1.318086870144001,1.0252366132436586
LoVo,387447,-3.727342469020989,-4.212248317934626
MSTO-211H,73707386,2.8647689708389943,3.0722875019243236
FTC-133,54613361,1.5430217136639572,0.35934010231204766
SNU-61,12001922,2.043150446887516,1.8032819766200918
DMS 273,374536,2.442253811681885,1.8644573942560467
LXF 289,10302451,1.735451917587997,3.391512712248877
CAL-51,2858523,3.1959449804225524,2.995580472549964
Panc 04.03,23582824,1.118403221753994,1.1325942782481253
KMRC-1,6505803,1.455434702084088,-0.5627509886913443
CAL-51,4261,2.4552246887350417,1.701428966721831
SCC-9,5746,1.774962232755205,1.1265087746942504
NCI-H661,71466578,3.739107690689307,4.630829120029898
ONS-76,54619267,4.0364090976663,4.189508731873892
NCI-H522,100016,6.692385014202011,5.6264345873984905
G-401,11719255,3.853695059500007,2.8140921510029733
HSC-4,3815108,3.178044313970192,3.1328642250262573
NCI-H2171,5287620,-0.0573950216422359,-2.36462594882562
A4/Fukuda,5311,-0.1264358008137528,0.6799767284130656
NCI-H292,387447,-4.003442188855186,-3.8470490306012324
OPM-2,148124,-6.3849256320012575,-3.031845497955861
MDA-MB-453,alisertib-navitoclax (2-1 mol-mol),3.3277558601146215,0.11650857056612333
DMS 273,salermide-PLX-4032 (12-1 mol-mol),5.306834954267239,4.699979672387855
CA46,9967941,3.699441503938977,2.977656192181067
SNU-61,JQ-1-navitoclax (2-1 mol-mol),0.8164075639499123,0.2506579728804414
LXF 289,387447,-4.093727880786265,-3.899732922124902
CAL-51,5113032,4.55807021159329,4.8244167029976355
NCI-H727,serdemetan-SCH-529074 (1-1 mol-mol),2.331809225876462,2.000518565459818
OPM-2,241158,1.7102591321182437,2.439308731547268
ONS-76,16741245,1.9308546797770672,3.9155541425475913
Panc 04.03,322968,5.075488138121087,4.136766733866069
BT-549,135875424,3.804392758634582,3.757726697147875
A-673,54626689,4.6393725921997415,4.494829977356487
SNU-449,navitoclax-birinapant (1-1 mol-mol),3.571225842715355,1.525508499180966
HCC1143,3543504,4.280043771428645,4.4417172199309745
BxPC-3,107970,2.2592769610294448,2.4349863073641975
ONS-76,51037431,1.0002101292366832,3.050849073299913
G-401,24785538,-1.0602782345595374,0.8711442633973887
MDA-MB-453,SNX-2112-bortezomib (250-1 mol-mol),-2.8558068979293383,-1.5837360134175362
FTC-133,676352,3.9949531967924297,2.196847011334323
NOMO-1,53232,3.2414615649348772,2.31951139471549
LoVo,11625818,2.0848313295223844,4.321803488477403
A4/Fukuda,702558,5.147225783500614,4.3227719934990345
NOMO-1,11455910,0.2303469505827257,0.4043516218709764
SNU-81,4096211,1.97800800333133,1.449522051571917
NCI-H522,676352,1.6559488811299496,1.9592063964349273
YAPC,60750,-4.781219880342373,-1.6761618984507054
Panc 04.03,11612883,3.751429287253437,2.965149587245765
NCI-H661,67156097,-3.370555704228358,-0.5653366263942461
SNU-449,4705,3.898593282840832,3.4379765966415192
MDA-MB-157,9952709,2.6586157499418444,3.0560048059111207
NCI-H522,16038120,0.9671280612186928,0.8327775249332718
A4/Fukuda,4259181,-0.5702867723998835,-0.27785753723664963
LoVo,135398744,6.330186357549225,6.4188617278218665
OPM-2,637858,0.8070227403937857,0.9736154848546764
SCC-9,3038522,1.9571402343301385,3.0918593293680217
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498,-0.4444412257728328
A4/Fukuda,10127622,0.8035335483112384,3.3823365707036577
Panc 04.03,4378219,5.53220646065493,2.4871374171544427
EFO-27,JQ-1-vorinostat (2-1 mol-mol),1.2489296683546294,1.212759500395138
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138,1.905978463024957
EFO-27,11396600,3.826824277303455,3.840074230813563
LoVo,JQ-1-MK-0752 (1-1 mol-mol),1.4055408884057283,1.549616008631755
NCI-H2171,7251185,0.8673768610035957,1.81661990770389
NCI-H1623,5311281,4.903104817913162,2.7413598212557617
OPM-2,11317348,2.0151792351474755,1.4549785094950503
OPM-2,100016,3.804278037815123,5.227804561111401
LoVo,46224516,4.94892102130723,2.448868134620038
A4/Fukuda,9826308,-1.4955537783248567,-0.04237197555185976
LoVo,15547703,1.4569683263207862,3.2482773131592744
LoVo,227681,3.064150517180394,3.43821373420531
NCI-H727,5460769,4.510942150258337,3.083290525762239
NCI-H292,6918837,-2.538558148903755,-2.4381671777592127
A2780,132971,2.947129832610188,2.347446608358591
FTC-133,4788,5.605324981437421,5.591328432993525
A-498,selumetinib-decitabine (4-1 mol-mol),2.586259947527723,4.034346090620914
A-498,23582824,2.0595934555669886,0.9142869404493327
SNU-61,8515,5.6731171982359365,3.4314888099559058
MDA-MB-453,23582824,0.0198148722876335,0.7728683755427522
DMS 273,5329102,2.038563375095403,1.7728134231023993
NCI-H460,72193861,2.1658883750752844,1.5470381002466136
MDA-MB-157,6610355,3.680589360872168,4.5919231780884795
Panc 04.03,56649450,4.182465283011193,3.45070863078222
NCI-H727,124202324,2.79148434895864,2.5454799124914937
MSTO-211H,24772860,-3.3585393605141824,-1.8474904644019423
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776,1.4337647495320274
CAL-51,20959075,-3.1196535578382987,-2.721335950145313
OPM-2,322968,0.7466819505545055,1.9004965927939481
CA46,984333,-2.431082434536014,-0.31983298097484003
JM-1,1242560,2.356943306915098,2.633784854614431
NOMO-1,25126798,3.9519848152055848,3.276048512942712
MDA-MB-453,5738263,2.9414099779046934,3.463384880318971
OVISE,10074640,3.3556303567674064,3.234818803072822
SNU-81,JQ-1-MK-0752 (1-1 mol-mol),4.555770786077887,1.3682852591330874
MSTO-211H,159324,-0.971759723426381,3.326084406223503
Panc 04.03,46191454,2.0071895522726377,2.0616902349234287
SBC-5,9826308,0.1778598819423294,0.537874827006588
BxPC-3,1641662,3.0109567862503654,3.54334162894228
NCI-H460,2708,4.613368759945332,5.026825376072022
MDA-MB-453,2746,1.6853152695376463,2.89929711262617
NCI-H292,2858523,3.0406792249868633,3.0308241391857407
LoVo,52912189,0.3784309245329977,2.081972329565717
BxPC-3,navitoclax-gemcitabine (1-1 mol-mol),-2.057283602704844,-1.0216398177466501
NCI-H460,9936388,2.3098343611543415,-0.026181600940465743
A4/Fukuda,176870,1.9874765150136215,2.430599565833627
LOU-NH91,49793307,0.2442451207819767,-2.227760499543574
MDA-MB-453,2945648,2.145365576847094,2.8845627463485717
SNU-449,54596490,5.440438718305218,4.7059382139366726
NCI-H2171,9927531,3.1501077196413783,4.277360636725178
CAL-51,25150857,2.2346870378683934,2.3778549876366473
YAPC,navitoclax-sorafenib (1-1 mol-mol),5.55182899322967,2.0248053934159147
NCI-H727,9444,4.415864627267573,4.079724077006897
CA46,71466578,1.7711352492213497,2.438602341328687
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.6820022323415253
G-401,11507802,0.4930201538787991,1.0053432666145918
OVISE,11214940,-0.1911189695405239,2.160858175287702
MDA-MB-453,135999136,4.2113637134750395,3.368520440931418
CA46,445455,4.357290874085763,3.9340034197711167
KMRC-1,5335621,6.052276706579308,4.356356057241165
Panc 04.03,36462,3.526332093717117,2.5267506055778415
SBC-5,56963564,-0.838635946263744,0.8377695554319767
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997,2.2345730866384073
NCI-H727,46224516,2.477743379244975,2.371715703427576
NCI-H292,11222830,1.205012148013641,1.8534645438786828
MDA-MB-453,24771867,4.091824937074987,2.839910171590202
NCI-H460,72376,-0.5460239014371263,-1.5212668299099044
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023,1.2517805521874725
LXF 289,9911830,2.045852319971143,2.652514805663594
LoVo,1242560,3.2639930925900305,3.6028588947461846
NCI-H292,6918736,3.734181331597608,-1.443485577282207
G-401,11717001,3.7897150646045863,4.137234856218563
ONS-76,46398810,2.9642978938134004,2.6071512339912006
NCI-H522,1242560,4.210520049105227,3.416472207149726
EFO-27,3081361,2.362036241237279,2.3338565769981576
SBC-5,11222830,1.4112085967579189,1.6963201351275172
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,1.9556231688998311
CA46,11213558,2.4131379110887496,1.0780253956587336
FU-OV-1,6918837,-4.1157354170673495,-2.627429557716587
A4/Fukuda,56946209,-6.395954164738885,-4.681691253756336
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745,-1.1686277483524097
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492,0.9690366945930009
OVISE,vorinostat-navitoclax (4-1 mol-mol),1.48951856204489,0.939745842622118
MDA-MB-453,navitoclax-birinapant (1-1 mol-mol),3.002333269444996,1.6331784451404558
A4/Fukuda,216239,1.5760740052804734,1.9483048471266482
FTC-133,4578,5.173307644971936,4.3578142245423415
NCI-H146,selumetinib-JQ-1 (4-1 mol-mol),0.7874306910270304,1.3973086904533114
NCI-H460,54618164,4.49670945938676,4.165994488245353
CAL-51,42642645,0.4324607401831485,0.8191548039296397
BxPC-3,24771867,1.9124988819938955,3.1148702125468106
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335,1.8783275982361203
NCI-H460,15953870,5.00315267734786,3.561525522470801
A2780,24964624,-0.4628922796959323,2.1841993232916868
CAL-51,654092,0.82886283906252,-0.1592676254064172
G-401,5281321,-2.57337969869382,-1.5417758821259395
MDA-MB-157,3634881,2.7842407118999852,3.301083683229866
MDA-MB-453,42642645,1.5292302084545462,1.0340575992915708
BT-549,54618164,4.423974096662665,4.239101021456774
A4/Fukuda,16741245,4.963846947143099,3.514528130941431
BxPC-3,44632017,0.4026385498906549,1.0936084114604967
ONS-76,9911830,2.941904202808556,2.375064356943775
NCI-H146,navitoclax-birinapant (1-1 mol-mol),-2.693365824422348,0.16962719968057738
ONS-76,4477,-0.2351585842599584,0.7193495247899839
JM-1,44493528,3.997956862382446,3.9844200972084787
NCI-H146,5702613,3.149923076768629,2.918810532121648
NOMO-1,25150857,2.063048355345986,1.6344566275647074
LoVo,24856436,-0.7244956111709783,0.3905321406672644
OPM-2,53481919,3.0492738202957206,2.774966793667277
BxPC-3,44507138,1.658490789748868,2.6387249785713753
FU-OV-1,2113511,4.466585490981426,5.432299832477921
NCI-H661,2749,0.7713739826565964,1.9325869571884404
NCI-H1623,53495165,-0.5563852526996439,1.0215727150212075
NCI-H522,6610216,4.154510920860766,4.042158615252579
BxPC-3,148198,-2.171424706341701,-3.4127211552130734
MSTO-211H,4788,5.119342350142264,5.727487781754965
A-498,1750826,-1.7479882416802337,-2.01625382557575
HSC-4,136227924,4.2199200707906845,2.7334819532241084
Panc 04.03,selumetinib-UNC0638 (4-1 mol-mol),4.963542223842957,3.182365993725565
LoVo,54618771,0.7060685526757626,1.072522710424272
DMS 273,10322450,3.6367733537116167,3.505387208540685
ONS-76,1750826,-1.6505794475434372,-1.5525459555133858
MDA-MB-157,135440466,3.174924928897617,2.168181835079065
NCI-H727,241158,6.115461447477091,3.9067679797526687
HCC1143,46398810,2.1694021244377333,2.601859503629059
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416,1.088964831256343
SNU-449,3062316,-1.3612378425924234,1.1895986909786962
SNU-449,11977753,-2.005546044599541,-1.4063172238954922
JM-1,24771867,-4.48997165682624,-1.0753998508688851
NCI-H2009,11507802,1.1556617167312242,1.7854096374199884
HSC-4,11964036,1.64347500999081,1.3949990066118585
Panc 04.03,5479543,4.112837907412102,3.7514911812422764
ONS-76,439501,-2.2755976390662163,-2.06717660174294
JM-1,54639126,4.392955654749798,2.5127281368984247
CA46,11167602,1.6890466560929325,2.137534734321635
CA46,135411,0.0331424760277949,-0.14258050446960227
MDA-MB-453,tretinoin-navitoclax (4-1 mol-mol),3.844804044479517,2.0937587988644792
Panc 04.03,11625818,5.081289492721679,4.533677376360942
NCI-H292,12001922,1.805770236255338,2.0231383755801122
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.8344387028979239
MDA-MB-453,5278396,3.602107220771141,3.4714941012852414
NCI-H522,6438330,2.681865372615506,1.8146363521843951
A-673,71466445,2.638210082463498,3.391446415881863
MDA-MB-453,25105715,3.2581724710849778,3.4852980352699667
A2780,17759555,2.3500586644289165,3.405524142354831
YAPC,124202324,3.68667481758741,2.63491712305784
NCI-H522,25227462,-0.4562280137645088,-0.05525860831640762
KYSE-70,10074640,3.109810551584267,3.092434538656986
HCC1143,5278396,2.995823973274505,3.8623360677473695
HSC-4,5479543,4.052409111099337,3.7907904890346744
NCI-H661,446155,0.1985182541705634,2.5619137186044663
YAPC,53495165,-1.0203233667221312,0.6972131348994047
FU-OV-1,11719255,3.4823701199113097,3.465379163607062
NCI-H2171,5278396,3.2627520221828115,3.094811237792568
MDA-MB-157,9911830,0.0801478348660684,2.6369744251747305
OPM-2,9911463,3.091122447781221,3.211185091192052
LoVo,25126798,3.7423562181337338,3.8404938501663275
EFO-27,9911463,4.361076045114702,3.975524956488386
HSC-4,docetaxel-tanespimycin (2-1 mol-mol),1.367923691324148,-3.038629092579725
A2780,5280436,2.9198027340920434,3.0827807371932385
SCC-9,5311037,3.6943722712183007,3.9812987871467924
ONS-76,5978,-2.168221630618191,-1.9625500205896902
A-673,44819697,-3.745571155852308,-1.090267665418989
CA46,24785538,1.2011715151517115,0.5528617391275603
HSC-4,9936388,2.361545024779824,-0.3424433328280593
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.345515398228877
NCI-H460,49793307,0.4479933662320887,-2.5127874033278106
A2780,64971,1.607646338152048,2.339871509079463
JM-1,72193861,0.5763432020354632,0.14616217542778642
NOMO-1,11625818,1.7683333213472852,3.224988510105185
NCI-H522,navitoclax-PLX-4032 (1-1 mol-mol),3.539669986895116,1.5731543644052308
MSTO-211H,11507802,-2.113337212450165,1.633891285900958
NCI-H661,53232,0.4849867031297817,2.649234513615503
YAPC,16720766,-1.1916244870670316,1.1648417342323167
NCI-H522,208908,1.8410391152152548,2.034935252854203
MDA-MB-157,5284616,2.798393493195082,2.4511551610930313
MSTO-211H,6505803,-0.0669493563910609,-0.6293099785860242
NOMO-1,56649450,3.0749194455734012,2.211567453602995
NCI-H727,9967941,3.73486297967426,3.505048737770512
SW1463,15547703,3.1824451623977312,3.032690495382841
FTC-133,24951314,1.987520160616717,1.4940835086923658
MDA-MB-157,24772860,-2.2599749907314175,-1.9142660880098732
G-401,2749,1.3663456978729704,1.1345485374999504
BT-549,16065773,1.5788570773866877,2.577440842520395
OPM-2,11955716,-2.9191891869850015,-2.093044780876912
NCI-H661,176870,2.3474624932942207,3.4704802060111963
NCI-H292,66577038,2.9683700205355765,3.0802388082806953
MSTO-211H,54143018,-0.309857947329572,0.5636843361179139
OPM-2,3634881,2.0291765129520467,2.57945253184179
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243,1.7703154293191605
A-498,44607531,1.7098722083353044,1.7986265979499811
KMRC-1,2749,2.412459730094544,2.3036149329406737
NCI-H292,57519531,1.7489075965122454,2.6201481887683
NCI-H727,11404337,0.8145711342672778,-0.25500881497688677
CA46,salermide-PLX-4032 (12-1 mol-mol),5.07380877764379,4.500811075235538
SNU-81,107985,-4.076050447844214,-3.3159689352392205
SNU-61,24785538,1.5668080683488936,0.6490876910800578
SNU-449,56946209,-2.472995255165521,-3.9140667020016418
KYSE-70,452548,2.3575041584151637,0.31870303534969074
BxPC-3,5280436,3.644569175052812,3.6201327756996227
JM-1,409805,3.649428990507172,3.7505016908080764
SNU-81,17755052,-1.02795410661762,1.5721243027109246
DMS 273,SNX-2112-bortezomib (250-1 mol-mol),0.148208176798338,-1.8674479496681655
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906,2.240671677190021
G-401,54618771,0.8582285882331511,1.1619712714719588
LoVo,4788,4.577300245187766,5.686946436655024
A2780,24771867,-2.9740519428749055,0.4011893049012059
NCI-H292,4261,1.3935441456482582,1.86326773624628
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075,1.2424746765618895
NCI-H522,2729026,3.0595997973682043,2.5049035399375557
MSTO-211H,448949,1.6774063902575909,2.169387562794006
BxPC-3,9825149,2.348819386499172,2.514767583091934
NCI-H522,44607531,1.4505766804532754,1.5056811647355863
NCI-H292,ISOX-bortezomib (250-1 mol-mol),0.5542499080925709,0.794256879668836
A-498,1285940,4.242355519484504,3.6796657811337123
BT-549,selumetinib-BRD-A02303741 (4-1 mol-mol),5.411757040622344,4.594731940967841
NCI-H661,44543605,4.030509034099432,3.8291423607901565
CAL-51,12003241,-1.2189714227076325,-1.5854881794445819
A4/Fukuda,135411,0.1560078623072997,0.06659339296455237
HCC1143,675434,4.285446752444937,4.682389270704046
CA46,11719255,3.04595311036835,2.2967564083871794
BxPC-3,654092,-0.3546902897816355,-0.23619699859748955
NCI-H292,11238147,1.7384499640365698,3.003446243350847
LoVo,285033,-2.045623665035502,-1.7495048429492903
NCI-H1623,136227924,2.959018127447204,2.994317868771534
OPM-2,5329102,0.9197947820907424,1.3276889220506574
OPM-2,208908,1.37961789198716,2.0748324701407195
MSTO-211H,124202324,2.766151060695559,2.67036181981567
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425,1.9276771309173868
SBC-5,selumetinib-piperlongumine (8-1 mol-mol),5.086049517752745,2.9777136906206945
SNU-81,55508,3.0035688840672767,2.917662571707959
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.7539577638495903
A-498,24821094,3.8657770123239574,3.008656688978698
DMS 273,6918736,-3.620580414510608,-2.090830702558885
JM-1,3062316,-0.5573937765637444,0.6971433221134433
JM-1,56649450,3.7062904943567263,2.561702300690953
SBC-5,24856436,0.2896075356546521,0.5464722279739701
BT-549,285033,-1.3520552126123144,-1.48969216527588
OPM-2,5746,0.8583790934138843,-0.3175324472723919
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449,4.290805359914206
G-401,6914657,-5.660532663542792,-4.9101296716974785
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-1.3213768915951252
HSC-4,2858523,3.1192513569149245,3.1194133243387756
NCI-H522,675434,4.236381328267226,4.502431052061612
CAL-51,25183872,-0.1080661998677032,-0.9250265493420388
BT-549,4259181,2.4625999028961743,0.34115328197226896
NCI-H522,11455910,0.4156799864056491,0.6592341276691642
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893,-0.08919507517767278
EFO-27,JQ-1-UNC0638 (2-1 mol-mol),3.1988831496339536,1.823014022054628
NCI-H460,3543504,4.388423548450019,4.378148311537788
LOU-NH91,11626560,1.802766880846386,2.0456586139596182
NCI-H522,2871966,1.782445654343025,0.11632353438573695
G-401,135440466,1.822823734742602,2.1193482147883342
A-673,10172275,4.325815901444083,2.1198063651529093
LoVo,3385,1.4948122184820352,3.846365206418262
OVISE,BRD-K27188169-navitoclax (2-1 mol-mol),1.3102218056663513,2.287458481636092
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259,-1.0480775267386269
A-673,637858,0.7164978632133837,1.489900668304639
OPM-2,4915,5.457147549775398,2.6986901469218445
CAL-51,11626560,0.7349282975065881,2.1111751690900546
NCI-H661,2729026,2.3445725854556696,2.678425042312859
KMRC-1,25126798,3.86147373401716,3.6894926545799382
KMRC-1,107970,3.035071998795665,2.3943977680156503
MDA-MB-157,16219061,1.3123257474603047,3.2960366879010756
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121,2.438178279354224
NCI-H292,erlotinib-PLX-4032 (2-1 mol-mol),3.1994790670479,2.6733064973987943
NCI-H2009,24964624,2.271229049936602,2.57183230538068
NCI-H522,7251185,1.2190943442977031,1.9213306487309338
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.462984828084814
G-401,52912189,0.0594470173160698,1.5213111728836313
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213,2.149902494334791
OVISE,702558,5.699669356311473,5.293632321212565
BxPC-3,selumetinib-navitoclax (8-1 mol-mol),-0.6113329982147029,1.8132729880936729
EFO-27,54678924,2.818156902929417,2.202136484287406
LOU-NH91,44607530,2.1348137775706646,1.990490907518015
EFO-27,24180125,3.663788732934096,3.075347106983141
NCI-H661,135421197,1.0600684669241136,2.0544567560789124
MDA-MB-157,56963564,-0.5852778857487072,0.620016677797065
OVISE,navitoclax-pluripotin (1-1 mol-mol),-0.9390281108513666,-0.2694715077292564
LXF 289,6505803,-2.367756082461904,-0.17862454853427623
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808,-1.1600641296308947
A-673,5278396,3.572368012209165,3.312692746238231
MDA-MB-453,135421197,0.8806711164351635,1.8041778140444464
NCI-H661,11396600,4.301216087095742,3.695804566976048
G-401,148124,-6.018913106580182,-3.3819921826961985
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884,2.811373036622301
SNU-61,208908,2.000237947522829,1.830314049035033
NCI-H661,5329102,2.676948448482624,2.070813987067015
NCI-H146,148124,-0.9007997951548676,-3.0650535571734077
HSC-4,446155,4.1145986724492865,2.820342387879188
NCI-H661,3825829,3.711058317012711,4.028881039175105
OPM-2,135411,1.0006691045824918,-0.028187364212477438
CAL-51,3815108,3.0623029951861396,2.944296625218334
NCI-H522,2858523,2.9817407099898676,2.857086519115278
YAPC,2708,5.2324194580289065,5.036828906146585
Panc 04.03,4917,3.7974030923782274,3.2979605505891696
KMRC-1,51039095,3.0507646213845008,2.8461919857118807
MDA-MB-157,44632017,-0.0621812067979977,1.3268083246635525
KYSE-70,613753,3.646356391333843,3.314399570058985
OPM-2,11364421,-7.162542415885671,-4.36357125522056
KYSE-70,11964036,0.6479741930424838,1.5756488939965265
EFO-27,9915743,1.432055126276498,1.3149646475966883
LoVo,selumetinib-piperlongumine (8-1 mol-mol),1.883455735434258,2.298140312588255
A2780,9935249,1.4583070792637778,2.3373824425868985
NCI-H292,25105715,3.507158893285561,3.393456316413244
JM-1,5566,2.903571956440186,2.719791832739471
NCI-H460,16722836,2.818869820371906,1.8124236091143817
MDA-MB-453,71466380,3.4268898477848784,4.402660918411226
MSTO-211H,24753719,3.2448003358152286,4.342135045406939
JM-1,637858,0.5231851777275447,0.8299821783786121
MDA-MB-453,11152667,-1.4808178636693017,-0.03967220623567901
HCC1143,44185566,2.5224843451498273,2.671235399698826
SBC-5,53481919,4.872311947173971,3.8973980586319397
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834,1.9613941384020634
LoVo,3038522,4.270533501697307,3.2435735787949223
OPM-2,5280436,1.5288125622159816,2.698447531419624
A-673,71680916,4.0499723530429295,4.322399656962529
LOU-NH91,6610355,5.077923698507978,4.6547343337700555
SW1463,10127622,-0.1211197806374188,3.0471869209764035
ONS-76,2126,3.999900921085769,4.500302423423175
NCI-H522,53301938,4.938312106360689,1.6032151115433348
NCI-H2171,3552672,1.63504499488054,2.5514682939951308
SNU-449,375860,2.655390537146391,-0.024172946815464016
MDA-MB-157,54626689,4.568687551235484,4.701784004228038
KMRC-1,5746,2.0919022066371484,1.29300225964177
CAL-51,24964624,1.6704816041215405,2.581001245217389
EFO-27,46199207,3.7203826311454096,3.2959135097619576
A2780,439501,-2.4090624878410316,-2.7129681771529124
LoVo,89183176,4.107889784939482,4.514805808463331
NCI-H661,24772860,-4.399665014096174,-1.9141753951587586
NOMO-1,46224516,2.27353152393119,2.215297243940581
NCI-H460,5281672,4.99885948312363,4.8322377799428455
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935,1.5156544096142173
OVISE,navitoclax-birinapant (1-1 mol-mol),0.2692297316447783,1.7909486863636084
NCI-H460,9967941,4.030885542149613,3.574290758938354
NCI-H292,44819697,-0.5623825720804246,0.0012381341514913964
OPM-2,216468,0.7655721379939343,1.0932080000175433
ONS-76,60700,0.0915142349819345,-0.16267294837283205
YAPC,17755052,3.2330221121257874,1.8058805284072497
EFO-27,444795,5.488221670965637,4.771912618336059
YAPC,24797083,1.6153709299916277,1.5489371459094952
NCI-H661,51039095,3.3700376717556315,2.5033305823543994
MDA-MB-453,25154868,3.2796937080857296,4.0239248790541655
A2780,decitabine-navitoclax (2-1 mol-mol),1.762746087507787,0.8321247005236279
KMRC-1,9911463,4.4126092990485395,3.7214363846776615
NCI-H727,JQ-1-vorinostat (2-1 mol-mol),2.062672486797119,1.1648025000783357
G-401,107970,2.0352708529532824,2.1492597819751076
FU-OV-1,25195348,3.3767609447508846,3.4709515884953106
NCI-H1623,11234052,4.315313421055944,4.040772317547024
MDA-MB-157,151289,0.3130009139891556,1.204863205414013
EFO-27,56973724,4.318199286965652,3.21258024376258
NCI-H460,5328940,3.322075361136407,1.5499707657098292
NCI-H2171,11964036,0.8555185627034467,1.1588473867691074
Panc 04.03,24821094,4.144896314615952,3.383269130503253
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.5552833247527347
Panc 04.03,selumetinib-MK-2206 (8-1 mol-mol),2.306008489562984,2.2884628849023394
FTC-133,5280436,3.005172717589714,3.470481949644788
NCI-H292,49766530,5.348764781206105,-0.44185349038305816
NCI-H661,selumetinib-decitabine (4-1 mol-mol),5.0553831746033815,4.33780455757317
FTC-133,219104,4.114698267906641,3.9952070750455095
A-498,BRD-A02303741-navitoclax (2-1 mol-mol),1.0685247130671895,2.4065734750160166
ONS-76,6918736,-1.0728340962982743,-1.8845326240663374
A4/Fukuda,16065773,1.900447949816596,1.9902291127311775
FU-OV-1,25126798,3.715640842708804,3.937530938475163
NCI-H460,6505803,-0.4074860596498978,-0.7120077373970224
ONS-76,44491742,4.314760532803232,4.325155534314827
MSTO-211H,6914657,-1.9341273237470331,-3.6406292600266035
G-401,136227924,2.3105932180874365,2.523215833966805
Panc 04.03,148198,-3.912302089259141,-3.1126089110875825
CAL-51,23725625,3.781531245600544,5.084257972995466
NCI-H1623,7251185,3.63742147878688,2.6243304197087425
A2780,44589607,1.4452328541597397,2.2018033986779857
A-673,675434,3.949120496105267,4.567772497360975
KMRC-1,25227462,1.6145893273286742,-0.1600146451160933
BxPC-3,selumetinib-BRD-A02303741 (4-1 mol-mol),1.732263513385207,3.5046326565029715
HSC-4,2749,1.8453067540575636,2.2773286748615202
DMS 273,6438330,2.6669951536881182,1.605440545091744
KMRC-1,44491742,6.09620831621162,4.314300171294711
MDA-MB-453,3465537,1.8912554302439897,2.424691109662392
SNU-61,156414,1.6812768260110038,1.02019527668335
YAPC,11625818,4.8006567630911094,4.122857080962008
CAL-51,9911463,4.251278022142156,3.8382327899584983
MSTO-211H,68056272,2.8034566103574825,3.7575510686172127
OVISE,9911830,4.830872688345326,2.6270317380294097
MDA-MB-453,6917907,3.1299164846836796,-4.993315113559599
SNU-449,9444,4.238096768887569,4.150574979854623
SNU-61,3062316,1.255261088163193,1.1094109111435273
A2780,11178236,-3.658526043242797,-3.605710877648948
MSTO-211H,219104,2.9811404214526136,3.984997855623202
CA46,11364421,-6.636542851208846,-4.928422409063326
NCI-H1623,3689413,0.664737487618683,0.3144051687244925
YAPC,9907093,4.959151627500645,4.169558631546442
ONS-76,19582717,4.438276624405871,4.215816869764289
LoVo,446155,3.732759169917468,2.877384528265618
G-401,5566,2.967754959970698,2.766120995203303
JM-1,navitoclax-PLX-4032 (1-1 mol-mol),0.5328133860295355,0.12072482481453198
HSC-4,9884685,0.6492053944574516,0.7377165488350366
CA46,4788,4.772802977698259,4.858630078858729
SBC-5,selumetinib-PLX-4032 (8-1 mol-mol),4.703781138829708,3.508496471352182
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.7993804007229917
Panc 04.03,6918837,-2.8853122799888085,-2.0821540333411432
NCI-H460,71466380,4.4879606530616725,4.208149293232155
CA46,25183872,-1.226882585953409,-2.3310221642999998
NCI-H146,12001922,1.0892970499924846,1.7360777696311702
SBC-5,11625818,4.225517908096314,4.314625156457272
JM-1,vorinostat-navitoclax (4-1 mol-mol),-0.3924776625427159,-0.11834196154933195
LoVo,2708,4.2308362163689415,4.881009888766366
OVISE,72193861,4.281646205908775,2.2412999774080307
NCI-H460,16720766,0.8258921674033131,0.7912005458337942
LoVo,4378219,2.040258922351895,2.3741981229428957
MSTO-211H,24901704,1.657456360567008,3.3196286474313137
A4/Fukuda,4477,0.5783674149898913,0.5466741909251289
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026,3.2889392617682223
CA46,107985,-3.181693098398671,-3.8912255742442268
DMS 273,JQ-1-MK-0752 (1-1 mol-mol),0.7328961203568959,0.9071974885970796
EFO-27,19582717,3.374407024388894,4.501671918978113
NCI-H1623,15953870,1.9962949386047493,3.580606242931611
FU-OV-1,46199207,3.737847668041784,3.2421765118004418
A2780,11213558,0.737897067491707,1.51465078484751
NCI-H460,9926054,2.081701465030928,1.93109586466676
NCI-H460,11404337,1.7201854837770862,-0.20866745514314125
NCI-H2171,2749,1.9442537074322577,1.0135278513982915
HSC-4,49846579,1.975916395804951,1.5873086066028774
NCI-H2009,56963564,-0.2763231945711286,0.5493165720088572
Panc 04.03,3825829,5.002168928220905,4.356338277356716
HSC-4,5738263,3.918173826320675,3.463013091171705
MDA-MB-157,9926054,2.0716850398098368,2.235010643557914
OPM-2,50905018,4.056598853615348,3.942846692087648
BxPC-3,9915743,0.4274244099837221,0.44944295513584703
HSC-4,16725315,4.164866459292326,4.30187766143462
SCC-9,11175137,3.431057653368815,2.695652854180254
A-673,BRD-A02303741-carboplatin (1-1 mol-mol),5.048794854025553,4.117218811467774
NCI-H146,107985,-3.379993708562796,-3.9317060308475664
SNU-61,3689413,-2.128463404187725,-0.6460520856014127
KMRC-1,9903786,4.024109374851969,2.711062843290357
JM-1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7492754152668983,0.24011889800733058
SNU-61,73707386,3.625444775073466,2.8013596968288166
ONS-76,11238147,3.0900457426442864,2.4181103391897163
KMRC-1,selumetinib-UNC0638 (4-1 mol-mol),3.730844045001738,3.1191660888822814
SBC-5,JQ-1-vorinostat (2-1 mol-mol),1.350348201689009,0.8833470448323452
MDA-MB-157,piperlongumine-MST-312 (1-1 mol-mol),0.2909221181293618,1.938474592525119
OPM-2,44607531,0.9426576866563848,1.3290710309207412
BT-549,409805,3.826135579342285,4.89661753307862
G-401,6505803,-2.085126737120111,-0.573903263713318
ONS-76,9866186,2.0020907987509657,0.9439244799066853
BT-549,1641662,3.5282995747020514,3.618656277972422
MSTO-211H,3384730,2.0695323326007387,3.127609706641075
NCI-H292,439501,-2.469830491210978,-1.9834957216742544
NCI-H2009,11964036,0.3874991337590915,1.542053320072315
Panc 04.03,9840324,5.85151623174837,5.930571247812115
NCI-H522,5311,1.356899837189567,1.1589096294098429
ONS-76,5311,1.4287655491580966,1.4401164754889617
NCI-H146,JQ-1-navitoclax (2-1 mol-mol),-2.878043275810858,0.1917989101254192
EFO-27,24775005,4.127014722833266,3.8048805287328764
NCI-H460,5278396,3.885794996406102,3.5972859856742234
NCI-H2009,23725625,3.8804106674125713,5.2793575064884575
NCI-H146,25102847,3.053262776547781,2.5784933018942575
JM-1,11396600,1.6173586604508372,2.769947554865212
SBC-5,168312962,-2.5718885882949896,2.046214652153987
DMS 273,46215462,1.755765775691153,1.4266015432301729
YAPC,107985,-3.02393363080246,-3.4975737438312673
KYSE-70,5566,3.0340425256076813,3.0199579521884403
G-401,BRD-A02303741-carboplatin (1-1 mol-mol),4.945197636740216,3.7928784521628507
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984,1.4755576818243596
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704,0.12721119369947226
CAL-51,11404337,-1.4033364127444676,-0.3296278386233897
A4/Fukuda,25183872,-2.565081518812491,-1.8639421060746395
SNU-61,3815108,2.973673139417603,2.5392465271287925
KYSE-70,11507802,1.463595053056406,1.650089778028052
A2780,10296883,3.5268945611299927,3.575051155163075
FTC-133,24797083,1.5806228477994335,1.5039566501902255
MDA-MB-157,122327,5.563359607134461,4.427248255158717
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048,0.7747356001544462
NCI-H146,4378219,1.8118272794434884,2.0042325908849294
SNU-81,54143018,-0.9079963072010888,0.7933743837553006
NCI-H2009,49850262,3.4451640543988233,3.9785817290139467
KMRC-1,54143018,1.481383467839363,0.8505877886707109
NCI-H522,11507802,0.900021964921284,0.9881281554043925
A2780,6438330,0.9178294762259074,1.7112525745144997
A-673,selumetinib-piperlongumine (8-1 mol-mol),2.5365769801397,2.6212219344255066
SW1463,82146,3.98984472956996,3.336450378190623
BxPC-3,135984461,1.8776729747018608,4.132222513641189
NCI-H2171,56946209,-6.55665845628197,-4.59067363434375
KMRC-1,selumetinib-MK-2206 (8-1 mol-mol),2.4382383240498244,2.2510957464937076
HCC1143,54619267,5.25191473393144,4.121776240724078
NCI-H2171,46907787,0.7633638606493435,1.0618195440794715
NCI-H1623,216468,3.833399887526913,3.206805092641181
MDA-MB-453,9803433,3.6839578739817935,4.519344821095074
SCC-9,11955716,-2.333323067647372,-1.2766169523655402
A4/Fukuda,54619267,3.184419267966046,3.660775674690767
KYSE-70,387447,-2.8804562370412765,-4.0028438521907255
FTC-133,135398744,6.510037604259866,6.487935025396151
CA46,2842253,3.7037662444842696,3.428131481506349
BT-549,12001922,2.460799936977109,2.0533736888400687
LoVo,107970,2.0597080136849795,2.2971683953451567
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.597037283272062
CAL-51,3385,3.064238699960593,4.035363659981511
CAL-51,375860,-0.3577134594482877,-0.025108807641430322
OPM-2,3025944,3.8735985412418943,3.909880069085695
NCI-H522,53325874,4.347038439567835,4.139684931095601
MSTO-211H,216239,0.7405720543436254,2.3701479454010563
CAL-51,9868037,3.5441777448678615,3.3944968023769855
A-673,49836020,4.096681472773702,3.3773848949173355
SNU-61,erlotinib-PLX-4032 (2-1 mol-mol),3.033607579022277,2.650757714425219
LoVo,49836020,1.6927786584323,3.1553047667588485
OPM-2,5291,3.3293230980723254,3.0281820748486403
LOU-NH91,9884685,4.047485572984955,1.0162027151751645
HSC-4,36462,0.7755986988683452,2.2965757552300756
SNU-61,46907787,2.0753699666277936,0.6098591521758031
NCI-H522,5951923,5.621144710124551,3.6992422848999484
SBC-5,445091,4.3721050746953845,4.2925605968169975
MSTO-211H,6252,0.7966303392140095,1.2397655917637356
MSTO-211H,6610355,3.5448971464264507,4.477339105365476
DMS 273,selumetinib-MK-2206 (8-1 mol-mol),1.7350778472906083,2.1467803968318333
CAL-51,15953870,3.220977372988981,3.3485806914480554
NCI-H460,25150857,3.536831166282903,2.5392729161145446
DMS 273,3854666,0.530051590236263,0.9997238074363419
LXF 289,9825149,1.6285560242869113,2.2868411045463906
NCI-H522,67156097,-2.1513446238308656,-1.5210601298012147
MSTO-211H,3062316,0.3213577633457804,1.3275162352428589
LXF 289,11485656,2.2610473771175847,2.6951425496273886
BT-549,4477,0.6326595549350394,0.5981630950578996
NCI-H2009,54454,1.843451372115344,2.7242046525282846
SNU-449,16013152,4.866412327860677,4.300927739134188
SBC-5,16115403,-4.662279180425711,-4.014619751127628
A2780,2842253,3.957240977141399,4.163288159400601
MSTO-211H,135398516,-0.6247457561994184,2.1327255435569294
NCI-H146,navitoclax-pluripotin (1-1 mol-mol),-2.9432727760472326,-1.0325891109300414
YAPC,702558,5.05880400043124,5.3625217175039435
MDA-MB-453,409805,5.496183153122164,4.822357967894723
G-401,25161177,2.410029759496817,3.3266818473785547
A4/Fukuda,3025944,3.254701794903189,3.9934175845574655
NOMO-1,126941,-2.339513844414448,-3.464286854509563
FU-OV-1,159324,3.7929038817112746,3.3242704244591605
MSTO-211H,2113511,3.4014041807223228,5.463919373581323
A4/Fukuda,1242560,1.4412010240031818,3.167625435819445
OPM-2,327653,2.4944005218311984,2.4832232684509172
HCC1143,navitoclax-pluripotin (1-1 mol-mol),0.3469367515592647,-0.5934016502487495
KYSE-70,46398810,2.5990171625416916,2.629537175155458
MSTO-211H,44486219,3.5621328730435216,4.315825532926517
MDA-MB-453,6450551,2.407686053683273,2.6508214777821615
A4/Fukuda,24180719,2.900503133545593,3.379097176850394
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416,1.856327449128675
A4/Fukuda,11234052,3.83864189929063,2.758315135068605
ONS-76,10231331,-2.145918525616272,1.4885576145757087
JM-1,11656518,1.5501827619920003,0.41520500642185054
SNU-61,ISOX-bortezomib (250-1 mol-mol),1.4968983788663748,0.7433711862605576
EFO-27,16741245,5.191473652546265,4.224284064834037
DMS 273,216468,1.1199955960897896,1.383958220291031
MSTO-211H,3689413,-2.1873545800685865,-0.4962224775774462
NCI-H727,10074640,3.0722260002613697,3.2331520592783365
BxPC-3,66577038,2.7392816080167117,2.9271966737211725
OPM-2,44489675,4.196628172603179,3.7409902788210347
A-673,1239801,2.654695998337671,3.841628787658581
G-401,9444,5.739332402240228,3.8951906931098397
NCI-H661,SNX-2112-bortezomib (250-1 mol-mol),0.017075608398325,-0.9317365484338422
KYSE-70,71466380,5.08916461895765,4.7006434732391895
NCI-H460,3025944,5.476008686130055,4.222689847869623
OPM-2,375860,-0.7230228450862618,-0.6241507500210417
G-401,262093,2.911602765721858,2.4505996519636244
OPM-2,12001922,1.1641343868089369,1.5524042707325683
SCC-9,9903786,2.6448761987997917,2.915524024316539
YAPC,1750826,2.252131937951327,-0.2920550776514613
JM-1,9840324,5.823306366003189,5.431954933490061
SNU-61,4705,2.600761934037586,2.7221642435202584
HCC1143,24821094,3.095995819095247,3.052209525914478
A-673,JQ-1-vorinostat (2-1 mol-mol),0.4793000681263289,0.4711285506280403
HSC-4,15983966,0.1445652725334258,-1.5446998060772648
MDA-MB-157,9887053,3.277628039368057,4.08809476555357
KYSE-70,969516,2.5944329315988552,3.0000947518975414
CAL-51,135421197,1.6266864976107616,1.8185082777869743
LOU-NH91,11175137,1.9157928307161511,2.71133729663812
NCI-H661,168313047,3.0111797961595523,2.2305329101554174
Panc 04.03,16659841,4.736684370351261,4.200177429207308
KYSE-70,16720766,1.38091635176305,0.738725968914311
SNU-449,BRD-A02303741-navitoclax (2-1 mol-mol),3.897294679895557,2.784702595659607
NCI-H2009,9911463,4.220122302208283,4.0479659961385455
HCC1143,selumetinib-navitoclax (8-1 mol-mol),3.081871684463836,2.510473376131811
MDA-MB-157,44491742,3.772080854170876,4.291001075056988
A-673,216239,1.7434495050319987,1.9295277874180272
MSTO-211H,9967941,1.8027522151796112,3.848040829258004
YAPC,3815108,3.3369752363492315,3.2036742857135128
MSTO-211H,73707398,0.6990065379334892,1.5926186690227473
NCI-H727,4788,5.448581481072406,5.694573731135596
A2780,9911830,1.8386970616579583,2.161786892352302
JM-1,3038522,1.6953465924304043,2.431347477798118
FTC-133,107985,-2.14591043360211,-3.2209719264842316
NCI-H727,3503,3.7902677592538265,2.4310027030697396
ONS-76,selumetinib-navitoclax (8-1 mol-mol),-1.4029292063040089,2.2773179539704778
KMRC-1,24771867,5.5206603877823275,2.113012276946103
KYSE-70,3634881,3.4536977245329363,3.230433393579273
SBC-5,119607,3.910029744126627,5.280202712743345
NCI-H292,serdemetan-SCH-529074 (1-1 mol-mol),2.3213297405207083,2.1737288295443533
Panc 04.03,5329102,2.9853977590279075,2.284386037883584
SNU-449,selumetinib-JQ-1 (4-1 mol-mol),3.9590560352886457,2.1361762891392
A2780,9826308,-0.0101157672837292,0.061840213802843484
HSC-4,135440466,2.2202939224472655,2.122282912268505
NCI-H727,6917907,-5.56846167215282,-4.97028827231728
MDA-MB-157,123631,3.9412563374531864,2.531865529113267
MSTO-211H,11640390,2.078497045728262,3.8663616944586834
OVISE,54649381,4.33420809644373,3.7437335165501207
MDA-MB-157,9868037,3.2071579521245823,3.3993366759276102
A4/Fukuda,67291369,-0.3870993856905487,0.9425012951398394
A4/Fukuda,10113978,1.900139268592958,2.501953642652518
KMRC-1,doxorubicin-navitoclax (2-1 mol-mol),-0.3990728174038296,-0.8400215127940879
A2780,46199207,2.4758344041689093,3.1939869020193457
NCI-H2009,151289,0.8401149520435854,1.2603695861150195
DMS 273,4477,0.2378478748071137,0.44917925613196674
HCC1143,6852167,2.667487538311212,2.8880857417280423
NCI-H460,5335621,5.645903220513178,4.618507873882387
NCI-H460,54613361,2.8642714411834502,0.10077359990519462
A2780,6852167,1.374383856311773,2.3544126359337003
SCC-9,11707110,2.5707994933885736,-0.27263897804153636
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831,1.921646045622869
MDA-MB-453,BRD9876-MK-1775 (4-1 mol-mol),0.1986827293321165,0.3445342791957954
EFO-27,6610355,3.735872349212987,4.496195555383436
ONS-76,navitoclax-piperlongumine (1-1 mol-mol),2.7557969357291476,1.922974356641326
OPM-2,16038120,-1.581922980476964,0.15337789116525888
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622,2.071265066397738
HCC1143,10410894,4.771687149558392,3.277984106147497
YAPC,54454,3.200830039856186,2.7836984398558746
DMS 273,6252,1.7538621935564394,-0.6157751371359186
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367,-0.8722276264600656
G-401,44491742,3.951665256591854,3.9541930175077327
DMS 273,11625818,4.382645377089847,3.805810679211167
LOU-NH91,3503,2.9647844947930397,2.402072506916499
G-401,446155,3.2535633304842144,2.4190817466831738
DMS 273,675434,4.24768091674901,4.255153474871354
Panc 04.03,erlotinib-PLX-4032 (2-1 mol-mol),4.205995552769646,3.0711756314424816
YAPC,ISOX-bortezomib (250-1 mol-mol),1.2420544087730638,0.9459619129185515
Panc 04.03,168313016,6.087789512449841,4.921603442848474
NCI-H1623,24856436,0.944997546799197,0.35643673705454026
ONS-76,ISOX-bortezomib (250-1 mol-mol),0.2723721998746015,0.721871886857887
LoVo,3025986,-0.1762115912359206,-0.7867422902220573
A-673,10184653,1.446453264453446,1.1480315459182155
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633,2.027621327166843
LoVo,66577038,2.852951614414874,3.02807328807887
NCI-H522,3136844,3.3827652175643577,3.953421611058457
A-673,3676137,4.749608800479587,4.434819157886895
SCC-9,409805,5.497565328609373,4.774057564805996
DMS 273,6918328,-1.955094157059326,-0.42439000122422277
LXF 289,4259181,0.8555931132792622,0.3757552082271057
OVISE,448949,2.233154508177948,2.0797542690544084
JM-1,675434,3.7844228868956296,4.005904477898582
NCI-H292,5566,3.044146869319611,3.225882200079175
EFO-27,227681,1.958013080406725,3.6272481674483483
EFO-27,65064,5.385038331959097,5.064590728308602
A-498,9907093,3.786767310891997,4.235079015015762
SNU-61,676352,2.4274144006766893,2.0121544275313585
MDA-MB-157,135421197,1.265960780615991,2.154162117808122
NCI-H460,10074640,3.83137833519258,3.1626173139156033
BxPC-3,46199207,2.8626203608628416,3.1143277818751285
CAL-51,387447,-3.720200693098244,-4.579596574964889
NCI-H146,56946209,-6.937271673290349,-4.4195537324384135
EFO-27,46907787,4.067144836646944,2.2893881446883038
NCI-H292,2729026,2.9142630754738037,2.846228040347157
LOU-NH91,1716436,1.3649900096390022,3.1035763282375934
KMRC-1,8515,4.713762602344707,3.8620208042211965
MDA-MB-453,crizotinib-PLX-4032 (2-1 mol-mol),2.6505270517489596,1.959466835777099
SNU-449,448949,1.5810053045793695,2.159915612970366
SBC-5,4096211,1.588189246491771,2.1072026557792523
NCI-H661,26596,-0.5563822784391794,-0.6206581975898312
A4/Fukuda,51037431,0.9928208538339424,2.9694205616211877
HCC1143,doxorubicin-navitoclax (2-1 mol-mol),-0.0488581620418106,-1.0803592342273975
OVISE,5311,2.608797421965248,1.5499717132607762
A2780,11238147,1.47132390494783,2.5733547750704626
NCI-H1623,676352,1.987229853680802,2.1657532010713973
Panc 04.03,126941,-1.1535511280443094,-2.02534345995149
NCI-H727,9926054,2.0492739470784445,2.118211995946505
LoVo,65064,4.389937632551182,4.942393338276308
SNU-449,52947716,1.9936156354056855,-0.040053833781322545
Panc 04.03,5351362,1.307383541492636,1.7488118546334186
HSC-4,vorinostat-navitoclax (4-1 mol-mol),1.9548576859286355,1.3848096212337058
NOMO-1,44493952,3.580250185381126,2.824304351622727
A-498,676352,1.77005199556574,2.2779646772248245
Panc 04.03,5280436,1.6844699655115762,3.754028456657259
CAL-51,16736978,0.375988055286384,1.8208887325844736
MDA-MB-157,54618771,3.1146330047846877,1.2941169203670742
NOMO-1,6450551,1.2307950565416117,1.1648842333366454
MDA-MB-157,tretinoin-carboplatin (2-1 mol-mol),3.238516076449109,5.1040213492188355
G-401,25105715,3.9034348367564258,3.3622826350942097
BxPC-3,151289,0.5689607060021993,1.3494104797299002
NCI-H727,44543605,4.300237824274415,4.038107235903893
SNU-81,2907,6.641268536629272,2.352612654210526
SNU-81,613753,2.2388707005796507,3.053178452186316
JM-1,168312962,1.22629450044224,0.6142028442990303
LOU-NH91,168313200,3.810508485111527,3.060279326513446
NCI-H146,3854666,1.3221451848305394,1.7384826216061189
KYSE-70,322968,3.381611542483835,3.811291644170288
ONS-76,241158,4.846225597872182,3.7786008000022404
SNU-61,selumetinib-PLX-4032 (8-1 mol-mol),1.220990708913243,2.7892648785825087
KMRC-1,JQ-1-vorinostat (2-1 mol-mol),1.4567711420543266,1.0655990764887222
CAL-51,5291,4.8235616489491635,3.7286895212886177
SNU-61,SNX-2112-bortezomib (250-1 mol-mol),-2.113975984395572,-1.528328675024025
MDA-MB-453,168313016,4.163913885489913,4.348373683242691
A-498,60700,2.2087582051541257,0.3452330765216838
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609,5.198138949312697
HSC-4,6918878,5.2813290465493505,2.8136626650635
MDA-MB-453,9884685,-1.4419247946131482,0.6484873159795144
A2780,2746,1.939184711313242,2.657058593547156
NCI-H661,148198,-4.235070372495308,-3.5396109898176222
HSC-4,54678924,3.092091974621669,2.298733066041582
A-673,2113511,4.0082027727586,5.168664322577546
A4/Fukuda,5287620,-3.30087759062066,-2.2492549379458806
SNU-449,selumetinib-MK-2206 (8-1 mol-mol),3.758556004242712,2.9095251493556367
LOU-NH91,6918328,0.1478473020386815,0.3859145911644451
BxPC-3,3385,3.820290029267426,4.237619782349901
MDA-MB-453,44185566,2.487729821066063,2.552105279274708
LXF 289,46907787,-0.1426698074457199,2.5762913000182954
EFO-27,piperlongumine-MST-312 (1-1 mol-mol),1.300459178940563,2.047694119865579
EFO-27,9887053,4.025142225668377,4.324139058716113
BxPC-3,4259181,0.1397018777458316,0.4981842544946059
SCC-9,10184653,-0.319006591471168,0.9967766917722471
SNU-449,53232,1.6560937312011326,2.801196701863979
BxPC-3,53232,2.859321527409702,2.5628415259982713
NCI-H460,71304818,2.359856693071434,2.402819898975459
NCI-H2009,11178236,-2.605718631753464,-3.0463174154571
FU-OV-1,400769,0.1189863997269066,-0.4250476836366893
NCI-H292,vorinostat-carboplatin (1-1 mol-mol),3.668554918362719,3.452199636807135
FTC-133,72376,-0.3430893294901544,-1.3141778614152404
LOU-NH91,2858523,2.98680776080117,3.010103319784635
LoVo,6918837,-3.586713596901602,-2.444739844994219
SNU-449,erlotinib-PLX-4032 (2-1 mol-mol),3.286095103916852,3.36370019821842
CAL-51,6918837,-3.0563476396929703,-2.6927755833679816
NCI-H292,676352,2.616071543582294,2.218656268580437
NCI-H522,11626560,2.464867345362881,1.4016389917431225
HSC-4,SNX-2112-bortezomib (250-1 mol-mol),-1.2345732834782526,-1.4007134012856892
A-673,11167602,2.442600782118551,1.8945147960385662
OPM-2,11222830,0.0961911151739945,1.1720257540548018
A4/Fukuda,7251185,1.076285820033946,1.6786259759723916
OPM-2,24978538,1.9225155298388676,0.13487289331071156
CAL-51,135411,0.595745817277345,0.630148061697358
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968,3.5107439178418827
HSC-4,3025986,-1.9523671858491285,-0.7427721403782285
BT-549,54618771,1.4883156908959423,1.6386006329547669
DMS 273,1239801,5.369367906855259,3.2158260395846905
SNU-449,374536,4.370390285639732,2.1986508406265703
MDA-MB-157,168313016,4.249309770188466,5.050185916986654
NCI-H522,446155,3.2752737209903504,2.4050070033351076
BxPC-3,9935249,3.9268263105803727,3.2432304656293156
A2780,16725315,3.2354385253964253,3.6317385781748044
NCI-H522,11647372,2.460433695225771,0.8250374778298603
MDA-MB-157,3689413,-1.567220624306923,-0.4776206246268933
NOMO-1,36314,1.6795260413615891,-1.513301032909586
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.12157463492564602
ONS-76,46199207,3.062888044588984,3.3028192995003405
HSC-4,2746,3.845189406581069,3.144394946739217
A-673,126941,-4.88778992999732,-3.132580088288863
A4/Fukuda,2874250,4.0164309105299685,4.452621619555723
DMS 273,navitoclax-piperlongumine (1-1 mol-mol),2.7902567268334786,0.9441592774191294
Panc 04.03,3136844,4.698465140769799,4.596936247125181
KYSE-70,53232,3.7067207893488017,2.928266198196707
CAL-51,24180125,2.8082301472193203,2.983116776859691
Panc 04.03,9884685,1.6842032304446288,1.1418043614193183
NCI-H460,11626560,2.497647926194901,1.7988470275015158
SNU-449,168312962,3.745202246753347,2.4915822618735897
HCC1143,9935249,3.8757786370374303,3.281984968692234
SNU-449,613753,3.229445182846538,3.2958010746446105
OPM-2,44491742,3.727542800888903,3.8538924080317662
KYSE-70,9936388,-4.915846401119174,-1.3625361094757453
CAL-51,654092,0.82886283906252,-0.1592676254064172
SBC-5,448949,2.9920694717704204,1.854716639139177
OPM-2,46843906,-0.5330027912440064,1.1957215921067557
CAL-51,5566,3.271951139375183,3.0387312284188135
KMRC-1,53232,3.79650380515527,2.946246962143876
CAL-51,11228183,3.6770505489909007,2.233276935944915
SW1463,24785538,0.6322996420886741,0.7325960530321055
A4/Fukuda,119182,-4.160589878424858,-2.0021870506422412
A-498,107970,3.0044685679861054,2.3644513411747186
CAL-51,11612883,1.9359641259018452,2.932744341800943
A-498,11317348,4.2355090436144875,3.538613981667371
LoVo,67291369,1.4516021942624118,2.5599384145600808
A2780,11222830,0.6433638933511314,1.2401357248602718
BxPC-3,241158,3.755569293331497,3.920327447095944
SCC-9,6610216,4.4695629784882795,4.259774632494682
CAL-51,374536,3.1977545561189347,2.569166337821826
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296,2.6939250785655755
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942,-0.6101889934251089
SNU-449,72376,1.1438392823146497,-1.44728165881536
A-673,4259181,-0.6373852614685119,-0.20911038989875297
DMS 273,168313200,2.725135044490621,2.7835642859701655
NCI-H460,9911463,4.421747687015995,3.904473157723786
JM-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.988694058348957,3.9214789308293074
YAPC,119182,-1.6155541294016968,-0.8378020817196195
SBC-5,6184667,2.5027552360756946,2.9462320574724594
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326,1.6959558467484563
G-401,2858523,3.0226653633513,2.86373260856768
MDA-MB-157,10184653,0.5581112583171038,1.5242932431159355
A4/Fukuda,19582717,0.7629696429231957,2.998438862690507
NCI-H460,53392493,4.733063337287369,2.8752713847378986
OPM-2,72193861,0.7906161175639799,0.159207833967176
NCI-H146,44491742,2.6808030102351323,4.109730109727742
NOMO-1,46398810,2.1682472320454504,1.937146851762569
DMS 273,16736978,0.9096800466601204,1.4866808837854086
NCI-H292,navitoclax-piperlongumine (1-1 mol-mol),2.359221869060842,2.1289284173880993
CAL-51,16741245,4.222373420591208,4.166286272034026
MDA-MB-157,10074640,3.629475203970288,3.1657951282370034
SNU-449,2828334,6.138780539354761,6.234527447568597
HSC-4,9823820,4.434899642824078,4.149044786888515
A-673,11238147,1.6374380314183412,2.3356778658668444
EFO-27,selumetinib-PLX-4032 (8-1 mol-mol),5.056777545277596,3.9391694827466184
A4/Fukuda,4915,4.811112690158961,2.8327582968790765
JM-1,42642645,-0.9084434189288264,-0.13794986330371103
MDA-MB-157,3854666,0.668628762558335,2.159962004385924
SBC-5,2841722,4.592516057239796,4.318801012543563
BxPC-3,2742550,6.208235416241253,3.89148218283422
NCI-H2171,168313200,1.615164123973231,2.6277175979131524
LOU-NH91,46843906,2.60442098689998,3.2678615987360033
DMS 273,54619267,3.628421853226673,3.843755491659306
CAL-51,16725315,3.2794500362302,4.132761848480891
MDA-MB-157,10127622,3.2546864424502076,3.7612036112246003
NCI-H2171,16725315,3.053630151756443,3.4518910500502176
SCC-9,9935249,4.690276947265519,3.405263095009555
NCI-H460,44507138,4.578042897326484,2.568732316657431
NCI-H1623,5282054,3.865413044747809,3.9023160172867994
HCC1143,984333,-0.0539665216618622,0.6462787680929537
CA46,selumetinib-PLX-4032 (8-1 mol-mol),4.812160149058309,3.296691941595354
MDA-MB-453,9840324,6.873328025428986,5.817376513789935
Panc 04.03,176870,4.897846724128431,3.634724727878456
NOMO-1,11640390,1.5691640408186416,2.4205560060169695
Panc 04.03,409805,5.536204895331733,5.212350929919717
MSTO-211H,71466445,2.2675767772231024,4.347081817157584
NCI-H2171,9915743,0.832341910278816,0.7320919440043664
A4/Fukuda,5281672,3.917758560865086,4.397143681598399
LXF 289,11427553,2.4541082171467368,2.7969054766600436
Panc 04.03,7251185,3.2944683029692237,2.7578225994738728
NCI-H522,9933475,1.020852520604034,1.8744929616215062
JM-1,24180719,3.5833576580940005,2.985187712794515
SCC-9,15953870,4.1491811794097995,3.7120531213942782
Panc 04.03,56946209,-4.443392589569815,-3.8581703924832658
BT-549,6918837,-1.3661230802503712,-2.1463462438486114
ONS-76,56946209,-3.559106939272703,-3.9324285937849144
OVISE,44507138,4.185704551553473,2.6196554210069114
NCI-H292,441298,3.4530013870499037,2.640737558761026
EFO-27,374536,3.468329704237433,2.507804712924252
NCI-H292,568763,1.0095796953036382,0.6314792320136872
NCI-H522,122327,3.7548997428021904,4.50982378019874
FTC-133,409805,6.0297974484260655,5.00542681738763
KMRC-1,3384730,3.706671423221143,2.7953442070401935
HSC-4,5351362,1.6988999536887646,1.4715247194970917
BT-549,448949,1.6914375683866394,2.205028279524741
JM-1,753704,3.307600856766594,3.9614586764224624
CAL-51,25195348,5.6667768045179905,3.2656298004449202
CAL-51,3025986,-1.0834382414923172,-0.8864866345343525
HCC1143,15547703,3.062266000318877,3.1128632917129835
EFO-27,navitoclax-PLX-4032 (1-1 mol-mol),3.1574015935029083,2.152260910153728
CAL-51,135999136,4.2132345103647015,3.5820701884130166
ONS-76,55283,0.3588409196586273,3.025813961039544
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.5152910800619048
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485,2.0533390016242374
SW1463,25262965,-1.5690747748042335,-1.7827218704301477
FTC-133,241158,4.091507154193835,4.046380316019096
KMRC-1,23582824,0.9449566223543509,0.9310063158078207
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086,1.0494978286282828
FU-OV-1,16013152,4.2048953133679765,4.233679957410005
MDA-MB-453,613000,0.0740651651217389,2.3878382261259326
MDA-MB-157,24797083,0.6098010922803769,1.559113779115962
NCI-H460,10074640,3.83137833519258,3.1626173139156033
CAL-51,16722836,0.8083581946159574,1.8164461331596413
NCI-H146,tretinoin-navitoclax (4-1 mol-mol),-1.851053903762128,0.8949943043753593
G-401,BRD-A02303741-navitoclax (2-1 mol-mol),3.4869097822802915,1.163324499664155
G-401,10322450,4.220475308231234,3.582436368151592
G-401,15983966,-4.354524639754001,-2.329706984181376
CA46,9887053,1.048475441216289,2.166750595605212
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035,4.408104233513147
NCI-H1623,11152667,-0.7587975819891684,-0.2462260315417485
HSC-4,11609586,5.018303752842559,2.8573472089488603
OPM-2,67156097,-3.031514601372161,-2.315861595698206
G-401,984333,0.0612358592539302,0.44248889627457416
LXF 289,9908783,5.689655754809611,5.171016072367595
SCC-9,5329102,2.2394800798474677,2.186092552309413
NCI-H661,17759555,2.3282310316349935,3.889273490688314
LXF 289,24856436,0.8419130403195528,0.2864888693758605
SBC-5,159324,3.4028835437957112,2.9106906566244213
JM-1,6184667,1.7187669889057045,2.4162344454982745
MDA-MB-157,11396600,3.7386973485738424,3.6663283978552514
BxPC-3,216239,2.4917493719892274,2.5818734251557705
MDA-MB-453,72193861,1.6700607918257404,1.7635319678475567
CA46,selumetinib-tretinoin (2-1 mol-mol),4.988677002369049,2.527581648615998
KMRC-1,9915743,1.4003501061845525,0.4166372249532169
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863,1.5430991442133992
A-673,12001922,0.9671300191794728,1.782975312478863
A-673,1323703,5.495685082034704,1.538418273874212
SCC-9,2729026,3.0647326637868573,2.6898697538004295
HCC1143,navitoclax-piperlongumine (1-1 mol-mol),1.8457079169425925,1.6645665611951634
NCI-H2171,3503,1.152076889590999,1.9629190918751491
JM-1,252682,6.042634536055517,6.469814634751703
CA46,44137675,2.206940954689562,2.743611037253509
CAL-51,11152667,-1.203722258692511,-0.5285822812589518
LXF 289,135984461,4.539632657840611,3.774553131539206
EFO-27,docetaxel-tanespimycin (2-1 mol-mol),2.492630012164076,-2.6512391705505807
SW1463,11507802,1.438199099446833,1.4061623474782605
BxPC-3,25062766,1.590701824067561,2.200207261583573
EFO-27,45279963,4.232301991437958,3.9328225722735817
G-401,selumetinib-MK-2206 (8-1 mol-mol),1.699600486285741,2.0852361737903595
NCI-H2009,42642645,0.1491359953679814,1.1138762726617868
FTC-133,53495165,1.6157050027500164,0.8423868170346489
NCI-H292,11640390,3.2514062698758015,3.6625419277345053
A-673,135423438,2.29660224903782,1.4898980545764124
SBC-5,9911830,3.21689826570876,2.7027569162390797
MDA-MB-157,36314,-4.695989096441824,-0.3122875065196838
NCI-H1623,5328940,1.639592653942716,1.4886876445938382
SNU-61,135999136,5.618921387112628,3.157605726091091
CAL-51,25102847,1.94226811064499,2.2715010805532967
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037,2.611464774403939
A2780,68056272,2.2410901197134923,3.659430090220506
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814,1.6689548247076111
KYSE-70,24856436,0.5719980221753466,0.10027314499695286
CAL-51,46398810,2.084696284876613,2.4500515319148604
NCI-H661,16720766,3.873672796747104,0.5471887931799562
LXF 289,11234052,4.719623128458786,4.423361976434731
NCI-H146,selumetinib-PLX-4032 (8-1 mol-mol),4.7955071162055,3.2823476147850044
MSTO-211H,107970,1.929708493397844,2.4823625610817968
MDA-MB-453,9929138,5.862527790185705,4.768257671690264
G-401,285033,-4.902412101243927,-2.461935896757639
OPM-2,6852167,1.7172653102666242,1.6290542036138902
EFO-27,11228183,3.371245966973651,2.57391017556353
CAL-51,17759555,3.5733302595078182,3.665054069351581
SCC-9,24785538,2.4612574042553432,2.0980283795774435
KMRC-1,11364421,1.724167601186248,-1.9710257972321177
MDA-MB-453,24748573,1.9919110400088051,2.197744864911222
EFO-27,5460769,4.47484627366887,2.973415635826721
HCC1143,49850262,3.2153342375189533,3.6942112671813043
Panc 04.03,66577038,3.1738099516277667,2.934589913780667
NCI-H661,11238147,3.129195095759777,2.906728903014561
SNU-61,6623618,1.73773822434396,2.3315020343941355
EFO-27,16720766,3.656433318818957,0.7625783678999427
BxPC-3,969516,1.4378873066513898,2.963665533660404
JM-1,54596558,3.768195826371459,4.146119226736499
LOU-NH91,5738263,3.7277759973822726,3.7313299186274764
JM-1,25183872,-4.29494207596009,-1.945863629870101
NCI-H292,89928392,1.456532385863884,1.743390334831358
NCI-H460,119607,4.735621464768821,5.21351196316808
NCI-H460,322968,5.369771337760045,4.121412424697403
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517,2.0427017262275817
CAL-51,9907093,3.7886359098281783,4.085976807599176
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,5.132598956347504
LoVo,123631,1.2882244486240189,2.278206073987345
NCI-H661,crizotinib-PLX-4032 (2-1 mol-mol),2.1767708357401188,2.1804826281892544
MDA-MB-453,15983966,1.8434310309669164,-0.1605767958187911
A-673,selumetinib-PLX-4032 (8-1 mol-mol),5.680938960321501,3.5910470032206736
HCC1143,135440466,2.588436572703006,2.487624642830984
NCI-H146,9926054,1.7480459470636802,1.8973090372183534
KMRC-1,5278396,3.6212610119500783,3.6360945817393526
A2780,46191454,-1.192769752942619,1.3943163714964206
A4/Fukuda,25062766,1.3929374396347198,1.7367089531050524
NCI-H292,53232,1.814131755875953,2.9915052808054168
ONS-76,24771867,4.286887453999452,2.1461199847783727
FU-OV-1,31703,-1.7023718917237094,-0.6082748584115845
A4/Fukuda,66577038,2.118562328013949,2.5721075642549374
NOMO-1,445455,4.303833401854377,3.6088392336654134
NCI-H2009,12003241,-1.6852069192913937,-1.143053259061735
LXF 289,42642645,0.485507292149712,0.8735427664863902
NOMO-1,46199207,2.5514936314753434,2.8489448638479944
NCI-H460,322968,5.369771337760045,4.121412424697403
Panc 04.03,5328940,2.517395347800957,1.9061779805873307
SNU-61,9936388,-6.308071034865157,-3.0579468660836455
LoVo,4261,-0.8211989197292223,1.4876434522175428
A2780,136227924,2.141563547945887,2.6753276886494377
DMS 273,11175137,1.5448586489611442,2.193767679959035
LoVo,44202524,1.5416570481285088,1.9674001179202285
HCC1143,9907093,3.794716934303189,4.189131433393849
NCI-H292,6610216,4.846288432835765,4.311655140456476
BxPC-3,11178236,-3.5754762678880567,-3.081093371830802
MDA-MB-453,5978,-2.563797038396111,-1.6092481228292848
NCI-H146,5460769,1.8747395178404,2.6621991328383934
CA46,11238147,1.5462987380530164,1.9891994937499167
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063,2.1612270646768583
LoVo,2828334,5.515630519838643,6.1405056302446175
KMRC-1,5287969,-1.8174868244268352,-1.8492263280861516
NCI-H460,676352,2.985829219207002,2.1583158322591953
SNU-61,23635314,-2.2430318809352556,-1.9960929895470423
NCI-H460,11612883,2.88158995470921,2.8339310965787683
HCC1143,24951314,0.9489239510798212,1.5344525428593385
OVISE,387447,-4.037756707187744,-3.6861787850099237
JM-1,568763,-0.4685251193741573,-0.23807242236554274
SNU-449,9907093,4.078651849005814,4.299816893564823
BT-549,53392493,1.9491955503491856,2.7297662999597327
MSTO-211H,24180719,1.9210037149309027,3.6521645951725783
NCI-H1623,23635314,-3.504391783968502,-1.44544123600223
MDA-MB-157,135875424,2.7117106005077276,3.977266797787923
NCI-H661,54678924,1.9600004323573317,2.317210567591794
DMS 273,25105715,3.6490952941772496,3.220613270518187
NCI-H1623,216345,4.517328735854535,3.8890157577118383
SNU-61,5282054,3.0015154117441996,3.3545297031173207
SNU-61,10302451,2.848073588995495,2.7913754964867707
CAL-51,16720766,0.5416929462446769,0.5274499236567375
ONS-76,BRD-A02303741-navitoclax (2-1 mol-mol),3.993242759783489,2.588316606566412
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917,0.5620315335789379
NCI-H522,46398810,2.2314734558486053,2.152330242523504
JM-1,67156097,-2.627968736143573,-2.3526384580895363
LXF 289,60700,2.2902498510351528,0.19165269984196892
BxPC-3,2945648,3.219283504871713,3.059104757077123
A4/Fukuda,65064,3.1077716650538707,4.226917277049342
NCI-H292,tanespimycin-gemcitabine (1-1 mol-mol),0.0441766051027791,-0.5234612135769199
BxPC-3,10077130,4.243605425717339,2.9529315807265544
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815,0.9506229961208501
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615,0.616754071928653
NCI-H292,carboplatin-UNC0638 (2-1 mol-mol),3.385304428653225,3.5425911761330524
LoVo,168312962,0.7059894109575258,1.8914566155251575
G-401,65064,5.209946412003188,4.49392945016885
NCI-H146,148198,-5.323171419653744,-3.7431686233175467
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739,-0.7084253099107636
A-673,UNC0638-navitoclax (1-1 mol-mol),0.924898873011094,0.901726199934581
HCC1143,2746,1.9419289545652112,3.3534495196912
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775,3.1950588009687233
JM-1,decitabine-navitoclax (2-1 mol-mol),-3.5626840909623234,-1.0521076439220856
NCI-H2009,10385095,0.2451756361843044,1.4294166006458529
OPM-2,11167602,1.1745103577473592,2.210538610028662
CAL-51,26596,-1.4638590943230956,-1.087288829134696
NCI-H460,1716436,4.318712917611328,2.9912501563020495
ONS-76,71304818,2.469307822454373,2.4622067018140372
BxPC-3,11626560,1.2674200020854305,2.018742076591515
CAL-51,104842,-3.020036586723177,-2.8002620019323676
NCI-H460,49793307,0.4479933662320887,-2.5127874033278106
FTC-133,5284373,3.681008384459256,2.4963269354554796
SBC-5,11455910,0.8715920005264659,0.9098375201409907
MSTO-211H,49850262,3.597717946429448,3.991079280250025
DMS 273,2871966,0.6484564569530932,0.21519742388778987
OPM-2,2729026,2.502425703285658,2.357134319243943
KMRC-1,JQ-1-navitoclax (2-1 mol-mol),1.5220385393532236,0.6095021487258235
NCI-H292,9840324,5.8141064790381884,5.8996716713869946
NCI-H661,375860,0.2037463104187888,0.3479160093998843
NOMO-1,6918328,-2.206625897840938,-1.3232355031311838
NCI-H522,54143018,0.2801073306793095,0.34052223915045504
OPM-2,23635314,-4.85335222903722,-2.8256359236430804
NCI-H1623,1716436,2.729344651836522,2.904371633958058
CA46,60700,-1.6899904219212585,-2.4386911261348394
SNU-81,10077130,-1.1742608263747976,3.0683417390039605
MSTO-211H,9907093,3.5779290533064856,4.208820837777969
CA46,2126,3.4622152695614767,3.8199381815356257
CAL-51,49766530,0.4609697007955676,-0.4033712171836128
CAL-51,6438330,3.884194225982375,2.1010547993443844
KYSE-70,68056272,3.571583007543391,3.6045183491586523
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175,1.3764027235498306
EFO-27,68056272,3.9995237189063784,3.7091484636647896
SCC-9,241158,3.962823581088113,4.110810314447825
NOMO-1,5746,1.3002002606442051,-0.25070809995510096
MSTO-211H,44202524,1.4972222665959742,2.211930837851912
NCI-H727,49793307,-2.322611372156632,-3.1373831033461346
NCI-H146,4578,4.154543455900732,3.9232995966173876
NCI-H522,JQ-1-vorinostat (2-1 mol-mol),-0.7689256810946783,0.7879784774747294
LoVo,107985,-3.583734032756361,-3.5412818064319596
YAPC,984333,0.9591784056691972,1.1617443176855538
SW1463,1750826,-6.63000221324875,-1.729357571338082
NCI-H1623,crizotinib-PLX-4032 (2-1 mol-mol),2.4308697458394652,1.8598996948303306
HSC-4,9866186,0.7177643600632182,0.9761384640474727
G-401,navitoclax-pluripotin (1-1 mol-mol),-1.0942323522272883,-1.3592350125078512
ONS-76,135398516,1.9151603507117831,2.1698530757142285
LoVo,11964036,-0.4950100771581299,1.1792724973944586
KMRC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.7808089870084007,1.8076577775809515
CAL-51,11964036,0.7531640395115359,1.4017578738903744
SBC-5,5328940,3.016318294707136,1.715133167446711
SNU-61,9444,4.091366887299019,3.946904381966546
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149,2.707362023146867
A2780,676352,1.788840905955693,1.962200922542766
FTC-133,JQ-1-vorinostat (2-1 mol-mol),2.666931641938378,1.127706567320719
JM-1,7251185,0.7253388444333596,1.3505793173545888
Panc 04.03,JQ-1-navitoclax (2-1 mol-mol),4.611253227928805,0.8353070720627094
NCI-H460,52947716,-4.997624319891589,-0.23207392390939355
NCI-H2009,6505803,-0.1719772058921901,-0.30485805481256084
OVISE,25126798,4.262747569123806,3.8248997823483966
G-401,54678924,1.6253720221899297,1.778916383786581
Panc 04.03,tretinoin-navitoclax (4-1 mol-mol),4.366288248143094,3.0258825544215657
A2780,135421197,1.3895584306244824,1.5779213962335206
EFO-27,25126798,3.692256603979053,4.026621734567922
DMS 273,73707398,1.2764695344106731,0.6953775110643226
MSTO-211H,10296883,3.6762481855456985,4.021936021489641
LOU-NH91,60700,-0.2604526525302556,0.3171100879578845
Panc 04.03,8515,4.900392472396633,4.08405310845249
A4/Fukuda,216345,2.739557201577506,3.199981138246793
A-673,24978538,2.0217931845087596,0.406803195878868
SBC-5,11152667,-0.3838978082878119,-0.39912562812870156
NCI-H460,15983966,-0.5601417251503862,-0.9758137648187651
EFO-27,400769,-0.0834796845468066,-0.4970498626541618
YAPC,2858523,3.168058012530131,3.0553781512161367
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596,2.0628752584716343
NCI-H2171,227681,1.8296199533038344,2.7967305662716173
NCI-H460,11455910,1.4134750909778395,0.8872450346684911
G-401,44566777,-0.9568944013200004,0.60791964441505
NCI-H292,5328940,1.2067364026743148,1.8338142083876343
G-401,navitoclax-sorafenib (1-1 mol-mol),1.5806960178530294,0.9466462039630348
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.4232305032059984
JM-1,25154868,2.919888649987432,3.8781552660468113
LoVo,44185566,1.1715497148164364,2.4058642979239138
ONS-76,54618164,4.167815792355048,4.238326351952696
NOMO-1,151289,1.0922355572005962,0.18974702799452386
G-401,44493528,4.310857122389352,4.30742296025572
KYSE-70,89928392,5.113782206339635,1.7739185431304896
NCI-H661,89928392,1.5970967591597882,1.7038034857413242
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709,-3.2379936810921857
KMRC-1,3503,2.6706031423305845,2.283435472499607
G-401,11455910,1.3171347053017213,0.6086589263941247
SNU-449,208908,2.01293579360495,2.0664363012039666
G-401,57519531,1.5783303012871783,2.1651451981723895
MDA-MB-453,11427553,2.8599395215861567,2.95219658462015
LOU-NH91,241158,4.097895358021133,4.088161374405405
G-401,24951314,0.7541386929645643,0.7920278330307958
MDA-MB-453,208908,1.869724740513474,1.9018552684685317
YAPC,46398810,3.0625661294812216,2.7788203140719245
LOU-NH91,1750826,-0.8784962447018205,-1.6710272123800707
FTC-133,ISOX-bortezomib (250-1 mol-mol),0.3351331605659957,0.5934553638117863
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209,2.97627445515626
MDA-MB-157,100016,3.517936084480814,6.379003123118994
HCC1143,60750,-4.413462787403808,-1.892418440678011
NCI-H661,selumetinib-BRD-A02303741 (4-1 mol-mol),5.5299727991020555,4.04011828942512
HCC1143,159324,3.533344711636858,3.281984968692234
JM-1,1750826,-4.271139507623605,-3.289928325980558
CA46,selumetinib-JQ-1 (4-1 mol-mol),0.1147444107016205,0.04478091608167311
A-673,11396600,2.723776149104898,3.1736281785134697
NCI-H1623,24964624,2.070631930148384,2.606582458792227
MDA-MB-453,104842,-3.389911854354977,-2.8387239615686566
SNU-81,49793307,-4.215972202332142,-3.236508340631902
A4/Fukuda,54618164,3.3817410387547575,3.724585811350426
NCI-H2171,26596,-1.7584148860978708,-2.218098229315257
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155,1.5041547258812957
ONS-76,676352,2.5309673509494535,2.2281582827412016
SCC-9,4378219,1.9931327421657885,2.857879592549582
CAL-51,613753,3.3238399640193177,3.220629213401754
Panc 04.03,49867926,4.237506736984018,4.403220990329397
NCI-H292,salermide-PLX-4032 (12-1 mol-mol),5.437042614590839,5.047148197095705
NCI-H727,selumetinib-navitoclax (8-1 mol-mol),-2.0021206675207885,2.2564633143506976
MSTO-211H,3543504,4.118160915221066,4.448922311794033
NCI-H460,6252,1.4342703041264255,0.7607886428624216
OVISE,navitoclax-gemcitabine (1-1 mol-mol),-0.8912301406187855,-1.0690658157750836
NCI-H727,3825829,4.725008182252989,4.0962982141228705
OPM-2,119182,-0.8289962289267476,-2.012617499603087
LoVo,54613361,-1.4267659732177436,0.034731390229790986
HSC-4,navitoclax-PLX-4032 (1-1 mol-mol),2.8756909366575023,2.251984549431582
A4/Fukuda,126941,-4.18863393868508,-3.0064645142813307
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089,-1.7026120378925376
NCI-H460,136227924,3.925006850615035,3.0479806284192676
NCI-H727,3136844,6.195563862298742,4.34971881480578
MDA-MB-453,136227924,2.410345496671846,3.005438505575907
SNU-61,51037431,3.7250627983577513,2.9285203410272116
SNU-61,3384730,2.3184170398790154,2.245629735457998
Panc 04.03,24753719,4.39873379823384,4.437498658439488
SNU-81,5978,-4.726956734092058,-1.7878798926942758
SNU-61,9967941,2.1294940171884043,3.2984017025056316
SNU-81,selumetinib-piperlongumine (8-1 mol-mol),-0.9226947877098262,2.0481997609353524
ONS-76,5470400,1.68546701619173,0.016616798547906722
JM-1,52912189,-1.1165299764243126,0.24263728104130297
NOMO-1,52947716,-3.339302012338735,-3.550106588152557
JM-1,26596,-2.491901301923365,-2.7398740035503915
NCI-H661,445455,5.2176896422295025,4.763603654657651
SBC-5,216468,3.330480208625043,2.843558301261338
NCI-H292,5311,1.7806932533505695,1.8801760589678327
Panc 04.03,9935249,3.3873751996630177,3.3849520090291243
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871,-0.939380062248164
CA46,25262965,-5.196703638661911,-2.9865697594339213
NCI-H460,11626560,2.497647926194901,1.7988470275015158
CAL-51,54686904,4.850424917483252,3.3484677350036884
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994,0.8844587205090303
NCI-H2171,6918328,-2.9240080597430813,-0.4367312904845973
CAL-51,3825829,3.9510679995615257,3.9492785143396527
SNU-61,65064,4.771880102821997,4.920867708773433
CAL-51,124202324,2.033990287468598,2.705281118319673
NCI-H1623,11494412,1.2552972437851018,1.8705435942470001
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415,-0.2616009993453293
JM-1,135398516,1.8505892369708832,1.365546251614549
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708,3.909510278736128
HSC-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.591026933435327,2.4874166155987654
LoVo,1641662,3.111662868893329,3.4890530962773134
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142,1.2298474114669202
HCC1143,24856436,0.4052757500096688,0.7784402518154233
YAPC,73707398,1.1307339717786768,1.5081465644654952
FU-OV-1,24771867,2.3744516407985485,2.614546704505681
NCI-H727,piperlongumine-MST-312 (1-1 mol-mol),1.950169428347768,1.9702389789368526
SNU-61,2749,1.958913212534665,1.500994771736668
CAL-51,20959075,-3.1196535578382987,-2.721335950145313
A-673,6918878,1.2344260030899934,1.6554576948266322
LOU-NH91,73707398,1.1540810865513749,1.4108346172427249
NCI-H2171,107985,-3.896160678794096,-3.4738953617548445
KYSE-70,12003241,-1.4257688129039825,-0.882967884095073
MDA-MB-453,10296883,4.2989687155614735,3.675435022349871
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266,2.213805066249736
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858,1.1718599020688802
NCI-H727,selumetinib-JQ-1 (4-1 mol-mol),-0.7236905390047186,1.6214922073187317
NCI-H661,4259181,-1.4326329693308524,0.2792735846735203
JM-1,salermide-PLX-4032 (12-1 mol-mol),5.264877641383212,4.347588202455413
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086,0.08303077777289511
SCC-9,25183872,-1.5689686359020558,-0.46570567701355736
NCI-H727,6438394,3.7246032061112553,1.3390432939806494
NCI-H1623,selumetinib-navitoclax (8-1 mol-mol),2.5972184822142004,1.9224645090889683
Panc 04.03,9911463,4.4327726522455855,3.8475749882084687
ONS-76,2733487,6.718347537986806,6.226542320434776
MDA-MB-453,25062766,1.9156877669914651,2.2838713365370267
NCI-H1623,36314,1.7259264714185265,-0.6064502979794645
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879,3.3369596332995894
MDA-MB-453,11234052,3.3366002038414493,3.763158047088635
NCI-H661,54143018,-0.94518686271758,0.5971314918425336
NOMO-1,72376,-3.881755374018637,-3.591626470014291
NCI-H1623,104842,-3.8091356035642434,-2.6080096960554844
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324,2.5194454726656543
JM-1,71466445,1.831003524042788,1.988944491421516
EFO-27,49766530,-2.657964166176686,-0.14875154257694195
NCI-H661,753704,5.093119647973415,5.005525103022
OPM-2,11175137,1.4890519960627426,1.617465894169367
G-401,carboplatin-etoposide (40-17 mol-mol),0.9786260223785996,1.5586791071843609
A4/Fukuda,5746,-1.1009867615741116,0.11623102569710321
SNU-449,44489675,3.6193477306301927,4.15317664293607
NCI-H661,12001922,2.629031416850278,1.8249727916211225
DMS 273,11640390,3.3173332454053717,2.8302784619861283
SNU-449,4259181,0.6587440570439733,0.30348777849821273
EFO-27,24964624,2.939505532014586,2.7983617370785527
LoVo,4096211,0.5868958804653562,1.9571669799557396
A2780,2841722,4.258280317113099,4.20736750262994
CAL-51,24771867,-0.5018492111736887,2.690964313545566
G-401,46907787,-0.0293884143124787,1.4958144323525386
JM-1,24772860,-4.004711239665373,-2.992987845692611
MDA-MB-453,71680916,4.8348560692055695,4.6566144812580355
JM-1,11507802,0.223918960474334,0.5269099940093078
A-673,462382,-0.040658639847304,0.4928050448132973
NCI-H661,216345,4.176204855685743,3.9184602891048605
BxPC-3,9907093,4.5613416209155755,4.2015283677977315
HSC-4,216468,2.5769925673594227,3.321520107036875
NOMO-1,60700,-1.0021705320646457,-1.382820305477687
YAPC,11455910,1.8317787914833017,1.1128795857328044
SNU-449,11175137,3.183352091664916,2.740144455498123
A2780,2113511,4.588817591987419,5.386314943555338
NCI-H146,613753,2.6314812615131222,2.9323626446018993
SNU-81,10231331,-2.370371712203436,1.4649424337524013
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109,-3.9973670474630603
NCI-H661,168313016,5.326553105852446,5.007939623284018
CAL-51,25126798,3.926975819986009,3.891973604086841
Panc 04.03,1716436,3.048029385411991,3.092890068092259
EFO-27,11625818,4.615590718074381,4.688722033306938
A-498,44495899,4.223152889477574,3.4304861717826487
A2780,3825829,2.5427924978442467,3.6303298678657665
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021,4.428025669161153
NCI-H1623,2858523,3.2758661507497115,3.0270873784749956
A-673,49793307,-5.444897343264971,-3.66300495412498
MDA-MB-453,9935249,2.561550169446695,2.8952265491371194
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954,-1.232112298618678
LXF 289,3062316,-3.851151802003845,0.5920763824511114
MDA-MB-157,2874250,4.29768331905581,3.94460243420984
HSC-4,4521392,4.744801099229743,4.438646011422241
EFO-27,23725625,5.484413053531449,5.116050371010584
MDA-MB-157,navitoclax-MST-312 (1-1 mol-mol),-3.237142139083902,0.6943931032859112
NCI-H2009,5460769,1.3316086312624285,3.008085996233358
LOU-NH91,654092,0.641619390442256,-0.1616566209107747
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,4.215420432950989
SNU-449,9887053,4.621717664819675,4.249211186068934
LOU-NH91,54618164,4.244208934703923,4.231390143690231
MDA-MB-157,24951314,0.2652102931153908,1.5215057976735489
SCC-9,4261,1.568262163612179,1.844313811174183
CAL-51,262093,2.862241975448649,2.9375601050700317
DMS 273,100016,5.677769516399485,5.319076777010979
A2780,44137675,1.3252793631369038,3.1184754324239337
DMS 273,71466578,4.37241227128359,3.3692056596933755
A4/Fukuda,1566236,1.4071330472860828,1.787489815621952
SNU-61,navitoclax-gemcitabine (1-1 mol-mol),2.2784859242088062,-1.1051906009979369
NCI-H2171,25102847,1.8897460049958847,2.524256806667343
MDA-MB-453,60700,-1.6006047446684224,-1.0928341637162517
A-498,11404337,2.25955984981305,0.3187185254569363
NCI-H2171,10302451,3.986494326049399,3.550044927786281
YAPC,10184653,0.1561987566095487,1.4089976254353835
NCI-H661,9967941,4.170813203069281,3.643529065737381
BT-549,24901704,3.7794480452342,3.581544337290211
A2780,3038522,3.0311112283818864,2.777621897494928
NCI-H522,67291369,2.1338291538877514,1.8755932585490183
HSC-4,753704,4.983094182740762,5.019169850557826
G-401,44607530,1.0217800111575093,1.6133023675339428
OPM-2,19582717,1.9960397366001383,2.864991065782852
NCI-H2009,104741,-5.941055510927969,3.6029393403000616
OVISE,9936388,2.6758567859836826,-0.3380771951888141
NCI-H1623,11178236,-2.2917099582879144,-3.055960426467935
CAL-51,5746,-0.6872762444946757,0.8365467085849508
JM-1,3503,1.2397121319894746,1.6014601115719516
LoVo,26596,-4.043483931746528,-1.0652528426286836
ONS-76,44486219,4.293725912166159,4.367983691327719
SNU-81,vorinostat-navitoclax (4-1 mol-mol),1.2655278546702862,0.5002808428506832
NCI-H460,24964624,3.5490884182562565,2.443645770491396
A2780,448949,1.9574027813966313,1.6366764393200532
G-401,6918878,1.5849207586223315,1.6989936916742137
EFO-27,123631,3.2705036111065957,2.591039827540852
NCI-H460,71466380,4.4879606530616725,4.208149293232155
NCI-H146,126941,0.4535750644224253,-2.853429739992754
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363,1.2550136129349607
JM-1,25062766,0.7257031347370316,1.4173175572865213
BxPC-3,44819697,-0.5900667288519075,-0.19065151436258898
DMS 273,49766530,-1.3487399530522592,-1.6674994214610128
G-401,6918837,-4.518653911968971,-3.479613152436751
FTC-133,25195348,4.144583358862902,3.4451994417748444
BT-549,5281321,-3.0037540013163433,-1.2169593004481567
Panc 04.03,44241473,4.425072929332434,4.842763718903191
YAPC,5278396,4.010893890545004,3.6735260275747676
ONS-76,5287620,-2.6985711183159573,-2.10853289421514
SBC-5,11612883,3.4240653421197877,2.7165053366917427
SNU-81,doxorubicin-navitoclax (2-1 mol-mol),-2.5154002454653277,-1.159240545049823
A-673,tretinoin-navitoclax (4-1 mol-mol),2.75284038442573,1.8068977529204455
SBC-5,219104,3.745930190487188,3.7401763722623484
SNU-61,176870,2.732721688120773,2.4616722096136163
CAL-51,36314,1.3238047725901672,-2.311682969950367
SNU-81,carboplatin-UNC0638 (2-1 mol-mol),2.7350455316868416,3.030150410504181
DMS 273,71751553,4.31191978803821,3.7411520828332514
NCI-H2171,400769,-1.2297634018381476,-0.8519996467342892
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891,4.91304484690648
NCI-H727,71304818,2.536891878991305,2.4061238428728875
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567,1.509415039608418
CA46,135398516,0.7680931483587626,1.340783552180095
MSTO-211H,100016,4.243846732059744,6.225818307481146
NCI-H522,selumetinib-MK-2206 (8-1 mol-mol),3.9815155524182337,2.2616220297550016
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651,2.945597389952584
SW1463,25183872,-1.2446986167158185,-0.7647875387762665
EFO-27,122327,4.8281000238128,4.754565157711458
MDA-MB-157,11222830,0.6776847499576403,1.7437899008755846
NCI-H2009,25150857,2.992056775880064,2.5319583188367822
NOMO-1,216468,1.212023833941809,1.2115413781199433
JM-1,11152667,-1.617053586455527,-2.2351047261352632
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,2.0991452880510857
A-673,25126798,3.569829443135804,3.709134884526805
DMS 273,148198,-4.27913692458833,-3.7523954740289183
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203,3.682566932473835
LXF 289,5329102,1.6667075021580833,2.062198290668337
HSC-4,53495165,1.6708694504220498,0.36697002942154655
CAL-51,969516,2.948027689121256,2.8207709938278804
NCI-H661,5746,2.052034109930783,1.280181873759532
A4/Fukuda,9967941,2.4411204768161983,3.336345615118089
MDA-MB-157,89928392,-0.9485630303355488,1.7093350691542297
NCI-H460,12001922,2.3574763109101253,2.027964489288985
SNU-81,327653,3.5323829695882267,2.85898661449989
NCI-H661,124202324,2.0891928025286943,2.73631958282659
BxPC-3,42642645,0.6313588777440967,0.8658073460601582
NCI-H2009,24772860,-3.0306018162615342,-1.7861454061945352
A-673,6610355,3.502413574243847,4.458637294543991
SNU-61,57330099,3.603690788773508,3.9828640257233663
NCI-H522,2749,2.969505400884835,1.6797673413536653
NCI-H661,57519531,4.09429699672183,2.7034073582418183
MSTO-211H,2126,4.496176254172968,4.835086337659299
KMRC-1,10410894,3.4812991400934585,3.1447672743261195
EFO-27,44237094,3.2066908421034332,2.8382127167116384
LoVo,16725315,3.2447595903434627,4.469181303130452
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552,3.747010745823096
MDA-MB-453,2842253,6.29942483998937,5.431925787372422
A-498,135875424,4.978423270774445,4.3857208394049785
Panc 04.03,9903786,4.611047286699123,3.104456151185846
SCC-9,54639665,4.512228528266098,3.3604926819798475
JM-1,24856436,-2.211637583066154,-0.5468386190384521
A4/Fukuda,5311037,4.577970147235868,2.7441264717314384
NCI-H522,66577038,3.0388231599187017,2.948234521973823
BT-549,25154868,5.818557590138654,4.406208664786157
KYSE-70,6505803,-1.025033993677824,-0.3939054965528749
LXF 289,11396600,4.152956454399736,3.747484135314331
SNU-61,navitoclax-MST-312 (1-1 mol-mol),3.0006796747399394,0.7870252958012353
SBC-5,126941,-0.8684780314881991,-2.9356770971667085
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667,-0.4924035393132826
OPM-2,9933475,-1.3895511853659537,1.5395264812652045
YAPC,11214940,1.707662344700129,2.2559276428425683
EFO-27,4259181,1.8274060730963064,0.7039582245455336
NCI-H460,446155,3.79922347841428,2.7592887627387888
NCI-H1623,carboplatin-etoposide (40-17 mol-mol),1.5186330340389391,2.8819388473647543
A4/Fukuda,3634881,2.7004024711225596,2.735499244836029
NCI-H661,1566236,3.2299922345410006,2.3536673365102954
MDA-MB-157,6450551,1.4635370045174534,2.9916307872066312
NCI-H146,vorinostat-carboplatin (1-1 mol-mol),1.5707903367584717,2.6037040669540295
BT-549,6918328,0.6487197523295809,0.43841123636397433
NCI-H727,11175137,3.085433657363398,2.7984203094365485
NCI-H460,3854666,3.1385110084048065,2.225237735395285
LoVo,44241473,4.10673515965005,4.725306634295122
G-401,10074640,2.6430496317806957,2.7016626748048638
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264,1.028380341530447
SBC-5,2126,4.14698296213378,4.557366624914556
ONS-76,3503,2.5109588721491938,2.4003291507834703
SNU-61,5470400,-1.745187092277687,-0.9929747841627736
NCI-H661,36314,-4.592945905020296,-1.0971031841723304
JM-1,451668,-4.255879556837535,-0.7019866115895783
NCI-H1623,5978,-1.0298747552622975,-1.3974641691127818
DMS 273,136227924,2.538513279360657,2.692772517556794
SBC-5,selumetinib-navitoclax (8-1 mol-mol),4.706526584593769,1.7419147685868257
A4/Fukuda,6918638,-1.9449982869755031,-0.157173142398355
HCC1143,16038120,0.5509172721588973,1.0793463972600272
BxPC-3,44185566,1.4327209520395616,2.6731639130376634
ONS-76,2858523,2.9452513130208975,3.119471061283302
NOMO-1,46191454,0.6880471005756411,0.0966893386693973
NCI-H292,216239,2.858200088172953,2.5200496189463952
DMS 273,11178236,-4.200581603954177,-3.1205120070402796
OPM-2,10074640,2.1693178922200813,2.645621588113627
ONS-76,5566,3.1751487050742804,2.9946513506119494
BxPC-3,10385095,1.8732992891777025,1.4979571187154153
A-673,crizotinib-PLX-4032 (2-1 mol-mol),0.1365223010669094,1.466869326470799
MDA-MB-453,675434,4.221225816741011,4.297898645166874
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266,-0.7505892759843934
CA46,9825149,2.310107059064329,1.4393843473047687
MDA-MB-453,12003241,-0.9610578830621354,-0.9014320595514995
A-673,613753,2.7839803669097134,2.9244420373303086
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113,2.91513999856339
NCI-H460,3062316,3.704520183651484,1.547176613868254
CA46,carboplatin-etoposide (40-17 mol-mol),0.8336753262316364,0.13088324827398684
A2780,11427553,1.40474333506403,2.0537663194658053
CAL-51,5287620,-2.338247824560234,-1.9770875305494247
KMRC-1,11640390,3.901360175468555,3.455065134211706
EFO-27,16219061,3.8100949831762296,3.5834967057479146
A2780,31703,-4.480868228272363,-2.001134708085044
Panc 04.03,135440466,2.8713092707831116,2.313468338180525
SCC-9,16065773,3.2014379284662864,2.6725351373373396
SNU-449,148198,-4.785889264279132,-3.4739412145144537
OPM-2,2949965,2.476405976050771,2.340055005151105
ONS-76,44489367,4.840464292002439,4.732371726743
NCI-H146,navitoclax-piperlongumine (1-1 mol-mol),-3.055255187933708,0.7059550508332729
NCI-H522,vorinostat-navitoclax (4-1 mol-mol),1.5182214624562833,1.0607929183123141
MDA-MB-453,135411,0.2962177293375728,0.7118522532549711
DMS 273,123631,3.074313122611396,2.1981141695609754
CA46,19582717,2.2741322004032716,2.6283300659323565
A2780,3676137,3.624330330130062,4.15789846495664
BxPC-3,11964036,0.7144816609502266,1.3005734592632683
G-401,71466445,3.182548969694367,3.198260069680641
YAPC,navitoclax-piperlongumine (1-1 mol-mol),3.667001325655349,2.1464292055214544
A-673,49766530,-3.0139632371957705,-1.4224985624852016
JM-1,JQ-1-UNC0638 (2-1 mol-mol),-2.068621419812743,0.11061564683936304
SNU-449,11609586,3.2368097564340546,3.2802071639678103
G-401,46199207,3.084348249789013,3.029798274684643
A2780,11612883,1.284093973133662,2.411341982468882
KMRC-1,2708,5.927603665606935,4.679459152128959
EFO-27,SNX-2112-bortezomib (250-1 mol-mol),1.0533662240531856,-0.8555806929589038
DMS 273,135875424,3.231864587804135,3.379918532825079
Panc 04.03,2749,3.2242301239764184,2.2648467089418824
G-401,675434,4.2282934242266235,4.16391564117728
G-401,72734382,4.843742106159305,4.243902236905888
SNU-81,72376,-4.141271855112041,-2.703823829009023
LXF 289,208908,1.975389940693236,2.0934192045712523
EFO-27,11175137,3.0704812268942296,2.968630066799813
HCC1143,16736978,2.2332113551174415,2.1399261470531807
LoVo,24821094,2.523288695365458,3.072968049909117
A4/Fukuda,10322450,2.3588003127389277,3.5352907505568005
EFO-27,11152667,1.7712187839859168,-0.21247584829919577
A2780,6918736,-1.942572837589071,-2.091685194738914
FU-OV-1,285033,0.0377877938075082,-1.5073690494251986
KYSE-70,11626560,2.028097573065789,1.8148054584497755
CAL-51,400769,-0.1641693790968544,-0.6678927620132012
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323,1.278181189799689
CA46,11507802,0.4399982092061076,0.7365974286984689
SBC-5,tretinoin-navitoclax (4-1 mol-mol),3.0928632602038575,2.9452707218380185
SNU-61,44607531,1.8838139804325664,1.2714848519202322
MDA-MB-157,135984461,1.8807242402896556,3.5578786867993997
YAPC,68056272,3.685228443179594,3.8199969127334827
KMRC-1,3025986,0.2913922358554936,-1.5857215941051837
G-401,11656518,0.9589948119457968,1.5088056357939095
CAL-51,25262965,-2.904292987251918,-1.5149259322213402
NCI-H727,31703,0.5895859224805655,-0.5419352318016979
FTC-133,3025986,2.6500554516402515,-1.1774465843524633
OPM-2,11404337,-1.9830798838769188,-0.9028229043565114
NOMO-1,54649381,4.1030759428324455,2.9076342214130677
OPM-2,45279963,2.6394525890823335,2.5840274836371164
G-401,54619267,3.6389956680017495,3.7955745229405524
SCC-9,613753,3.4469207135602904,3.1925129459376222
FTC-133,3825829,4.910712910753543,4.117400985240921
NCI-H727,6918328,2.020699769993763,0.10616521317421895
JM-1,3384730,1.783412153965406,1.455222437335669
OPM-2,5335621,3.731372916139424,4.4114236550057075
NCI-H727,46199207,3.049846279584177,3.1688390592158697
NCI-H2009,100016,6.24887408197215,6.161776925522108
OPM-2,2742550,2.8639715022070713,3.1890250366720045
A-673,56649450,2.339222019664337,3.0877985015152762
LoVo,135928012,4.12079355273469,4.121235233663509
SNU-449,46215462,1.6240369462021291,1.8798163677513264
EFO-27,10385095,0.896347771716858,1.5592722796620933
BT-549,6917907,-5.828237871920148,-4.625543192751061
A-673,262093,2.1198375376891705,2.299801695188582
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517,1.8224895463750996
G-401,2871966,-1.4998546935779766,0.14052538339583692
NCI-H460,6610355,4.949206869720499,4.2442992601089715
NCI-H292,56946209,-3.439063202171596,-3.9580299606218743
MDA-MB-453,46907787,-0.524764523127372,2.0700779117501065
NCI-H661,9935249,3.279757521015836,3.020202893243022
Panc 04.03,5311281,5.064761813982229,2.8067112762222006
EFO-27,54765302,4.904683382842226,4.37046790652698
OVISE,24964624,2.347879134584806,2.517600125038978
MSTO-211H,6918878,2.3677965777112653,3.0820477268071476
KMRC-1,1641662,3.91383049133015,3.3968864344047827
NOMO-1,3025944,3.969971169930392,3.84901412101484
MDA-MB-453,10322450,5.853812101119735,3.681087746501367
A-498,675434,6.195396019607132,4.682613548223214
JM-1,16736978,2.465148690257062,0.8334012785670636
HCC1143,400769,-0.895432113907658,-0.5463593326963114
JM-1,5328940,0.4457439228433418,1.102312226207846
NCI-H522,156422,4.012108454967305,3.324267467865531
DMS 273,135999136,4.8097980755766505,2.778076975433176
A2780,44607530,1.3884091000724437,1.5684682402915369
KMRC-1,10302451,2.629362111325239,2.8676110819002
SNU-61,6918736,-1.624439463390885,-1.6297502892568434
BT-549,135999136,1.9798336492119424,3.9158523597023382
NCI-H1623,9926054,1.7409203229588674,1.8326272313378842
JM-1,16722836,0.523497579231149,0.7802254895206139
MSTO-211H,613753,2.697490548990984,3.159791606592316
NOMO-1,16725315,4.952538276899841,3.467747631677663
KMRC-1,16736978,2.1404631421072975,2.1131220149689627
A-498,123631,3.2458168084526564,2.6337824106666727
MDA-MB-157,decitabine-carboplatin (1-1 mol-mol),3.837030982901149,4.362162760158972
NCI-H1623,24951314,1.0133274480783143,1.524258562565588
NCI-H661,11228183,4.275001578251326,2.1870736779142677
FTC-133,5479543,4.4305420476204205,3.556600186173759
NCI-H292,136227924,3.1886204590132654,3.104924706147716
A2780,6184667,2.4201329833494705,2.7693367445107757
SCC-9,5278396,3.934746070394729,3.635331258410402
OPM-2,5743,-3.6176009576451142,-1.0962279865164746
DMS 273,66577038,3.0260629384717443,2.803764221741418
SBC-5,151289,0.3068057764327633,1.1503800245009475
A4/Fukuda,44491742,3.3943913096556444,3.9597860268566505
MDA-MB-453,135928012,3.1518499848728534,3.719805861149019
A-673,2828334,5.945698490544337,5.831698891662786
OVISE,44185566,3.1371413376940724,2.5521814947003887
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849,-0.06413544514759159
KYSE-70,5460769,2.831605222646697,2.5930235491244686
EFO-27,60700,0.0275300045157078,-0.37921751909829715
SNU-449,2871966,0.0642629453363792,0.4594972166697364
A-498,135411,0.9450284346401692,1.1728609589863255
CAL-51,151289,0.6583498849401344,1.208535273763721
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.7227768172524756
NCI-H292,54454,1.5363763322568371,2.7248077515844353
MDA-MB-453,984333,1.2010378495759917,0.4465668369589198
A2780,1242560,2.8030380184252346,3.2260576400790213
G-401,11625818,3.256149300060542,3.9443665002561192
EFO-27,2729026,3.178460421270277,2.8539201981375197
CAL-51,54454,2.240351559744082,2.519208099414243
SNU-81,5470400,-5.232383325772668,-0.3508142586708198
JM-1,selumetinib-tretinoin (2-1 mol-mol),2.58796154707147,3.024122109050323
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821,-0.7022419358556188
LoVo,51037431,2.9518330914759043,2.8506199994189667
NCI-H1623,57519531,2.253772853853667,2.550789141127387
BxPC-3,6918837,-2.8801990347910045,-2.577839120875524
SNU-81,452548,-0.1759999006209261,-0.7459524697208957
BT-549,327653,2.9888914918454854,3.1974129526046253
CA46,46199207,1.8825158344658808,2.7709811992624447
MDA-MB-157,10410894,1.6628456414259642,3.1172982994790384
SCC-9,66577038,2.999012470787333,2.995603942651479
NOMO-1,6918878,0.4522523514749809,0.4293102915675562
SNU-61,5281321,-1.743716860572046,-1.312635746684673
SBC-5,decitabine-navitoclax (2-1 mol-mol),2.675632395894592,1.639055428532519
HCC1143,9840324,5.44269474449066,5.785242567281992
CA46,11234052,2.4794836109026077,2.7655379703596052
CA46,11609586,1.0102139081655188,1.4036489906996426
NCI-H460,10385095,2.2920897819597896,1.1889989647770747
BT-549,11625818,5.0921701677816875,4.409980538141361
SW1463,400769,-0.5224692496950973,-0.5814521284136828
Panc 04.03,10113978,5.097338218314276,3.5716668862631087
JM-1,9907093,3.962832886035932,3.431557369661653
CAL-51,23582824,1.0413279539794644,0.614565488100956
Panc 04.03,135398738,4.347297256699442,4.543894217658061
G-401,3038522,2.1905688095022215,2.662171084427244
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648,2.4704786760603694
NCI-H146,4261,-1.8051480987265105,0.8899272743628798
DMS 273,2729026,2.67706862921606,2.5098466908180175
SNU-81,1750826,0.9975547695410114,-1.4594428094401874
CA46,168313200,1.9493207867170304,2.6113627650124016
OVISE,vorinostat-carboplatin (1-1 mol-mol),3.460247929578718,3.0655276748322624
A2780,57519531,1.3251208810116586,2.2723213216318485
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173,0.978912141246676
A4/Fukuda,11717001,3.8123333180630103,3.659167612238843
LOU-NH91,3634881,3.4323223488487593,3.3196285407197803
JM-1,11485656,1.6613246077420758,1.4157445003788498
SNU-61,107985,-3.1587785808489297,-3.586018550744036
FTC-133,2729026,3.353273516564875,2.4787430316865313
ONS-76,159324,2.5690437216419677,3.2661427818348625
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,2.1319476510549857
G-401,9927531,4.9703255494446035,4.106566354581662
LOU-NH91,25105715,3.511519280721543,3.445165729794902
SNU-61,15953870,3.2687219409332657,3.5480865759769613
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973,-0.8354229625337856
EFO-27,24951314,0.9989426715403756,1.683442230939332
MSTO-211H,5311,0.950405781568164,1.4307870906110594
A-673,9444,4.054770941664931,3.8185478628949068
MDA-MB-453,6852167,1.219966928776707,2.7124436737974222
DMS 273,3384730,2.794672653243152,2.055406059768342
NCI-H522,24964624,3.0091798278143003,2.0536016731487963
DMS 273,6918878,0.6913807013381441,1.6036984000775638
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.330274969790873
CAL-51,5311,1.4183219405835503,1.354822172658348
SNU-449,3136844,4.333259755823753,4.470342137940256
SNU-61,10074640,3.0465009012673923,3.209947991533107
NCI-H292,5738263,3.605646843776872,3.519144195123317
NCI-H2009,135440466,0.1778924686528867,2.300011514005177
SBC-5,387447,-4.42204631831661,-3.200549274829713
HSC-4,60700,-2.3901041148359,-0.2234699368847236
Panc 04.03,navitoclax-PLX-4032 (1-1 mol-mol),3.364460655624257,2.106055689671089
BxPC-3,322968,4.585795478380971,4.152690014625493
CA46,24821094,1.9467424475066963,2.60126952902825
SNU-449,5282054,4.57557530009064,3.9131018289552224
CAL-51,11625818,4.1129054868405905,4.469424591128181
A2780,16038120,0.4203115446628392,0.6353528826189376
MDA-MB-453,44484893,4.218904183145372,3.8067646430247297
YAPC,969516,2.7207948170212894,3.0844945550337717
SCC-9,6914657,-2.6898440352771704,-3.3031863399693355
BT-549,156414,4.402880659642667,1.7146866484472536
A2780,10410894,2.69442494781606,3.0191288486365186
HSC-4,1566236,1.9723291328750472,2.5616983794587385
CAL-51,53232,2.8018516258833395,2.7777684654985966
NCI-H522,73707371,4.918377506073214,4.082979063372594
FTC-133,2858523,3.137647378022636,3.0140143391142526
NCI-H146,2949965,2.1998257096859235,2.39952376779025
A2780,5291,3.6974106280730767,3.3510994943036185
A-673,11317348,1.5484644948233677,1.669868369021111
CA46,5284616,-8.167802056045408,0.6699788538690923
FU-OV-1,9840324,7.491199941931371,5.757288403492717
NCI-H292,17759555,3.476208496969499,3.5698184643468482
NCI-H2009,6918837,-3.78935135271195,-2.4138888331350556
NCI-H460,216345,3.827300936034388,3.8227011715568064
BxPC-3,54143018,-0.804639103071218,0.8798842619558483
SNU-449,11612883,3.957753067546404,3.0401105490637126
DMS 273,49867930,4.404291499076759,3.5690614257258706
FTC-133,15953870,4.441911294632587,3.634790172624542
NCI-H522,11612883,3.3366707819202666,2.3922163983406506
A2780,9444,3.815396075990075,4.053626600990082
NCI-H460,54619267,4.901891634717457,4.136549071524936
SNU-449,salermide-PLX-4032 (12-1 mol-mol),5.474676464487576,5.075922405255782
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108,-1.0119367884509545
A4/Fukuda,4521392,3.820585335578038,4.031232406585361
CA46,5328940,1.1838617633473132,0.921118595416447
NCI-H460,452548,0.6919333948360032,0.39682693626447696
YAPC,25126798,3.983335704988987,3.9197731191625262
SNU-449,322968,4.603056923598163,4.059310770314507
SNU-61,54618164,4.021673833793196,3.925854262119677
NCI-H661,400769,-1.492892337104586,-0.6957658317743993
G-401,24964624,1.4880998129973728,1.8772784961051519
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023,5.2585987468735595
OVISE,2945648,2.8352179600513367,3.1087577812197242
FU-OV-1,JQ-1-UNC0638 (2-1 mol-mol),1.6948403130228156,1.8232830666194895
BxPC-3,984333,0.8836461068661873,1.1086947760123667
NCI-H1623,42642645,0.9313727170286358,0.921552815179753
BxPC-3,71466445,4.819923879864087,4.302862532604263
MSTO-211H,126941,-2.2791548116201987,-2.684160588269725
MSTO-211H,20959075,-3.222615813929693,-2.676377126360172
BxPC-3,16741245,5.048799679028713,3.974256253225491
OVISE,12001922,2.261742632923514,2.017216975122578
NCI-H2171,135440466,1.9220793929810305,2.2608793065686537
BT-549,119182,-0.6766164524597643,-0.29897173231537694
KMRC-1,65064,5.386842832596526,5.026882491350474
ONS-76,16725315,4.104726960292652,4.112017530076586
ONS-76,6505803,1.3937943977095182,-0.524529110250112
MDA-MB-453,JQ-1-navitoclax (2-1 mol-mol),-0.5308919352690735,0.6141449323124518
FU-OV-1,25062766,2.359728819743937,2.242238417847778
KMRC-1,5566,3.18269246163038,3.0185048887402797
NCI-H460,6438330,3.783082395235063,2.3713425537840824
CAL-51,135440466,2.9511327404143755,2.3520905821168925
DMS 273,23582824,1.3511796414129456,0.9815209402434566
CAL-51,56946209,-4.496983035262223,-4.18514735480691
OVISE,176870,4.342841287056181,2.8414320789772107
KMRC-1,11494412,2.978505743964039,1.6013507849367372
A4/Fukuda,54454,2.014078017992857,2.496246219684864
MDA-MB-453,2733526,2.894784526555574,3.820558311141736
HSC-4,11625818,4.485436042124793,4.539247134442956
NCI-H727,2733487,6.440431233061491,6.25080044858522
HSC-4,54618771,2.9865797342969564,1.579057122875087
CAL-51,12003241,-1.2189714227076325,-1.5854881794445819
A4/Fukuda,52912189,-0.8285591911559074,0.5817242995075059
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.1818957676178479
CAL-51,6610355,4.388066889778601,4.63352205238444
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448,0.24281716434347145
NCI-H1623,56649450,-0.2540238687607088,3.0949194762309786
A4/Fukuda,9444,3.1818692272898423,3.7792151537753575
NCI-H2171,55508,1.786136919471965,2.6748725980059906
NCI-H522,9840324,6.2981118504366735,5.671593960815186
DMS 273,409805,3.6932334728164826,3.9198164496902814
SNU-81,selumetinib-UNC0638 (4-1 mol-mol),-1.1313432157917445,2.6480666554215433
NCI-H727,16722836,1.5817712487099789,1.5608736385515387
HSC-4,selumetinib-decitabine (4-1 mol-mol),5.3885261906416275,3.8588876817570292
G-401,5281672,4.259815588040996,4.337695413221004
FTC-133,4917,3.819256860929221,3.1268121500130395
YAPC,selumetinib-UNC0638 (4-1 mol-mol),2.613021216315863,3.069825091942464
JM-1,10113978,2.290370569955518,1.3895351759294632
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946,-5.196622515241971
EFO-27,675434,4.38679148408465,4.491452069125862
SNU-81,5460769,-2.0941921209529575,2.697683151896107
BxPC-3,5282054,3.885649252328735,4.0631654531065555
OVISE,6184667,4.390472676016808,3.1538649370821985
G-401,16659841,2.2879294183156396,3.1670518475186644
HSC-4,19582717,4.479728463380205,4.261345135590442
KYSE-70,1750826,1.0050628158627442,-1.1889081067368918
LOU-NH91,135659046,3.4412725013745336,3.8443283133853057
HSC-4,11396600,3.0766488056466104,3.8389584736039044
KMRC-1,11964036,1.816670768699429,1.4439078637035345
MDA-MB-157,decitabine-navitoclax (2-1 mol-mol),-2.3403643839095607,1.810681806698315
HCC1143,54618771,1.714955024233068,1.663148292071494
A2780,8515,1.754639935244518,3.587212528896402
FU-OV-1,36462,2.321134275550796,2.284076564963586
OVISE,selumetinib-UNC0638 (4-1 mol-mol),4.700379518419309,3.165171841401039
YAPC,216345,4.822006863531136,4.088915678935601
ONS-76,tretinoin-navitoclax (4-1 mol-mol),3.585528237924169,2.65634700106532
LOU-NH91,72193861,1.0473212139197163,1.9519062744511182
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426,1.9982852502337167
CA46,54618164,3.845436645537388,3.489974671052451
NCI-H292,446155,1.4424758906582096,3.049628328564194
HCC1143,9936388,-6.988875343339418,-1.3341548086575683
NCI-H727,9907093,4.262034183201205,4.198955272174827
ONS-76,126941,-2.856353430413947,-2.6392401721108034
A2780,11455910,-0.8495199814745813,0.5525686903082027
A2780,73707398,0.6651600447827565,0.9101013158615301
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561,-0.4562988523511482
MDA-MB-157,24856436,-0.6830375019554852,0.6852645480367129
LoVo,1750826,-1.736017877496402,-0.6358769981171475
NCI-H146,49766530,4.81095512251176,-0.7270743403286404
HCC1143,409805,4.31745443409651,4.7108184688414445
OVISE,159324,4.206537691518507,2.9761151748577346
SNU-81,10302451,3.60256279960024,2.6306588691929362
EFO-27,5282054,3.999430083075576,3.881247070143547
LOU-NH91,4917,3.4124252266322297,3.314284977440612
SCC-9,5328940,1.568072217369216,1.6404941671629558
OVISE,637858,1.8122421616924396,2.125866026811527
NCI-H2171,44607531,0.7654225162387793,1.4042513852132636
SBC-5,7326481,1.449700392659346,2.93322459600888
LXF 289,9907093,2.975231625485398,4.4175081181314795
G-401,SNX-2112-bortezomib (250-1 mol-mol),-1.620175957239239,-2.14384360410446
NCI-H522,navitoclax-MST-312 (1-1 mol-mol),0.9315063640095164,0.6226956867926772
KYSE-70,159324,1.7590392520862297,2.9710189977306696
NCI-H2009,3025944,4.548991530576528,4.331768766972514
SNU-81,135398516,1.5373988209241822,1.6966958220639827
A-673,9911463,3.7053308577681583,3.4842094887805435
CAL-51,9826308,0.5677925602140103,0.5291694843738105
SNU-449,10074640,3.65403010435808,3.2902865056828756
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273,2.9861942470798097
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687,-2.053502703417683
JM-1,11213558,1.11781575024048,0.8674214172810271
FTC-133,navitoclax-MST-312 (1-1 mol-mol),0.3680672721218185,0.6354259628190219
DMS 273,11396600,2.9821670224503025,2.9398531435656654
CAL-51,2742550,4.689941422286605,3.9082364430881644
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384,4.914291693192848
NOMO-1,24856436,-0.4465471145990737,0.14207596723551214
BxPC-3,54454,2.2110977916594945,2.3172681384622833
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302,3.9833660728003504
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838,3.8639979523908106
LoVo,54678924,0.9602640778132784,2.102629315683417
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853,2.2541447696506545
NCI-H460,9911463,4.421747687015995,3.904473157723786
CAL-51,3062316,-2.5625958708444205,1.4752711937967136
G-401,11404337,0.5096427987118028,-0.8137176903161131
A4/Fukuda,107985,-4.34456564276242,-3.637576086713992
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323,-1.5437188742536763
SNU-61,9956119,3.7156714580567063,3.169318961259868
FU-OV-1,navitoclax-gemcitabine (1-1 mol-mol),3.0788972572820597,-1.2820817043872967
EFO-27,53301938,6.290465616373669,2.160646245591255
NCI-H727,17759555,3.180616959518291,3.6919371340639717
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224,2.543782237593609
SNU-61,44819697,3.53302657640718,-0.9095957616380826
FTC-133,16065773,0.3113531910395277,2.654600605611261
G-401,tretinoin-navitoclax (4-1 mol-mol),3.928321185847307,1.7988853587950717
HSC-4,navitoclax-pluripotin (1-1 mol-mol),0.2476370471109345,-0.6718273477012611
NCI-H2009,107985,-3.3237358160703843,-3.1124162705754337
NCI-H146,3676137,4.978597159303883,3.9238324432120795
NCI-H146,16065773,1.505871551892472,2.372800169846424
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.763410338010364
NCI-H661,60700,0.4833445990508663,-0.516287106906092
A-673,selumetinib-tretinoin (2-1 mol-mol),4.294042915691989,2.9756064067670507
MDA-MB-453,44491742,4.088527945953042,4.258452295555726
NCI-H661,2945648,2.4705894827529984,3.0156699365474986
FU-OV-1,12001922,2.2107336164209586,2.1124978053346664
SNU-81,serdemetan-SCH-529074 (1-1 mol-mol),1.2075198291977594,1.8666168558033809
FTC-133,168312962,3.97521401805193,2.5276365308100406
NCI-H2009,24951314,0.5822698862930126,1.6397346378900741
Panc 04.03,3552672,4.635312487107652,2.7451155825370366
HCC1143,16725315,4.684699585721338,4.384566818555367
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208,2.026151310599852
A4/Fukuda,67156097,-3.3575882698535526,-2.162676908127393
NCI-H460,44507138,4.578042897326484,2.568732316657431
BT-549,262093,3.1295246575488354,3.011048130548695
A-673,BRD-A02303741-navitoclax (2-1 mol-mol),2.626339202884455,1.2450059615477047
LOU-NH91,23635314,-2.2216361010230545,-1.9435404833838632
HSC-4,11485656,2.41592786996926,2.328619762896018
Panc 04.03,2858523,3.1704472292667245,3.098413969809079
CAL-51,31703,-2.726607914110417,-1.129962075317515
SCC-9,11485656,3.6663619913543446,2.480057681948826
EFO-27,11234052,4.354926990140025,4.196363127854343
NOMO-1,11977753,-1.9426292333262003,-2.3420317091445657
NCI-H146,5280436,1.6778415991784894,3.0186361892987854
SCC-9,44589607,3.476138487776652,3.0021097855501764
YAPC,1716436,3.308380745751715,3.128421835028795
MSTO-211H,72376,-3.945669301292739,-1.789990254140327
CA46,6438330,0.8057128440407828,1.022628721887499
SNU-81,46907787,-1.0582449369350613,0.8497747962206339
ONS-76,53232,1.9476307600046912,2.7259519411733835
SCC-9,51037431,5.108150298111964,3.0164093334254742
SNU-61,11719255,3.5581483316812275,2.743132247535536
BxPC-3,serdemetan-SCH-529074 (1-1 mol-mol),1.9726746361730008,2.19326429321365
NCI-H522,8515,4.67214972936148,3.5896057704493556
A2780,104842,-8.58016789938804,-3.7660439057362343
KYSE-70,56946209,-4.444419695204879,-3.9337909752127906
NCI-H2171,46191454,1.782184086758524,1.131900252751098
NCI-H292,54618305,4.4370648491662195,4.604670601891244
A-498,16725315,5.296109915632034,4.336675353173255
A-498,11494412,3.741733086313002,2.053018537814951
JM-1,36314,-7.745176622378906,-2.824562942454804
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082,1.6570627383064072
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158,2.1241489376114204
A-673,erlotinib-PLX-4032 (2-1 mol-mol),2.801712278221697,2.9843761078630267
BxPC-3,72734382,5.457836982387995,4.874842679117772
NCI-H2009,72734382,3.739945681050146,4.847244252969878
CAL-51,65064,3.306239750209062,4.720731465660336
A4/Fukuda,6252,-3.645065834912594,-0.924936790657599
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394,-3.7135027134228813
A-673,36462,-0.225010248526114,0.9071775845321802
BT-549,25195348,2.629764497852918,3.3838217555735604
ONS-76,3385,3.2517912405561784,4.18589240792605
A-498,73707398,1.745059470984177,1.7008495243375106
A-673,56963564,0.0212663307031236,-0.11712331436007205
NCI-H522,984333,-0.7488997443424653,0.4564096440835017
NCI-H292,452548,1.0483210578903834,0.722563862963757
NCI-H661,57330099,4.147264508988866,4.343388462728439
KMRC-1,11167602,5.704956856257104,2.7393831418452828
YAPC,25150857,2.3485140693919178,2.58815646277863
LoVo,6918878,0.5506920931363443,2.6570520007642613
LoVo,5282054,3.3404837473565077,3.8186730040222856
G-401,445643,3.8388087856424,3.9503152278507283
Panc 04.03,31703,0.9238663549391216,-0.5034151969079506
KMRC-1,25150857,2.932634990579502,2.4395501022117667
LXF 289,9903786,1.8485652979864533,2.8431950459485233
MDA-MB-157,navitoclax-pluripotin (1-1 mol-mol),-3.540221681232844,-0.8688192769606776
Panc 04.03,25227462,1.6849134644206611,0.4783420927110607
LoVo,5328940,0.1711764774474706,1.7152324186752992
SNU-81,49850262,-1.5447601433950633,3.186049677588328
CA46,46215462,1.3062506059575565,1.082235748685776
MDA-MB-157,219104,2.454471278072077,3.880902917186342
MSTO-211H,168313047,1.6297190097298295,2.4274679281612306
NCI-H522,16722836,1.5816295407965617,1.2873473411046186
OPM-2,54626689,3.88605573030338,4.125925149664962
DMS 273,60700,-0.3389173956036069,-0.635978483181397
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876,0.9324220248236941
SNU-81,9826308,-1.744878476856413,0.013563671940992674
NCI-H661,selumetinib-PLX-4032 (8-1 mol-mol),2.9532845148669495,3.9538856580519304
NCI-H292,72734382,4.432039940054941,4.591780962335807
NCI-H661,11507802,0.3336368123539006,1.4833463852133593
Panc 04.03,676352,2.180457258433582,2.254926898196764
FTC-133,322968,4.798855030018761,3.90131817645957
G-401,16720766,1.0481135004094,0.12933243555851814
G-401,462382,0.38796721763981,0.5592109203194876
MSTO-211H,25062766,2.0532887481804605,1.9050197109587108
A2780,16736978,-0.7643928517553599,1.2929873832901335
NCI-H727,2729026,3.015864992302643,2.7354221193793196
CAL-51,135440466,2.9511327404143755,2.3520905821168925
A-498,selumetinib-MK-2206 (8-1 mol-mol),1.8815723158535835,2.5739148830181358
BT-549,72376,-0.6560931555152002,-1.3861215333570716
A-673,9933475,1.583729012108943,1.5229997861188846
ONS-76,navitoclax-gemcitabine (1-1 mol-mol),0.9931716655175384,-0.8698471715471612
EFO-27,135875424,4.6207788215281465,4.093997169876044
A-673,24785538,-1.1944412082957694,0.6320751813392524
CA46,135659046,2.986085914123542,3.2556424527573187
CA46,3038522,1.2076902647573031,2.5793837088035745
MSTO-211H,54626689,2.3486455994654767,4.411213806242053
SNU-61,44241473,4.262106100814371,4.5659049177715225
MDA-MB-157,25126798,2.9199314308838327,3.850840003056557
SNU-449,10410894,3.985550363358928,3.4669570318964764
LXF 289,53232,1.5859701947912777,2.806658876758695
ONS-76,JQ-1-vorinostat (2-1 mol-mol),1.13707340055611,1.0529355412268127
DMS 273,11234052,4.3748762471871725,3.2677241643341626
A2780,107985,-4.859396565896689,-3.72310619135426
Panc 04.03,44202524,4.489701680422056,2.885422896978989
LOU-NH91,44185566,3.062522771292805,2.755102244731791
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144,2.3556009646422957
EFO-27,36462,3.079082429258617,2.4383102195015356
JM-1,24821094,1.723225199642946,1.8978792831169573
KMRC-1,216345,4.164305633353381,3.5968415029319165
NOMO-1,168313047,1.7455342513633885,1.848059722825416
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822,3.250016904785271
NCI-H522,5282054,2.516149277526254,2.8765773156987184
SNU-81,26596,-2.2143193215677925,-1.4993529169369397
LOU-NH91,135875424,2.9424536382603215,4.056770319353838
HCC1143,446155,3.993343592958968,2.856786139752915
NCI-H1623,selumetinib-piperlongumine (8-1 mol-mol),4.451549095180413,3.1810965327906064
LXF 289,3081361,2.235375481166719,2.5133043001962836
Panc 04.03,6918638,0.956445062850862,0.7667319952888769
ONS-76,46907787,2.0367347893242247,2.076984933036158
FTC-133,5470400,2.075616738071143,-0.0740982928172154
SNU-449,9884685,0.40134732620175,0.6103119209226681
FTC-133,44566777,0.1715240988601806,0.6718616879711796
KMRC-1,9911830,2.7576147713752532,2.55929232278167
LoVo,navitoclax-pluripotin (1-1 mol-mol),-2.104287475086767,-0.5436380098376118
SNU-61,119607,4.552023022199627,4.931462620120555
FU-OV-1,2945648,2.6612648927829348,3.003454698678054
CAL-51,5282054,3.552468823116285,3.71830076929801
A-673,1750826,-4.326827801164573,-2.46891460170165
NCI-H661,23582824,0.4459994130921247,0.8551822075223648
A4/Fukuda,208908,1.6750686900112284,2.2475467643455103
LXF 289,24180719,2.719444673565486,3.788278121576781
MDA-MB-453,11647372,0.3935032395331521,0.915686450022807
NOMO-1,54454,3.4949720971193083,2.0645793885852424
SBC-5,1750826,-0.5333690682178334,-1.1873163436224698
SNU-449,11234052,5.346874708028275,4.212958410497251
LXF 289,159324,2.685439807189008,3.430285436308751
A-498,11964036,1.806054574855834,1.753631149417406
CA46,SNX-2112-bortezomib (250-1 mol-mol),-3.5188600200549507,-2.9577080150471873
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.9491254908417945
NOMO-1,11178236,-2.492998231075174,-3.315531697065035
BxPC-3,3503,1.5238678808710824,2.6017219866425934
A2780,5281672,4.494440141018236,4.29125707025898
NCI-H460,57519531,1.7606196796007008,2.336534917562245
NCI-H146,3038522,1.5824622735127496,3.0061202440755905
NCI-H146,alisertib-navitoclax (2-1 mol-mol),-3.5747410805145425,-0.7859544294249186
A2780,7251185,3.0282253021168835,2.0721170544921823
NCI-H2009,54143018,-0.2798924220132643,0.6421702936995679
NCI-H661,navitoclax-pluripotin (1-1 mol-mol),-0.6328260588885871,-0.7184933059974642
A-673,50905018,4.224820228350104,4.063595497450401
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557,0.7759088895175645
A2780,11640390,3.511086163886132,3.217662100410142
NOMO-1,984333,-1.7512214516120577,-0.23243177262510517
NCI-H292,3062316,0.0480521305272509,1.231669364625244
NCI-H1623,25183872,0.2518729007636168,-0.45251044194550977
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623,2.209683329486286
DMS 273,11647372,0.2469617170644157,0.8086474614315113
KMRC-1,12001922,2.9414276180440884,1.9379445206434804
A2780,54143018,-1.3409986451592475,0.5227004046052968
YAPC,49793307,-4.348408449857898,-2.5535941222791014
CA46,1716436,3.005257864158129,2.456697379555122
HSC-4,676352,2.328446260179327,1.995113195694444
LoVo,erlotinib-PLX-4032 (2-1 mol-mol),1.656921727064621,2.789576216314799
YAPC,12001922,1.7591466639310227,2.0149552520442255
MSTO-211H,5460769,-2.0887143253822615,2.41821953910237
CA46,3384730,2.283076300956678,1.5812060293334746
JM-1,9911830,1.0886367976495992,1.9117159261085226
BxPC-3,1242560,2.823718248478356,3.6260171313949523
G-401,44237094,3.2290132612915325,2.3745846825686003
BxPC-3,16736978,1.696086021540879,1.5345044623484896
SNU-61,46191454,1.739312628335972,1.347340933093213
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763,1.8987620636375595
NCI-H460,5329102,3.240160570329804,1.9972791545474349
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.110798646901794
LXF 289,216468,2.2889797638929683,3.4025099436200956
SCC-9,44819697,0.1293575980749295,-0.23934411629489205
Panc 04.03,675434,5.243078667682196,4.527106481036776
HCC1143,135398516,2.188515967576281,2.208403106716943
ONS-76,25262965,-0.7369683376858831,-1.2995693192245832
A4/Fukuda,53392493,1.8640822641046917,2.0165513711947054
A-673,2130404,3.217416760546526,2.4150526678365334
NCI-H661,72193861,0.3965882674238952,1.7228515212015125
CA46,119607,3.9558807366301374,4.419621636610459
CAL-51,24856436,-0.3083697359271743,0.5019823173921183
NCI-H2009,2828334,6.796615650463657,6.253461888121345
JM-1,135398738,1.1596934849395544,1.88013318010726
CAL-51,49793307,-3.2015156477281193,-2.7094002614538955
HSC-4,10410894,2.7401570440851155,3.057507988457577
KYSE-70,46843906,3.5210263801871498,3.081261064919865
KYSE-70,11178236,-1.2639965798928303,-2.699214322017017
EFO-27,6610216,4.772563131438148,4.40877474318588
JM-1,135659046,3.550517545140938,3.258949490380192
A4/Fukuda,3136844,3.333855932915555,3.6233635279479666
KYSE-70,53495165,0.5494520653774981,0.5870116386457129
EFO-27,9926054,1.857839666788878,2.1378108042546664
NCI-H460,16741245,2.175171044948558,3.813762437549562
NCI-H727,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.2513080779268564,3.9606330619401247
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496,-1.2029008591203483
NCI-H661,107970,2.2398777867932473,2.3939200030249115
LoVo,selumetinib-decitabine (4-1 mol-mol),1.6918156459461149,2.5110403959211403
SNU-61,51039095,2.128467827492616,2.9730581268860488
YAPC,104842,-2.4249346234244302,-2.209454873676323
EFO-27,11364421,0.0539420857608272,-1.014790107879709
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485,2.499962200300729
HSC-4,5284616,2.67117659303102,2.860495835232426
NCI-H146,UNC0638-navitoclax (1-1 mol-mol),-1.9432589760731351,0.7099517311522564
KMRC-1,100016,6.458679548763862,6.134630876325548
A2780,JQ-1-MK-0752 (1-1 mol-mol),0.9266829250462012,1.3532935413258684
SNU-81,UNC0638-navitoclax (1-1 mol-mol),0.5211429629753735,0.9656530646865095
LXF 289,10184653,0.2846387514020494,1.7854724712169046
G-401,docetaxel-tanespimycin (2-1 mol-mol),-6.677172451643826,-3.880591280195225
ONS-76,73707438,3.6763163562039103,3.885762048086834
CA46,10113978,2.0547387812543425,2.2330942136958756
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923,4.115429719314188
MDA-MB-453,9444,3.890114397090033,4.051463540805497
DMS 273,462382,0.1050500144131629,0.6696358157782138
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872,1.7417827704634132
SNU-449,327653,3.836895463512291,3.314847709951775
JM-1,4917,2.618606210388543,2.604539598981373
A-673,7326481,2.3948672158707027,2.918409495493859
LoVo,3543504,4.109477120593384,4.3420248683002125
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837,-2.010386639042986
FU-OV-1,322968,2.943455676205593,3.9222964304683035
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.808898676901501
NCI-H522,10172275,5.332939953657848,2.2842212398098405
FU-OV-1,11175137,4.687876560675478,2.775965655709165
NCI-H292,702558,5.809534673466565,5.3598872107628495
JM-1,UNC0638-navitoclax (1-1 mol-mol),0.2019375485573805,0.04274978242646563
FTC-133,4378219,2.0024564120700874,2.627637822731951
A-673,322968,2.685664332943325,2.6964624831906523
A4/Fukuda,11175137,1.0544671313881684,1.91049395729755
NCI-H522,9907093,4.234502914187168,3.8724656444866645
NCI-H460,73707398,3.251551904382877,1.5624101938086126
NCI-H1623,11625818,3.770410958253076,4.33600868378338
NCI-H2171,3384730,2.17478810564445,1.7751455748151963
EFO-27,navitoclax-gemcitabine (1-1 mol-mol),2.157503731341055,-0.8934831806682232
BxPC-3,135398516,1.0474106677719497,2.0013839709518084
YAPC,6852167,3.757016833172803,3.091596129787463
HCC1143,11178236,-3.0622306456236728,-2.8573932391949484
LoVo,168313047,1.791039731088859,2.468023614138253
CA46,9915743,0.7447060154867644,0.1525760120583273
CA46,16065773,1.8844207098737984,2.1456014406842567
DMS 273,2749,1.7681499736943271,1.3399371146780095
OPM-2,9549297,1.1861201303789202,1.6281264725048188
MDA-MB-157,selumetinib-PLX-4032 (8-1 mol-mol),5.042710602125305,3.363667715060314
G-401,3136844,3.887156631896907,3.6476894643099627
NCI-H727,24901704,2.771852034083143,3.181093460348632
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913,2.332144358704254
ONS-76,36314,-4.67770988102335,-1.40093569590053
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356,0.39646982125216845
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401,-1.1924119251502616
NCI-H146,54618771,0.1782763900918093,0.8769997592629467
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514,-0.780640038104143
BT-549,1750826,-1.15792790160721,-1.8376344676657195
A-673,4521392,3.83212246390289,3.971519290194792
A-498,10127622,2.6897842830613934,3.89268512010622
NCI-H146,24951314,0.0243539025761212,0.9503991022787136
LXF 289,11404337,0.1273620702572638,-0.08329968660560973
CAL-51,72376,-2.938334648898351,-1.8949503684414677
HSC-4,56946209,-4.10163917558625,-3.909057971077143
OPM-2,11719255,1.0053781432887028,2.4772416139396913
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276,2.869375207090499
OPM-2,54765302,3.66991118627716,3.560486745334552
YAPC,107970,2.510985201601563,2.2729601984693035
A4/Fukuda,6505803,0.0348674492980193,-0.6637863958575391
NCI-H146,421610,3.280213272702812,3.0439784192429427
CA46,10427712,3.800630662833656,3.6955252349807988
Panc 04.03,42611257,4.903884607697216,3.6367102179495983
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254,1.6131101908150567
SBC-5,54618771,0.9612938071948806,1.3512284126293068
NOMO-1,44819697,-3.3724853213010895,-1.5056271656805915
SNU-449,46843906,3.9850337221839074,3.2997122011424573
A-673,2733526,4.173930306540303,3.455958631629567
Panc 04.03,387447,-4.060832381569581,-3.8564899047237087
ONS-76,16038120,1.944596111088229,1.0771841841890721
Panc 04.03,12001922,2.0215480430072588,2.114544480417934
EFO-27,56946209,-4.24663912291577,-4.18527808252854
A4/Fukuda,15983966,4.102938700353478,-3.360766168288299
NCI-H522,10322450,3.5945001970925787,3.5013131315787582
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.3027028156993554
BT-549,16038120,1.0292862217749383,1.2154211286898837
JM-1,selumetinib-JQ-1 (4-1 mol-mol),0.3812013730118292,0.4011669404324883
FU-OV-1,selumetinib-navitoclax (8-1 mol-mol),1.6329291252143736,2.170669488521445
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912,-0.4798049275194724
OPM-2,10302451,3.176323712036339,2.816115104404214
BT-549,5291,3.9626748190842167,3.7710060091495445
A4/Fukuda,54143018,0.5698360241890451,-0.03978287202421859
CAL-51,5113032,4.55807021159329,4.8244167029976355
A-673,navitoclax-sorafenib (1-1 mol-mol),1.9636796155178384,0.9415859501955595
KMRC-1,15983966,1.4470823508624893,-1.20212727461759
SBC-5,409805,5.881004535625117,4.81431594257377
MSTO-211H,11717001,4.186640197436745,4.059746022680448
MSTO-211H,5351362,0.1292531164344693,1.5495495046710195
BxPC-3,navitoclax-MST-312 (1-1 mol-mol),1.414454953268366,1.0714493230373656
A-673,135398738,4.1394757023123505,3.1883867757335054
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166,-0.7619081522838151
NCI-H2009,12001922,2.0619007134450524,2.1484335407636332
CAL-51,3634881,3.319714226315486,3.390737677082883
SCC-9,5282054,4.577178009511458,3.8821865680871728
SNU-449,6610355,5.42598000328545,4.739228970411346
JM-1,100016,5.094244415703564,5.0055073483599815
DMS 273,16720766,1.3424969772091375,-0.11528246493880133
MDA-MB-453,82146,5.197355724890258,3.747578581885902
NCI-H727,219104,4.385991256377306,3.789302072215404
G-401,387447,-4.890417311710873,-4.704360658106638
SNU-61,445643,4.910443238015828,3.8844012431650485
G-401,445091,4.490925944707375,3.8418526825967394
Panc 04.03,10074640,3.644812120140466,3.2741197749867963
KYSE-70,3038522,4.319477989558539,2.891656695594196
NCI-H727,5311281,4.417954223041409,2.514030908605353
OPM-2,24889392,2.046562304125139,3.2696483082048062
OPM-2,9866186,1.7779199456036283,0.3126426376659614
NCI-H292,65628,4.3235700442832625,4.451451661357125
JM-1,5284329,3.614100674193798,2.5021856000776275
LoVo,49850262,2.4887252685350227,3.905552504294091
BxPC-3,24785538,1.143761767664292,1.7677290433249313
LoVo,176870,1.1282563754131285,2.98404754734854
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163,1.7532561978979313
EFO-27,73707398,1.1269975883077623,1.4951970364438114
CAL-51,49850262,3.6300011952383584,3.899180681811472
NCI-H2009,1750826,0.0733322198534379,-1.212124327669809
LOU-NH91,9903786,3.184012464559237,2.804579361888693
NOMO-1,9911463,3.1879476164010243,2.983115567569507
A2780,16722836,0.6661441985838381,1.2914288950453274
MDA-MB-453,11238147,2.2482376857817856,3.0455137262824503
NCI-H2009,11626560,0.9059448501577204,1.7037591726888652
LoVo,2746,2.3133613771451524,3.3879549317233826
NCI-H661,9840324,5.7754199175322825,5.863295876831604
SNU-61,10385095,2.7560205308704044,1.3187173679021402
A4/Fukuda,24771867,-3.7385177445932585,0.13076551703475423
NCI-H727,654092,0.4388886539996767,0.03841907338026747
NCI-H661,44507138,1.7319125686737762,2.5031072946868123
EFO-27,16013152,4.523705738143722,4.150128882842152
CAL-51,4259181,-0.5132501801478601,0.16890351105859103
A4/Fukuda,2746,1.0000278581130588,2.141889600984286
NOMO-1,10184653,1.080224838410231,0.43250098120426794
Panc 04.03,135398516,3.776050709281408,2.2217232111499254
YAPC,3038522,4.3203914817087234,3.178445686646461
NCI-H292,9926054,1.8794077191249725,2.0209918271581024
NCI-H661,5278396,2.727600530538007,3.6615242149121094
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654,2.1015056433701176
A2780,9803433,4.475774001896097,4.472557634499736
MDA-MB-157,11178236,-4.597953573249134,-3.280016279592809
ONS-76,44137675,3.612845962454732,3.421788573736527
LoVo,51039095,1.8047028032602028,2.8339430970442434
NCI-H522,tanespimycin-gemcitabine (1-1 mol-mol),-2.467840431866496,-1.0998459417552753
SNU-61,25183872,0.0265852822027559,-0.7266092038432675
NCI-H661,10410894,2.079430431888453,3.2587688234149734
NCI-H1623,11497983,5.112351206162292,4.039889713405485
FTC-133,navitoclax-gemcitabine (1-1 mol-mol),-2.9541403252647744,-1.188565394032824
NCI-H522,6184667,2.532079714436212,2.786684801713317
MDA-MB-157,selumetinib-navitoclax (8-1 mol-mol),-0.2333098537360622,2.0279848480964646
NCI-H2009,44589607,3.679148722712513,3.0697296105682907
EFO-27,44137675,3.925812188621705,3.6830385032489725
FTC-133,5328940,3.204514542529291,1.920681837530104
FTC-133,2708,3.4116435244290773,4.972421858641037
NCI-H661,24901704,2.3315866691701395,3.314038072725915
MSTO-211H,11719255,2.56955632094912,3.7352374507113204
OVISE,11626560,2.348997135596899,2.1478346605554672
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626,0.1898818020451914
CAL-51,9868037,3.5441777448678615,3.3944968023769855
MDA-MB-157,5328940,1.5742504795877947,1.8053453984976147
BxPC-3,19582717,4.685369750995796,4.395249138796512
MSTO-211H,6852167,2.890925130180435,3.076504350942139
CAL-51,5746,-0.6872762444946757,0.8365467085849508
OVISE,17759555,4.197708618199663,3.6462081506526403
EFO-27,6918638,-0.5643283195590469,0.7991978221531635
JM-1,439501,-5.872076466297635,-2.752083777561353
NCI-H522,44486219,4.336787525166091,4.295833052856241
SNU-449,11167602,2.762483283064935,2.748277870048802
NCI-H661,11640390,3.9877189690607993,3.7303685395333344
SNU-449,216239,2.7953722371364473,2.537481986309472
NOMO-1,17755052,-0.2814114025249274,0.6096147223484324
EFO-27,UNC0638-navitoclax (1-1 mol-mol),3.21943648938414,1.9967923342335943
A-498,54618771,1.1394352833671273,1.5001272355991149
CAL-51,176870,2.9999818119422175,3.2220181911919967
NCI-H292,11404337,-1.5117614396305947,-0.056444001466505016
HSC-4,9911463,3.832706037448295,3.941525185136458
DMS 273,5470400,-1.1243568241206934,-0.07153456828269027
OPM-2,25183872,-4.3499490255982085,-2.257295821960181
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894,-0.9043429986029803
LOU-NH91,31703,0.5806868540812907,-0.4329913673274226
NCI-H661,44493528,5.823125515558819,4.305371695241335
SCC-9,10074640,3.673307032160535,3.176105994456616
A4/Fukuda,11427553,0.0702382308883879,1.6114650324271835
SBC-5,568763,0.2965266090010964,0.5841571746463061
BT-549,25126798,3.990115132251306,3.98823227640967
SNU-449,9933475,1.8242814161965168,1.9027573917903344
BT-549,2113511,7.745487386721322,5.587131300424444
SCC-9,969516,2.533129063350548,2.8322394422799784
A-498,11178236,-0.0767055613398424,-3.284763208764129
YAPC,1242560,3.336355906074855,3.5989718664708197
YAPC,54626689,5.597039319211252,4.62477305518146
SBC-5,BRD-A02303741-navitoclax (2-1 mol-mol),3.4496626470660807,2.5953781394838047
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776,1.4907058660903272
HSC-4,6918837,-1.8301723200742368,-2.712064874859205
YAPC,656346,3.528875898488543,0.9281580301199517
LXF 289,5470400,3.745756378340341,-0.020376814224346056
NCI-H2171,168312962,2.801787293375821,1.2417766943338413
MDA-MB-453,6918638,-1.2403270134347248,0.01707510151801704
NCI-H522,1566236,1.6835491869847783,1.9617572323498444
NCI-H661,24964624,2.8216778680067836,2.710995542536918
NCI-H2009,5281672,4.642324044569225,4.655397126044299
Panc 04.03,navitoclax-gemcitabine (1-1 mol-mol),1.3720951008161577,0.04722854115118071
NCI-H1623,16065773,2.4078381094703456,2.574409388693046
CAL-51,46398810,2.084696284876613,2.4500515319148604
OPM-2,54143018,-0.7196855693728514,-0.32405835160060825
SCC-9,15547703,2.91115041464476,3.067520333961607
DMS 273,6914657,-3.971712341208325,-4.894332521909581
OPM-2,3676137,3.169610101166173,4.226819950092338
OVISE,3025944,5.5857056433387235,4.227228120430801
Panc 04.03,4259181,1.0934261994249337,0.5508236128386499
A2780,11683005,3.0394905793504963,3.192010244810754
HCC1143,5328940,1.7305674649682683,1.688093620109057
NCI-H2009,72193861,0.2482611586799762,1.953133350150942
NCI-H292,6914657,-3.659053204598075,-3.4820739132308556
NCI-H522,46199207,1.8719788650663136,2.972792081084248
CA46,53481919,3.755788894439918,2.64316651978947
LoVo,444795,4.8141558651213145,4.7072180475017245
FTC-133,9823820,4.816748988305079,3.9987310247787007
KMRC-1,6918837,-1.4377118656295438,-2.600618154002295
HSC-4,44486219,5.375029781512573,4.311633351458784
NCI-H292,54613361,2.8419740491204957,0.323340498955761
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727,-0.4304185515160359
CAL-51,11234052,5.18044926966805,4.230121771199316
SNU-449,387447,-3.8386512960067862,-3.989595342675638
SNU-61,53232,3.65751057839411,3.0321015948906638
LoVo,16038120,0.8839921956645777,0.9622306661317498
BxPC-3,219104,3.7528053800812615,4.035158905469218
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148,0.9118884210180117
SNU-81,24748573,1.8214275246808207,1.879624706584532
MSTO-211H,16725315,3.290115596802182,4.233551085991721
SNU-61,25154868,4.341936394973705,4.303039698492172
MDA-MB-453,1716436,1.6727209102312437,2.742444340742872
G-401,5329102,1.4807949874052762,1.6526113119893986
BxPC-3,6610216,4.298723179439111,4.299502141470144
ONS-76,5738263,4.146346761655981,3.275278419349861
A2780,51037431,1.9184867581168112,2.929888207784346
CA46,46398810,1.9636985074186508,1.711598814554701
BxPC-3,9936388,-5.112429278661846,-0.27948733084382554
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544,1.580290985165166
MSTO-211H,637858,1.3984482263345202,2.1186338265102744
A-673,5284373,2.9730764803314496,2.4349161175684095
JM-1,5284616,2.861882362083186,0.1869945394873364
A-673,64971,3.704564654457452,2.103694703552853
ONS-76,6918289,2.669224964930956,2.22478479580853
HSC-4,11167602,1.6360881716966182,2.774451627095605
NCI-H661,3689413,0.5447440822016135,-0.00027616438688494505
A4/Fukuda,12003241,-4.192136354440014,-1.1499886400885377
LoVo,10231331,-0.6826574775964468,1.8379830150607568
NCI-H292,219104,4.068792108053485,4.014504660922271
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.8466559037183015
NCI-H460,216468,4.763843832635099,3.2322314062150417
SBC-5,322968,4.849411960208385,3.5970563575567347
MDA-MB-157,135411,-1.5273896245850724,0.9491504774842693
A-498,6918837,-1.461997313484149,-2.215302709052035
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318,2.4148579260395477
MDA-MB-157,doxorubicin-navitoclax (2-1 mol-mol),-3.2378494218759637,-1.203943955586073
FTC-133,36314,-6.239918298117373,-1.0731556807876572
CAL-51,23635314,-2.261837237964324,-1.8396583788887264
NCI-H292,126941,-3.055153146808903,-2.3686784571201214
A4/Fukuda,23725625,4.971593284778653,3.7657325843606317
A2780,25105715,3.052833826388835,3.340803663349439
JM-1,9903786,1.587415218469425,1.8977738199972682
NCI-H460,5566,3.3663694984335533,3.1555663580765487
OVISE,262093,2.7343448368987597,2.808443883830648
CAL-51,25262965,-2.904292987251918,-1.5149259322213402
SNU-61,448949,2.574317813231787,1.8491552779852385
SCC-9,24180125,3.671852734769843,3.144859357345317
HSC-4,42611257,3.4394582921614933,3.4368161643516
EFO-27,46174525,4.9061854461465435,4.426103121359856
G-401,3384730,2.1525913455039474,2.083951085303859
G-401,3825829,3.962498358217521,3.513530176491277
A2780,53232,-0.3956468617212337,2.5405356851198557
YAPC,54618164,4.31457100114165,4.2460191257259305
SNU-449,54765302,4.743565917095417,4.4506418998374775
NCI-H460,24951314,1.96669984187411,1.4914131407393298
FTC-133,11364421,1.174405518858428,-0.9998063405676421
MDA-MB-453,carboplatin-etoposide (40-17 mol-mol),3.9287174119504225,1.7384251614789263
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657,0.9293321650714742
NCI-H2171,24771867,-2.6220866978549444,-0.3259870418147075
A-498,11427553,3.7697046176741185,3.2685035595747984
MDA-MB-157,5394,4.303334925677516,3.856270077312343
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134,2.9739779024955832
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372,1.279310152010396
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477,-0.45347310762415094
SNU-61,15983966,-2.103596771317332,-2.425657590270965
A2780,9927531,3.2712332494904226,4.387541008086404
MDA-MB-157,UNC0638-navitoclax (1-1 mol-mol),-2.9600993667864275,1.6476321293075284
NCI-H661,168312962,0.9705864877614524,2.1323933264832653
OPM-2,135440466,0.016624870652288,1.5845283532563017
NCI-H727,44486219,4.75896405378265,4.303266799302974
NOMO-1,637858,1.0893367728071195,1.0224846916777508
NCI-H727,23725625,5.500914308976136,5.020305325686856
NCI-H661,444795,4.831383676329662,4.574958932296163
NCI-H1623,10427712,4.824592613381889,4.289576726308641
CAL-51,11507802,1.2528060552922216,1.3652679512972503
SNU-81,tanespimycin-gemcitabine (1-1 mol-mol),-5.141011099555512,-0.4896367541179743
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944,1.7074836163096494
A-673,2949965,2.43157797191215,2.628463250017715
FTC-133,46907787,3.491897677971775,2.2522167410201477
BxPC-3,JQ-1-MK-0752 (1-1 mol-mol),0.0240612102256537,1.5567750265298037
JM-1,12003241,0.2073989775302392,-1.6518497158790297
DMS 273,72376,-2.307681046282287,-2.983696245843902
A-673,3025986,-4.4852998426095985,-1.0221762645405936
A2780,9823820,2.6289512031423836,3.0327012105912825
HCC1143,11152667,-1.9901975183751028,-0.3178715948810387
A2780,119607,4.019563194528792,4.691350631562883
MSTO-211H,136227924,2.717505566177341,3.1112137606647376
A-673,3025944,3.970835118137527,4.034727410583861
NCI-H146,11222830,0.9953145616857674,1.5729264655770145
NCI-H146,1750826,0.7822669653178473,-1.891663049423263
JM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.727165716436182,3.1226755875025707
BxPC-3,1750826,-1.1292189334445044,-0.532958496876332
CA46,6450551,1.1375422858810305,1.4223526681642784
NCI-H1623,46191454,1.8980276717062192,1.7383162538461614
CAL-51,24797083,1.5666479073716466,1.461375226939672
CA46,448949,1.4123991312197492,1.1221438542364528
OVISE,135999136,4.426271635938179,3.965784974107885
HSC-4,2742550,4.46855499399167,3.9183106300060824
NCI-H460,168313200,3.91056508525232,3.0192489705752767
NCI-H292,1750826,1.4118366921158176,-1.4093875405093115
HCC1143,452548,1.7974899966046338,0.5891355108605888
SCC-9,53325874,4.533787552290022,4.5403429695390045
CA46,24771867,-0.8036362931877258,-1.2624330070089258
A2780,72199292,-0.0351373222218005,0.6149864413939611
MDA-MB-157,216468,1.0474678727125786,3.533363467504236
SNU-449,65064,5.2463646910054536,5.038732280797163
NCI-H292,9952709,2.799114874088216,3.099991388668455
LOU-NH91,24964624,2.935669445800335,2.7101378209845994
MSTO-211H,5566,3.048712391825719,2.8290856287334156
MDA-MB-157,3384730,2.532514051685687,3.096059077425626
BxPC-3,753704,5.46289082133378,5.1727877878222115
A2780,SNX-2112-bortezomib (250-1 mol-mol),-3.4792243011702957,-1.844311721137274
SCC-9,12003241,-1.125345709331217,-1.338230423622705
HCC1143,285033,-0.1452813325821209,-1.4221702395194569
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.5449923400363215
FTC-133,9956119,4.526890245155382,3.754729497703072
SNU-61,3854666,2.8565665342705735,1.8074210008576301
G-401,16065773,1.1067048318222386,2.2250284549748733
G-401,11214940,0.8244141998238856,1.5664137399549674
HCC1143,54618164,3.885707225557291,4.250754858337989
MDA-MB-453,16013152,4.031304285322853,3.9962213690199024
SBC-5,24951314,1.1707148737631825,1.494833363033745
FTC-133,135398516,3.4482633492568913,1.939209069562892
KYSE-70,11625818,4.1356453826336965,4.3570810732653715
BT-549,16722836,2.2023880033470893,1.8445994863212838
MDA-MB-157,54678924,0.1283777680712135,2.2772950043116515
SNU-81,10410894,4.450607476297739,3.0213335597273616
KYSE-70,9926054,2.326174845830733,1.9368153852938437
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071,-0.9788998518445393
EFO-27,25102847,3.020723568572887,2.6349321717655645
MDA-MB-453,5351362,1.2969167061447922,1.5983343999752773
LoVo,9926054,1.9069881185353632,2.1542844370353986
NCI-H1623,46926350,-4.300601402935136,-3.910328653296913
SNU-61,16065773,0.792903808301444,2.4370611102406396
A-673,5287620,-2.2582011832849824,-2.3257622751851583
NCI-H727,9903786,3.725485605999375,2.795096429228338
KMRC-1,72376,-0.8386976675707333,-1.8322120839173603
JM-1,11640390,2.558073354039076,2.47910510738558
A-498,104842,-1.4921326822698753,-1.9836132200834187
LoVo,10127622,2.21220618035224,2.665384144567654
LoVo,11364421,-3.7348040522268624,-1.2397382409523277
FU-OV-1,57519531,3.042184872303348,2.546103055957391
MDA-MB-453,serdemetan-SCH-529074 (1-1 mol-mol),1.825240779322759,1.849834935483693
DMS 273,6917907,-5.615473283892677,-5.394636935020787
MDA-MB-453,2828334,5.6655606940020755,6.071773776208556
HSC-4,navitoclax-piperlongumine (1-1 mol-mol),2.6552743905338905,1.9751094762558075
A2780,3025944,3.330273751246369,4.093888831653539
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991,1.4110698204448853
Panc 04.03,11152667,-0.1106415062306802,-0.6168209122513579
SNU-449,selumetinib-decitabine (4-1 mol-mol),5.489476406274314,3.862008357689447
SBC-5,374536,0.1871414147839566,1.7381910068371127
NCI-H661,11222830,1.6760341955617937,1.5746515760613276
BxPC-3,89183176,5.843393871566337,4.55150990151384
JM-1,135999136,3.9281924738089016,2.468799437793175
BxPC-3,selumetinib-UNC0638 (4-1 mol-mol),1.3922516322535516,2.8666501884234634
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.05132791995828
SBC-5,navitoclax-MST-312 (1-1 mol-mol),1.562622268083127,0.9815665053747189
SBC-5,56946209,0.800516243447007,-3.6657232058088614
NCI-H2009,5328940,1.7426808664178373,1.7282971573932304
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004,-1.0760089044203796
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951,2.5073856449582803
SNU-449,9911463,3.778924364931394,4.014061374957106
HCC1143,3025944,4.170847171640537,4.203704921348368
JM-1,969516,2.095061675415332,2.2850596789473325
NCI-H460,3384730,3.247736649900264,3.1105530553114376
LOU-NH91,135411,2.1671070624345674,0.7909202021499523
FTC-133,44607531,1.7603587928522244,1.4286560839444167
NCI-H146,decitabine-navitoclax (2-1 mol-mol),-2.2755638944126644,0.18646200706455468
MDA-MB-157,445091,2.3343110617588785,4.317791608972084
HSC-4,16013152,3.4985623845199956,4.103633771389857
Panc 04.03,11427553,3.7212087866143433,3.1772564463067567
KMRC-1,10113978,4.2388531684480615,3.1593561939877395
A2780,10127622,1.5174517910950884,4.120623276334105
JM-1,navitoclax-gemcitabine (1-1 mol-mol),-5.563041913768145,-2.6377406867044852
NCI-H2171,89183176,2.3651641452605747,3.609049818064581
Panc 04.03,54618771,1.7180394725494992,1.1609224353789538
NCI-H292,11485656,2.2579953762585725,2.4179186635964895
LXF 289,322968,3.971478433961818,3.9897545268540178
SBC-5,vorinostat-carboplatin (1-1 mol-mol),1.8980945585311684,3.229679505564543
YAPC,10385095,1.3302689043535871,1.422758443890336
LOU-NH91,5329102,1.7122787452562382,2.187385290695126
SNU-61,19582717,4.214212535444011,3.5017313434673634
HSC-4,49850262,4.158516161733518,3.75497583377711
FU-OV-1,selumetinib-UNC0638 (4-1 mol-mol),1.7956327688699871,3.3702954737844486
NCI-H661,123631,1.2265867761007856,2.4742510012936334
KMRC-1,3062316,-0.7612421720697753,0.5008644334422495
BT-549,9936388,-4.888200161073446,-0.23798491946706835
HSC-4,24951314,1.4348411807415282,1.370256162992908
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353,-0.8466559037183015
A2780,navitoclax-pluripotin (1-1 mol-mol),-1.8595742905962285,-1.2393696326439831
SCC-9,9933475,1.8547363245124415,1.8806907008459137
CAL-51,9936388,-5.638746232401389,-1.3075814438930666
KMRC-1,ISOX-bortezomib (250-1 mol-mol),0.316621545277449,0.5378673399012441
CA46,72734382,3.577472012209052,3.3381355712438907
NCI-H661,16741245,3.244500107466936,4.288254521041581
SNU-81,docetaxel-tanespimycin (2-1 mol-mol),-6.596466940190321,-3.0872761905331747
HCC1143,11964036,1.1986784595252613,1.4509735328951874
NCI-H661,selumetinib-UNC0638 (4-1 mol-mol),3.9317627584077695,3.5720490832106067
A2780,126941,-2.3178428604154746,-2.7421276643556878
A2780,navitoclax-PLX-4032 (1-1 mol-mol),1.492192553915411,1.667666990881414
NCI-H661,24753719,3.905315348750775,4.296813448047546
SBC-5,25126798,4.2020115243555285,3.8829275303622213
NCI-H146,6917907,-6.190181636892531,-5.324246451757205
NCI-H661,1750826,-0.2904028146963975,-1.4460479923338545
Panc 04.03,navitoclax-birinapant (1-1 mol-mol),3.2417464009141845,1.6652524021063444
ONS-76,613753,4.08215787211526,3.2243732976818653
SBC-5,3689413,-0.1482568941323282,-0.12087370256772466
FU-OV-1,446155,2.635089718837861,2.746041507580129
SNU-449,216345,4.054978999003172,4.1911265871207775
CA46,6918328,-3.721989268042841,-1.6679425615599088
CAL-51,5978,-2.6819752982341463,-2.339554427289995
MDA-MB-157,57519531,1.1252399396652772,2.594586616757038
NCI-H1623,51037431,4.287686451446288,3.344420702099179
A4/Fukuda,5394,2.6676913787283305,3.5773938468956503
MSTO-211H,151289,1.1545674452198869,1.3014624160033108
HCC1143,3825829,3.893715702367038,4.055617568572165
MSTO-211H,374536,3.2477584475462904,2.7892725709416744
NCI-H460,6610216,4.838717363885395,4.2708682265328175
CAL-51,54618771,0.0049145289548569,1.4883232770095882
CA46,1239801,3.4142476342729817,3.052492687410997
A-673,9956119,3.229119212963112,3.329550314284642
NCI-H460,73707438,4.549718141383013,3.745705726228488
YAPC,9936388,2.1810367621372095,-0.36931355696220153
LXF 289,4705,5.10311909598278,3.1522706457524934
CAL-51,54454,2.240351559744082,2.519208099414243
JM-1,4788,5.493172342149484,4.931200430501813
SNU-449,262093,3.0394524195162766,3.0231188675602336
EFO-27,46926350,-4.056205960361391,-4.011432983974625
SNU-61,5566,2.945300560810773,2.9880886828621964
Panc 04.03,6610355,5.365295116093154,4.501461207863896
NCI-H727,navitoclax-piperlongumine (1-1 mol-mol),2.3472848325526448,1.8221318268423992
NCI-H1623,56963564,0.7315466561739135,0.7469006129833499
HCC1143,10113978,4.851592729588868,3.2473902332061613
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484,2.088329708838499
LOU-NH91,5311281,1.0411900413843744,2.4350634883478017
KMRC-1,24856436,1.3740575733249207,0.5447021301964852
SBC-5,400769,-0.0932857286492618,-0.6108452423891749
OVISE,11964036,1.5054845636014844,1.5921535777465534
JM-1,1716436,2.291915875842717,2.412333346390005
SW1463,6505803,0.5252870082270547,-0.5580284732658163
A-673,navitoclax-pluripotin (1-1 mol-mol),-1.5806846608606773,-1.281137023888097
CAL-51,119182,-1.323881847361974,-0.704133113302414
A4/Fukuda,4788,3.9402862208503753,5.190130520193436
SBC-5,9926054,3.0567796435466628,2.079181747901866
EFO-27,vorinostat-navitoclax (4-1 mol-mol),0.8763520950927793,1.4898719351474627
G-401,3634881,2.5006119442923938,2.926862848840674
NCI-H727,9911830,2.860892848593743,2.3980567243963384
G-401,9911463,2.712760379614347,3.3036738061975632
NCI-H460,15983966,-0.5601417251503862,-0.9758137648187651
BT-549,serdemetan-SCH-529074 (1-1 mol-mol),2.72716237465292,2.30941195658194
NCI-H292,31703,-1.868725819699569,-0.5278839992473693
NCI-H292,11175137,3.5103695935197328,2.711159355129989
NCI-H2009,3543504,4.270240870629309,4.540533930191473
EFO-27,702558,4.734643042503988,5.288970210017693
NCI-H292,107985,-2.5053359043606043,-3.3987205947763393
HSC-4,25154868,3.1331848354363063,4.3815857016334645
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545,-2.560671921518806
SBC-5,doxorubicin-navitoclax (2-1 mol-mol),-2.1214883367160113,-1.474257932742863
MSTO-211H,11364421,-5.484172518994792,-1.7579924488053467
NCI-H460,11238147,4.460003386993959,2.953438088841092
NCI-H2171,60700,-0.3771090207819011,-0.9337023868392496
LXF 289,1641662,3.640483694902119,3.4944154628243798
MDA-MB-157,49793307,-3.250396628323611,-2.128460074825847
A-673,3503,1.5343061624145853,2.1337320047236346
LoVo,10296883,3.831816674357036,3.8668604726292743
HCC1143,6917907,-6.676374133945339,-4.1955762121422415
NCI-H661,44185566,2.810411867420033,2.6274868889184306
NCI-H522,23725625,7.287275637495971,4.160881339197526
BT-549,11175137,0.9532540120968724,2.7829991387223005
BT-549,9840324,5.7680719211185005,5.823949620324584
DMS 273,42642645,-0.2214891751848421,0.4671559177944012
LXF 289,24797083,1.462636821965973,1.3315616452417087
A2780,9887053,0.4462184617201571,3.141642508267946
G-401,3689413,-2.428789331956376,-0.9163580832166063
NCI-H460,65064,5.803776096144955,5.104478899611039
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666,2.06558229619326
CAL-51,452548,-0.9080095532304931,0.20487779827345953
NCI-H460,54613361,2.8642714411834502,0.10077359990519462
YAPC,675434,4.582728256156342,4.577806047957516
KMRC-1,4578,4.295676817145532,4.366449308057713
BT-549,387447,-4.9509675804959,-3.774487759811568
MDA-MB-453,selumetinib-JQ-1 (4-1 mol-mol),1.824440496752652,1.641340568408415
EFO-27,11719255,3.4932821683662865,3.7399480302372967
OPM-2,219104,1.446566622432128,2.353978471703099
NCI-H1623,6610216,4.306736710776884,4.297328578166394
NOMO-1,23582824,0.0799476906959343,0.6646201240163954
NCI-H292,6610355,4.982353204264952,4.474540223738672
NCI-H2009,46191454,2.1369399253900347,1.8763703119286952
NOMO-1,3062316,2.517026306117631,0.6340757835003694
NOMO-1,119182,-3.695250738066314,-2.4061401291659226
SNU-61,decitabine-carboplatin (1-1 mol-mol),5.043967029141517,2.3406345207197234
FU-OV-1,11364421,-3.956792545928709,-0.9974563767770018
OPM-2,17755052,0.9533058757913144,0.9363589598499261
SNU-449,doxorubicin-navitoclax (2-1 mol-mol),1.3165597718985669,-0.5704874213991021
DMS 273,46199207,3.605640907411319,3.179633120499592
NCI-H522,55508,2.4640988254574356,2.8762851173930057
NCI-H292,10385095,1.2562128411100733,1.4406630473583277
SNU-61,piperlongumine-MST-312 (1-1 mol-mol),2.3794490551959107,1.7762223071072196
CA46,107970,1.651382626144423,1.9286909377141372
EFO-27,5746,1.7615281276545924,1.4725213497190361
OPM-2,24856436,-0.767009816479034,-0.26961451648319473
CA46,25126798,3.582571225160254,3.2755909566641845
YAPC,89928392,2.607647468641453,1.8213843787127693
MDA-MB-453,3062316,2.3886014193927285,1.2690295635819409
MDA-MB-453,387447,-4.667010811634082,-4.240776301256897
G-401,107985,-4.394015959361378,-3.700438549498121
A2780,decitabine-carboplatin (1-1 mol-mol),3.747400322321459,2.337390725455378
SBC-5,135875424,3.947045576812926,3.9455004956428485
KYSE-70,24785538,1.5800117539652696,1.437911616060532
BT-549,25262965,-2.559107571112332,-0.7820506571458489
G-401,selumetinib-PLX-4032 (8-1 mol-mol),2.777074550060763,3.361435204917978
BxPC-3,2828334,6.44946379786602,6.249524871745751
NCI-H460,3025986,0.3909368316008428,-0.982058054922125
DMS 273,11656518,1.6608448179793895,1.6153852652881968
EFO-27,3825829,4.213579429540561,4.227012702148722
NCI-H146,44493528,1.3818057906729433,4.125658780197809
CAL-51,73707398,0.7053044464230985,1.2069691691110007
NCI-H292,148198,-2.0841293800573446,-3.020062736488202
NCI-H460,2828334,6.134119597935603,6.121475643720412
CAL-51,439501,-2.444412450902406,-2.035631090176185
SNU-449,73707398,1.8238531786702632,1.423579007351472
A-673,10322450,2.1969870036583323,3.6152683157008014
NCI-H2171,71466380,3.3392440967630797,4.278216400029134
HSC-4,53392493,2.986961827224748,2.776605267312617
OPM-2,1239801,3.3443313732590543,3.000101947413957
LoVo,9935249,1.1872155844887071,2.812365272528766
G-401,1566236,1.5621622205700352,1.8875391432556867
HSC-4,9907093,5.592562690426939,4.292893261966929
MDA-MB-453,445091,4.203535883394564,4.30269387351
EFO-27,24821094,3.745327872256005,3.2134263145455346
KMRC-1,3038522,2.3225128068669676,3.1040440219338756
NCI-H2009,11427553,1.9586555200212517,2.6923803324993827
SNU-449,25227462,3.4571199035251565,0.9476674876281205
CAL-51,136227924,2.079284078064279,3.129975976442895
ONS-76,452548,1.1046001555889895,-0.11920956145369711
SNU-449,25105715,3.5056666677867625,3.464965359229728
CA46,156414,1.2808873732328336,0.9186113282655218
SNU-449,400769,-0.6000208096132458,-0.4604173698882444
HSC-4,tretinoin-navitoclax (4-1 mol-mol),4.058213789004076,2.614631029128723
NCI-H146,462382,-0.5302162316770459,0.18268220122065673
NCI-H460,613753,5.368273372553464,3.3161946424087114
MDA-MB-453,3136844,3.6967063162994114,4.2663510658457
A-673,5281672,3.4533278359325323,4.236138359358728
A2780,salermide-PLX-4032 (12-1 mol-mol),4.80403055299543,4.663983242725216
EFO-27,1716436,3.5844471141038823,3.145966935216847
SNU-449,3825829,4.613153689576251,4.277296219935062
NOMO-1,73707398,0.2786764614411772,0.424749252176918
A2780,568763,-1.431759576680003,0.3343107454466964
HCC1143,6918878,5.533567107436573,2.9372214943993002
LoVo,11455910,2.8170443999319574,1.1231819979857902
EFO-27,23582824,2.0177544133250187,0.7541868674869839
DMS 273,crizotinib-PLX-4032 (2-1 mol-mol),1.107090848194829,1.5457660822823118
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711,2.1868566539629684
MDA-MB-453,44819697,-2.6195477020037696,0.05154485600701283
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.5392551974416313
A4/Fukuda,7326481,2.3355820774301206,2.753984289168948
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935,0.061926722387197354
DMS 273,5566,3.001039957404815,3.0703089494070515
MDA-MB-157,148124,-6.016678597172854,-1.465664861271882
LoVo,11507802,0.9778049572121082,1.5290474692430334
NCI-H522,9444,4.166279980928258,3.9174801763359826
SNU-61,crizotinib-PLX-4032 (2-1 mol-mol),2.112541337520524,1.6134041254216158
MDA-MB-157,9549297,2.7932032986762008,2.6832392422475846
YAPC,3689413,3.09003195173071,0.34150246634259884
KYSE-70,10385095,0.9665013844498838,1.454839370238476
ONS-76,11222830,1.7336224967240552,1.6601105746622216
JM-1,11625818,3.7613008305210727,3.354061634874889
LoVo,16736978,-0.2277330125842315,1.4883180184750469
NCI-H2009,10074640,3.329342225437922,3.3271269427130856
MDA-MB-157,selumetinib-piperlongumine (8-1 mol-mol),2.303505265933228,3.395418000246413
NCI-H460,9866186,0.4176494313944011,0.7195406589835579
DMS 273,piperlongumine-MST-312 (1-1 mol-mol),1.0735064497414797,1.5147293067424912
A2780,60750,-0.3844759756013921,-2.836113522329954
MSTO-211H,5329102,1.1990183253858175,2.0004053822136014
NCI-H292,60700,-1.1983388185725197,0.22468525694539163
OPM-2,16659841,1.643311806599576,2.696100286749973
NCI-H661,11427553,3.4193847918785782,2.8281041760435586
DMS 273,445455,4.9732665628078045,3.965876886730713
NCI-H460,9967941,4.030885542149613,3.574290758938354
NCI-H460,5281321,2.142807178276493,-1.0563438895265425
HSC-4,44137675,2.9134227764609735,3.5208581816014077
HCC1143,2729026,2.66692124656069,2.7024252137483518
LoVo,1566236,1.5203890875485482,2.1560978848972736
NCI-H146,2842253,3.419228107779433,4.64319958075478
BxPC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.1893497843020568,2.066273290331382
G-401,navitoclax-birinapant (1-1 mol-mol),1.830641570341204,0.47590865115650094
NCI-H522,5311281,2.6748920868920125,2.377999816000451
NCI-H2171,2945648,2.4840683519833835,2.53407172269684
OVISE,9840324,5.37005208850368,5.652265099021663
NCI-H522,11485656,1.866098793785005,2.0040839174220513
LoVo,5280436,3.7935840263164984,3.4430497595139102
SNU-61,11152667,-1.0116802565381595,-0.9809178092292303
NCI-H460,2708,4.613368759945332,5.026825376072022
JM-1,6918328,-3.1408711543116854,-1.4830389883486754
ONS-76,1716436,4.404636467874722,3.0772050915099918
A-673,vorinostat-carboplatin (1-1 mol-mol),1.8302271851347216,2.5449241001485494
EFO-27,241158,4.165561573655071,3.9503298039685153
A2780,7326481,2.2466116261364215,2.783501738614382
SNU-61,11507802,1.2021022137126776,1.4657913604759207
MDA-MB-157,11404337,0.0143481506183785,-0.3754191051960168
CA46,71466445,1.6737757590775906,1.9538419435646173
NCI-H727,5329102,2.005304296489746,2.024554991727878
HSC-4,51039095,3.5449735354798,2.6533260279761874
SNU-61,135411,1.4786327368897634,0.40383751693370834
KYSE-70,23635314,-2.258343718513796,-1.3070172174611445
LoVo,54619267,3.1603381625719,4.011092573832172
A4/Fukuda,71751553,4.0599050322296995,3.7910453368941717
MSTO-211H,156414,0.8242215144670997,1.5845582971594252
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566,4.766412064249907
FTC-133,44185566,3.3632936032593403,2.8306759216491737
DMS 273,448949,2.08082767357287,1.7803703263669328
NCI-H2009,71466578,3.1093531088855797,4.794998734077553
G-401,44632017,0.8985354611426208,1.3816464511069477
BT-549,selumetinib-MK-2206 (8-1 mol-mol),3.7435094380917793,2.647978575788973
HCC1143,107970,2.31840177997234,2.361524257249448
NCI-H661,156414,0.2928474479064595,1.287842231599779
OVISE,216345,4.54917324344274,3.8699694869349424
SCC-9,25227462,0.3695734481821194,0.8115759435003882
FTC-133,46199207,4.2182762440826576,3.2271081712095593
Panc 04.03,9926054,1.9560696374821285,1.936178216185761
G-401,6918736,-2.2327850291733577,-1.9586113459291326
SCC-9,44607531,1.3853072214617428,1.5428825506436312
NCI-H146,serdemetan-SCH-529074 (1-1 mol-mol),0.832618254010713,1.7330499000475954
HSC-4,171352865,4.360447231593142,3.08758019378154
OVISE,613753,2.681502253258482,3.313805492298507
A-673,5282054,2.3452018577417166,2.9343878747789636
CAL-51,5328940,1.595278406971918,1.8093936024127475
G-401,426756,4.944025345893246,4.03262156183207
BxPC-3,selumetinib-PLX-4032 (8-1 mol-mol),0.9505923867338788,2.7266102665969214
FTC-133,73707398,1.7335394908123083,1.5556551913021925
LoVo,20959075,-3.964629838563966,-2.7651890381779007
LoVo,46907787,0.5340804086119918,1.887785211456791
FU-OV-1,9907093,3.428205270837273,4.233034922900973
NCI-H146,5470400,-3.389889619220011,-0.13573830991181507
FTC-133,60750,-2.331663889988264,-1.6770348212714756
NCI-H661,637858,2.3544841299222927,2.082035281377785
NCI-H460,24772860,-0.596461213785507,-1.7569578532321706
FTC-133,135999136,5.800253145127344,3.9123089988659694
SNU-61,2945648,3.4316222719918903,2.5825347152624785
SBC-5,52947716,-5.148190181120178,-1.3693420774752507
G-401,5311,0.6627378317361174,1.1424809491192882
SNU-449,25183872,-0.2769192593247403,-0.4503440699162155
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.079245644078659
A2780,444795,1.1255727490438436,3.655083487740404
HCC1143,11404337,-0.7051632820466462,-0.04022212962498023
LOU-NH91,23582824,0.7266398713670753,0.6908398951769158
JM-1,24964624,1.3785887120991174,1.229142496163321
SCC-9,6918328,0.8244293983868239,0.337137719061025
SBC-5,44507138,1.9527307391432291,2.4719328859625085
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084,-0.1796696668031571
HSC-4,3081361,1.976322212956416,2.134426502474993
MDA-MB-453,navitoclax-piperlongumine (1-1 mol-mol),1.490500263606314,1.4086050153521217
A4/Fukuda,73707398,-0.4328093310020208,0.6231336092730337
NCI-H146,2130404,3.7873290414593983,3.0507339921547514
NCI-H522,11656518,2.6059049947054533,1.3306520701264188
A-498,11626560,2.3564203123568648,2.17213802969955
A2780,17755052,-1.4995675278651837,1.4958886544877348
HSC-4,2841722,4.578140166849417,4.280071333702827
JM-1,44462760,2.3346005220819785,2.5882714930699553
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372,1.3777251769759737
FTC-133,4261,1.6400921135700228,1.6662356814629369
LOU-NH91,54618771,2.8270991446030593,1.3586043166304895
NCI-H1623,16720766,0.9555863303424396,1.1073533208777855
BT-549,44632017,1.021144372127497,1.7904245481531662
NCI-H292,107970,2.31632347859771,2.367394834115785
SCC-9,24753719,4.411411644196846,4.311397971185345
KMRC-1,4917,3.6746853329943248,2.8741722280958357
NCI-H661,72734382,5.266471995298585,4.691524899447522
SNU-449,4578,4.5704959764236675,4.540269908098806
KYSE-70,9887053,4.5630363901990565,3.9584766834134
NCI-H460,81146,4.483282466350705,4.921564825357829
G-401,637858,0.5800115670130345,1.3532595351099344
BT-549,5280436,2.325988989460079,3.516421046486131
HSC-4,107970,2.304506496588027,2.349616977208043
NCI-H292,421610,4.310067764922952,3.3151036012759163
MSTO-211H,11175137,1.4320314455831638,2.6068519239229415
BxPC-3,11175137,2.81920931641519,2.7680907693875714
G-401,vorinostat-navitoclax (4-1 mol-mol),0.632092146955943,0.7267798151089704
NCI-H292,11625818,5.668815438823822,4.530937971358204
BxPC-3,3025986,-1.3024282207469429,-1.0099313054915955
NCI-H460,11364421,0.3566052665939138,-2.0381260356605186
MDA-MB-157,3385,-0.6145392702282009,4.562597523520632
DMS 273,44589607,2.105355871894398,2.2252474688341275
SCC-9,107970,3.0149180037966095,2.3644666077846868
Panc 04.03,17755052,3.2992451395509503,1.6518004742153047
LoVo,10427712,4.119455144779727,4.2387849852932895
MDA-MB-453,ISOX-bortezomib (250-1 mol-mol),-0.3200221310037367,0.658429512499052
OVISE,9825149,2.776616936788869,2.3069293512924505
DMS 273,44185566,2.401025824688418,1.8001830047739642
SBC-5,selumetinib-MK-2206 (8-1 mol-mol),4.137952563186265,2.003056748173924
EFO-27,5329102,3.2209933806874926,2.165872688117444
NCI-H2009,3503,2.6223022737526085,2.595691381442357
SNU-449,66577038,3.1506640300230075,3.0382903237063137
SNU-449,135999136,4.264029635041134,3.6731746250714785
MDA-MB-453,16725315,3.1590887754383847,3.967760162644289
SNU-61,6505803,-0.8091898598550518,-1.1686508352417717
Panc 04.03,6438330,3.1739512088269968,2.57968153191121
SNU-81,124202324,-1.5604837877349913,1.6966734552905587
Panc 04.03,navitoclax-piperlongumine (1-1 mol-mol),2.817487895898936,2.012377176842672
FU-OV-1,49850262,3.0107305406398206,3.89959469866481
FU-OV-1,selumetinib-MK-2206 (8-1 mol-mol),-0.4869777969309855,2.405375002582788
ONS-76,54618771,0.5276024038238057,1.120770528254408
SNU-61,5311,1.5459052759872411,1.1298868678571186
CA46,11612883,1.866301185217262,1.8175777550845402
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009,1.8251852717633816
A-673,11960529,3.1772019850221054,3.8237182408602437
YAPC,400769,-0.4056066486406303,-0.23067317248481312
KYSE-70,107970,2.5727619321994353,2.2647322239878624
JM-1,5291,3.241129374385646,2.902164192520731
KMRC-1,9444,4.31479767249553,4.172137649168731
NCI-H727,44819697,-0.26094531007839,-0.055510371144355954
NCI-H2009,5351362,1.2372754831617516,1.626272955532605
LXF 289,53495165,1.0389398894889437,0.6114439342618645
ONS-76,vorinostat-carboplatin (1-1 mol-mol),3.120131426487973,3.0932147350561467
NCI-H727,123631,2.758434269009812,2.3263263111635144
NCI-H2009,5311,0.3641463076187463,1.6331428116117706
MDA-MB-157,241158,1.407364121620741,4.04632294582604
LXF 289,24785538,0.6202102990423739,1.5593790816915416
BxPC-3,10074640,2.675443562621253,3.2514806985741798
G-401,4378219,4.593157039926137,2.246717258703737
CAL-51,445643,4.334473435217703,3.8639521199450946
OPM-2,2858523,3.124441680057984,2.767978146854712
NCI-H522,tretinoin-navitoclax (4-1 mol-mol),4.26592131531013,2.020685701752589
HSC-4,11175137,3.5997845208099797,2.5670406498284772
MDA-MB-453,25126798,3.9955340419002057,3.9142006520786583
SNU-81,159324,-2.5700546068481502,2.256226331528235
SNU-61,3552672,2.025857953798933,2.6081536187871226
FTC-133,246676,4.92384525208296,4.3910826888226975
MDA-MB-453,11364421,-1.677319267600166,-1.3369519043169862
CA46,122327,3.963727711050333,4.0113212030220895
LXF 289,262093,3.4150141342974605,2.9353613098221887
NCI-H292,6918289,2.42392533304279,2.8969696020883964
NCI-H661,25154868,3.681430006213129,4.341167013910006
NCI-H522,327653,3.011425661783578,2.8535422428395196
KYSE-70,44202524,1.884457998669868,2.3492344137899313
A-673,8515,3.2253171108003023,3.1571727312613387
SNU-449,6505803,1.2866498789511422,-0.4002410291339696
FTC-133,10074640,3.79174067417729,2.9931046908794166
NCI-H522,72734382,6.037966635177564,4.061907279589419
NCI-H460,navitoclax-gemcitabine (1-1 mol-mol),-0.7753344502406821,-1.3213768915951252
NOMO-1,46943432,0.592792127892358,0.9236553588559395
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056,6.2260093185436505
MSTO-211H,15953870,2.3250629767102273,3.7944608220944547
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373,-1.2350342374757945
NOMO-1,24951314,-0.0494287054100275,0.30032170857867624
NCI-H292,6918328,0.4467511585294103,0.332781321189896
SNU-81,72193861,-0.4444993909438327,1.016603021732703
SCC-9,9956119,4.352516606884389,3.638297086781943
CAL-51,66577038,4.134711160885491,2.891304592510693
MSTO-211H,44489675,3.600660518296678,4.016065994577385
SNU-449,11494412,2.814472666417892,1.943273723373771
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902,0.22061687284726417
NCI-H522,11364421,-6.31463288554187,-1.9819226764245423
OVISE,11222830,0.6942836946088363,1.6848205694712957
LoVo,135398516,0.8347424818537327,1.9415327188701974
MSTO-211H,409805,4.793476239157615,4.891866201942816
SNU-449,selumetinib-piperlongumine (8-1 mol-mol),4.611443902148163,3.616225222163356
MSTO-211H,9926054,1.9546831701161536,2.198822236002881
NCI-H292,2749,1.484796478537434,2.2028231148240236
OPM-2,702558,4.8466631372101725,4.325806858860324
LoVo,71466445,2.646256567071358,4.085266233819942
BT-549,16659841,4.205377629414311,4.0004547765868
KYSE-70,3025986,-0.3454993097331295,-1.0799391528813818
NCI-H2171,15953870,3.344319567560605,3.2936016648912996
Panc 04.03,11640390,3.824707626147026,3.823405558376136
NCI-H292,5278396,3.8202006656128735,3.653455770378058
NCI-H460,5311,2.161812802665503,1.6194982583318351
CA46,54596558,4.227379600712383,4.089039449790089
NCI-H522,50905018,5.2003053075185734,3.7769904304906623
JM-1,54596490,4.858476490911798,4.087968504112382
KMRC-1,5281672,4.43646792139098,4.775521339136308
SBC-5,46199207,3.436092011920994,3.073155397762634
NCI-H661,46907787,3.1119891404607083,2.561578098365231
NCI-H1623,11222830,2.056201659978474,1.537612592903103
SBC-5,3038522,3.9213361824350024,2.8695564518755874
NCI-H661,9926054,1.7811448977738318,2.097670864558995
LOU-NH91,969516,2.9922565120136944,2.8798570237778267
MDA-MB-157,5329102,3.39801486229995,1.9960894947192822
SNU-449,445643,4.11461116511151,4.05535298782752
NCI-H522,9887053,3.177768808520637,3.214454135012458
NOMO-1,16065773,2.6012917178973405,1.7401080186886373
G-401,67291369,1.7656191364648908,1.8596255880315105
HSC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.8141472051881076,2.166986050359001
MSTO-211H,11609586,2.648073114002603,3.1262620750460623
A4/Fukuda,25195348,0.8993846970771071,2.5699705748560087
NCI-H2009,54649381,3.659944396907473,3.993058806523889
CAL-51,3025986,-1.0834382414923172,-0.8864866345343525
EFO-27,52912189,5.780518526906142,2.4101062976834426
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942,-2.4546645403416307
A-673,123631,1.860693828866879,2.185190388508114
A2780,44632017,0.0856486258730489,1.154126030976639
A-673,24901704,3.0162186042420966,2.7637964969014677
OPM-2,168312962,0.8773607091058507,0.7567435272661046
NCI-H292,46398810,2.6001901820453166,2.6331498482432285
SNU-449,53495165,1.8844225218094013,0.7140948414142172
YAPC,2749,2.2394739682848512,2.321253001171264
NCI-H460,4788,5.894567383019075,5.690873803003432
LOU-NH91,637858,2.168731257760998,2.172950045618841
NCI-H727,11427553,2.8726920198872397,2.827043935369686
NCI-H2171,5978,-3.1305615418900468,-2.9905011019240226
EFO-27,969516,2.57565712333896,2.923357895796011
SNU-81,11152667,-1.3658791794225291,-0.3567083860792413
LoVo,2858523,2.923658201852042,2.961575928607665
FU-OV-1,56946209,-4.492733112758285,-4.1113267299238805
CA46,9549297,1.0960598621603344,1.5558003949169756
ONS-76,6917907,-5.751164378556486,-3.91986893907542
NCI-H460,51037431,2.104101453867928,2.918631022931325
CA46,68056272,3.136594245199668,2.9543642997824673
CAL-51,54143018,-0.6388505972102335,0.5333401492792494
SNU-449,5284329,2.300938885216567,3.4010971686891485
A4/Fukuda,11609586,0.4485915276425587,2.0549491229889894
NCI-H146,9933475,1.6402256772331771,1.8578122308618763
NOMO-1,9927531,5.049638663441057,3.995018971149189
A-673,148198,-7.755828732328633,-3.888635565251941
SNU-449,2113511,6.338115821615388,5.662628506055574
NCI-H522,49793307,-5.2014711504438,-3.0481874675676317
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332,6.469698874178379
FU-OV-1,44493952,2.9850522959236883,3.530472663516119
NCI-H661,5328940,0.9675290055268168,1.8105397826343834
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693,4.024355118279397
NCI-H727,60700,1.7894131654495464,-0.13527807373253617
MDA-MB-157,10385095,0.7848337329764868,1.4684403579960017
DMS 273,46224516,2.6849968878024297,2.4497125393193238
G-401,1641662,3.2482177517563766,3.12488994407345
NCI-H292,448949,2.3471350598248795,2.234114068841982
ONS-76,3038522,3.87205505246704,2.9344611503376052
G-401,216468,0.7704979015554879,1.4201841553670669
NCI-H727,10127622,-2.4732053445147333,3.4428744800711852
JM-1,erlotinib-PLX-4032 (2-1 mol-mol),3.366484807659052,2.8462584975222245
LXF 289,16722836,0.8079280065417594,1.8206676497802385
FTC-133,11167602,2.051836472120041,2.7887813062117295
LXF 289,3825829,3.6707575370566534,4.286124706474824
CA46,25150857,1.719157108492683,1.64728406023058
NCI-H727,3025986,0.1020219293656271,-0.9453080294398588
MDA-MB-453,107985,-4.386344018126506,-4.036772020979914
NCI-H1623,72193861,2.1993190803521423,2.055400045536642
MDA-MB-453,decitabine-navitoclax (2-1 mol-mol),3.3987025983008468,1.0083610580727964
ONS-76,12001922,1.7268373273866384,2.0604168289656632
LXF 289,5460769,3.06478422280727,2.652190888923238
MDA-MB-453,doxorubicin-navitoclax (2-1 mol-mol),-1.00600213948852,-1.4056791615867072
LoVo,9967941,3.621110602900207,3.6094979433404
HSC-4,navitoclax-MST-312 (1-1 mol-mol),0.8559820038991849,1.0278308137120402
NCI-H727,5113032,6.018394893069797,4.877017583908932
MDA-MB-157,5351362,0.7984725267524495,1.631007667185747
JM-1,1641662,2.861679408031504,2.7648385966356455
A-673,JQ-1-navitoclax (2-1 mol-mol),0.2328293171340499,0.41747395103887086
MSTO-211H,445091,2.4700472101717312,4.441030285829091
NCI-H146,11404337,-1.5914515878545687,-0.46300351634421966
CAL-51,11364421,-3.809863778172731,-2.5590372539638024
A2780,4096211,0.5297517602102724,1.495174132612492
SW1463,23635314,0.7077124425294024,-1.7485707967188375
EFO-27,9933475,2.2279721994416364,2.0252639111326185
CAL-51,135875424,4.33643967165441,3.9164161638333552
NCI-H1623,15983966,2.013058792543676,-0.8545724374058662
SNU-449,3038522,2.1807259662851735,3.1036800084955773
SNU-81,969516,2.098687325749346,2.6553523974289748
SNU-449,9935249,2.650976699885872,3.3719835184726565
LoVo,10385095,1.3603816893768768,1.3488768371820774
ONS-76,322968,4.979501026393853,3.868467267488
DMS 273,9933475,2.0005654751864865,1.9975918424357844
CAL-51,71466578,5.340961831553399,4.510501612119294
Panc 04.03,selumetinib-PLX-4032 (8-1 mol-mol),4.2289817394660805,3.2648883866558513
MDA-MB-157,1750826,-3.091616753079083,-1.3826383070804693
G-401,salermide-PLX-4032 (12-1 mol-mol),5.25337589730296,4.602978098793454
NOMO-1,702558,2.777027807122979,3.924436319274085
YAPC,60700,-0.2763967023007928,-0.24743445454612356
CA46,5287969,-2.5448622649608925,-2.2776783797285374
CA46,15953870,3.0438117584706164,2.9373860571209587
A2780,selumetinib-UNC0638 (4-1 mol-mol),2.0119949051388493,3.158868581374063
YAPC,6610355,5.243598963135711,4.4441392526157255
SNU-449,4477,0.3396527753410003,0.30479415447322755
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152,1.8121399983496937
SCC-9,168312962,1.0708744032070256,2.686321591581716
SNU-449,119607,5.345576432951938,5.405412314572992
LoVo,135999136,5.7154474843469565,3.889303096765325
NCI-H146,984333,-0.904410626141992,0.13888567789477604
KMRC-1,54619267,4.117989845600413,4.0331077358369
A4/Fukuda,11485656,1.5130746228374388,1.9401022091870164
BxPC-3,5311,1.3160685062040935,1.5898054906617793
NCI-H522,3038522,2.4524519125835473,2.8984172578220493
SNU-61,89928392,1.2163192063780537,1.2639699222371745
FTC-133,5287969,-0.5047683720981219,-1.4438243783563032
ONS-76,25062766,2.430053801867403,2.2166105034688837
NCI-H2009,44486219,4.368704582532332,4.291061253244606
NCI-H522,637858,0.9732265340904396,1.5606570032600242
NCI-H522,44632017,0.530418286591973,1.162649773958742
SW1463,11485656,1.9271812519349985,2.047741177452634
SCC-9,46843906,3.309522412048413,3.041473840437813
A4/Fukuda,6914657,-5.308594861321554,-4.915878613822557
LOU-NH91,36462,3.2256365983613677,2.536474611960857
NCI-H1623,3825829,4.488518875119825,3.9945397794391306
MSTO-211H,56946209,-4.75779739938848,-4.141945957973771
YAPC,11427553,3.397606686380644,2.8196920890434023
JM-1,426756,3.661156723786521,3.724804549938973
JM-1,10184653,1.3269176228991806,0.6435632599846679
NOMO-1,11497983,-3.443590431300748,-1.5599386626594025
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926,-0.025787398313395403
A2780,9952709,2.339079626269582,2.5674817064135373
MDA-MB-157,9866186,-1.7048510464532898,1.3547056634367056
CA46,216239,1.3191761483145148,1.888443209172255
MSTO-211H,176870,1.3974668510804569,3.3971051174801774
LoVo,vorinostat-navitoclax (4-1 mol-mol),1.8172554757062631,1.152909096352445
OPM-2,135928012,2.8826672527394956,4.058404177113497
BT-549,9915743,2.34179420613382,1.7687299851816332
LXF 289,71304818,2.1201305139291033,2.688358658276464
HCC1143,11214940,2.1301365232114144,2.0728580238742564
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668,0.6517716404015544
KYSE-70,11404337,0.2060464556058333,-0.3970623232333338
NCI-H2171,11152667,-0.915095731247344,-0.755316996299923
HCC1143,46191454,1.52291312584366,1.6369383483559827
SNU-449,71680916,5.959793136995753,4.806032052728518
YAPC,219104,4.027438046449075,3.9806475287304126
JM-1,446155,2.7706022090916793,2.1804149548839074
BxPC-3,46398810,2.2883583084835126,2.6719904247139414
OPM-2,2828334,5.82639787583413,5.780025434575211
A-673,44137675,3.4578104481213905,3.241158114349887
FTC-133,7251185,3.0292037228467628,2.727112513798355
KMRC-1,676352,1.883475825529446,1.9934305262316458
EFO-27,1641662,3.8267974599371417,3.734970053026528
G-401,168312962,3.2015141434031547,1.3996534294967349
CAL-51,2945648,2.7250935788350064,3.110737563858698
CAL-51,71466445,4.7818956768695715,4.299709386405706
JM-1,5113032,4.766616079684312,4.584821326516835
SCC-9,24821094,2.906183993814488,3.182805611573732
NCI-H661,piperlongumine-MST-312 (1-1 mol-mol),1.6507934598054954,1.7672504118932215
NCI-H292,216345,3.474677020151061,3.9995120991258664
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015,1.8357305370044048
SBC-5,9549297,3.510799485826288,2.0554574593781263
CA46,156422,3.7635879578153126,2.9616389829174814
MDA-MB-453,71466445,1.9167870178623896,3.9372063227001486
A-673,54596558,3.847043372257958,4.348271863339436
OPM-2,10231331,0.6444733525039235,0.7982196153454858
HSC-4,5335621,5.235604448739508,4.519709207852658
CAL-51,11719255,2.5837610433465588,3.5775822335691942
Panc 04.03,44493528,4.362737332857046,4.397450945893936
SBC-5,carboplatin-etoposide (40-17 mol-mol),1.335045540127449,2.4075006288711625
NCI-H522,24821094,2.425713290484283,2.7791852446094145
CAL-51,6610355,4.388066889778601,4.63352205238444
MDA-MB-453,6438330,2.0150251794967655,2.1660302568437224
Panc 04.03,46199207,3.759856924739056,3.3047426159225974
SNU-61,9866186,1.5207851909017442,0.695202631158724
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137,4.3435461040408025
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645,1.8030822764092875
Panc 04.03,71466578,5.726073349824824,4.8685250477844955
NCI-H727,107970,3.133468251114326,2.3597450986098054
BT-549,60700,-0.4810674620852896,-0.10083674067374698
OPM-2,51037431,4.229346700902662,2.8467846975221818
MDA-MB-453,56946209,-4.730570165381635,-4.260632373722903
NCI-H460,72376,-0.5460239014371263,-1.5212668299099044
BT-549,44241473,4.976602861760902,5.027164324401474
A2780,24748573,1.2286507677110594,1.823369654509189
NOMO-1,5311,-0.031303965270056,0.4381407237700837
A-673,9927531,4.216692000672551,4.452512148959318
NCI-H1623,46199207,3.747077477678168,3.1775818388694947
NCI-H292,71304818,2.830949431838268,2.5561074952335083
NCI-H1623,9911463,3.95788841498078,3.842394583589339
SBC-5,9825149,2.9056064620320896,2.046058410878264
NCI-H460,11612883,2.88158995470921,2.8339310965787683
OVISE,6918878,5.066606594706477,2.7560110262260182
FTC-133,5278396,3.726623182659884,3.6132036874377014
Panc 04.03,24775005,4.54660450697204,3.7872673728678943
CA46,1641662,3.144498035259472,2.656393418877249
MDA-MB-453,16722836,1.2443221263797826,1.5824452792741086
CA46,54618771,1.203400154931592,0.1625685746224294
HCC1143,613753,3.4353326628352714,3.2566609479814046
A-673,60750,-4.61356677624384,-2.6602548439242737
A4/Fukuda,1641662,2.3667755294261297,2.851696410826912
OVISE,navitoclax-piperlongumine (1-1 mol-mol),0.5165659112827317,1.2043466716169409
MSTO-211H,375860,0.0606650448750636,-0.3521915902922678
BxPC-3,6184667,3.26727461265582,3.1886508786662806
CA46,227681,1.829365253324193,2.3520313579174355
SW1463,11964036,0.627645429671571,0.8611900788538045
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941,1.4363682780239444
FTC-133,49766530,-1.1381086002707512,-0.40896462500002834
SNU-449,selumetinib-BRD-A02303741 (4-1 mol-mol),5.2718140952083585,4.212922074677523
NCI-H292,11364421,1.76762986564817,-0.7806742837194863
KMRC-1,44819697,1.235264283084374,-0.17733920655282057
NCI-H661,9907093,3.834837743900246,4.300128286704517
DMS 273,17755052,0.9609599247674856,1.5206348426849061
SCC-9,11364421,-0.952029021799848,-1.1930989932304044
FTC-133,135984461,4.350998124633342,3.955016210167044
JM-1,11497983,-3.7280544169699192,-0.9402757870454255
MDA-MB-453,24753719,4.38597739181452,4.270027223406904
ONS-76,168313047,2.901208476511606,2.3123741670090108
NCI-H460,67156097,3.7191617083219097,-0.357684946377717
SNU-81,selumetinib-decitabine (4-1 mol-mol),-2.7455044109926168,1.925390934068737
A2780,9866186,0.3046354439957303,0.652534395000621
HSC-4,219104,4.150323587810277,4.001299144531734
SBC-5,168313047,3.954131669958023,2.17797942019752
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333,4.221704714093048
NCI-H292,15953870,3.631273190289841,3.77613433576532
SNU-449,5281321,-2.557888043471457,-1.143949671406315
HCC1143,702558,5.703077608026742,5.240498165720706
EFO-27,644241,3.241988529302909,2.5259050352335044
Panc 04.03,9911830,2.4999304852863404,2.7510468569169864
NCI-H522,9967941,3.44539283334302,3.349747170212294
BT-549,44607531,1.5480457992975702,1.7905254016596766
BxPC-3,44607531,1.3275313586220698,1.4489659978396665
KMRC-1,24951314,2.7376925539969927,1.7106140863037411
JM-1,10231331,5.343116821873739,0.6816943598091508
A-673,25262965,-3.9892118887375303,-1.983820587022506
FTC-133,1716436,3.3698315146098015,2.963949323371777
OPM-2,2733526,4.066729211955922,3.263814687591168
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345,2.1252020612791345
DMS 273,3825829,3.788583241717048,3.4314281122138732
KYSE-70,3825829,3.6022414485207452,4.159100742583281
BxPC-3,5351362,0.9304368738373464,1.5011476241184705
NOMO-1,6918736,-3.755126975181922,-2.2374607926592924
A4/Fukuda,11977753,-3.131569873612884,-2.244687356032
SBC-5,navitoclax-pluripotin (1-1 mol-mol),2.5594903061856744,-0.7689624027710262
MDA-MB-157,navitoclax-piperlongumine (1-1 mol-mol),-2.7470196870152894,1.7421019863397171
A2780,73707386,2.710080958425795,2.6696878825458445
SW1463,44819697,-0.8614164905769626,-0.5644314125773948
YAPC,24180125,3.806846010722946,3.223641302541275
NCI-H727,54649381,3.660865770056845,3.6685720174387013
SNU-449,2708,5.735631765174737,5.007297937217461
CAL-51,54143018,-0.6388505972102335,0.5333401492792494
LXF 289,753704,4.962227230589067,5.036342965955489
NCI-H2009,9907093,4.391694288558607,4.348961442239299
EFO-27,387447,-3.111228692284437,-4.172808358439342
NCI-H661,65064,3.46809117241053,4.7970381231215615
SNU-61,5278396,3.627128978826316,3.2987421679972435
NCI-H727,452548,3.7056139041011034,0.15598970674910997
NCI-H292,16720766,0.3451831901206211,0.6596257545471762
SBC-5,serdemetan-SCH-529074 (1-1 mol-mol),2.482890846632963,2.0971706010996103
A4/Fukuda,100016,4.8831896191852096,5.23739156952274
G-401,25126798,3.708942608188802,3.612599454324614
SNU-61,24951314,1.416243399270427,0.7629180821776929
CA46,89183176,2.547561715641907,3.004799131059422
Panc 04.03,2746,3.3610494767062513,3.5259632180142098
FTC-133,107970,3.2744864550719126,2.218108299143534
NCI-H661,6918878,1.4921814323330362,3.2190105645701186
YAPC,24951314,2.2257819926279243,1.5711341355051849
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925,2.379175120342011
LXF 289,216345,3.67485776854348,4.126481452114952
G-401,5287969,-2.352936827953192,-1.9303728132191051
LXF 289,5566,2.9960878643930218,3.0717837417185687
JM-1,71680916,3.747509118270568,4.074865532846345
LoVo,16741245,3.141864677583783,4.016281918151635
NCI-H661,54649381,3.920223147571483,3.8716193870975446
EFO-27,25154868,5.200143123549252,4.509466172908796
SCC-9,25126798,4.663845786250664,3.8176787046433134
A4/Fukuda,24964624,-0.76967256635286,1.679845897435852
A-673,11178236,-6.344930978772708,-3.251802618361128
SNU-81,3825829,3.873341985908314,3.5939624495593536
KMRC-1,36462,3.0698954920529324,1.892934722885729
NCI-H661,262093,3.4983141095274126,2.8665225424535015
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743,0.90631509979797
G-401,676352,1.5550652369933835,1.8104955610626048
SNU-81,11228183,0.0397441918833689,1.024935086269465
MDA-MB-453,10385095,0.8735195901829151,1.2654045349437517
KMRC-1,16065773,3.457331493974802,2.883121550137551
CAL-51,5328940,1.595278406971918,1.8093936024127475
CAL-51,56946209,-4.496983035262223,-4.18514735480691
FU-OV-1,5329102,1.609553320034118,2.002682808478732
YAPC,3062316,1.4892918633711576,0.9161911502545793
NCI-H661,11609586,3.2377833862635206,2.7503158876348754
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985,2.095756694234921
NCI-H661,serdemetan-SCH-529074 (1-1 mol-mol),2.3260585064542014,1.9489862425257263
JM-1,36462,-2.702351282209385,-0.08557639505146028
EFO-27,55508,5.431657737658487,3.6824728953527233
CAL-51,10296883,4.0377332681132305,3.848601365112749
CAL-51,123631,2.4616591372530605,2.4578509040286267
A-673,53481919,3.7180877845578073,3.3503705731180826
JM-1,107970,1.4704012549786991,1.7712739537179047
CAL-51,5278396,3.885366261927898,3.5696720499720884
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475,0.036412780623394495
KYSE-70,4096211,2.254549645630953,2.2731307239032588
DMS 273,11609586,1.9163652577621844,2.157786667983176
EFO-27,9903786,4.039986452778869,3.0919157037688016
CAL-51,6917907,-8.395782425589301,-5.294011701612875
A-498,54454,2.893611310147977,2.6177078838850103
A4/Fukuda,49793307,-5.572580515048152,-3.9040937588973925
NOMO-1,4259181,0.2459758371125145,-0.5925200738737112
SNU-449,107985,-3.1392486992039235,-3.3886248649353647
FU-OV-1,5278396,3.713343254157872,3.5807528608188637
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908,3.7469446610765935
A-673,5460769,1.3883868162718005,2.3706403560081157
SCC-9,568763,0.9120329628896908,0.8685079747145059
CAL-51,72199292,1.0008292341873897,0.548336003237049
MDA-MB-157,8515,2.4995790404865983,3.9819811750247482
NCI-H661,374536,3.546483103952357,2.4137515734827506
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077,2.135199061651098
FTC-133,53392493,3.195209876090235,2.775194122951408
SBC-5,selumetinib-tretinoin (2-1 mol-mol),5.430491518611957,3.1260532309796467
SNU-61,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6699368728217061,2.994112158720181
BxPC-3,selumetinib-MK-2206 (8-1 mol-mol),0.2275715298784707,1.9781030275134177
NCI-H2009,3825829,4.333180881174198,4.106986069546879
A-673,6610216,4.190818336865809,3.925276579475187
LXF 289,1750826,-0.5305094201812034,-1.3921194279385072
MDA-MB-453,44543605,3.7347256504274418,3.8617869243196328
BT-549,24964624,2.3327253679943696,2.624008761040942
DMS 273,24797083,1.0969779553781829,1.2889655719742021
NCI-H2009,24856436,-1.037334288977755,0.5745291750712319
ONS-76,73707440,4.1934861569389845,3.8018797991861883
NCI-H2009,1242560,3.090706196906407,3.725233358865661
NCI-H2009,6610355,3.511475006316147,4.5810276593679635
CAL-51,51039095,2.1842093640891416,2.797487152282977
CA46,11404337,-2.4021967063511434,-1.1621121255320328
A-673,decitabine-navitoclax (2-1 mol-mol),0.9419890820834614,0.6155162648426533
NCI-H292,11152667,0.5464898224488388,-0.49513906665384716
CAL-51,25154868,4.656760297450745,4.3231949018838955
NCI-H727,doxorubicin-navitoclax (2-1 mol-mol),0.353164953880874,-0.880450978041354
HSC-4,66577038,3.591157601556467,2.933599717869937
LoVo,11175137,1.7419612548831422,2.5545536410187437
Panc 04.03,46215462,2.9027075063139804,2.0022890231117363
G-401,1750826,-3.031444880989549,-2.2964697020607434
SCC-9,462382,0.912003027061621,0.47617869551821707
NCI-H2171,71304818,1.9125624841179896,2.1124090224862297
NCI-H2171,6252,2.1051572182795,-1.0539618394180514
G-401,51037431,3.9974576184013726,2.9830558983846838
SNU-61,219104,3.1068483513637033,3.2383614198711994
SBC-5,60750,-3.858196401702703,-1.8809368075255037
JM-1,72734382,2.7239851923699443,3.571506122712665
EFO-27,2733526,4.707486415914075,3.6667690791631666
A4/Fukuda,71466445,1.4546499284121797,2.225832486814864
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355,2.8107015986412893
NCI-H460,24797083,0.9153025805785596,1.3689640085904937
A4/Fukuda,54596558,4.022693113590735,4.315453957811259
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405,-0.50681820118369
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492,2.3183672772958146
HSC-4,44202524,5.184990397771561,2.286864687154973
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592,3.0431956261502067
SNU-61,selumetinib-piperlongumine (8-1 mol-mol),1.4116770683714617,2.2394820602879495
OPM-2,9915743,0.7579871544404475,0.47102094834606234
CA46,56949517,4.303265452215328,3.401974122370165
HSC-4,tanespimycin-gemcitabine (1-1 mol-mol),-4.488052486534361,-0.670917040255593
CAL-51,24785538,0.7720267524795773,1.6490802816568055
EFO-27,navitoclax-piperlongumine (1-1 mol-mol),2.507192070148125,2.0082158541274833
CAL-51,10322450,3.881825194853649,3.953346839051463
A2780,241158,1.61479428578643,3.30953336373278
CA46,JQ-1-UNC0638 (2-1 mol-mol),-0.7861923396287928,-0.10634273469286182
LXF 289,10074640,2.806214579062189,3.1867665644102994
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928,-0.46071916750920716
NCI-H522,119607,5.115168095819997,4.831748240731076
A-498,6918638,1.620608219340894,0.798288441809158
CA46,10302451,0.2515382956842912,2.6445522464083293
NCI-H727,11152667,-1.354343634557878,-0.1554578291293953
NCI-H292,135999136,4.360218039072087,4.047426140577342
NCI-H292,322968,4.489137987914782,4.113402883332652
KMRC-1,11238147,2.6910045327617422,2.748137436393595
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264,0.9648159845176513
NCI-H522,9911463,3.273817127322074,3.514927054180232
A4/Fukuda,26596,-3.7061252239164553,-2.4362549922313477
CAL-51,2945648,2.7250935788350064,3.110737563858698
FTC-133,10113978,5.149340897630058,3.389349884014696
G-401,25227462,-4.354739504605027,-0.2896210609462753
CAL-51,3634881,3.319714226315486,3.390737677082883
NCI-H522,5280436,1.9285860105900432,3.012647952368763
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278,1.8243846159991355
A-673,285033,-3.783680268063714,-2.8030325929680107
KYSE-70,11497983,4.3699696445826035,3.755836567307855
EFO-27,135423438,3.7049046399150134,2.5410940904024946
CA46,26596,-3.5845712744961324,-2.8326681733931163
A2780,24785538,0.5365701421591345,0.7250003798241687
NCI-H2009,8515,4.894015987740437,4.1107200693994175
DMS 273,carboplatin-etoposide (40-17 mol-mol),3.245479848916456,1.7199211253617674
JM-1,387447,-6.033292615187937,-5.177136029631571
DMS 273,9956119,4.190734481617164,3.282715237470198
A2780,navitoclax-birinapant (1-1 mol-mol),-1.2503932555480053,1.1037988419103275
NCI-H146,36462,-0.9223549938225544,1.3215284867833648
NCI-H1623,11485656,1.644044907667622,2.4572432143402434
NCI-H1623,24821094,-0.2323488781711246,2.8607271350491033
HSC-4,53301938,4.738168418112686,2.4272620909823512
LOU-NH91,676352,2.464978676736505,2.1848914850838486
NCI-H146,46926350,-6.324766796143129,-4.2909306664236535
ONS-76,16722836,1.7132123007700326,1.7026694011803059
YAPC,327653,3.117178905090827,3.2987997475421826
OVISE,24901704,4.2849421736627615,3.49811909824128
JM-1,54618164,3.458143614246244,3.5324615003571616
A-673,445091,4.1466370846962075,3.921450528407651
OVISE,5329102,2.956482132219437,2.134400600452323
HCC1143,5470400,2.3870928447001867,-0.4066525167584669
BxPC-3,salermide-PLX-4032 (12-1 mol-mol),4.912455807166081,4.850160025421958
SNU-61,3503,2.986460298481687,2.338843980243907
DMS 273,11455910,0.4737958394902512,0.578521464326894
NCI-H460,46907787,4.3372157131836255,2.512983389765001
CAL-51,216345,2.9520334452605637,3.962591160761999
A2780,6450551,0.1349302943593443,1.6320242550708484
LoVo,46398810,1.578557668618055,2.4237073297907727
SNU-81,15953870,1.3050219745867302,3.4448976257004564
A-673,54613361,-0.6759826855411176,-0.43148086727185164
SBC-5,11234052,4.136817608168693,4.147035861644139
NCI-H460,36462,3.103581216464206,2.360442342119469
MDA-MB-157,selumetinib-JQ-1 (4-1 mol-mol),4.112916907677963,1.8024221103285478
A-673,168313200,1.7801049656035806,2.815963249703951
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645,2.0844013852483934
A2780,100016,4.757543521992015,5.583748536893551
NCI-H727,selumetinib-tretinoin (2-1 mol-mol),0.6638203077807998,3.4022074332450227
CA46,25105715,3.628482142858773,3.0510975114731496
HCC1143,9911463,3.749174224015704,3.883569450461689
LOU-NH91,4477,1.3512747052000795,0.662524043468966
A2780,UNC0638-navitoclax (1-1 mol-mol),1.9262711606440108,1.1934418687431583
FU-OV-1,25154868,3.6525772823030502,4.3315801589204375
A2780,168313016,3.896841135664639,4.345685232190477
MDA-MB-453,JQ-1-UNC0638 (2-1 mol-mol),-0.1830175507337199,0.8006629691521759
FU-OV-1,selumetinib-piperlongumine (8-1 mol-mol),2.8006116127321463,3.180469911435066
NCI-H292,15547703,3.23498204624142,3.311523219933232
JM-1,5329102,1.4301495534996294,1.0626796733005828
NCI-H522,3384730,2.8239588226941104,2.2951958714145446
A2780,9911463,2.7303797257759235,3.454204899960085
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744,1.5041861793087135
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642,3.281716113758067
YAPC,9887053,4.707664045043398,4.108192288684032
HCC1143,10074640,2.8253679093766104,3.1719951267426723
LXF 289,11178236,-2.9660816129263297,-3.1866383088386634
A2780,ISOX-bortezomib (250-1 mol-mol),0.49630436037141,0.49260162467650603
KYSE-70,135398516,2.3739819683449697,1.9555830999656618
A-498,57519531,4.461574036812888,3.0602713445915413
NOMO-1,9840324,6.741383080584752,5.088850392910772
BxPC-3,10427712,4.346184062898943,4.357216608082225
NCI-H292,selumetinib-decitabine (4-1 mol-mol),4.672876887029793,3.8097825379117953
LoVo,25062766,1.8850615394111836,2.121318729873778
FTC-133,262093,3.024825063724614,2.6588112267457635
HCC1143,44819697,-2.8669414823386115,-0.5036111442879257
BT-549,5351362,2.1022372489581227,1.5191159222124384
FTC-133,selumetinib-navitoclax (8-1 mol-mol),3.0170288782836163,2.0621374058957
MSTO-211H,53325874,5.432400358349695,4.720159465204967
NCI-H460,serdemetan-SCH-529074 (1-1 mol-mol),2.824761318038116,2.110798646901794
DMS 273,7326481,3.48743847164077,2.8772981053689057
JM-1,11955716,-2.692308040243548,-2.38230946680708
SNU-61,JQ-1-vorinostat (2-1 mol-mol),1.221813874955551,0.048300134352546875
MDA-MB-157,2842253,6.170125707570699,5.663318014443906
SNU-61,54454,3.789888893365768,2.6600401431046214
NOMO-1,5460769,4.769752092364765,1.943976054221811
A2780,285033,-3.502152061737446,-2.6533115810694103
HCC1143,44495899,4.517503920361928,3.3923536304746875
NCI-H661,31703,-1.814857416200904,-1.0405895483985845
A-498,piperlongumine-MST-312 (1-1 mol-mol),3.2083615282552853,2.1678429162167627
YAPC,navitoclax-pluripotin (1-1 mol-mol),-0.110540489139909,-0.6793099629136176
A2780,2729026,1.9590477988732768,2.618552537804322
JM-1,89928392,-1.0810313065311572,0.3815138854259451
JM-1,10410894,1.2527004533251185,2.451033875791515
NCI-H661,16038120,1.553795977052523,1.0994315102319978
LoVo,135421197,2.0078610802467307,1.7286693031082379
HSC-4,24901704,4.088081803824046,3.6519817529485983
HSC-4,135411,-0.261300177061483,0.7540823435366663
NCI-H522,4917,2.9130794248329392,3.0557882668358984
JM-1,11364421,-7.32386861469755,-4.552389145252237
NCI-H2009,10127622,-1.471627480680591,3.76227811408393
DMS 273,4917,3.103248515982538,2.9161447724344987
OPM-2,44462760,2.3304413416808463,2.9545271877341053
YAPC,9956119,3.92905072911681,3.717617633399369
A4/Fukuda,5113032,4.450145517718883,4.49968639840328
NCI-H1623,49793307,-1.4788317062169576,-2.585833563131292
BxPC-3,637858,2.219072546092823,2.195969609397397
NCI-H1623,1566236,4.077529389730835,2.431724454077319
G-401,23725625,4.115882586635449,4.274012333003181
SNU-81,crizotinib-PLX-4032 (2-1 mol-mol),1.4380831221683867,1.5634193026480352
DMS 273,252682,6.321322886147215,6.42258474350167
KYSE-70,135411,1.9014599224142343,0.815059344808377
NCI-H2171,49867930,3.814749813399888,3.6480188479393725
SW1463,10302451,2.197754569420114,2.9653220250819907
Panc 04.03,salermide-PLX-4032 (12-1 mol-mol),5.297407479315669,5.018418701309395
NCI-H522,71466445,4.480637973076106,3.4380992285571867
NCI-H727,6610355,5.167779637611195,4.563788983899415
A4/Fukuda,613753,2.966875582154842,3.0000385665179543
ONS-76,4261,2.2909626551681757,1.5890137573779435
YAPC,serdemetan-SCH-529074 (1-1 mol-mol),2.033605312871709,2.257559848458143
KMRC-1,31703,0.3325905755235477,-0.839902516072474
SNU-449,445455,4.484776409201516,4.806534814708075
A-498,6918878,4.306638073301365,2.8815793964309444
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974,3.581941931010117
OPM-2,1750826,-5.079410714013139,-3.0303448249948186
NCI-H1623,9915743,-1.6977137550638366,1.205719827737993
CAL-51,crizotinib-PLX-4032 (2-1 mol-mol),1.2740742707449055,2.1319476510549857
SNU-449,7251185,2.777592648573664,2.71939660256134
NCI-H522,2733526,4.089503686239825,3.6755269743735806
LoVo,24180719,2.381979820549913,3.471238002387771
A-498,49793307,2.582548635431232,-2.1410513565840024
FU-OV-1,selumetinib-PLX-4032 (8-1 mol-mol),1.0793153404708502,3.507000809174611
NCI-H522,4788,5.8756804910396925,5.251779459197256
G-401,374536,1.448879337840406,1.4581283016723454
SBC-5,135440466,3.787084066930897,2.2789612185630626
BxPC-3,36314,4.043064497836865,-1.4378068207336716
SBC-5,11626560,2.9533832336239985,1.8487599168364865
OPM-2,613753,2.6904302784099845,2.8176516143899586
G-401,71466380,4.3225707153388,4.163538712471574
G-401,45279963,3.527434868311602,2.9788257586557507
MDA-MB-453,1239801,4.069717893467032,4.26150642606012
A2780,11719255,1.8256962189728296,3.132892439616685
KMRC-1,navitoclax-gemcitabine (1-1 mol-mol),-4.218093403904549,-1.5148917058022031
HSC-4,11404337,-0.2351979780524762,-0.356603371774551
A2780,crizotinib-PLX-4032 (2-1 mol-mol),0.8552062968209889,1.481621970547838
JM-1,5978,-5.097158196512326,-3.401873838668075
BxPC-3,6917907,-5.822397614063261,-4.981375330872409
NCI-H2009,52912189,1.2519346625881922,2.6290981566956617
KMRC-1,6917907,2.5901706443444477,-4.127927848494353
YAPC,selumetinib-JQ-1 (4-1 mol-mol),3.639146337556592,1.2866066745527762
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367,4.103884457595493
KYSE-70,2746,2.8005709054024224,3.2051065357857613
BxPC-3,638278,3.0042450495358923,3.338952026277288
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.8955618472132252
HSC-4,31703,-2.446577735650292,-0.7388673397068791
NCI-H661,11152667,-1.7022631730770723,-0.22223709512998632
SCC-9,73707398,1.5896934234406246,1.4736034965924534
FU-OV-1,148198,-3.302287500778492,-3.4529117692999627
MDA-MB-157,5287969,-2.775456728988527,-1.7847833536849997
OVISE,6918289,3.317561176891493,2.9459778806942563
CAL-51,JQ-1-navitoclax (2-1 mol-mol),3.0806992030623053,0.7539577638495903
HCC1143,10296883,4.463772522749199,3.9372946129019626
FU-OV-1,25150857,2.264135178575504,2.6444212812823196
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396,0.671998683489536
BxPC-3,16725315,4.1100247270568815,4.529594074459272
EFO-27,11707110,4.483747329636401,0.2745173887470623
A-673,2858523,3.068752318729834,2.8859907057565413
OVISE,5280436,4.204860612632051,3.307947703222548
NCI-H727,122327,5.896927010318378,4.642474852479321
CAL-51,448949,2.479839067238928,2.0287505449569063
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108,1.745163236329691
HSC-4,72199292,2.0552941548988506,0.9518430621505212
NCI-H2009,36462,0.0033291412741449,2.2334993670141547
Panc 04.03,JQ-1-vorinostat (2-1 mol-mol),1.3014737329174946,1.2208428579994954
JM-1,71466578,1.9829041072742877,2.68198489126073
A2780,JQ-1-vorinostat (2-1 mol-mol),0.2041997396935529,0.5912029575760717
LXF 289,67291369,3.4412292386368746,3.4620357854297628
NOMO-1,5281321,-2.1390969134868656,-2.277591281064009
NCI-H661,387447,-3.746079371333459,-4.223718096750627
NCI-H460,10385095,2.2920897819597896,1.1889989647770747
EFO-27,3543504,5.270070957864149,4.47026582849106
NCI-H2009,11497983,-2.437134563400756,4.215914968678746
NCI-H2171,4917,1.7834364774656617,3.0467508771431135
MDA-MB-157,4578,4.4846224734546025,4.700394883957722
A-673,9935249,0.595201632659186,2.0262285580079724
NCI-H146,4096211,2.4692816884948856,1.7088456731531578
NOMO-1,60750,-2.6028640292275567,-3.0304518320969085
NOMO-1,676352,2.3647709516043336,1.9512740484465896
SNU-81,168312962,1.078666024421789,1.3826548779936234
A-673,3081361,1.7117642477526505,2.0257986668056382
NCI-H460,46398810,3.30325787352206,2.729345109713167
FTC-133,24771867,3.849205905915908,2.864972536595137
KMRC-1,409805,5.852991634240623,4.851955231900198
LXF 289,2708,6.094251503540483,4.996685534246256
A4/Fukuda,11647372,-0.68075141177871,0.6518398227913227
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735,3.4973112480950452
NCI-H522,3025944,4.039653719751215,4.161202679311603
HSC-4,6918289,2.856015155241233,2.757808618414113
MDA-MB-453,erlotinib-PLX-4032 (2-1 mol-mol),2.999832239704596,2.9106377733288262
MDA-MB-453,67291369,1.3466484853812946,2.5252616261622167
A4/Fukuda,11178236,-5.149024442366163,-3.5679894630180105
NCI-H661,168313200,3.81404568417466,2.902960479816611
EFO-27,219104,4.121088157278177,3.854654328465611
KYSE-70,46191454,2.1451937437577575,1.726470359832346
SCC-9,9927531,5.254709651648818,4.9325133197427595
A-673,navitoclax-piperlongumine (1-1 mol-mol),0.5796855962539734,1.1113396908891886
CAL-51,16038120,-0.248771562775031,0.817384064208539
JM-1,3634881,1.559410928505107,2.5432176173933256
SCC-9,5113032,4.570528604758655,4.900950403515505
CAL-51,68056272,3.9955701948507247,3.7003817679235023
CAL-51,4521392,4.667802355757324,4.478247694532687
BxPC-3,navitoclax-piperlongumine (1-1 mol-mol),1.3224342280969303,1.730217379705492
Panc 04.03,BRD-A02303741-navitoclax (2-1 mol-mol),3.819752111817625,2.640804070682809
A-673,serdemetan-SCH-529074 (1-1 mol-mol),0.8484968738221454,1.6346456758949122
SNU-61,9887053,4.377899885829067,3.2388202799086305
NCI-H2009,25102847,2.121570289721804,2.7630288881121374
NCI-H661,54454,0.5886754914082402,2.7012233118806557
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603,3.4487560201879432
MDA-MB-157,46174525,4.215722898807237,4.617874958671934
LoVo,5978,-0.9838296745754056,-1.976746247059758
NOMO-1,44137675,1.7607667559168472,2.7848702765732813
JM-1,ISOX-bortezomib (250-1 mol-mol),-0.4363685688396392,-0.08690990809359421
FTC-133,216468,3.7386330008080018,3.7132465336684404
NCI-H522,5284616,3.1429047752915036,2.102652597933808
A-673,6450551,1.2504532759531255,1.6884506923426639
MDA-MB-453,2126,4.599537631708682,4.454161326426262
FTC-133,12001922,3.1425787892022656,2.007847533954482
BxPC-3,6610355,3.939463034432562,4.506243879375481
Panc 04.03,72193861,4.339971647759762,2.173966896856953
DMS 273,984333,0.9143511576606916,0.4054603677807102
NCI-H460,126941,-2.220790788147435,-2.9677292132462565
SBC-5,11178236,-5.106449128542812,-3.1543793757539818
A2780,11497983,-3.587231584220661,1.415687841006169
EFO-27,5278396,3.98166727080577,3.6491879294862497
NCI-H460,40482356,5.06381124686115,4.225183489416832
OVISE,51039095,3.497583622307714,2.949889827941835
HCC1143,56946209,-4.25120546555742,-3.7528138729018603
NCI-H2009,3025986,-0.6988289053859157,-0.6135433610285738
DMS 273,44543605,5.15097132829554,3.7911387443932902
HSC-4,23635314,4.118860430098142,-1.9121772252269427
FU-OV-1,107970,2.0514231206369686,2.1408206900702367
HSC-4,selumetinib-JQ-1 (4-1 mol-mol),3.950475054879744,1.5119002713127108
A-498,5284329,4.906845392884974,3.7608512631198296
NCI-H522,selumetinib-piperlongumine (8-1 mol-mol),2.5567872657123307,2.96469871048081
A-673,11612883,1.6900414301434703,2.13418428889117
DMS 273,11507802,0.7884214749573938,0.8802413246001648
NCI-H661,44486219,4.876697308801278,4.322654275152869
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178,3.0823975491549054
CA46,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304542005494123,3.964406532601377
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444,0.8426997036053541
SNU-449,135875424,4.841371934548395,3.9956019157379434
HSC-4,carboplatin-etoposide (40-17 mol-mol),1.986163410800157,2.925103705329939
NCI-H292,72376,-2.1951743702669573,-1.444879206186887
CA46,36462,0.0715644321871689,-0.149530252699309
A2780,54678924,1.3135335490837166,1.8285905284667254
JM-1,9926054,1.6867956204893688,1.4831419315972434
LOU-NH91,4788,5.956614254075031,5.779183116148131
G-401,navitoclax-piperlongumine (1-1 mol-mol),0.8522562027001119,0.931924367647947
YAPC,9929138,5.651296587688524,5.338492345819959
CA46,613753,2.777360120502711,2.784095349617955
BxPC-3,159324,1.5239234886257875,3.2432304656293156
DMS 273,9911830,2.0619640796568848,2.1928923210341456
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161,2.45937862006118
ONS-76,17755052,2.9613727126940126,1.5735675793860562
Panc 04.03,navitoclax-MST-312 (1-1 mol-mol),2.2985193388482177,1.390968471222508
DMS 273,serdemetan-SCH-529074 (1-1 mol-mol),2.0860866366199584,1.786434657164385
BT-549,56963564,0.7590937126260752,0.6075641700072439
A4/Fukuda,135398738,0.2588260022635366,2.8372926177834676
FU-OV-1,6918328,-0.3184221939986219,0.18312692499428948
NCI-H2171,119182,5.854927706564024,-1.2803661318087731
LXF 289,46224516,3.632609368126253,2.755477306715838
BT-549,66577038,3.347380186099457,3.1083434268510173
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528,0.932961823286551
NCI-H460,25183872,2.110783783288614,-0.5444348743133528
CAL-51,17759555,3.5733302595078182,3.665054069351581
HCC1143,4788,5.8180322078124265,5.611919167995178
NCI-H727,selumetinib-PLX-4032 (8-1 mol-mol),-1.7195859584086806,3.3910594171271047
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103,1.9732179241075831
A-673,11656518,-0.6930464248114873,1.3230366797873754
NCI-H522,12003241,-1.5672925136718587,-0.5406267113840646
NCI-H2009,19582717,2.816304614086765,4.3841095619130845
LXF 289,9911463,2.935801973679381,4.165703037640765
NCI-H1623,44202524,1.6623127043604982,2.2476366936208882
NCI-H522,9952709,3.5153076410238477,2.736924154684323
EFO-27,4378219,5.419366677908557,2.640888348519516
FU-OV-1,11404337,-0.2130364442314083,-0.39583515341969694
FU-OV-1,119607,4.651010364988691,5.304925846142308
NCI-H146,135875424,2.9115600315347057,3.7778178149729484
LOU-NH91,11152667,-0.304989451834292,-0.350618086152633
SW1463,439501,-0.3046644173954531,-2.105866675594347
LoVo,25022340,4.929882293123705,3.052675865809604
NCI-H1623,23725625,5.633484297207613,5.188752380580099
KMRC-1,439501,-2.7889227637684773,-2.1190835683228473
A4/Fukuda,9907093,3.513986602103764,3.6408956125575855
A2780,969516,2.2684147801302155,2.6351173387260003
HCC1143,24753719,5.247680835091332,4.272445095851717
DMS 273,25183872,-1.4455230978287994,-1.1775896565898172
SNU-81,3854666,0.9917295007006844,1.7380478461274407
NCI-H522,57330099,4.380671698756577,4.076667618642049
A-673,135421197,0.3124298336996849,1.276909639258654
NCI-H460,46398810,3.30325787352206,2.729345109713167
NCI-H661,52947716,-6.022145864838143,-0.8654409592806332
CAL-51,9907093,3.7886359098281783,4.085976807599176
FTC-133,erlotinib-PLX-4032 (2-1 mol-mol),4.762605584233989,3.0522049013368577
SCC-9,11640390,4.170413196512925,3.7726425199982936
SW1463,56973724,0.8689023909239705,2.738699073328856
HCC1143,24180719,4.266131781804432,3.7519019045962
KMRC-1,135398738,5.381791034510906,3.8324231552126053
BxPC-3,36462,3.4182720226712457,2.55893312982189
MDA-MB-157,4261,1.9483424687424111,1.6876016926784145
NOMO-1,2708,4.2098167660909525,3.2389877966447282
A4/Fukuda,10410894,1.64506751408979,2.9562161311554394
A2780,3384730,1.1479192192658911,2.264211060959101
SNU-449,439501,-4.772752939359215,-2.046775887221189
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288,-0.8027981317699071
DMS 273,51037431,4.4079331684726775,3.2081741069226677
A2780,16741245,2.3123767413084786,3.9003499955693934
SNU-81,42642645,1.3921275935464503,0.37814460295681585
CA46,44632017,0.5480853683486498,0.7220542329681402
A-673,71304818,1.350808371963784,2.0387964051707272
SNU-449,6914657,-4.967870149056919,-3.988136873997235
MSTO-211H,25150857,2.632878402859221,2.2013043646927235
MDA-MB-157,26596,-2.8480155125253623,-0.9019934281521206
LXF 289,9929138,7.38651684018349,5.56033783191314
G-401,25183872,-1.5190566583165497,-1.1637691952932874
A-673,241158,1.6738540084680422,3.411710228172739
SNU-61,25195348,2.878615726844662,3.302499112314472
MDA-MB-157,53392493,1.7008245883035995,2.5936336602749304
LoVo,68056272,4.365145786196869,3.5944860620245347
NCI-H2171,6918837,-5.273009588122425,-4.176577435907669
NCI-H460,168312962,-1.8333752522095308,1.5142963104629104
CAL-51,44259,0.1826439745217317,0.9645806644359888
HSC-4,285033,-0.8602386046724618,-2.0303966153491424
EFO-27,25105715,3.778793980481446,3.419081600148725
A-673,1641662,3.2069303925294625,3.026415065445164
KMRC-1,3854666,2.659759078644905,2.358985391904314
DMS 273,375860,-0.4468381354972334,-0.4781166843332285
NCI-H661,10231331,4.850159308010921,2.7032593136426497
DMS 273,16725315,5.248612259787856,3.730389684332733
NCI-H292,crizotinib-PLX-4032 (2-1 mol-mol),2.353099722482166,1.9622822295593507
NCI-H661,73707398,1.1965083244926786,1.4290272419270005
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764,-0.5384168851300721
NCI-H1623,135421197,3.7764453326534855,1.9901167093094252
BxPC-3,24951314,1.2340413323146109,1.561721086110095
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844,1.5354919222242496
NCI-H146,119182,2.1823445512420308,-0.6756567671751429
G-401,4578,4.054730999265937,4.142131849410704
MDA-MB-157,6918837,-2.759774975538005,-2.259382313410914
EFO-27,9907093,4.474758252228614,4.2090047510044295
HCC1143,navitoclax-gemcitabine (1-1 mol-mol),1.7090792961792267,-0.5009153395412745
NCI-H727,navitoclax-MST-312 (1-1 mol-mol),1.3064491848942938,1.16822358571043
FU-OV-1,carboplatin-etoposide (40-17 mol-mol),3.4615233575458992,2.7756179811871204
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023,-0.8131248289516664
NCI-H460,3025944,5.476008686130055,4.222689847869623
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122,1.475879435182729
NCI-H292,9915743,-0.4817131806939655,1.2881771158483062
LXF 289,44202524,1.498501439362416,2.59012807746294
OVISE,135411,0.7729741022965545,1.0580539693459503
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445,4.63069951656721
NCI-H2009,5746,1.7505534195957702,1.218589299534437
A4/Fukuda,10184653,1.3612642262853822,1.1337356125968532
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382,1.7510718563386383
BxPC-3,ISOX-bortezomib (250-1 mol-mol),0.0666490306431122,0.6301991620916116
JM-1,375860,-0.4977027167273706,-0.6240518566075277
SNU-61,46943432,3.2717403410494397,2.063475049634698
NCI-H146,168313200,1.5894074456272884,2.9321920631561045
HCC1143,piperlongumine-MST-312 (1-1 mol-mol),2.011691576039941,1.8523711225215767
NCI-H2171,6184667,1.4164127707768046,2.58047361832993
DMS 273,10184653,1.3805891581139824,1.2391054651961846
HSC-4,JQ-1-navitoclax (2-1 mol-mol),3.2016872805134025,0.8898931033664214
SNU-81,24856436,-0.0712468901893707,0.2872808839954337
LXF 289,71680916,5.339150924844951,4.71743581657083
CA46,5291,2.960224941202677,3.122543785440536
NCI-H2009,5329102,2.1297157842750756,2.2477526768350597
HCC1143,49793307,-2.279288310815399,-2.2113638710259322
HCC1143,15953870,6.0969880807250085,3.5095504866945824
BxPC-3,2749,2.8971498792709784,2.13165147885945
SNU-449,12003241,0.2005365129445947,-1.1424389943097004
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393,2.1624370813080684
MDA-MB-157,2733487,0.3711294020076626,6.239053995921113
NCI-H292,3025944,4.3344233170115185,4.211307499151823
FTC-133,637858,3.731185140297224,2.196210893348738
NCI-H1623,387447,-3.670338978810225,-4.114322611546393
JM-1,5394,4.3191880254190425,3.005332279548453
NCI-H292,alisertib-navitoclax (2-1 mol-mol),2.7354640490460724,0.8809188232389843
MDA-MB-453,24964624,0.7400526464517642,2.184056902426468
SBC-5,637858,3.033148612268187,2.0455237185784396
HSC-4,3825829,4.330540788358233,3.9554827222808
LOU-NH91,26596,-0.8372049149458933,-0.6637812217899949
Panc 04.03,24180719,4.502790622897018,3.592730197315947
MDA-MB-453,44486219,3.97168660448306,4.107919756138706
ONS-76,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0736426571342059,3.7394701018969165
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566,0.8843017554661745
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609,1.174466623145517
MDA-MB-453,carboplatin-UNC0638 (2-1 mol-mol),3.2412925949460223,3.2021005283909405
A2780,46398810,1.6945681809511193,2.182340806810142
ONS-76,44493528,4.396938069944904,4.4076932204198895
HSC-4,3854666,2.969420021692798,2.320057758893681
SNU-449,5291,3.951163668523845,3.7690058849573838
MDA-MB-453,216345,3.4613524333124337,3.7787085895427124
NCI-H727,71680916,5.541731669631066,4.76343744411883
NCI-H460,4261,3.676509117184606,1.8144473049014729
NCI-H2171,10184653,0.99528741531969,1.0383624144458654
FTC-133,54626689,4.834884112239084,4.706102609865014
A2780,55283,0.78738067747292,2.2404092500033546
OPM-2,753704,3.6202062566191984,4.11402430677899
NCI-H522,53392493,1.8355339375888644,1.9559640592033325
DMS 273,10127622,5.766745520319409,3.7321617991088107
ONS-76,BRD-K58730230,4.314454311755605,3.9436475859310196
MDA-MB-453,49766530,3.3081056054922064,0.1732531320657608
A2780,16065773,0.67384212990199,2.083465661398145
JM-1,241158,1.7269305863155773,2.3219188168089375
A4/Fukuda,71466380,2.851115718652883,3.8623537003528954
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322,3.430965026535186
MDA-MB-157,16722836,1.792866712111087,1.7118031014085273
NCI-H460,6852167,4.590065962834362,3.023142804150315
SCC-9,375860,0.1694000381305893,-0.20351052569503775
CAL-51,54649381,3.902782783768603,3.985127089532328
EFO-27,2708,5.128228617584202,4.902747672363784
G-401,6450551,1.2745400494425214,1.6842226079186633
SNU-449,168313016,5.914877518762689,4.96419008619196
NCI-H661,654092,0.3537062860674825,-0.1720411908909685
SNU-61,5284616,3.808934677012338,2.3186705297362344
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113,0.9137967954784805
KYSE-70,25195348,5.534160735777195,3.5135408875084004
NCI-H2171,135421197,2.0026019926205185,1.5795454441152186
NCI-H460,4261,3.676509117184606,1.8144473049014729
DMS 273,1641662,3.247845954250749,2.927786323802477
BxPC-3,6914657,-4.023901786471393,-3.445666527012024
CAL-51,9936388,-5.638746232401389,-1.3075814438930666
A4/Fukuda,25161177,3.5710974046751804,3.5176318317805992
NOMO-1,24821094,3.1222382635594967,2.4206637442826313
A4/Fukuda,53232,1.4709221708336295,2.704051522823493
A-673,9840324,5.96119566119886,5.564183166942541
LoVo,613753,3.444351424595812,3.319469461696027
FTC-133,4477,0.2258553638980791,0.2618203131020923
MDA-MB-453,11214940,4.455338804672604,2.3288716524551982
A2780,56649450,-0.3009304069219352,2.97798301583971
HCC1143,89928392,0.2924123173203115,1.4753148490219323
BT-549,6852167,2.654575121453327,2.9473372117643386
G-401,375860,-0.2910974790080222,-0.06488587401582711
NCI-H661,613753,3.3170674343428708,3.1733773190527628
YAPC,71304818,2.728620236586343,2.590667866316503
NCI-H292,3503,2.756562172316919,2.66168372855417
OPM-2,44819697,-1.6539436611429392,-1.4895442425866077
HCC1143,60700,1.3373007617879429,0.040398587791866426
MSTO-211H,446155,-0.2868964860821164,2.5469755830935825
A4/Fukuda,2708,3.0461577581065007,3.590277451087811
SNU-61,126941,2.173772773827979,-2.3812802499481234
DMS 273,selumetinib-piperlongumine (8-1 mol-mol),4.661418163963333,2.3770954818572143
HCC1143,444795,4.803024181226615,4.609317164472831
JM-1,441298,2.4952150007247393,1.9448095156815333
DMS 273,44507138,4.08877163590395,2.206601795041425
Panc 04.03,5291,3.9842309161066063,3.699417621710367
BxPC-3,3062316,-1.891072672499,1.143494609586652
KYSE-70,15983966,-0.1847866067827735,-0.9539372061595474
LoVo,doxorubicin-navitoclax (2-1 mol-mol),-1.249111657931932,-0.9296163357879638
DMS 273,44607531,1.5313743675110545,1.5371294647736549
NCI-H292,5746,0.9253562515034884,1.476195592383962
NCI-H146,6914657,-5.6838858588772245,-4.645681006731389
EFO-27,25150857,3.1416161415552173,2.619205729042816
SNU-61,54618771,-0.470226071786205,0.8778749241916026
BT-549,1716436,2.964006130486385,3.0341740476899592
BxPC-3,4521392,4.6952932183187,4.309148155282958
BxPC-3,5328940,0.9544734009845622,1.6720373216606759
LoVo,vorinostat-carboplatin (1-1 mol-mol),2.43633518664014,3.2022007408641375
Panc 04.03,16013152,4.359497957481629,4.23209561784818
A4/Fukuda,3062316,0.4248767517614322,0.7760008865967505
A-673,11609586,1.032418246609784,1.9452097881967225
SW1463,322968,1.9625017896764745,3.114048980264231
JM-1,11427553,0.2949480151387566,1.1672548812590877
CAL-51,11497983,2.6322425573174213,4.185464226977305
Panc 04.03,12003241,0.3752932920389255,-0.7200469215611244
FU-OV-1,216345,4.02478525181321,4.154199377957061
NCI-H522,89928392,1.1479343378844449,1.062733441228181
NCI-H460,11485656,2.6212830818798065,2.2894279859074067
LOU-NH91,6438330,3.480541802748286,2.4993389599962104
MDA-MB-157,11228183,0.9797898244038654,2.3223255765115214
A4/Fukuda,10385095,0.4549399411675465,0.9960768374366935
G-401,241158,1.9889661714459972,3.4221000991909887
MDA-MB-157,5282054,1.4096594950320644,3.634803903614467
NCI-H522,11404337,-1.4542746262182442,-0.5679882875589443
NCI-H661,322968,4.732962604670861,3.6090690417278455
NOMO-1,65064,5.083490310509571,4.38052789282364
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284,-0.37967486141451073
BxPC-3,1716436,3.6064873492654943,3.21195180964141
NCI-H2009,24753719,4.192950544032197,4.489289141259967
BxPC-3,136227924,2.62858882862477,3.000442000867915
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967,-0.9646868873646877
SBC-5,3854666,0.5257720708282073,1.9233096899914117
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876,0.20862152522376523
NCI-H460,1750826,3.3189287492303197,-0.988766761041148
A4/Fukuda,4705,2.104501352907832,3.0119285861309
BT-549,24821094,3.680768028115557,3.2711167901735183
NCI-H727,vorinostat-carboplatin (1-1 mol-mol),4.5535915499208,3.0061465718623883
A4/Fukuda,46398810,1.5683404384737003,2.0543614224591265
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702,0.9902257844207669
MDA-MB-157,3062316,3.257879214731084,1.1524135301617333
NCI-H727,71466380,5.170266193783112,4.410211369584808
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377,2.433758260066143
HSC-4,16038120,1.7232268235274473,0.904333776866432
FU-OV-1,53392493,2.412509849766808,2.6592655928229942
NCI-H2171,3634881,2.317126021520602,2.902038033582228
DMS 273,54618305,4.272082763698834,4.04724543938168
LoVo,docetaxel-tanespimycin (2-1 mol-mol),-4.329942307031701,-3.4533889361266126
SNU-61,9926054,1.8929452670989917,1.8362042720945178
MDA-MB-453,216239,1.9202357593604051,2.335013689650709
A4/Fukuda,252682,6.117343290485243,6.414311870420602
Panc 04.03,11455910,2.454958233695195,1.2740900256270549
MSTO-211H,24951314,-1.1401244239295247,1.3390513900394185
A2780,navitoclax-sorafenib (1-1 mol-mol),1.0762822607268765,1.3298862028133251
NCI-H146,67156097,-2.3396756899377595,-0.8794012502915478
NCI-H727,alisertib-navitoclax (2-1 mol-mol),5.700791179880255,0.8786251390478371
FTC-133,25150857,3.5794152247995004,2.4179116636326077
KMRC-1,24797083,0.8876318381449373,1.461199143871866
KMRC-1,5282054,4.624285853166485,3.437780406801477
MDA-MB-157,36462,0.1516360669313773,2.083705599983782
SNU-61,11609586,2.423992088951442,2.4783770673113947
MDA-MB-157,4378219,2.6716514190617104,2.7834441751712133
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107,0.7116087468243457
A4/Fukuda,57519531,1.5811593813701257,1.6778483943336813
EFO-27,136227331,4.702115323060179,4.063332859671143
MDA-MB-453,9952709,3.2945084007394616,3.2488498957018535
G-401,54143018,0.971383874427432,0.34480281212604813
EFO-27,9927531,5.387402639259967,4.840389959519152
DMS 273,3025986,-1.574939205922683,-0.832312057205441
NCI-H522,26596,-2.5500947066960276,-1.6199481483506657
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373,2.2014417983216927
CAL-51,5280436,3.749440064194485,3.3980941697465634
SNU-449,25150857,3.008716268425874,2.5563664773224963
KYSE-70,23582824,2.6933165956875964,0.5483249976941428
OVISE,54454,2.25285494204451,2.9859606037796835
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569,2.4968026765135263
MSTO-211H,5282054,2.057664237493602,3.8655041660271494
CAL-51,16720766,0.5416929462446769,0.5274499236567375
HCC1143,selumetinib-JQ-1 (4-1 mol-mol),2.450816568945253,1.7764530885245902
EFO-27,navitoclax-pluripotin (1-1 mol-mol),-0.1072190892754552,-0.5427344662288469
SNU-449,446155,0.8119451390236352,2.6408775126483515
NCI-H146,375860,0.4213004900992469,-0.027527194561387955
CAL-51,5281321,-0.4656602142962174,-1.3189931263068793
SNU-449,navitoclax-piperlongumine (1-1 mol-mol),2.97767132898613,2.0681166414482197
NCI-H2171,44462760,3.915746717375186,2.585221009897871
SNU-61,151289,1.0402759766313254,0.9167555490895571
DMS 273,24856436,0.3584417497554937,0.25911231417439695
CAL-51,71466578,5.340961831553399,4.510501612119294
HCC1143,44607530,2.3193328073886628,2.0338320866042934
SCC-9,3136844,4.895725881728452,4.185072993477144
CAL-51,148198,-3.728190383000159,-3.62865813017216
DMS 273,25126798,4.049346019168164,3.662752739838108
A2780,JQ-1-navitoclax (2-1 mol-mol),-0.0889318851591051,0.5636171488776641
A2780,9825149,2.396834344892177,1.9036702946119
CAL-51,104842,-3.020036586723177,-2.8002620019323676
A-673,676352,1.522059533133182,1.785916719346306
FTC-133,9967941,5.123707260677636,3.8077102678920887
NCI-H2171,56963564,-0.0417490265139498,-0.3316249413257154
DMS 273,753704,5.000496745911757,4.296828314043776
JM-1,6918837,-6.173851145057706,-4.655843217270912
KMRC-1,285033,-1.948983558292048,-2.2016300749448643
FU-OV-1,54454,4.96368280899624,2.7368611162322383
LoVo,11152667,-3.1828514843907967,-0.5608545454532031
A2780,3081361,2.3669572433114663,1.9510950092850252
CA46,11497983,3.715862022418827,0.4201506755384893
EFO-27,9952709,3.7128554087131658,3.238910051252577
SCC-9,3503,2.580691900576731,2.6114478241258934
CAL-51,42642645,0.4324607401831485,0.8191548039296397
NCI-H522,462382,-0.0152056919239,0.5433272645655486
NCI-H661,44632017,0.8459474985730225,1.423439079838309
LXF 289,44137675,2.0502885463252665,3.829461233579801
SNU-61,11404337,-0.7844361329588494,-0.4359461294681546
FTC-133,15983966,2.5675405254421113,-0.5928025477868191
KMRC-1,56946209,-5.003023698532595,-3.9182042898272225
CA46,9866186,-0.3275085520058725,0.05779761999623595
DMS 273,23635314,-4.293922540672693,-2.8436010783930907
LOU-NH91,4259181,1.0248896787271708,0.44942527239966074
SCC-9,46224516,2.803045033456012,2.6350534511277264
SCC-9,6918837,-2.658799999554452,-2.6608117203115746
FU-OV-1,tanespimycin-gemcitabine (1-1 mol-mol),2.043943445508653,-0.037239238700160875
LOU-NH91,15983966,2.104720476479653,-0.9788166722013983
NCI-H661,285033,-2.1039671806681985,-2.053003365143489
G-401,16722836,1.0452487365316014,1.328122487484396
SNU-61,11964036,1.5202881054490238,0.8880920122168514
MDA-MB-157,374536,-0.5698586384338129,2.0515266830141763
OVISE,168313047,2.139797955827927,2.443884876274645
LXF 289,400769,-1.8947060859446272,-0.3855912456622088
BxPC-3,10302451,2.105262518783424,2.818281841516615
KMRC-1,446155,2.327207673229407,2.7319984531240373
KMRC-1,selumetinib-decitabine (4-1 mol-mol),7.0489920004822855,3.2481450151475753
MDA-MB-453,421610,2.7771188964172664,3.120706979775004
SBC-5,navitoclax-gemcitabine (1-1 mol-mol),-2.8520173060125296,-1.3961765752273652
OPM-2,2113511,3.5660346238413565,4.842493506779999
ONS-76,31703,-1.5971524717515937,-0.7145955416980532
CA46,100016,3.773189878640827,4.748150759683324
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817,3.3652468256300536
EFO-27,11167602,3.5204241483481686,2.6938733775642976
SNU-81,6505803,-0.5044882096333503,-0.21874553383134102
NCI-H727,1716436,2.7605133955676178,2.9951860190637127
OVISE,10302451,2.747913318530857,2.6467964155193444
NCI-H292,24772860,-1.7688616980402292,-1.8148079855283918
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279,2.113647393553926
Panc 04.03,702558,5.6133476434957,5.464321710738391
NCI-H727,24964624,2.2819429425827984,2.433625291475021
MDA-MB-157,2828334,5.757584300180036,6.101798804071081
NCI-H2009,67291369,0.975633217461442,2.8724794170962467
EFO-27,421610,3.836140121936173,3.2113306142010405
G-401,vorinostat-carboplatin (1-1 mol-mol),1.81058220615163,2.799366829132569
LXF 289,11626560,1.452143156792952,1.7104047497944312
LoVo,carboplatin-etoposide (40-17 mol-mol),1.7816353489464614,2.9366908300042547
NOMO-1,9444,3.521396869825756,3.2457874037114487
KYSE-70,24821094,5.190593902676824,2.8407007244745404
NCI-H292,104842,-3.713576042756873,-2.356529563534945
CAL-51,23725625,3.781531245600544,5.084257972995466
MDA-MB-453,11175137,2.676203543730399,2.6190850305853264
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982,-1.2546619429274983
OPM-2,3038522,1.4393753112244685,2.611423202140717
KMRC-1,107985,-3.501321688193531,-3.4788328350205653
G-401,selumetinib-piperlongumine (8-1 mol-mol),2.3292817687818768,2.600365246912117
FTC-133,9549297,5.410509835078823,2.607225918967629
HCC1143,66577038,3.1905565845946993,3.2451924048261263
A-673,73707438,5.240927680887528,3.959048984253006
LoVo,44137675,-1.419079349485425,3.5129426343782444
SNU-449,3503,2.7484718807665396,2.365645843968121
JM-1,11960529,4.3881984442046384,3.4746233756688367
FTC-133,5460769,4.281031552964228,2.7065005009809626
LoVo,3025944,2.9449078290251256,4.251813285599454
A2780,613753,3.052273906836147,2.937739686530285
NCI-H661,navitoclax-MST-312 (1-1 mol-mol),1.292744867259036,0.865033482333499
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243,0.05541034585704725
NCI-H727,119607,4.980733327072692,5.315705692637377
A2780,15983966,-5.363621110890126,-2.6067585928993697
LOU-NH91,52912189,2.021653283813576,2.500697210719654
NCI-H2171,46926350,-4.867098709680934,-4.293441292111496
JM-1,11222830,1.159649219525665,0.9212045624299465
Panc 04.03,9887053,4.247469701197239,4.10661676921062
MDA-MB-157,6918878,0.7604288199483474,2.7855531876564954
DMS 273,25150857,2.151062266440261,2.190153447601613
NCI-H2009,637858,2.463099291034241,2.217934885055415
A-673,89928392,0.0772153864579325,1.144220215224831
OPM-2,56646779,4.429673228200906,2.3430789811998274
CA46,selumetinib-MK-2206 (8-1 mol-mol),2.416379770776117,1.6522958872841502
MDA-MB-157,104842,-7.463907387011825,-2.406928811700782
ONS-76,tanespimycin-gemcitabine (1-1 mol-mol),1.9345282385200928,-0.8893123312108021
CAL-51,selumetinib-navitoclax (8-1 mol-mol),4.759192445659263,2.0991452880510857
SBC-5,23725625,4.5493880465204235,4.804523492563132
CA46,16736978,0.453820731366511,1.0913125631249874
SNU-81,5287620,-3.371703836172312,-1.874366361377656
OPM-2,9929138,4.40255967212205,5.071955303042965
CAL-51,107985,-4.126908547019261,-3.5750837074805406
SNU-61,4261,1.9153687598051303,1.578305477398008
KYSE-70,5311,1.3049127753558711,1.6199357556902916
A2780,2874250,4.6617329815359545,4.663065161925751
A2780,46843906,2.4977538844634637,2.208161542532209
FTC-133,11234052,5.0298463189452445,4.196397136486666
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448,2.202601626244933
OVISE,5282054,4.4060399380094415,3.779961034461343
HCC1143,4096211,1.556998125169598,2.354996298536375
NCI-H661,11364421,-5.690348879388773,-1.7216633579318394
MDA-MB-453,docetaxel-tanespimycin (2-1 mol-mol),-3.838890117483947,-2.15593230475997
A-673,11427553,0.6536689467636717,1.734646039657993
JM-1,6917907,-6.147483124234289,-5.839585196764732
A4/Fukuda,9926054,1.7963505717751411,1.5548827538831376
Panc 04.03,65064,5.203402541242721,5.260683512416369
MDA-MB-157,25154868,5.338832763625219,4.408176561040162
A2780,3689413,0.5219259729031659,-0.7606155276142752
NOMO-1,2828334,5.727397129817869,5.432087621458233
NCI-H292,selumetinib-PLX-4032 (8-1 mol-mol),2.9334189816499476,3.3969380388730572
JM-1,carboplatin-etoposide (40-17 mol-mol),-1.4071886446096369,0.28209677124977495
A-498,10385095,3.0502652475567347,1.67864697549076
NCI-H460,5280436,4.847067650781305,3.4668862907561016
NCI-H146,71304818,1.6140243095299662,2.0133779557558737
SNU-61,135398516,5.118120351018792,1.7393309425614631
HCC1143,9967941,5.23006520077408,3.8101942536822855
SBC-5,51039095,3.807088636542375,2.4328454629875664
NCI-H460,docetaxel-tanespimycin (2-1 mol-mol),-0.9537223333522225,-3.4232305032059984
NCI-H1623,vorinostat-navitoclax (4-1 mol-mol),1.3203635672750993,1.2315264610936696
HCC1143,44137675,2.963488174732173,3.5470179378644047
EFO-27,15983966,2.453959425588555,-0.7346148769161159
NCI-H1623,10184653,-1.536462891864862,1.2275680599770167
JM-1,216468,0.5768131010636649,0.9909308313711481
KYSE-70,5278396,3.1929088159597656,3.4122163810464134
SW1463,216345,4.078496637973622,3.8291856472268115
MDA-MB-157,54619267,4.18775168816921,4.171940086866702
LXF 289,16065773,1.584092119185821,2.77997259009371
Panc 04.03,107985,-4.416167995938274,-3.49231935312826
SNU-449,11238147,4.105269625362408,3.0305487500447517
ONS-76,66577038,3.2799369572038977,3.0401234277071474
NCI-H1623,156414,-2.396664487331107,1.2733732697866658
DMS 273,4578,4.680938801431088,4.059185468454896
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035,3.5864249510777806
OVISE,73707398,1.6715872061037895,1.4933984391125616
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818,2.2397678585570127
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902,2.2932551425906698
G-401,2945648,2.835527608429738,2.231506731902742
BT-549,89928392,1.2423762488932544,1.823570246618931
NCI-H146,107970,1.621489555747201,2.0705441890901572
OPM-2,71466380,2.758760560312852,3.6991615127270245
HSC-4,15547703,3.6362413258054063,3.2315447576878604
JM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.7552309582979843,0.7006948266972688
EFO-27,navitoclax-sorafenib (1-1 mol-mol),3.3507850442139024,1.8844147554181747
MDA-MB-453,navitoclax-MST-312 (1-1 mol-mol),1.1594914654574615,1.0481525863491463
HSC-4,17759555,2.4253306074953978,3.5518459737793835
FTC-133,2945648,3.116487231281591,3.1924091460952297
BxPC-3,3825829,3.4267099071969738,4.102105758967471
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699,3.4345888084145373
NCI-H1623,3025986,-1.391492623029173,-1.0080728135844967
BT-549,3025986,-1.1986125704978905,-0.6337528105451611
JM-1,25227462,-4.63830716322272,-2.3225768379209897
EFO-27,4477,1.1283660363220671,0.6462104861823454
LOU-NH91,52947716,2.984350097195249,0.17463910098896185
CAL-51,44489367,4.725330666921359,4.449603120686006
DMS 273,2949965,2.5486766063035056,2.4673039725546797
MSTO-211H,36462,1.134601353001676,2.328002897142975
BxPC-3,4917,2.980696163243889,3.2256965059918925
CA46,9903786,1.650432742323398,2.0282324621621806
CAL-51,156414,1.13799157004995,1.631066159675359
OPM-2,6610355,3.590135914900994,3.8761665651413013
FTC-133,doxorubicin-navitoclax (2-1 mol-mol),-1.6634242865770594,-0.9781072821617345
NCI-H661,439501,-2.903837615768139,-2.1603504262400866
Panc 04.03,9952709,3.610885547265169,3.38555741426484
BT-549,navitoclax-birinapant (1-1 mol-mol),-2.097754918128948,1.6694191365082576
CAL-51,selumetinib-PLX-4032 (8-1 mol-mol),4.984071600611491,3.763410338010364
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.700688578667866
OPM-2,2708,4.148168261065231,3.3541227250320707
NCI-H661,10385095,0.8549868667974337,1.3577372845794609
JM-1,24785538,-0.4888535449792195,0.4321178918608025
FTC-133,6610216,5.488595178062795,4.431626633286642
MSTO-211H,216468,0.7149646325927866,3.2964839746415624
LoVo,selumetinib-MK-2206 (8-1 mol-mol),-1.1472378913456864,1.6061591856680177
NOMO-1,5978,-2.430694050184869,-3.0307539126625147
DMS 273,216345,4.389361768667068,3.520064740093143
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883,2.6365776390999183
LoVo,676352,2.5317553470156646,2.141672877037412
Panc 04.03,107970,2.70125557955606,2.4544081156040005
HCC1143,11427553,3.376761154443363,2.916582181322089
BxPC-3,piperlongumine-MST-312 (1-1 mol-mol),2.334096835358741,2.060425740196896
FTC-133,salermide-PLX-4032 (12-1 mol-mol),5.419117653198884,4.744887871287889
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326,0.23395089241323577
NCI-H292,11626560,1.446983052748098,1.9315338876572283
EFO-27,3062316,-1.351094232476051,1.2344909457315645
MDA-MB-157,2746,2.873003215594031,3.3993755395907197
LOU-NH91,24180125,2.532676427085935,3.0461772053376195
JM-1,135411,-1.048960589681706,-0.08257686727498997
NCI-H146,644241,1.2089846023639548,1.857685134484152
A4/Fukuda,72199292,-0.4044306818473915,0.7877463029476811
SBC-5,135421197,2.079587314097717,1.901863600049616
SNU-81,6918837,-2.735310336273069,-3.1285049872184025
JM-1,7326481,2.606242200480973,2.5763820142426583
LXF 289,67156097,-1.7104573080698593,0.06270300188909324
CAL-51,89928392,1.068329558331595,1.6577198454934023
A-673,6505803,0.2745970276233078,-0.7941420063942581
FTC-133,carboplatin-etoposide (40-17 mol-mol),1.440649023013039,2.7943331797982065
SNU-61,15547703,3.101064478021952,2.8652202338355552
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585,1.9809065456205448
SNU-449,16065773,2.84526561612217,2.8312545229766335
MDA-MB-453,53392493,1.7017875748321412,2.5467246663764516
SW1463,11317348,3.510696959395443,2.2247211346866247
MDA-MB-157,11214940,-0.245291289631715,2.456266750601103
ONS-76,navitoclax-pluripotin (1-1 mol-mol),-0.9678858040482444,-0.9575891239360472
OVISE,44202524,4.183655897410181,2.6685356196286905
A-673,11964036,0.9382905451812168,0.9724397576171643
LXF 289,3503,2.5386473527097837,2.3304627309851944
MDA-MB-453,54678924,1.5140521677167769,2.0055216952242962
SCC-9,2749,3.600343159035071,2.242574591652142
CA46,9840324,5.575806842573594,5.3985471274777
DMS 273,54143018,0.522600880214995,0.042112180926284076
KMRC-1,selumetinib-PLX-4032 (8-1 mol-mol),3.77714123562175,3.1738305076835656
FU-OV-1,25102847,2.696211974787464,2.4764628318756303
KMRC-1,73707398,1.5458693028147192,1.3501853219086335
A2780,5287620,-3.13264442622338,-2.3854094931862715
NCI-H460,54619267,4.901891634717457,4.136549071524936
EFO-27,2945648,3.241602940948522,3.20852989885092
NCI-H522,25105715,3.4847863866008755,3.4342869806161325
SBC-5,638278,3.4285441526954687,3.1129653243069426
KMRC-1,piperlongumine-MST-312 (1-1 mol-mol),2.0343376342805906,1.8846711237046443
CAL-51,6918328,0.3807555589851347,0.0859481361231194
NCI-H727,11497983,4.370504456176288,4.026976383415231
NCI-H460,4259181,-0.2054535095090753,0.2863615232965768
FU-OV-1,16741245,4.362196150231273,3.711221684427827
SNU-449,9911830,2.1326623866395487,2.6878089954217326
NCI-H727,5278396,3.8599732465447247,3.571123673641944
MDA-MB-157,44566777,-1.1276584651283623,0.7444965724976117
LXF 289,656346,1.157307128170796,0.8154546687277979
CAL-51,176870,2.9999818119422175,3.2220181911919967
NCI-H661,JQ-1-vorinostat (2-1 mol-mol),1.2466897580827978,1.0626924373921247
SNU-61,10184653,-0.5580603125211917,1.086273258974538
OPM-2,25126798,3.830489811395835,3.460624167842417
SNU-449,49793307,-2.0136733678876335,-2.14869020457044
NCI-H2009,60750,0.952457111724262,-2.038128434006844
MDA-MB-157,60750,-2.031758614917575,-1.715148725788432
Panc 04.03,selumetinib-tretinoin (2-1 mol-mol),5.031160903281955,2.996008615695013
MDA-MB-453,44137675,2.41330993625909,3.3534560766163395
DMS 273,5287969,-2.213452126148289,-1.9447588578101347
LOU-NH91,11609586,3.3390226168587716,3.019812026876003
NCI-H661,24951314,0.8780582238506052,1.544180195455406
A4/Fukuda,6852167,0.513003696591474,1.7658638328432794
CA46,5311281,1.0891225881142432,1.7115826613330398
A2780,11625818,1.819164792403796,3.63148266399318
LOU-NH91,51039095,2.9779244840652295,2.5996969398055736
NCI-H661,4096211,1.4698398043308702,2.113846326828855
LoVo,4705,1.5085236639058903,2.869547346776427
MDA-MB-453,46926350,-4.337117227146235,-4.284884797738077
SCC-9,5738263,4.330654025732234,3.5886295491341826
YAPC,46199207,3.321634350680955,3.2457470994968944
A-673,71466578,4.1904953682389,3.7003370764613215
G-401,10127622,3.1466102465201793,3.951692784980174
A-673,5311281,0.6354511881397967,2.1791103325919607
Panc 04.03,6917907,-5.49357619863333,-4.712300054796424
OPM-2,216239,1.2934585013066655,2.0211509259713494
KYSE-70,1716436,3.404085131889099,3.079336593951407
NCI-H727,9887053,6.41036176282966,4.072248822896005
NCI-H460,11404337,1.7201854837770862,-0.20866745514314125
CA46,24901704,2.114836921018661,2.1033207735639
NCI-H292,9903786,2.498172259524573,3.0190836537780563
A4/Fukuda,9927531,3.7257201794253776,4.299038897430785
CAL-51,2113511,6.39897875596168,5.467431154053096
OVISE,409805,6.403340651497087,5.075514219013914
HCC1143,11626560,1.5863706836040057,2.1291271076400524
CAL-51,26596,-1.4638590943230956,-1.087288829134696
A-673,23725625,2.0065405091728272,4.285249985420136
DMS 273,6610355,5.006954006570411,4.2125006058772225
A2780,24901704,1.9524214470888757,2.8284865390430913
SCC-9,11494412,1.4365999648395638,1.8458747162738351
DMS 273,4788,5.897035505528926,5.503789570552277
NOMO-1,46907787,-1.215006340822028,-0.18006572563058554
EFO-27,676352,2.5978940444924703,2.2183193530146936
A-673,44607530,1.766367479354274,1.5014730482409209
SW1463,9887053,1.032433665952219,3.4009617118431414
EFO-27,54619267,4.322845534804342,4.177603725119954
G-401,9907093,3.2734126555601506,3.634135937419284
NCI-H460,24772860,-0.596461213785507,-1.7569578532321706
NCI-H292,JQ-1-vorinostat (2-1 mol-mol),-1.255345642631911,1.3620475571078776
FTC-133,119607,5.542629368531396,5.354700602963322
SBC-5,11364421,-4.061592659681506,-1.5912641694518856
Panc 04.03,5566,3.3462548914340204,3.2062294413182792
NOMO-1,6505803,0.1224616163714439,-1.1001817486929466
NCI-H146,24772860,-4.237473750878659,-2.003337816741666
NCI-H1623,11609586,3.053283731487635,2.690665483831668
CA46,208908,1.4900061271350116,2.1283692228662208
BxPC-3,9956119,3.6276214672042975,3.5585725019253704
SBC-5,BRD-K27188169-navitoclax (2-1 mol-mol),2.901601885739978,1.9743817848983753
CAL-51,10410894,3.3356149928792513,3.1767251732563464
JM-1,9927531,4.0230036766634125,4.004013071043274
FTC-133,9866186,-0.0573555179634338,1.1241319570634065
OPM-2,3136844,3.3377711403827783,3.534154139548306
FU-OV-1,3815108,2.287889788505342,2.9523224642495074
CAL-51,10410894,3.3356149928792513,3.1767251732563464
FTC-133,selumetinib-piperlongumine (8-1 mol-mol),4.667559315189104,3.205983167295795
LoVo,5329102,1.3429054297502294,2.069567524951353
A2780,168313047,2.060680306449853,2.1708987750381765
HCC1143,104842,-3.076711821193911,-2.295014913501406
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884,0.44068443674583935
LOU-NH91,6918736,-0.749268328982244,-1.711139221440135
LXF 289,11625818,3.3628594045115805,4.548683684633645
LXF 289,5311281,0.8902308213691446,2.1819937612645934
SNU-449,5351362,1.2849200933546208,1.8054457841087657
NCI-H522,135875424,3.5456342124976445,3.5561087048187816
MSTO-211H,44185566,1.3875680654995235,2.7806034083658915
BxPC-3,24964624,2.317613094015834,2.3694708486293923
HSC-4,6852167,2.6632521076475446,2.8824752498957418
NCI-H661,409805,4.01937565581764,4.954549168832439
NCI-H2009,16038120,-1.1539994385349277,1.1919466038943514
NCI-H2009,5978,-2.257242885332271,-1.7783609298966858
EFO-27,56649450,4.209581770525167,3.564200144486258
DMS 273,5287620,-2.166812480100597,-2.1798963238272964
LOU-NH91,613753,3.2819891552194327,3.3648051544936353
NCI-H460,73707438,4.549718141383013,3.745705726228488
LOU-NH91,24785538,0.7950573935003075,1.8967000462036676
KMRC-1,71304818,3.217910603872335,2.374989050706457
MDA-MB-157,carboplatin-etoposide (40-17 mol-mol),-0.0660482957905645,2.7911211214049505
LOU-NH91,15953870,3.547895487506012,3.7058461167454517
SNU-81,3384730,-0.4505726212948157,2.5369819601975188
SNU-61,1750826,-4.373387519590766,-1.591904455479045
MDA-MB-453,753704,5.23059705064669,4.890624200253736
A-673,119607,5.020937738944074,4.7932006561793505
KMRC-1,9907093,4.272059047954712,4.13885981594054
CA46,11640390,3.3312213559791397,2.5285938308144624
SCC-9,24771867,5.065268858490301,2.9968015879421337
ONS-76,5280436,3.697781558026248,3.4216186852022106
JM-1,10427712,3.737784417116883,3.6621581595315456
FTC-133,3081361,3.8958462184451697,2.2088412586685373
KMRC-1,56649450,3.8757723452520136,3.306014256751453
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073,-1.9036334420421281
LoVo,159324,-0.9516179858777442,2.812365272528766
ONS-76,2841722,4.548555296080543,4.297690685370725
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152,-3.2113545176436276
SNU-449,5460769,0.9117409452183444,2.9987440223641313
NCI-H460,6852167,4.590065962834362,3.023142804150315
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235,-2.102737327460834
KYSE-70,176870,5.518340217914711,2.8560225388094636
HSC-4,alisertib-navitoclax (2-1 mol-mol),1.936953944798388,0.9329455332242083
JM-1,vorinostat-carboplatin (1-1 mol-mol),1.5414150367145687,1.898152350263953
FU-OV-1,15953870,3.743404981829692,3.7673579491799685
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.9289889074698597
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998,1.228510208047843
LXF 289,654092,-0.8888310934038361,-0.1782516389506783
BxPC-3,9826308,0.5055656835854033,0.41330367103363036
LOU-NH91,25150857,3.1116403082593096,2.610852501363239
LoVo,JQ-1-vorinostat (2-1 mol-mol),0.1759239316074218,0.9694899810931549
A2780,375860,-0.912616297645574,-0.14723692080410228
LOU-NH91,6852167,3.2671273023515934,3.042018306265096
CA46,24753719,4.040239779097469,3.1002401180868784
HCC1143,135999136,4.602247958833588,4.158210309624072
SNU-61,selumetinib-MK-2206 (8-1 mol-mol),0.3339128925553656,1.826703398407993
CAL-51,11960529,3.662834723962616,3.980977656684585
SNU-81,20959075,-6.025577396301825,-2.5058694022823933
NCI-H522,57519531,3.3673050119485555,1.920653239083622
HCC1143,135421197,0.8918606552263807,1.8711033613462227
SW1463,24978538,1.1634359901262634,1.060026648054036
HSC-4,445091,4.370395830414555,4.3716013136274405
SNU-61,5329102,2.445912447276521,1.8737692166939994
G-401,23582824,-0.1091259215243222,0.8587426018015668
MDA-MB-157,11485656,1.3019788320898549,2.4827435545314946
NCI-H1623,11964036,0.5644570453188236,1.4680661451660948
MSTO-211H,1242560,2.686361074048806,3.5951580979172717
A-673,65064,3.1048319417370775,4.093739686547092
KYSE-70,208908,2.5295165235288004,1.8977815986132915
SBC-5,2733526,3.427490731511537,3.7994650857679044
ONS-76,6184667,3.7303112000686256,2.8831380680917773
A2780,23939,3.9158411595028046,3.686652465931891
JM-1,1566236,0.6280103536338946,1.5059459421087906
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.779276540508454
NCI-H727,ISOX-bortezomib (250-1 mol-mol),1.608281700069038,0.8678302782153535
CA46,11396600,2.515122226404857,2.5152874622178527
BxPC-3,262093,3.443903516481154,3.1456551250978957
CAL-51,1566236,2.769525954778687,2.22424683782902
JM-1,3025944,3.553601432401545,3.7843963344520444
CA46,31703,-2.2435350155349023,-3.0029472153611665
FTC-133,25105715,3.757366730830659,3.338752429276159
LOU-NH91,54649381,2.7277802519486514,3.8742705566082334
A4/Fukuda,11364421,-5.769651092108399,-4.064047178426503
A4/Fukuda,5978,-3.163562671527086,-3.021236613158993
NCI-H1623,969516,3.836806795163693,2.965642574029718
NCI-H2009,5113032,6.328717344861362,5.153847670271321
HSC-4,7326481,1.9301811465772087,2.9451713183412433
DMS 273,54639665,4.46621146803559,3.0526431297410066
YAPC,9926054,1.8358643335634888,1.908203116912071
NCI-H460,11238147,4.460003386993959,2.953438088841092
OPM-2,9887053,1.8393709016316329,2.4978067352985738
JM-1,168313016,3.8541200519849017,4.053524131926389
NCI-H1623,285033,-2.516722374910668,-1.7478923664375738
KYSE-70,5351362,2.601126509135012,1.6395029149786757
NOMO-1,10113978,3.435868796737405,2.4549002903312083
HCC1143,17759555,3.749709067386792,3.775746306616495
NCI-H292,11964036,1.1514824488888922,1.4065872978369571
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039,4.152624528121265
FU-OV-1,46943432,0.7627718951481175,2.7150493104597193
NCI-H292,4917,3.248446822462735,3.249704685574323
FU-OV-1,452548,0.3745426606957432,0.4947258058547556
A2780,24180125,2.723679145549484,2.6126885567857543
SNU-61,9911830,2.7749851076050187,2.4608151437850667
DMS 273,6918837,-4.776469138555483,-3.8644780882227776
NCI-H460,54454,2.7807551042334935,2.5979191372193036
SNU-61,5978,-3.491631614089224,-1.86945902214608
G-401,5287620,-2.7219963273379766,-2.0450886061692675
ONS-76,9884685,2.079600161824297,0.809406198518294
NCI-H460,6610216,4.838717363885395,4.2708682265328175
CAL-51,51039095,2.1842093640891416,2.797487152282977
MDA-MB-157,2871966,-0.7905554969861216,1.1751085774292767
G-401,46926350,-4.213486210672068,-4.276132079617714
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585,2.3742378861759423
OVISE,10184653,1.818458167845024,1.0152137243055015
A-498,6918328,1.134294475717993,0.35215105383151657
A-498,10302451,3.720340150939392,3.165108445426004
CAL-51,9935249,3.84795648434564,3.1661515063830636
NCI-H292,24856436,1.0729923244387796,0.7426195240147693
A-498,409805,6.12415200666612,5.220094513407908
EFO-27,24889392,4.405449300162506,4.42717227868705
NCI-H1623,navitoclax-piperlongumine (1-1 mol-mol),2.7839098581302366,1.597774307642842
NCI-H460,159324,4.0462841352482855,3.281590144776351
LXF 289,16720766,0.4842655504206017,0.772962983941261
LXF 289,54649381,3.6309892426510406,4.066424971464248
G-401,decitabine-navitoclax (2-1 mol-mol),2.109547843543789,0.384297415498267
JM-1,71751553,4.311473922741218,3.663448564838577
MDA-MB-157,2945648,2.730573332542116,2.777414018069278
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963,1.4154845769301112
SNU-449,67156097,3.7845495552330024,-0.33361476815531677
NCI-H2171,24951314,0.4758147687646419,0.497077507101071
A2780,24180719,2.9021439553303026,3.538218776179386
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175,-0.6429372934501113
A2780,54454,-0.2144211598876236,2.3552937455497815
A4/Fukuda,16659841,2.2699989015311437,2.7735259994828523
Panc 04.03,44137675,4.02019355498934,3.8000487266962977
HCC1143,25150857,2.69660437037969,2.443262303269872
BT-549,104842,-3.414515083122074,-2.5550924566228046
NCI-H146,11960529,3.5646000180725146,3.4885023031292497
MDA-MB-157,11238147,1.748896698587814,2.9233529945702994
SCC-9,72376,-1.0275629780171365,-1.8946531859916633
MSTO-211H,57330099,2.804758704858228,4.4013089142062265
MSTO-211H,135999136,4.2061059176098645,4.052128830069531
LOU-NH91,46907787,1.567116016960845,2.554870521891038
G-401,navitoclax-MST-312 (1-1 mol-mol),0.8926313701991264,0.4098876685002571
NCI-H2009,71466445,2.5164920571758036,4.317589594971044
OPM-2,54618771,0.7318105179081044,0.29417080663092277
A-673,1716436,1.8403672814357532,2.9345274844041915
LoVo,crizotinib-PLX-4032 (2-1 mol-mol),1.6425571440672022,1.9324603495711932
SNU-449,selumetinib-tretinoin (2-1 mol-mol),6.057400941930893,3.8552239007201687
FU-OV-1,327653,2.5930307991109784,3.1932086691455415
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247,1.09052866251962
NCI-H522,56973724,3.7409361942384183,2.345420269296683
NCI-H146,25262965,-1.0264838155868825,-1.72178509410658
CAL-51,2749,1.4482754145936665,2.052945887909417
MSTO-211H,4477,1.290064962685197,0.19759552496104887
NCI-H292,637858,2.5198155256882813,2.2641828345213852
DMS 273,3136844,4.133948633698644,3.6345622870063927
HCC1143,654092,-0.1725481204081408,0.005195331115134861
NCI-H727,72734382,4.575159301501077,4.625852441002542
NCI-H1623,ISOX-bortezomib (250-1 mol-mol),0.4701818373659249,0.678454872734624
NCI-H522,6918837,-4.666914399076351,-3.1620575791340917
HSC-4,11228183,2.0585180361700313,2.507468717252452
NCI-H1623,107970,2.966658693868389,2.3647241264376273
A4/Fukuda,5278396,2.678829799859676,3.2441295887911785
SNU-61,25062766,2.174077685737065,1.9396066400296612
HSC-4,JQ-1-vorinostat (2-1 mol-mol),2.1995872566354864,1.2747828767918141
ONS-76,5460769,1.8809234095271896,2.819999380974765
BxPC-3,448949,1.967823553768285,2.06111722529184
FTC-133,42642645,4.559192948180462,1.044031293193849
MDA-MB-453,4705,2.8938913201458583,3.1583324583330095
NCI-H727,54454,4.237398664855094,2.5768890561632953
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967,2.2729380760068456
MDA-MB-453,tanespimycin-gemcitabine (1-1 mol-mol),-3.3001321684488825,-1.4721796691788185
NOMO-1,19582717,2.563142509513499,2.9153552641772307
A2780,445643,3.2119323974162786,3.6943904374372165
MDA-MB-453,6918837,-5.413037386455184,-3.2921539478443504
BT-549,72193861,1.0619418160757952,1.9354697001107726
HSC-4,44607530,1.7156299328297433,1.7498112598999078
A-673,11455910,-0.0977898825280259,0.6435842820789064
SCC-9,262093,3.396257832039873,2.94538032428581
JM-1,148198,-6.864264453079388,-4.311419446532551
LoVo,selumetinib-JQ-1 (4-1 mol-mol),-1.8361098312254576,0.7932062315134839
CAL-51,8515,3.5852991976047863,3.964966869144921
NCI-H292,49793307,-2.523289852336332,-2.5971363104840375
NCI-H1623,2708,5.67986318014104,5.067275897147065
SCC-9,3025944,4.376039606027409,4.266731605053114
LXF 289,24772860,-1.828128181459349,-1.7069806196793404
NCI-H1623,5287969,-1.6741359655835943,-1.8016022819350908
A-673,54454,2.1191092291244877,2.6644504573507755
HCC1143,10302451,1.8641137803790455,3.2966673227019885
NCI-H292,54649381,3.811841265663476,4.04946339498421
FU-OV-1,44607530,1.1358438423183184,1.892442355163918
OPM-2,5702613,2.283159730657738,2.5017366012102666
LOU-NH91,11612883,2.793800542696417,3.117809077648369
DMS 273,11214940,1.0513565801549722,1.942324097351539
FU-OV-1,65064,4.9743661807936235,4.877620784419866
A4/Fukuda,23635314,-5.004930640559638,-2.5466373797333186
NCI-H146,44137675,3.928890295501361,3.5132817551734274
NCI-H727,carboplatin-UNC0638 (2-1 mol-mol),3.50410186086625,3.360331139879434
YAPC,navitoclax-gemcitabine (1-1 mol-mol),-2.531110642636913,-0.5660200731291093
SCC-9,25105715,3.642638215460893,3.4202215921263486
HCC1143,219104,3.69834662828724,3.804714971788328
CAL-51,46215462,0.9657515518660452,1.7889804304363466
FU-OV-1,9936388,1.7648084748519457,-0.2084824383048156
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725,4.128366056429482
A2780,65628,0.1843862993724733,3.690617695423403
SNU-81,11647372,-4.046967337474091,0.49801195111220076
NCI-H460,44589607,4.73035444754351,3.126696444268859
SNU-449,9549297,4.8793656902716345,2.7552255460598216
SCC-9,11625818,5.698343618019975,4.467067481262571
LOU-NH91,54619267,4.2625648850210665,4.196432021448773
SNU-81,676352,1.7899908822518449,2.0523998275332858
CA46,4096211,0.9281979530192106,0.9211038340988889
FTC-133,6918638,0.7173410835371117,1.073868603276181
A-673,10074640,2.0498537136670696,2.857825304069586
FTC-133,9907093,5.562055210260789,4.117219959761901
HSC-4,24775005,4.677905847548428,3.5150481841859835
A-498,selumetinib-PLX-4032 (8-1 mol-mol),2.57044020856199,3.393275218566939
CAL-51,11964036,0.7531640395115359,1.4017578738903744
NCI-H146,16736978,0.7510083752799234,1.311595287097188
YAPC,15547703,3.1542356669454055,3.216301271288374
NCI-H1623,25195348,2.589072393428722,3.5845680294259217
JM-1,5311281,0.5908340552261697,1.8576537531479709
SNU-61,9840324,5.730394861191507,5.6961906079373
CAL-51,322968,3.332930006684798,3.802765345906167
BxPC-3,613753,3.1887459622848935,3.353416950952783
A4/Fukuda,9887053,3.945623871756388,2.9005220386193407
ONS-76,119607,5.207716304164231,5.192440113865535
G-401,11955716,-2.313708507563708,-1.731064872448786
EFO-27,9840324,6.098788849131883,5.8710603173861635
Panc 04.03,219104,4.644038290885272,4.035807565027456
HCC1143,25262965,-0.487374364701845,-0.958471706892424
EFO-27,25227462,1.7048102531951876,0.7509191323890974
HSC-4,10074640,3.187745953835862,3.1109943477123356
SNU-449,5287969,-1.7501228923890362,-1.3612963711088408
BT-549,49836020,-1.94641857460656,2.8974140348032207
BT-549,36462,2.0708174288882075,2.5536701885530917
SNU-449,135421197,1.7191553190938056,2.1049306700548405
EFO-27,49867926,4.359647239344765,4.257538285960096
NCI-H727,568763,0.1873556014231215,0.44321228964084897
SCC-9,5287620,-3.0509576220001953,-2.080044053430938
SNU-449,3543504,4.913571994290616,4.539647813893986
BxPC-3,12001922,2.0478076671218317,1.9905094943016888
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333,2.1762135322809035
NCI-H661,54618164,4.023349318575714,4.095480594921482
ONS-76,JQ-1-UNC0638 (2-1 mol-mol),1.9548647661287404,1.5401624627921107
OPM-2,5287620,-2.918074250075414,-2.359424825537242
SBC-5,71304818,1.011143162310159,2.261971044413801
NCI-H522,navitoclax-sorafenib (1-1 mol-mol),2.7725846762531856,1.1638436736741182
CAL-51,216468,1.370586512271769,2.945122823525015
MDA-MB-157,25150857,3.068531629493821,2.31282626442461
ONS-76,10074640,3.173150149140259,3.1869847531004307
NCI-H2009,5470400,0.3791383114910072,-0.3100246535487483
CAL-51,54619267,4.1828818787298765,4.1028237912760845
A4/Fukuda,5738263,2.3624425097256676,2.5818441983720377
SCC-9,1239801,5.7667211168431205,4.29940773188451
CA46,11152667,-1.1506421067609531,-2.3313422399972126
LXF 289,9444,4.020808033871241,4.241942959448545
Panc 04.03,25062766,2.3535958479396166,2.2948780366547488
MDA-MB-157,71466445,-0.8161407888171323,4.227561124871126
NCI-H661,10302451,1.6315200392387812,3.3589817984389385
NCI-H522,10385095,0.7404415633977295,1.2236109091870766
LoVo,53495165,-1.2075385636979648,0.5449837988750825
NCI-H1623,613753,3.253043904005535,3.5017672277966
SNU-81,49836020,-3.195484765979539,3.0856928732486186
A-673,73707371,5.345141037142936,4.053284288296823
JM-1,71466380,3.0146886034862885,3.8829755268595556
MDA-MB-453,135659046,3.699316020945489,3.71102439513008
LXF 289,72193861,1.9781400147016948,1.9595021131941381
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165,2.6100567718820975
Panc 04.03,46843906,4.199928797005276,3.3773833048298143
NCI-H460,16725315,5.407057101640495,4.342828899747371
SNU-61,375860,-0.3575080218905608,-0.13446359523825188
SNU-61,216345,4.373705885149758,3.54901171639523
CAL-51,25154868,4.656760297450745,4.3231949018838955
NCI-H146,10172275,4.247153556222009,3.156577014329563
SBC-5,122327,4.539216274618647,4.577524171596374
A4/Fukuda,24785538,-4.18833617701787,0.4369223414196039
NCI-H727,54618305,5.896457883643312,4.437268275983051
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698,1.2031559932522393
NCI-H727,6918736,5.488213607701973,-0.5100362658951318
NCI-H522,168313200,1.7984937800694238,2.758663321918446
OVISE,11396600,4.241731433198166,3.95947791332437
ONS-76,25154868,3.0856348617246048,4.481623190646477
LXF 289,135398516,1.6034740470130215,2.400638811196899
G-401,9967941,2.755238424074781,3.351105421524397
NCI-H2171,44493528,3.677120674941258,4.107327950901816
DMS 273,135398516,0.9081791710880508,1.9117576463750807
CAL-51,219104,3.260140555917495,3.7733370649265385
SNU-449,9927531,4.924705078398161,4.734139708808709
A4/Fukuda,9840324,5.782088483619631,5.49037937857617
DMS 273,11404337,-1.7233190830375906,-0.8307473250735966
MDA-MB-157,24964624,3.531877357122639,2.6424468026462318
CAL-51,44486219,4.943814728636009,4.346895919241316
LOU-NH91,216345,4.715464564049095,4.056527928452335
LXF 289,124202324,2.1762748500922657,2.7357187093116044
HSC-4,23582824,-0.585849233367442,0.4742965728653541
LXF 289,25126798,3.2757893610597923,3.9166228887184644
SBC-5,4788,5.245695847909484,5.615765458845629
ONS-76,24856436,1.9295271968291927,0.6054313198522673
SNU-61,24753719,3.71513491278392,3.7296784795708318
MDA-MB-157,vorinostat-carboplatin (1-1 mol-mol),2.089611871642824,3.2247128269101033
LXF 289,54618305,4.64176895308047,4.680767060686556
CAL-51,9926054,2.2227862000004577,2.0755475239925185
DMS 273,11427553,3.72076353850383,1.8278715710001279
NCI-H460,25126798,4.092385726400508,3.8240574173219186
SNU-81,1716436,3.163180638308135,2.9900371707541074
SW1463,426756,2.2352578961733967,4.124855103491905
NCI-H1623,6918638,-0.0742651507067239,0.7061087525306894
NCI-H522,46191454,1.7170402718959707,1.1273498190502251
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885,1.9287603766661645
MSTO-211H,49766530,-4.866552298919663,-0.8669702051258991
NCI-H2171,11228183,-0.0614644470988351,1.0786828147071577
HCC1143,5311281,1.3434544130633397,2.605284936410814
ONS-76,10410894,3.505250871213463,3.050456881130515
LoVo,navitoclax-piperlongumine (1-1 mol-mol),1.788433807521411,1.7192335695388712
SCC-9,46398810,2.8303032541075455,2.632426788090494
OVISE,5351362,2.5456705040985708,1.7108004903866436
CA46,navitoclax-birinapant (1-1 mol-mol),3.397408717118992,0.41765114914255524
NCI-H522,5287969,-0.7039868347543177,-1.7000838417705526
KYSE-70,9840324,6.215387239369238,5.78151555668982
G-401,2708,4.061322582720861,3.8356761952816654
MDA-MB-453,selumetinib-PLX-4032 (8-1 mol-mol),5.5493324312500825,3.3749263581863027
SNU-81,selumetinib-MK-2206 (8-1 mol-mol),-1.5641952931996328,2.1339197898325013
A2780,9868037,1.6123332444026346,2.420908314626564
EFO-27,selumetinib-MK-2206 (8-1 mol-mol),3.7293539227770824,2.6624447261241335
NCI-H292,2708,4.789540620747355,5.109123700742013
HSC-4,11238147,3.6589845000918504,2.719937897677312
NCI-H2009,168313047,3.1000323585702083,2.429040584361454
OVISE,3689413,-2.3316050545360136,0.12544670221410037
NCI-H522,71751553,5.137300136027492,4.075074879416913
NCI-H661,9444,4.500292949687679,4.201798088072758
BxPC-3,54649381,3.6406106092590007,3.8946953299614804
KMRC-1,selumetinib-piperlongumine (8-1 mol-mol),4.604012019572112,2.9827231091557582
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247,0.8551957021985669
KMRC-1,10427712,4.418169957842134,4.359850274533638
FTC-133,9935249,4.194644265855045,2.80643595052077
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488,0.9071925613438606
SBC-5,5280436,3.662085558148715,2.7593590402993673
JM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.97629163512536,0.25402112774817825
BT-549,462382,0.0307570083617302,0.5999691578397158
Panc 04.03,445091,5.978315194185719,4.498264916653878
A4/Fukuda,3011155,4.269088750580724,2.584528442415198
G-401,selumetinib-tretinoin (2-1 mol-mol),2.678729484296938,3.5639598856397163
A-673,57519531,1.198988142705803,1.7786931091010814
SNU-61,3025944,3.777150750907422,4.169523143244938
CAL-51,11497983,2.6322425573174213,4.185464226977305
JM-1,12001922,1.1772658700026328,1.2551636773358277
A4/Fukuda,375860,-1.1918610484687095,-0.48550015539926755
LXF 289,5978,0.6093029371771528,-1.6485149433667516
FTC-133,5329102,4.217502606235289,2.0235808361362895
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846,3.2067053561165317
OPM-2,10296883,2.7550650350156474,3.163304276946868
FU-OV-1,4259181,1.2776952629591818,0.33133208467698166
BxPC-3,100016,6.453363473458683,6.148861495210439
YAPC,168313047,2.3481335437424957,2.490702898771328
NCI-H460,10184653,3.574651577310896,1.5558497114016574
OPM-2,3062316,1.3077504545650411,0.760443091325983
NCI-H460,9956119,4.485375019847723,3.837902501667214
ONS-76,3815108,3.0019527232257555,2.9111967348546726
NCI-H2009,6918878,-0.4863456687538305,3.0527417801541525
NCI-H727,10302451,3.178772538514987,3.3344342816671313
NCI-H727,2945648,2.622160220955332,2.7670102782257864
SCC-9,71751553,4.89059631642312,4.510928539433352
SBC-5,36462,0.3494520767872783,1.9503113711497482
G-401,4477,0.236688812816839,0.360118224728712
DMS 273,9926054,1.8030373867492464,1.7620970367468465
MSTO-211H,2828334,5.714930690846282,6.094251302062987
A2780,24797083,0.8113195258872324,1.4247473119025913
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546,1.0773012460553746
FTC-133,44486219,4.933137185021197,4.181829701548335
CAL-51,6918736,-2.0480142356294637,-1.361776619548283
NCI-H522,72193861,-0.7243330419144597,0.8643379263138762
BxPC-3,JQ-1-navitoclax (2-1 mol-mol),-0.3389644558379706,0.9570096108916796
ONS-76,25102847,3.483061373005376,2.694356238167996
NCI-H727,168313016,5.705554517808247,4.80047864694198
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484,2.2664226983879447
OPM-2,25161177,3.2493247866394497,3.203759295643289
NCI-H292,374536,1.098561227965989,2.6361666028551163
NCI-H522,54618771,1.252244709003548,1.2583368620756767
KYSE-70,44486219,3.9722791166403657,4.387519339804063
FU-OV-1,72193861,4.196952295232924,1.6861848509730604
CA46,56973724,2.349278499068081,1.8643002072524224
A4/Fukuda,2729026,2.569130626356953,2.3819346806757595
YAPC,148198,-3.117185181322903,-3.276652795458678
A-673,24753719,3.397650756866718,3.729576932829449
NCI-H1623,16659841,4.138965758514941,3.9912841446457406
NCI-H727,637858,2.2360670355510086,2.144598427179222
NOMO-1,31703,-1.8429032714500968,-2.5956919333833715
LoVo,65628,4.171555925906434,4.403779449027594
EFO-27,322968,2.5694057659070264,4.081846271363519
NCI-H2009,216345,4.438201480917741,4.136140447116652
BT-549,5282054,2.5925054001589976,3.8110069418002657
FTC-133,6918837,-2.2077574090678307,-2.265491157524216
DMS 273,54626689,4.997985813086497,4.5095591958247105
HSC-4,16741245,1.7716610997683242,3.8405842847206406
SNU-61,6438330,3.4216884605560085,2.1656399020753745
FTC-133,9936388,3.0046059879710363,-0.15340948813490038
OVISE,3815108,2.0996140723315913,2.890993395832104
NCI-H522,navitoclax-piperlongumine (1-1 mol-mol),1.629477440849753,1.157453327194751
NCI-H292,5281321,-0.9498489394799606,-1.3256758665054897
BxPC-3,25126798,3.172026591671247,3.8430847884195525
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968,4.191956361838871
BxPC-3,11213558,1.5061777503093252,1.5754729369059066
BT-549,3503,1.5652779265398058,2.6004002126920147
FU-OV-1,1716436,3.524722071533676,3.0192753939566206
MSTO-211H,15547703,3.049193057044517,3.2952375817858903
KMRC-1,11427553,3.2258060185151343,2.7511177819591217
NCI-H292,46191454,0.9903655583180804,1.7791907110314502
CAL-51,135928012,4.192641653546412,4.132687228466302
NCI-H2009,44202524,1.444691297679544,2.293078470544846
HSC-4,erlotinib-PLX-4032 (2-1 mol-mol),2.314385393540324,2.632178302268914
SCC-9,2858523,3.190510944053216,3.0073909841016753
BxPC-3,15953870,2.831569416015373,3.5619093093055505
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291,-2.5565636484940844
SNU-449,135398516,1.5851782119809552,2.2104864264569564
SNU-81,9843750,-0.6437789188002867,4.004304274912496
SNU-449,11427553,2.8197595076352564,3.185994137925671
OPM-2,11656518,2.629079922396914,0.6775829400134721
BT-549,135398516,2.1186047788766085,2.2006551154865326
OPM-2,176870,3.9257377377060383,2.5334835264507896
OPM-2,46926350,-5.934740852723627,-4.7803334513524
HSC-4,2729026,2.4603123985812276,2.710008058579055
KYSE-70,9444,4.1582482593031145,4.2237168436559305
FTC-133,9933475,4.176811369298493,1.9886818212754511
MDA-MB-157,51037431,2.1321019948022046,3.4001170255511544
NCI-H522,carboplatin-UNC0638 (2-1 mol-mol),3.513501660159428,3.1129285720375544
FTC-133,44493528,6.31419839504633,4.498341150112447
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882,-0.7284185776644897
KMRC-1,11507802,3.5140789318254426,1.9527867467498918
KMRC-1,25183872,-1.331773303463366,-1.0555859631789373
OPM-2,16219061,1.6139038412518538,2.42549572110317
LoVo,25183872,-1.0423877479811554,-0.7291160606207094
NCI-H460,navitoclax-pluripotin (1-1 mol-mol),0.2287186529333839,-0.700688578667866
FU-OV-1,6623618,4.441105176868704,2.4314221122088227
DMS 273,4259181,0.4383145170351891,-0.21014674244675294
A-673,docetaxel-tanespimycin (2-1 mol-mol),-8.62633538117336,-4.048899982079012
KMRC-1,89183176,5.996613867274686,4.263612731883383
MDA-MB-453,9825149,2.3540085594050204,2.0585082453737797
Panc 04.03,decitabine-navitoclax (2-1 mol-mol),3.786860225423862,2.2564218056082854
G-401,4788,4.978954455161412,5.304701492190398
MDA-MB-453,52947716,-7.0217551266009375,-1.805127824798257
SBC-5,6918328,-0.0891350348900322,0.018900771725620734
HCC1143,49836020,2.702530837822698,2.8628495131083955
MDA-MB-453,9956119,4.182542041452956,3.828249960518927
A-673,136227924,1.815433973878695,2.5465925023017233
HCC1143,9956119,3.9159046092458785,3.7773282104895105
OVISE,ISOX-bortezomib (250-1 mol-mol),-0.1243058727191033,0.8433080869779762
BxPC-3,11234052,5.706263551465742,4.285069953320406
NCI-H727,44259,1.5490626006331412,1.211963140258664
SNU-449,24964624,2.993830455857875,2.8819629627238808
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919,0.9448268971090951
LXF 289,3025944,3.4981276099044134,4.3031556011180285
A-498,24964624,2.395732501339878,2.6703516600445925
DMS 273,4096211,1.7794100041919845,1.4201534723372315
NCI-H146,SNX-2112-bortezomib (250-1 mol-mol),-4.105126294975654,-1.7352980051035056
SCC-9,16722836,2.261290441734353,1.6807829228110251
LOU-NH91,452548,2.191181432305291,0.27399660661289327
KYSE-70,2828334,5.886367586734188,6.123433178925498
EFO-27,6450551,4.042476340029328,2.9723242017475804
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542,3.056910532816443
SCC-9,1716436,3.7585685406918783,3.1126041826306134
NCI-H2009,409805,3.859994247591149,5.20880940961869
Panc 04.03,SNX-2112-bortezomib (250-1 mol-mol),-2.269720015649412,-0.9005868739549466
SCC-9,54618164,4.4493976732458576,4.181428409924205
OVISE,5470400,-1.924229347102114,-0.28482192635101994
EFO-27,44607531,1.7985046151445,1.6129989266217635
KYSE-70,439501,-1.7979650249976522,-2.147528591947298
FU-OV-1,JQ-1-navitoclax (2-1 mol-mol),0.4181206302825215,1.0987478311461247
NCI-H460,11175137,3.7005840280640374,2.684878357993842
ONS-76,71680916,4.956248935312428,4.566898273971031
NCI-H1623,10410894,1.736668634267143,3.2117453686572746
KMRC-1,6918736,4.048742051120841,-1.338458226649882
CA46,25161177,3.91788686206549,3.214254467403015
MDA-MB-157,6852167,3.8998726158787007,2.66469405668843
HSC-4,11364421,-0.0916399418549534,-1.5528734047899713
CAL-51,2746,3.539110169106334,3.23520854919787
SNU-449,24748573,1.9316038598597545,2.4412715231402884
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188,1.771834174142328
KMRC-1,9926054,1.768451409600443,2.0698953224875765
SNU-61,4917,3.0491510397841015,3.0016967961316707
FU-OV-1,5335621,4.183078950789895,4.586422863602767
LXF 289,44607531,1.6515112206427849,1.7334890610509577
A-673,11640390,1.6795118149646189,3.1283545466345624
DMS 273,51039095,3.4577395537233526,2.694400182398173
NCI-H460,126941,-2.220790788147435,-2.9677292132462565
NOMO-1,5281672,5.39154363605107,4.146910275567798
SW1463,11214940,-1.9875595606860448,1.914312284218749
SW1463,72376,-4.419423024557842,-2.342505662613606
OPM-2,613000,1.2483941007528057,2.338793787530095
NCI-H292,445091,4.263425815338472,4.473783954614754
MDA-MB-157,46926350,-4.132103643787292,-4.090462676658148
Panc 04.03,10296883,4.422301293811254,4.09160678280511
SCC-9,11964036,1.807051006133268,1.4006779673764536
YAPC,11626560,1.7222365359336271,1.922510044547724
LOU-NH91,375860,-0.2088041582630222,-0.08194302046344269
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831,1.2874579600684442
A2780,374536,0.6453837370733745,1.3743402288245272
LoVo,5351362,1.2957137522113673,1.3891335543025827
DMS 273,navitoclax-PLX-4032 (1-1 mol-mol),3.5987731605667284,1.1830873260392074
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277,-1.229282169041396
LOU-NH91,322968,3.304915281144932,4.214577320456331
OPM-2,54596558,4.064764759335406,4.164282085019437
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448,1.9196537292220544
A-498,UNC0638-navitoclax (1-1 mol-mol),0.9874220571731112,1.986417657682324
MSTO-211H,44137675,1.9879298255329003,3.7886936954618466
NCI-H2171,42642645,-0.8345775302937554,0.5660290129111634
A-673,5287969,-3.109107778120567,-1.8084544364166875
HSC-4,5566,3.1631957469062684,3.0832177125846805
NCI-H146,5284616,1.616711114994892,0.8684317348386779
FTC-133,10184653,4.443025626482117,1.0694134602220975
BT-549,241158,3.5488750117076484,4.042359602194353
CA46,25195348,1.4184238486273535,2.4442652392823305
BxPC-3,11497983,5.307904838671978,4.313912088901259
MSTO-211H,4096211,1.4030307395810702,2.1062071007330925
CA46,11175137,1.918070959510412,1.5361930982670213
NCI-H460,doxorubicin-navitoclax (2-1 mol-mol),-0.1987090661532434,-1.2176149981396651
NCI-H1623,5566,3.3003894636357565,3.0472880490671175
SNU-449,25262965,-2.560427276701697,-1.0238390398623654
FU-OV-1,16038120,1.1817724128349547,0.948956798571269
NCI-H460,6438330,3.783082395235063,2.3713425537840824
SNU-449,selumetinib-navitoclax (8-1 mol-mol),4.616443457041138,2.0454289328552338
LOU-NH91,12003241,-1.4006618643370652,-1.2410930583012638
NCI-H2009,89928392,1.462956527326012,1.9125535889282081
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918,1.586334971263962
NCI-H661,53495165,0.322884771008066,0.9796063724643187
FTC-133,16659841,4.779782303247626,3.8396181821652586
FU-OV-1,176870,2.993075468358777,3.404269811186272
MDA-MB-157,24771867,-2.9284017086321197,2.007301508351056
MSTO-211H,5328940,-0.7344582610548551,1.92553370933442
A-498,25126798,4.108305960475203,3.9149866237706954
HSC-4,piperlongumine-MST-312 (1-1 mol-mol),1.1147970090966637,2.0111949775340507
HSC-4,5460769,1.9290612526481368,2.3629390903990877
JM-1,9826308,-1.254578223347674,-0.23448264207589845
ONS-76,124202324,3.376244033970937,2.4094992474513193
YAPC,135984461,4.395865755985396,4.259201201903548
DMS 273,5746,-0.0149388723107023,0.4792077776167055
FU-OV-1,4917,3.642085139957623,3.094663183413
LXF 289,49793307,-1.960491877422628,-2.622013970883119
OVISE,107970,3.0608588072726444,2.4096308480237822
BxPC-3,446155,2.3080345350315015,2.7876847508758056
OPM-2,65064,2.528451354351822,4.244546022508585
SNU-81,5278396,1.9031243607798085,3.1958184478447773
NOMO-1,5351362,2.08054014163225,0.9130005259230144
A4/Fukuda,675434,3.712142385749843,4.188933170764019
ONS-76,44241473,4.684511997660941,4.726350579298757
NCI-H292,54619267,4.1033140795833445,4.15913952464551
NOMO-1,5470400,0.2862684612003833,-0.11867818255385944
LXF 289,1716436,2.59582131383783,3.044650594653159
OPM-2,71680916,3.9051822114426025,4.104971108251414
YAPC,72193861,3.178335780336401,1.8541913009371596
HSC-4,148198,-2.795908666323494,-3.4304423797439085
Panc 04.03,piperlongumine-MST-312 (1-1 mol-mol),2.325884658046027,2.2036912450179176
A-673,25161177,3.4603475867806788,3.250727838381571
NCI-H522,9866186,0.2313673592680447,0.7797389455661168
CAL-51,24772860,-2.425084956958233,-1.769375771258849
KYSE-70,72734382,4.428008981499565,4.619231278038982
EFO-27,44491742,4.311239061696844,4.2313224307275075
CAL-51,322968,3.332930006684798,3.802765345906167
OPM-2,68056272,3.036834126647856,3.069180596873526
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417,2.4617397978159556
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226,3.0170610801452233
LoVo,11485656,1.8604760547282393,2.1568017442070415
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195,2.573686113164923
CAL-51,10074640,3.192334769578339,3.2311518540267663
CA46,piperlongumine-MST-312 (1-1 mol-mol),1.0820043516957718,0.9782259814239551
SNU-61,452548,0.6134547199912214,-0.4119728385264805
MDA-MB-453,5311,-0.5257883568365231,1.3022534435732376
HCC1143,23582824,-0.3689859010226292,0.795564055616855
SBC-5,7251185,3.120445126947185,2.4277773436213286
NCI-H292,24901704,3.391496569820259,3.4722525858105007
NCI-H522,10410894,2.9293088965189553,3.103362737535804
SNU-61,23582824,2.5643180100002225,0.8670586385516159
HCC1143,16065773,2.712611567173667,2.719688698986798
MSTO-211H,46191454,1.2859626841233986,1.9424708886318063
DMS 273,72199292,5.337691921623293,0.9254314611961197
LOU-NH91,46398810,3.045211454343731,2.6266466474220547
HSC-4,135928012,4.241462346184107,4.2750868949379575
NCI-H727,3384730,3.6794289647639737,3.2992233434663336
SNU-61,4788,5.909414847709577,5.7343095043353856
A2780,5329102,1.3737092942346336,1.7732273123696973
MDA-MB-453,444795,4.759998515464953,4.350800691074512
CAL-51,BRD-A02303741-carboplatin (1-1 mol-mol),6.00849408957599,4.597037283272062
BxPC-3,11507802,0.9945684314547258,1.8262205140689682
Panc 04.03,24889392,4.270107644861146,4.214772945686943
MSTO-211H,46215462,0.9168806818627014,1.932497162480448
MDA-MB-453,11167602,2.244240898320102,2.6365457088666044
A2780,400769,-2.1774855243121425,-0.8158365865831015
ONS-76,52912189,4.881284158574923,1.849921562581179
BxPC-3,44137675,2.990010873447489,3.5951880881684004
HCC1143,753704,4.831564496260181,4.885317221351088
SNU-61,9915743,-0.5579526190142376,0.4093106595121303
OVISE,1242560,3.5076159129293956,3.507000765601142
CAL-51,6914657,-5.067352950634086,-4.621524206585845
LoVo,selumetinib-UNC0638 (4-1 mol-mol),1.1151231376311057,3.0192861916640563
NCI-H292,9907093,4.58058164849987,4.212362644145921
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032,0.7028037843763937
Panc 04.03,vorinostat-navitoclax (4-1 mol-mol),1.7756869415630383,1.2085437424276366
EFO-27,6852167,4.289895730200754,3.161288056739075
A4/Fukuda,148124,-6.6912736941139865,-3.3355834465088834
MSTO-211H,24785538,0.8010437121318222,2.0305517137333062
NCI-H661,49850262,3.557667726590132,3.7106766693504825
BxPC-3,navitoclax-PLX-4032 (1-1 mol-mol),1.642487970123168,1.746046690089354
EFO-27,4521392,4.521895501485345,4.347488801838264
A-673,65628,3.827084992759042,3.7289992941073318
SCC-9,11427553,3.060791645335887,3.0882167047716313
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954,1.239974370064199
NCI-H661,36462,2.012090600363037,2.1896910741315954
CAL-51,11625818,4.1129054868405905,4.469424591128181
SNU-449,252682,6.455952915446744,6.635635190677668
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202,1.562748665532572
HSC-4,2828334,6.111197262680893,6.295246227895165
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568,2.3348627493536505
A-673,753704,3.1138845387287657,4.43911174571176
NCI-H292,409805,3.708436738901026,5.147620592038612
NCI-H2009,72376,-1.9106633783650309,-1.3673220012465364
OPM-2,24753719,4.370940438199297,3.546169955095185
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098,3.0598495862269006
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073,3.2943729526839514
LoVo,9915743,-0.8819018227786422,0.8108086885287275
BT-549,4788,5.920199401047736,5.654527109832462
CAL-51,2858523,3.1959449804225524,2.995580472549964
OVISE,2742550,5.280611289386831,4.041817920458719
HSC-4,5470400,-1.775367561967962,-0.03326554796890124
FTC-133,3503,1.9089172693495084,2.4596102258460153
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951,0.8203541638784353
MDA-MB-453,4578,4.4862028800041545,4.16470439995858
EFO-27,16038120,2.346094356536249,1.1022784378859547
SNU-61,66577038,2.989851386241242,2.85527931406024
CAL-51,4259181,-0.5132501801478601,0.16890351105859103
CA46,decitabine-carboplatin (1-1 mol-mol),2.864981631125043,0.46220346623784747
LoVo,SNX-2112-bortezomib (250-1 mol-mol),-2.7337701225380786,-1.1142830483962494
SNU-449,3552672,3.5064135830435563,2.8026209748583386
SNU-61,44589607,2.748444545219875,2.5299494453718303
ONS-76,2945648,2.901632251679741,2.915254186371747
ONS-76,44607531,1.762572438348297,1.5359831967054742
DMS 273,2874250,4.3291006423311025,4.273499343880061
SNU-449,9840324,5.822936489993131,5.98683508749171
NCI-H460,6610355,4.949206869720499,4.2442992601089715
HSC-4,11612883,3.5946567658341197,2.963324878095885
NCI-H522,11175137,2.853962760117135,2.420516126908955
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345,2.8423416118097755
A-498,5281321,-0.4472251536664238,-1.1770746598251554
OVISE,25154868,4.508600245054991,4.589380990355027
Panc 04.03,44185566,3.115745823738928,2.825936057913184
SNU-61,49793307,-2.3504304765085573,-3.358045075153691
CA46,44607530,1.320133740199814,1.3206026326745657
SCC-9,10385095,1.4052834583911455,1.4897013882065064
HSC-4,675434,4.235689784331333,4.51704926146379
NCI-H522,16725315,3.2253372097194752,3.8138224110610666
FU-OV-1,1750826,-4.024957616345245,-1.5071741717639453
HSC-4,57519531,1.2769425534379089,2.546163996769242
NCI-H292,9868037,4.01216306257403,3.4784679917136456
G-401,52947716,-7.497954818853376,-1.0419770102039
EFO-27,5280436,2.3763113561475997,3.45647493636537
SNU-449,11625818,4.573588862325648,4.658323628325246
CAL-51,135999136,4.2132345103647015,3.5820701884130166
NCI-H146,19582717,2.457603508665216,3.4110380435359553
HCC1143,1716436,2.8430583337953284,3.0182203909791685
DMS 273,9911463,3.7655644930376257,3.3208854106059844
NCI-H460,54649381,4.173104904963283,4.00504288182631
NCI-H727,6918837,-1.02939028052569,-3.1866778361391233
BxPC-3,6852167,2.5268139587107754,2.853218861078491
MSTO-211H,168312962,-1.9489367550084584,2.238941949065328
CA46,17755052,1.7120394846678155,1.0463075165701898
ONS-76,3676137,5.654292431942107,4.7606705264991085
A2780,11175137,0.1901581111291173,2.321377274130604
NCI-H727,10427712,4.338841626329874,4.266744501792353
LoVo,241158,4.012317425862525,3.9544191758064517
Panc 04.03,3062316,3.5966054915380647,0.7846936653523515
SNU-81,54454,2.7601348658589,2.735745171287046
SBC-5,3136844,4.085952663076754,4.428455975771155
BxPC-3,4261,1.8613797726144792,1.8099481726265312
YAPC,11364421,2.3126725462898508,-1.0647734889672094
NCI-H727,387447,-3.6268426938273457,-4.137456404734499
A-673,11955716,-2.8120675934907107,-2.0596758516266616
Panc 04.03,selumetinib-decitabine (4-1 mol-mol),4.200719534788661,3.477205512452991
FU-OV-1,135440466,0.9480137026796296,2.3003869699514814
NCI-H146,25150857,0.3973439930915976,2.0531771141851927
SNU-449,46926350,-1.1609870247475182,-4.102507371101224
MSTO-211H,9840324,5.369584805162093,5.742270557999668
G-401,5460769,-1.872739736028161,2.6255264256261235
CAL-51,568763,0.0917223714484538,0.5833224015273942
MDA-MB-453,5951923,4.303369563038856,4.317830416691802
KYSE-70,66577038,3.0162273972396005,2.754533659521734
LOU-NH91,16722836,1.148829534310261,1.774480803835429
FU-OV-1,613753,3.071481920375854,3.2699740550012257
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454,-0.8289528082332197
CA46,49766530,-5.499020578204802,-2.189912958094743
SNU-61,11175137,3.4257878627613505,2.563691783090278
HSC-4,969516,2.6364274978390703,2.921584895827023
A2780,10074640,2.580771204793581,2.8455516559372795
EFO-27,10410894,3.5790791622635907,3.412020121360554
SNU-81,8515,4.116210915577815,3.2758284420527004
KMRC-1,322968,4.639571189041566,3.7970799174496985
EFO-27,54626689,4.866384531477491,4.65174404440394
LOU-NH91,9911830,2.650870613913377,2.5670726447809566
OPM-2,135659046,2.7260896342727396,3.4894176512488224
OPM-2,6917907,-6.048813777211379,-6.015221158896295
SCC-9,151289,2.789872420286255,1.0201019775775895
NCI-H661,4705,2.5155315968978127,3.1329029580783168
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904,3.7040975070908426
LOU-NH91,25154868,5.6992218929630205,4.694877080066524
NCI-H522,54619267,4.072629967998864,3.9122053562947388
BT-549,11222830,1.721965279957128,1.7882836764944487
NCI-H146,53301938,3.7804038583893504,2.1990140562067038
FU-OV-1,selumetinib-JQ-1 (4-1 mol-mol),-0.403195367038434,1.8937167761540694
NCI-H727,selumetinib-MK-2206 (8-1 mol-mol),-1.8356480928534216,2.2313043301239532
MDA-MB-453,7326481,2.376694251985227,2.8989796174534543
HSC-4,6914657,-3.070952064512468,-3.7447845172043746
MDA-MB-453,72376,-2.4391350280385033,-1.3388864990342118
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548,1.493078832505432
CA46,2130404,5.640885888744477,2.091732584959807
G-401,216345,1.83916726924219,3.301271511931728
LXF 289,54143018,0.7636513295056184,0.5794873266239535
MDA-MB-453,246676,1.942789144720036,4.066038378594814
A-498,19582717,5.689025629434131,4.555400901308974
MSTO-211H,11964036,1.836732040985672,1.6203353175427353
A-673,3552672,1.3462933778606576,2.6410772689034174
CAL-51,11152667,-1.203722258692511,-0.5285822812589518
CAL-51,67156097,-2.385254348530768,-0.8563961613235145
CAL-51,65064,3.306239750209062,4.720731465660336
A-673,piperlongumine-MST-312 (1-1 mol-mol),1.0809583866306374,1.439027912465936
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967,-0.8073758591399308
MDA-MB-157,6917907,-6.62909111977728,-4.4744889698000865
HSC-4,64971,1.7199562834608897,2.531907483421867
NCI-H460,135440466,3.295247648571462,2.2479807383597192
MSTO-211H,57519531,1.3086690033484818,2.492432055560629
G-401,9926054,1.744192331951833,1.8383739767795462
OPM-2,24821094,1.5161257655930716,2.826732765333999
NCI-H727,1641662,3.969866081416476,3.4979293938396863
YAPC,66577038,3.3954554117120224,3.1151448888187794
A4/Fukuda,36462,-0.7730347482869518,0.8473294580159206
DMS 273,135440466,3.3485559592244214,2.1792365461919045
FTC-133,445455,5.178470647326205,4.7733347645602535
Panc 04.03,72376,-2.048199615123948,-1.503152919189508
CAL-51,10302451,1.350542324147247,3.3426395340701744
JM-1,11214940,0.7147440273172748,1.1940729938997905
A-498,25183872,-0.6220750954527926,-0.4338017849284037
OVISE,44607531,3.0758971794813093,1.5435679142751102
A-673,53392493,1.8369213613876785,1.9894229047672995
LoVo,11719255,3.552916809155198,3.441199993454142
SNU-61,439501,-1.3808373898758073,-2.01169247911348
NCI-H460,104842,-2.7771726159534773,-2.697922950093719
CAL-51,11364421,-3.809863778172731,-2.5590372539638024
BxPC-3,71466578,5.509660254732227,4.681016691264048
NCI-H522,12001922,1.5621076115514363,1.9365104524689454
KMRC-1,11626560,2.283484204530191,1.7059467175668142
MDA-MB-453,5329102,2.150481946774112,2.084468065788504
DMS 273,navitoclax-gemcitabine (1-1 mol-mol),-2.068576653592491,-1.48008849792416
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.7659960204806683
ONS-76,16720766,0.8880370259188662,0.5478314556182728
EFO-27,56949517,4.565823410262603,4.447573016183781
DMS 273,11222830,1.4389641717758948,1.2221477316240625
LoVo,36462,0.97058855741136,2.2019065998491514
OVISE,SNX-2112-bortezomib (250-1 mol-mol),-0.8591608441303084,-0.7392713329194619
Panc 04.03,16038120,1.7157321990683845,1.1491223559791988
LOU-NH91,3062316,-1.7568876367320156,1.3058140942534657
A2780,9903786,1.372407357095215,2.431346017315358
OVISE,49766530,-2.0570642495309004,-0.6012103534360619
G-401,doxorubicin-navitoclax (2-1 mol-mol),-2.722419727945218,-2.0313634898934656
SNU-61,11427553,3.286064968901604,2.448589149000864
A-673,72193861,0.2228627716233472,0.7316666989678151
Panc 04.03,tanespimycin-gemcitabine (1-1 mol-mol),-1.7855747696836677,-0.7838734414793055
NCI-H2009,3815108,3.061482559784255,3.007684484036939
A-673,2126,5.190382873813306,4.188403699624174
ONS-76,10302451,3.399700001459874,3.246114380975184
G-401,9825149,1.4427851681991832,1.8231182722975925
NCI-H522,44202524,1.1337498661514331,2.0345446532522455
SNU-61,52947716,-2.831948664567002,-0.21829326352110012
A4/Fukuda,2945648,2.3216808345706035,2.4053285236442195
A-673,25105715,3.2161270828318207,3.4035641903610605
NCI-H522,11178236,-5.864645603629742,-3.430371009321091
JM-1,216239,1.5816975151035817,1.4922109702475859
CAL-51,9903786,2.1849161121493847,2.6982414373660704
SNU-449,9936388,0.4589950900054629,0.33306293693994526
NCI-H292,9927531,4.942242070848643,4.90814847954691
NCI-H2171,25262965,-0.9052216234257174,-1.7709089708385974
OVISE,selumetinib-MK-2206 (8-1 mol-mol),3.824616242676661,2.3728741228655803
JM-1,24901704,1.786623485766962,2.1758928491718224
SBC-5,656346,0.6270929807498155,1.0747695623160949
KMRC-1,89928392,3.173061856078121,1.599506032537525
NCI-H292,156414,1.4083938325335852,1.797383169186385
LXF 289,135875424,3.2815298243266553,4.29715395255848
A-673,11494412,0.2373053627626316,0.4972885089149579
A-673,5746,-2.085801833901771,0.35284705527030835
DMS 273,9935249,1.448801275140577,1.94660491418848
FTC-133,11404337,1.1811341910019733,-0.06932964688339709
MDA-MB-453,57519531,4.708696705883037,2.6148653853700936
FU-OV-1,11152667,-0.9879051128837576,-0.08447689962168121
A-673,44493528,4.641329710074662,4.195070345203019
NCI-H460,2828334,6.134119597935603,6.121475643720412
NCI-H2171,16659841,2.989016667138281,2.859850595249297
FU-OV-1,73707386,2.8924737769549633,2.694723407868253
FU-OV-1,24901704,3.02942514713799,3.4753597009118966
NCI-H727,4259181,-0.7375001764594127,0.32731716696060376
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755,3.008390843893258
KMRC-1,navitoclax-PLX-4032 (1-1 mol-mol),3.702338136233157,1.8045814559127
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574,0.06143772610055618
MDA-MB-453,17755052,-0.3952702915340721,1.3541585314117262
DMS 273,46398810,2.5474695176149527,2.3964331515510584
G-401,5278396,3.0023073980849424,3.1329799142797357
NCI-H661,24821094,2.278259467148376,3.2354127452282957
NCI-H146,11364421,-6.559818289293388,-2.5512379261646827
JM-1,24797083,0.8026470280931975,1.0630971180946387
NCI-H522,168312962,3.69802370811012,1.5835850938278182
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764,0.7716319483548468
BT-549,16736978,2.673955173636492,2.0213051165760505
A4/Fukuda,46907787,-1.6446005772830188,-0.08911053439783206
ONS-76,654092,-0.1261556450149646,-0.3878134236611808
NCI-H661,6610355,4.759868911507443,4.584253974824162
Panc 04.03,JQ-1-UNC0638 (2-1 mol-mol),2.939045539650312,1.726850858756151
G-401,25154868,3.6071608181606063,4.265924360057387
MDA-MB-453,4788,3.7423511350995255,5.457025293225743
MDA-MB-157,11960529,3.789984251684095,3.9044704669070716
SCC-9,16720766,1.7269628893506093,0.8392277614152198
NOMO-1,753704,4.4431191000277375,3.912908279080039
A4/Fukuda,6450551,1.0528971846899622,1.550270712059839
YAPC,24964624,2.625771283300636,2.496700011314411
A2780,82146,3.1377115486631273,3.495001440156959
MDA-MB-157,1566236,1.4232096904008935,2.4964104564256853
LXF 289,25183872,-1.882522005728347,-0.6529499305698352
KMRC-1,24753719,4.192591897270876,4.285877290948025
LoVo,44607530,0.9946707755477716,1.521102735334989
SBC-5,44632017,0.6241642112624288,1.4267195984704015
SBC-5,23635314,-2.6646956028329223,-1.7725730641047601
LXF 289,54619267,4.7435335143288935,4.294888334243117
BT-549,46199207,3.7007120058669623,3.262550992554503
KYSE-70,6914657,-2.943523310206574,-3.648858093721086
A2780,89928392,-0.8241966309638568,0.7933923116033711
MDA-MB-453,54618164,4.967166731196573,4.087379874280721
SNU-81,selumetinib-tretinoin (2-1 mol-mol),-2.852334261178199,2.5123947732966023
NCI-H460,4788,5.894567383019075,5.690873803003432
DMS 273,24951314,0.5391494064850418,0.7821389154337612
NCI-H460,1750826,3.3189287492303197,-0.988766761041148
CAL-51,2749,1.4482754145936665,2.052945887909417
OPM-2,1566236,0.7571858740606694,1.5553671594495526
A-673,selumetinib-decitabine (4-1 mol-mol),3.170233971616513,1.902868543694726
EFO-27,11626560,3.0674086659258646,2.18050470057216
BT-549,216345,4.357029009920563,4.233809777287633
KYSE-70,3081361,2.4267899196210982,2.342210404653809
NCI-H146,156414,1.153076826996135,1.0471183382874878
NCI-H522,135411,0.5669945497970937,0.45648130394724185
BxPC-3,6438330,1.9774707221451924,2.4047047846278553
MDA-MB-453,9903786,4.505035222499518,2.807272245947366
YAPC,5281321,0.2366473375234088,-0.877865594513401
MDA-MB-157,71304818,1.9463509570918949,2.4458669646340487
BxPC-3,56946209,-3.950691768305054,-4.26058480053189
LOU-NH91,6450551,3.4853298595759687,3.060907243509456
G-401,1242560,3.581659075050411,3.2741782839431597
MSTO-211H,3854666,2.1662920246080963,2.216918077042998
NCI-H522,25062766,2.616535601519866,1.9982056631746452
Panc 04.03,3038522,3.0958365698912154,3.0855926992387284
NCI-H460,25183872,2.110783783288614,-0.5444348743133528
SCC-9,71304818,2.8421374335972653,2.556093010788654
SCC-9,65064,5.356580923551092,4.99403473257212
NCI-H727,25183872,0.4102957812787974,-0.6537849048681966
NCI-H460,81146,4.483282466350705,4.921564825357829
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598,0.2821700679386118
MDA-MB-453,54765302,2.0573663082868405,4.025383915072206
KYSE-70,10302451,3.1884398798129525,3.1819259387020575
LoVo,49793307,-4.412709808216002,-2.8314861816434727
SNU-81,36314,-5.848392982376778,-1.8041745825520739
A-673,navitoclax-birinapant (1-1 mol-mol),1.618517186072499,0.432839081087559
Panc 04.03,2733526,4.292486036611722,3.857377532402408
CA46,9926054,1.6892727173627182,1.6775772607006463
NCI-H522,2746,2.8917767436803414,2.735013990746396
LOU-NH91,67156097,-3.1227398262817587,-0.41160023732038603
NCI-H146,5284329,3.6277290639514455,2.9845402468178124
KMRC-1,644241,4.9037113640465035,2.00945286239179
A4/Fukuda,60700,-1.3381290141173086,-1.336143418041596
NOMO-1,24753719,4.496099764979975,3.320433616501943
NOMO-1,9903786,1.612481289648159,1.8873328472571176
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182,2.655064388897898
JM-1,54618771,-0.5043757930015165,0.36443934732909566
G-401,3854666,0.6606077023561356,1.0381964973164037
EFO-27,24978538,3.143555245211511,1.4925936245070164
OVISE,322968,2.654176014952692,3.6557373098754624
EFO-27,alisertib-navitoclax (2-1 mol-mol),2.9537662820479693,0.9314556544065757
FU-OV-1,637858,1.762395691671764,2.1494184843059987
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.8524012440452142
ONS-76,11626560,1.9844806011562912,1.773856482166041
LoVo,216345,1.1599721320761718,3.886256613925448
SNU-449,9926054,1.9385314164963827,2.0624446268351746
HCC1143,568763,-0.6390257750571487,0.5031237602490932
MDA-MB-157,JQ-1-MK-0752 (1-1 mol-mol),3.739596804581883,1.7534186099611
NCI-H292,72193870,4.439424680926146,2.472198454015171
NCI-H522,11228183,3.862798460505377,1.2134816839202136
CAL-51,4788,6.061217822513647,5.422423848457054
LoVo,4521392,4.145025799048703,4.381112421564987
HSC-4,11626560,2.5873766751252436,2.066905184918583
NCI-H460,60750,-0.8382921927225392,-1.9549154900811223
JM-1,44137675,3.718094845766921,2.7985421586216703
HSC-4,71304818,1.898043557267106,2.3100274486468284
CAL-51,25150857,2.2346870378683934,2.3778549876366473
CA46,2871966,-1.7971239931694716,-0.3050056902156153
DMS 273,54454,3.225049529812471,2.5398378139765456
ONS-76,25183872,-0.170903852827654,-0.6371529955644455
SNU-61,984333,6.216581141210495,0.52389216150982
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.2379582835781975
A2780,71466578,2.665399831677294,3.8387269322479334
HCC1143,docetaxel-tanespimycin (2-1 mol-mol),-1.7966403961348645,-2.629438686023076
CA46,24797083,-0.1839530161688024,0.9878267494077215
CAL-51,135875424,4.33643967165441,3.9164161638333552
NCI-H2171,3689413,-2.7117222930063867,-1.034310716695628
A2780,11396600,2.9320615716687564,3.3656394638690386
SNU-449,navitoclax-PLX-4032 (1-1 mol-mol),3.4557412405701258,2.3272287347660874
G-401,56963564,0.504836775176006,0.21280185393341772
LOU-NH91,44632017,2.871860814691948,1.9449312292224727
CA46,11214940,-0.2735426892992921,1.3196153177798078
NOMO-1,67156097,-2.629595584457773,-2.456457581484023
NOMO-1,26596,-2.074766602044621,-2.5928953927719296
JM-1,50905018,4.16446369685189,3.506592450285164
NCI-H2171,445455,3.811797523558628,4.019121496016717
EFO-27,16736978,1.8793599511128067,1.8761013332817837
JM-1,54678924,1.2599632015511184,1.6972149360359108
NCI-H460,5281321,2.142807178276493,-1.0563438895265425
SNU-449,5738263,4.026622535351311,3.686835410915877
SCC-9,216239,3.331867398285969,2.667746402047172
G-401,10410894,3.279247022117546,3.05647303609627
SNU-61,11222830,1.6415416447740467,1.5692003916465236
CA46,2113511,3.5674790523720317,4.439534133847225
NCI-H146,72734382,2.9399655016804114,4.052511769344059
NCI-H522,613753,2.504960527289346,3.059329930382991
G-401,156414,1.0662464633968871,1.4153033017767331
BxPC-3,5470400,-0.5134005920596514,-0.62923357352965
KMRC-1,1242560,3.860865345198952,3.683232015681918
BT-549,1242560,4.319126066576065,3.7480013274729305
OPM-2,66577038,2.8274271292709536,2.664892667858043
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531,3.331676695087641
DMS 273,16013152,3.9042510131977353,3.5588148657212497
NCI-H522,448949,1.6947060599097594,1.7771023156860597
MDA-MB-157,5566,3.489209385839125,2.9325277532730016
Panc 04.03,53392493,3.71782736184095,2.8431438801395728
BxPC-3,55508,4.124435576281598,3.545328336229707
EFO-27,carboplatin-UNC0638 (2-1 mol-mol),4.02907602487195,3.742864134130597
NCI-H661,4521392,4.344795346058825,4.385204512248976
JM-1,119607,3.9456515069078,4.414114440737997
NCI-H292,SNX-2112-bortezomib (250-1 mol-mol),-1.594180190580018,-1.2585784625047407
NCI-H460,3385,3.2657114863965573,4.041979671878836
A2780,327653,2.026169684275287,2.8693890904253982
SBC-5,vorinostat-navitoclax (4-1 mol-mol),1.5319499176143987,1.249724749844653
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045,2.128409494943888
JM-1,4261,-0.3533034531676731,0.41510210120461516
HSC-4,135875424,3.4627713632233537,3.9912523599525707
A2780,44491742,3.4077888459991774,4.071771856406458
Panc 04.03,135999136,5.549073334475873,4.240178171535839
SCC-9,57519531,3.918058558817349,2.9044320194637483
LoVo,3815108,2.2685826541267615,2.893504519913354
DMS 273,71466445,2.157471967137961,2.580068346847247
NCI-H661,44241473,4.80522256986357,4.718326118492343
ONS-76,6438330,3.0471678199579206,2.08451517317755
Panc 04.03,2949965,2.626604824548014,2.9082076306960083
OPM-2,676352,1.691725548140899,1.7833623061196517
SNU-449,16722836,2.5551835494173325,1.7598157002665555
A-673,11152667,-2.304412849002376,-1.0247821069626162
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262,2.9614510636989
G-401,151289,0.7906130786084481,0.90092604086688
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274,1.645359943853969
LoVo,25195348,3.880726101323461,3.390333001874193
NCI-H1623,11404337,1.3417738865788873,-0.0511330608156392
BT-549,3062316,0.532185160328145,1.4796895503109722
NCI-H146,doxorubicin-navitoclax (2-1 mol-mol),-3.7183112313857216,-1.484068019612434
EFO-27,44185566,3.1194970070950276,2.8717903220859125
A4/Fukuda,16725315,3.095723533871789,3.690687901961274
LOU-NH91,3854666,2.9087049696787544,2.4412841040500863
NCI-H460,676352,2.985829219207002,2.1583158322591953
MSTO-211H,23725625,2.234746785874409,5.009817383275054
SCC-9,5351362,1.6846115382104403,1.5047160420506245
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699,-0.502424866971401
NCI-H522,241158,3.3210308536521156,3.41518081849765
A-673,10127622,5.418104152685571,3.5115280765607166
MDA-MB-157,serdemetan-SCH-529074 (1-1 mol-mol),2.3164799956967665,2.086977686554393
G-401,53232,3.5991410971239866,2.677039905463799
OPM-2,5287969,-2.4106191892149185,-2.3683421268201807
SCC-9,637858,3.7694424070181127,2.150191416591827
NCI-H2171,5282054,2.409902559914623,2.8519070586377437
NCI-H292,1242560,3.487131794973456,3.680698644388245
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974,1.001902079858634
CAL-51,3503,3.2899889427654245,2.2985024222093164
DMS 273,selumetinib-BRD-A02303741 (4-1 mol-mol),7.1319495853751045,3.8056789482093585
Panc 04.03,51039095,3.732934843851844,2.888325344576336
NOMO-1,5329102,1.5937414073922636,0.9310350503005042
ONS-76,1242560,3.484199229378892,3.3793062320648737
G-401,24180719,3.4290114124184568,3.2697150634734378
A-673,11485656,1.6006257465541904,1.9371597900307271
NCI-H460,5278396,3.885794996406102,3.5972859856742234
ONS-76,4788,5.851184911612036,5.6766218091752725
NCI-H661,11234052,4.193192571907383,4.1515517104217565
LoVo,46174525,4.300656487428364,4.590001580605435
CA46,135875424,2.985562686352135,3.1329441889121212
SNU-81,6610355,3.7225360861185592,4.282241834162804
MDA-MB-453,JQ-1-MK-0752 (1-1 mol-mol),0.5621675718726626,1.556315222326261
A-673,1566236,1.6605846703776754,1.898917938926661
LXF 289,55283,4.7983814176360715,2.8552342920142086
DMS 273,1566236,1.8001113918747356,2.0899053210347596
SCC-9,4477,0.0462068475019735,0.3401392222057896
BxPC-3,439501,-2.27553783948146,-2.130259854661681
G-401,3503,1.5245243202568906,2.048522466053764
SNU-449,5280436,2.098309971831213,3.4901881896812306
LOU-NH91,119607,5.561970464467383,5.4122597006710995
MSTO-211H,6918328,-0.4462053694736546,0.2863334822928411
A2780,10231331,0.3686619766312378,1.8026423060356889
SNU-449,44137675,3.6126407514409378,3.7143403016053127
Panc 04.03,9866186,0.4755964236535121,0.9548498153562502
JM-1,40482356,5.622716652052393,3.626314911567107
CAL-51,49766530,0.4609697007955676,-0.4033712171836128
G-401,11960529,4.93979495553103,3.392035795217542
HCC1143,6505803,-0.5233928936461414,-0.17671226950599409
KYSE-70,676352,2.557270596786296,2.034605955400174
A2780,135398516,-0.3122960179418635,1.4298574763627234
NCI-H292,23635314,4.8326715815763395,-1.493423552369946
SNU-449,15547703,3.400796461378631,3.319203771940662
CA46,navitoclax-piperlongumine (1-1 mol-mol),1.4441341288477034,0.25671487827695283
LXF 289,46843906,2.101940493524925,3.247736714244304
DMS 273,46174525,4.164871991455526,3.41699705411032
NCI-H727,selumetinib-decitabine (4-1 mol-mol),-1.5172256962408457,3.6167379769835533
SNU-449,6917907,-5.317414756413243,-4.647160373827381
A2780,4705,2.567744201920244,3.10955391347336
KYSE-70,73707438,4.323396479680616,3.613905344146718
NCI-H460,5329102,3.240160570329804,1.9972791545474349
NCI-H661,5282054,3.5253080606128133,3.71539712578827
NCI-H1623,119607,5.952206355872506,5.286188872187723
NCI-H522,64971,2.9291780846019413,2.314483271073814
CAL-51,11222830,1.6762547521470548,1.4447920168352177
A2780,vorinostat-carboplatin (1-1 mol-mol),2.197042842116113,2.6979090864098043
SCC-9,25062766,2.812414712404745,2.223857836295043
YAPC,31703,-0.7401868256368748,-0.7410296588052907
KYSE-70,2858523,3.054228167220651,2.93360500277191
MDA-MB-453,1242560,3.902800159671119,3.617912503398082
MSTO-211H,71466380,4.302501611697816,4.450535217433729
NCI-H2009,3689413,0.5343246791806224,0.22565874943373904
G-401,15547703,3.220896426279267,2.950579726864815
NCI-H522,11719255,2.5592835843852337,2.960217837036329
LXF 289,46191454,2.351463869671111,2.058420282819581
LoVo,71304818,2.0724805960279027,2.4588573683007833
A-673,5311,0.6764453858481513,1.0415030767643652
KMRC-1,11175137,2.246406512349146,2.584142123459273
MDA-MB-157,568763,-0.4149964884485024,0.8019046386521208
LOU-NH91,11213558,0.661761515775888,1.7193002130566637
CAL-51,2733487,8.211583338705053,6.192946667822497
LXF 289,16741245,5.010251526780332,3.9075329031852757
SNU-61,24797083,1.0556452382424049,1.6739706461033912
BT-549,44137675,4.586830027774197,3.7389296621288257
CAL-51,15547703,3.503799403292956,3.2765851070822047
JM-1,3136844,3.4340507925237307,3.442095339276434
NCI-H460,46191454,1.6495265120274705,1.8639391578022424
CAL-51,16722836,0.8083581946159574,1.8164461331596413
FTC-133,25227462,2.318225674680384,0.2593265166751602
A2780,51039095,0.059669762784491,2.366342267970474
OPM-2,54613361,-1.307423897840743,-0.651297624071794
LOU-NH91,5328940,1.6284519107294106,1.815620335531672
HSC-4,11640390,4.10313790521596,3.7624302450089355
LoVo,11222830,1.6500045227885836,1.6674904608036452
NCI-H2171,53495165,-2.473385034422452,-1.8248462729376742
MDA-MB-453,5281321,-0.6344069396712416,-0.7982413026416368
FU-OV-1,9926054,2.079351745951841,2.1571204607321963
G-401,36462,-0.1566510321668276,1.1819969724050852
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987,1.111255524359132
NCI-H1623,11427553,2.6307082318350132,2.853929218463479
A-673,6918638,-0.1443248090306654,0.2676440207200207
OPM-2,54596490,4.128803973627264,4.146848922994434
G-401,24753719,3.1602445998928186,3.8414091052200394
FTC-133,selumetinib-MK-2206 (8-1 mol-mol),6.933601402972985,2.292451434692243
DMS 273,637858,1.5802330029013405,1.3492550410496762
OPM-2,72199292,0.0645754970830883,0.3901002670631628
SNU-449,5328940,1.97588831229785,1.802097610055464
OVISE,49793307,0.0210083556696064,-2.52279781337962
A-673,11647372,1.3285775791052634,0.7498014766441756
OVISE,6918328,1.4244682512544402,0.1483925023053454
Panc 04.03,25154868,5.1819399857498025,4.473167266032224
EFO-27,17755052,1.748867275877649,2.1310105337084213
EFO-27,decitabine-navitoclax (2-1 mol-mol),3.595019869203868,2.1853687949675225
SBC-5,375860,-0.6399303579455221,-0.08658041088345642
HCC1143,selumetinib-piperlongumine (8-1 mol-mol),2.549848868109157,3.095189627758846
MDA-MB-157,451668,4.959725465812671,4.164479750931326
YAPC,54619267,5.29132207947154,4.150232747254026
OPM-2,36462,1.377546018006998,-0.06727106763259079
BxPC-3,3081361,1.7902484572067556,2.122651474602072
SNU-449,11455910,0.8938620280411973,1.1921679403422523
NCI-H1623,25022340,5.5347014016683875,3.497066748984699
NCI-H522,409805,3.737006742854017,4.1545670338138025
CAL-51,568763,0.0917223714484538,0.5833224015273942
HSC-4,12001922,2.169357927696289,1.8955567793574977
CA46,2742550,3.5037926309603944,3.255236702807078
LOU-NH91,11507802,2.1124947170440533,1.9307613110710746
LXF 289,6852167,2.2044562779321635,3.028739606236509
ONS-76,26596,0.1332187247782509,-1.4102877452260238
KYSE-70,9903786,2.353212274658888,2.546633548274374
DMS 273,10385095,0.5027476993233067,0.9006001664408566
ONS-76,3025986,-0.4351415981508911,-0.8253699217057907
MDA-MB-453,89928392,1.7795585771799345,1.3056345727581755
LXF 289,676352,2.537691956872654,2.1527711492130073
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972,-1.7117980228508967
HSC-4,135659046,3.804399419736421,3.6191885651038076
OVISE,alisertib-navitoclax (2-1 mol-mol),-0.6471026369576864,0.7599954816054038
SNU-81,6623618,-2.7236989498385733,2.464453375109467
HSC-4,5282054,3.7951129778884822,3.826066219748096
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798,0.8805977561305114
A-673,16219061,2.4523595679466954,2.5343628210854394
SCC-9,123631,1.8109604294388877,2.1866753975443163
A-673,11364421,-5.84995188170368,-3.2570665230679037
A-673,216345,3.678855080389337,3.393339710795273
A-673,439501,-3.092013019617277,-2.487769210853277
NCI-H460,1566236,4.3513012021592505,2.5323319564023783
LOU-NH91,25195348,3.759766884877561,3.299469518817127
DMS 273,23725625,4.676663171220921,4.2056167167723855
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706,2.1740424012647543
CAL-51,6852167,2.546662292056567,2.9276211206723817
OPM-2,5738263,2.0935625564909737,2.641034623790907
SCC-9,5311,1.75647433259966,1.5256471316891742
SNU-81,5291,3.232691727920098,3.400767824771373
FU-OV-1,262093,2.4810055989466018,2.9232419532977976
LoVo,56949517,2.258326270055845,4.297043034009883
A4/Fukuda,9825149,-2.050748608979426,1.8712226094420372
CAL-51,53392493,1.8808489153668793,2.4749626927965203
NCI-H522,4521392,3.962796694444569,4.08110144756434
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518,-0.200515894572156
NCI-H2009,11612883,2.3268324416241777,2.861199434517423
NCI-H292,65064,3.148033598452649,5.205046012541159
NCI-H292,44589607,3.354505508461316,3.051759678587294
KMRC-1,462382,0.2791911345900462,0.44398916180445885
A4/Fukuda,5291,3.6218734753047226,3.307563673585773
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.8765687476733
A-673,135440466,1.1776565801361647,2.243018292565155
Panc 04.03,60700,0.3719609401953118,-0.2574352854427778
LOU-NH91,66577038,3.4622279905398052,3.117180463470855
A2780,24856436,-0.502193855863573,0.15787389629607196
CAL-51,6852167,2.546662292056567,2.9276211206723817
JM-1,5311037,4.072371281952103,2.394679450475898
NCI-H460,374536,2.933441634270558,1.8951025336701641
NCI-H460,216468,4.763843832635099,3.2322314062150417
SW1463,421610,3.2195561799423804,2.946390147049151
NCI-H460,439501,-2.362377537788676,-2.0463565148018428
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393,-0.26807285394569186
MDA-MB-157,24978538,3.306703195844951,1.1090068710229588
MDA-MB-453,54618795,1.052632381834858,1.107553149833439
EFO-27,6914657,-5.685084863882177,-3.9700216853192876
NCI-H661,9866186,1.9017456959186525,1.1080030194544108
CAL-51,6623618,2.223133904662847,2.4771386749698685
OPM-2,5281672,3.1701528707347015,4.245584495876864
CAL-51,1716436,3.275997904874087,3.046368161756046
NOMO-1,25183872,-0.6960845434284378,-1.8623165578741934
EFO-27,216239,3.3875560857040887,2.5252546923127075
NOMO-1,54619267,3.207870909981956,3.690214560481286
NCI-H460,400769,-0.4007490431715684,-0.424300790258841
SNU-61,6610355,3.885584601382451,4.212352071664544
BT-549,vorinostat-carboplatin (1-1 mol-mol),4.114114464716558,3.347896795759518
JM-1,10077130,2.0136903876831993,2.3798317516168916
NCI-H661,81146,4.823771143587,4.60448433081503
LoVo,56946209,-4.467950537911531,-4.157898814830423
NCI-H522,5460769,0.5614535105182378,2.308295054354572
CA46,9927531,3.0223750820915978,3.756863265307788
CAL-51,11612883,1.9359641259018452,2.932744341800943
CAL-51,11427553,2.069280384014222,2.9070984965491657
NCI-H727,5746,2.1304383256196293,1.0706603157234706
MDA-MB-453,16219061,1.5030881414961583,3.181989112070715
MDA-MB-453,68056272,3.261695748545246,3.4071754616182215
A4/Fukuda,6610216,3.4719570509087445,3.91529293785065
CAL-51,piperlongumine-MST-312 (1-1 mol-mol),2.124506315707809,1.7227768172524756
SCC-9,107985,-2.37702169012632,-3.4605486424537877
MDA-MB-157,23939,3.513284021833553,3.955159934250995
OPM-2,262093,0.5720462757198622,1.513185401849977
NCI-H661,5351362,2.412641003608378,1.632287407769301
BT-549,53495165,-2.465962418573161,1.1175140394485295
A-673,decitabine-carboplatin (1-1 mol-mol),2.7905557903359246,1.5000440304738234
HSC-4,1716436,3.018983829466311,3.240392396012285
A4/Fukuda,10231331,-0.0070700765814584,1.7124680438439706
OPM-2,25105715,2.7306053213312027,3.3047040426235115
CAL-51,3384730,2.4775948365465905,3.0557329238663344
DMS 273,vorinostat-navitoclax (4-1 mol-mol),0.8220813286666946,0.5192655900543871
KMRC-1,262093,3.6313310555506817,2.7304984961948877
KYSE-70,5311281,3.780874632943925,2.52762397560981
Panc 04.03,135659046,3.760242578723066,3.8979192908236615
NCI-H460,46199207,3.5033257005335163,3.257078897385765
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062,-0.31739112465324637
NCI-H522,285033,-5.015646919007219,-2.24376421068973
NCI-H1623,31703,-1.093718795909536,-0.3419083271845908
CA46,8515,3.648186715161825,3.047376708039298
A-673,54618164,3.9765209939943857,3.803745785922393
MDA-MB-453,71304818,1.4463301677266325,2.3163936958093196
SNU-81,656346,0.6811147423088999,0.851234517617561
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376,-0.3171753997245187
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205,1.0154048368844932
OVISE,71680916,3.981894618274443,4.684043705385403
LOU-NH91,56963564,0.9665729866263152,0.30309110315498944
NCI-H661,23635314,-2.0342629068452056,-1.8646441010341783
LOU-NH91,12001922,2.55699926148122,2.1562953029564262
JM-1,31703,-4.919166892515249,-2.8633757582176957
EFO-27,16065773,2.8503557299543063,2.638515201196411
DMS 273,107970,2.226748766743483,2.126000041093201
MDA-MB-157,67156097,-2.087594374926874,-0.2275690691020341
BxPC-3,JQ-1-UNC0638 (2-1 mol-mol),0.9591872546469856,1.4315602361262727
LOU-NH91,46199207,3.3608515659177147,3.2399106472627204
DMS 273,JQ-1-vorinostat (2-1 mol-mol),0.2212996861992737,0.029422752462290775
BT-549,2871966,1.6191257261573118,0.865767214123469
BT-549,46926350,-4.493585638609818,-3.8279791401872836
OVISE,54626689,4.712933516379989,4.838969897379222
NCI-H460,119182,0.2489341964189734,-0.7963368172645688
MDA-MB-453,7251185,1.8406187352582624,2.4934435225542977
JM-1,4521392,4.181937683636394,3.7380949991137244
LoVo,44589607,1.625549992230134,2.7740960988176555
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393,1.2158055680247193
A-673,24951314,0.6400096482448101,0.664695696783788
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525,1.4812951746020224
A2780,11152667,-1.0749204847082217,-1.0423029771055905
BT-549,5329102,2.9790267437316285,2.1858380240161748
G-401,17755052,0.028133790527295,1.3710020055850891
CAL-51,11238147,2.100409816322544,2.7268956370601565
FTC-133,16725315,5.918216987208106,4.056090285257738
HSC-4,10127622,4.548794444843462,3.9735220261804614
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599,1.7306047052561369
HSC-4,72376,-2.108784759313747,-1.7626311396037146
HCC1143,11455910,1.411815978618001,1.2679807764676214
G-401,6610216,3.9425308150709,4.129924086943961
OPM-2,73707398,-1.391957592490296,0.25355642439126025
Panc 04.03,crizotinib-PLX-4032 (2-1 mol-mol),2.2047528734152655,1.9933068663384674
MSTO-211H,11396600,3.2938939565791765,3.534584506707792
NCI-H2171,15983966,-6.379176066325201,-2.3471054476638677
HCC1143,9903786,3.3387804215378885,2.9003320329289033
JM-1,3385,1.6679469335870958,2.6807996494185944
NCI-H460,SNX-2112-bortezomib (250-1 mol-mol),-0.7287978777704803,-1.1818957676178479
JM-1,44487872,4.651129481786086,4.285769171592559
NOMO-1,439501,-2.35226533453039,-2.3876855365547405
Panc 04.03,568763,0.8595160951448656,0.6525870393275731
A-673,15953870,2.6171812575314757,3.324912594473353
CA46,6917907,-5.812984110767001,-5.431546188651048
A4/Fukuda,11404337,-2.650657466190433,-1.0149733352603156
MDA-MB-157,6184667,1.80494393962058,3.092185899585595
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471,1.2549224461214115
NCI-H522,25102847,2.0692872541383784,2.3971909607726776
EFO-27,2113511,5.820212709586459,5.453926149633832
Panc 04.03,2729026,3.1546590032208948,2.827103326261075
MDA-MB-453,9866186,-0.0857862406385878,0.9153678057971092
CA46,44491742,3.801952242992866,3.7675839696707
MDA-MB-157,16720766,-3.610201854539628,0.8276862604444577
NCI-H522,168313016,4.366007701234683,4.332627858011532
JM-1,53232,3.389128909220105,2.445073792612833
ONS-76,24901704,3.4855009095109435,3.2977822107609365
FTC-133,3136844,4.271719807093853,4.353921243753376
CAL-51,54619267,4.1828818787298765,4.1028237912760845
NCI-H146,17755052,1.2442303799433287,1.4912039547395994
FU-OV-1,2858523,3.1344850445874752,3.158458502184554
NCI-H292,5280436,4.014624366310106,3.5455808677879888
BT-549,15547703,2.0718927663287703,3.3862562529943956
A2780,25126798,3.236047242798602,3.810197561952308
Panc 04.03,2945648,3.066534391812563,3.072072554029918
SCC-9,56963564,0.633234370730304,0.4450242906844406
A4/Fukuda,11507802,0.3746235533355334,1.01083095300781
Panc 04.03,3025944,4.694936485248253,4.172020629822115
SBC-5,46398810,3.6562963267762183,2.4785682290306092
JM-1,49793307,-5.3555461291239075,-4.481027888646621
SNU-81,67156097,-1.5845934662844448,-1.1134115145809245
A2780,72376,-3.651935268939024,-2.84615417162088
CAL-51,25195348,5.6667768045179905,3.2656298004449202
NOMO-1,10074640,3.0496099519927435,2.9266277810480483
FTC-133,46174525,5.692041239325808,4.643570718218964
YAPC,409805,4.253424942012428,4.851961952888914
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276,1.724337803529028
SNU-61,11626560,1.823906724750755,1.4985974990193944
A-498,16736978,3.6467697702535182,2.0909439839248454
JM-1,9967941,2.969647244173239,3.001365408411504
MSTO-211H,3815108,2.5678993468563913,3.095761732253506
KYSE-70,637858,2.812350468450961,2.1476021702554853
A-673,16013152,4.069813049540754,3.523083499848708
A2780,4521392,3.924686212385386,4.049310924847895
A2780,23635314,-2.3171748001501635,-1.6451329808033608
JM-1,3689413,-3.612287026066889,-1.9396172827387321
CA46,navitoclax-PLX-4032 (1-1 mol-mol),3.7945066500570057,0.4166133215454999
OPM-2,64971,2.0053510879561296,2.0279717703376132
LXF 289,9935249,3.315625346230847,3.430285436308751
Panc 04.03,984333,1.398892433045171,0.775657185748592
DMS 273,676352,1.7083859345894283,1.9149971058896509
MDA-MB-453,4096211,1.6956492567589403,2.1125219375042814
DMS 273,9903786,1.811418424711566,2.530227536052775
BxPC-3,3634881,3.024771766376516,3.4309849156207317
ONS-76,54618305,5.4771970245541866,4.502384967388134
Panc 04.03,44491742,4.30815140156182,4.34337745012981
A-673,tretinoin-carboplatin (2-1 mol-mol),4.33843308891482,3.9354455100904824
MDA-MB-453,123631,2.1950816453081545,2.134750530259136
A4/Fukuda,426756,4.168045276817785,3.636513423984774
CA46,252682,5.8821335535914905,6.2998464640295255
Panc 04.03,2828334,6.268769524950107,6.283211427694442
EFO-27,135411,0.9008731550993504,0.9393212818366421
LXF 289,15983966,-1.3187435990338214,-1.4177162324071608
A4/Fukuda,3384730,1.825152720179272,1.6962401123309017
SCC-9,11404337,-1.771041191231111,-0.04320032371833303
SNU-61,6610216,4.086517799339023,4.141695973004002
LOU-NH91,446155,1.33101507486467,2.5372337203500686
KMRC-1,71466380,4.698779777562497,4.349983240405429
SNU-61,46398810,2.7474251169458346,2.371496051407652
NCI-H2009,9826308,-0.026532071259288,0.7701543222319606
NCI-H2009,56946209,-2.630012103472263,-3.925277192682929
HCC1143,46843906,3.1964507186723305,3.09022729228488
A-673,2742550,4.033526638201744,3.355569744327813
SNU-81,11507802,0.99367607100598,1.140646728854165
KMRC-1,11485656,3.5314695534539045,2.4148527079844224
SBC-5,57330099,2.8388792643726295,4.163441898291816
LXF 289,219104,4.555444774518925,3.9245223996727945
Panc 04.03,9907093,4.451330392346362,4.352070110836913
DMS 273,19582717,4.273838780275844,3.2093926761411766
SBC-5,3815108,2.9831729144642956,2.8658235652686
OPM-2,168313016,3.5498730155612863,3.8575112313837616
ONS-76,10427712,4.642311539672088,4.413245161099365
NCI-H522,54765302,4.051221649365855,4.201178366955619
JM-1,44620216,4.114569245447781,3.513458616834253
MDA-MB-453,9887053,5.45770037243801,3.8521728337510863
A4/Fukuda,72193861,-0.8043632874402014,0.6756348120456542
G-401,25102847,1.393287045797279,2.2393479638767975
SBC-5,11507802,0.0977610232609949,1.7150990875057301
JM-1,168313200,1.89690041567587,2.8084930141884796
FTC-133,3634881,3.4388146515237468,3.32082579380368
NOMO-1,10427712,4.067466468396052,3.800688087346328
SNU-61,6918328,0.4046547109968232,0.07166824481028672
NCI-H2171,23635314,-3.6505205606038382,-2.3478159275256147
SNU-449,6438330,2.777557669825017,2.511498778675809
JM-1,25161177,3.865095276574429,3.0426924005511773
LOU-NH91,3025986,-0.3413799803632848,-0.7451738452895181
HCC1143,53232,5.137172207040132,2.950163133857125
LOU-NH91,53232,2.5403477328432933,2.672069454181624
NCI-H1623,24797083,2.165751455730843,1.5812610997133245
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651,3.2293725484971163
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609,2.16062942950021
SNU-449,3025986,4.266276949739511,-0.7134252405953145
NOMO-1,2858523,2.9127751570608136,2.946416387009097
A-673,6918736,-0.9753951922870552,-1.9510862967487301
A2780,44202524,1.0300821380640774,1.906509544998724
DMS 273,25154868,4.488535380180048,4.196606370713753
NCI-H146,navitoclax-gemcitabine (1-1 mol-mol),-4.8472150579078646,-1.6577794583482424
BT-549,100016,6.139281322747303,6.28781025961797
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006,2.8260542666203703
SCC-9,148124,-0.9222891029936632,-2.1728258108139737
DMS 273,11494412,0.2734180035919979,0.7260823643061195
A-673,ISOX-bortezomib (250-1 mol-mol),0.1019689677537875,0.17773091206582756
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355,1.031484535772697
EFO-27,16725315,5.151426492732951,4.358073056796914
KYSE-70,3689413,0.9447440025313596,0.03604921351658334
A2780,navitoclax-MST-312 (1-1 mol-mol),0.9234968671687596,0.5086136212917277
NCI-H460,285033,-0.7054560098467199,-2.0310428494136055
KMRC-1,5311,2.4483949186029794,1.3713297145749608
Panc 04.03,54618164,4.2869772681873695,4.2104652491690295
NCI-H727,676352,2.629502567411482,2.1246145532199714
HSC-4,24779724,5.454925638847944,4.0826860045774955
A2780,23725625,2.4195603562256873,4.281595640024915
CA46,56946209,-5.9555571874685755,-5.229842567754124
NCI-H146,6252,-1.7817409080320272,0.45130661052464743
SNU-449,44589607,3.7188226068257872,3.0218651154146885
LoVo,969516,2.402995535890804,2.7159224012862113
KMRC-1,carboplatin-etoposide (40-17 mol-mol),4.177751638329711,2.6628359750547186
CAL-51,9935249,3.84795648434564,3.1661515063830636
NCI-H1623,53392493,3.831222645051568,2.7430572375704196
MDA-MB-453,54596490,5.641262539800198,4.322499482609087
A-498,42642645,1.5845020846141176,1.3293538572777992
FU-OV-1,4788,6.1006518616017615,5.6625198203267475
DMS 273,6852167,2.1769146352356707,2.249326185331343
LoVo,11612883,2.4190290931093954,2.7835169748106585
A4/Fukuda,54618305,3.964460418875751,3.8964567918628155
NCI-H2009,17755052,1.0629457660851225,2.278509667754697
EFO-27,5113032,5.5462842201226925,4.824883645221234
LoVo,9907093,0.4604974674369004,4.16785427592685
SCC-9,44491742,4.764074483400304,4.2947798218806055
NOMO-1,53392493,1.775943290565707,1.7943278016326119
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924,2.3764786169621046
SNU-449,16725315,5.255161508937853,4.431327329894674
SNU-81,9825149,1.815233140933264,2.016250518248668
NCI-H522,60700,-0.5552110519793028,-0.3592925098229924
NCI-H2009,375860,-0.9754800160336818,0.04396992401372286
OPM-2,44607530,0.8834373674969361,1.3702234763625742
MSTO-211H,2708,3.2234156242084073,4.857570571934105
OPM-2,15953870,2.653227585048534,2.9574321930397542
DMS 273,11238147,3.12717198165546,2.4164045150914104
OVISE,3062316,1.3579552700407893,0.5123108224020243
NCI-H522,11955716,-2.355417617820864,-1.6592084264100606
LXF 289,44486219,3.8558224358877298,4.452341580813895
NCI-H522,4261,1.255814980012561,1.4993791582604639
SBC-5,11396600,3.6683316442381617,3.5633135693491385
NCI-H727,448949,2.521247711014773,2.1126555919058556
CAL-51,126941,-2.448006630223804,-3.4182448626086592
MDA-MB-157,156414,1.5733069512528617,1.5832217174355785
Panc 04.03,selumetinib-BRD-A02303741 (4-1 mol-mol),4.320411537707366,3.3947015169952954
A2780,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4355880611725125,3.8741701134469997
FTC-133,2871966,2.512715884905784,0.4541912073740375
NCI-H460,tanespimycin-gemcitabine (1-1 mol-mol),0.0048174492306964,-0.7659960204806683
KYSE-70,168313047,2.1859183661660624,2.3182672361471086
OVISE,serdemetan-SCH-529074 (1-1 mol-mol),2.136633519186749,2.1914411296561314
LoVo,54454,2.7172548619434025,2.5455356602287607
SNU-61,73707398,0.7144154314829279,1.3245322209096515
MSTO-211H,9866186,-1.5986440722967756,0.8089202955085777
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416,1.0868126377929743
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909,2.74067515301007
NCI-H2171,57519531,1.5586354952126105,1.842808373268905
CAL-51,JQ-1-vorinostat (2-1 mol-mol),1.2952868621484117,1.2379582835781975
NOMO-1,451668,-1.632426084818391,-0.8933245425247162
CA46,5282054,2.3254868404716755,2.824929608640075
MDA-MB-157,54618795,2.0481333451118204,1.2941169203670742
OPM-2,11707110,-2.1571352516283113,0.7354761031565008
CA46,3136844,3.7113001526336338,3.5048879972379243
NCI-H2171,984333,-0.9596445260901963,0.12894187097995435
NCI-H1623,11507802,3.5238050648518136,1.8683511447103884
NCI-H460,46191454,1.6495265120274705,1.8639391578022424
EFO-27,BRD-A02303741-navitoclax (2-1 mol-mol),3.819919815231351,2.8021136864797245
MDA-MB-157,7326481,2.299098205794017,3.1753463031565103
EFO-27,1239801,4.748117996702423,4.367506290162147
NCI-H460,969516,4.1763077592827225,2.991945631261313
G-401,44202524,1.447982360696086,1.8561783857466922
A-673,JQ-1-MK-0752 (1-1 mol-mol),1.0252952721702926,1.0218813067278183
NCI-H460,2749,2.5004778765083695,2.0592220000248225
DMS 273,119607,5.531574360726778,4.522225558847734
FU-OV-1,10074640,3.835416148861087,3.3223239557155697
DMS 273,navitoclax-MST-312 (1-1 mol-mol),0.9055949261710712,0.45893494597044215
MSTO-211H,9911830,2.3480580098381747,2.8453059515800994
SBC-5,135411,0.301348299555382,0.6339383717863639
MDA-MB-453,6610216,3.7821562137745217,4.057554043524557
SBC-5,2708,2.061546130614232,4.879970621150766
KYSE-70,11396600,3.829938839575827,3.638826721388712
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334,0.13982534134644756
A4/Fukuda,11152667,-2.4230854517211977,-1.4076560289684672
SBC-5,36314,-4.885811702708602,-2.058040304406967
DMS 273,9884685,-1.1971048738595964,-0.021233054455349586
SNU-61,vorinostat-navitoclax (4-1 mol-mol),2.3944367596721547,0.727103542738704
NCI-H2009,439501,-2.087429471182781,-2.0685205497922654
MDA-MB-157,1716436,1.1718034720311097,3.029491440979097
ONS-76,216239,1.6729885995968985,2.1908963831282744
NCI-H460,9911830,3.1326305509826824,2.746034043782737
A-498,2858523,3.0988346297597293,3.1325880310117578
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205,2.7420029339425946
OVISE,969516,2.883429877122848,2.877752863691755
SBC-5,3825829,3.3495967392740953,3.989681432915124
LOU-NH91,5278396,3.7974378044691495,3.729778897338441
MSTO-211H,9935249,0.534197831206919,3.326084406223503
JM-1,9911463,2.675259516581914,2.814823791144625
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477,3.0610597894326594
SCC-9,60750,4.9910553033212866,-1.7650982965944249
SCC-9,387447,-4.584813930042193,-3.6239317677937293
SNU-81,25062766,1.4859068805404914,1.9452674293675098
NCI-H661,2708,6.321788786635088,4.814231585332095
NCI-H460,57519531,1.7606196796007008,2.336534917562245
KMRC-1,613753,3.207263348750723,3.1772467668695903
KYSE-70,67156097,-2.3379446798215127,-0.12754266255936675
OPM-2,10127622,2.4771662101119194,3.1323074509998383
LOU-NH91,5291,3.971687681340124,3.8270958415989753
DMS 273,6918638,-0.6329393875591668,-0.14544364501157944
A4/Fukuda,16722836,0.6102638619225811,1.0619798006588648
NCI-H1623,11175137,3.026300100874371,2.805929189367547
SCC-9,122327,5.629849115039079,4.681227554255518
CA46,11625818,3.63093624941088,3.253650145773378
FTC-133,navitoclax-piperlongumine (1-1 mol-mol),0.208088727166438,1.6847362822305691
Panc 04.03,156422,4.828457411788627,4.066588273406501
DMS 273,5278396,3.2906012116635694,3.2109256464298053
HCC1143,53495165,-2.177337144630303,0.7256028505728729
OPM-2,1641662,3.0681099569104653,2.924502406407031
A2780,BRD-K27188169-navitoclax (2-1 mol-mol),1.5548908643939203,1.6584066806890143
NCI-H1623,doxorubicin-navitoclax (2-1 mol-mol),-1.3303127155633732,-0.7786428942170864
FU-OV-1,navitoclax-MST-312 (1-1 mol-mol),2.560090479517714,1.098822190784695
A-498,6917907,2.9475757171512575,-4.050145627450116
G-401,10385095,0.8697787767816428,0.9932186572820154
MDA-MB-453,702558,3.1332940697725435,4.89744257299132
BxPC-3,15547703,0.9056764589340796,3.1008711894592573
A-673,44632017,0.706241354368095,1.1148059699920285
FTC-133,JQ-1-navitoclax (2-1 mol-mol),0.6314108059190333,0.5697178896042283
NCI-H661,11626560,1.806538061239003,2.074143565731299
SBC-5,9840324,4.760330511699364,5.802565920478185
NCI-H727,46398810,3.032466795061864,2.488877762955474
HSC-4,654092,0.2566378579351391,0.07560039462941197
G-401,5978,-3.1887203575088727,-2.7410442796032384
A4/Fukuda,11238147,1.0973923844128086,2.014030024489104
MDA-MB-157,JQ-1-navitoclax (2-1 mol-mol),-0.7190689296194697,0.8670087309574375
NOMO-1,54678924,1.1055951494804663,1.4457059760422908
JM-1,135421197,0.410328587733175,1.3562041299832805
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774,-2.087355132205099
BT-549,216468,4.5222519285579885,3.566283100797901
NCI-H2009,136227924,2.9896301065010933,3.2104407120262746
SCC-9,2828334,6.128266495621781,6.333583076596828
LOU-NH91,3025944,4.356407657994756,4.333158260955886
ONS-76,5329102,2.3644433253395545,2.0868861902768843
DMS 273,53495165,-0.9870251488119351,-1.5169122204116439
NCI-H1623,3634881,3.389178636612412,3.3288121974503726
NCI-H1623,446155,4.270765867841268,2.867926752075001
ONS-76,984333,0.6472143254241693,0.7369491030860099
SBC-5,3081361,3.306292226806483,2.249420682900362
NCI-H2009,11625818,4.7000574258268255,4.5198495830111005
CA46,24775005,3.732581966598925,3.313288675240707
SCC-9,11222830,1.8600220042192213,1.573671332085243
KMRC-1,12003241,-1.418239320082467,-1.0778912194677446
SNU-61,613753,3.0121134483838037,3.0681112842598073
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433,0.7147467032570873
SBC-5,4261,2.0931810634834105,1.5328805906540708
HSC-4,serdemetan-SCH-529074 (1-1 mol-mol),2.5503350460616505,2.1357718834294115
JM-1,445091,4.048660068158945,3.5343327253775074
NCI-H292,44185566,2.325959343920572,2.69545120536677
SNU-81,6918328,0.0758058419703895,0.03635600729922368
A-498,16659841,6.0591016575330325,4.212228311694003
NCI-H460,51037431,2.104101453867928,2.918631022931325
MSTO-211H,5978,-2.861470631068365,-1.7451974057154291
SBC-5,6918736,-1.7962623830849138,-1.5175421336840367
NCI-H2171,11178236,-6.134942659978268,-3.2538253235971593
ONS-76,11427553,2.8550216000544695,2.4781692160992916
JM-1,11234052,3.3092904099829115,2.656510122882277
NCI-H661,ISOX-bortezomib (250-1 mol-mol),0.8750807194042233,0.6974842478559298
MDA-MB-453,11719255,3.0016884563631057,3.3741803094700358
HSC-4,241158,3.797905223062241,4.090863025347748
SNU-61,49766530,-2.178873950286192,-0.7868869870931781
ONS-76,54454,1.5364254879481318,2.3784225489422424
NCI-H2009,54618164,4.160237516111787,4.223462895403384
CAL-51,3136844,4.799885860604426,4.483524856121214
DMS 273,selumetinib-JQ-1 (4-1 mol-mol),2.4189081702185096,0.5403128411744542
SCC-9,46926350,-4.135183666473923,-4.067412087896639
YAPC,5460769,2.316930709954587,2.530652463808485
YAPC,135411,0.9254838530178896,0.7024719671864765
A-673,11228183,1.918128583172148,1.076834544001163
MSTO-211H,24856436,-1.8779899697418416,0.7963251772118913
LXF 289,44185566,2.4809324153017265,2.806147584824856
OVISE,654092,-1.3076939787912127,-0.14320818366556573
A2780,6918328,-1.1386748973241003,-0.4693557637200626
FU-OV-1,44819697,-2.23904448126328,-0.5649540242162339
BT-549,42642645,1.6219324424635808,1.0287855728302455
JM-1,216345,2.231105973795255,2.765009622978391
G-401,73707398,0.5507155331982622,1.053932678760913
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,1.031521446631777
KMRC-1,16722836,1.9243244677044424,1.5186135244729653
NCI-H1623,135875424,3.67415188779786,4.194526619984888
NCI-H2009,638278,3.464543124143687,3.4724479344937462
NCI-H727,168313047,2.9561297907786717,2.438878064916719
SNU-81,439501,-1.707157001292212,-2.025618221368785
MDA-MB-157,11234052,1.0821323764870938,4.089302921596439
NCI-H727,11364421,1.2179988120980565,-1.1971655381209554
BxPC-3,2729026,2.140647578797141,2.814745816222736
NCI-H292,46224516,2.488403107417036,2.700369679367645
MSTO-211H,5746,0.1838030897357816,1.4544830804902056
NCI-H727,5280436,4.172163827724594,3.559427789545884
NCI-H727,9911463,4.409308573364914,3.7480452383374723
LOU-NH91,9907093,4.908801109640004,4.257136994536667
HSC-4,24772860,-3.179601965562413,-1.9539943507719848
MDA-MB-453,10302451,3.3014196832790628,3.270637762770531
A-673,2945648,0.1856393110329161,2.42057110754902
G-401,56946209,-5.714614119541748,-4.391529636790536
MSTO-211H,452548,-2.0931551112296742,0.160683309610479
NCI-H2009,5280436,3.59103147994178,3.736172846377704
CAL-51,241158,3.781489879449518,3.9235113685350376
FU-OV-1,24772860,-2.86759244210788,-1.5719947594983568
DMS 273,54596558,4.317274835352231,4.31141078165942
DMS 273,71466380,4.5698020131067745,4.150733978133658
ONS-76,11175137,2.2807611594224975,2.5507396482605205
NCI-H522,136227331,5.948504593030567,3.7285967131027262
KYSE-70,262093,3.701785722517592,2.7813609616234545
KMRC-1,119607,5.885636542486439,5.103758549200179
CA46,16722836,1.2778374610309875,0.6542227047296295
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874,2.7736338929288418
SNU-61,24772860,-2.9174361907600592,-2.201386811145609
LoVo,322968,3.2361743048313536,3.9102852333348928
NCI-H460,168313047,3.736921155938788,2.459395908582358
LOU-NH91,123631,3.064358892537756,2.6414154055669803
NCI-H146,10410894,2.10877812565835,3.0548427844166137
OPM-2,107985,-4.911691484457119,-4.175062461555193
HSC-4,4917,3.66079963002401,3.021015696227404
SBC-5,72376,-1.1693945126287038,-1.780195242272649
KYSE-70,11238147,3.36128873589197,2.769616306515165
CA46,9935249,0.2545497442771542,1.0537142228041174
SCC-9,135421197,2.7056920215811293,2.1771460951244195
FU-OV-1,123631,2.446979601054181,2.612337906412827
MSTO-211H,12001922,2.4775669078904397,2.0939150045209733
NCI-H661,3543504,4.269759852401949,4.312937733817997
FU-OV-1,53495165,2.0201630022514263,0.6727264655215884
NCI-H2009,448949,2.535639173937985,2.1486834882239862
EFO-27,285033,-1.172211692399995,-1.7461523969505015
YAPC,5978,3.3733616775717716,-1.4581791469364658
BT-549,9911463,4.268645247281358,4.090633272228513
NCI-H522,2113511,5.298827483301359,5.25337198221608
SNU-61,1242560,3.7603648536411622,3.2249978572378883
A2780,3503,2.123197367997407,1.9626985754304922
JM-1,262093,0.3077511100871351,1.6725525371197605
DMS 273,11612883,3.047294051558191,2.2021203054476803
A-673,156414,1.4246196000990916,1.272845257728848
HSC-4,JQ-1-UNC0638 (2-1 mol-mol),5.303785757115223,1.685497822145405
SNU-81,3385,3.194341332216005,3.613896240080576
SNU-449,44486219,4.185988120780244,4.448867726857702
SCC-9,25262965,-0.8228501050995407,-1.4782947078595794
NCI-H146,9967941,1.5373910611842192,3.235003804819681
HCC1143,969516,2.4763079586135546,2.7604602825372235
ONS-76,12003241,-1.3579895274230906,-1.0498723432538895
SNU-61,selumetinib-tretinoin (2-1 mol-mol),0.2011452068154318,2.966429701102498
OPM-2,26596,-3.75281027154887,-2.504684784898349
KMRC-1,11955716,1.3700469468180672,-1.7548159151182565
ONS-76,445091,4.207927105180806,4.0512624414571
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.9150121039355517
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.732771534628392
JM-1,11964036,0.6346833811859819,0.2544136720925045
MDA-MB-453,24180719,3.640576555720147,3.3388464858788365
NCI-H146,3689413,0.5626872136369616,-0.3630797616838657
A-673,5335621,4.03269099593382,4.383165250908365
FTC-133,44491742,4.538470926749077,4.307696897849313
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712,1.4717298897600923
LXF 289,23725625,4.938564251049365,5.220647083955664
OPM-2,11612883,1.2708799210561326,1.7589935804322945
CA46,11485656,1.2289823963881294,1.6898699540275532
SNU-61,227681,2.9666568152307993,3.0566118931018997
NOMO-1,135421197,1.2386186938920458,1.3494539552484568
NCI-H1623,vorinostat-carboplatin (1-1 mol-mol),3.549282836614641,3.3431385381531356
BxPC-3,135421197,1.4419000032460958,1.8908172218692574
CAL-51,66577038,4.134711160885491,2.891304592510693
BxPC-3,11485656,2.0481416814216375,2.484394769847275
LOU-NH91,3689413,0.742189593443008,-0.365183889119703
OVISE,crizotinib-PLX-4032 (2-1 mol-mol),2.5474980530955844,2.1559893135696657
JM-1,49766530,-3.0151701370453794,-2.2146042398010564
NOMO-1,15983966,-5.011559396504552,-3.6715766006716395
HSC-4,24856436,1.7831446753384608,0.47716974659040573
OPM-2,387447,-6.258797979541162,-5.3764859252312185
A-673,54765302,3.022220101838166,4.053020378411051
A-673,5479543,3.2499245267113928,3.1026806079991434
SBC-5,docetaxel-tanespimycin (2-1 mol-mol),-4.858337371172803,-3.2250405902831356
A2780,441298,1.2276441630256645,2.5002786830711443
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923,0.5079189507547275
HSC-4,65064,5.180183799352401,4.928334299688989
OPM-2,3384730,1.6721258053175836,1.5465887359558481
NCI-H522,387447,-5.403881314975521,-4.138866472385947
MDA-MB-157,11640390,1.4666591993417384,3.814240459261478
CA46,9911463,2.565133854881976,2.838709573254616
FTC-133,227681,2.0408407851095416,3.575487124644734
JM-1,285033,-4.464347137363986,-3.329686729335407
KYSE-70,16736978,1.1213704825993671,1.8325819178714442
MSTO-211H,2729026,1.9618514095460544,2.7873886104738768
NCI-H661,24180719,3.917772031076744,3.4599094316118677
NCI-H1623,400769,-1.0076663191396935,-0.5404487085448332
YAPC,9840324,5.782457936566159,5.965926590632447
Panc 04.03,57330099,4.388225142481581,4.550272639165888
G-401,135659046,3.5574575455214608,3.482378208064712
A4/Fukuda,148198,-4.99238512913244,-3.9626788798287267
CA46,126941,-4.174426911659592,-3.0684258163154188
SCC-9,6610355,5.330005746360321,4.585310285445087
KYSE-70,44185566,2.2395157674699875,2.608096044790744
NCI-H1623,462382,1.1150663609789129,0.741139738895985
CAL-51,6914657,-5.067352950634086,-4.621524206585845
A-673,selumetinib-BRD-A02303741 (4-1 mol-mol),7.378712483637354,3.714071232105181
EFO-27,54618164,4.628305371415217,4.214549610841757
JM-1,23582824,0.2805180690676545,0.53107718400092
NCI-H460,44185566,3.2105564381381035,2.5743533442630953
CA46,52912189,-0.9978651387823436,-0.006455665384575564
NCI-H2009,9935249,4.414461781647313,3.3625076404456884
NCI-H2009,135928012,4.098076343567735,4.298845747641405
CAL-51,60750,-3.4379358682898973,-2.0306612984448513
MSTO-211H,8515,1.6806311840995682,4.215581471586793
ONS-76,15983966,-3.1712265481751243,-1.188957134885992
NOMO-1,56946209,-4.862706213909506,-4.6344229529065455
NOMO-1,24772860,-3.4546209155075687,-2.9866069564248803
FU-OV-1,44185566,3.182046500186311,2.7386792841098693
NCI-H2171,11977753,0.3036523614034643,-1.509888009289875
FTC-133,31703,-0.768913830642622,-0.9007673380563124
EFO-27,984333,0.9554706085777084,1.0161649785594107
NCI-H292,5329102,1.7855476735914897,2.2338588784301434
CA46,409805,3.3808362620175187,3.5692661577015303
MSTO-211H,25183872,0.3972499543283658,-0.8759442925709952
LOU-NH91,24180719,4.451607655435679,3.643673131983705
A2780,44185566,1.1999498835751436,2.073473101945763
JM-1,piperlongumine-MST-312 (1-1 mol-mol),0.8602384647056689,1.0713860308792236
NCI-H2171,6505803,-0.0596794204500112,-0.5565076432123992
CA46,66577038,2.896384523521911,2.498698162036049
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059,1.9477055432386365
CA46,12003241,-2.799565618947511,-1.5591391318371641
NCI-H661,10427712,3.832896992750264,4.295079004194517
SNU-449,107970,2.557902386411369,2.4512617746612015
Panc 04.03,2874250,5.078270927101478,4.197180078731775
NCI-H292,54626689,4.661071465435288,4.641667119264834
NCI-H460,23725625,5.666756485817308,4.968482126891117
CAL-51,53232,2.8018516258833395,2.7777684654985966
FTC-133,decitabine-navitoclax (2-1 mol-mol),1.1951853583551142,2.04082926463392
EFO-27,53495165,0.9078503906950024,0.9326493697902373
SNU-81,65064,4.179756271690876,4.513484480623381
BT-549,3689413,-0.9397914335397376,-0.2636190582155384
NCI-H2009,66577038,3.427367822074961,3.1384397932904475
LOU-NH91,10302451,4.426232341068122,3.3896497323126535
CAL-51,168313047,1.9592520089902103,2.4344797602605164
NCI-H292,135411,0.5538002090667975,0.7381222651926546
LXF 289,2874250,5.409057432200043,4.275041726259986
EFO-27,4261,1.4655103146060633,2.131191090404646
ONS-76,25150857,2.480326692853007,2.44059673985949
G-401,11175137,1.9335599830838224,1.9523775151413512
OPM-2,5460769,4.223891374112808,2.033045555941418
NOMO-1,10385095,1.0593467546243338,1.00158717739421
LOU-NH91,2126,5.273491801207327,4.782972218040301
MDA-MB-453,11625818,5.002273286989784,3.942414330611439
OPM-2,44632017,0.7121474472673729,0.5695426464964115
LoVo,135411,-0.4629764704945864,0.6012011427975281
EFO-27,16722836,2.503686118945589,1.7535045868197585
LOU-NH91,10074640,3.3386477352477715,3.1600541041881605
DMS 273,11719255,4.586791904076426,2.692354270015903
OPM-2,136227924,1.7425170628423947,2.2664967732681998
YAPC,vorinostat-navitoclax (4-1 mol-mol),1.7986594173334518,1.462914615429739
KMRC-1,vorinostat-carboplatin (1-1 mol-mol),4.1908249815251075,2.9011406785305853
NCI-H522,2828334,6.021027928266713,5.82536997804637
KYSE-70,72193861,1.5917149982909504,1.9237964070975968
MSTO-211H,9911463,2.6842905920893108,4.130962027247494
MDA-MB-453,969516,2.9001694226946153,2.9540816511711556
CAL-51,44632017,0.9975947899898204,1.2701773552912992
LXF 289,10231331,2.4249622135671824,2.5367419042971706
A2780,25195348,2.1109786238814943,2.983028252279073
NCI-H2171,44202524,1.9759332673432517,1.872832807315212
Panc 04.03,1641662,4.251343925322988,3.72051015350846
NCI-H292,54686904,5.52345614596139,3.785740279355687
DMS 273,7251185,2.13119393000196,1.8533859422780574
LoVo,9956119,3.291456775833892,3.6162072400950223
BxPC-3,11404337,-0.6361724208993981,-0.28020606293794825
NCI-H2009,119182,-1.1305543955582442,-0.5198294402750764
BxPC-3,selumetinib-JQ-1 (4-1 mol-mol),-2.4444526852208206,1.3004238522110816
NCI-H2009,5278396,3.446569775137936,3.7630211945684517
SNU-61,327653,2.3439595497702985,3.0799305115299127
Panc 04.03,11238147,2.6863632300229936,3.0426462447851708
LOU-NH91,9926054,3.1176474597994908,2.0627901014310983
NCI-H727,5566,3.3170373665309416,3.0568704641179454
SBC-5,25150857,3.1636616713903893,2.369282141407373
A4/Fukuda,11719255,2.014724282446697,2.63146157132927
NCI-H460,374536,2.933441634270558,1.8951025336701641
Panc 04.03,135875424,4.739147054003967,4.170902894352932
NCI-H522,9825149,2.538976142931882,1.77783515679581
NCI-H522,11964036,1.1738559849313974,1.1083958722613365
NCI-H727,docetaxel-tanespimycin (2-1 mol-mol),-0.2306371483754844,-2.6485030387141433
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5644155308039651
SCC-9,5566,3.224791432055543,3.0224491099041235
NCI-H460,9936388,2.3098343611543415,-0.026181600940465743
A-673,salermide-PLX-4032 (12-1 mol-mol),5.197476716146756,4.529796702565082
NCI-H460,16720766,0.8258921674033131,0.7912005458337942
FTC-133,54618164,4.149608396421597,4.082345921815273
NCI-H727,5281321,2.7498034475542803,-0.971800766959445
BT-549,31703,-0.610163723442028,-0.7153604735039677
JM-1,11609586,0.7887510712984062,1.4962129697631135
MSTO-211H,65628,3.7458295220001,4.308643614089383
NCI-H661,9887053,5.171148908960024,3.644824023760967
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053,3.265653188684886
G-401,9887053,1.7608751069117703,3.1072374883869003
HSC-4,ISOX-bortezomib (250-1 mol-mol),1.0749923378755126,0.8136959018841052
A-673,7251185,1.3487938120123666,2.0365815369019815
ONS-76,4259181,0.68334491499701,0.32925901632588106
NCI-H292,613753,2.7114183475644857,3.3476598627550995
CA46,tretinoin-navitoclax (4-1 mol-mol),4.197829514755647,0.5876765463432226
JM-1,25126798,3.029145333632086,3.3258455901616757
CAL-51,3815108,3.0623029951861396,2.944296625218334
SCC-9,16725315,5.212889946477865,4.298703879960455
NCI-H661,alisertib-navitoclax (2-1 mol-mol),3.068945671773435,0.6407672494167213
NCI-H522,serdemetan-SCH-529074 (1-1 mol-mol),2.019053107898385,1.7985621178523874
LoVo,16722836,0.1488668556579147,1.6474065935965438
A4/Fukuda,25262965,-4.823082336145625,-2.519406002567979
OPM-2,53392493,1.6243275023991692,1.8469365649438414
HSC-4,9926054,2.0278633205902468,1.8393850443887174
SNU-81,9936388,-6.314751034125396,-3.3075212647971943
G-401,9823820,1.4384887897470693,2.8639680819793267
YAPC,24753719,5.0641073859888,4.327198468264262
OPM-2,24772860,-2.8738620885527153,-3.027159762000525
MDA-MB-157,10427712,3.542893078297904,4.501842188305733
A-498,4259181,1.547873530266754,0.6354673387992805
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196,-0.30242722758427426
SBC-5,9927531,4.452264212548339,4.70996701903142
LXF 289,119607,4.549732560104057,5.350105345532907
MDA-MB-453,piperlongumine-MST-312 (1-1 mol-mol),1.140334319354309,1.8845822825374867
NCI-H2009,11396600,4.054693544346837,3.8743138062117164
SNU-81,15983966,-3.5187473914136738,-2.1364379815146264
Panc 04.03,11494412,3.764008563191269,2.518833929971895
OPM-2,216345,2.3930113976289364,3.027743187261509
JM-1,66577038,2.266129645862272,2.4896614936380836
SNU-449,15953870,3.8419288275174326,3.7489131985455786
BT-549,9903786,2.513972936103366,3.0889024317393283
OPM-2,44202524,1.1830318509158162,1.2293157233408951
OVISE,6623618,2.0550481440983153,2.434978755056437
SNU-449,11657048,5.413893492178721,4.439082967731749
NCI-H2171,67291369,-0.2342814323553679,1.3088677430576237
MDA-MB-453,UNC0638-navitoclax (1-1 mol-mol),2.401691334113767,1.25647544552695
NCI-H522,11238147,3.4337502548923404,2.557320823777318
MDA-MB-453,16065773,1.7584918793826552,2.3014697716427945
LoVo,136227924,4.6796674015936075,3.012347721729559
LXF 289,3854666,2.0847029854583377,2.351134694133335
OVISE,984333,-1.5189255907846522,0.5751287448330055
A2780,159324,-2.166969557176003,2.3373824425868985
SCC-9,17755052,1.3521912896367647,2.0808312432263225
OPM-2,9823820,1.0965123517529505,3.0301426092997694
DMS 273,12001922,1.9670879212293255,1.8451043772472644
KMRC-1,24180719,3.956198558970242,3.343955116563821
KMRC-1,637858,3.0556928718558707,1.895595983365558
NCI-H2009,6917907,-5.363195379340594,-4.907391967562275
SBC-5,24748573,1.8248605513332548,2.3507326414519225
CAL-51,452548,-0.9080095532304931,0.20487779827345953
BT-549,2858523,3.192172893232417,3.0395359984813974
KMRC-1,219104,4.439460794922528,3.5522551173166463
LXF 289,2858523,3.038787864461457,3.068731961925602
NCI-H1623,9907093,3.838952634819664,4.118088729500518
NCI-H460,168313047,3.736921155938788,2.459395908582358
JM-1,5287969,-2.2665073107333997,-2.0828659949519333
NCI-H1623,2828334,5.745033734102683,6.256590620938347
NCI-H522,53232,3.4340993190045763,2.4398816362507727
MDA-MB-157,24180719,1.846017762198611,3.3469936676992638
NCI-H727,2858523,2.9690043699309094,3.1381573210595115
HSC-4,3384730,1.6775009570022803,2.9104640448904977
MDA-MB-453,66577038,2.2210808109899687,2.8492790157809025
CA46,54619267,3.4754479185856604,3.5333174423259197
BxPC-3,selumetinib-decitabine (4-1 mol-mol),1.0861669276123684,3.32135860732331
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147,4.394886657795302
DMS 273,89183176,4.012998903778193,3.674501176735869
LXF 289,89183176,5.264029999533809,4.741783259489344
HCC1143,25154868,3.6479876335061863,4.403145378735683
NCI-H460,5566,3.3663694984335533,3.1555663580765487
EFO-27,3384730,3.632582575012134,3.321990297387854
YAPC,3854666,3.60977300269674,2.3094682589023448
CAL-51,11960529,3.662834723962616,3.980977656684585
NCI-H522,4096211,1.7167000910654833,1.5002297697909759
LXF 289,46199207,3.0446562724495676,3.039442291031342
MSTO-211H,44507138,3.561974329612715,2.4651585428833376
BxPC-3,10127622,0.1850831315580212,3.334440652355369
SNU-81,57519531,3.6375637578947098,2.2614446760401474
NCI-H522,46926350,-4.757002390021422,-4.031393982196214
LXF 289,675434,4.434927450149955,4.645425209115653
SBC-5,2858523,3.0625939376722147,3.008211479471118
YAPC,3025986,-1.0818355674515514,-0.6027932236107982
G-401,753704,3.840031862409327,4.563807159255574
NCI-H2171,9933475,1.8341202855706125,1.8274503690948725
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609,2.9438531877046032
BT-549,5746,2.744550621458616,1.5057734534677383
MSTO-211H,2733487,6.00734552009151,6.211433831838288
LoVo,9908783,4.437010992006648,4.971642810486281
NCI-H2009,46398810,2.5614683956162554,2.7158024737962534
NCI-H292,15983966,2.054572304908195,-0.3304641199710881
G-401,46943432,1.6295589064479152,1.8097939913906544
LXF 289,54618771,-0.5375230222620658,1.5080637156940002
NCI-H2009,4261,0.1994590765469732,1.8752633909109335
NCI-H292,119182,-1.3574963176080912,-0.8651075115751544
LoVo,675434,4.114717976727459,4.460886687884022
CAL-51,613753,3.3238399640193177,3.220629213401754
OVISE,tanespimycin-gemcitabine (1-1 mol-mol),2.9974689860461785,-0.3895299939804714
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125,3.6597388867812874
MDA-MB-157,7251185,1.2275966709755557,2.65835195213128
LOU-NH91,168313047,3.5347026371928565,2.3996096955300077
Panc 04.03,11175137,3.811547013287204,2.849754566694797
YAPC,46191454,1.528991916080322,1.800470632024401
Panc 04.03,246676,4.5210437514033615,4.613459740124116
LOU-NH91,107985,-2.204555775629559,-3.153643546806086
JM-1,9884685,0.5602575931973728,-0.20705691468409426
KYSE-70,26596,-1.4453873864890578,-0.6172152782424527
SBC-5,11238147,3.923057921789592,2.82029077017552
CAL-51,5351362,1.1872361858703535,1.4864247213895447
CAL-51,148198,-3.728190383000159,-3.62865813017216
MSTO-211H,10074640,2.8901374693183848,3.2611370874356385
CA46,navitoclax-gemcitabine (1-1 mol-mol),-1.1536671772218576,-2.0475991845363506
Panc 04.03,54618305,4.994656380487723,4.410400318767481
HSC-4,9444,4.231424733159592,4.245159409546473
ONS-76,136227924,2.542073211711186,2.98425186421178
CA46,navitoclax-MST-312 (1-1 mol-mol),1.8648125815203176,0.027862033376009166
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066,0.926637462926799
A-498,4705,4.1964696083385595,3.1614043264155804
NCI-H292,4788,6.000922818610643,5.832230298714377
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293,1.6164427325958146
A4/Fukuda,168312962,0.589698091471745,0.972819176671064
MSTO-211H,135421197,0.8053711662366769,2.008416610787622
G-401,9826308,0.736562536874994,0.1632647580666833
JM-1,44202524,1.2333959484520816,1.2598140802729618
SNU-449,135984461,4.468051833024593,3.972318275898152
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854,2.1458569201638666
HSC-4,135999136,1.7584955345229645,3.9802083487493127
HCC1143,6918328,-0.4969866258783406,0.16261458436227552
A4/Fukuda,2871966,-1.2628046939905593,-0.14867071284940617
HSC-4,89928392,1.9678897287961257,1.697566110125496
CA46,7251185,0.9564015595877396,1.5209739199107646
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632,1.7383094200744225
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907,3.487617848934853
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297,-0.7507473260280905
YAPC,9967941,3.379913520192136,4.054200295570182
Panc 04.03,119607,5.706581209982884,5.45948247809707
KMRC-1,46926350,-4.153095302049271,-3.7343049292120902
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775,0.15087749428711988
OVISE,5287620,-0.8119274098935182,-1.9737109622718918
NOMO-1,135440466,1.6123042261647436,1.6383909388107958
A-673,11507802,0.3878845266361032,0.9950038865777843
G-401,tanespimycin-gemcitabine (1-1 mol-mol),-2.3448363007854325,-1.5888099279790717
NCI-H2009,3854666,0.912328636385412,2.7533422142907398
SNU-81,2749,0.983670801340458,1.5728928075822954
A4/Fukuda,25105715,3.290295740743095,3.1982392067585743
OVISE,erlotinib-PLX-4032 (2-1 mol-mol),3.714460286615586,2.8538507812176483
ONS-76,salermide-PLX-4032 (12-1 mol-mol),5.250502452848782,4.610305968156686
CAL-51,9903786,2.1849161121493847,2.6982414373660704
LXF 289,5113032,5.558232749512156,5.009651557554687
NCI-H522,46224516,2.9506377913569244,2.1991645151728587
FU-OV-1,56649450,4.970206677695459,3.349578892412065
CA46,erlotinib-PLX-4032 (2-1 mol-mol),3.1947109713205033,2.6619201787616715
MSTO-211H,9887053,4.1066593545259975,4.351548573069635
CA46,6610355,3.575030613446337,3.8526112839470006
NCI-H522,445643,3.9693726836499863,3.977118066280901
A-673,46224516,0.8314688808424526,2.1639686772171074
NCI-H661,6918736,-3.5059805921507823,-1.432441768950588
NCI-H522,selumetinib-PLX-4032 (8-1 mol-mol),4.633194208623746,3.489522605373546
A-673,3825829,3.830298825271896,3.6236705634577357
ONS-76,11396600,3.887590392789339,3.7022624237672583
LXF 289,5282054,3.512278681739004,3.9080269281156705
A-673,54618771,0.7910545462175201,0.7959166510758193
KMRC-1,25062766,1.7411663615582824,2.090358920913935
EFO-27,71751553,4.378478985868248,4.607161350539428
EFO-27,10074640,3.872803440374816,3.3000923110164604
ONS-76,24964624,2.710261416606334,2.2469150119930883
LOU-NH91,53392493,2.3846272258457737,2.767130620306078
CAL-51,46199207,3.548155956826357,3.225988860055249
DMS 273,227681,4.814934070367145,2.7943150927521345
HSC-4,9908783,6.127900398037499,4.969300778217818
HSC-4,10184653,-0.7296444895073179,0.9062309522078845
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546,2.8242966273297787
NCI-H1623,44185566,3.0587688781610667,2.5974390319054415
KYSE-70,6918328,0.2213620303324437,0.310261516560959
MDA-MB-453,327653,2.9444810987281533,3.0676143492887524
FTC-133,4259181,2.1331002918337925,0.43611529060687515
NCI-H292,60750,-3.187051343712646,-1.9101120054314995
KYSE-70,60700,2.818490002790748,0.11662233259774774
MDA-MB-453,24821094,0.7464785951288041,2.337621303806461
NCI-H2009,656346,1.3969032628362248,0.8716681793692382
SNU-61,24964624,2.494415785344137,1.9924447126551512
NCI-H661,4261,1.9569329914003135,1.5231601504809864
SNU-449,54618305,4.668068655096509,4.417087834219078
LoVo,135875424,3.182508442374063,3.917200561822489
LoVo,6623618,1.7195113979524326,2.4406211689585033
A-498,135398516,3.177268179593805,2.3858334170743905
BxPC-3,26596,-1.629746525957504,-0.5123890769035995
NCI-H460,2749,2.5004778765083695,2.0592220000248225
KMRC-1,46398810,3.012918063271682,2.5721577806328373
NCI-H522,5291,3.860595721411624,3.540506874164484
SNU-449,36462,4.301758862194218,2.669365209441437
SNU-449,6918837,-1.494845192804234,-2.1681644448706807
CA46,11955716,-2.7152267118714204,-2.550356399025164
NCI-H1623,168313200,4.911870039242249,3.0481018378693987
NCI-H2171,10427712,3.6918148562663937,3.7726230021547087
NCI-H522,262093,3.0660845932794656,2.571257164691657
BT-549,168312962,3.315695506914068,2.5035270568056056
MDA-MB-157,15953870,0.7968689532543627,3.688079676653062
BxPC-3,carboplatin-etoposide (40-17 mol-mol),4.727119373262846,3.0664194216547447
SNU-61,11364421,-2.983927558247801,-2.3604346731540127
SNU-61,3101542,4.3555934573063695,2.782555535013539
NCI-H460,52947716,-4.997624319891589,-0.23207392390939355
CAL-51,44543605,3.919885801001582,3.97466485131308
NCI-H292,12003241,-1.027467238096921,-1.0966745064617824
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957,1.190805901656573
Panc 04.03,navitoclax-sorafenib (1-1 mol-mol),3.337045495454646,2.042750205527825
NCI-H292,25154868,5.001413217408079,4.399868233540341
NCI-H292,36462,2.4286801987130486,2.6744711256402502
HSC-4,navitoclax-gemcitabine (1-1 mol-mol),-4.75214371637746,-0.9370952403021042
NCI-H292,159324,3.210621191245253,3.3315391463233937
SNU-81,24978538,1.1236702452048486,0.6922735153234818
A2780,9929138,3.988043631552867,5.389215457018398
HSC-4,16065773,3.311693132411482,2.7785093557710416
A4/Fukuda,400769,-1.555916482707746,-1.2947842379963461
A2780,11977753,-3.718954593203518,-1.7376920084203797
FU-OV-1,60700,0.8482129777629449,0.03792161157642389
DMS 273,168312962,2.633531304827929,1.4279711434349922
SCC-9,8515,4.77911141452934,4.102043202521467
A2780,71680916,3.658218554445846,4.392792172933951
FU-OV-1,5328940,2.1307155577669143,1.8174182713562603
NCI-H661,42642645,1.2812432760018797,0.6855093146552015
A4/Fukuda,2113511,3.845432548996496,5.160759709222552
SBC-5,19582717,5.27972019168548,4.201623639064078
HSC-4,11222830,1.068056053085511,1.6630085978053568
CAL-51,10427712,4.2973287072996085,4.341030193005624
A4/Fukuda,44185566,1.3030950937163224,1.7429223497891015
ONS-76,5278396,3.742938248744769,3.6173800543291237
MDA-MB-453,46943432,1.9398007817238585,2.53872355318842
NCI-H727,984333,1.9308701128060968,0.7786769337028318
MDA-MB-157,24889392,2.1225906954298535,4.120050185470866
FU-OV-1,ISOX-bortezomib (250-1 mol-mol),0.954548859556388,0.8064053034957207
A4/Fukuda,46843906,1.071626560517578,1.708518286392873
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.3604404782991097
HCC1143,44241473,5.874360916813842,4.80740967907051
NCI-H460,vorinostat-navitoclax (4-1 mol-mol),2.672492910118056,1.3944639409742272
EFO-27,6918878,4.955152670116511,2.9556901265098854
CAL-51,5281672,3.9430830045045857,4.49530041944791
NCI-H146,9915743,-0.2957101551438801,0.8872477751602105
G-401,89928392,0.7343580800154272,1.0562724577448908
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515,1.8805324068776232
EFO-27,6184667,5.467001643500489,3.2024667886653497
NCI-H727,3854666,3.6466691501950512,2.432332592251137
LOU-NH91,9825149,6.244850491409518,2.4085807667888486
NCI-H146,11178236,-6.140205122942071,-3.5373473216348152
HCC1143,navitoclax-birinapant (1-1 mol-mol),-1.1255303234100646,1.2597513097651138
ONS-76,448949,2.486443038536461,1.9933904372559867
BT-549,57330099,4.335540938726609,4.1350041804184565
CAL-51,44819697,-1.9765663783606575,-0.8411792771596754
SNU-449,5278396,3.499051739077657,3.7324496258306086
LXF 289,9956119,3.057634534881657,3.789807690948369
A-498,9933475,2.3013420942123655,1.9784203885762295
DMS 273,10074640,2.948045052381196,3.031539906269121
LOU-NH91,25102847,2.3579155704363206,2.4672929538735104
G-401,5311281,1.6046025374895514,2.3772565315397207
A-673,219104,2.2996165619151507,2.962084400550462
FU-OV-1,42642645,1.0692746742635495,0.876220150764976
NCI-H460,135411,0.3374737909082799,0.7120094031697388
CAL-51,6252,-0.2076922850947726,1.1642234839890129
NCI-H1623,selumetinib-JQ-1 (4-1 mol-mol),2.0981342871867903,1.4797286953220765
LXF 289,10296883,3.609856485747645,4.025984638661339
KMRC-1,54626689,4.972873475873264,4.62951362758769
A-673,JQ-1-UNC0638 (2-1 mol-mol),0.3202130450215845,1.0218700338798792
HCC1143,1750826,-1.2654463091368686,-1.2230121028849157
SNU-449,24785538,2.8069089427026346,1.8508284106629276
LOU-NH91,53495165,1.612116489462364,0.894520190969493
EFO-27,11609586,3.640431752283184,3.0533174990556944
LoVo,tanespimycin-gemcitabine (1-1 mol-mol),0.1756680673297083,-1.0009599997856258
Panc 04.03,104842,-1.0125052126256155,-2.161954108113127
NCI-H522,6610355,5.34603712705315,4.53875488733131
NCI-H661,11656518,2.215339329496845,1.8951103694864384
NCI-H661,6505803,-0.5859050253944337,-0.7149363500157606
NCI-H292,5351362,1.0382380370911135,1.4306813102758518
EFO-27,11612883,3.4595212211892377,3.0016634920908443
FU-OV-1,vorinostat-carboplatin (1-1 mol-mol),2.1636839207385914,3.1032192044114804
HSC-4,10302451,2.384078053411002,2.821468126159004
NCI-H292,46199207,3.366381535989616,3.3195344942603895
LoVo,262093,2.370412929490009,2.926463680787789
BxPC-3,445643,4.432772060189362,3.9594212374234754
A-673,carboplatin-UNC0638 (2-1 mol-mol),1.4546927004142935,2.9326258951155753
A4/Fukuda,46224516,1.3171235816864948,2.309694130550345
JM-1,3854666,0.4999957819555636,0.8220943267208586
NCI-H292,124202324,2.857386903129287,2.8063304069794617
BT-549,1566236,1.7296376770428397,2.5215931788586854
LXF 289,11364421,-2.6687395721676577,-1.4695340243620363
NCI-H146,navitoclax-sorafenib (1-1 mol-mol),-1.8992247000680913,0.8371258465708139
FTC-133,148198,-1.6568063805549866,-2.8160125820437854
LXF 289,11640390,5.398484732926136,3.6220646770066818
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944,1.5385455518777773
LXF 289,2749,2.818144236178911,2.2594199447249763
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522,-0.46052155258824246
JM-1,135875424,2.019666731209586,3.134921258171894
SCC-9,4705,2.492131143046821,2.9618904282109906
NCI-H2171,151289,1.4157771037164255,0.7116532711594807
NCI-H522,644241,2.1349742590503427,1.4467738600388995
A-673,445643,4.040507929851862,3.7964230906674885
JM-1,6252,-5.0324479776154885,-1.92333494313725
NCI-H292,208908,4.322795663590344,1.8954510700214553
A-498,2871966,1.0686849145956876,1.1637270357997507
G-401,12001922,1.3873374697674952,1.7355590971027246
DMS 273,44491742,3.7307306463602545,4.057673906076718
A4/Fukuda,11396600,-8.215434514364686,2.995569632140412
HSC-4,3689413,2.5472025828962055,0.2608916470413822
MDA-MB-453,4378219,1.7417226469020404,2.1352671655809146
ONS-76,387447,-4.115404850127739,-3.7808404030916942
LOU-NH91,656346,1.0077735762311986,0.9584218314306399
A4/Fukuda,3081361,1.810117399969756,1.9467754626273415
NCI-H460,6505803,-0.4074860596498978,-0.7120077373970224
NCI-H146,45279963,2.8359939324557706,3.055691035534538
OPM-2,6184667,1.6391974127027074,2.7970384713488734
HCC1143,148198,-3.881060339055355,-3.6259991984344184
A-673,421610,1.6759942643549426,2.9379117610867627
SNU-61,4259181,0.2985440005718957,0.12053403597110066
LXF 289,44819697,0.5606163889857397,-0.2228021160170197
KYSE-70,168312962,-0.2970816131627225,1.884126134684239
NCI-H146,11494412,-1.136229477240518,0.7044395382155173
OPM-2,2746,0.9082445461467812,1.836823660760143
MDA-MB-157,6918736,-2.3678025624565175,-1.5688748585871535
DMS 273,135659046,3.477426326571923,3.519851731205971
HSC-4,126941,-2.3076253927529127,-2.4590977098262563
CAL-51,57519531,1.893237876741888,2.4126420561341675
MDA-MB-157,3038522,4.043799431595376,3.003917284628565
ONS-76,SNX-2112-bortezomib (250-1 mol-mol),-0.0712128201037348,-1.1249681409425418
BxPC-3,54613361,-0.6294380958983512,0.3340575725741905
CA46,25102847,1.8345278315547784,1.6857281411772689
FTC-133,5746,0.3858378554684238,1.1525647977926974
BT-549,10113978,3.95693770646699,3.273406984048488
A2780,54618771,-0.248592168161829,1.0321334827691515
SNU-61,6917907,-7.995083965311066,-5.653181892532214
ONS-76,3384730,2.185678697527176,3.0952273239344295
LOU-NH91,11228183,0.5456186750940368,2.64304550748373
MDA-MB-157,25227462,1.286146426910961,0.11717102063932902
Panc 04.03,selumetinib-JQ-1 (4-1 mol-mol),2.1482953038113286,1.6649763455017885
BT-549,439501,-3.1266914034371567,-2.1534949169247644
LXF 289,409805,5.2068809837223435,4.660450107890612
OVISE,148198,-3.4121309130102055,-3.2927602089892685
YAPC,262093,3.6115167721531343,3.104726277201649
NCI-H727,5738263,3.354715168796171,3.494238512006124
A-673,6918328,-0.9424380212903694,-0.446964930156841
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246,1.9100304348097494
JM-1,445643,3.755930816022248,3.4661286610252713
A2780,25154868,3.617715738937927,4.294274202678251
Panc 04.03,81146,4.4293645850092735,4.739082673642464
MDA-MB-453,4521392,4.261545411784443,4.380712918620742
CAL-51,5460769,1.3780575552768597,2.637232710803222
SNU-81,9926054,1.3093723678717843,1.8864238832515978
CAL-51,2113511,6.39897875596168,5.467431154053096
NCI-H460,136227924,3.925006850615035,3.0479806284192676
NCI-H522,24856436,0.0798065953372803,0.3492167217501317
SBC-5,9967941,3.629642521259923,3.369488384730439
A4/Fukuda,462382,-0.2406989279082468,0.6650580126496418
OVISE,11640390,4.491956307789174,3.626205791474169
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843,2.1238777227023977
CAL-51,24180125,2.8082301472193203,2.983116776859691
LXF 289,25262965,-2.558275633709226,-1.4568505864499484
NCI-H2009,9903786,1.8298580590992315,2.804477649319031
SNU-61,54678924,1.5881868934361725,1.795307114312698
YAPC,24785538,1.575520805381804,1.57374013603406
NCI-H2171,676352,1.591250217642193,1.7694813183579496
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413,3.3382658258512494
ONS-76,BRD-K27188169-navitoclax (2-1 mol-mol),3.629677877626108,2.5210435905131248
NOMO-1,3689413,-2.5325178418163174,-1.278612644562263
OPM-2,5284373,2.335601496737994,1.76781551570065
NCI-H661,10127622,4.958480333722226,4.479049541034429
ONS-76,44185566,2.3053400119978735,2.4003147567112944
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053,2.979393498677608
HCC1143,11485656,1.8564802256291268,2.499493170338692
G-401,613753,2.8041503953296187,2.8150396214688453
MDA-MB-157,11657048,4.26764748298064,4.354325199297086
ONS-76,24951314,1.2212354664419371,1.3387788380766867
A2780,36462,-2.0824592368546893,1.0246106282800493
FTC-133,vorinostat-carboplatin (1-1 mol-mol),4.046796900888368,3.0305727220096337
OPM-2,72376,-3.1510357921092376,-3.6279643549574248
OPM-2,6918328,-2.875264730320658,-1.3800273145093847
NCI-H522,decitabine-navitoclax (2-1 mol-mol),4.970964992537572,0.6947102879145757
EFO-27,168312962,3.0506772104926343,2.3107372453417736
NCI-H1623,107985,-2.7226564689550488,-3.2548532678892195
MDA-MB-453,46398810,2.51328952557295,2.5326953767324913
SNU-449,49766530,-0.9876450445747244,0.05423144982753316
OPM-2,25102847,1.4573873057147737,1.961759692620866
G-401,3081361,2.1638535645332664,1.8982445946820397
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866,4.1856631778868
A2780,24951314,0.3580646626980762,0.7043857921604796
SCC-9,2871966,2.1501352130214695,0.6084306471510096
EFO-27,53232,3.845715413797161,3.046947052714594
A2780,5460769,-5.6757466443406575,2.1560265801594767
Panc 04.03,10322450,4.721553837851545,3.9032804810370982
NCI-H292,selumetinib-JQ-1 (4-1 mol-mol),0.7417417133593783,1.6036740661675062
SNU-449,23582824,0.6769149785817056,0.8307522571365077
LoVo,selumetinib-BRD-A02303741 (4-1 mol-mol),1.3489379302549531,3.5493844720294914
ONS-76,3854666,0.984876663182433,1.909899342308565
MDA-MB-453,71466578,1.854784458712459,4.341583582907933
BT-549,piperlongumine-MST-312 (1-1 mol-mol),1.4526674208496635,1.8793151991668489
MDA-MB-453,15547703,3.861172408325267,3.1320747773654123
MDA-MB-157,252682,6.150103454129247,6.450644247666357
G-401,46398810,1.5664917458517695,2.229793838018848
NCI-H1623,327653,3.600793829240414,3.260070915235697
SBC-5,6610355,5.221010400785003,4.312983297208158
A4/Fukuda,6918878,-0.3411937140873722,0.8953013163033124
SNU-81,3062316,2.330723232319837,1.0903765191675736
OPM-2,9903786,2.6412283094975657,2.0006631820927288
HSC-4,15953870,4.269670192757531,3.5483296487173486
JM-1,984333,-1.6115401451915106,-0.07179884980175702
Panc 04.03,46174525,5.826098059849913,4.562724741723757
NCI-H292,5460769,0.0770188109309223,2.762848898300856
FTC-133,216345,4.490711794352075,3.6429416536404826
BT-549,alisertib-navitoclax (2-1 mol-mol),-0.0458580768045358,0.9468786671573192
FU-OV-1,5311,1.028726852721831,1.510153477304015
LoVo,9911830,1.9062113768292104,2.6275704455894293
CA46,23582824,0.075225101675958,0.41036630535740687
JM-1,alisertib-navitoclax (2-1 mol-mol),-3.873969254990661,-1.2327149604909808
EFO-27,24797083,1.960036113572856,1.4573758870565983
NCI-H1623,5460769,3.63452416726077,3.0378359634122045
NCI-H661,5311,1.0541651051557333,1.6204225165554988
G-401,119182,-0.7625552993148171,-1.07529253403156
KMRC-1,navitoclax-MST-312 (1-1 mol-mol),0.8819471903820566,0.7982773798513295
ONS-76,11507802,1.2556507557201144,1.5225962670456838
KYSE-70,6918736,-3.61435843984592,-1.13704782937227
NCI-H2009,4788,5.716428228211685,5.735507276557428
ONS-76,54686904,4.527599605979478,3.4309433832621945
CAL-51,2729026,2.5757432896171517,2.8020601104848697
ONS-76,3689413,-0.2845128895134612,-0.5406501600992235
JM-1,676352,1.381688063426603,1.5415859633305429
NCI-H2171,11238147,2.9150011478889795,2.2845652981163287
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715,2.486839304468074
Panc 04.03,5738263,4.451939152518209,3.8013060513044605
HCC1143,71304818,2.928848735179534,2.5089323250548885
OPM-2,9826308,-1.153894104617258,-0.16368868570724232
OVISE,73707438,4.551111956107329,3.7116828601129037
KMRC-1,448949,2.0346247593103257,2.049185111403051
NCI-H661,44589607,2.97822499860898,2.904483389137153
YAPC,3503,2.818608145608573,2.420589103913851
NCI-H522,3825829,3.960912701697082,3.582267371161533
NCI-H661,5738263,2.7657344337958687,3.480592743066418
CAL-51,168312962,1.4117577594763937,2.0341127174814
CA46,4261,-0.8863355705331979,0.27300043480435043
CAL-51,241158,3.781489879449518,3.9235113685350376
A-673,2874250,4.616954738528679,4.352700365224745
BT-549,46191454,1.72486803708685,1.8433856534288
JM-1,6918878,0.0294179493888284,0.4989657890215862
CAL-51,4521392,4.667802355757324,4.478247694532687
CAL-51,9915743,1.1260994347217144,1.3243514010241457
NCI-H146,46943432,1.2283557348915184,2.159951947209584
YAPC,168312962,3.6522382892319185,2.1846624016109017
NCI-H522,44493528,4.173254194812623,4.296301585001513
BT-549,10296883,4.161421407524775,3.825959537194432
OVISE,11152667,1.81896217810704,-0.2172153209691182
G-401,6852167,1.9492633511801831,2.3547206072661915
NCI-H292,168313047,2.7678931286458974,2.5229279571631
A-673,5329102,0.93841525470917,1.3618891550503163
A-673,11404337,-2.7698937773977033,-0.7336250560978453
BxPC-3,11222830,1.6538054387944447,1.7260147742496477
KMRC-1,25102847,3.2500467863275735,2.5658701554837857
MDA-MB-453,400769,-1.402270827463697,-0.6174404492970497
OVISE,89928392,2.0483381338479907,1.6675081399572327
MDA-MB-157,136227924,3.402219650297347,2.946091927607018
SNU-449,JQ-1-UNC0638 (2-1 mol-mol),5.2681139205860354,1.8655956884679725
BxPC-3,5738263,3.0337675506106576,3.496128875795335
NCI-H292,16741245,5.797273118380107,3.948130496415367
Panc 04.03,11404337,1.3784278741672673,-0.010836108164111175
HSC-4,2130404,3.512147769522711,3.148609065401577
SBC-5,5329102,3.79532117952851,2.118521134290833
SNU-449,57519531,5.8010509150022145,2.7188609642065713
KMRC-1,1750826,-1.909836969824086,-1.9268795407989971
DMS 273,53245473,3.723579099176344,3.2663874026806625
A4/Fukuda,44137675,1.307300702935143,3.0883506750300556
LoVo,72734382,4.052668353480041,4.62455772031156
SW1463,57519531,1.6287135351441295,2.177389604510142
SNU-61,16038120,1.3103584397228891,0.5036170096017281
CAL-51,9926054,2.2227862000004577,2.0755475239925185
KMRC-1,15953870,4.40931040558564,3.66175268394696
A4/Fukuda,46191454,-2.2780561859524457,0.2900509083876479
EFO-27,6505803,0.9411407576336728,-0.7186076545592277
A4/Fukuda,24951314,0.2081517019188384,0.698652876482305
A-498,10184653,1.9377607214538883,1.2651506206098724
HSC-4,doxorubicin-navitoclax (2-1 mol-mol),-1.2623488821486932,-0.8433654099818565
NCI-H522,9911830,2.121034111225194,2.2650239646512746
YAPC,53392493,3.0834263437199705,2.631528169466202
FU-OV-1,JQ-1-MK-0752 (1-1 mol-mol),1.194664031604259,1.7691499423877945
FTC-133,15547703,3.427766539334031,3.331106034833094
SBC-5,11404337,1.1992857421773124,-0.34084061553624595
NOMO-1,654092,-2.6158486127541343,-0.9198869957387192
JM-1,navitoclax-sorafenib (1-1 mol-mol),0.8658356793776997,0.22103917344779947
OPM-2,49793307,-4.879066461483742,-4.463734622876876
JM-1,11717001,4.327873015149225,3.7526562784648005
MSTO-211H,969516,2.440842922513423,2.974837960399017
NCI-H460,9926054,2.081701465030928,1.93109586466676
LXF 289,9936388,-5.793518221083613,-0.6954838398593693
LoVo,10184653,-0.0525672628767589,1.2285725514830323
G-401,9866186,0.2347893748246883,0.5984799933580497
ONS-76,BRD-K99584050,5.369990310930208,2.7454899319245647
KMRC-1,168312962,3.867746451267385,1.4792510561699606
YAPC,452548,0.3485834104810916,0.6035647845189931
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597,1.5021437519033471
FU-OV-1,6450551,4.626381712180732,2.8254133807163653
EFO-27,carboplatin-etoposide (40-17 mol-mol),3.749556119159122,3.1016451227173354
SNU-449,5978,1.8233754703073703,-0.8136655958920752
LOU-NH91,44589607,2.878199319266369,3.1810070493957827
CAL-51,tretinoin-carboplatin (2-1 mol-mol),4.904159369397283,5.132598956347504
A4/Fukuda,65628,3.8428022223998366,3.2345465127912187
A2780,42611257,2.862805810765337,3.371756434257016
FTC-133,49867930,5.271360985380777,4.693902160219156
SNU-61,56946209,-2.5026309203687314,-4.377882527075603
FU-OV-1,3062316,-5.013660753129892,0.9738157565653576
KMRC-1,vorinostat-navitoclax (4-1 mol-mol),1.4468975732833491,1.212127918358594
NCI-H522,123631,2.114949756755372,2.364507966521144
NOMO-1,52912189,-0.5265680930430634,0.06882852770440294
HCC1143,selumetinib-tretinoin (2-1 mol-mol),4.123174212921891,3.8810260449637455
CA46,2733526,4.193969711090682,3.1087690224567877
G-401,44819697,-1.6952135460319926,-0.8476598728985223
MDA-MB-453,44507138,1.496822662467132,2.2872878059149424
NCI-H2171,9825149,1.181898582623386,1.7693982765764846
OPM-2,8515,3.0418796641091226,3.209992051212852
Panc 04.03,4096211,3.5665133346619684,2.2528867468284512
KMRC-1,6610216,4.1544949822147,4.324812149047796
NCI-H460,25150857,3.536831166282903,2.5392729161145446
OPM-2,11977753,-4.6820583055789,-2.2379764406113023
G-401,49793307,-5.199300209786212,-3.60098824332597
A2780,1239801,3.465676691044825,3.660646965908056
Panc 04.03,46398810,3.688960594211219,2.6554182467057608
G-401,65628,4.0909837295628275,3.7917333220116842
BT-549,53232,2.511840395622571,2.8909804946214184
NCI-H727,104842,-0.3454800108905812,-1.9361474168059627
NCI-H292,6852167,2.409220580223775,2.8883257957629036
KMRC-1,15547703,4.785371110425684,3.0209652273573955
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615,3.335349017797085
BxPC-3,16722836,0.8866010617403134,1.9272417838839198
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625,1.1231870374148292
LXF 289,168312962,1.364587801939814,2.4690506645815247
G-401,11626560,1.1843690178322546,1.4583201776372394
YAPC,3825829,4.484241364021175,4.04792798164743
NCI-H2009,46943432,2.8478796444115835,2.6670705518973294
SNU-449,16038120,1.104181711259477,1.0930967626440065
MDA-MB-157,72193861,0.2105280638919307,1.964316009432066
ONS-76,46191454,1.5088295462826262,1.6701638855922867
LXF 289,439501,-1.653941874457911,-2.0636353016257214
MDA-MB-453,54649381,4.094182376460235,3.7817636375957564
EFO-27,11507802,4.116687062031661,1.6334003145207374
ONS-76,crizotinib-PLX-4032 (2-1 mol-mol),2.136807968488312,1.6237121859202888
SNU-81,11427553,2.1196099795437733,2.1004181810602476
SNU-61,54143018,-0.3273600933762652,0.22605977322512566
HSC-4,17755052,1.8179922614483863,1.7136907193137834
EFO-27,2130404,3.4270754566369748,3.2788537158272932
FTC-133,24821094,3.776872089794721,3.0186368267823283
SNU-449,44607531,1.5485785292308227,1.6656461325160163
KYSE-70,24772860,-1.2328668610311222,-1.2170548557525738
NCI-H522,11214940,1.077396173859641,2.0332923856421967
SNU-449,1474550,4.524224948734458,3.603519114583965
LXF 289,44589607,3.4320685896186585,3.0373984848231452
OPM-2,31703,-1.5109362720248076,-2.761236596691053
A4/Fukuda,445455,4.756694709293823,3.8680277083060717
LoVo,71680916,4.224958300762603,4.7680638323746445
KMRC-1,25262965,-3.4791684180939,-1.350908419865084
NCI-H1623,54613361,0.8976129642368637,0.1229452371001721
DMS 273,15547703,2.68216153568037,2.8110345882552044
HCC1143,5311,1.090656828429124,1.5030857708614243
SNU-81,JQ-1-navitoclax (2-1 mol-mol),0.6755199584386623,0.713012815185309
MSTO-211H,11977753,-3.756718801235006,-1.454558618172661
NCI-H661,51037431,4.262261435001038,3.3303428026177984
EFO-27,25183872,0.6822597295955183,-0.6285982693379212
BT-549,docetaxel-tanespimycin (2-1 mol-mol),-6.584782072874471,-2.7492671471006735
MDA-MB-453,16659841,4.43927192393091,3.81386265269238
SNU-449,3854666,3.254678167809475,2.5039983924963427
JM-1,selumetinib-navitoclax (8-1 mol-mol),1.96596855152698,0.5975398765171759
HSC-4,46174525,4.818915916273074,4.498433384585729
NCI-H727,25062766,3.0095924827905813,2.224400545366792
EFO-27,9823820,4.474335567240953,4.107490407705808
CAL-51,4917,3.122174268556499,3.1274940490695315
SCC-9,676352,2.0394457592349093,2.055800136948034
MSTO-211H,4259181,-0.7585521679245923,0.20630745345656112
Panc 04.03,3854666,3.6180263181428622,2.7067671128587323
A2780,11214940,1.8716907673631955,1.7675683765349026
Panc 04.03,445455,5.108054343544362,4.631933983571022
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776,-1.1060512847511672
DMS 273,3081361,3.0365977955778805,2.336792464797029
BxPC-3,126941,-2.8667568441276083,-2.4976071416120207
EFO-27,6918837,-4.778560341054376,-2.558167534755048
JM-1,9956119,1.3894298966841814,2.524383326233413
CAL-51,60750,-3.4379358682898973,-2.0306612984448513
SNU-449,12001922,2.031450773900583,2.069362771881012
SNU-81,119182,-3.3799134284972614,-0.8079838890472193
CAL-51,6918878,3.0110486558166274,2.955550041108548
CA46,44819697,-3.819793103454841,-1.6872101894853437
OPM-2,46199207,2.048842595102616,2.8967187086019375
JM-1,11977753,-2.0561747941195674,-2.367642062287016
MDA-MB-453,16038120,1.4822204990084098,1.109133153111211
BT-549,selumetinib-tretinoin (2-1 mol-mol),5.357160165486871,4.132915135774972
G-401,135928012,4.758772301459146,4.166847460718219
LoVo,445455,4.556737788306169,4.522085892459023
FU-OV-1,11964036,-0.3048537688067435,1.6258922265557256
CAL-51,3825829,3.9510679995615257,3.9492785143396527
NOMO-1,66577038,2.985459327680272,2.5028860083519264
YAPC,4259181,0.8211273757017798,0.6433833283630341
BT-549,2708,5.415828272287544,4.757370859254134
OPM-2,4477,0.1075725295912922,0.6296857138972011
ONS-76,23635314,-1.3572631369234491,-1.9359028082436012
Panc 04.03,168313200,2.993774278353398,2.855029235855401
A2780,25262965,-4.532154518345387,-2.275070651992572
LoVo,24951314,0.8531724175888866,1.4199247116658207
SNU-61,6918837,-2.02709157063253,-3.6921088529672286
LOU-NH91,6918878,5.623996708869271,3.2034211787770626
LOU-NH91,16725315,5.120050781978422,4.428208444032446
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376,0.7580549590010477
NCI-H661,16722836,1.177222753188902,1.8179951501398153
A-498,9935249,3.347418171794467,3.2126332679494807
NCI-H2009,44185566,3.0429431135599607,2.810358481087925
Panc 04.03,25126798,3.7756614801897377,3.885333867818697
LOU-NH91,24771867,3.0978851297923895,3.0760927719582223
Panc 04.03,10231331,4.944041434313903,2.189937583593223
Panc 04.03,9967941,5.787601223768576,3.9117997244701836
HCC1143,11497983,5.345504804401821,3.580815645820889
MDA-MB-453,6505803,-3.8322805026755806,-0.9622033045666711
LXF 289,285033,-1.4335563326434544,-1.5621465718766152
NCI-H292,3689413,1.7536313837601494,0.23149068015178162
OVISE,54618771,1.319775250733869,1.1967133356150148
SNU-81,135411,1.0381613293566891,0.5410155594861416
NCI-H2009,451668,5.323035746604961,4.211154048467413
SNU-81,3689413,1.1974270464491454,-0.46857185870471196
FTC-133,5738263,4.07617232189308,3.706620801307947
NCI-H1623,5291,3.880629558524794,3.7506786333763817
NCI-H727,51039095,2.7124063556691267,2.5414056036337143
DMS 273,262093,2.141936221481062,2.1171663772932563
CAL-51,6918328,0.3807555589851347,0.0859481361231194
A-498,24951314,2.536702379510054,1.70892892508155
OVISE,135440466,-0.9475229728449716,2.3844822410167392
A2780,11404337,-0.8981705286722745,-0.7623830823758491
OVISE,selumetinib-navitoclax (8-1 mol-mol),1.5927997425042688,1.9565241063370389
Panc 04.03,24951314,1.470760951451068,1.7319011660710542
NOMO-1,4705,2.5023829157060926,3.0964438720891114
BxPC-3,176870,2.768163283404042,3.105634780844359
G-401,11609586,0.8694160359503889,2.0282519511224733
EFO-27,doxorubicin-navitoclax (2-1 mol-mol),0.6327917719948324,-0.7794278083355691
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324,-0.39826388017943953
NCI-H2009,15983966,-3.9047819028388178,-0.057274083233857506
JM-1,16659841,2.088291676862089,2.558837571709491
NCI-H146,5311,-0.0389435386139853,0.992056581363108
A2780,72734382,3.371521062177298,3.982081167270037
A-673,2708,2.956024737310482,4.043888106456099
NCI-H460,11152667,1.2005763717636435,-0.8637275487397618
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945,3.2980885391310317
G-401,60700,-0.931594906554522,-1.2969578253071237
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633,-0.8600526659349194
NCI-H146,31703,-2.278385754586821,-1.609601440067955
KMRC-1,445643,4.4248475697731005,3.8894509552136625
SNU-61,tanespimycin-gemcitabine (1-1 mol-mol),-0.5770554338848054,-1.2823710404901385
KYSE-70,54613361,0.0645626216296427,0.35942627740349403
CAL-51,444795,5.053001195278548,4.731576452481246
KYSE-70,54619267,5.587983352589812,3.9521710816086295
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506,2.376466773224169
NCI-H522,135984461,5.248212763135773,3.32502818785896
CA46,10385095,0.6992054873225039,0.8488374182441778
G-401,16038120,0.8239725572719159,0.652514460753401
A2780,selumetinib-tretinoin (2-1 mol-mol),2.739843613325444,3.4553953659365213
NCI-H1623,6918328,0.1782181011891448,0.20631343168604882
G-401,31703,-2.7567506026552904,-1.864844945347341
OPM-2,11497983,4.2316824511311,0.4440823546622514
NCI-H522,46215462,1.6065433434555243,1.589407334539596
JM-1,selumetinib-UNC0638 (4-1 mol-mol),2.9715297614660474,1.9733308552629165
A-498,selumetinib-BRD-A02303741 (4-1 mol-mol),2.466660305447313,3.7812078740317356
A-673,16741245,3.6856166817392393,4.031766541698608
DMS 273,44486219,3.889102530118227,4.141928303716373
ONS-76,3062316,0.3527292351029743,1.2795954622756254
NCI-H1623,4521392,4.396491619301915,4.273860374484695
SBC-5,3062316,3.347274022566764,1.2658574457471894
OPM-2,374536,1.7033153768622478,1.0844062026624142
NCI-H292,5291,3.74340966649761,3.776920492624338
G-401,123631,2.330078370852269,2.2242845272335314
HSC-4,135423438,1.814117839489682,2.6603938334845987
CAL-51,25126798,3.926975819986009,3.891973604086841
NCI-H727,409805,5.9670224431598875,4.875261944469668
A-673,4917,1.8117239982797952,3.036828955228951
DMS 273,57519531,1.9430749026869305,2.054472447499105
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043,3.405044163213395
HSC-4,25262965,-0.4495508061813805,-0.816015919032305
OVISE,327653,2.506626214633075,3.171469779075841
A4/Fukuda,71680916,4.641498651595925,4.261951318758523
EFO-27,104842,-1.4311942194738418,-2.4314872165992516
A-673,11626560,-0.097195247735582,1.2955526943193212
NCI-H146,3384730,2.6214971804948908,2.6519331576712104
MSTO-211H,26596,-0.5653018529577997,-0.9358228634162136
JM-1,445455,3.9843646189648863,3.9294107657531208
CAL-51,11427553,2.069280384014222,2.9070984965491657
SNU-61,20959075,-3.60077638491687,-2.7605396550071317
LXF 289,25062766,1.8533275351899623,2.0041797865751265
LOU-NH91,24797083,1.602297413523094,1.524509540625515
CAL-51,24771867,-0.5018492111736887,2.690964313545566
NOMO-1,44632017,0.9405041708842384,0.8524011994044891
NCI-H146,25195348,0.0229507172684141,3.0293668912384244
A-673,151289,0.5990139557366498,0.7687784216390418
JM-1,72376,-3.929922218649067,-3.7325425138668846
NCI-H727,12003241,-0.657143782776601,-0.6899248403808009
JM-1,24180125,1.1035620934920058,2.2485413710402935
LoVo,24964624,-0.96112559187181,2.3391640874291175
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224,0.5451039425116669
OVISE,6610216,4.867128617935935,4.269197987314703
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466,4.821625728826945
CAL-51,11507802,1.2528060552922216,1.3652679512972503
A4/Fukuda,25227462,-5.883792654516593,-1.3573280004652728
BxPC-3,5566,2.8001360517565628,3.0148750979497976
DMS 273,119182,1.6620070398785467,-0.9209933623808431
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465,0.9286076302278975
NOMO-1,168313200,3.152434526133537,2.813011954581204
A-673,navitoclax-PLX-4032 (1-1 mol-mol),0.8994506626912233,0.8617513642842741
NCI-H727,24856436,1.7647429516878397,0.5822229543491473
KMRC-1,72734382,5.690666345136703,4.158123748303043
A-673,56949517,4.212065281653062,4.108608388327246
BT-549,135421197,3.4062158650675265,1.9026293121991094
DMS 273,vorinostat-carboplatin (1-1 mol-mol),2.6049111550172506,2.3298888157700524
NCI-H1623,10074640,3.727129107489099,3.1238632505195785
YAPC,5329102,2.676937714502371,2.0767327480067923
YAPC,docetaxel-tanespimycin (2-1 mol-mol),2.5986620559096902,-2.7878498748497016
NCI-H2009,4917,2.9963488408029417,3.136992543928867
NCI-H727,44589607,2.894616632949603,3.0934905491677376
G-401,5328940,1.7098947779411977,1.40945763127544
FTC-133,10410894,5.920528547603018,3.294812149108252
CAL-51,216468,1.370586512271769,2.945122823525015
MDA-MB-453,227681,3.97271964535407,3.19754959457879
A4/Fukuda,5284616,3.229953451024844,0.34147020429548297
NCI-H460,753704,5.635234970240753,4.992376140199674
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243,3.1923591638153255
SBC-5,crizotinib-PLX-4032 (2-1 mol-mol),2.792734881189652,1.8612947249129428
NCI-H1623,25150857,2.7146098705885127,2.479689215449675
YAPC,JQ-1-vorinostat (2-1 mol-mol),2.9118979144458548,1.271683880034429
LOU-NH91,2729026,2.877851429076431,2.805239226793927
CA46,46191454,-0.333651418813281,0.14475660800991202
FTC-133,65628,4.302527639906617,4.448267723678684
A2780,72193861,-0.1120033238626439,0.8921393761987703
SCC-9,49793307,-2.052824266331224,-2.6271265427634383
BxPC-3,135440466,1.2091890795281053,2.2580486958597503
NCI-H146,11455910,-0.4209962248823531,0.8768521590345286
A-673,46398810,1.6125076634642133,2.1683829007821016
SNU-81,11626927,-0.7774954189098839,2.5984619234763873
JM-1,45279963,2.536030346276664,2.4842671038024045
MDA-MB-157,5746,1.4435337882328911,1.1959761603321497
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684,4.503548918198677
ONS-76,2874250,6.058821088556036,4.7519134342470934
A2780,5284329,2.502098244540034,2.6577635898934
LoVo,53232,3.084407514553567,2.8838341123110176
ONS-76,navitoclax-PLX-4032 (1-1 mol-mol),4.335120397658034,2.143498426380924
OPM-2,9927531,3.0625153090482757,4.2364132921704485
SNU-449,44202524,4.173676721592596,2.3888633316228236
SNU-61,124202324,2.5924607447988643,1.7894536674689843
JM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.853804462612268,-2.8835980982198777
CAL-51,44819697,-1.9765663783606575,-0.8411792771596754
FU-OV-1,2708,5.501261259949465,4.894166567049869
EFO-27,selumetinib-JQ-1 (4-1 mol-mol),3.927546340306408,2.1974479355670886
SNU-81,16722836,0.5712028725805488,1.2376431222068593
SNU-61,1716436,2.6740680266491763,2.9266159314833464
OPM-2,3854666,0.6659331794855328,0.9738064263962117
DMS 273,71304818,2.423766397759693,2.2838759584124206
OPM-2,44185566,1.967847411757682,1.592765706874026
SNU-449,25154868,5.089625763576692,4.6360976936516645
JM-1,serdemetan-SCH-529074 (1-1 mol-mol),0.850280297026697,1.0217460594368877
NCI-H661,5281321,0.7671093512543088,-1.2073272181942798
SCC-9,44185566,3.0958673753547785,2.521955366149838
MDA-MB-453,16736978,1.2653262263884038,1.0879734857333554
KYSE-70,9935249,3.427959003246725,2.9710189977306696
MDA-MB-453,11178236,-5.341922221503707,-2.676986942451862
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496,4.8626707058606
EFO-27,24180719,4.15462806748021,3.617257633749877
NCI-H727,44607531,2.33451518290986,1.4446467935390948
NCI-H292,10410894,3.620691172443616,3.3633258455302264
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943,-2.2405862115964648
MDA-MB-453,10184653,1.4947310227918462,0.3921849375925815
MDA-MB-453,11228183,3.436796326739784,2.2222893299048923
DMS 273,67291369,1.8884432049214537,1.7726077564800369
NCI-H2171,54619267,3.4799425585632204,3.759351997812318
MDA-MB-453,448949,2.258073743229602,2.249870905142141
A2780,135440466,1.248320725279374,2.144408032934872
NCI-H146,9866186,0.8123633746782326,0.8682408090114437
CAL-51,JQ-1-UNC0638 (2-1 mol-mol),2.957186158032418,1.606764685719253
A4/Fukuda,10074640,2.009206402328629,2.814711610778862
KYSE-70,31703,-0.0860185315527888,-0.6854580066136289
A-673,11497983,-0.3979292238924095,0.7357511828753893
A2780,12003241,-2.743381978251489,-1.0573758527366732
A4/Fukuda,25102847,0.4372365282678318,2.168302331908856
KMRC-1,11717001,4.773123606238519,3.817894946589145
FTC-133,36462,0.6793689394766376,2.506170900001204
SCC-9,23582824,0.351039434592286,0.7619761986192225
BT-549,2729026,3.014205222238777,2.844602609725506
EFO-27,selumetinib-piperlongumine (8-1 mol-mol),4.5130277383980015,3.7602237531496856
LXF 289,46943432,1.4312531154305732,2.912480006550781
NCI-H727,11625818,5.425399240643101,4.32035885673594
HSC-4,44507138,3.308450875381542,2.5738163126851874
A-673,969516,1.3043572294505754,2.6214225066300467
FTC-133,969516,2.842702479050133,2.8799534411031074
HCC1143,11609586,3.6708937391840206,3.0584797981331513
DMS 273,2733487,6.43119993607997,5.534220616449705
LoVo,10302451,1.0215583424111876,3.150433011381598
KYSE-70,46174525,4.613744209458669,4.41040907596722
SBC-5,65628,3.417870630997437,4.324426070479734
DMS 273,24180125,3.0640550148835812,2.5290642117265567
OVISE,452548,1.282500130328104,0.5164490664890306
BxPC-3,71304818,2.4465042326182247,2.608381176479
ONS-76,54143018,0.4309751541382265,0.40415913889205757
OVISE,24856436,2.006053298804951,0.886547310582516
MDA-MB-453,71729975,-0.0804754192781109,2.1162360694984916
NCI-H1623,65628,4.265717950525356,4.301284640692514
DMS 273,9927531,4.953960158421894,4.625985025623208
BxPC-3,426756,6.38858222821808,4.431356727706216
NCI-H2009,49766530,0.9767616789625324,0.13872836639288927
JM-1,2858523,2.95851246958296,2.6581322319146494
YAPC,9935249,3.6850704434892823,3.314790427343647
A2780,654092,-1.3080416104753447,-0.5569854171512334
OPM-2,6918638,-1.573449675489913,-0.7847441049978712
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744,1.0625182719175006
SBC-5,25105715,3.9151038194938352,3.3800114300583406
SNU-61,168313047,1.9617236271133212,2.3490659930164868
A4/Fukuda,11317348,1.1392337694005448,1.6474056381020405
NCI-H522,25262965,-1.3157493467877637,-1.7649846312931006
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021,1.2865177991275498
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567,-3.0535213183237357
MSTO-211H,44607530,1.4093785076150551,1.9767535594377486
HSC-4,984333,1.2474358256824072,0.8867343265036832
CAL-51,alisertib-navitoclax (2-1 mol-mol),0.1244503961193178,0.12157463492564602
ONS-76,9967941,2.912852232249919,3.68463775354697
DMS 273,24753719,4.257561408038297,3.633344980074552
CAL-51,24772860,-2.425084956958233,-1.769375771258849
MSTO-211H,44632017,1.2059374560785627,1.3201820793144257
NCI-H146,5978,-4.422435519224839,-2.5773638956206186
G-401,2746,2.560873344661061,2.7914498239172207
A-498,navitoclax-sorafenib (1-1 mol-mol),1.1504287043269172,2.0981576206837684
NCI-H2009,11152667,-0.3244172236423036,-0.3651054367574716
BxPC-3,erlotinib-PLX-4032 (2-1 mol-mol),3.269235353902274,2.631002482070664
MDA-MB-453,219104,3.605347452429255,3.49954042484236
KMRC-1,5280436,0.1724698964633139,3.3407171660087562
A-673,25154868,2.9619598302203176,4.444216345562886
A-673,135999136,4.231524255529223,2.701514842138146
FU-OV-1,9884685,-0.2158788705773567,1.0263457640545652
NCI-H727,11626560,1.656358651993978,1.6866007654112614
CAL-51,9866186,1.45916914556855,0.7403743820798909
HCC1143,44507138,1.5952303095871043,2.7548114107347614
CA46,9823820,1.6053302041689723,2.767367465743715
NCI-H522,docetaxel-tanespimycin (2-1 mol-mol),-6.262465399444894,-3.06224458447039
CAL-51,12001922,2.008779489179369,1.8132586851236747
FTC-133,selumetinib-PLX-4032 (8-1 mol-mol),5.295700336992507,3.0766421257303187
NCI-H292,19582717,5.466560288208149,4.443082566380211
A4/Fukuda,374536,-1.0311095755670416,1.145853557449434
OPM-2,10113978,1.3298356496360293,2.4655198172347634
SNU-449,9903786,3.696408358539977,2.9354431216674617
JM-1,25195348,3.46638875562813,2.5704931952231753
NCI-H1623,5746,-0.5390712999232294,1.3676346946725761
KYSE-70,71466445,4.079477869375345,4.062662658059278
NCI-H460,44185566,3.2105564381381035,2.5743533442630953
MSTO-211H,6918837,-2.204195063499652,-2.3094371048726283
CAL-51,54613361,0.2180057854442524,0.23506372486624477
A2780,216345,1.0708930445758365,3.5183248843085058
HCC1143,100016,7.122041956726765,6.22792211648802
NCI-H522,5278396,4.518604091155278,3.2259336086249983
SNU-61,54619267,4.677926252875765,3.857844505796876
OPM-2,135421197,1.341685947169011,1.4818598076883394
G-401,72193861,1.057396802085585,0.9155712675415567
NCI-H727,15547703,3.504014494953252,3.1065113314360895
NCI-H292,11178236,-4.939590057195551,-2.9693668681895087
MDA-MB-453,44241473,4.685974466458818,4.490654313621592
MSTO-211H,60700,-2.4521642225491065,-0.07037608588107029
BxPC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.5266408566121297,-1.3524170958093864
NCI-H2171,4096211,1.8093642806404184,1.0093041546770662
NCI-H146,68056272,3.3997347898500063,2.7967946854792354
A2780,984333,-1.5561630492039429,0.3081204625652191
NCI-H2171,5479543,3.509510962528721,2.7326964427761014
ONS-76,6610355,5.379398654611739,4.547797755000333
G-401,2742550,4.179048555325354,3.362974689928132
OPM-2,44137675,3.238695939616315,3.0941869647100693
NCI-H661,selumetinib-navitoclax (8-1 mol-mol),5.100563052002661,2.123228946526846
FU-OV-1,387447,-1.63105242136749,-4.074105860886737
LoVo,3825829,3.571391318080427,4.057985656262703
JM-1,11404337,-2.1014875230304315,-1.206778568156189
FU-OV-1,9929138,5.415072941349914,5.484557040202851
SBC-5,5738263,3.46908634421933,3.319922228608533
KMRC-1,navitoclax-piperlongumine (1-1 mol-mol),1.9271011950938683,1.5292535452832363
G-401,4917,3.172752348635073,2.9871142065872878
A-673,44589607,3.5509265356046305,2.2169000963624317
A-673,selumetinib-navitoclax (8-1 mol-mol),2.703259710676399,1.2335891495992302
CAL-51,2828334,6.190580852669228,6.124517524197959
MDA-MB-453,BRD-A02303741-navitoclax (2-1 mol-mol),4.399808633782925,1.9346286946394398
SNU-61,67156097,-2.2274361546113854,-1.2592339139335076
OPM-2,65628,4.597670741376445,3.352691862770497
MDA-MB-453,3038522,2.334816038150176,2.8098720122994907
HSC-4,2708,2.9878251305615477,4.9702001281499
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472,2.02992985685407
CA46,54678924,0.940253932332064,1.394362399221484
SNU-449,11964036,1.3997299371502423,1.4891809717569122
DMS 273,54613361,-0.0987092047967699,-0.34135227935848783
SW1463,2749,1.5016847157281326,1.5672535917742452
A2780,4477,0.2147996237825641,0.31229114578367484
NOMO-1,9907093,3.6530797436282434,3.293094302138366
A-673,54618305,4.212251300263772,4.061964263609442
LOU-NH91,65064,5.187256751294022,4.959807518275811
NCI-H2171,72376,-3.3432588050758296,-2.8003392691080595
MDA-MB-453,72199292,1.3092335372039157,0.9965703589788832
NCI-H522,107970,1.611650854248594,2.3455868256349808
A-673,444795,4.685959151928419,3.799001816368543
HSC-4,6505803,0.688410933428746,-0.46660584708068065
CA46,11455910,-0.2967360934235351,0.13151144288121386
NCI-H460,6252,1.4342703041264255,0.7607886428624216
BT-549,49793307,-0.000238716840207,-2.0727046285258117
CAL-51,68056272,3.9955701948507247,3.7003817679235023
A-498,vorinostat-navitoclax (4-1 mol-mol),0.5641326032533043,1.1409320922871862
A-673,227681,3.19347186106623,2.952537745282387
BxPC-3,54618771,0.182098153600537,1.0579379383652836
A4/Fukuda,3385,2.3595203579832553,2.625042942161491
LoVo,36314,1.7018910931264415,-0.5839787569203462
BxPC-3,11152667,-1.4400195695513092,-0.4805912616591765
SCC-9,3025986,-0.0492814979551807,-1.2703842172151072
MDA-MB-453,4259181,0.7923345004369465,0.3735492877369555
Panc 04.03,9927531,5.313421559596226,4.723759653513697
LoVo,448949,1.89047161937067,2.1193712341296127
KMRC-1,5978,0.0310598033875183,-1.572187150855327
NCI-H292,262093,2.9868554632365556,3.096170462502479
CAL-51,9884685,-0.2528326244590672,0.6965478755175338
KMRC-1,135421197,2.781168744821282,1.8397463442331228
A2780,56973724,1.317874340119369,2.380757937619144
A4/Fukuda,46943432,-0.0927442133672991,1.2590642298310002
HSC-4,50905018,4.462883747891921,4.445617781006546
JM-1,448949,0.7740790697885386,1.2550853466560894
EFO-27,11964036,1.3211691780165964,1.4620859448130004
A4/Fukuda,637858,0.8198578842358093,1.0848265355958109
OPM-2,5282054,2.4375164125334217,2.7312028790123155
ONS-76,637858,2.646425044184718,1.9050690585518155
HSC-4,439501,-1.7709622187792924,-1.9643835721519278
KYSE-70,24964624,1.4483005111507754,2.290379123404282
LOU-NH91,5282054,3.3765969574471315,3.943131810191191
A-498,selumetinib-UNC0638 (4-1 mol-mol),2.905526592026194,3.440788896550568
SNU-81,5281321,-4.892530389502709,-1.3245543221500429
HCC1143,168312962,3.1559735288767468,2.120525370156647
JM-1,126941,-4.3883192692313955,-3.2172681135860186
SCC-9,54143018,0.8755026739061308,0.3670195295676359
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798,2.7200787591915274
SNU-449,1641662,3.672188762237013,3.719847922265765
NCI-H146,54765302,2.77091239654666,3.9583505633047174
NCI-H146,11427553,2.364557310661393,2.24345770327182
CAL-51,159324,3.1794720270506307,3.1661515063830636
YAPC,71466445,6.285156806731666,4.275468002478388
ONS-76,5351362,1.281569720069414,1.3055637213419289
NCI-H292,doxorubicin-navitoclax (2-1 mol-mol),-1.8265545031559949,-0.7705722253165406
BxPC-3,6505803,-3.0514917868960767,-1.0581847533823237
A-673,45279963,3.7593508340409287,3.130907422573722
CA46,3465537,3.345448990020783,2.0453424224644348
HCC1143,168313016,5.718985268806146,4.855649555729615
A-498,400769,-1.6101267353788036,-0.038945109154634866
NCI-H2009,10184653,1.0890186290305244,1.4300009860433402
NCI-H522,426756,6.015863149473534,4.040445397962621
NCI-H2171,44819697,-4.1780638649943675,-1.0863871044574216
DMS 273,24785538,0.640909019865508,0.414682595305937
NCI-H146,6918638,-1.4860665745363582,-0.20120193053435273
NOMO-1,3543504,4.095340640265792,3.7093187489763513
NCI-H661,151289,0.3755226510544496,1.1208213871064086
G-401,53495165,-2.4189675718778516,-0.8665162237210149
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136,2.3606224235207636
YAPC,6918837,-0.3723714565085887,-2.432068703323074
BT-549,219104,4.096633484715141,3.91794127458744
LXF 289,24753719,4.56569970094865,4.422068811833253
CAL-51,25102847,1.94226811064499,2.2715010805532967
A2780,doxorubicin-navitoclax (2-1 mol-mol),-3.696476342878232,-1.9732838750093769
OPM-2,54618164,3.637238343412542,3.6463838158863036
MDA-MB-157,2733526,3.146610844933737,3.8296354202528495
KMRC-1,54618164,3.981312375484732,4.064259977634608
CA46,375860,-0.5712781411665353,-0.6595235127469425
G-401,24772860,-1.622851891505981,-2.226315139677504
NCI-H1623,119182,-1.1196330586869003,-0.5274640660304474
A-673,984333,-2.7710011035310074,0.34649280686429434
KMRC-1,49793307,-2.5218593870176793,-2.399664299617805
ONS-76,alisertib-navitoclax (2-1 mol-mol),2.05248890000496,0.662330244707883
DMS 273,11152667,-1.0918930552191226,-1.172104798506687
NCI-H460,44620216,3.8133491956675902,3.7683201131030386
MDA-MB-453,19582717,2.5916230237173696,4.072242263168723
SNU-61,53495165,-0.6572534585269733,-0.5713663363300472
JM-1,6505803,0.12933264701109,-0.7583448800830466
SNU-449,60700,1.1315850608054705,0.14684588392332942
CAL-51,676352,2.3367523995253454,1.9544078398999085
LXF 289,89928392,2.4967474535679623,1.7277831090959586
LOU-NH91,11625818,5.704636625331963,4.704412095789906
MDA-MB-453,156414,0.9469838239648454,0.546450660077825
OPM-2,462382,-0.5185214646773461,0.32493105761567975
A2780,53392493,1.4842280461046395,1.9216716532934484
DMS 273,9823820,3.9764583445605006,3.169411668166313
ONS-76,24772860,-0.9083480450936676,-1.678212125425374
KYSE-70,11612883,2.3570058511886396,2.7788840996597006
SCC-9,3854666,1.6335835525169635,2.3841834414399856
KMRC-1,375860,0.0373834100132385,-0.0043725202595255
SBC-5,9866186,-0.1944977114504531,0.7910739131116408
NOMO-1,11719255,2.6566855899212944,2.2450629217706064
CAL-51,702558,3.5144984342436563,5.190415350236877
ONS-76,51039095,3.253449307143194,2.7093083140997787
CAL-51,SNX-2112-bortezomib (250-1 mol-mol),-1.7705274817452763,-1.3027028156993554
BT-549,carboplatin-etoposide (40-17 mol-mol),3.0956073566699147,3.0483077506552854
HSC-4,selumetinib-navitoclax (8-1 mol-mol),1.957846901945355,2.234667715735165
BxPC-3,216468,3.632186197150132,3.2631514117315885
SBC-5,2742550,4.323082293816951,3.892170647820025
HSC-4,24797083,0.9836127584085878,1.61285916861581
OVISE,4788,6.030976207458705,5.776874890186408
LXF 289,11455910,1.909862916296106,1.4829488631045353
SCC-9,16659841,4.917362195715636,4.166416447481596
G-401,49766530,-2.7444300270308113,-0.944666917553128
HSC-4,6450551,4.030000721690881,2.9357931170196934
CAL-51,6918736,-2.0480142356294637,-1.361776619548283
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208,-0.7791808659951529
SCC-9,4096211,2.914802879806832,2.5582365525397996
EFO-27,168313200,3.5651936579716277,3.2117562530730948
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573,6.438750277852581
SCC-9,448949,2.996737074861378,2.1941816872107585
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338,4.394966825295177
NCI-H460,selumetinib-decitabine (4-1 mol-mol),7.324082171117594,3.732771534628392
NCI-H661,15953870,2.9876041506010003,3.6009443818306783
KMRC-1,6918638,1.621172594092556,0.5496053302460655
Panc 04.03,44489675,4.301555650291772,4.085110677237731
HSC-4,54143018,5.46718478704898,0.5254719549939693
NCI-H661,11175137,2.5272908163527745,2.729225082499716
OVISE,piperlongumine-MST-312 (1-1 mol-mol),1.6778401901556628,2.21675357985484
NCI-H292,24753719,4.2962074219620225,4.368863661536757
NCI-H146,11228183,-2.941805953111262,1.4703901336252312
MDA-MB-157,65064,3.084719541991811,4.739583148665459
HSC-4,44491742,4.173988284907792,4.35290944345359
CA46,9933475,1.582522184359856,1.6123070908551886
JM-1,53245473,3.7598021769733414,2.390706590295038
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.2890672162084065
KMRC-1,702558,5.7321455674333475,5.1344696276346955
EFO-27,262093,3.0007323703470896,3.149735092933865
A4/Fukuda,72734382,2.815137004147321,3.5871409590422925
NCI-H727,44185566,2.6786881549102626,2.6123596528283097
OVISE,25062766,3.2029018764111896,2.40678275258787
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226,2.313928217360663
CA46,3825829,3.8503527939376583,3.1130336655389534
EFO-27,JQ-1-navitoclax (2-1 mol-mol),3.2464971768878086,0.957311098370164
BxPC-3,60750,-2.6920891843690273,-1.7582147325714943
EFO-27,1566236,1.9834366009012432,2.5942047796095964
LXF 289,53392493,2.5437082258312804,2.753247652772607
NCI-H460,135421197,3.2510260026522233,2.0701319283502113
JM-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.316937276009384,-2.7861489278829703
Panc 04.03,44607531,1.8924568500741572,1.5219173551923413
ONS-76,15547703,3.220128707821482,3.2019208268933785
BxPC-3,123631,1.9141625570683185,2.352224811159205
NCI-H2009,24180125,3.399696031265864,3.184517970075836
A-673,19582717,3.777631654850071,3.393780407505038
FU-OV-1,12003241,-1.039273875540509,-0.7231620524265746
SNU-61,409805,4.743067556302579,4.388252007068592
DMS 273,11364421,-1.741561290091182,-3.9329959859300403
Panc 04.03,11214940,1.7867172186781857,2.099592089284051
NCI-H522,31703,-1.0005486569838078,-1.6084647464367887
KYSE-70,5287620,-1.7159794680358271,-1.826461045473438
A2780,11507802,0.380240885087182,1.1938319852449397
ONS-76,54613361,0.8570205233962582,0.23262520105801404
KMRC-1,2729026,3.101959850286169,2.702756436540829
NCI-H522,136227924,2.2034936459857506,2.6777722265422774
NCI-H661,52912189,3.763222756257729,2.6736012088009846
ONS-76,262093,3.354802573562099,2.8712872123539
A2780,675434,3.840840752716624,4.334899137528126
EFO-27,24771867,3.839082818590537,2.772557326293961
BT-549,44185566,3.1570730526396407,2.877841848788647
NCI-H2009,89183176,3.352860584382055,4.587034916886869
A2780,2949965,2.158264003903123,2.454020270537489
MDA-MB-157,119182,-3.4496410534325093,-0.7585341840151153
MDA-MB-453,2949965,2.588847266095094,2.596169933528364
MDA-MB-453,71576739,4.365206221166654,3.727428486415344
A-498,11455910,2.747308138802023,1.3529234497838574
A4/Fukuda,448949,1.1686862984883333,1.6269034244121983
OPM-2,10385095,0.6586756349946576,1.0562823591975214
BxPC-3,52912189,1.4214477046132656,2.403985010053419
JM-1,46907787,-1.9243382261841309,-0.16060291733645574
G-401,3385,1.38862488630676,3.284813001569384
LOU-NH91,24978538,-2.307670841327046,1.455273297055336
BxPC-3,25262965,-1.1326145626109247,-1.4642390298612904
KYSE-70,9915743,1.2522553618909642,1.029681783694919
A4/Fukuda,42642645,-1.373677794386147,0.4325353786552774
A-673,44202524,1.1944686936342714,1.6826358435749755
FU-OV-1,66577038,3.5319441468561648,3.0408892392780573
SBC-5,BRD-K99584050,5.772271611565925,2.653966392062277
MSTO-211H,2749,1.2029234831790616,1.9970774187017926
EFO-27,2858523,3.4178086224101527,3.1751393083475663
NCI-H2009,54613361,-1.6701870677586086,0.02980485875933214
CAL-51,11626560,0.7349282975065881,2.1111751690900546
YAPC,446155,3.8433351119798695,2.711344277503021
KYSE-70,3854666,1.6457032232411275,1.9279234243298335
MDA-MB-157,49836020,-4.4611089332084335,2.700080127148971
Panc 04.03,10385095,1.3607276101908192,1.4572298464495486
NCI-H522,piperlongumine-MST-312 (1-1 mol-mol),1.211540874463276,1.4296501226267815
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.641466976183809
NCI-H460,31703,-0.6563705559837907,-0.5771960707781764
HSC-4,135421197,2.1482643592466495,2.005000366899173
KYSE-70,216345,3.953496119268799,3.939476983045486
NCI-H2009,44259,0.1981246725332563,0.9844885105653254
NCI-H661,24771867,2.8989054210712784,2.516397757127763
LOU-NH91,89928392,1.577129115434841,1.6793273543355645
SBC-5,44819697,-0.6119786373907494,-0.7588909852400733
CAL-51,135398738,4.757337519270393,4.477754586349834
A2780,11234052,1.762226904306368,3.6577625474423217
EFO-27,5287969,-2.249416082595734,-1.887952609509867
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167,0.7805869095989486
EFO-27,72734382,4.838814549837177,4.909583266194366
A2780,2126,3.67742533530732,4.086860841686052
NOMO-1,656346,0.9377734591624955,0.4677659255868609
NCI-H522,439501,-5.784929410118117,-2.346489387815298
NOMO-1,4521392,4.093982124965485,3.952039287995025
NCI-H2009,452548,-0.9979896146805513,0.5096341338224772
NOMO-1,327653,2.81345515165661,2.5717300764805135
A-673,46191454,-1.7005324627981964,1.0840496829787822
A2780,168312962,0.1167104942518841,1.0790950188213686
HSC-4,11214940,4.953530718305131,2.3126403483419224
KYSE-70,44507138,1.8487883665285316,2.633011577463144
MDA-MB-453,5566,2.956907653722259,2.8122165845287297
SNU-81,selumetinib-PLX-4032 (8-1 mol-mol),-1.7498226144583562,3.018609171673682
SNU-449,24753719,4.452712705797618,4.322753062293781
HSC-4,6184667,2.683776581109496,3.170967128921567
Panc 04.03,4477,1.027037586587599,0.6129036348565939
CA46,24951314,-0.0442972386064399,0.38442601452249714
MDA-MB-453,JQ-1-vorinostat (2-1 mol-mol),-0.5883390027404639,0.7259109094259059
NCI-H460,637858,3.384702960830197,2.1876822219813636
MSTO-211H,54618164,3.0389284404004795,3.869676221066576
BxPC-3,135875424,4.118804534986376,3.962197182883969
LoVo,374536,3.1459286411718055,2.323050184428097
SBC-5,65064,5.87027592575748,4.990497341720877
A2780,2708,1.6817262399506028,3.8397792677103593
NCI-H292,11427553,2.7677841547579347,3.13766554508074
EFO-27,10184653,2.474041422726229,1.5189763730250772
LXF 289,16038120,0.5250135720403194,1.0328997534412006
LoVo,piperlongumine-MST-312 (1-1 mol-mol),2.135338171440717,1.8035225292882553
OVISE,selumetinib-JQ-1 (4-1 mol-mol),1.7685285533186823,1.6683712961384654
LoVo,navitoclax-sorafenib (1-1 mol-mol),2.5511515051305893,1.955582154025062
BxPC-3,10184653,-0.596247884950306,0.7598325218875143
KMRC-1,54618771,0.2036698487849761,1.2866163584892722
FTC-133,4705,5.547028107549284,3.3230667573609454
A2780,107970,2.1177540249197246,2.226509526262011
DMS 273,15983966,-4.308041598319055,-3.112274242812061
DMS 273,JQ-1-UNC0638 (2-1 mol-mol),0.3284926048856003,1.2215998325325874
HCC1143,637858,1.5767538824178036,1.9325610885944848
OVISE,753704,5.218614122812972,5.128816462215436
NCI-H1623,148124,4.04127286799143,-1.5393915942874679
NCI-H661,1716436,2.7606212382296205,2.940609551059632
A2780,5328940,1.6938804432156576,1.5888450927686157
Panc 04.03,doxorubicin-navitoclax (2-1 mol-mol),0.7758881761631229,-0.2864250879696039
A-673,52947716,2.7267743407084333,-1.5206546721071696
LXF 289,51039095,1.6878089310027404,2.792892378127695
LoVo,24753719,4.853832341629896,4.260605195488542
FU-OV-1,16065773,3.3464590574422424,2.4746335638756607
Panc 04.03,439501,0.3022334331499904,-1.8012468365088523
NCI-H2009,44137675,2.9238442509206606,3.875094447172835
SCC-9,24964624,2.350052808289582,2.5879852044740916
BT-549,56946209,-4.178729112607428,-3.879734821031862
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038,2.9194152571135095
NCI-H460,1716436,4.318712917611328,2.9912501563020495
MSTO-211H,4917,2.9904400598930088,2.9763190188024744
NCI-H2009,5282054,3.436101167626708,3.879019869932816
FU-OV-1,53232,3.5510277872612903,3.029708304921664
NCI-H460,3503,2.4668231300278154,2.413532921077618
CAL-51,6252,-0.2076922850947726,1.1642234839890129
CA46,44607531,1.0933116261411373,0.9112953690188584
NCI-H2171,44589607,1.1207968177639505,1.8778907407066072
ONS-76,selumetinib-PLX-4032 (8-1 mol-mol),-0.2158611974685485,2.9065358150139393
BT-549,5311,2.3943998607281314,1.7077865133875063
SNU-61,44491742,3.859456688826312,4.055361150759151
JM-1,46943432,-0.1491870155181681,1.04438162007178
HSC-4,156414,0.4374127066870092,1.3696948605143324
EFO-27,tretinoin-navitoclax (4-1 mol-mol),4.088217515777896,3.2710785417887775
OPM-2,42611257,3.2957467857000404,3.040945158252947
A2780,136227331,3.7351205807719863,3.453370488689166
MDA-MB-157,71751553,2.589623955944651,4.707647058571988
HCC1143,262093,2.740628946324062,3.013356868703359
NCI-H522,56946209,-5.885513086137786,-4.103561789151134
A2780,67156097,-2.4563073864206633,-1.741312450848147
FU-OV-1,136227924,3.2834953568281597,3.090907779161689
NCI-H1623,241158,4.3681147628536445,4.093606217291331
ONS-76,2828334,6.172523844471339,6.109600480478085
BxPC-3,11625818,4.084435736278963,4.448913822187337
DMS 273,5281321,-3.764975659067455,-2.0340723628797717
KMRC-1,3825829,4.43742858244417,4.035211875662921
JM-1,5280436,0.8051765864900793,2.4522960999685157
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846,2.758943675067941
MDA-MB-157,9927531,5.35009923211275,4.699625056928622
OPM-2,56963564,0.1507827744052812,-0.23332065798780416
JM-1,9825149,1.1101255190052433,1.5728978561952998
A4/Fukuda,136227924,1.9204852137512072,2.4433298029699175
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266,1.2621068138485372
Panc 04.03,16065773,3.1082338307326687,2.6166504307829888
KMRC-1,148198,-3.0121915653316953,-3.115528435054054
NCI-H727,11612883,2.6691234813665226,2.8151770589655043
A-673,25183872,-1.50300168442849,-1.1399118177094636
NCI-H292,5470400,0.7410873105484811,-0.1577005982327366
SNU-61,24771867,2.3194270269791772,0.9332029205000447
ONS-76,2729026,2.9392891978845626,2.8375189217428916
NCI-H522,54618305,4.230012053256092,4.381807599191199
MDA-MB-157,6918328,-1.4439105140240134,0.07958208935383607
SCC-9,11609586,3.4579622750703902,2.973886347538352
NCI-H2009,73707398,1.4628489872410333,1.638342595757714
BT-549,613753,3.1113642662223913,3.340647966642498
NCI-H522,11396600,3.374818989992459,3.3495576538444425
A2780,227681,3.163289337051595,2.9177219558608916
SNU-61,42642645,0.1547953205487765,0.4359829346287142
EFO-27,24753719,4.6250624916483405,4.347358372112639
NCI-H522,1750826,-4.884358581349171,-2.1034946289969194
NCI-H460,3854666,3.1385110084048065,2.225237735395285
Panc 04.03,16736978,2.069266987472695,1.6908494148362119
KYSE-70,135875424,3.720063911223788,3.995489400069833
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981,-0.5840325959374638
NCI-H727,4369359,4.470803757423574,3.7695567198193958
SNU-61,10296883,3.559313583941647,3.7883488133675973
MSTO-211H,24748573,5.719931334372704,1.9926213340717118
SNU-81,5479543,2.97701110816304,2.983962823420933
BT-549,2733526,4.582584043539932,3.6897413364553886
A2780,135423438,1.4521240670524396,1.8407636830652845
A-673,24772860,-3.1744597884682997,-1.961619259567798
G-401,15953870,2.2768915791068483,3.188945231047867
DMS 273,5738263,3.533950076223639,2.932682622859204
BT-549,SNX-2112-bortezomib (250-1 mol-mol),0.8532729508269209,-0.8778895087326807
MSTO-211H,10385095,1.0224754227931234,1.1680067454975647
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616,1.92657384367538
EFO-27,25062766,1.510659268863457,2.1336340176634336
FTC-133,11612883,4.310092339589411,3.0441921328329364
MDA-MB-453,11455910,-0.0078824359576409,1.1456550235703942
FTC-133,23582824,1.291713189645836,0.6123869797104172
MSTO-211H,6918289,3.158366552983379,2.6663530201131356
CAL-51,9826308,0.5677925602140103,0.5291694843738105
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995,-2.3446769453668708
LoVo,JQ-1-UNC0638 (2-1 mol-mol),3.1589551233195428,1.403407754702024
NCI-H292,25195348,2.925898223014509,3.416304242683907
NCI-H661,71466380,4.502023854991524,4.639197894138878
SNU-449,17755052,1.8812917370069304,2.2071664801768343
SCC-9,11977753,0.680369597029185,-1.573493682754681
DMS 273,selumetinib-PLX-4032 (8-1 mol-mol),5.046947236193085,3.863531339306569
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116,4.058943184600126
JM-1,carboplatin-UNC0638 (2-1 mol-mol),2.589326672729891,2.5507510672068827
OPM-2,56973724,2.552424788495835,1.525807466385092
ONS-76,24785538,3.425081329750359,1.833478984283302
OVISE,6914657,-4.467384055269322,-3.683697502844371
CA46,7326481,2.91557869092902,2.412678202561888
SNU-61,445091,3.84586130327939,3.9484367092144934
SNU-81,387447,-4.728664972971387,-3.8518254055962418
A4/Fukuda,613000,-0.1954730319333323,2.52462280372583
JM-1,54143018,0.7319009489566454,-0.5907012828668483
FU-OV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2027157770718528,-0.6691147912334394
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911,-0.3789207085738642
NCI-H2009,11222830,1.732127254120576,1.6390980376712796
Panc 04.03,25105715,3.6014191473601236,3.678123833043312
BxPC-3,3038522,3.5132521338876352,3.0950275856650564
SBC-5,2945648,3.183732803518487,2.9338716575582193
SNU-449,6450551,3.816508101047544,3.107314896333362
A2780,4261,0.5678575604143293,1.232650301510479
JM-1,54639665,5.005029028557516,2.87576888362231
MDA-MB-453,55508,3.100658329893645,3.579058202161178
FU-OV-1,vorinostat-navitoclax (4-1 mol-mol),1.2627597867759035,1.5991404561621005
OPM-2,71466578,1.093801721105574,2.6380409082609835
DMS 273,219104,2.8685320291275276,2.7378817075408626
MSTO-211H,36314,2.7056254754018,-1.2417366179215172
NCI-H661,135999136,1.375733620998009,3.8831315160332305
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011,3.501743252612905
A4/Fukuda,387447,-5.631039688913266,-4.993266531638053
ONS-76,65064,5.2757302482281005,5.061959646618436
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606,1.6869370161224975
LXF 289,613753,3.241655631161551,3.1766892307052887
NCI-H661,25262965,-2.0298208680132253,-1.5378223281931285
LXF 289,6438330,5.338014468481796,2.4254033584399086
HSC-4,51037431,1.5211622982639597,3.241089630489274
HCC1143,ISOX-bortezomib (250-1 mol-mol),0.6900085602161256,0.9528338134435195
A-673,613000,2.3658771635142877,2.3373386911678167
A4/Fukuda,135421197,1.440002399326734,1.404676097542062
G-401,tretinoin-carboplatin (2-1 mol-mol),5.235487615212222,4.056426572263126
NCI-H522,322968,2.453472191773609,3.1792579236811456
JM-1,702558,3.1195416036187646,4.198173520373512
NCI-H1623,60700,-0.6326390393669364,-0.24377438307422877
KYSE-70,71466578,3.801340757329347,4.600395968975868
OPM-2,969516,1.7213945625906069,2.3426560298409984
FTC-133,71751553,4.47121108066688,4.602342899230457
HSC-4,4261,2.7283942469645424,1.841584503740894
DMS 273,60750,-2.8080851182888096,-2.6809883820342053
BT-549,11955716,4.243153956403502,-1.4232571597109882
ONS-76,104842,-3.1760610756826826,-2.310970015013505
JM-1,54619267,3.2762986321752656,3.500147876945155
NCI-H460,11427553,3.3912724357702873,2.802129103371217
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037,1.6758894892676828
KYSE-70,3503,4.330341802091645,2.554968279640161
LoVo,6505803,-0.2027234925460443,-1.0154125579666715
A2780,123631,2.055120977987268,2.1527559254984237
CA46,216345,3.098455032375494,2.526310399851515
SBC-5,216345,4.3270666561224935,3.9274041287014514
SBC-5,104842,-4.617883126488141,-2.5962517162765772
KYSE-70,3025944,3.9400169946897226,4.140623330553736
JM-1,16725315,3.055633956084052,3.5164664750598735
KYSE-70,3385,2.7043091028991175,3.9136851961648618
SNU-61,241158,3.885428513145571,3.894062105341222
Panc 04.03,44819697,-0.3269217472163675,0.21938031363547128
LOU-NH91,151289,1.7382502757713727,1.343361433497229
SW1463,72193861,2.3780707386668563,1.1004482989386304
FU-OV-1,3081361,1.2672435670761582,2.494712129297416
NCI-H2171,5311,-0.0981787470707459,0.8764064068278772
OVISE,15983966,2.4746719809654474,0.2937075301652538
CA46,56649450,3.397645307363617,2.2853119171755285
G-401,135398516,1.567409789625541,1.8846304954488662
A4/Fukuda,285033,-4.063528792592557,-3.165378101613235
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546,-0.33534794720508365
SNU-81,2113511,5.998073078967423,5.343117976932242
SBC-5,984333,1.1242620116457585,0.5890831892676615
DMS 273,31703,-1.0453531837534489,-1.2179014766714167
SNU-449,11955716,-1.9372940063200903,-1.816697495678316
JM-1,156414,0.9517000986854224,0.8638255407725717
A-498,5746,0.9967598286589636,1.4277086669741375
CAL-51,168313016,5.819136604546001,4.943242673526496
SNU-61,doxorubicin-navitoclax (2-1 mol-mol),0.8790870297518688,-0.9091350046463924
SNU-449,selumetinib-PLX-4032 (8-1 mol-mol),4.586042131351809,3.662922229394091
DMS 273,285033,-4.2902604104934685,-2.4246212517377876
NCI-H1623,25227462,1.3835292391956049,0.566336600691693
SNU-449,46199207,3.2102080061749665,3.216932004478299
NCI-H727,54619267,4.766187279700058,4.020273757351976
KYSE-70,2729026,2.877153539650856,2.6672726967049916
JM-1,9866186,-1.392842627261666,0.014803715241432975
CA46,9956119,2.2503821303322864,2.624402818686315
NCI-H1623,10302451,3.5735543079001553,3.0272778437623624
NCI-H460,119607,4.735621464768821,5.21351196316808
LXF 289,36462,2.912637639845359,2.431410777221528
HCC1143,208908,2.564266394778906,2.060134315075262
CA46,doxorubicin-navitoclax (2-1 mol-mol),-1.6756299291036936,-3.0019141190881093
HSC-4,10296883,4.12801319058873,4.069496869094391
NCI-H460,44819697,0.8384181776379687,0.16978686399785733
A-673,644241,3.265724898737132,0.97212748435427
SBC-5,55283,1.6476943611515316,3.0223800783115844
CAL-51,60700,-0.6497243984818711,-0.3147256658777052
NCI-H460,44819697,0.8384181776379687,0.16978686399785733
NCI-H460,2113511,6.407699041859446,5.770252062331801
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725,1.4267102020349025
NCI-H146,44819697,-3.0409273944044672,-0.6108431618782317
CAL-51,2729026,2.5757432896171517,2.8020601104848697
OPM-2,25262965,-5.528707504919602,-2.7476946534690256
BxPC-3,67156097,-2.0030489961064664,-0.34949029619739164
SNU-61,11455910,1.387165489844305,0.8323246950620578
MDA-MB-157,6252,-1.2956844965038024,1.208480344209977
BxPC-3,decitabine-navitoclax (2-1 mol-mol),-0.3566314519475204,1.9904228709782072
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777,1.8881442999465587
MSTO-211H,5284616,-7.533473618112548,2.6271785540983337
CAL-51,ISOX-bortezomib (250-1 mol-mol),1.1183162335023276,0.9150121039355517
NCI-H146,11609586,1.562173805318663,2.5364189268663884
A2780,tretinoin-navitoclax (4-1 mol-mol),1.5980580193271057,2.475099267219794
KMRC-1,9908783,5.060189279561186,5.072828982873098
OPM-2,3825829,3.9075204590636226,3.3736134065944365
FTC-133,439501,-1.0725688155870328,-1.80735226506265
MDA-MB-157,73707398,-0.5856522541525173,1.5807099189040639
YAPC,71466380,5.668462841036745,4.567627028485282
YAPC,81146,5.922853011724604,4.627193602673465
SNU-61,9935249,2.942554259952632,2.416242825822858
FTC-133,72193861,2.4976681850124516,1.792596397478845
NCI-H2171,3025944,4.816182739912449,4.102205631234166
BT-549,6918638,1.3825585614023566,1.0923799251824249
A-673,24180125,1.1732098097274752,2.544588509772376
KYSE-70,46907787,2.9670215892594793,2.3509383689737473
NCI-H2171,54678924,2.405018759443171,1.6217302629840133
FU-OV-1,15547703,4.297867355017808,3.200048842161639
EFO-27,49846579,4.098108273885428,1.714581958928014
HSC-4,24748573,1.230311327364621,2.286884441937391
BT-549,10427712,4.3521452258648505,4.440474219525848
EFO-27,126941,-4.256911665013358,-2.748336670386667
NCI-H2009,4096211,1.934112859371262,2.40559378959873
MDA-MB-157,salermide-PLX-4032 (12-1 mol-mol),3.2199843556039593,4.830917661763526
NCI-H146,135999136,1.6477982136645704,3.3872197356959504
HSC-4,selumetinib-PLX-4032 (8-1 mol-mol),3.794219924107932,3.347290434663815
SNU-449,2746,3.928036011173348,3.4571221783346435
CAL-51,11228183,3.6770505489909007,2.233276935944915
Panc 04.03,123631,3.678186856777378,2.4951531188386356
MDA-MB-453,6184667,2.451074325070958,2.94545817567675
EFO-27,6438330,1.8682975687900552,2.394690952406854
NCI-H661,11497983,4.324872079299071,4.011879750169339
Panc 04.03,637858,2.9634699724220783,2.361437025929294
SNU-61,168312962,1.49910092402229,1.8890050960330305
NCI-H522,25183872,-1.6150957585419312,-1.237484485139951
A2780,6252,0.4918472463671758,-0.7834841542413337
A-673,15547703,3.0802315016781843,2.792400774607234
NCI-H1623,36462,0.862958596391428,2.221650898620651
MSTO-211H,44819697,0.327886174428457,-0.2326153108895384
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.304534421983402
SNU-81,19582717,3.466001022974326,3.3235551244970907
A2780,6610355,3.3735704633901973,4.296189601907673
SCC-9,119607,6.006958395758143,5.371251084945849
NCI-H146,11625818,3.4222174762792843,3.5685351257571396
CAL-51,11178236,-3.674192911743539,-3.409655754464693
NCI-H460,168312962,-1.8333752522095308,1.5142963104629104
NCI-H661,4788,4.879892558412017,5.532420448338923
JM-1,4705,3.374089362448498,2.9617003506429427
LoVo,3634881,2.800959668083557,3.466047130638179
OPM-2,11178236,-3.008129792299995,-3.617078356112476
CA46,9884685,-1.0270691788705264,-0.3011350843578558
MDA-MB-453,44589607,2.562256212112598,2.717692410578625
SBC-5,54454,2.279469523172582,2.4907845620365365
LoVo,5311,0.3380696500116906,1.4425645978661583
NOMO-1,100016,4.546215242968586,4.761122499947118
CAL-51,71304818,3.0248956992793565,2.4535322099886256
HCC1143,216345,3.8986832350959792,4.00329795261173
CAL-51,54618164,4.021329289838694,4.095070956331461
NCI-H292,135398516,1.6270415918019412,2.1017365073177503
HSC-4,71466445,6.061667629347064,4.243141932218816
BT-549,51039095,3.595187367514741,2.8608529178638236
MDA-MB-453,26596,-1.0726693130426117,-0.9462565479060318
CA46,4259181,0.0375174782651609,-0.449650672892281
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345,1.206406471188743
SBC-5,9887053,2.384081187432928,3.859634454278072
FTC-133,25154868,4.81278236826852,4.624425712412946
SNU-61,44202524,1.623676041505741,2.1427835807045725
Panc 04.03,6914657,-3.724597953552904,-3.480022462844228
EFO-27,445091,4.884678811382666,4.447115432035921
SCC-9,54619267,4.260733417129102,4.231267525301243
LOU-NH91,3815108,3.3787088400125422,3.035523244851659
NCI-H2171,135875424,2.950178944342904,3.355586780988674
HSC-4,selumetinib-piperlongumine (8-1 mol-mol),4.641326276625381,3.4724222205925073
LOU-NH91,11404337,-0.9599092047687252,-0.04702485991874365
SBC-5,5746,-1.5208844717109098,1.079594556419244
NCI-H460,135440466,3.295247648571462,2.2479807383597192
OPM-2,1242560,2.912152501304371,2.859176594811527
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,2.9694452249806154
BxPC-3,11364421,-1.186359589843585,-1.2261212243104138
NOMO-1,11626560,1.0628914473501356,0.6196035266513147
MDA-MB-157,5311281,2.9465431337253065,2.364906334127668
LoVo,753704,4.37626239298451,4.9478693644474285
LoVo,1317464,3.6287749925486743,2.976027334239944
LoVo,11626560,0.8234069861143318,1.958842980615383
SCC-9,60700,0.6764265945588348,-0.10750694904958534
YAPC,5351362,2.7486257978183812,1.4900285758712954
KYSE-70,24797083,1.8843278101436565,1.4363573289621565
LXF 289,65064,4.964411921317377,5.08552461695671
SNU-449,16736978,1.6431800441666105,1.905712444859733
HSC-4,BRD-A02303741-carboplatin (1-1 mol-mol),4.481505642686289,4.027505394737111
CAL-51,3062316,-2.5625958708444205,1.4752711937967136
Panc 04.03,49793307,-2.352687994078586,-2.1098271363661056
MSTO-211H,10302451,2.2723798321327826,3.557818872988509
A-673,54619267,3.9525164677601015,3.5767329527389893
G-401,448949,1.8289326894340776,1.754184230844414
SCC-9,15983966,-4.042628093805887,-0.8860478638234995
CA46,3854666,0.2733202158609283,0.5846244093386495
SBC-5,42642645,2.1700569257248734,0.4573531678624701
FTC-133,6184667,4.171777093513536,2.9693016043336837
A-673,3543504,4.433549859321033,4.087866216635322
CAL-51,409805,3.8515087112009656,5.0551596460620365
SNU-61,5287620,-1.5621550618200195,-2.1251815654195854
BT-549,6610216,4.341228931549091,4.407076634742202
MDA-MB-453,44566777,-0.164341777615228,0.43258669549732554
CAL-51,219104,3.260140555917495,3.7733370649265385
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187,-1.7243945188923604
A2780,65064,4.350950935999884,4.5026214673475575
G-401,9803433,5.696660690430479,4.464990873516325
BT-549,11626560,2.6049019780447473,2.037528840364859
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214,4.19824092300434
A-673,107970,1.5652885370840817,2.2610713157144904
A-498,46199207,3.6222117747737057,3.301095031246318
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053,-1.7500221919125207
BT-549,11364421,-5.683704390961643,-1.9465066640528859
G-401,25195348,3.8836243061511215,2.99539472261421
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003,2.9410082700704394
LoVo,24901704,1.9806347162028537,3.295207182333951
NCI-H2009,11485656,2.228831542035607,2.6058190229003726
NCI-H2171,1750826,-2.946975931831454,-2.765109095063654
MSTO-211H,5738263,2.0448017247583996,3.66761643851769
SBC-5,2729026,3.0750341046070933,2.596426610421722
A-673,60700,-2.9578260017137437,-1.538487569096204
KMRC-1,216239,3.2937854483312172,2.4592478708871757
G-401,7251185,1.5631627066286176,1.9622564146053707
NCI-H522,568763,-0.6787143148403639,0.2117108228528937
MDA-MB-453,52912189,0.0253127265648339,2.055076510585207
NCI-H1623,637858,3.185553411157662,2.18341112070525
BxPC-3,65064,4.239552039257921,4.958806992792322
BxPC-3,44202524,1.2355479078044973,2.0611468192549594
HCC1143,10231331,3.1675049490504943,2.245724783037865
NCI-H727,4917,3.0740580007272125,3.1470348885193316
NCI-H522,46907787,0.5375692456309028,1.3542180078532875
G-401,4261,0.8301994759372666,1.148439264824763
HSC-4,46398810,3.0881815243810897,2.5681184358104407
NCI-H460,16722836,2.818869820371906,1.8124236091143817
CAL-51,107985,-4.126908547019261,-3.5750837074805406
EFO-27,445643,4.157223404562412,3.991060337963304
NCI-H661,327653,3.5614910429728295,3.0879016813166853
A2780,15547703,2.917961616739491,3.102683164358873
Panc 04.03,11222830,1.7267772277517466,1.710871724927063
NCI-H727,445455,6.030056890362138,4.3700752156688925
A-673,72199292,0.9360047714765588,0.824513662319587
DMS 273,2945648,3.171749675698132,2.6174732716319897
SCC-9,6917907,-5.592045136043938,-4.293150325862493
CAL-51,72193861,0.6423702350358801,1.5871286632757426
SBC-5,5281321,2.671163534426493,-0.9122439868734671
NCI-H2009,10231331,-1.9302715463885551,2.0806929177080904
SCC-9,3825829,4.24505295528646,4.017456429040118
NCI-H661,702558,4.861012061293982,5.210357665519724
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554,1.8927473271335808
MSTO-211H,451668,4.9569649646478515,3.9997246750229563
A2780,9908783,4.382006664554736,4.989765420168038
EFO-27,44566777,0.6667958565864378,0.536489522833804
SNU-449,11228183,3.721594588319689,2.4633521255931052
MSTO-211H,322968,3.0218271531726897,3.938083823344822
NCI-H522,135999136,4.552466214525868,2.772420297784444
BxPC-3,375860,-1.018881063070817,-0.10033733203189446
FTC-133,46398810,3.783858454202458,2.4543498959655
LXF 289,446155,3.7142968943868073,2.3603127601910674
NCI-H146,54619267,2.4574193717136663,3.956511504891613
JM-1,400769,-1.2746733592438322,-1.5303729928805767
BT-549,5328940,1.7912058861852873,2.0208861552506203
NCI-H460,15547703,4.965379127843483,3.122930008600099
JM-1,10026128,4.426440879951995,3.1898824027202735
LoVo,327653,2.9108064375514604,3.0760673549995134
HSC-4,5329102,2.7247882686097458,2.188738891460894
BxPC-3,5460769,-0.1362128387149436,2.8132955230479495
SNU-449,148124,1.515559327544478,-1.3068017235068226
KYSE-70,24951314,1.3178292218062186,1.611223844636146
BT-549,11485656,2.9441987555380855,2.6486555572663155
CAL-51,9866186,1.45916914556855,0.7403743820798909
NOMO-1,5278396,3.0205756000124775,2.984192335995869
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257,1.2107458192141136
KMRC-1,42642645,1.142476115564406,1.009217547733343
NCI-H460,100016,5.855223104671776,6.3509961137721564
MDA-MB-157,25062766,0.4624374403471977,2.1725934470486545
MDA-MB-453,107970,2.0242856345207834,2.1534363505126284
DMS 273,16741245,5.579276049340643,3.57904732166185
BxPC-3,3689413,-0.056748072256038,0.3471559988930246
KYSE-70,25126798,3.963979956832577,3.6545048517476904
A-673,54678924,2.025744293137832,1.5830848660554009
HCC1143,25062766,2.2830484377909492,2.229725605293387
NCI-H2171,11625818,4.794880990749841,3.567920188428788
MDA-MB-453,2729026,2.974469204821206,2.5514971848199868
G-401,9933475,0.0956350981602405,1.5877384513233366
NCI-H460,51039095,3.9314979002332535,2.6578076948770915
NCI-H522,219104,3.343081396349963,3.1441847748727967
NCI-H661,56946209,-3.6194559692185018,-4.166011521591286
SNU-81,568763,0.5116878508289208,0.17626983187829776
A-673,67291369,2.4007963238191854,1.6652716254464
LoVo,3854666,1.417426416420887,1.7520650114813003
MSTO-211H,439501,-1.1644309958543906,-2.096295990209541
SNU-449,285033,1.5882926770841097,-1.2364687820123448
CA46,6918878,-0.7300256707111569,0.42388985445043964
NCI-H146,71466445,0.6815814889300492,3.159470270142769
SBC-5,10385095,2.1758850118167077,1.2366415996428366
A-498,637858,3.4757595298108974,2.241256000760221
ONS-76,11964036,2.0748582848578865,1.0909284178609564
NCI-H727,16725315,4.353817237787042,4.350898326032331
G-401,10427712,4.653472001336551,4.048038627166922
CA46,10127622,5.462644164632326,2.719561370627355
SNU-449,25161177,4.378304661297746,4.1583395933005445
MDA-MB-157,49766530,-2.405889714389838,-0.4178033362432509
FU-OV-1,23582824,0.4003812349581704,0.6955828854892648
FTC-133,24180719,5.041424864241871,3.4249685381459574
CA46,3689413,-3.563387503989764,-1.8335950454083199
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012,1.9741543225290556
CAL-51,tanespimycin-gemcitabine (1-1 mol-mol),-2.7031816507325517,-1.304534421983402
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947,3.718925897860683
NCI-H522,6918638,0.2628749411775776,0.3649836732453695
EFO-27,10127622,7.049186817655218,4.561911040598952
MDA-MB-157,400769,-0.9429856644264992,-0.5100291860342252
CAL-51,54618164,4.021329289838694,4.095070956331461
LOU-NH91,9935249,4.429052878520747,3.3856117807361987
NCI-H727,49766530,1.5110740555461553,0.38234245605237777
A-673,9926054,1.7717409858597033,1.7718475025354357
HCC1143,5351362,1.6023771560954885,1.597159973770796
NOMO-1,54613361,-1.5441782746277026,-0.8569805362303796
JM-1,613000,2.2697515166000355,2.310790799784187
CAL-51,49793307,-3.2015156477281193,-2.7094002614538955
NCI-H1623,1750826,-0.130863987039663,-0.8622672099701318
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516,0.0581255988153445
NCI-H460,107970,2.752075604137296,2.4551440913814147
SNU-81,JQ-1-vorinostat (2-1 mol-mol),0.90621526316067,0.24451427438470905
CAL-51,46199207,3.548155956826357,3.225988860055249
NCI-H2171,10074640,2.5219754676966435,3.0125278872277725
A2780,selumetinib-navitoclax (8-1 mol-mol),1.1083480952702989,1.7374483832938037
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225,2.5394025048352704
JM-1,11238147,1.2374439058156688,1.9879597989720716
SNU-449,54678924,2.162306121493456,2.1421998159177016
NCI-H522,3854666,0.0482767863302698,1.3168869993934191
KMRC-1,selumetinib-JQ-1 (4-1 mol-mol),4.265974961239561,1.3904045082507503
HSC-4,10427712,3.709601221495256,4.41113850926476
KMRC-1,10296883,4.079927671527966,3.863814431546932
A-673,46907787,1.1836850249017303,1.2994390302326226
NCI-H460,67156097,3.7191617083219097,-0.357684946377717
Panc 04.03,11364421,2.200002813497647,-0.7127094424457867
A2780,57330099,3.934423580004946,4.090357511440901
KMRC-1,400769,0.144742351180573,-0.22583566337474534
LOU-NH91,25062766,1.8056251936091945,2.160408450733598
NCI-H460,11175137,3.7005840280640374,2.684878357993842
HSC-4,124202324,2.961748327308983,2.643140558732447
DMS 273,46191454,0.2871755056280096,1.0978249569359404
LoVo,23582824,-0.7966748622900964,0.7988409840991396
FU-OV-1,24785538,3.56375796516153,1.9125523696395232
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883,2.724148817347216
CAL-51,216345,2.9520334452605637,3.962591160761999
KYSE-70,11427553,3.0124804015996185,2.720093259997301
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704,2.433623655795395
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898,1.870129686674346
A2780,54618164,3.641335469190071,3.844626576192469
SNU-61,2708,5.501133929338057,4.120805713408155
CAL-51,702558,3.5144984342436563,5.190415350236877
CAL-51,11175137,1.2330676481368064,2.6276333362979614
OPM-2,119607,4.667002181538018,4.619024373445245
BxPC-3,4096211,0.9773140949236826,2.1560176412490573
NCI-H146,2749,0.7789788955457625,1.289732265035404
LXF 289,16725315,3.2486511295045677,4.447107414517334
HCC1143,4261,1.976797651434544,2.0288720157224787
SNU-449,11152667,1.3844218204303944,-0.04442608821559606
CAL-51,52947716,-4.729660133739893,-0.569542348030481
SBC-5,4477,-0.6853772163114386,0.6294986100972927
A4/Fukuda,44819697,-1.7397384839387715,-1.34615941973079
NCI-H2009,54618771,-0.2233577251443086,1.6467632071220841
LOU-NH91,2733487,6.3296049393179485,6.144397246887272
G-401,erlotinib-PLX-4032 (2-1 mol-mol),3.757739778609172,2.9169817158133573
NCI-H146,89928392,0.6603214053079605,1.1747726699829621
SW1463,10231331,-1.1566445252598772,1.844468790008987
MDA-MB-453,11977753,-1.828846421242697,-0.8632802074486382
HSC-4,445643,4.123722857917103,3.8396979641208127
EFO-27,42642645,1.7670896576814532,1.0591926517029904
EFO-27,crizotinib-PLX-4032 (2-1 mol-mol),3.36614562688719,2.238870506051724
BxPC-3,5311281,3.739267965753581,2.296520601996884
SBC-5,44185566,3.097813648169307,2.3718379926566264
LOU-NH91,5351362,1.6461408289790205,1.6386822083055879
EFO-27,50905018,5.404252445104634,4.188614355028521
MDA-MB-453,374536,3.68630764751743,1.6156818373028805
G-401,25262965,-3.9564581939856582,-2.046937868732555
CA46,2749,1.009648399882346,0.7726383236681029
SW1463,387447,-4.88012723681038,-4.197950375869272
A4/Fukuda,8515,2.244185004641864,3.4057679633797
NCI-H1623,24901704,3.7829050158791064,3.3790805484058053
HCC1143,71680916,4.5741598898507565,4.9214686798384575
YAPC,54143018,2.4773688492488892,0.49011485095714724
FU-OV-1,49793307,-0.2872221589202163,-2.382330357631094
Panc 04.03,168312962,4.832441653848414,2.4250778179292185
NCI-H292,11609586,2.9930145326420146,2.9908394926276305
NCI-H727,25150857,2.574637897952517,2.5789685952720576
NCI-H292,6438330,2.681078996624105,2.651730553816005
OPM-2,12003241,-2.9738714531294232,-1.2011407835110517
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163,2.8519525943078685
NCI-H522,151289,0.0217168787144745,1.0739475789051907
NCI-H146,docetaxel-tanespimycin (2-1 mol-mol),-0.2232334336717333,-3.662421902966543
BT-549,11238147,3.2866911979765803,2.900046223037644
OVISE,9866186,0.5630702781820192,1.1365132086263363
HSC-4,6918328,0.4827098957230251,0.27287927343219476
NCI-H2009,135411,0.2253946709705592,0.9142398871593567
JM-1,10385095,0.4126425157623973,0.8404908448371249
CA46,45279963,3.66447519946476,2.5734728591772176
A-673,44197249,4.247235211402652,3.2366836838863935
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069,1.2174153480888577
NCI-H661,135440466,2.665416885593315,2.5750095529364585
G-401,168313016,4.483065775660181,4.258036426652759
BxPC-3,168313047,2.402437406788064,2.3325143265856205
NCI-H661,2746,2.7828270451310786,3.3259214706446754
FU-OV-1,11612883,1.8669069183790803,2.8829819522866003
DMS 273,53232,2.0931635545137266,2.883368317406803
BxPC-3,9903786,2.126136875029704,2.7994594611039814
NCI-H661,11625818,4.41260734243293,4.444276982012887
NCI-H522,16659841,2.9113601324358287,3.172555330467922
OVISE,53232,2.4849914286727426,3.067311858356045
EFO-27,135440466,3.806006891786582,2.416588306639168
SNU-449,5746,3.348109332475853,1.3799693047797978
CAL-51,969516,2.948027689121256,2.8207709938278804
FTC-133,11238147,4.273178384451577,2.9605783411788513
NCI-H522,24748573,1.6076101041751254,2.0254693419530185
MDA-MB-453,46224516,2.0758190952131215,2.203877071288181
LXF 289,6918878,2.1668969721619833,3.1769278774094936
OPM-2,451668,-1.14063259637223,-0.3467315291429807
HCC1143,3689413,0.0716522323698814,-0.035603828464923215
SBC-5,135398744,6.447254342428179,6.4124321421749935
CAL-51,227681,3.694103991631346,3.2653536755366326
CAL-51,5287620,-2.338247824560234,-1.9770875305494247
A2780,3062316,2.0817886994426704,1.199946987193816
SNU-61,2858523,2.9582475566417195,3.025971713058922
SNU-61,54649381,3.9147762798202863,3.43089362723472
A2780,10385095,0.5603604864283975,1.0695526150197936
MDA-MB-157,11152667,0.7570225590856333,-0.7280800411016929
ONS-76,400769,-0.3525004301248006,-0.3317232508033787
A-673,409805,3.491559756034339,4.207502303199559
SBC-5,10184653,2.5351322042771356,1.33530380479667
NCI-H727,66577038,2.8647542032772604,2.993437099267604
A-498,6505803,4.020571046679738,-0.11001457299885331
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045,-2.956101527365015
NCI-H522,2708,5.085998334781725,3.9772629946848457
BT-549,45279963,4.047021813577569,3.8617538086275003
LOU-NH91,25183872,2.2713164299079627,-0.5038426444681202
FU-OV-1,24797083,1.8707999880079529,1.500399725686484
SNU-449,44607530,1.456313243054954,1.8564768141397747
MSTO-211H,1566236,2.167071233614174,2.5012740825618267
JM-1,24951314,0.1302219808330525,-0.03168601338052082
EFO-27,53392493,1.9151019076026368,2.7757983256454692
FU-OV-1,16725315,4.930691545287574,4.2418420245298964
NCI-H1623,12003241,-0.4868602659209724,-0.8898392519105792
SBC-5,148198,-1.371938553790338,-3.6970832113379815
BxPC-3,17755052,0.5794893802598977,1.905437731116291
SNU-61,11485656,2.115016827038527,2.1277732522913326
LXF 289,2729026,2.289348740995074,2.7903324819121518
MSTO-211H,654092,-1.1984807631004837,-0.2372777854193286
A-673,5291,3.269854942504113,3.2657264675817244
LOU-NH91,4705,2.8449970854381945,3.5377188409809124
SBC-5,24753719,5.823724927288436,4.308114085568325
SNU-61,675434,4.254516948181055,4.300240343795424
A2780,5278396,2.562980728115376,3.3697564539807043
DMS 273,122327,5.509571347430681,4.145292352600274
A-673,9884685,0.1604809562987641,0.35014502811171283
NCI-H1623,16722836,1.0817030477122866,1.604516380331616
NCI-H661,67291369,1.7470049727917394,3.029223316596259
A4/Fukuda,135398516,0.099848878431286,1.3615390323380498
A-673,568763,-0.0608974572236531,0.12651894305138991
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115,3.7935949808424665
SNU-81,11178236,-8.196337700198193,-2.195073503364366
OVISE,navitoclax-PLX-4032 (1-1 mol-mol),-1.1204888715090109,1.7347993458708657
A4/Fukuda,46215462,1.453707580765341,1.2006648567318254
HSC-4,6252,1.1187983220422375,1.338141482726541
HSC-4,3062316,-0.6194675763886993,0.5534492566586522
NCI-H1623,57330099,4.486652982197453,4.303840153258227
BxPC-3,23635314,-1.513116034089344,-1.440361061801166
OPM-2,46943432,-1.735277326796896,1.0326284755547694
FTC-133,11175137,3.295108533345337,2.5396607780272604
SNU-61,100016,6.106397388471953,5.739309233407803
MDA-MB-453,446155,5.408001660467943,2.7672344767622707
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194,2.166155573439053
MSTO-211H,168313200,3.954855187852925,2.75884696285637
LoVo,2729026,2.166128688763036,2.708848125026117
FU-OV-1,73707398,1.0047751906041116,1.511564722241865
LOU-NH91,44241473,5.33179348194517,4.981849805836742
YAPC,135440466,2.1529261418392807,2.202791970330749
KMRC-1,568763,1.1483170277588293,0.2655843375439869
CAL-51,656346,0.8466306406200714,0.9929537097808084
MDA-MB-157,327653,1.3811083957143218,3.1231907539285255
NCI-H460,107985,-2.632533954936978,-3.351841133068893
NCI-H460,135875424,3.211754300989152,3.9402728426688425
BT-549,119607,5.663531776682701,5.228647660489218
KYSE-70,4261,1.9447398866595849,1.7335627200507073
CAL-51,44543605,3.919885801001582,3.97466485131308
SCC-9,44566777,0.4714703461280546,0.9620008370335554
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783,1.7612472356416768
EFO-27,10322450,4.618987367546035,3.988891102734472
LoVo,452548,-1.7762082467733018,0.3153660760744898
G-401,24821094,2.5559581237528097,2.7672830975083174
Panc 04.03,docetaxel-tanespimycin (2-1 mol-mol),-0.4013709222669032,-2.024537552511617
KYSE-70,135999136,5.194226724950964,3.891628093671122
NCI-H146,6438330,-0.4558524131736901,1.5101795657048838
BxPC-3,31703,-0.5929664629875476,-0.7422525528500076
Panc 04.03,5470400,0.9135030177256964,-0.30399140044033535
KYSE-70,25150857,2.5963104301055258,2.58736736043634
OVISE,selumetinib-piperlongumine (8-1 mol-mol),3.917327807535022,3.340041060299521
A4/Fukuda,439501,-3.252400391503616,-2.3043322128047636
SBC-5,107985,-2.339881885950972,-3.536208711304356
NCI-H146,25227462,0.2247724046939956,-0.33581598114908373
JM-1,44491742,3.590859136704876,3.876323506963543
YAPC,6505803,-0.1975849276423945,-0.5895746209717593
MDA-MB-453,10113978,3.193218839681212,3.066553817544003
A-673,16038120,-1.140194872712738,0.5387895839568617
FTC-133,675434,4.640800834602054,4.725585561800757
MDA-MB-157,439501,-3.062684000428755,-2.108653138851419
SBC-5,10074640,3.660613951501144,3.065799958417392
DMS 273,3689413,-1.7704206659692223,-1.6187650667191826
SCC-9,36462,2.4622585602605493,2.3012642739814875
NCI-H1623,46843906,3.212648418277938,3.166526624382919
NCI-H2009,676352,1.803439035619831,2.2963442372094325
CAL-51,387447,-3.720200693098244,-4.579596574964889
SNU-61,navitoclax-pluripotin (1-1 mol-mol),0.1014096267424324,-0.7852429506688575
CAL-51,44632017,0.9975947899898204,1.2701773552912992
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122,-0.4918524672131886
DMS 273,9936388,3.4086707637717883,-3.7931581396582597
NCI-H1623,24180125,3.727544824819635,3.0201354618369023
NOMO-1,969516,2.327280884248625,2.281789597045059
A4/Fukuda,1750826,-3.1003590099134284,-2.935743867985325
Panc 04.03,5281321,2.674318568781228,-1.0736608220681738
FTC-133,176870,5.80195413779655,3.572991736544606
CAL-51,10113978,3.4506321601115397,3.3797587006926864
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193,2.436906245869865
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566,0.16963403909043176
A2780,3385,2.4446535707127537,3.3029169855771645
DMS 273,45279963,3.8289869697511527,3.0624160769846145
OPM-2,11609586,2.7966274513563496,1.8471919845764788
NCI-H1623,26596,-1.1542368606327895,-0.9547763496151715
SW1463,5479543,1.0422897086412093,3.2362518260348274
SNU-449,53392493,3.0071956547718113,2.914003072772665
Panc 04.03,11178236,-2.395899374087587,-3.1295370762982264
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344,1.1493293650838323
OVISE,BRD-A02303741-navitoclax (2-1 mol-mol),0.9537570528694392,2.340924887777266
NCI-H460,9866186,0.4176494313944011,0.7195406589835579
FTC-133,53232,1.7186310962422595,2.595085598518027
BxPC-3,216345,4.279216843902863,4.126762949572186
A-673,10296883,3.758044639987347,3.4532666791397038
ONS-76,11178236,-3.26201925681368,-3.3586773881966807
CAL-51,25062766,1.9168321284868295,2.107559023119767
NCI-H522,6852167,2.4506568165817777,2.532046710531826
SNU-61,72193861,1.1230875557226898,0.9953630332061617
ONS-76,vorinostat-navitoclax (4-1 mol-mol),1.54700333580169,1.2513079582031947
BxPC-3,3543504,4.240175882152398,4.491374098849529
NCI-H661,73707438,4.487630336801632,3.90251088388838
OVISE,638278,1.1296919637825429,3.425003185992285
A4/Fukuda,36314,4.126705075384559,-2.043446796502358
SBC-5,10127622,7.037598772691409,3.291784551165078
MDA-MB-157,selumetinib-decitabine (4-1 mol-mol),4.44139235410904,3.6178296799784495
BxPC-3,49766530,0.5943123243750338,-0.3347732017803689
LoVo,54143018,-0.354466194309244,0.5138181569870242
BT-549,44589607,2.161067974853105,3.136586767855781
LOU-NH91,3136844,4.41334270983783,4.391133488954242
OPM-2,5311,-0.071810443528602,0.6612664085144528
G-401,JQ-1-MK-0752 (1-1 mol-mol),0.1350272017197765,1.160453389657795
HCC1143,676352,2.389016147507623,2.079516804462084
Panc 04.03,11657048,4.4356176445581,4.1535871945854606
NCI-H661,navitoclax-piperlongumine (1-1 mol-mol),2.7076431504633676,1.756277499239683
DMS 273,doxorubicin-navitoclax (2-1 mol-mol),-0.5717172949913683,-1.6513968934456722
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807,1.8477645189645502
NCI-H1623,374536,0.6337427379168257,2.2845391342098624
SNU-61,3825829,4.102120147241808,3.602159324770716
DMS 273,56649450,3.5073695444545288,3.120365508265226
CAL-51,24785538,0.7720267524795773,1.6490802816568055
OVISE,16038120,2.1825815777023965,1.1798115256607893
EFO-27,6918328,-0.3264411901724555,0.22627961852302847
FTC-133,3025944,4.352563236352026,4.30424402693838
A-673,89183176,3.363943107585485,3.5601292951705146
KYSE-70,123631,1.697265417228948,2.217899812642303
MDA-MB-157,441298,1.9245422363016824,2.6980980788765243
A-673,156422,4.078876073319714,3.4763339114118033
BxPC-3,676352,2.25430531813019,2.2493093302442286
HSC-4,25150857,3.233332545340528,2.70656482097047
G-401,24856436,-0.0141865957174665,0.3244884559339193
MSTO-211H,49793307,-4.316049670445352,-2.0699657511409173
OPM-2,11485656,1.3184852346481954,1.7495820254009056
HSC-4,208908,1.4999275809756432,1.8292541244812783
MDA-MB-453,54613361,-2.035930507333412,0.06909184878518108
G-401,serdemetan-SCH-529074 (1-1 mol-mol),0.8425945982642317,1.7194918405249617
EFO-27,44589607,3.0601109795549295,3.0844769824183396
SNU-61,44493528,4.287806417412906,4.3119265150473645
G-401,11152667,0.9519757620011424,-0.7168082884273274
NCI-H2009,5287620,-2.745575302534365,-2.0833377354562765
ONS-76,23725625,4.840348822045759,4.976166658461167
CAL-51,44620216,5.469091994130916,3.885771224790643
NCI-H460,9903786,4.057661845653794,2.8392254812878077
A-673,11214940,1.1675505170406824,1.8092696030674864
A-673,24964624,2.426022149354347,1.8129976329731048
BxPC-3,9866186,0.8001699279354296,1.001693203558641
FTC-133,25062766,3.8237771334178903,2.102508615736246
HSC-4,42642645,1.8060847122685193,1.0508687467631699
HSC-4,11178236,-3.2670379451965164,-2.825944490413408
HCC1143,JQ-1-vorinostat (2-1 mol-mol),1.5570491988867368,1.1185763010849492
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229,3.1311313071984
MDA-MB-157,selumetinib-MK-2206 (8-1 mol-mol),3.246099259686085,2.383644979293697
NOMO-1,46843906,1.7610241193794407,1.243474597668291
NCI-H2171,6917907,-6.363958938419671,-5.07636632188007
DMS 273,11707110,5.189560989731051,0.6923090442530261
LoVo,6918328,-0.3156299102516719,0.10045609968146695
HSC-4,vorinostat-carboplatin (1-1 mol-mol),3.405772607796717,3.3500856324988395
NCI-H2009,44632017,1.0717713653211387,1.75588645140918
DMS 273,11626560,1.283315066012986,1.2834821251535535
MDA-MB-157,11317348,1.0421206228140214,3.4958749970879968
A2780,5311281,0.918852428114819,2.192384798668576
DMS 273,2113511,5.781557942421417,5.386692203294953
LOU-NH91,10184653,1.5324310696398793,1.4783659315062139
BT-549,selumetinib-navitoclax (8-1 mol-mol),4.705621989339038,2.43367937264354
Panc 04.03,73707398,1.757833710000806,1.518591877785335
JM-1,JQ-1-navitoclax (2-1 mol-mol),-2.0715419523140883,-0.2896747166919818
BxPC-3,11455910,2.77826122800999,1.2812164162211734
MDA-MB-453,11955716,-2.2213534191245303,-1.4229364929011594
A-673,navitoclax-MST-312 (1-1 mol-mol),0.824497586093143,0.2155784900348806
NCI-H661,3634881,2.923822089210327,3.287139606887085
NCI-H460,5281672,4.99885948312363,4.8322377799428455
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808,1.588762228098043
KYSE-70,4259181,-4.187670573846372,0.1145314142031958
BxPC-3,2756,5.8394588105914105,3.7044460464707587
HCC1143,24901704,3.259585605807663,3.4438698766420397
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374,2.3075059624304677
CAL-51,5470400,4.528848471588079,-0.3948336721974553
JM-1,10296883,2.092198976716966,3.10374044224674
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176,-0.7245760825091372
NCI-H146,46199207,1.7925573568525552,3.0773801354999843
OPM-2,448949,1.278414281383,1.1952187160213126
NCI-H146,216239,1.510222966819436,1.9723487661394827
HSC-4,9903786,4.262681016067309,2.8199450930251944
ONS-76,57330099,4.261013423315652,3.910443838778931
NCI-H522,148124,-6.241132033807486,-2.3648986077416385
SNU-449,156414,1.8120811787876097,1.9628600709520148
NCI-H2171,2746,1.1013983502046127,2.172727333302745
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268,-0.39894931578644965
LXF 289,135398744,6.087135496005038,6.459953663227045
SNU-449,3689413,-2.168376107627999,-0.1959338745640491
A4/Fukuda,5351362,0.320845740356061,1.0544572788010904
A4/Fukuda,446155,1.0805751863544764,2.280786549933118
CA46,151289,0.6780663351050565,0.46866839752316125
ONS-76,selumetinib-JQ-1 (4-1 mol-mol),-2.481078216030984,1.4923306720792027
NCI-H292,UNC0638-navitoclax (1-1 mol-mol),0.2061924649473525,1.8602779467798607
NCI-H460,11625818,5.428588497019925,4.502584737784317
A2780,119182,-2.871948238792312,-1.504646823358006
ONS-76,10385095,1.1655527010487017,1.5781753880671203
EFO-27,51037431,5.317639691280149,3.100086630898935
A-673,72376,-3.645473298633041,-2.8782588173580548
MDA-MB-157,24748573,1.7707431454067368,2.2263401769200515
JM-1,6610355,3.6312795132079136,3.885637175000436
EFO-27,44819697,-1.290536172530674,-0.7279247319404258
A2780,5702613,3.197014181878355,2.924638129568537
A-498,25102847,3.3376740856950335,2.877603250323148
KMRC-1,3634881,3.321374403116886,3.14132444490911
OPM-2,3081361,1.5210485339307265,1.9111691658532128
LOU-NH91,3038522,4.554088179549466,3.163819796406208
SNU-61,216239,1.9834133881004128,1.9967271798744002
FU-OV-1,124202324,1.4335087059128786,2.9437739795336877
NCI-H292,72193861,2.2952018559260363,1.83603467289126
MDA-MB-453,53495165,1.832682106227088,0.671529199681861
NCI-H2171,31703,-2.460746582121975,-1.6509842995827027
NCI-H460,2729026,3.0609463870825926,2.8218637562756133
SBC-5,9868037,1.591902673624677,3.222338875557855
LoVo,44632017,0.6073588127957028,1.3530398443138774
JM-1,25262965,-2.478831797463893,-2.627842585660559
SCC-9,148198,-2.735497552895971,-3.225539663753596
CA46,89928392,0.0283947615438792,0.2523619962880273
OVISE,5566,3.518034595538079,3.1283561045412727
HSC-4,5278396,3.3910828172613128,3.60791890169521
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388,0.36711920344116117
KYSE-70,4788,5.890959200463747,5.6752495333742035
SNU-61,serdemetan-SCH-529074 (1-1 mol-mol),2.1746130433144386,1.794140683874065
Panc 04.03,374536,2.376032280196277,2.4280201928400245
NCI-H661,20959075,-3.3600823520668306,-2.548401718174988
LXF 289,3543504,4.042070583449167,4.66090937707677
SNU-449,5287620,0.008240040829162,-1.948847807225699
HCC1143,11719255,3.553533872223464,3.6711466188742503
NOMO-1,54618164,3.731990472759892,3.6674123137749786
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889,1.2885000001185267
NCI-H1623,5311,1.5946462199665867,1.6044623790655133
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076,1.5392551974416313
LOU-NH91,216468,5.562373540734892,3.625562228321078
JM-1,9915743,0.8499678141273637,0.5094073860200072
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426,1.9104856016001177
NOMO-1,107985,-4.118574275669005,-4.094849616063471
JM-1,135423438,1.5495237102322077,0.5106461669591192
A-673,24856436,-1.1403661815810562,0.08217609874395503
CAL-51,5282054,3.552468823116285,3.71830076929801
CAL-51,11178236,-3.674192911743539,-3.409655754464693
G-401,6252,-0.6004387834343344,-0.7964284239752843
KMRC-1,4261,3.216149224144429,1.7279696845031753
MSTO-211H,54454,-0.190602208325988,2.5523252845009368
CAL-51,4917,3.122174268556499,3.1274940490695315
HCC1143,54649381,3.828405406955801,3.9576659640831604
EFO-27,25262965,-3.442895730672298,-1.3252603894853856
NCI-H522,54626689,4.6269731577498066,4.629567658257945
KMRC-1,123631,2.4243478642730634,2.14712904015599
JM-1,JQ-1-vorinostat (2-1 mol-mol),-2.067527251050835,-0.21567551426414697
MSTO-211H,6438330,1.6419113469823416,2.2694562095934656
CAL-51,446155,1.9002286289262065,2.7647328914794542
MSTO-211H,25126798,3.885175037199499,3.9136931372734525
KYSE-70,54626689,6.762622459467938,4.687097641326584
FTC-133,navitoclax-pluripotin (1-1 mol-mol),-1.324010652875928,-1.214055484986274
CA46,4705,3.1649236354970154,2.8570726823965042
LOU-NH91,36314,-6.12634068503974,-0.6331005557761544
OPM-2,49766530,-3.767684481967312,-2.097940482974829
NCI-H460,135411,0.3374737909082799,0.7120094031697388
NCI-H2009,6623618,3.0922058987418315,2.3775722723844757
KMRC-1,44185566,3.110367208302614,2.514639427670582
Panc 04.03,9933475,2.3468691227324965,1.9903457545757883
NCI-H146,25105715,3.2144396386290617,3.2479004902397914
SBC-5,25062766,3.305997596539037,2.1605463714419506
G-401,11364421,-5.069536717957333,-3.1765662541383186
OPM-2,1285940,4.143301448340403,2.8771728455323187
NCI-H661,46843906,3.609730466041,2.9582279991651883
JM-1,selumetinib-piperlongumine (8-1 mol-mol),2.3811879474866093,2.022493575043445
NCI-H292,selumetinib-MK-2206 (8-1 mol-mol),0.2769010439937888,2.4376559097323653
ONS-76,656346,2.4725060186946974,0.8853373839935875
A-498,135421197,2.4500558267656873,2.2786569150429994
YAPC,5280436,4.973863444979394,3.6006581800910014
NCI-H522,53481919,3.906372094667401,3.56680098531721
CAL-51,448949,2.479839067238928,2.0287505449569063
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167,0.8490239445356568
NCI-H727,15953870,3.6175866373148713,3.4733575331671163
A4/Fukuda,4378219,1.9024946719152895,2.05081150150474
ONS-76,374536,5.32668572402577,2.3179147606624255
HCC1143,387447,-2.8902460626215216,-3.9582327470419165
A2780,navitoclax-piperlongumine (1-1 mol-mol),1.0612869409921282,1.4418299954663194
OPM-2,3543504,2.699241331915609,3.766181417835972
G-401,54618305,4.431468655886698,4.1137463312291445
A2780,54649381,3.634529154077109,3.4996348863400732
LXF 289,5287620,-2.3080718171081385,-1.7649552732542413
YAPC,637858,2.16601707981449,2.254039669966307
NCI-H522,9915743,1.083108246388964,1.0066112076927105
KYSE-70,25183872,-0.2407157689495178,-0.5249059901546859
NCI-H522,56649450,4.1349782138767655,2.895506318289236
OPM-2,52947716,0.8847701060718332,-3.5482844218839245
SBC-5,124202324,2.6085939591802307,2.4269761062017743
DMS 273,2742550,3.72774264414297,3.517598788885102
NCI-H522,BRD-A02303741-navitoclax (2-1 mol-mol),5.562601250875811,1.7525046878567208
NCI-H522,44491742,4.766943404170333,4.349665421485315
MSTO-211H,3503,2.7854032891391163,2.1998891578202913
FTC-133,10427712,4.710340548147587,4.284150424526729
SW1463,56946209,-2.6004240108086187,-4.366900896588336
KMRC-1,11178236,-3.5821993315226175,-2.9332251016167867
NCI-H146,5281672,3.80713040102785,4.37370995839987
SBC-5,16038120,3.1431644252796835,0.781788552712118
NCI-H522,421610,1.9391714098470076,2.984890174190385
DMS 273,9866186,1.1265446059819233,0.5732082227928911
SNU-61,11717001,3.914635952460324,3.9437088562147213
NCI-H522,JQ-1-MK-0752 (1-1 mol-mol),0.1872499419058635,1.403123861141192
LOU-NH91,44137675,3.1585262513685612,3.7218141136723966
JM-1,5335621,3.4974928376934766,4.079244923785051
CAL-51,444795,5.053001195278548,4.731576452481246
SNU-81,68056272,2.81466177200511,3.4642454698626124
MDA-MB-157,23582824,1.002360199735323,0.5873661361815529
CAL-51,44185566,1.8630594392382311,2.5663340365896206
MDA-MB-453,54618771,-0.4179555738274852,1.107553149833439
MDA-MB-157,16038120,1.7351596622267822,1.1402131807467832
OVISE,44589607,3.8530354372246394,3.0278575251670965
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485,0.9053475136052307
NCI-H460,400769,-0.4007490431715684,-0.424300790258841
SCC-9,5460769,4.655053652221148,2.4779292900501635
MDA-MB-453,135398516,1.6443590350340722,1.7784164795719968
OPM-2,444795,4.04932788863876,3.363302791367245
MDA-MB-157,navitoclax-birinapant (1-1 mol-mol),-3.5674569438027977,1.414162120455704
OVISE,navitoclax-MST-312 (1-1 mol-mol),0.1298249702458385,1.0067347928512944
HSC-4,11656518,1.5757846986297326,1.9859967275571089
MDA-MB-453,navitoclax-pluripotin (1-1 mol-mol),-0.3400363144819007,-0.8006448875327985
G-401,3062316,1.3877203939609295,1.3803617741491023
SNU-61,16013152,3.3306050431250056,3.7422391896319893
NCI-H292,4259181,-0.3596950747779806,0.6003713438331648
G-401,6918638,0.0373379560261908,0.07987444333913618
NCI-H460,53232,3.485336782178725,2.635853516795014
NCI-H292,navitoclax-pluripotin (1-1 mol-mol),-0.7245377190748261,-0.7144340474257892
HSC-4,262093,2.780665409693215,2.939115062421846
LoVo,100016,6.001395250082881,6.17584464279098
OVISE,2729026,3.0624747536258843,2.7664128388978457
SNU-449,46174525,4.694645250518289,4.604439644649889
MDA-MB-453,25102847,3.185871702253412,2.6499752606618587
NCI-H661,selumetinib-piperlongumine (8-1 mol-mol),4.143402820216487,3.4560818716950625
LoVo,208908,1.8298234127328137,2.0502205792889403
DMS 273,36462,2.158918041886743,1.1635252922600505
SCC-9,252682,6.244434841835944,6.602904590769253
CAL-51,3689413,0.5709426612715743,-0.1439984468414681
ONS-76,5328940,1.5304760606777814,1.7334269724561984
KYSE-70,46199207,3.0458734214111436,3.1845118446787724
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225,0.9536957226660324
NCI-H727,16720766,2.0944103672723577,0.8335467326593242
CAL-51,16741245,4.222373420591208,4.166286272034026
HSC-4,23939,4.494005895197972,4.370376166674476
LoVo,60700,-0.3967380120150421,-0.4972185168177037
MDA-MB-453,25262965,-0.03783703480807,-1.6484213294866357
A-498,374536,-1.3715174839162405,2.070739050609492
SNU-61,107970,2.0644711824277757,2.2972172971731477
G-401,702558,4.958816468985481,4.542178795217706
MDA-MB-157,tanespimycin-gemcitabine (1-1 mol-mol),-1.0230607950179071,-1.0539838084556905
NOMO-1,16038120,-0.1786929053902652,-0.05336738866696209
HSC-4,3543504,3.922868331711394,4.491491359533865
NCI-H460,vorinostat-carboplatin (1-1 mol-mol),4.479996249659036,3.3253255137610154
SNU-61,10410894,3.2150759349666176,3.129160378610681
JM-1,2746,0.8560843341026924,1.8610015983165125
NCI-H2009,15547703,2.9018345982556935,3.417857473934356
A2780,246676,4.314588687253318,4.093691700645461
CA46,135398738,2.145043320547598,2.3821081068124923
MDA-MB-157,55508,0.9028127001821934,3.555503122931625
Panc 04.03,71304818,2.709197405012258,2.715931999786132
MDA-MB-453,53301938,4.664434739240087,2.239353650306848
A-673,46843906,1.5511639515888018,2.0160048826966666
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384,-0.18360821059674087
MDA-MB-453,3543504,4.170014094465671,4.226355833810163
NCI-H2171,5470400,-1.4637445210918176,-0.8860473700897874
NCI-H292,25062766,1.6798511870535655,2.0804837183871125
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.3619469499325294
A4/Fukuda,16736978,-0.5754825114210159,1.4165868424970256
JM-1,2749,0.0460059123026362,0.9010280458791743
SCC-9,46215462,2.815249887965138,2.1598538871655655
SNU-61,24821094,2.5022209832597757,2.9767218770772375
LXF 289,44493528,4.295099384269069,4.2196265421276635
KYSE-70,54649381,4.140433754758901,3.877685800677907
CA46,JQ-1-navitoclax (2-1 mol-mol),-0.4595467452216603,-0.39155455397498273
SNU-61,9826308,1.2155896819085543,0.29432671087415097
NCI-H522,49766530,-2.92412408259348,-1.047632729165055
HCC1143,44493528,4.485488370266477,4.217779366525767
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555,0.10012762665639803
CAL-51,3081361,1.780158758130264,2.1319850967271456
DMS 273,2746,1.8465116882146249,2.3572256559201743
HCC1143,5282054,3.2164949694146237,3.7901910253389604
LoVo,navitoclax-gemcitabine (1-1 mol-mol),0.8957448181446594,-0.8164024389630868
SBC-5,644241,3.9213876276885458,2.3246995919566773
DMS 273,702558,5.649496210085508,4.35176979954698
NCI-H661,25183872,-0.013752841490686,-0.726551973571715
NCI-H1623,71751553,5.091527890142487,4.474034051662587
SNU-61,10322450,3.828611192492266,3.5526603601246696
YAPC,44589607,1.444383642816813,3.15986031093007
FTC-133,426756,4.37678677221598,4.58042499027149
DMS 273,25062766,2.819032107658894,1.9553817991663311
KYSE-70,375860,-0.042936769343065,-0.24385733727472117
NCI-H292,6623618,2.2662127680014708,2.4981893955949883
A2780,3634881,2.2771511965432767,2.9591405742032713
FTC-133,11427553,5.52425857278767,2.8468898836278287
FTC-133,613753,3.41594619216373,3.318303057623165
DMS 273,5978,-4.4169630962529896,-2.300962152737697
MDA-MB-453,135398738,3.241714649843938,4.161548701584818
G-401,252682,7.482268639703102,6.471715304196468
CAL-51,126941,-2.448006630223804,-3.4182448626086592
KMRC-1,1716436,3.642710819139985,2.903723526819706
KMRC-1,9967941,4.338887861114791,3.7319187562449407
ONS-76,serdemetan-SCH-529074 (1-1 mol-mol),2.2978761416603812,2.1459912494589113
A-673,16725315,4.562355532440761,3.6507076369807554
NCI-H661,54613361,-0.43407763491745,-0.13271158576224873
NCI-H727,17755052,2.165535951118127,1.7764276421588832
LOU-NH91,4521392,4.279385220000522,4.426447077866193
NCI-H661,448949,1.832526735111792,2.114751251526494
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881,5.821662123320085
JM-1,24753719,1.6485500810507543,3.288207920457344
CA46,42642645,0.1424242949920916,-0.3147551516878886
A2780,122327,3.970459431332868,4.4322955023524635
LoVo,11609586,1.9215259939554383,2.81496402837005
NCI-H292,piperlongumine-MST-312 (1-1 mol-mol),3.188802005351175,1.914004992512382
Panc 04.03,6918328,0.7116207668770654,0.2292019128977956
YAPC,10302451,3.503177254309001,3.1140391752418064
Panc 04.03,262093,3.918875507815306,3.21489453706202
Panc 04.03,4261,1.8035720705799856,1.544401338087201
HCC1143,11238147,3.6259374679037943,3.1103539362027055
FU-OV-1,24951314,0.7779749033617789,1.4997379448857624
CA46,135440466,2.9995621349054007,1.6044127221351296
SNU-449,675434,6.334911868299287,4.650524845893364
G-401,568763,-0.8413074079434755,0.17827701740218602
A4/Fukuda,421610,2.9916322722523425,2.763414470135425
NCI-H727,11964036,1.415853516680377,1.2931095101952874
SBC-5,53232,3.018737473370281,2.8723324748529553
NCI-H1623,2746,3.1722069840164533,3.297887327333904
A-673,25102847,1.6240664882379,1.9417977138846967
NCI-H146,71680916,3.9962882248297182,4.508899965650911
CA46,702558,3.0016875761250383,3.96630808040168
HSC-4,3465537,2.7025414883497443,2.675065138499213
SBC-5,15983966,-3.760719305706525,-0.9279497022109297
NCI-H661,10184653,-0.0970326303224196,1.3719344473928965
KMRC-1,docetaxel-tanespimycin (2-1 mol-mol),-1.2179749713416546,-2.178538019278169
MDA-MB-453,3634881,3.217596499324366,3.214662330688738
KMRC-1,54596558,4.448003654736506,4.335674139349934
SBC-5,6438330,2.801398037891768,2.3191006858834093
DMS 273,11317348,1.436395200538785,1.834523367555681
MDA-MB-453,241158,3.8848602363142697,3.808215045950808
CA46,72376,-3.3789820311778764,-3.4597221125532496
EFO-27,1242560,3.615097330539702,3.654188693214313
BxPC-3,51039095,2.7952547650191297,2.767685581012857
BxPC-3,71466380,5.524538311672043,4.568264730313752
A2780,49850262,3.28716577139928,3.2808178565573245
EFO-27,148124,2.931737870457193,-2.0461024316311534
DMS 273,65064,5.260786534928717,4.464233585819813
NCI-H727,5328940,1.5210077536616875,1.806028663886848
SBC-5,20959075,-3.707780876124786,-2.4083899938489566
LOU-NH91,5281321,-2.3527775967876097,-1.0628248840179717
OVISE,123631,2.580734449711204,2.422880222860985
BT-549,navitoclax-piperlongumine (1-1 mol-mol),2.0033323756459325,2.1553660527254794
OVISE,56946209,-1.506774361262591,-3.580568240512522
DMS 273,5282054,2.793045570742954,2.860760229589402
SNU-449,11626560,2.613161578711923,2.202691758065728
HCC1143,vorinostat-carboplatin (1-1 mol-mol),2.950179443799285,3.2874348172502432
KYSE-70,11214940,1.7563649507227177,2.2719080257653523
Panc 04.03,15953870,4.151399322633975,3.8201482267653004
LXF 289,16736978,1.6084503302226174,1.903950692524152
MDA-MB-157,60700,-3.9633933148193066,-0.11753934458128762
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544,2.655812449590189
NCI-H522,11152667,0.761836671652074,-1.058806442725674
SCC-9,1750826,-1.358939777918893,-1.2034036698560915
CAL-51,3854666,1.1494535123186709,2.058640013896164
CA46,11656518,1.817934601803022,0.5715315784301298
CA46,46843906,1.200591966763502,1.33140155053784
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864,0.3017456108188906
CA46,24772860,-2.6679944090404035,-3.0194543730913996
G-401,24771867,0.701574094296253,0.6406522583586919
SBC-5,44202524,1.3408029920565403,2.1452077616420797
NCI-H2009,44507138,1.543580962147717,2.588026950877537
OPM-2,24748573,1.2641689672749945,1.7333899537435373
NCI-H661,3025986,-0.862198206140106,-0.8430737803788608
ONS-76,107970,2.339276188405755,2.3870733076593407
BxPC-3,54619267,3.7277591748612866,4.142352450983061
ONS-76,4917,3.1821597264511863,3.3233646798422614
NOMO-1,44493528,4.211717002525977,4.118031471034748
SNU-449,421610,4.477929285236737,3.2710150085175895
NCI-H460,4259181,-0.2054535095090753,0.2863615232965768
G-401,327653,2.827166761380022,2.834363973982158
SNU-449,10302451,2.626140201612578,3.42504240787346
OPM-2,24964624,1.0133948666397414,1.1802745110106485
NCI-H460,decitabine-carboplatin (1-1 mol-mol),5.711922209034068,4.215420432950989
SBC-5,441298,0.8643210359830038,2.576671654359982
NCI-H727,44489367,5.9503570299169875,4.541845383372904
HSC-4,123631,0.7882754974693414,2.29176422364328
ONS-76,24753719,3.8801096922841656,4.308990479741946
A2780,53495165,-2.5208465146636008,-0.9059105526979505
SCC-9,135411,1.0456929507985402,0.7503601559432331
A2780,6918878,0.724096247903148,1.8167235603160712
A-498,45279963,3.865048616527305,4.064854547482093
NCI-H522,51039095,-2.208127710853326,2.2409651394742185
LoVo,5335621,4.644708398315867,4.3582655082139095
HSC-4,46199207,3.2853086951025197,3.3106933286013787
KMRC-1,45279963,3.811973271229391,3.586550161897303
LXF 289,56946209,-4.292268406284497,-3.9399595580297735
OPM-2,24775005,3.1759511003243532,3.4027241415382408
MDA-MB-453,11609586,2.797782394552202,2.6551175476476327
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175,2.459876499806542
A2780,53481919,3.3933560170788355,3.422955931780486
G-401,25150857,1.6513368879801875,2.062754397088698
NCI-H460,selumetinib-JQ-1 (4-1 mol-mol),5.042112520146055,1.3619469499325294
G-401,126941,-1.029913917257394,-2.774311289773725
FTC-133,JQ-1-MK-0752 (1-1 mol-mol),4.281585420865333,1.8665408860268193
MDA-MB-453,BRD-K55473186,2.6877336742225424,3.8588889053944
MSTO-211H,5311281,0.6318902138586533,2.1756915201157296
CAL-51,44589607,2.4963130908502107,2.840543380922033
KMRC-1,11234052,5.10610802043039,3.6551028194949247
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314,2.8912961276104854
HSC-4,5291,4.568554891244716,3.7517529334706547
KYSE-70,3543504,4.273044270546896,4.454176278086794
NCI-H522,54618164,3.979913879048498,4.066227828154994
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581,3.2676255022738716
DMS 273,439501,-3.5888564067388633,-2.308509763160088
MDA-MB-453,122327,4.8881767020652775,4.4089507605559035
A2780,6918837,-3.827695834319955,-3.327746391429005
A4/Fukuda,44489675,3.3968348796203003,3.812437209710561
NCI-H522,25195348,4.252884841670477,3.2278902594922267
SNU-449,11404337,-0.5921655065432572,-0.19941114410634764
MSTO-211H,12003241,-2.79016034960529,-1.18521281403935
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287,3.4908259284064225
SNU-61,654092,-1.5451038120184588,-0.41967080291641456
NCI-H1623,4705,0.0935418442786881,3.010343626237743
NCI-H460,3543504,4.388423548450019,4.378148311537788
NCI-H522,23635314,-4.582316729083318,-1.504234716048115
LXF 289,6918837,-2.0130943060067454,-2.492024717141499
LoVo,31703,-2.470313869470646,-0.5981414175942773
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949,0.5721753472960611
FU-OV-1,654092,-1.6613932676517214,-0.13571071168195042
OPM-2,60750,-2.943046758118922,-3.2702051125798963
Panc 04.03,serdemetan-SCH-529074 (1-1 mol-mol),2.4838177280551057,2.217939125373584
A4/Fukuda,445643,2.2110077600401996,3.625068689464386
JM-1,25105715,3.1433974364296526,2.9987778218012355
KYSE-70,9967941,5.193135802047497,3.5871931542878572
Panc 04.03,24748573,2.946919213932378,2.4480551059020006
MDA-MB-453,6918878,0.409116855324534,2.647190205045858
Panc 04.03,24901704,4.022965674422846,3.7697700125806795
CAL-51,16736978,0.375988055286384,1.8208887325844736
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885,1.0411785137738832
NCI-H727,carboplatin-etoposide (40-17 mol-mol),5.344630715975986,2.791315356347655
Panc 04.03,462382,1.207122186011881,0.8211516071161705
BxPC-3,568763,0.1839879990612418,0.6034736999065373
A4/Fukuda,11640390,-1.5428779369431247,2.8165800303240838
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102,2.9175097978272237
NCI-H522,216239,1.926799438191183,1.8816168081971316
G-401,53392493,1.8463111416757765,2.1727341598403513
KMRC-1,241158,4.823138037217212,3.8699661349533447
A-498,5566,2.910612965628124,3.1602141897105116
SNU-61,17755052,2.932810476371255,1.5040557690051137
HSC-4,49793307,-1.7279713732228117,-2.8354274417204044
SW1463,49793307,-1.9541064611693424,-3.1302459048907054
LXF 289,11964036,0.5627528071719251,1.584356120474511
FU-OV-1,11228183,2.3859582400300683,2.723904647472974
EFO-27,5311,0.9089041307391243,1.6444881480295692
SNU-449,44819697,-1.6819344520854818,-0.27209500386820407
G-401,JQ-1-UNC0638 (2-1 mol-mol),-0.8221581174940659,0.9303877894069388
A-498,168313307,4.423397924448837,2.9483163157854575
NCI-H522,19582717,4.722348713472889,3.416631320913678
FU-OV-1,9903786,2.8592788804010936,2.9157007232067245
DMS 273,444795,4.3404236236698495,3.465497047101627
A2780,56946209,-4.674045280410088,-4.067166844678101
A-498,tretinoin-navitoclax (4-1 mol-mol),1.5109888268131983,2.524280965239779
A4/Fukuda,3503,1.0521499831923595,1.9253549114770627
SBC-5,6918837,-2.402107568310104,-2.866109877257254
YAPC,23582824,3.2647123156294855,0.7206370770419759
HSC-4,159324,3.192829599869501,3.3620934020962547
ONS-76,54619238,4.4304444652836805,4.729564745665245
G-401,11228183,5.702662541402335,1.111145851342471
JM-1,44819697,-3.7816867530650535,-2.140740831005039
SBC-5,54143018,-0.8844414516239579,0.6480355440244425
A4/Fukuda,44589607,1.1710928843495056,2.2076975704948
ONS-76,44543605,3.8219566402137457,4.079350114438817
YAPC,15983966,2.0827072702810847,-0.7339163713014721
SBC-5,2749,1.818007095297154,1.769343988956293
FU-OV-1,44487872,4.488734888040304,4.609412271800528
EFO-27,44197249,3.884486906001317,4.219256608255961
NCI-H2171,10385095,0.5588950968794439,1.0056737240701101
LXF 289,5351362,2.37199640031851,1.6420006644397196
OPM-2,54618305,3.930022905522119,3.8528474699388675
NCI-H146,327653,2.704686127708374,2.744179104168752
OVISE,11497983,4.4381003844097595,3.960550888265847
NCI-H522,11977753,-0.2877362686640902,-1.668035538582162
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1728813429939284
NCI-H522,11707110,3.8955176091352857,1.1039583758767013
HSC-4,3676137,3.997252050059137,4.643657604494283
CA46,BRD-A02303741-navitoclax (2-1 mol-mol),3.6671520767068095,0.7570484703891114
A2780,9840324,5.381878860524984,5.596427408392002
BT-549,crizotinib-PLX-4032 (2-1 mol-mol),2.4648473849576384,1.9881338146199894
FU-OV-1,6917907,-4.405886494893828,-4.840821956821549
CAL-51,71304818,3.0248956992793565,2.4535322099886256
FU-OV-1,51039095,3.5191953123451096,2.7808333837472303
SNU-449,5470400,0.6313893315276518,0.10106124358249717
MDA-MB-157,6438330,1.1379279588809148,2.042078075812529
NCI-H727,969516,3.103754409621015,2.9654651978341544
LOU-NH91,439501,-1.197324809082114,-2.0018466632535374
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977,0.5299068008926424
FTC-133,148124,-3.926787463073679,-1.6340029785854722
NCI-H146,24901704,3.4954665576646216,3.120388731341623
NCI-H146,6505803,-0.3489025917214021,-0.5479895831093259
BT-549,44819697,3.658602858416661,-0.47707530577329804
Panc 04.03,5278396,4.260606427966062,3.6463336690171184
G-401,11647372,0.0479330615057392,0.8571199569466391
EFO-27,71466445,6.412452895571818,4.347984501549212
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993,1.6581345079743206
SNU-61,selumetinib-UNC0638 (4-1 mol-mol),1.9080621375720417,2.668071474843876
NOMO-1,1716436,2.6410194121109773,2.555304529228137
JM-1,navitoclax-pluripotin (1-1 mol-mol),-1.136595381126137,-2.141853974544504
SNU-61,46199207,3.1956978461436014,3.1340368912340746
LXF 289,4261,1.4002862892534345,1.7956059326787792
DMS 273,46843906,2.9019571008738763,1.886477200826842
SCC-9,25150857,2.532575506870741,2.458801740226684
NCI-H460,navitoclax-MST-312 (1-1 mol-mol),2.434638176735655,1.1300196354414376
NCI-H727,24785538,-1.326987163467981,1.7819476494666124
NCI-H661,11404337,-0.0954545894437525,-0.48729317277264494
MSTO-211H,66577038,3.302731292752764,2.9542499183753432
OVISE,126941,-1.5326684035544371,-1.8787641671168638
BT-549,44566777,1.3521548270810906,0.898254556951756
A2780,3025986,-2.2950808421603983,-1.2633874823215794
NCI-H727,16736978,4.598640955798025,1.9299674288739563
JM-1,6610216,3.7780643735318615,3.8106812207835143
MDA-MB-453,168312962,-1.3854623993271444,1.4976931298677028
LoVo,2749,2.494181165729376,1.871697180161276
OVISE,15547703,4.212246909591729,3.342344201296407
ONS-76,16736978,2.0849164003870877,1.8086802463332894
MDA-MB-453,1714884,2.9618056579194585,3.4322420346246947
DMS 273,327653,3.1988672985426847,2.6130041131938606
YAPC,2828334,6.193046978626199,6.340048282330101
CAL-51,10184653,1.4453250777347395,1.7223522688938342
Panc 04.03,9936388,2.385451093408398,0.09743033450999133
NCI-H2009,4477,0.2115452666376647,0.6064193562009963
A2780,322968,2.566344426002007,3.109388150672582
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596,2.310596864609844
EFO-27,216345,4.384346641524126,4.147146235523014
Panc 04.03,UNC0638-navitoclax (1-1 mol-mol),4.190054196085194,1.7437276424100747
LOU-NH91,9956119,4.571782850484356,3.6438859587070294
NCI-H661,1641662,2.9325574972427813,3.5027418289508803
CA46,44493528,3.81061502276679,4.031521756603212
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037,0.798219434276281
A2780,11647372,-1.4335547211387447,0.5598333884728253
SCC-9,176870,2.779248818408345,3.064422058658168
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434,0.5128418618210493
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564,0.7408128864227049
NCI-H2009,25183872,2.394233803753281,-0.5749658000140649
BxPC-3,selumetinib-piperlongumine (8-1 mol-mol),1.5279722865269718,3.203525217704858
FTC-133,selumetinib-JQ-1 (4-1 mol-mol),3.749238444437789,1.9350557616690633
NCI-H727,11222830,1.7878002384813196,1.6540861183021953
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319,-0.3904591993181151
SCC-9,9823820,5.247901285797655,4.102968363259007
FTC-133,44462760,4.267925011817446,3.1851949905957526
EFO-27,salermide-PLX-4032 (12-1 mol-mol),5.523351402733512,4.888691613335086
DMS 273,54618164,3.989243888703328,3.8929249257932
A-673,5470400,-1.9410984929514092,-0.7499613170937401
A4/Fukuda,56973724,1.7857996527787343,1.8204568671299202
NOMO-1,5311281,1.2143454060885572,1.7144742564984279
CA46,135423438,1.6657304721140649,0.9585348872591315
HCC1143,5287620,-1.5012475814925117,-1.7350241280561363
EFO-27,107970,2.9901836608736883,2.341771729144693
EFO-27,7251185,1.6138148752584345,2.8811800311678746
LoVo,11214940,1.900565531770479,2.106677088924651
NCI-H2009,6450551,1.0382100121131883,2.902160730990994
LoVo,3081361,0.9226789940369008,2.2772747192959466
SBC-5,BRD-A02303741-carboplatin (1-1 mol-mol),4.575375432825298,4.108966625647253
Panc 04.03,2113511,7.412620584739622,5.59345702201411
G-401,crizotinib-PLX-4032 (2-1 mol-mol),1.2254709557426715,1.6265543583417665
A2780,42642645,-1.071178701221225,0.15546817029813745
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051,2.0402574884782787
G-401,72376,-2.6056367900842745,-2.7301333543943302
NCI-H460,54618771,1.6853262233131374,1.1994889088701177
BT-549,selumetinib-piperlongumine (8-1 mol-mol),4.450190552332179,3.585516282551467
NCI-H1623,60750,-5.650217340343659,-2.0590236685800853
BT-549,49766530,-1.005486623843658,-0.5136279215019988
NCI-H292,10184653,1.6188231902933972,1.5179535712933239
NCI-H727,5282054,3.939726324876112,3.7227021779577907
Panc 04.03,11485656,3.4698409381110435,2.60978629318054
NCI-H522,24772860,-1.6489481573528793,-1.646868961588337
NOMO-1,136227331,3.913043208951298,3.0748345207194903
FU-OV-1,984333,0.3323688812243723,0.8552838023200583
LoVo,9911463,2.8816718818913176,3.8738551425669407
NCI-H661,6917907,-5.078778116905793,-4.918212647769919
SNU-81,25102847,1.5499571993593506,2.0209297441119203
CAL-51,159324,3.1794720270506307,3.1661515063830636
A-673,122327,3.9666709409894527,4.41376735150268
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911,4.776170038005094
KMRC-1,2858523,3.233729541186922,2.9928436699303096
LOU-NH91,9823820,5.384931157369051,4.0955539342962455
NCI-H2171,5287969,-2.1635291246577286,-1.8662165233510963
A-673,426756,2.5032328390514365,3.708782095048857
HSC-4,24964624,2.5086826728272538,2.380315167681256
NCI-H1623,176870,0.1873243677029567,3.303598534779783
KMRC-1,7251185,3.109058235493882,2.411568864322046
NCI-H727,6610216,4.563405769903236,4.279496592092095
BxPC-3,15983966,-3.8778410742282694,-0.3540392266141223
G-401,46843906,1.9398273455018735,2.295901156834714
NCI-H661,126941,-5.16742432120375,-2.923083070221168
FU-OV-1,5746,2.910322472492285,1.2545647461033265
CAL-51,11609586,1.5077859423552509,2.9370573705538954
NCI-H292,navitoclax-birinapant (1-1 mol-mol),3.1013974556417825,1.7375812340211703
NCI-H1623,23582824,0.0165284592292431,0.9523631081255496
SNU-449,31703,3.0847938162993707,-0.27139288093555636
A2780,4788,4.492604658524488,5.332786656694319
Panc 04.03,25102847,3.783052108341051,2.7250693037408893
FTC-133,selumetinib-decitabine (4-1 mol-mol),6.596226241094775,3.8375734827225445
NCI-H522,5113032,5.82110442960573,4.693058397433752
KYSE-70,16038120,2.0286855638164054,0.7821360285988892
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544,3.022487045147465
JM-1,2828334,5.9839290329767945,5.541388182929196
G-401,16736978,0.7492323653316314,1.7597686104707477
CAL-51,107970,2.299284460939792,2.272769454870666
NCI-H522,carboplatin-etoposide (40-17 mol-mol),3.969229835066765,2.1123453053882706
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007,3.0551153722325943
NCI-H460,51039095,3.9314979002332535,2.6578076948770915
MDA-MB-157,9903786,1.458865596348786,3.0381195363112714
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127,2.557015905584622
Panc 04.03,54678924,3.3151598744761626,2.3219659245689757
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012,-1.0813966753231379
ONS-76,25195348,3.7356955751438754,3.4176791988095165
MSTO-211H,71466578,5.31450298723974,4.693327020872456
CA46,crizotinib-PLX-4032 (2-1 mol-mol),1.0865859048820203,0.9536360660201312
LOU-NH91,10385095,0.9698085069900604,1.6029086488702553
FTC-133,24856436,2.183528137346661,0.5008828772848715
A2780,54613361,-2.0737031658574043,-0.28563977380951333
CAL-51,5311,1.4183219405835503,1.354822172658348
NCI-H522,51037431,4.989409718658752,3.1622742777899915
Panc 04.03,11647372,2.0191280123179824,1.6551079304634235
NCI-H727,327653,3.8552398443183193,3.2271026736005073
OPM-2,9884685,-0.7869928949425254,-0.4833396118760032
BT-549,676352,1.8104954024890367,2.164934600332907
CAL-51,46907787,3.297361866649883,2.3283633608899
EFO-27,11494412,4.723849828867172,2.0105978905904083
A2780,60700,-2.20534635529039,-1.3266992759713663
A-673,5281321,-1.2857978730590742,-2.0754545068705106
NCI-H522,navitoclax-birinapant (1-1 mol-mol),2.79987001717094,0.9564413658061826
NCI-H661,6610216,4.875851858170822,4.2013314058345115
NCI-H460,6917907,-4.956095121428261,-4.509510538876197
A4/Fukuda,5460769,3.0365194168079572,2.138515216253253
BxPC-3,3025944,3.477531707151509,4.2877601968944585
CAL-51,16065773,2.8749329306977853,2.309677052001353
SBC-5,navitoclax-piperlongumine (1-1 mol-mol),3.0140004933884796,1.9897445363434507
EFO-27,2874250,5.869363689503336,4.458622504357632
A-673,702558,2.7000584853196936,4.479356789153541
HCC1143,107985,-3.4652614368177432,-3.6704319690872387
SNU-81,navitoclax-piperlongumine (1-1 mol-mol),0.0853232254018234,1.2009392633241323
NCI-H522,3025986,-1.0139106356663683,-0.938559158523772
NCI-H2171,439501,-3.0635131055453924,-2.2945971003871333
NCI-H522,444795,5.191031194563041,3.7894117272792234
NCI-H661,53392493,2.28152765608909,2.5936080066138323
Panc 04.03,445643,3.9306423242452673,4.0649119912282865
NCI-H727,selumetinib-piperlongumine (8-1 mol-mol),-1.6426158910123243,3.040374197203891
NCI-H292,25150857,2.3048085705836563,2.6977221785688
NCI-H727,25126798,3.836281743476004,3.9158422890066924
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416,5.006848729176884
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187,-0.5614740561805773
ONS-76,9887053,4.335145594020597,4.086562776311253
OPM-2,675434,4.053836549963459,4.086527042819845
KMRC-1,16725315,5.238650021868635,3.9002802455301473
SNU-449,piperlongumine-MST-312 (1-1 mol-mol),1.362794205944183,2.0159110600420562
A4/Fukuda,151289,0.1986917338936865,0.7293927042387103
SNU-449,ISOX-bortezomib (250-1 mol-mol),2.1712489431250437,0.8630107763134508
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291,0.8463604549380443
CA46,selumetinib-UNC0638 (4-1 mol-mol),4.090188755292698,2.5633060265703183
MDA-MB-453,56963564,1.2952259038449256,1.1211446080168488
NCI-H522,65064,5.303150406450188,4.685606164895936
NCI-H2171,24772860,-3.209318985857815,-2.121613633944504
KMRC-1,104842,1.0931359128213904,-2.461050486080928
NCI-H460,16741245,2.175171044948558,3.813762437549562
OVISE,4259181,0.909929291036465,0.4720139567844659
HSC-4,46191454,1.405754738797376,1.6525947360198578
KYSE-70,2749,2.2442090130660577,2.009012509303407
SNU-81,400769,-1.1944669265215293,-0.518435847204349
NCI-H2009,6852167,1.9075911063810396,3.072338101909395
SBC-5,241158,4.402731015442316,3.83026981056922
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236,1.085415097050607
HSC-4,44185566,3.0805483382503844,2.59700730087429
FU-OV-1,17755052,0.0450390211671309,2.072031447950324
KMRC-1,53495165,5.726132279462146,0.4222609735685376
NCI-H146,6184667,1.5836777358218528,3.009081079633904
NCI-H1623,selumetinib-MK-2206 (8-1 mol-mol),1.9939850846524236,2.1645524234846225
HCC1143,55283,3.9101720152241226,2.800401979567841
OPM-2,71466445,2.165442844786418,2.2034233436309716
A2780,49867926,3.0666746223408157,3.698745513484442
LOU-NH91,17755052,2.4120102833965844,2.271591156286749
MDA-MB-453,49867926,4.180155964726801,4.0662761495417605
Panc 04.03,25183872,0.1973991794911014,-0.6172004782747106
CAL-51,9967941,3.511576456928413,3.6416336932445232
SBC-5,6852167,3.965917526242172,2.804807153708408
NCI-H292,navitoclax-gemcitabine (1-1 mol-mol),-2.2738254252186314,-0.5868405680728417
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294,2.8883786102865496
NCI-H522,54596558,4.342696772784201,4.462874882679255
HSC-4,2733526,3.5101027459294425,3.827780011023854
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981,5.139933387897927
OVISE,decitabine-navitoclax (2-1 mol-mol),0.3462958100091469,1.25232723681998
MDA-MB-453,4477,-0.2020943624975227,0.4547844354664667
NCI-H2171,72193861,0.5955631718249997,0.4647292536257481
NCI-H292,2828334,6.458495810735601,6.276784275138272
ONS-76,7326481,1.79748139254514,2.9576752763621488
A-673,44607531,1.457749077960986,1.210265556704268
NOMO-1,73707438,4.2876330596581305,3.983631042868362
NCI-H460,60750,-0.8382921927225392,-1.9549154900811223
NCI-H522,4259181,-0.2456063667287351,-0.09828594399285556
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366,1.3222951351489778
ONS-76,969516,2.910086136195903,2.9518258988578396
YAPC,49850262,3.6789282041181095,3.833402772523024
SNU-449,44491742,3.9284370838515903,4.3993614616074055
MDA-MB-453,11485656,1.765591398344026,2.367988484801588
NCI-H460,44607530,3.4043015144880444,2.1665501069189586
OPM-2,56949517,5.349058842742104,3.6967489255655015
SBC-5,216239,1.5582588949606833,2.4116703888279885
NCI-H661,219104,3.9372744940630646,3.6089752102319057
NCI-H460,44484440,3.757520830720006,3.569790624568958
MDA-MB-453,44462760,5.00879187339522,3.78029189604271
ONS-76,5281321,-1.2480266745690851,-1.2972687165740246
LOU-NH91,5566,3.288881685822646,3.162091185163062
MSTO-211H,72193861,1.6065459514404858,1.669938507428259
NCI-H1623,16038120,-0.158474112921266,1.0362160482550251
BxPC-3,11238147,1.751681691561693,2.7993799131825585
YAPC,3025944,4.720838189364642,4.229162724858413
SNU-61,1239801,4.195034605110225,3.7212530189225395
NCI-H522,11640390,4.472705990017258,3.164690970173764
OPM-2,11238147,3.2386204402735874,2.035481393554528
YAPC,16722836,1.8948218470527252,1.7559059813227318
MSTO-211H,4261,1.9115438043118669,1.9970374829898077
BxPC-3,24901704,3.2492386456059266,3.5329993183034203
A2780,2742550,2.799223861459344,3.4300017253980952
LoVo,6918736,-4.296362304597629,-1.1879074491820725
NCI-H292,3854666,3.3764205876154074,2.519633745928365
G-401,11222830,1.5347756238466792,1.322076566621117
CAL-51,44620216,5.469091994130916,3.885771224790643
NCI-H146,6918328,-4.616864565737749,-0.7164134497490042
SNU-449,100016,6.350050439021361,6.445611777050193
CAL-51,6438330,3.884194225982375,2.1010547993443844
A4/Fukuda,451668,-0.3897468918932548,0.4158088657074704
NOMO-1,135875424,3.068632733482165,3.2081361958491033
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148,2.4151773683816327
MDA-MB-453,9907093,5.353373126975176,4.0427790022292465
SNU-81,11404337,-1.7380856142345846,-0.3169763141879093
BT-549,3634881,2.142843752657143,3.3804034184821914
SW1463,6918837,-3.406571913442127,-3.183019354949289
HSC-4,6610216,4.241818899552939,4.240473929885373
G-401,135421197,1.4306754302223277,1.5478685622206052
MSTO-211H,400769,-2.118881346037636,-0.3865526167991736
OPM-2,56946209,-6.715247823396851,-5.131742838825464
OPM-2,156414,0.898749748032719,0.8157068084902042
SCC-9,2708,5.420316309291021,5.1006617854742045
BxPC-3,72376,-2.7426383250741786,-1.9033484483297385
LXF 289,44607530,1.309750089611443,1.8885132563369598
A4/Fukuda,216468,0.7779788317268376,1.3248789618161123
ONS-76,9936388,2.029236983033262,-0.8481777316446549
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383,0.3426395740848869
A4/Fukuda,15953870,2.701018205920996,3.0191234997869962
A4/Fukuda,3825829,2.918538307685252,3.513573826664236
NCI-H522,1716436,2.601362471636894,2.9041516520405266
NCI-H460,16725315,5.407057101640495,4.342828899747371
NCI-H661,969516,2.7370069869182996,2.954986096633791
SNU-449,9915743,1.6643053553641087,1.388466833136485
NCI-H522,16219061,2.1788816492377054,2.520113461819107
NCI-H1623,25126798,4.062693377799547,3.8541730675439037
LoVo,46199207,2.62459096292295,3.1171074936977767
Panc 04.03,2126,5.406308275886939,4.778400479785592
NCI-H522,702558,5.065903257418961,4.56762162558022
NCI-H661,44489675,4.0470438340050086,3.9352745011256776
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975,4.955140949712413
CAL-51,11175137,1.2330676481368064,2.6276333362979614
EFO-27,tanespimycin-gemcitabine (1-1 mol-mol),1.7387659506719169,-0.7566430334209504
A-498,119607,5.756544485429512,5.263828027700847
CAL-51,89183176,3.8950338695454088,4.556353165792258
FTC-133,2828334,5.859070513237425,6.104752647055915
KMRC-1,135440466,2.425894917183188,2.231775190717499
NCI-H2009,36314,-5.253596358515139,-1.2453398616601308
G-401,11238147,2.0802759078276853,2.548390702510445
NCI-H661,452548,0.003417557634082,0.3426530915407885
NCI-H292,5282054,4.085287507740134,3.934303948420057
HCC1143,10385095,1.0799280769088206,1.5820561463146796
A4/Fukuda,11626560,-1.03034976821798,1.031621662440019
FTC-133,65064,5.375666939367713,5.092543087807075
BT-549,753704,4.958873098850826,4.994726008720908
KYSE-70,46224516,2.993089177283032,2.3891515131501757
CA46,11707110,2.876405562319207,0.4932017011915233
LXF 289,11609586,2.9430338892136354,3.090609131959736
KYSE-70,10296883,3.691258417269261,3.7095566154649675
A2780,tanespimycin-gemcitabine (1-1 mol-mol),-1.0115297721833665,-1.993235144928098
DMS 273,67156097,-2.1294955352549,-1.7680606853166707
NCI-H2171,11955716,-2.5749004703466976,-1.7383187887466158
LOU-NH91,124202324,3.0671378719618283,2.9208979523523366
A2780,135659046,3.385733838662662,3.45971323554223
OPM-2,11427553,0.184758700497643,1.355420671254064
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377,3.193747788824771
OVISE,11427553,3.886061021243629,2.8233698412880077
A2780,24821094,2.7975033336102095,2.9244858002999483
LoVo,10410894,2.092646303934145,3.315197676966126
CA46,327653,2.398308016277815,2.447140506352918
NCI-H522,135440466,2.851321997265629,2.278754110451112
NCI-H661,9903786,4.646166413465223,2.9135022604759797
ONS-76,docetaxel-tanespimycin (2-1 mol-mol),-1.0307664921769042,-2.4077242645113586
CA46,11427553,1.0834968953052575,1.1485515940336088
Panc 04.03,6450551,3.8538949310121353,3.2466927765880285
A2780,644241,1.9281614760038184,1.239124231879471
A2780,3815108,2.053113262637462,2.5419061993682357
NOMO-1,71466380,3.4384411266907295,3.8838959578678414
EFO-27,serdemetan-SCH-529074 (1-1 mol-mol),3.002804413616897,2.3413271881543736
A4/Fukuda,24821094,2.016569070962388,2.815368403659428
LoVo,3503,2.2987332704820016,2.4126481703187035
LXF 289,46398810,1.8383298322371264,2.6456716123402186
NCI-H146,42642645,1.3339409860624971,0.7297838055734331
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408,-1.9661265778804777
HCC1143,135984461,4.873829103860087,3.9528209095222
LoVo,23725625,5.102020281972671,5.186822166723124
NCI-H2171,4477,0.0540600744484099,0.5433315489081783
Panc 04.03,24964624,3.127575767188385,2.6803184463159937
CA46,676352,1.5563040092860552,1.70253211529346
ONS-76,135440466,2.234484066901876,2.1984928316046988
EFO-27,31703,1.037291503873681,-0.48203828212136285
MDA-MB-157,208908,2.741119640746793,1.9323851328782369
G-401,46191454,0.141864729037356,0.9351628091193926
LoVo,439501,-1.7683171506776545,-2.185950633170975
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813,3.329633763223056
A-498,36314,4.095863504824457,0.12990923966015536
G-401,ISOX-bortezomib (250-1 mol-mol),0.1394395041296586,0.2699362774071455
NCI-H727,9935249,3.73205967923935,3.161931249864024
KYSE-70,53392493,3.454381994737171,2.6731574216299596
HCC1143,11234052,5.229903952882612,4.229430812200004
CAL-51,4705,2.903463840875761,3.0180200616192643
MDA-MB-157,56946209,-3.6171244608990905,-3.6820933105086486
LoVo,3689413,-0.0015328635235731,0.016354116366529017
NCI-H460,46199207,3.5033257005335163,3.257078897385765
BxPC-3,135411,0.8341107494370649,0.5724768569155977
NCI-H727,46191454,2.1799448668848105,1.955406341925956
OPM-2,25195348,0.9238255530721258,2.5589687656866658
SNU-61,JQ-1-UNC0638 (2-1 mol-mol),2.3060253857026343,1.155380657652106
SNU-61,656346,0.8749051442535513,0.7223003731960942
JM-1,136227924,1.2038413750130548,2.065276987777506
SNU-449,49867930,4.864159132996777,4.7769773146597565
A2780,2733526,2.8794725769531997,3.5962243058168126
OVISE,23725625,5.908959950408421,5.0957994737820345
BxPC-3,60700,-0.122761385712052,-0.43621391191481435
OPM-2,53495165,-4.146839218250571,-1.9783116210157285
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497,0.9647662753596616
A-673,25227462,-5.829932006274449,-0.0441784077254684
KMRC-1,6918328,0.9635513821249304,-0.08525284435623215
JM-1,89183176,3.1890961462334335,3.0203908374594284
MSTO-211H,16038120,0.2471942161915729,1.1355657341473882
JM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.175928698896838,3.6742047613326547
ONS-76,6918878,5.0214366982824306,2.4689340198619925
CA46,60750,-0.9269398092944348,-3.9803012225226784
HCC1143,42642645,1.0566197638440329,0.7806212139295441
OPM-2,3503,1.0860674816661569,1.866090548708503
BxPC-3,11612883,2.2063280154469993,2.799416112721658
NCI-H522,16065773,1.5488087432962436,2.2615789467526675
A-673,3634881,3.109333818891092,2.8479514219330753
NCI-H2171,71466445,1.378191899492029,2.7335050929044633
SNU-81,JQ-1-UNC0638 (2-1 mol-mol),0.4433096898383019,1.2727799577400667
NCI-H292,17755052,1.3393568867062529,2.007909879016951
NCI-H522,11427553,1.733163384028149,2.2589402487249215
G-401,selumetinib-JQ-1 (4-1 mol-mol),0.629673615073819,1.3870992682637833
BT-549,24797083,1.6394182791354686,1.474549918599736
OVISE,6438330,2.2515103089504818,2.359773910297908
LXF 289,10410894,3.939992216810496,3.4836800073799568
EFO-27,60750,5.390319994108079,-1.207688321148781
BT-549,400769,-1.1296625579443007,-0.3014437223101249
SCC-9,2742550,4.1692460597635135,3.9366686565385307
JM-1,5281321,-3.43257780081901,-2.450557867665945
OVISE,24771867,1.656692666128474,2.6654107876835
SBC-5,3384730,0.0954837515635063,2.948990336223549
BT-549,navitoclax-sorafenib (1-1 mol-mol),3.9279804703061703,2.04663385792203
A4/Fukuda,2749,1.141581020051295,1.0181376575124608
G-401,1716436,2.4290804430946547,2.8530248531121822
NCI-H2009,23635314,-2.363129056883172,-1.8459690449552968
SNU-449,3081361,2.056588488576824,2.524180828283204
NCI-H522,969516,2.4900188230240485,2.8191380547191245
MDA-MB-157,11626560,3.460415978238755,1.7583017457954382
NCI-H292,selumetinib-UNC0638 (4-1 mol-mol),2.5678319047053244,3.5084025101901886
HSC-4,11719255,4.924721636143113,3.6609644878489522
KYSE-70,17755052,0.9465092626724514,1.7040537811201393
G-401,25062766,0.8725390828623283,1.947259656546842
KMRC-1,4477,0.198014478122684,0.7322241746766552
SNU-81,44197249,-2.185783961489413,3.1690619291197226
A-673,10410894,2.502904420433103,3.193675250661071
ONS-76,6914657,-4.101072641720643,-3.617635202813101
MDA-MB-157,53495165,-1.8622859982145463,0.578427907676573
Panc 04.03,72734382,5.165438336919353,4.821707725921025
FU-OV-1,navitoclax-pluripotin (1-1 mol-mol),-0.2689466648852067,-0.7661099260796815
CA46,613000,1.1767209163070167,2.429669222432577
EFO-27,3503,2.721888959468924,2.481449631417736
SNU-81,decitabine-navitoclax (2-1 mol-mol),0.903824446896739,1.4934639088895676
MSTO-211H,6917907,-6.416473568686441,-4.8235414255094256
CAL-51,675434,4.354107922133551,4.568692677435534
CA46,5278396,3.312720557512005,2.9022891471565804
FU-OV-1,9911463,4.1305925074662575,3.9153088899964756
DMS 273,5328940,1.9629216769229116,1.6797463722272419
LXF 289,54454,1.7599180903835134,2.6383042308037137
A2780,446155,3.1527811730433366,2.4630875050731387
CA46,11222830,0.90552754986452,1.0101573514562165
MDA-MB-157,15547703,2.7177027433879912,3.2460082694439945
A-673,9915743,0.6829950735134661,1.014153501301639
Panc 04.03,50905018,4.96616490546014,4.312453478294109
NCI-H146,50905018,3.857703749758686,3.997475664784586
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596,0.2688317225507995
CA46,148198,-5.7845042531785,-4.111353803002438
BxPC-3,11427553,2.964396595429347,2.8943620624699444
JM-1,17755052,1.8568486472237824,0.30048501664298555
MDA-MB-453,135875424,2.7753375231350104,3.74362672196586
LoVo,52947716,-5.666189039665748,-0.24966907788391246
SNU-81,3543504,4.205084802754879,3.9294573881575205
CAL-51,9887053,4.486783389261201,3.9317953498530973
YAPC,SNX-2112-bortezomib (250-1 mol-mol),0.1222425985645655,-1.0328957723767984
FTC-133,6852167,4.78859095347106,2.883316317521787
SBC-5,46907787,3.799315463541784,2.1407232855383524
SNU-449,6918638,1.2557717528626495,0.8043028534421849
NCI-H2171,6438330,1.125878118169246,1.5148425913790147
ONS-76,15953870,3.841628876209717,3.6916224047775987
KYSE-70,44493528,4.735176242945038,4.386503195784426
BT-549,71751553,4.2471267374516435,4.710074452507928
NCI-H2171,46943432,3.4065574915710735,1.5851466795501634
SNU-61,carboplatin-UNC0638 (2-1 mol-mol),3.8198655410363287,3.438247168135375
A4/Fukuda,135875424,2.943838777845953,3.2817292651447354
SCC-9,25154868,5.2906536290113975,4.500578365943706
A4/Fukuda,11964036,-0.0142982917472374,0.5424269941559299
NCI-H292,10302451,3.577296661602114,3.047482120086341
A2780,135999136,1.5930192405329104,3.124271998805611
NCI-H292,54618164,4.184972812062346,4.157989094583078
LXF 289,107985,-2.691798131563437,-3.3358366673896165
NCI-H522,44137675,3.8599044567005434,3.5486317297722674
CAL-51,3503,3.2899889427654245,2.2985024222093164
A2780,409805,4.989244714218352,4.253557240961606
HSC-4,71466380,3.6804948915169784,4.566465640297463
JM-1,6918638,-1.945896791217812,-0.9499692790501679
SNU-449,44566777,0.6479277578392284,0.7116134314942354
MSTO-211H,387447,-3.4382078488280063,-3.983108786924078
DMS 273,9915743,1.912374780622189,1.0282961027827715
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022,1.0697603691469462
NCI-H661,16736978,1.5408428303752983,1.8790587535769787
MSTO-211H,44241473,3.911097970359605,4.872092017937366
NCI-H460,60700,-0.2314807684970784,-0.3084830987774822
A2780,serdemetan-SCH-529074 (1-1 mol-mol),0.9740349619499052,1.7017249415344506
JM-1,227681,1.6891640861629382,2.4620302833476186
G-401,JQ-1-navitoclax (2-1 mol-mol),-0.4060053682032895,0.2898135364818816
NCI-H661,656346,0.6919490200967222,1.3626357530282809
SW1463,5311,0.7635678260369684,1.2051900291858273
NCI-H460,387447,-2.436463262555682,-4.055833076086757
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113,0.8233480764035561
HSC-4,9825149,2.985341504866837,2.190436934505369
NCI-H727,25262965,0.7692581364380534,-0.9535639132394057
A2780,10077130,2.5506457702723786,2.6775268995714527
BT-549,selumetinib-JQ-1 (4-1 mol-mol),3.8001526734522617,2.120009476559008
NCI-H661,136227924,2.7818959309662183,3.0440978639341876
SCC-9,446155,1.3937663931747788,2.8190414806310535
BT-549,73707398,1.468839183930599,1.5281416989001182
A-498,navitoclax-PLX-4032 (1-1 mol-mol),0.6341402769109122,2.1808869080626017
CAL-51,6623618,2.223133904662847,2.4771386749698685
LOU-NH91,327653,3.620861790086289,3.357387353575649
BT-549,67291369,4.3793706620025095,3.5858560448244576
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716,-2.973495260662552
NCI-H460,3025986,0.3909368316008428,-0.982058054922125
Panc 04.03,11228183,3.2874901590346934,2.8184842170372364
LoVo,25262965,-3.8912736240644694,-1.6924317906778668
SBC-5,73707398,1.6541333685248465,1.2754633225198975
NCI-H661,89183176,4.289155461605826,4.5319967137839345
G-401,44241473,4.28251451131172,4.609269954345942
BT-549,2746,3.8188337512891137,3.476611665072994
YAPC,25062766,2.237282024435701,2.417207066569531
LXF 289,20959075,-2.4089188058085,-2.6718870744038763
SCC-9,53232,2.1606412524830017,2.9918209890651606
G-401,56649450,1.8227428945555348,3.1160600636930287
MSTO-211H,11222830,1.162959487763126,1.731726536120928
JM-1,15953870,2.1778700018066144,2.80616392906706
LoVo,15953870,2.9352023189332703,3.453726237110379
DMS 273,15953870,3.8128904638275216,3.4938685369056777
G-401,JQ-1-vorinostat (2-1 mol-mol),-0.8769966942019048,0.6157107216185171
CAL-51,1750826,-0.4147302595408071,-1.2322177449981424
NCI-H522,9884685,0.1045560296672991,0.026959681352964004
HSC-4,327653,3.5197711195347434,3.2817370005190605
BxPC-3,6918328,-0.2318480121478282,0.012928104929149238
NCI-H661,10074640,2.974634579766932,3.2628870397153964
FTC-133,11178236,-4.398882676695501,-3.227431519695944
CAL-51,6450551,1.9748462748620472,2.7090053281903903
NCI-H522,SNX-2112-bortezomib (250-1 mol-mol),-2.0311318982301665,-1.214543416304169
SCC-9,5978,-3.875351555062552,-1.94172483570991
LOU-NH91,5311,1.697115177859265,1.7875835791195345
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876,3.643799771174656
A4/Fukuda,49766530,-0.1813275565198268,-1.977654685499317
CA46,5978,-7.34958411963843,-4.043348381369446
JM-1,15547703,2.5122126082355227,2.494157795724473
HSC-4,3038522,3.958216901800584,2.9502922200616815
MDA-MB-453,24901704,3.2296574944609735,3.2394626274699374
SCC-9,23635314,-1.650613607792241,-1.7187043744632118
KMRC-1,11612883,3.608500084904783,2.519358814532423
OVISE,24772860,-1.0102375693918164,-1.736593102086263
A2780,11626560,0.43489025720173,1.322175577396415
MDA-MB-453,51037431,1.3361098813185686,3.260068435191853
HSC-4,4705,3.95336427523857,2.863057996198525
A4/Fukuda,24748573,1.3032837048402657,1.6877216520354745
OPM-2,51039095,-2.6866952618976434,1.9268035270288095
KMRC-1,11609586,2.4412406506497155,2.785842158532331
ONS-76,11609586,3.485979398565755,2.821218881354271
LoVo,12003241,-2.8621949377385465,-0.7565452245716231
DMS 273,241158,3.177272786345067,2.9737758277354063
KYSE-70,20959075,-2.927604227069557,-2.5727798675259157
SNU-61,16722836,1.3959733890222568,1.4997410755777438
SBC-5,89928392,2.3719311856170537,1.719229748295823
CAL-51,decitabine-navitoclax (2-1 mol-mol),4.2164288882213,1.7993804007229917
A-498,4261,1.667462132250413,1.9099915577060094
SNU-449,23725625,6.429990861305722,5.289147664425439
A2780,4259181,-1.27299012623329,-0.2558929321343004
ONS-76,10127622,-2.1347139098699706,3.257258051716946
A2780,1641662,2.3828094640764412,3.2064364426918597
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891,2.2146014290002847
Panc 04.03,9549297,5.2530677537073975,2.54019526046102
MDA-MB-453,53481919,3.1180191774885735,3.7599311527892825
JM-1,56963564,0.0249959117693502,-0.23327872308000677
HSC-4,11234052,4.4583786214563865,4.231044058561582
A-498,SNX-2112-bortezomib (250-1 mol-mol),0.1538165542627618,-0.7484763995502529
BxPC-3,119607,5.22613990212802,5.441212604536743
BxPC-3,5278396,2.866816315326302,3.6598903168739723
LOU-NH91,400769,-0.4518117512524929,-0.233324122171786
A-673,doxorubicin-navitoclax (2-1 mol-mol),-4.20921708976932,-1.9983727139378005
FU-OV-1,16722836,-0.0099462763207794,1.9285412747299795
SNU-449,46907787,4.480861537403045,2.6795872098664764
NCI-H292,24748573,1.9235457900331792,2.478737742859723
NCI-H460,2113511,6.407699041859446,5.770252062331801
HCC1143,selumetinib-UNC0638 (4-1 mol-mol),1.3639730576271398,3.3402993741109865
NCI-H1623,46174525,4.205988468269685,4.4267438015605185
NCI-H1623,6917907,-5.728045829659389,-4.970571990376008
MDA-MB-453,1641662,3.085427143962118,3.5514605285145775
NOMO-1,3854666,1.0231806307237967,0.5812563959984687
SNU-449,24821094,1.9429996101140543,3.3473406099362815
SNU-449,crizotinib-PLX-4032 (2-1 mol-mol),2.114422576149497,2.13168331449633
Panc 04.03,216345,4.594435961426402,4.117398504057295
DMS 273,2708,4.711982190259564,3.727842355265527
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309,1.0650072930094256
A-673,11222830,1.3107049031534492,1.2372310158792004
SCC-9,219104,4.323236898621614,3.9693166926182397
KYSE-70,11455910,0.6771697782379181,1.3941155449281093
MSTO-211H,9915743,-1.0722844498490078,1.5815356070144413
HCC1143,3062316,0.306898118520016,1.0698271019696293
NCI-H460,11427553,3.3912724357702873,2.802129103371217
NCI-H1623,675434,4.403585448845777,4.524318967304005
NCI-H1623,135928012,3.849713333151309,4.347350944741364
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473,1.4802025652908803
LoVo,serdemetan-SCH-529074 (1-1 mol-mol),1.6319978332110785,2.168901593324905
KMRC-1,11222830,1.6210071273597368,1.6832338264133773
NCI-H661,44607530,1.6067743901515843,1.7110590137753428
HSC-4,24753719,5.996217074466553,4.369579388067149
NCI-H1623,44607530,0.6082825778474802,1.6937643334726424
G-401,409805,3.720272745750916,4.009951902367082
MSTO-211H,24771867,-1.256499005348058,2.740012984397594
LOU-NH91,100016,8.416108067142021,6.368019868541629
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652,-1.1480860393383308
MDA-MB-453,9911830,2.483477791354312,2.542406978834442
MSTO-211H,216345,2.6222222224733702,4.011209217276509
A-673,5738263,2.33182798743241,2.946473987857
NCI-H292,navitoclax-MST-312 (1-1 mol-mol),1.1730740558558932,1.1039200890873142
CAL-51,16038120,-0.248771562775031,0.817384064208539
SNU-449,11222830,1.6348775900621026,1.7008340594162075
SBC-5,11656518,1.8588197700646856,1.5028250759477801
LoVo,637858,1.5179613366947162,1.8483676901993027
OPM-2,16065773,1.0643824527623371,1.9213845051580771
LoVo,17759555,2.3197484044750905,3.480248181528969
LoVo,23635314,-2.3980395881052723,-1.2907845932309463
OVISE,241158,2.9923875981017134,3.8741356536107556
LXF 289,6918736,-2.4177135652368476,-1.39934022067849
NCI-H727,24180125,3.0565666249941015,3.015284231200855
HCC1143,72193861,2.4539335535877607,1.784833692719221
LXF 289,17755052,1.3903450452706496,2.0678241998270783
SNU-449,24797083,1.6612369643963127,1.469294752887659
A-673,9903786,1.5948741514342302,2.05466076577355
FU-OV-1,docetaxel-tanespimycin (2-1 mol-mol),1.25716738994227,-2.3550206279490196
SCC-9,3552672,2.2159119862051355,2.9263211681957495
G-401,9903786,2.8038927126182327,2.3804629163618927
CAL-51,36314,1.3238047725901672,-2.311682969950367
A2780,4917,2.608891014350475,2.9977440441081256
BT-549,446155,2.043062772915461,2.781745419083109
LOU-NH91,2828334,6.123728588021327,6.239359112761872
SCC-9,89928392,1.8759175792930969,1.8376930942968779
LXF 289,54613361,1.2100808209747431,0.2192593749427243
BT-549,navitoclax-pluripotin (1-1 mol-mol),-0.784652451279203,-0.6643521946528012
YAPC,4788,5.944205132488497,5.81354175203908
NCI-H661,11485656,2.0326011859644075,2.5219930045269017
A4/Fukuda,56649450,0.8497740308893211,2.6166894126221796
JM-1,151289,0.6364544108799082,0.3908742885040361
SNU-449,1566236,1.8764566240908545,2.457098198335429
NCI-H522,11234052,4.642717967560772,3.720593061388483
MDA-MB-453,262093,2.6969191096415113,2.7781034325457097
SNU-449,36314,1.881882754123643,-1.3008974540539495
FTC-133,3552672,1.929463221662531,2.777634762897922
DMS 273,44202524,0.9824733163321672,1.9230680878933755
CAL-51,2708,4.939881356462198,4.974292044146339
NCI-H661,doxorubicin-navitoclax (2-1 mol-mol),-1.1391297012173984,-1.1307408332874163
LOU-NH91,44507138,2.849532358816909,2.503174252340121
A4/Fukuda,24856436,-2.105951383298443,-0.2891133634386703
EFO-27,9967941,3.205966960393555,3.9616497068096446
NCI-H460,24964624,3.5490884182562565,2.443645770491396
A2780,71304818,1.3100858151797232,2.2049805492252865
LoVo,16065773,3.0239362353443195,2.3780036489091363
MDA-MB-157,19582717,3.2682056974125744,4.511928658957967
G-401,44607531,1.4405644617048554,1.2692772991633228
DMS 273,426756,5.171527401006451,3.991809975365717
A-673,selumetinib-MK-2206 (8-1 mol-mol),2.344238409661225,2.1026251124876896
A-673,3465537,3.0102553460613626,2.3676022408892656
KYSE-70,135398744,6.338938630156892,6.325301567517437
NCI-H727,439501,-2.2848783314382133,-2.0203463944875706
EFO-27,1750826,-2.462449966677767,-0.7243644382099559
NCI-H522,selumetinib-JQ-1 (4-1 mol-mol),1.1620563079754236,0.9231717704025735
NCI-H2171,15547703,3.4091207334536717,2.8897710753681265
BxPC-3,24753719,4.274594841538204,4.333631393610051
A2780,49846579,2.326369228321655,0.7173071795863564
KMRC-1,135398516,2.513650186922018,2.28566682584759
LXF 289,12001922,1.5738020993239468,1.984373180171926
OVISE,107985,-3.603598955800668,-3.44886251479387
FTC-133,crizotinib-PLX-4032 (2-1 mol-mol),3.9800326864083506,1.8802664342415778
MSTO-211H,51039095,-0.728954813106199,2.9479814102869364
MDA-MB-453,24856436,0.153871218683687,-0.022491770256469472
OVISE,12003241,-0.8183931153803442,-0.9670095678368675
JM-1,219104,1.4868441806857289,2.2375821151464494
KMRC-1,24901704,3.4724240700357414,2.8395291702264416
CAL-51,25105715,4.077363851334658,3.4004469341332113
Panc 04.03,5284616,3.514498334257777,2.7635389847138048
NCI-H2009,446155,3.3217785993510884,2.748464581886881
NCI-H1623,66577038,3.365380490578284,2.899375676726334
NCI-H460,72193861,2.1658883750752844,1.5470381002466136
NCI-H522,17755052,3.243909986839396,1.3710655640020324
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655,4.614350396866447
LoVo,9936388,-7.372990206557469,-1.0667399827406927
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742,0.6580280788230028
A2780,46907787,0.387414270491788,1.170162851851769
A-673,25150857,0.7583223763798244,1.9561153079404412
KYSE-70,11175137,2.267736133904179,2.70010248474379
KYSE-70,6852167,2.2981101713941814,2.7545946413496574
SNU-61,3081361,2.723820700669796,1.8650332546303312
NCI-H661,6252,2.9131036022991728,1.1748367321274995
NCI-H1623,9903786,3.0418604220511436,2.9420155270120576
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.6372009601302056
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782,1.0438746774105068
SNU-449,10322450,2.7236273289045942,4.121488984515609
LXF 289,4096211,2.4023988219433337,2.449165642946343
SNU-81,10026128,-0.7780702377310673,3.573364585221325
KYSE-70,6610216,4.087252338732691,4.130878303927114
MDA-MB-453,44607530,0.880863900568506,1.6136172432108211
NCI-H522,24978538,3.1859390482195216,0.9939134867062996
SBC-5,107970,3.247043743319875,2.2288217852791306
DMS 273,969516,2.584462316279732,2.574961085062197
MDA-MB-453,5284616,0.7898078062241378,1.1893388282357769
A2780,16720766,0.7344228111589829,-0.013296935156791796
OPM-2,25154868,3.783948059993976,4.14197594099314
DMS 273,44493528,4.2569430545307725,4.309985355716226
MDA-MB-157,25022340,3.479219964634342,3.0971767721217645
LOU-NH91,15547703,3.808438680736899,3.30351235440979
CA46,426756,4.77193452473935,3.5687366177010715
DMS 273,2858523,3.0502279484440233,3.027722442738368
EFO-27,3676137,4.310046032716647,4.60749919930072
MDA-MB-157,3025986,-1.856662168016076,-0.8928909386795063
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705,-0.48407893165972593
LOU-NH91,44607531,1.3180545967249335,1.6390409215334367
G-401,46215462,1.5390133747858452,1.484115007754983
OPM-2,7251185,0.5721351512480617,1.5276313456997952
CAL-51,15953870,3.220977372988981,3.3485806914480554
YAPC,11964036,3.221056153642411,1.5018101346469752
BxPC-3,208908,2.4547812946400502,2.0131430158266763
MDA-MB-157,44589607,1.2787513073565453,3.0009581823074996
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868,-0.36556657249165503
NCI-H727,72193861,2.684204612264405,1.6149856838075736
MDA-MB-453,5287969,-1.436813958809434,-1.8393757221321594
NCI-H727,15983966,2.109759483394555,-0.5313958401090332
KMRC-1,216468,4.973373200756221,2.973903646703068
SNU-449,52912189,4.380826008996873,2.5009058530550146
SCC-9,46174525,4.3512864598075645,4.381405645241532
A2780,3011155,5.55303778809739,2.950447838696891
SBC-5,135999136,5.333154079184271,3.7228859475536353
YAPC,322968,3.8135092450764656,3.785645355855814
SNU-449,vorinostat-navitoclax (4-1 mol-mol),2.197410731070427,1.543573546774063
NCI-H146,5328940,1.6811042727449883,1.6258936386064378
CAL-51,168313200,3.900876548563449,3.1160177257666946
DMS 273,1750826,-1.913269562568005,-2.720950818434916
A2780,54618305,3.781380565087532,4.347943225020074
NOMO-1,9936388,-6.523282887173488,-5.067255397624685
NCI-H460,5282054,4.802373462225767,3.828395176520849
SBC-5,82146,3.3774942308101785,3.9170744672564966
NCI-H727,56946209,-2.7175198163763232,-4.202219566494353
FTC-133,3062316,3.806169585149848,1.7153917494770388
A2780,9967941,1.4564169862408056,3.250192019732337
DMS 273,5351362,1.0025978169272032,1.0887139602879903
SCC-9,16038120,1.877705535955449,1.1740347276954555
NCI-H522,6917907,-6.015261010654924,-5.020364930225533
CA46,4477,-0.2706834990523855,0.3415512179892006
NCI-H661,erlotinib-PLX-4032 (2-1 mol-mol),2.455448460706525,3.212215924987273
SNU-449,11178236,-2.056078636199096,-3.568800713867613
SBC-5,5278396,3.3013936373431996,3.566210214129205
NCI-H1623,44493528,4.638812765070766,4.445356049673041
NOMO-1,16720766,-1.891739380903732,-0.8218473103144985
G-401,2729026,2.5705443446476828,2.361467625489883
G-401,6917907,-5.905222634362146,-5.449504392166666
MDA-MB-453,2858523,2.664825786894245,2.8352391438581552
CAL-51,navitoclax-piperlongumine (1-1 mol-mol),2.2643943730886944,1.779276540508454
LoVo,11427553,2.604805449600099,2.8846510672329044
G-401,11234052,3.7167035951130423,3.505669161696632
FU-OV-1,168312962,3.576057642182836,1.9226002596652167
JM-1,11228183,-0.9199972643114134,0.3213260031449845
ONS-76,65628,4.406189432641036,4.087292988941006
Panc 04.03,11964036,1.4501208375942458,1.5097998061603009
YAPC,17759555,4.434513834785858,3.5711551253079024
Panc 04.03,5311,1.931700632460216,1.7956097737545915
NCI-H522,tretinoin-carboplatin (2-1 mol-mol),5.2025586729101185,4.225718478336729
NOMO-1,49793307,-3.1091933140229,-4.099666311439526
MDA-MB-453,46174525,3.691895458218128,4.385833306052412
G-401,11977753,-3.640604480016117,-1.7528522425519941
A-673,16722836,0.9037523157925,1.169860207734704
MDA-MB-453,5494449,3.8003034085581993,2.5426589805696684
NCI-H522,25150857,1.47132219158847,2.151968931124554
OPM-2,5311037,3.4844810711382936,2.7572272810702594
LXF 289,11152667,-0.4789950074309144,-0.43316141371618255
CAL-51,9911830,2.6702149728757343,2.4383258489621435
KMRC-1,4378219,2.060133570967863,2.5427065414393577
SNU-61,navitoclax-sorafenib (1-1 mol-mol),1.8672566595023088,1.160511363414196
CAL-51,156414,1.13799157004995,1.631066159675359
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173,1.4759044862861848
NCI-H727,89928392,1.7873251449620886,1.6275602032881609
KYSE-70,6918837,-2.6267197721971582,-2.9095017165823567
JM-1,135928012,4.176764785732949,3.711848485598076
NCI-H522,10427712,4.202859541756615,3.911583034218795
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793,1.031521446631777
CA46,5470400,3.727677755196873,-0.232575588502329
KMRC-1,navitoclax-pluripotin (1-1 mol-mol),-0.6870292633838142,-0.7923690618419722
EFO-27,9936388,3.039710224097925,-0.18545176775664907
NCI-H292,54618771,0.019803014891406,1.1060359396843291
KYSE-70,25262965,-2.1035778811550836,-1.285227978622161
ONS-76,selumetinib-piperlongumine (8-1 mol-mol),-1.0642702210035522,2.7726433594365147
MDA-MB-453,11656518,1.9818038641727111,1.2021341965782175
YAPC,5282054,4.005772938817316,4.045190643707549
SNU-449,24180719,3.8016565421464072,3.8332010756308095
FU-OV-1,15983966,2.2280291717608947,-0.8878579441652156
SBC-5,11485656,2.2866280503579812,2.319860660168849
ONS-76,702558,5.821489397293988,5.030666844255692
SCC-9,9911463,4.4493328300482995,3.9498683275684656
HSC-4,72193861,2.788231918333871,1.7920340302623172
DMS 273,2126,4.20633218634453,3.845092665698145
OVISE,46199207,4.361349086507746,3.2153687577768864
Panc 04.03,241158,4.444137488799797,4.34930181838324
NCI-H460,654092,0.4612941847378306,-0.25190286453896077
A4/Fukuda,45279963,1.9027034071047564,3.101710096615167
NCI-H292,44259,1.4427392496176257,1.1213962599810738
FU-OV-1,17759555,4.190415677120393,3.702763865094027
SNU-81,3634881,2.620060882721275,3.0575691922398933
NCI-H2009,107970,2.2954238398166344,2.3871390649997886
LoVo,5278396,2.046108484267772,3.565744496885056
NCI-H146,vorinostat-navitoclax (4-1 mol-mol),-3.3112811386444525,0.13327158610004533
HCC1143,12003241,-0.0421467164139253,-0.8361150096017633
Panc 04.03,46926350,-3.8788763459733473,-3.9407450597445393
A4/Fukuda,4578,3.815086457915261,3.977390405133076
CAL-51,9929138,6.421072450841616,5.469326099624231
CA46,decitabine-navitoclax (2-1 mol-mol),3.2544479904294383,-0.833595561154601
SNU-81,4259181,-0.3131255720640173,-0.0010613572500795118
KYSE-70,675434,4.695192974207532,4.635057815548154
A2780,selumetinib-MK-2206 (8-1 mol-mol),0.1736531975308503,2.3327265186990926
A-673,135659046,3.595490040408381,3.494427768050995
NCI-H522,4578,4.727447650100284,4.250761517095473
DMS 273,54765302,4.301325739041371,4.051488089772715
A4/Fukuda,135440466,-0.9873079875011114,1.812314560160259
LXF 289,24821094,2.4128137194258215,3.2252807566260344
NCI-H460,5746,0.0249012606464236,1.3122663258938878
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195,1.3640545396700852
A-498,25062766,2.0793230877467166,2.3466899765168234
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058,3.0618199975408147
Panc 04.03,10127622,4.886231353649791,3.7561127558092102
G-401,57330099,4.350194890812272,4.238604211891246
NCI-H1623,168312962,4.13769742192025,2.1718548948162253
SBC-5,5566,3.1825236444892124,2.9440755051184584
Panc 04.03,9825149,3.055289787116955,2.3670432960756203
BT-549,11507802,2.533090965918468,1.75288496040707
OPM-2,5951923,4.162321290800766,3.4860842748748557
MDA-MB-453,salermide-PLX-4032 (12-1 mol-mol),3.8592412133005265,4.514682625159323
NOMO-1,9935249,2.770043096032674,1.4237894329335052
LOU-NH91,11640390,4.567382593568383,3.7574606429864925
MDA-MB-453,135440466,2.739035638886915,1.9506223653391848
HSC-4,644241,2.6183127396598262,2.503883302374934
MSTO-211H,17755052,-0.0733710656781619,2.3376698188010523
A-498,crizotinib-PLX-4032 (2-1 mol-mol),2.697469324317316,2.1244077817354032
BxPC-3,5281321,-1.5422365883768068,-0.9449957529139158
MSTO-211H,9444,4.1850544738080915,4.124112662002778
LoVo,17755052,-0.1303127354802701,1.463696078259514
KMRC-1,44137675,2.117874577310701,3.530275885674976
A4/Fukuda,9911463,2.417745886609146,3.3258671307501793
MSTO-211H,3101542,4.302130070317232,3.3072006572092936
NCI-H146,426756,4.36191990335561,4.089123208609208
Panc 04.03,44589607,3.8783822611027454,3.1130350182908955
G-401,24901704,2.2796887972749307,2.8341412984559002
MSTO-211H,285033,-3.2380358495287695,-1.8494833627447105
BxPC-3,452548,1.628130986083035,0.6556181950047504
SCC-9,9926054,1.898935947612019,2.063921154139247
MSTO-211H,1750826,-4.930051018535606,-1.3958793901993152
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101,0.45335019980858526
HSC-4,216345,4.5807127841732775,4.174526648031196
LOU-NH91,168312962,3.892175490150028,2.7440578930545634
MSTO-211H,53232,-0.5437095856797647,2.5078999551766774
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576,0.38756808860171105
EFO-27,5335621,6.264647611417884,4.594462332105269
CAL-51,1716436,3.275997904874087,3.046368161756046
NCI-H460,53232,3.485336782178725,2.635853516795014
MDA-MB-157,54454,1.950382699789776,2.6205297124607885
NCI-H292,44489367,4.492014578968512,4.663462210945776
KMRC-1,4521392,4.136909747869898,4.488107575924793
HCC1143,selumetinib-PLX-4032 (8-1 mol-mol),-0.2774552513051289,3.509044635819155
HSC-4,56649450,2.6853332826773144,3.295073591023923
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.6785222591223423
BT-549,9926054,1.9687680834705423,1.9983868086087524
SCC-9,9911830,2.3699428367857145,2.618554132783851
CAL-51,selumetinib-BRD-A02303741 (4-1 mol-mol),6.310844826141485,4.330274969790873
FU-OV-1,409805,4.026686349090877,5.149124233752133
BxPC-3,387447,-4.571753731996322,-3.9283173866441463
CA46,44486219,3.6158388001945463,3.815165325769021
EFO-27,135659046,3.7618075322397297,3.7588953347386624
NCI-H661,104842,-3.978937701952532,-2.979819681040142
SBC-5,16741245,1.694771238369721,4.066701188052843
FU-OV-1,676352,2.7826635655764473,2.154992018539233
CA46,969516,2.1845952347247306,2.2105602815496743
ONS-76,decitabine-navitoclax (2-1 mol-mol),2.571137533276933,2.0561586403028014
HCC1143,9825149,3.0211594258387486,2.266377120833719
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785,-0.6402710859343095
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935,1.8686113770309418
MDA-MB-453,selumetinib-UNC0638 (4-1 mol-mol),4.2655945403569815,2.7984411432679352
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272,1.960597975116482
MDA-MB-453,676352,1.703646310562033,1.7956816053149274
CAL-51,46191454,0.2698308836515951,2.019021008455034
Panc 04.03,9823820,5.907522872650916,4.235026961255494
SNU-81,44259,0.6272555485824429,1.102769078028158
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325,2.3747084576149784
EFO-27,445455,4.405247459654703,4.919058383936004
BT-549,11152667,-0.4620191787747055,-0.37968700729769367
HSC-4,23725625,4.12890848458229,5.152405088476497
BxPC-3,11640390,3.353927872983648,3.71778617958351
HCC1143,216468,1.9778651637296407,3.50638769680123
Panc 04.03,49766530,1.2448845141630578,0.028455219600740097
SCC-9,10427712,3.976850957625781,4.304205530823291
HCC1143,36462,4.303888689757339,2.1595976109566717
NCI-H460,262093,3.3627537421549314,3.062937365710293
SNU-61,56963564,0.6866306287041547,0.23240861991332618
SNU-449,2858523,3.0307383113048676,3.0063914951936717
KMRC-1,11214940,1.677559369833433,2.158682951739692
A2780,216239,1.3949646663017006,1.917082672571493
MDA-MB-157,89183176,3.472749903375588,4.306524934806893
NCI-H146,11152667,-0.8780602169524299,-0.6596362043606996
NCI-H460,9956119,4.485375019847723,3.837902501667214
CAL-51,vorinostat-carboplatin (1-1 mol-mol),3.249812174722343,3.384748606098871
A2780,BRD-A02303741-carboplatin (1-1 mol-mol),3.111500594060002,4.192854249671254
DMS 273,6450551,2.589238729256945,1.5353726181254441
NCI-H2171,5311281,0.8399284053106422,2.414027957496972
SNU-81,23635314,-3.737654632526069,-1.467036650983998
FTC-133,119182,-0.5312905210850081,-0.47720910321298277
A2780,656346,0.4231070640442763,0.8000389544011189
HSC-4,441298,2.8371907900438535,2.535372320748687
MDA-MB-157,285033,-2.194765851649468,-1.9872779252460424
JM-1,73707398,-0.8556338999048841,0.3637712884308717
JM-1,6852167,1.3157742507093588,1.4958878781066414
A2780,11364421,-5.7057574677584295,-3.1544525811864177
NCI-H522,54596490,4.410611853984333,4.356727520004036
NOMO-1,159324,1.6027654254866297,1.4237894329335052
A-673,107985,-4.827881226135439,-3.582660891231096
NCI-H460,piperlongumine-MST-312 (1-1 mol-mol),2.8290325142840036,1.9491254908417945
NCI-H661,5287620,-2.104840782561513,-2.0745781561588674
LOU-NH91,119182,4.180997641513534,-0.5183042176513881
SBC-5,10113978,4.162999994539472,3.0327023382099765
A-673,252682,5.861850244558702,6.58031760601998
NCI-H2171,5281321,-4.274427204887198,-1.9901993638220263
EFO-27,3854666,3.6632128701571194,2.4409051140825473
A-498,25154868,5.700321852894753,4.55687729363824
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652,1.346700652311251
CAL-51,31703,-2.726607914110417,-1.129962075317515
KMRC-1,9840324,5.892638074147807,5.693381037663446
BxPC-3,49850262,4.227475038244019,3.9617138195329242
JM-1,6450551,1.340572992486765,1.2077265310224587
KMRC-1,148124,2.1112012667960656,-1.15640289173587
MDA-MB-453,navitoclax-gemcitabine (1-1 mol-mol),-2.0425828682575684,-0.618454722037845
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528,-0.04708672289563221
NCI-H522,7326481,4.603358487226629,2.728271821607809
KMRC-1,3025944,4.220614757043024,4.276725770335579
EFO-27,9935249,3.352272124535396,3.2566936741492523
SNU-449,10296883,3.939630786750968,3.8526713117260756
A-673,42611257,3.360985567795572,3.1647022906357645
MDA-MB-453,156422,3.699160121301749,4.036222658347597
A4/Fukuda,89928392,-0.3543848103605003,0.7072646574472222
SNU-449,10385095,1.0986031812390589,1.343809408192984
HCC1143,6438330,1.6030228226948184,2.118538379625927
MDA-MB-453,3854666,1.8999840682298523,2.327428636256693
SCC-9,46191454,1.8170261878735936,1.8521427434160451
OPM-2,9825149,0.9763440152106764,1.3506827191974424
NCI-H661,vorinostat-carboplatin (1-1 mol-mol),2.835829919183064,3.1600783047383643
BxPC-3,25150857,2.298115585090939,2.6546471521210337
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033,2.5963886996815786
NCI-H2171,25227462,0.3993487036849301,-0.06911805425568229
JM-1,24748573,1.2692721555493711,1.545183878261419
EFO-27,selumetinib-navitoclax (8-1 mol-mol),4.865349283387626,2.2746140441568468
JM-1,doxorubicin-navitoclax (2-1 mol-mol),-4.099692246271054,-2.7851505937990244
KYSE-70,5281321,-0.9979352327108848,-1.1744803888483406
NCI-H460,11507802,2.848054270429628,1.743102940432159
SCC-9,4259181,1.940043087837339,0.6010625706633703
ONS-76,135421197,2.4329108516652775,2.1829490931943307
CAL-51,52947716,-4.729660133739893,-0.569542348030481
JM-1,123631,2.636256127990424,1.9203413202063486
HCC1143,1641662,3.4150871228937563,3.5538948372948282
NCI-H292,8515,4.694095877434875,4.008135900241651
SNU-449,71304818,1.9790204353457292,2.5986901948927255
A2780,5566,2.7251077604344696,3.0415165566425095
EFO-27,82146,5.16738023752069,4.113890740289282
NCI-H727,107985,-2.9799734550318204,-3.4645164756917284
CAL-51,446155,1.9002286289262065,2.7647328914794542
SNU-61,4378219,2.193359587578685,2.5407618728609065
NCI-H522,1641662,3.4912081270508293,3.148263915090366
FTC-133,44607530,3.0000417574370157,1.7836055701807538
A-673,448949,0.8158812974066569,1.7281878326367448
LOU-NH91,20959075,-3.4746906487579494,-2.820269189819143
SNU-449,5113032,5.017862259712187,4.991407539882954
NCI-H522,6450551,3.1458433056927295,1.7363099361363632
SNU-449,16659841,4.200866251374559,4.122739971384906
NCI-H460,409805,5.4278006548731295,5.2812001766153776
MSTO-211H,46943432,4.749068259324704,2.8426720985078835
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425,0.600531721015782
ONS-76,navitoclax-MST-312 (1-1 mol-mol),0.8596431807362984,1.0505322773644954
SCC-9,11455910,1.869884665357408,1.1978966124022026
Panc 04.03,613753,3.3040029053289772,3.4870293009642648
OPM-2,6918736,-1.006954953557461,-2.3178490040964674
A2780,3854666,-0.0414990172822217,1.1174442206694162
FTC-133,25183872,2.254027462535002,-0.46225542702346223
MDA-MB-157,387447,-4.079240132125457,-3.86068571444876
SNU-449,54618771,0.9697829427454708,1.5624162467124711
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866,1.3654315339319083
MDA-MB-157,72376,-2.1484578807410553,-1.4182518214293045
SBC-5,5287620,-1.4097460130546278,-1.9656585324245799
FU-OV-1,54649381,4.3760479468817675,4.003877082019373
NCI-H2009,26596,-1.5885219134108934,-0.5472393717566223
A-673,66577038,2.223533674143975,2.7876158270956513
SBC-5,6918878,2.928817535111611,2.984615833787608
OPM-2,11640390,0.8264429779628358,2.261547827626121
NCI-H460,3503,2.4668231300278154,2.413532921077618
SBC-5,156422,4.2102641448485345,4.089740012837127
ONS-76,216345,3.2166812322741043,3.7387098483803864
BT-549,15983966,-4.218963036377602,-1.0137382439962281
A4/Fukuda,3038522,1.5780319148667876,2.652229915553729
BT-549,23582824,0.5256314804740283,0.6357495628773144
NCI-H146,2871966,-2.058689249756004,0.3336655851532443
OVISE,17755052,3.2346427318945263,2.102889447513231
OVISE,44819697,-1.8576377458936848,-0.24768989649614448
SNU-449,46398810,3.267032406348896,2.7777504754209956
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727,2.9525043711000465
A2780,11228183,2.2113347222865123,1.0420491017051434
NCI-H1623,piperlongumine-MST-312 (1-1 mol-mol),2.715053183810439,2.0170145128986547
NCI-H661,tanespimycin-gemcitabine (1-1 mol-mol),-0.3480588357963589,-0.9367340619770904
SNU-81,46398810,0.3023493978041217,2.1168802802078455
KYSE-70,11152667,0.5949086715112851,-0.5403348730847196
LoVo,73707386,4.416344333605744,2.839276192185078
NCI-H522,5746,0.3558137383480795,0.9217495704433541
NCI-H460,135421197,3.2510260026522233,2.0701319283502113
MDA-MB-453,11507802,1.551744908234443,1.8726024929499225
A-673,4096211,1.8222389073608836,1.3884637187391702
NCI-H727,136227924,3.2179651731130585,3.0521617651921953
NCI-H460,16065773,2.454458456288103,2.6373339177592654
SNU-61,24901704,3.3171528895384115,2.827031879332462
NCI-H292,11612883,2.84187428422206,2.9824670217263645
NCI-H2171,9907093,4.086146580877247,3.7455292419338297
NCI-H522,3634881,3.092168984490579,2.942806127858976
G-401,9915743,0.7240748800691799,0.9570342225568096
SNU-61,46843906,2.645147040347038,2.4632477673622084
SNU-81,73707386,1.6277005390789234,2.6839537046718753
NCI-H1623,4261,0.4244365105903193,1.6322998050360429
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687,2.664334162626716
OVISE,1750826,-3.1689535405206715,-0.9962574833000483
OVISE,25183872,-0.2641805795712313,-0.4618306958875757
MDA-MB-157,753704,5.007751734334353,5.035889325771424
CAL-51,54618771,0.0049145289548569,1.4883232770095882
NCI-H661,25195348,2.4001868352132445,3.251290239313676
KMRC-1,3689413,-1.8207429228817171,-0.3614595653151774
HSC-4,650361,3.951915492066197,3.5851408395096285
KYSE-70,10427712,2.9549225300897977,4.2788997415419905
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842,0.8448952907720886
OPM-2,11717001,3.8340096164502135,3.743424019579083
NCI-H727,11214940,2.165075102098245,1.9088086780135165
KMRC-1,11404337,1.3121470144090095,0.07036711435635161
MDA-MB-453,24951314,-0.4314694021522904,1.1743858980574822
SCC-9,135398516,3.38372398158662,2.4221901361816096
KMRC-1,11977753,-0.1874629547163491,-1.7493048983367567
NCI-H2009,25062766,1.439977805675878,2.179243891378883
NCI-H2171,6918638,-1.5146784294865197,-0.21295524303410887
Panc 04.03,3081361,3.5741960453568464,2.5758800890345883
BxPC-3,73707398,1.0061551215696194,1.4822743483975394
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361,-0.6865269477511304
BT-549,11404337,-0.1293922368150601,-0.154848062533834
SCC-9,5281321,1.285660121438517,-0.8759035432766786
SNU-81,104842,-4.044454085478647,-2.687196040342095
CAL-51,6610216,4.7761200098267365,4.271859305689512
JM-1,9933475,1.5625695981291614,1.3377524583155356
NCI-H727,11485656,2.2939690780404423,2.3723187522798113
A2780,426756,4.623757394028108,4.047961586686236
A2780,5311,0.5155233924036543,1.1074317653772574
NCI-H146,11707110,3.3128142773805176,-0.40879102628117037
MDA-MB-157,11977753,-1.6055696025393866,-1.3562692279015687
A4/Fukuda,11494412,-1.359408079628026,0.5793100297335884
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097,1.267993558469828
LoVo,11977753,-2.85765012298846,-1.249178403729458
FU-OV-1,56963564,3.5833852081145836,0.7041833551711852
NOMO-1,375860,-0.5184264862355304,-0.6974482659659551
EFO-27,3136844,4.472321824110979,4.39049706716661
MDA-MB-157,selumetinib-BRD-A02303741 (4-1 mol-mol),5.186273377251054,3.9700469289258855
NCI-H292,168312962,3.5892294654935726,2.63565591864531
CAL-51,44607530,2.3415901962162855,1.860783213735781
EFO-27,2949965,3.1309950522818277,3.015516207882606
DMS 273,carboplatin-UNC0638 (2-1 mol-mol),3.439220302346012,3.3215768949016455
A4/Fukuda,12001922,1.2276815023009988,1.7168437172302717
CAL-51,24951314,1.3730048574034712,1.3475817205476963
A4/Fukuda,135928012,2.23734461349398,3.944145828316662
SNU-81,10127622,-3.2164123245129095,2.809934293905131
MDA-MB-157,navitoclax-PLX-4032 (1-1 mol-mol),-2.380477221349832,1.5960258196790713
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642,-0.46563361271555725
OPM-2,122327,3.690232587907526,4.11683451951463
NCI-H522,5329102,1.9502496806074603,1.571461645901001
NCI-H2171,9903786,1.7901794952315444,2.898867414951663
HCC1143,SNX-2112-bortezomib (250-1 mol-mol),-0.3762551319629964,-0.8095004384836693
YAPC,676352,2.46422610000008,2.2648568213504827
NCI-H292,44507138,1.692325111571909,2.5054559226421884
SNU-449,2945648,2.540265867455936,3.121635457550579
MDA-MB-157,navitoclax-gemcitabine (1-1 mol-mol),-2.3120540291625766,-1.0014492167642868
A-673,3136844,3.9161258830055736,3.9786988512414827
OPM-2,151289,0.8971834485048114,0.3598226720112097
LoVo,219104,3.1119995266948237,3.7528304251705964
NCI-H1623,9936388,-4.968103162812744,-0.6777736701134658
DMS 273,11485656,2.8704893197930272,2.02213249270603
LoVo,73707398,0.5951327141059009,1.340018643930379
NCI-H2009,135421197,1.5480281661357902,2.0968709514981962
NCI-H1623,409805,3.8984511674912943,5.015843137461396
CAL-51,1750826,-0.4147302595408071,-1.2322177449981424
MDA-MB-453,54143018,-0.7571444922765344,1.2429260787625718
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203,-0.8785467012744789
HSC-4,54619267,4.093335991980471,4.200898493915171
BxPC-3,4378219,2.0321108717651426,2.5365009231176114
NCI-H292,5978,-1.7096488796134024,-1.7834560191976658
A2780,71466380,3.7792629508428783,4.25656284718318
MSTO-211H,44589607,1.2735087838172758,3.226802914916082
NOMO-1,54143018,-1.1216489579847602,-0.6833461397441399
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857,-1.0290436784696666
A-673,46174525,2.7075701285598375,3.4773562046410524
NCI-H661,3854666,2.0669995151297633,1.9278310008265078
NCI-H1623,322968,2.7878661836218863,4.04431413770796
Panc 04.03,52947716,3.0713971775620448,0.26976558134912093
DMS 273,9840324,6.645778367521572,5.449742809123812
NCI-H460,15547703,4.965379127843483,3.122930008600099
FTC-133,11228183,0.2445093238012437,2.364168015255579
NCI-H522,9935249,3.002706281912375,2.305634447533199
NOMO-1,6610216,4.0700997553747325,3.800792505444623
A4/Fukuda,46199207,1.9027513858957976,2.961516030523577
EFO-27,16659841,4.389988364450653,3.986661874407008
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278,2.3277294055034123
CA46,11977753,-4.21997551918338,-2.5859893154278693
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253,0.8314352946579338
SBC-5,54613361,-1.7173374464522142,-0.16658042960113462
MDA-MB-157,16065773,0.9216763205067852,2.5737838808615487
NCI-H1623,selumetinib-BRD-A02303741 (4-1 mol-mol),6.385895152539582,3.4952111670374877
SNU-81,44137675,1.234825635215107,3.243141166514864
OVISE,9929138,5.66720682434708,5.399966663889002
Panc 04.03,16725315,5.278537246983346,4.65111769591913
A4/Fukuda,6438330,0.8804707138455458,1.2995630865229901
NCI-H292,984333,1.6058463338689488,1.08282778018224
NOMO-1,11396600,3.3888037624860674,2.6151514786657613
SNU-81,24964624,0.6434241987426411,2.1147824875979055
BT-549,11964036,1.9997330886235436,1.5284121096880026
A-673,135411,0.3370419809316401,0.2500468227086049
NCI-H1623,10296883,4.489600285768525,4.065214108159941
NCI-H292,2733526,4.552154891253422,3.776374426342285
YAPC,6914657,-3.2827547721856423,-3.7008951531971546
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459,1.8014831494905719
NCI-H2009,327653,3.1880644035572825,3.371873074877364
CAL-51,3384730,2.4775948365465905,3.0557329238663344
FTC-133,3689413,-0.3036251064519336,-0.4173936355287772
MDA-MB-453,11964036,0.3676608059270313,1.2988580263061373
NCI-H2009,5281321,-2.3281539094269843,-1.2634172698140285
FU-OV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.708642246881296,2.26497844235382
LoVo,654092,0.3814222362545946,-0.01855652209633686
MDA-MB-453,50905018,4.488581944485688,4.025874015804172
HSC-4,selumetinib-UNC0638 (4-1 mol-mol),3.54677113858736,3.2592053783501855
OPM-2,46215462,1.142494911690201,1.3713852360286247
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574,1.8059744686338257
A4/Fukuda,5329102,0.822909221294871,1.5034197369589792
A4/Fukuda,11228183,1.827405863351363,1.0198998712122413
Panc 04.03,5460769,2.0457621674825224,2.646907341551798
MDA-MB-157,9933475,1.5029335433067268,1.9963196319784797
A-673,12003241,-2.2168793422392103,-1.2898331147341948
NCI-H460,54618164,4.49670945938676,4.165994488245353
NCI-H292,11656518,2.099021496243428,2.182506426538707
SCC-9,51039095,3.242385267473305,2.837406690367839
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685,4.443695813225928
SBC-5,3634881,3.763213110876527,3.332912526533517
SCC-9,984333,1.3591962563360305,1.0468611523488125
CAL-51,72193861,0.6423702350358801,1.5871286632757426
SNU-449,6610216,3.892858260461962,4.276749575432479
HCC1143,6918837,-2.8885170378203995,-2.3300301933467473
DMS 273,10427712,3.7833762157010655,3.9593465260931526
SBC-5,ISOX-bortezomib (250-1 mol-mol),0.5037473854516791,0.68536871529994
LoVo,8515,2.0502092932288543,3.847487949204805
ONS-76,5311281,3.0534152046102507,2.207703500292495
EFO-27,100016,6.711163327148508,6.46407941250288
A-498,6610216,4.284288503720797,4.332869766877644
SNU-449,docetaxel-tanespimycin (2-1 mol-mol),0.921733403174168,-1.8772159678898088
G-401,71466578,3.958692091033976,3.6961906526422945
A2780,2749,1.2168739363641357,1.2531812067523576
LXF 289,23635314,-2.0420734326640253,-1.835164379249972
LXF 289,24901704,2.332916050939017,3.5697079685464894
LoVo,9887053,2.8676927346989265,4.00966548658846
OPM-2,6918837,-6.102124609605729,-4.379852926744433
NOMO-1,72734382,3.160209893803666,3.15059591540619
A2780,44507138,1.3155442648841038,2.2674268439373844
NCI-H661,9915743,-0.8538809858854721,1.2874819417523207
SW1463,168313047,-3.1836020137929246,2.4620524989373793
SNU-81,55283,4.080745185244615,2.1133649922114888
YAPC,159324,3.323857793241652,3.314790427343647
HCC1143,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9300366262923152,4.348034412511641
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194,2.6688404407030064
A-673,31703,-3.778183583095139,-1.750109144980362
OPM-2,439501,-4.648238189793765,-2.510188533879202
A2780,452548,-4.864509732913544,-1.2996519787318501
CA46,71304818,1.9606514180280712,1.843509892570732
LoVo,25150857,3.1045912764862056,2.465894093924024
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915,2.3929725926447674
OVISE,446155,3.256033609420766,2.9830368955414177
SBC-5,54626689,4.608121703383126,4.573042547435063
DMS 273,11497983,-3.3171386440582467,2.08812078862225
BT-549,46398810,3.037551805065761,2.6271824709394895
KYSE-70,44819697,2.67312291481412,0.06300417081765312
DMS 273,10113978,3.3411401717417135,2.840800648939192
YAPC,11178236,-2.1853000629740342,-3.0122979501889855
EFO-27,89928392,2.3405290602814586,1.8807489336084433
NCI-H727,3062316,3.1124899612632135,1.652226430562717
MSTO-211H,9825149,1.7087798179810727,2.2843246321267108
OPM-2,25062766,1.526966504091227,1.5150979918693428
LoVo,24797083,1.0858534416002044,1.3443621916973214
MDA-MB-157,11612883,1.9249665557248452,2.8407569255553575
MDA-MB-453,24978538,2.762094535978925,1.2180026027864412
A-673,55283,2.8138583621562288,2.4374531590775628
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781,3.868645039644361
OPM-2,11228183,2.227238978219669,0.4746470121453297
SNU-449,11640390,3.8548607423510384,3.8242785469499028
NCI-H522,5281321,-1.0736628447197911,-1.2637532653792694
NCI-H460,25126798,4.092385726400508,3.8240574173219186
JM-1,9887053,1.8224498727300744,2.27595706265914
MDA-MB-453,3689413,0.605092083526794,-0.047351093214247617
BT-549,322968,4.038930181616003,4.183328153715414
G-401,969516,2.4612878169829067,2.471757324676674
FU-OV-1,10127622,2.361983631252389,4.04648440765688
G-401,5738263,2.503403034491448,2.7261049129695976
MDA-MB-453,5328940,1.6011356292327752,1.7535879938242025
HSC-4,25105715,3.6888708464756337,3.3454120252429913
G-401,5291,3.6897209629580616,3.315049079734264
SNU-81,148198,-1.0516438667772403,-3.0637428247387914
FU-OV-1,25183872,1.8271723160300688,-0.7567489927601582
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.9365617653912872
JM-1,9935249,0.9666917954448688,0.7898837295554421
JM-1,44607531,1.0390724505323097,1.2507470082092493
BT-549,5566,3.2694223641451887,3.098239612427512
LXF 289,637858,2.285720521187594,2.292030239578222
SNU-81,56946209,-4.781557694686043,-3.910227865380755
FU-OV-1,89928392,1.4286122200262183,1.6665020297237234
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375,-1.1984578051844845
CAL-51,54618359,4.544084907505638,1.9678541135676215
LoVo,15983966,-3.091518031584947,-1.1512610252625448
CA46,5746,0.6077367646083516,-0.7819527277629177
CAL-51,2733487,8.211583338705053,6.192946667822497
NCI-H522,4705,3.8595388748644375,3.1681452916362516
A4/Fukuda,5284329,2.3119801528783244,2.512039164477673
DMS 273,ISOX-bortezomib (250-1 mol-mol),0.050266361305609,0.4168514766713372
OPM-2,6505803,-0.5489645461029444,-1.1077759007087513
NCI-H146,11955716,-2.61946993472624,-1.365636450658199
Panc 04.03,19582717,5.125237161512837,4.513851205056059
LXF 289,9926054,2.043368643335034,1.9742079539431376
BT-549,136227924,3.266068806496957,3.2444853538659015
LOU-NH91,24901704,2.9181520482303585,3.4049403138666325
A2780,11167602,1.1290528312474395,1.94685875462259
HCC1143,15983966,0.2074313732487278,-0.9413155293751586
G-401,piperlongumine-MST-312 (1-1 mol-mol),1.0766364038162666,1.3634314887226564
JM-1,2871966,-2.1290689366468354,-0.04083418448426295
FU-OV-1,6852167,2.292876265150526,2.734524807800789
MSTO-211H,31703,-2.679199045886266,-1.107301165368438
BxPC-3,5335621,4.830409945539455,4.547030718901909
SNU-81,6438330,3.0600940001891863,2.2180239293559985
CAL-51,6918878,3.0110486558166274,2.955550041108548
LXF 289,6610355,4.558728947318035,4.75581778123204
KYSE-70,12001922,1.7900886800743383,1.9584829710977363
BxPC-3,60168763,4.708123265391542,2.7699981821380346
CAL-51,44137675,3.485867182081199,3.2162138102933566
SBC-5,carboplatin-UNC0638 (2-1 mol-mol),4.8107215741986105,3.1918400150984776
NCI-H460,216345,3.827300936034388,3.8227011715568064
NCI-H522,15953870,3.615553645162116,3.481230302346566
A-673,46199207,3.2534509529249176,3.2006776949086277
SCC-9,10127622,7.404435857651999,3.837752866527654
Panc 04.03,11977753,1.829262770264154,-0.623437809916355
HCC1143,168313047,3.0210205197435935,2.41281412840537
EFO-27,3465537,3.52414234339403,2.731237349264887
A-498,462382,4.566729065673536,0.671719977489635
FTC-133,45279963,4.126382655862848,3.922727449156048
G-401,71751553,4.092007605377758,4.142521923586537
MDA-MB-453,119607,3.891659451485504,4.957601815507893
MDA-MB-453,3384730,-0.7236289420344145,3.0636676193323082
SNU-61,6184667,2.8549853776409937,2.783713395283241
NOMO-1,23635314,-2.3321691272104697,-2.7129166865387595
SNU-81,54618164,-0.3986435357924686,3.7492915776650477
NCI-H727,65064,3.1010913931031867,4.868388843046048
CAL-51,44607531,1.640429423812436,1.551665242571687
CAL-51,72376,-2.938334648898351,-1.8949503684414677
NCI-H522,126941,-2.655181013676553,-2.7365663496053645
ONS-76,3025944,4.431691617199171,4.476927524517586
NCI-H460,25154868,3.4600493825904564,4.32870397106587
FTC-133,71304818,3.18789827914798,2.591664395954358
CAL-51,151289,0.6583498849401344,1.208535273763721
LXF 289,11238147,3.4273419568352006,2.894991587844235
BT-549,BRD-A02303741-carboplatin (1-1 mol-mol),5.675509495895237,4.4714946322533
KYSE-70,702558,6.39879445367054,5.237352554298817
CAL-51,124202324,2.033990287468598,2.705281118319673
MSTO-211H,46907787,2.574686905184434,2.7891809630658377
MSTO-211H,4521392,4.029667841571139,4.288731634079849
EFO-27,ISOX-bortezomib (250-1 mol-mol),0.3269008359156463,0.7954993405579099
A2780,9549297,1.1491610880845489,1.97309018044265
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277,-0.27249189803169127
NCI-H2009,2729026,1.97459320968498,2.8972524216599504
HSC-4,5311,1.8002123285320597,1.521312386289391
YAPC,135398738,5.4751822545753415,4.528475143767893
Panc 04.03,285033,-1.1400173305697017,-1.4927966565088024
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402,0.5119526944992193
A4/Fukuda,71466578,0.6387062903604859,2.764746510536828
CAL-51,135398738,4.757337519270393,4.477754586349834
A2780,selumetinib-PLX-4032 (8-1 mol-mol),1.6060841409900903,3.788832347184422
A-498,24785538,3.3641680302296564,2.129563063182844
HSC-4,452548,-1.2537746146037845,0.6277843302436336
NOMO-1,6918837,-4.687337521865761,-4.005183451899027
A2780,6505803,-1.803583295606165,-0.8873782468857625
YAPC,387447,-2.999100837413036,-4.100680334714215
NCI-H292,25183872,-0.4983801682636667,-0.5636731861782472
NCI-H1623,44137675,2.921297693984664,3.527055769774468
LoVo,46843906,2.381362357237743,3.0264558905475862
MDA-MB-157,5281321,-2.46264909171439,-0.8223659283046088
NCI-H292,44137675,3.1459685562862707,3.6184411356652153
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106,1.134181468209174
JM-1,5470400,3.917661049847631,-0.43026382620617715
NCI-H522,52912189,0.1662181985496506,1.4801862220143662
MDA-MB-157,15983966,-4.787780953616188,-0.7564179099166728
CAL-51,10322450,3.881825194853649,3.953346839051463
CAL-51,6918837,-3.0563476396929703,-2.6927755833679816
NCI-H661,54639126,4.507619035006863,3.892858317952825
NCI-H661,5311281,4.526772174839299,2.513960527602781
NCI-H460,selumetinib-MK-2206 (8-1 mol-mol),3.864749533949913,2.079245644078659
LXF 289,3025986,-0.453776319374568,-0.6790087739048655
Panc 04.03,25262965,-1.014076783670677,-1.4329594113862105
MDA-MB-453,5746,3.800897853250581,0.5140597276152201
SBC-5,15953870,3.487984127844562,3.6614674271977674
HSC-4,decitabine-navitoclax (2-1 mol-mol),3.5629592535507557,1.9274033152127064
OVISE,3025986,-0.0395702470459638,-0.5406550857306763
FTC-133,5311,2.4215013743463647,1.653274106210109
NCI-H2171,11485656,1.3701169509015756,1.9302686813487961
A4/Fukuda,5282054,2.418862118344995,2.9656848323950338
NCI-H1623,25102847,3.8675819706398418,2.3951838354192057
OPM-2,984333,-0.0237710386013994,0.16956140258469873
FTC-133,387447,-3.6414317999651336,-3.8440523273565916
BT-549,5311281,2.333978253730499,2.7499334209742377
OVISE,16720766,3.986904391501256,0.9123867999848853
NOMO-1,11612883,1.4996443311921075,1.7765993705571574
NCI-H146,5282054,2.6062567229872924,3.3394578102624983
SBC-5,6917907,0.6114763356012877,-3.353870963360515
NCI-H727,24951314,2.050368453430269,1.3938650647119368
MDA-MB-157,613753,2.6621381248494456,3.21368017731879
JM-1,44486219,4.06629583721778,3.7049952793819414
CA46,285033,-4.358161131916293,-3.734807829559454
A-673,9952709,2.6406542482442545,2.736330863700263
BxPC-3,124202324,2.2278087185314694,2.6841516547803024
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569,-0.6372009601302056
A-673,6852167,1.8255345198368305,2.295977166663841
NCI-H146,6610355,3.561762383324193,4.239867590060152
NOMO-1,46215462,1.6253213091786816,1.2273044674735785
CA46,439501,-3.521132637790176,-2.5182482844987586
KMRC-1,5329102,1.6227643750477536,2.0694664348037013
MDA-MB-453,568763,0.1355288059345826,0.49908077191427713
NCI-H2009,15953870,4.632669867834425,3.796142766606981
G-401,16725315,3.2068580834321048,3.635472192032452
SNU-81,25154868,4.054299809836995,3.9862783368326893
SNU-61,2742550,3.576212598776706,3.4917355097597
BxPC-3,44589607,1.722183316619471,2.9255146054469963
SNU-61,3025986,-0.1307165413786875,-0.7962678265439221
NCI-H1623,3062316,1.6941172744123574,1.7729202403615443
ONS-76,16115403,-5.005393778847352,-3.918672023433538
LXF 289,12003241,-2.348837864712453,-1.146690145327327
DMS 273,168313016,5.378851860414917,4.180501798406923
CA46,54765302,3.694944477545822,3.676992223481313
MDA-MB-453,vorinostat-navitoclax (4-1 mol-mol),-0.1886705997266854,1.0108236273923965
A2780,10113978,1.7525717433500034,2.752555668928732
OVISE,9911463,4.4041109725525525,3.750148913601028
ONS-76,44589607,2.6985455021272573,2.901879057327723
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965,3.956935664777072
FU-OV-1,JQ-1-vorinostat (2-1 mol-mol),0.8626774662663057,1.1021118087524
NCI-H522,JQ-1-UNC0638 (2-1 mol-mol),-1.3225503189993402,1.3763616920570487
A2780,26596,-4.32263985415392,-1.9526610229578738
SNU-449,53481919,3.639889931386733,3.9070561902934817
A-673,135875424,2.9734448822107886,3.5476534884470268
A-673,49867926,4.049605811998934,3.4928869202691475
MSTO-211H,16720766,-0.9979081980160748,0.590476836086767
MDA-MB-157,24785538,1.324170410962965,1.6744978400656447
CAL-51,107970,2.299284460939792,2.272769454870666
OVISE,11178236,-4.082767785475175,-3.0413412928242396
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941,2.4720253806126
A4/Fukuda,25154868,2.544294393199085,4.216896103527283
CAL-51,46191454,0.2698308836515951,2.019021008455034
NOMO-1,136227924,2.5449106490851263,2.314402814331452
KMRC-1,24821094,3.705597482955712,2.7432125987862355
A2780,5282054,2.567919090275208,3.167353855367347
NCI-H2009,11404337,-0.0657811746758558,0.04306713186712805
HSC-4,409805,5.399675964474335,4.816121352173409
LoVo,24772860,-3.380615847351667,-1.6835918973756465
MDA-MB-453,54626689,4.438407624810902,4.581517671154765
G-401,104842,-3.837747012299513,-4.39166189045765
BT-549,135440466,3.2033555971359267,2.620916423426165
MDA-MB-157,docetaxel-tanespimycin (2-1 mol-mol),-4.4000012039018594,-2.0597630702211496
NCI-H460,5280436,4.847067650781305,3.4668862907561016
NCI-H727,10385095,1.3903964913374658,1.5052599206647193
NCI-H727,262093,2.950291125725139,2.859809402989519
CA46,25227462,-5.088225796968986,-1.849963168215111
HCC1143,439501,-0.7374061663212956,-1.957422846784074
MSTO-211H,10113978,1.403014421240365,3.2604770655436566
SNU-449,72734382,5.7131640484247805,4.763071720888409
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489,-0.7344124354401645
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068,4.200692881418785
BxPC-3,24772860,-3.1359973170310993,-1.8837165298114131
LoVo,5281321,-2.272723057934536,-1.4539542852581269
FU-OV-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9353082171221765,2.2019857045208875
MDA-MB-453,10427712,3.2513664008238874,4.076671613408499
Panc 04.03,53495165,2.8699642151767746,1.0863689346650895
FU-OV-1,54619267,4.302850520300199,4.156144715420188
MSTO-211H,24964624,0.1425074184859401,2.6957400149695165
G-401,135875424,3.147536590476696,3.295923038793209
ONS-76,selumetinib-tretinoin (2-1 mol-mol),-0.7324247564116871,2.705211085730974
A-673,selumetinib-UNC0638 (4-1 mol-mol),2.386430695912322,2.8930576204330145
MDA-MB-157,9967941,1.858403940770751,3.643119565703184
LoVo,ISOX-bortezomib (250-1 mol-mol),0.9349202186753368,0.62178566351134
NCI-H292,11497983,4.544493181272098,4.411506527885183
HSC-4,3011155,4.427149856421904,4.027640334344013
NCI-H1623,17755052,0.7357373094762232,1.8413637030120364
SNU-61,navitoclax-piperlongumine (1-1 mol-mol),1.6755715296131175,1.1332559038439387
BxPC-3,5746,0.9856415477525818,1.3559937541383331
OPM-2,24901704,1.9220236520558196,2.4437137470765267
MSTO-211H,2858523,3.0747353868294627,3.1145346376521097
BT-549,107970,2.9169966931039113,2.4974775488659127
NCI-H292,135875424,4.14052752249008,4.054906031421154
LOU-NH91,107970,2.5070848864255093,2.3807534007405353
MDA-MB-453,6918328,-2.060631340343386,-0.5549128143131047
KMRC-1,44566777,-0.0538941449270197,0.585573967759326
HCC1143,17755052,1.15684078766818,1.831745734792709
Panc 04.03,9956119,4.202347043107845,3.6300743328213283
G-401,54613361,-0.5160099475891917,-0.2265480628368883
NCI-H460,6918837,-0.9355989207233988,-2.490971076286326
SCC-9,10302451,2.205114392498864,3.0213692826393497
BT-549,24856436,0.2415814283223239,0.8211638937272072
Panc 04.03,25150857,3.139734816867742,2.6518146530718933
A-498,9866186,-1.262750837313692,1.05550369770075
SW1463,11497983,4.077621288565615,2.194331614899845
LoVo,124202324,1.6089295836770297,2.5163521948741887
JM-1,46215462,1.389060279673689,1.3122792065395115
A-673,2729026,1.806074207860909,2.433861636193283
MSTO-211H,241158,2.290519528489604,4.007656133539973
A4/Fukuda,6917907,-6.123586781218294,-5.645019768393102
NCI-H460,11485656,2.6212830818798065,2.2894279859074067
A2780,135875424,2.703796648613349,3.38845643952432
NCI-H292,10127622,7.746640801358069,3.6719157030910514
DMS 273,9887053,1.8082863610482875,2.935282429090541
EFO-27,426756,4.432789586131128,4.3727922387171425
MDA-MB-453,2749,0.298775024907787,1.7842499421807938
NCI-H460,11222830,2.8861636193629323,1.7228094310494342
NCI-H460,119182,0.2489341964189734,-0.7963368172645688
MSTO-211H,676352,2.2606828184976955,2.197904393398905
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816,1.3079981059087242
SNU-81,16736978,0.587276282018702,1.7320464025744966
BxPC-3,10113978,2.7603674185652536,3.5797003378906256
SCC-9,6505803,-0.8932206272709824,-0.431745499385757
HSC-4,122327,4.034102983304833,4.725772485355119
MDA-MB-157,107985,-3.8805729202788304,-3.3372867450413213
HCC1143,5566,3.096162587379626,2.948777148148223
BT-549,5738263,2.4683192628765753,3.5355326100001867
A-498,3854666,2.914304878080617,2.9017744918405004
SNU-449,navitoclax-pluripotin (1-1 mol-mol),0.5416887924611083,-0.7409661341599605
ONS-76,73707398,1.7098056225756528,1.3212840857715553
A2780,10322450,2.9165978660974545,3.553733024744769
CA46,3062316,1.4079672687586804,0.3909270362129601
HSC-4,selumetinib-MK-2206 (8-1 mol-mol),1.8625647516668664,2.3758526681456913
BT-549,71466380,5.5332032048485065,4.641409470865465
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198,1.210489167781068
KYSE-70,24180719,3.52071426185984,3.282375259754705
BT-549,10385095,1.777553004720717,1.2995450801649746
JM-1,4259181,-0.0762731042787348,-0.42478806441393857
BxPC-3,12003241,-1.7282705692868598,-0.9523720382078895
LXF 289,9840324,4.681234496405457,5.95983110464795
KYSE-70,17759555,3.816264723168541,3.43712192183779
NCI-H292,9911830,2.887423578139022,2.623005572270817
HSC-4,9840324,5.223554072523372,5.755726564114122
G-401,selumetinib-UNC0638 (4-1 mol-mol),3.413545127228383,3.2262834781445737
A2780,9915743,1.3754925129164983,0.7952092840589386
NCI-H2009,10302451,1.2105403110698565,3.330778775281207
JM-1,tretinoin-navitoclax (4-1 mol-mol),0.3453404774126501,0.6175611453251877
ONS-76,9935249,3.5330143946083874,3.2661427818348625
BT-549,11427553,2.4752578658091524,2.9118314866287336
G-401,148198,-4.717755806624399,-3.6906910232225614
NCI-H661,JQ-1-UNC0638 (2-1 mol-mol),3.1332466289853884,1.6276319811220632
NCI-H460,5351362,3.0809857123464037,1.5940432966621898
BxPC-3,5978,-3.126756112961715,-2.005623954225201
OPM-2,11396600,1.8817984525619431,2.6190144823871204
A-673,5328940,0.9058407904985936,1.3816937704338443
LoVo,16720766,-0.1141862087465287,0.6564676454184807
LoVo,11404337,-0.8407014552816361,-0.32285674367979206
JM-1,11455910,-0.0097968256607179,0.27148523731523644
A2780,54686904,3.0280150906907206,3.005403587724764
G-401,selumetinib-decitabine (4-1 mol-mol),1.9675825066475652,2.6397801227087974
SNU-449,9956119,3.198924280342594,3.8337501191695873
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752,-2.418577550701228
SNU-81,60700,-1.0304958014583914,-0.20832364852000582
SBC-5,navitoclax-PLX-4032 (1-1 mol-mol),2.6386672409141756,2.0344006302371453
Panc 04.03,216468,3.559067681626077,3.650379366103392
OVISE,46398810,3.0089868889673426,2.6600310801005373
MDA-MB-453,11494412,1.83607541398336,2.196986055553865
NOMO-1,409805,3.6617718212828874,3.5628400034752916
BT-549,25062766,0.9643791751629904,2.006329070933696
FTC-133,446155,0.3759987857405991,2.6451416871172926
KMRC-1,23635314,0.7760380281113136,-1.6975215580891787
SW1463,15953870,3.283482316204368,3.5230778464833334
LoVo,46943432,3.050109964187685,2.555275458560401
HSC-4,46907787,5.727789952108257,2.4910796787374854
BT-549,navitoclax-MST-312 (1-1 mol-mol),1.130665765716481,0.9980872539259907
FTC-133,135440466,5.15132472260749,2.360692038136022
SW1463,568763,0.7789022422759734,0.3170529427291447
JM-1,25150857,0.7748927856999902,1.4335627951362782
A4/Fukuda,71304818,1.5363144884487692,2.0874414468825075
HCC1143,tanespimycin-gemcitabine (1-1 mol-mol),0.1249858816054574,-0.6488982782132497
NCI-H661,24785538,4.2805678056942,1.919256996537654
FTC-133,5282054,4.434007222498336,3.7758900326334466
A2780,613000,1.210736664046428,2.5820827973893477
SNU-449,6852167,2.6501635563943977,2.957829327688133
NCI-H1623,5280436,2.3425513929901043,3.2809049097941854
SNU-61,11625818,5.738401007397874,3.8953737057328066
NCI-H146,selumetinib-tretinoin (2-1 mol-mol),5.090146461709555,3.0768923726071558
G-401,selumetinib-BRD-A02303741 (4-1 mol-mol),3.259716171612134,3.429340525275509
G-401,11396600,3.403558125152034,3.1613048135501383
LoVo,11396600,2.965288622606591,3.8398955808323314
YAPC,5311,2.641039705119952,1.6109849225201567
HSC-4,168313047,3.0036663016787015,2.3813167182257273
LXF 289,135440466,1.0541158239349229,2.3508759584888477
FTC-133,navitoclax-PLX-4032 (1-1 mol-mol),5.2980010762745415,1.6156287079995577
SW1463,16720766,2.9834843450585193,0.3846601710539862
Panc 04.03,2708,5.3340089352485816,5.123460810890812
MSTO-211H,11612883,1.8196539401694043,2.962974620806549
G-401,219104,1.9483296496250493,3.0420255381819263
OVISE,3854666,4.260793298508907,2.5207356344992893
JM-1,327653,2.4402793258430786,2.6260977970091086
SNU-449,984333,0.3609894515007521,0.9011974884537259
NCI-H146,40482356,6.02837292181762,3.8293213537159914
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836,2.011811477417644
HSC-4,9952709,2.643320259436509,3.2270184040836485
CA46,71680916,4.255070441315874,3.8752577193733226
MSTO-211H,119182,-3.3068023354733156,-0.7609199275997411
HSC-4,4788,5.270141450772874,5.777899752263315
MDA-MB-453,11612883,2.003650622053601,2.5797381212687718
A-498,2729026,3.0720683032694827,2.7312391912295806
CAL-51,135659046,3.6035863494873137,3.63009728617358
A-673,16736978,0.9204710311128564,1.5260551758844216
SNU-61,selumetinib-navitoclax (8-1 mol-mol),-0.634937533687344,1.7414692836450714
G-401,5335621,4.041162639386401,4.20478083315757
NCI-H292,11647372,0.0082735983152987,1.2212434042218494
NCI-H661,46191454,1.844409109204796,1.5367638774449808
NCI-H460,439501,-2.362377537788676,-2.0463565148018428
NCI-H146,BRD-A02303741-navitoclax (2-1 mol-mol),-1.9757799692204725,1.0692675369064522
JM-1,navitoclax-birinapant (1-1 mol-mol),0.1360362208330573,-0.07638522761569995
A4/Fukuda,5328940,-0.5379688872377596,1.4498733313959962
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125,4.411926661832222
LOU-NH91,25126798,3.943021506059378,3.8735834612817577
CAL-51,56963564,0.4281851677964957,0.6880942158588028
Panc 04.03,24785538,2.964340727211602,1.7873536190688515
SNU-449,56963564,1.9660320048352,0.8608874030858314
SBC-5,156414,2.5142262290401516,1.3136581798073892
FU-OV-1,46398810,1.7086224401878771,2.678552369821442
MDA-MB-157,426756,4.156862898324412,4.4472339715325715
G-401,4521392,4.161493335374481,4.006969603132586
OVISE,36462,4.611657944155446,2.4183187664241825
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139,2.0349281862963013
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918,-1.1192681381486136
CAL-51,5351362,1.1872361858703535,1.4864247213895447
CAL-51,119182,-1.323881847361974,-0.704133113302414
NCI-H522,24753719,5.009376195679754,3.78157381183336
JM-1,tretinoin-carboplatin (2-1 mol-mol),2.443432654603248,3.5520161399428285
HCC1143,9915743,0.7364353129897024,0.7353732916837042
NCI-H460,navitoclax-piperlongumine (1-1 mol-mol),3.830586656387486,1.9365617653912872
NCI-H522,24889392,3.251100273050004,3.2579492313389085
LoVo,11178236,-1.6059359070935737,-2.808223660042748
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212,3.997383430347414
CA46,23725625,5.582899861703026,3.4251412017787124
NCI-H460,25154868,3.4600493825904564,4.32870397106587
CAL-51,36462,0.7338920585832341,1.7936824570410008
EFO-27,5281321,-1.9543223460886947,-1.2109015730498498
LXF 289,11612883,1.9814919247106189,3.2168281584294975
HCC1143,2828334,6.454192166435682,6.314392447401702
A4/Fukuda,3854666,-0.0838776105349313,1.0255029743951376
CA46,10322450,2.6264913036213606,2.918813336754289
NCI-H2009,51039095,1.8360035457780568,2.827253634252384
BxPC-3,10231331,0.6961573218104748,1.871330167430822
LOU-NH91,56649450,2.5557041031897705,3.41498011449642
G-401,216239,1.6826916037000108,1.7713554882855695
CAL-51,carboplatin-UNC0638 (2-1 mol-mol),3.3460163341878726,3.462984828084814
HCC1143,5281321,0.7613054606946723,-0.888509938438835
EFO-27,72376,-1.8608022629783372,-1.4806845316575115
NCI-H2171,19582717,3.772812394316534,3.1628708531026977
MDA-MB-453,10074640,2.421510718072182,3.0419316831753314
G-401,11317348,2.32763680059041,2.0260412173853166
FU-OV-1,selumetinib-tretinoin (2-1 mol-mol),-1.802800887870168,3.9503307730330937
NCI-H146,2729026,1.2131739481587438,2.411001995943775
OPM-2,46907787,-3.368300500627006,-0.6288412958698665
HSC-4,navitoclax-sorafenib (1-1 mol-mol),2.0260640638250154,1.782992752947865
KYSE-70,15547703,3.259406085484829,3.318671068675449
NCI-H522,107985,-4.282222583037789,-3.4519093828750225
A4/Fukuda,9933475,1.717973727652582,1.8808868760596484
CAL-51,6505803,-1.1525670311484852,-0.8841542439284722
HCC1143,5329102,2.41968992927328,2.168982846611181
MDA-MB-453,46215462,2.7539180673476986,1.8606973256953396
LoVo,151289,0.7390860710542093,1.1841858229685387
SCC-9,10296883,4.238304408621306,4.100838858724486
LOU-NH91,54454,2.054793401572522,2.6193467879178196
A4/Fukuda,9884685,-2.10728676228506,-0.3238901421268667
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156,-3.5120360011967797
JM-1,11317348,1.0457451678280252,1.2489092025478687
MDA-MB-157,5287620,-1.8230093056434509,-1.8498722889339592
FU-OV-1,24821094,1.823018038350918,2.9408951269724435
Panc 04.03,15547703,3.067090198790942,3.246358063681984
DMS 273,568763,0.8680081273298318,0.18759115464317783
KMRC-1,16038120,1.697027615564608,1.2224480095620371
A4/Fukuda,11214940,3.3298423014633585,1.5881111963224221
LoVo,168313016,4.599216339831628,4.6433536355512794
JM-1,3011155,4.445867330482826,1.8875366247040524
NOMO-1,135411,-0.3073928829727976,-0.03775960117235012
A2780,24772860,-3.463956246093966,-2.3005721037036913
MSTO-211H,11625818,2.0984197145893853,4.535141148140927
FU-OV-1,219104,2.911303350256359,3.919497325680493
SBC-5,JQ-1-navitoclax (2-1 mol-mol),3.919217693519999,1.0006455015734712
SBC-5,49793307,2.0795512515040144,-2.725663387557718
CA46,53232,2.437328600755792,2.5550673318253754
EFO-27,24901704,4.244323432217726,3.481677571098708
CA46,2746,0.9501634288999758,1.6590874901100026
Panc 04.03,selumetinib-navitoclax (8-1 mol-mol),2.4072445179954665,2.090799032088503
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842,1.246330671533026
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768,0.938281362509823
NCI-H661,9956119,3.313685900900753,3.704590996277494
SW1463,44185566,1.4171512734588314,2.1312693711113777
FU-OV-1,3384730,4.633609637548597,3.002818076179651
SW1463,3384730,2.9539510373394458,2.1726595548248517
MDA-MB-453,3825829,3.844348445708714,3.8606993381063974
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937,0.8698137637256157
Panc 04.03,400769,-0.067858138339059,-0.3421530627297427
CAL-51,445643,4.334473435217703,3.8639521199450946
EFO-27,156414,2.3785601677308215,1.5152639554519864
NCI-H2009,4259181,1.0344432117954978,0.6609927488179523
MSTO-211H,16722836,0.7655247341289007,1.6565857529597006
SNU-81,11364421,-4.012430935720713,-2.1346750709644637
CAL-51,selumetinib-piperlongumine (8-1 mol-mol),4.057759894730394,3.5552833247527347
A-673,2746,1.857945511282164,2.5351939763335736
OVISE,navitoclax-sorafenib (1-1 mol-mol),0.9257424766739848,1.4454086503864068
NCI-H460,135398516,4.13019906717736,1.8809045732025285
BT-549,25183872,-0.4430920052505824,-0.7451707226094036
JM-1,49846579,-3.8749150343559498,-0.3862619628009507
NCI-H522,10127622,6.598645867237379,3.8613683986080276
OPM-2,446155,0.7744505725193765,2.0659031018055938
G-401,10296883,3.7583450228982342,3.406540127135409
DMS 273,1716436,3.74376938939547,2.85969239175621
SNU-449,serdemetan-SCH-529074 (1-1 mol-mol),2.2114452533334212,2.36017188989278
NCI-H522,44566777,-0.9754694174653856,0.6160902714723124
MDA-MB-453,53393127,2.113910519669698,3.793615381667154
FTC-133,49793307,1.1308238833509443,-2.0258726777750846
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596,2.555983620890662
A-673,135928012,2.926877088120134,4.049488583377601
NCI-H661,5280436,4.871704282803626,3.2666740430648424
NCI-H661,docetaxel-tanespimycin (2-1 mol-mol),-5.324368950628822,-2.8787926323884774
JM-1,5282054,2.3244175489984573,2.4851524312378697
JM-1,9549297,1.5955396397117223,1.5301953171583924
NCI-H460,11507802,2.848054270429628,1.743102940432159
A-673,387447,-4.940230504934896,-4.524459452114847
LoVo,89928392,0.5944678691764933,1.523031536636087
SNU-449,navitoclax-MST-312 (1-1 mol-mol),1.1854227296029016,0.9669211683433804
BxPC-3,doxorubicin-navitoclax (2-1 mol-mol),-1.6348135682657186,-0.7348797538697105
NCI-H2171,67156097,-2.093355563734418,-1.845194242871863
CAL-51,9929138,6.421072450841616,5.469326099624231
NCI-H522,11609586,2.3447481698139545,2.214268202938053
JM-1,56946209,-6.537344033049601,-4.982533271179951
MSTO-211H,54649381,3.373909346349482,4.123242717231053
A-673,4261,1.089626824326701,1.0405382424547855
SNU-61,56649450,4.501229591303133,2.533282842880963
EFO-27,5738263,4.449588569174732,3.6771783821589445
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515,-1.9322990164662395
EFO-27,462382,1.6036436678954449,0.650095474088494
BT-549,24180719,4.750015939259711,3.6589430110187027
HSC-4,73707398,0.9895931551524366,1.4169892551886962
LXF 289,52912189,-0.1394416798850269,2.367982370034769
DMS 273,BRD-A02303741-navitoclax (2-1 mol-mol),4.151780169779293,1.3445689683919069
NCI-H2009,31703,-0.97323545782719,-0.683877822939765
NCI-H2009,219104,3.953506929532588,3.9668821964504843
A2780,11626927,5.568414170846121,2.377940296183925
NCI-H1623,navitoclax-pluripotin (1-1 mol-mol),-0.2970825131911801,-0.6333585252830694
Panc 04.03,4788,6.095957987809042,5.865359315270418
OPM-2,4259181,-0.0185783035827133,-0.3406707457036518
LOU-NH91,9915743,1.51930479588737,1.7861327943152943
G-401,2828334,5.836351566381613,5.805592277521345
LXF 289,3689413,0.4542816941401804,-0.4386270160787912
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467,1.257041654139089
SBC-5,119182,0.2964340092945935,-0.5701490930855841
JM-1,2729026,2.071801783442454,2.0920504414180248
SNU-81,11214940,1.7135053171337324,1.8812386426377785
SBC-5,439501,-2.4874901722547977,-2.0334081517235223
OPM-2,46174525,3.627220507837432,3.4123980131201295
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402,-0.1637974795995481
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765,2.422748464174829
NCI-H2009,3062316,-2.678423554108453,1.634719295254703
HSC-4,6438330,1.0116267584860468,2.2897637522889944
A2780,1317464,4.304763369285543,3.0931904175059826
G-401,3025944,3.816605103301755,4.136148756139375
NOMO-1,9915743,0.4758643096003905,-0.010690057608607952
CAL-51,9877608,5.917079709597661,3.0087939217500126
LoVo,71466380,3.017013363980257,4.358697703344343
HCC1143,53392493,2.60613854373917,2.6723797718477957
A-673,6918837,-5.129930095166698,-3.9017093206562325
SNU-61,60700,1.2670278964841577,-0.7357225362542337
OVISE,6918837,-1.5846953199834826,-2.6062165988636514
NCI-H727,11609586,3.3120945172723917,2.896132124862566
CA46,tretinoin-carboplatin (2-1 mol-mol),4.700900152183415,3.283886882331373
NCI-H1623,5281672,4.562545083615407,4.6117636497753
NCI-H2009,6918328,-0.9509353973047906,0.15456879970221707
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664,3.400960015924693
OVISE,16722836,2.434488476233433,1.84148363734641
JM-1,10127622,5.153041805169496,3.5035195441577143
NCI-H1623,252682,6.46254793762087,6.614170055863682
JM-1,53392493,1.8440760854554048,1.8590357152163106
MDA-MB-157,168312962,1.1798186112423137,2.1995757704301626
YAPC,44819697,-1.3460219164430964,-0.04884203957908646
KMRC-1,44607531,1.585622780528836,1.64362174060946
NCI-H2171,6918878,0.0284372668850805,1.6421388511673094
MDA-MB-453,44607531,1.359301388322155,1.4617363751357118
ONS-76,11485656,2.5953354109263262,2.4440521148460075
MDA-MB-157,135398516,1.565807276365399,2.364182874921252
A2780,24753719,3.5545225878481745,3.865037886818061
NCI-H661,6918328,-0.1140400883450083,0.17074437647791818
JM-1,4578,4.1991230056704785,3.944794737859076
A4/Fukuda,9903786,0.7546004224414102,2.1529398639098987
CAL-51,11485656,2.6541256228973773,2.303392523435677
NCI-H292,24964624,2.911439833663599,2.693749191345571
NCI-H661,6918837,-3.3797686305940156,-2.566305599700138
EFO-27,71304818,3.2919872626583486,2.608875040658762
MSTO-211H,4705,2.457156821386339,3.27720799373957
DMS 273,107985,-4.548014092027974,-3.5927795609793254
SNU-61,2729026,2.4451253635155106,2.657543535558134
JM-1,60700,-2.9904484465209036,-2.3876493783318504
SNU-449,JQ-1-MK-0752 (1-1 mol-mol),5.5892167281424285,2.0634154338369397
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257,3.6067766535032733
SNU-449,24856436,4.072390930567189,0.748948230709754
NCI-H460,159324,4.0462841352482855,3.281590144776351
NCI-H2009,11175137,2.49599907102206,2.873263515737742
A-673,208908,1.851861192467165,2.02814318497882
BxPC-3,25183872,-1.12027566647844,-0.6197452560236895
EFO-27,5328940,2.731901822530229,1.9693197862600669
HSC-4,135398516,2.2759469773851224,2.22743762192397
HSC-4,11647372,1.1815136799972823,1.0663371649664906
CA46,16038120,1.1324791438314847,0.18964491525819763
MDA-MB-453,9868037,1.568237926564538,3.1480590475942227
A-673,446155,1.1478268834845686,2.4516499228093083
A2780,5479543,3.565203320915574,3.1109017606884213
MDA-MB-157,10322450,5.067042624032479,4.141166613459899
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236,1.1832095111554095
MDA-MB-157,9915743,0.9957990206413116,1.2053090730176919
A4/Fukuda,219104,2.2512696330904447,2.4885569467681496
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723,3.120170359416449
SBC-5,12001922,2.404615034975172,1.8820775839188415
A-673,51037431,1.861905373589415,2.8863630259390174
A2780,637858,1.382423379201008,1.4162437149232057
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759,0.8402221425586605
A2780,9884685,-1.5939943621043984,0.30918865798212414
JM-1,5311,-0.0672732572458771,0.4708407702072892
CA46,15547703,2.518572103836232,2.5040508184809216
BxPC-3,54618164,4.016743819691475,4.146012724537723
BT-549,2749,3.5786970568950913,2.0888866276237827
SNU-81,73707398,1.1294477244846828,1.158157554073763
SNU-61,docetaxel-tanespimycin (2-1 mol-mol),-4.617294417621486,-3.452956433048894
A-673,55508,3.3138750706926157,2.9119969285896423
SNU-449,carboplatin-etoposide (40-17 mol-mol),5.135900435909966,3.388581043290092
MDA-MB-453,23725625,4.029710365908802,5.127087343465402
A4/Fukuda,4261,-0.9007526332595048,0.9064826646493769
NCI-H727,446155,4.65589483782911,2.8620262962022553
NCI-H1623,44486219,4.206804435599472,4.442464982289289
MDA-MB-453,441298,1.8295928982069447,2.5709037000371673
SNU-449,54454,2.520106415523585,2.5426370906768976
A2780,387447,-4.368237522415053,-4.48408328724522
MSTO-211H,11152667,-3.5300772231011703,-0.4963932596431102
SNU-449,25195348,3.622170031481097,3.667534283863519
MDA-MB-157,322968,2.1225136411127545,3.8606227564438225
A2780,168313200,1.7543183926879495,2.6366207450942443
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625,1.5183466091355018
SNU-449,5329102,2.0099859216843075,2.21730202054854
NCI-H2009,322968,4.70725114827159,4.015540958185229
KYSE-70,16722836,1.4327625680833322,1.882117173828854
MDA-MB-157,11609586,1.0926317538630208,2.966193271023859
FU-OV-1,10231331,3.398558944555642,2.3102834855225223
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172,3.130757129412938
NCI-H292,docetaxel-tanespimycin (2-1 mol-mol),-3.440758677710888,-2.7601695993183144
LOU-NH91,11238147,4.007302405058718,2.9091585225891525
LOU-NH91,49766530,0.361985362717411,-0.7351596123064472
YAPC,9444,4.346283036692295,4.103898978758938
NCI-H522,15547703,3.471643136947843,2.825640243913152
NCI-H522,375860,-0.630771500248647,-0.24349307301150674
CA46,119182,-4.388833865288787,-3.2043580959224314
OPM-2,10410894,2.9147321100270593,2.9303229295651705
CAL-51,erlotinib-PLX-4032 (2-1 mol-mol),3.3535318918945647,2.9694452249806154
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803,1.4263501122669318
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617,-4.149288841278264
NCI-H2171,4261,0.9024779156039784,0.8598842263524874
NCI-H1623,25262965,-3.228781743363827,-1.3566733580804191
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139,-1.9283770408204748
MSTO-211H,10427712,4.183883954719584,4.432379624372876
EFO-27,navitoclax-birinapant (1-1 mol-mol),3.2392186746278244,1.515897386408376
A-498,9967941,4.3277437867326025,3.672922285391965
HCC1143,25183872,-1.001460572121427,-0.5233177521382669
NCI-H522,crizotinib-PLX-4032 (2-1 mol-mol),2.133335771815486,1.4893516188631575
CAL-51,17755052,0.5283491907817935,1.7751161221455043
SW1463,44137675,3.7114847318755806,3.632125590164928
BT-549,5278396,3.375604766419473,3.684733768597334
NCI-H292,3025986,-0.8794264876923694,-0.7970261918374958
NCI-H2171,3825829,3.727904622873516,3.420222314769004
EFO-27,327653,2.4330037956805133,3.3436598845797256
NCI-H460,637858,3.384702960830197,2.1876822219813636
G-401,5746,-1.2143401521495898,0.4816788695976253
A2780,5281321,-0.7497434400684011,-1.7437335058642651
NCI-H460,409805,5.4278006548731295,5.2812001766153776
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771,0.8416793616059447
SNU-81,11964036,-0.3940350311201446,1.0465422387184056
OPM-2,53232,1.210133300080481,2.712228829786546
A-498,216468,3.41587450505901,3.80022531757662
LoVo,6852167,1.8421975016001388,2.6680274642034494
SNU-449,53325874,4.456238471946744,4.651337579591732
FU-OV-1,10296883,4.259179003182187,3.9299589704956417
LoVo,3136844,3.7568853791466608,4.424678380187767
HSC-4,637858,2.398043952194309,2.2003390464640336
NCI-H522,9927531,4.749051096908956,4.479409201566955
MSTO-211H,53392493,1.8202473930982712,2.908716858881748
Panc 04.03,11626560,2.20525660125161,1.9251112972288618
EFO-27,11178236,-5.208504296414087,-3.1316473419529047
SBC-5,3503,1.24841833111282,1.9781165007614832
G-401,11640390,2.8162749001609417,3.2705263601846917
NCI-H727,selumetinib-UNC0638 (4-1 mol-mol),-1.3488333019368446,2.7827054341905284
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158,3.204622679632113
FTC-133,54454,1.7579296666098376,2.443009367328133
MSTO-211H,54613361,-0.4311183648022992,0.23780479759023698
G-401,5282054,2.6200467258422235,3.0533459432837176
NCI-H727,135440466,0.3181577925646752,2.207936074905734
SCC-9,6852167,2.7106856908699255,2.6422950603527213
NCI-H2009,124202324,1.390796248932456,2.8009287983235116
SCC-9,54618771,0.4910288003516506,1.3821410362749027
A-673,9826308,0.1905391916215918,-0.12575286877298922
KYSE-70,446155,3.830415114438346,2.9575115857509946
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.447049506015454
CA46,10296883,3.259152671675197,3.026194506596852
NCI-H661,159324,2.633762936698375,3.020202893243022
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827,1.7006579879027242
LXF 289,5328940,2.0490491787199687,1.826592360784353
KYSE-70,400769,-0.6610715268602807,-0.29428836284328463
BxPC-3,9911463,3.950256717526944,3.8857479378744126
MDA-MB-157,119607,5.813382396653367,5.245914283908727
NCI-H727,168312962,2.354698653601169,2.062574133209407
G-401,67156097,-1.3508759360204068,-1.4968484674078468
HSC-4,53232,3.536415160688875,2.6669301704844837
BT-549,9866186,1.9395157417186848,1.025837451335353
A2780,46174525,3.809782337657401,3.613049998939905
NCI-H661,24797083,0.8737198077858661,1.4622336262009343
OPM-2,107970,1.3408908225452507,1.825966100850941
HCC1143,3038522,3.729990546362485,3.2253833076690843
JM-1,5746,-1.3315669786621744,-0.6486172791095766
OPM-2,9935249,1.874633336412032,1.4435369166371803
A4/Fukuda,10302451,3.353566161735505,3.351388770948962
SBC-5,1641662,2.7360117188732684,3.510341064344631
CAL-51,25183872,-0.1080661998677032,-0.9250265493420388
HCC1143,72734382,3.642829686089203,4.573061610006587
SCC-9,67156097,-0.5297515363076177,-0.2638269379134723
LOU-NH91,17759555,3.0310153631552295,3.709395697051271
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249,1.157123941721868
FTC-133,6252,3.0791801983523297,1.2625158132101575
NCI-H146,10026128,3.971012402354388,3.3142702916752484
HCC1143,327653,2.9245812810780745,3.2694115340142567
NCI-H661,selumetinib-JQ-1 (4-1 mol-mol),2.8735822394027335,1.901420569976868
BxPC-3,docetaxel-tanespimycin (2-1 mol-mol),-4.5492420076102045,-3.394477754307125
SNU-449,SNX-2112-bortezomib (250-1 mol-mol),0.2827290486356496,-1.0825476869079302
A2780,71466445,2.121500658196736,3.175711988943437
FTC-133,11640390,4.129780643497309,3.6118264354455327
NCI-H661,66577038,3.3791675548307225,3.123205395521598
A4/Fukuda,89183176,1.286008536767452,3.093176247588903
KYSE-70,49793307,-3.275020883815728,-2.9594569072370573
NCI-H2171,36314,-6.271125424872196,-2.5299740266937456
G-401,5351362,1.1066788885055705,1.174872309116772
NOMO-1,44507138,0.557170216692965,1.6682679411143082
CAL-51,56649450,1.7310987503885624,3.226487980470886
MDA-MB-453,100016,6.0730906594859215,6.2515806033583665
NCI-H1623,6852167,1.7873387390250663,2.7371080310984324
A-673,16659841,2.6132078541729404,2.9104491244757997
OPM-2,67291369,1.773293288142809,0.7250093528689254
OVISE,374536,3.768512931442208,2.2789499059329272
CAL-51,11238147,2.100409816322544,2.7268956370601565
YAPC,11175137,3.2313352651289327,2.8893897140829363
NCI-H522,ISOX-bortezomib (250-1 mol-mol),0.0474854277983787,0.39605600401899466
OVISE,10427712,4.5158462716299415,4.334386836871655
EFO-27,5351362,1.1790960486008195,1.4565262308021503
NCI-H292,6505803,0.1482155149138876,-0.5158268013185776
SNU-61,vorinostat-carboplatin (1-1 mol-mol),3.629887150631109,2.720927508013395
DMS 273,71680916,4.789726238699708,4.06640238719734
CA46,10184653,1.13668363671425,0.8688655017580874
SBC-5,49867926,4.30527508614513,4.12104181719557
LoVo,11238147,1.4038592423826672,2.86355248061048
MDA-MB-157,11427553,2.127814795485051,2.684117611229236
SNU-61,11178236,-3.475859478717308,-2.5138478728078404
SBC-5,piperlongumine-MST-312 (1-1 mol-mol),2.5701291604117045,2.005004597305558
FU-OV-1,11214940,1.6800576649286882,2.0247555343297297
LoVo,9903786,0.6551100591729495,2.624020228480116
NCI-H1623,135411,0.3784026464220375,0.8857764700131788
LoVo,3062316,-2.119304437973892,1.3837117657840272
NCI-H661,46174525,4.042428757819544,4.514644576971782
SBC-5,51037431,0.5420283127367359,3.2107789793248234
A-498,3689413,-0.327867250415736,-0.07369055343705919
DMS 273,selumetinib-UNC0638 (4-1 mol-mol),4.157627757757485,3.090932016333649
CAL-51,54649381,3.902782783768603,3.985127089532328
A4/Fukuda,16038120,-3.113498344638628,0.5525199191548987
A-673,135398516,1.4288802928040978,1.8366392114824126
NOMO-1,135398744,6.340708200805823,4.398974265168681
KYSE-70,216468,2.031191966418552,3.054911012388212
A2780,67291369,1.1130592599106983,1.7419933979109328
NCI-H2009,654092,0.0283248260105453,-0.19750326625799175
NCI-H661,UNC0638-navitoclax (1-1 mol-mol),4.1455150469586535,2.009061369317566
NCI-H146,navitoclax-PLX-4032 (1-1 mol-mol),-2.8852479543284617,0.9718082580963658
SNU-61,11612883,3.050953505253589,2.5084596944529336
SNU-61,5746,1.3298489283886064,0.8859406075747543
KYSE-70,124202324,2.186627813347476,2.5899533572492635
SNU-449,carboplatin-UNC0638 (2-1 mol-mol),4.161475175536438,3.3742712979671823
BxPC-3,409805,3.7922849099240734,4.8716037496255105
A4/Fukuda,3552672,1.9607713184754867,2.642168570661614
KYSE-70,9907093,3.6347338213446454,4.270870087418065
SNU-61,12003241,0.1572719330395487,-0.8862995019260864
HSC-4,322968,4.636798889333657,4.144658647859205
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673,2.5960681473558287
CAL-51,16115403,-4.643171700082743,-4.088921801939978
LOU-NH91,2746,5.002248002286792,3.582446120041898
A2780,3543504,4.147653095225295,4.089211398133559
NCI-H661,25126798,3.9237728184770946,3.9256916094293826
DMS 273,4521392,4.235410021964807,4.019852416839542
BxPC-3,49836020,-2.380895293574403,3.3089206186874027
NCI-H146,JQ-1-vorinostat (2-1 mol-mol),-0.8208901447975969,0.7871188868180319
OPM-2,3689413,-4.501811354570108,-1.4553893933648114
Panc 04.03,selumetinib-piperlongumine (8-1 mol-mol),4.132461761791421,3.2994699069157583
NCI-H727,navitoclax-gemcitabine (1-1 mol-mol),1.335724896470854,-0.8591889478271827
NCI-H460,5328940,3.322075361136407,1.5499707657098292
ONS-76,25126798,4.148768722347094,3.734879375043966
OPM-2,57519531,1.419627244644159,1.855257220675952
BxPC-3,20959075,-3.864209289368053,-2.791336580892235
OVISE,54618164,4.29678583267412,4.195615509820465
YAPC,10074640,3.068654585130056,3.2592019144213786
BxPC-3,5287620,-2.837282092833542,-2.17778200709045
SNU-81,24785538,-0.3807988804027284,0.695156769145374
NCI-H292,5287620,-2.1513248285430997,-1.8828080237725981
NCI-H146,104842,-5.965892600420639,-3.6763162007899823
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236,2.1167261663072527
KMRC-1,17755052,1.9475900469511016,1.508045784816522
NCI-H2171,24856436,-0.4096039036242957,0.313281500117231
NCI-H2009,11364421,-4.013811791110126,-0.9782890730499593
MDA-MB-157,5470400,0.4579153499304774,0.24847839046179973
HCC1143,51039095,3.6749130279746938,2.620482132489081
G-401,11964036,0.0453230579510409,0.8516114687743681
NOMO-1,1641662,3.174576963224712,2.645693303601153
MSTO-211H,25102847,1.842661618149511,2.627445381671738
A-673,9908783,4.713034696547774,4.852066917155266
BT-549,71680916,6.0821013857398745,4.824143087896239
JM-1,11719255,1.4438675590466743,2.4733911582226997
HSC-4,2874250,5.810325396532396,4.650008570131197
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553,0.43671859495833865
NCI-H460,654092,0.4612941847378306,-0.25190286453896077
OPM-2,5328940,0.8145180628284293,1.1474197056851319
A4/Fukuda,44202524,1.0259860145116777,1.3470291957071625
G-401,11213558,0.7886605378704363,1.455420471721056
OVISE,135984461,1.6429740508824469,3.9442082432828967
NOMO-1,11964036,-1.1045639043109698,0.13814834392498618
CA46,6184667,1.8666466805539537,2.4932829782160444
NCI-H460,9903786,4.057661845653794,2.8392254812878077
BxPC-3,25102847,2.0998558206838913,2.650920030226353
SCC-9,5470400,0.9401931564199802,-0.03945257929316463
ONS-76,5284329,2.36276815665719,3.4027439482835997
DMS 273,25227462,-3.883072621079263,-0.09606188819002018
A-673,42642645,-0.8052568071576633,0.02580706715115431
A4/Fukuda,9549297,1.6255879909683784,1.8840165878218542
FU-OV-1,11427553,3.01783779671809,2.9512264338004304
SNU-61,5328940,1.147707594205283,1.4864931405362685
HSC-4,5281321,1.7816899121848235,-0.8369278266541527
KYSE-70,656346,0.9492660515895844,1.3944538078707682
NCI-H1623,72734382,4.853935764849827,4.617605334236122
MSTO-211H,67156097,-3.635314822435898,-0.5146593674141964
MDA-MB-453,637858,1.2138352699902215,1.8570546855982304
CAL-51,56963564,0.4281851677964957,0.6880942158588028
A-673,10113978,2.507382463710335,2.6911453365102767
YAPC,2946601,6.339465197306548,3.9708565602205073
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617,0.39960346766745547
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872,2.9403993744981767
HSC-4,65628,3.12205826618997,4.643628305956395
HCC1143,227681,3.1373347590378335,3.686575582497596
A-673,53301938,4.3782771731899555,1.256621511480371
G-401,66577038,2.320880294749871,2.7717473316334322
NCI-H661,9884685,0.1767392095869446,0.9482985439112923
SNU-449,6184667,3.7989058233577566,3.3181035422831116
OPM-2,24951314,0.2222837933942169,0.06075848470613206
LXF 289,56963564,0.2991276479966406,0.4208558405742939
HCC1143,11364421,-2.85203888888326,-1.414641617160126
NCI-H292,9936388,-1.1579069678838152,0.1398781610619329
G-401,10231331,2.894718734978725,1.8581273607079434
CAL-51,89928392,1.068329558331595,1.6577198454934023
NCI-H2171,53392493,1.8740494203136608,2.057684972853289
A-673,136227331,4.241984110268528,3.6275283767436592
NCI-H727,11717001,2.7053596974758594,3.766291240115421
A2780,16219061,2.814782356526162,2.8550056820663263
SCC-9,54454,3.1137155512464596,2.783909779407905
YAPC,12003241,-0.7644111057992425,-0.8242324971419568
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187,2.6785222591223423
SNU-81,5335621,4.181800470543683,4.242494120314846
CAL-51,5329102,2.0492492410301484,2.018338388043043
NCI-H146,10385095,0.6869778017915235,1.0615749480714984
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165,2.7051000490160755
SCC-9,2113511,6.3303497429476625,5.484099217410285
ONS-76,2708,5.792421817961339,4.439595708904531
SNU-449,11485656,3.58452534173841,2.6206764805817637
A-673,46215462,1.2771489946566346,1.5587396222873988
FTC-133,285033,-1.2963608176743802,-1.5089576669381608
SCC-9,6184667,3.279451062583292,3.0575004928773444
NCI-H146,16722836,0.0677462505380894,1.4153305409719754
NCI-H661,44137675,3.7576040576240257,3.7517446354074404
NCI-H1623,11612883,1.5649574760969076,2.621666346903538
LOU-NH91,3825829,4.327670981782257,4.042300671758356
SCC-9,5287969,-2.1272191034883874,-1.80739179090654
Panc 04.03,10410894,3.886544188244091,3.418406625012093
NCI-H146,135398516,1.5035346569298091,1.9912959499805896
A-498,4096211,4.004902569915099,2.3410766388817628
OVISE,104842,-0.680714151991963,-2.3215643119518505
SCC-9,135440466,2.439160969941936,2.4546630804029466
ONS-76,10322450,3.321198163736043,3.6827299806061005
SNU-449,81146,6.119223793669881,4.72019901283424
JM-1,148124,-7.840698833354439,-3.7620448635655155
BT-549,5460769,6.35928800843138,2.8691738638573963
MDA-MB-157,969516,1.7670354115722269,2.9005998179854005
LXF 289,5278396,2.6487510770020104,3.608367137591791
ONS-76,100016,6.019166856387977,6.036850853507032
A4/Fukuda,11707110,-3.666992219196893,0.5593771503754897
JM-1,6438330,0.1685207017328377,1.0075655210509609
SBC-5,navitoclax-sorafenib (1-1 mol-mol),1.4051935643931297,1.5844588245443083
BT-549,10074640,3.6929061121608577,3.1960992975424136
A4/Fukuda,46926350,-6.021657358635238,-4.211195012244122
SNU-81,selumetinib-JQ-1 (4-1 mol-mol),-1.924488986117384,0.721042132273042
SNU-81,4917,2.3748179961814375,2.852547241987462
A4/Fukuda,119607,3.918640768426122,4.514576690754766
HSC-4,613753,3.3632883902358715,3.321974844348715
DMS 273,135411,0.7219297948054574,0.30132072761259926
KMRC-1,46907787,3.729545872280723,1.8623027096123113
LXF 289,44489675,4.904101073680104,4.07260131539922
BxPC-3,6918736,-1.9181543280529496,-1.30564130832139
KYSE-70,65064,5.1318583658275205,4.880515136983938
HSC-4,25062766,1.8609848482730849,2.2614617270790722
SW1463,15983966,1.3055923116721375,-2.56604087017811
HCC1143,11396600,3.529486359294858,3.8964569982841675
SCC-9,45279963,4.124125049817703,3.85205583278913
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289,-2.479378644356452
NCI-H661,5113032,4.99918939361245,4.868174276405059
LXF 289,17759555,2.434653643868842,3.90576080852172
DMS 273,46926350,-4.333780789364997,-4.256245970122891
OPM-2,46224516,2.1207785622277373,1.9109536302210473
A4/Fukuda,9908783,4.281950187885367,4.598991310190274
A4/Fukuda,1716436,2.785785051354721,2.833965418969834
KMRC-1,54454,2.958009627513852,2.7262909747232285
HSC-4,73707371,4.771220465805862,4.9452024871632
KYSE-70,9911830,3.1951659700149886,2.7047623192059187
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346,-0.4749919187191836
HSC-4,16720766,-1.6245250648624636,0.5104144814193083
OPM-2,11964036,0.2409704368173301,0.41371823287153886
LXF 289,3038522,4.104388560491244,3.122116811269011
A2780,49793307,-3.5064247630527494,-3.4124937108185636
MDA-MB-157,12003241,-1.4339892472843776,-0.964989713910569
MSTO-211H,53495165,-2.281905985837366,0.830789979736862
MDA-MB-453,24797083,1.319210590833939,1.3834032976862292
HSC-4,25126798,3.2488654911973196,3.8605532861164455
BxPC-3,3854666,3.4835595653471167,2.3946806475422604
HSC-4,176870,2.813832788377266,2.83130625902175
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128,-0.45590772542241587
MDA-MB-157,alisertib-navitoclax (2-1 mol-mol),-2.615500389933575,0.5846598657241497
YAPC,135398744,6.484368053683043,6.377434660982434
MDA-MB-453,51039095,2.709903892694302,2.4110527510884725
CAL-51,24821094,3.2618915388877023,3.282841213623448
NCI-H522,1239801,3.903810420887451,3.4073133017104906
KYSE-70,7251185,4.369311092923008,2.6250855828537176
CAL-51,navitoclax-birinapant (1-1 mol-mol),5.691707887303523,1.05132791995828
G-401,60750,-4.380742093252711,-2.7071063961589528
YAPC,11404337,0.4717703732171429,0.19256608873171976
MDA-MB-157,9826308,-1.0851482905673768,0.7092512552113638
MDA-MB-157,25262965,0.470934001928582,-0.6593551906211917
FU-OV-1,10427712,2.3896052276409887,4.4185333969470975
CAL-51,285033,-2.914004430070481,-1.8241680483924037
CA46,246676,4.699933053014099,3.8029163978884015
A-498,9926054,1.5026788619071982,2.278930307542042
LXF 289,44632017,2.313535350982782,1.6865849403875817
NCI-H727,3689413,0.3749801507161196,-0.10070044020307577
SNU-449,1716436,3.0856052265463023,2.993917377076032
LOU-NH91,24951314,1.380037957351277,1.6782308228817906
SNU-81,46191454,-1.5874627182763832,1.3813556003685228
KMRC-1,119182,-0.1449504353389931,-1.136982257039122
NCI-H522,9823820,3.261618834820585,3.384491149727436
NCI-H460,11178236,-2.300904923417752,-3.159272018357043
A2780,5738263,3.096886997462696,3.141707780712116
NCI-H661,carboplatin-etoposide (40-17 mol-mol),2.8210696568936786,2.908606013044877
BT-549,5287969,-2.055370090828861,-1.5638540284784688
BT-549,11609586,2.735581966533724,3.3547740889411948
OPM-2,1317464,3.5924971065959244,3.028653354000188
NCI-H146,54639701,4.038686865533554,2.5615454655256604
LOU-NH91,3384730,3.7773271912609623,3.3056588299507585
YAPC,11152667,0.3482753398657929,-0.4617202464508467
SNU-449,702558,5.257858019653286,5.286165902871136
MDA-MB-157,selumetinib-tretinoin (2-1 mol-mol),1.8981533797930392,3.5942825554627285
FTC-133,6438330,2.249518605035186,2.34047158024334
NCI-H727,12001922,1.7281936629666887,1.8270325015730255
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685,2.9583856114366704
HSC-4,60750,-5.118377280037083,-1.9252705455227719
SNU-61,1566236,1.9599867850180668,2.224187059326316
NCI-H460,5282054,4.802373462225767,3.828395176520849
DMS 273,6610216,4.172124776089646,4.121577556610688
NCI-H727,6852167,3.356078560596427,2.574949426930425
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591,2.345515398228877
SNU-61,445455,4.539446073708065,4.166542834472382
DMS 273,3062316,3.60345807305724,1.1495622651793276
MDA-MB-157,9956119,2.310937024804907,3.7328444314682265
OPM-2,135423438,0.9866001177758746,0.984048987994351
Panc 04.03,16722836,2.845252730089092,1.7435979289265553
MDA-MB-453,9936388,0.6028011486270662,-1.2644924737264938
A-673,68056272,3.7833857366006094,3.492786065797915
HCC1143,16722836,1.2433455264432278,1.5227494067240606
DMS 273,72193861,0.4647891664131632,0.7223795664508548
DMS 273,navitoclax-birinapant (1-1 mol-mol),3.616691876772055,1.3311693667668476
Panc 04.03,11396600,3.73844061007523,3.9565790120850663
NCI-H522,6505803,-3.5272214952237344,-0.3683761218441125
CA46,56963564,-0.0544830399645368,-0.4286759577704791
A-673,9825149,0.7138432506885886,1.936286905842937
NCI-H1623,2871966,1.4286416314522286,0.5920550440644393
SNU-449,4096211,1.9400565485658428,2.4120571990940958
CAL-51,44137675,3.485867182081199,3.2162138102933566
MDA-MB-157,375860,0.0174110406826079,-0.0010713387788093636
MSTO-211H,327653,2.467891014920142,3.350367060528453
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371,0.10002528530173653
CA46,11178236,-6.883102305003874,-3.8185328413938158
NCI-H661,5291,3.8370923902638063,3.634454278080459
FTC-133,25262965,1.6757685209235111,-1.1770111041599005
SNU-449,24771867,3.0453458349703793,3.02105178685315
HCC1143,9911830,2.6182666070844447,2.735656615910884
SNU-61,44185566,2.430559307269213,2.0607938916266604
SNU-449,445091,4.4459202939225815,4.487783618979014
LXF 289,123631,1.612545473594554,2.470171026042433
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453,4.285976459361623
SNU-61,637858,1.6436621136217924,1.759824014806988
MSTO-211H,3025944,3.596075182431598,4.428563368492447
SNU-81,11612883,1.8877401103471,2.331916371443736
A-673,52912189,-0.9448854486243604,1.0474334112740824
NCI-H727,613753,3.184500780825273,3.35063294773813
BxPC-3,24856436,-0.8809901773698104,0.6583764433342388
SNU-61,3038522,3.6960216122526943,3.1198826310878007
KMRC-1,374536,2.325099751463231,2.1555447600752093
CAL-51,54613361,0.2180057854442524,0.23506372486624477
CAL-51,10385095,1.0305027810027567,1.351134554602969
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945,4.007037950972895
LXF 289,5281321,-2.4870532876216487,-1.144496070450722
SNU-449,10184653,1.7910926490151993,1.9438382930549836
SNU-81,9887053,2.281153151762533,3.376268824514479
KYSE-70,11485656,2.2230455690794404,2.4582452355646054
CAL-51,439501,-2.444412450902406,-2.035631090176185
A4/Fukuda,72967,3.695839205584607,2.5763921156210743
NCI-H1623,navitoclax-MST-312 (1-1 mol-mol),2.6356568038196175,0.9254056669327191
BT-549,57519531,1.7866000969199525,2.4258276843870274
YAPC,9911830,4.0093640169179325,2.686336457096615
KYSE-70,54143018,-0.2928055682999507,1.1860924711865457
ONS-76,6852167,3.4771955261396252,2.6340540859060075
CA46,216468,1.7849524837603168,0.8478000081857894
KYSE-70,71304818,1.8226881659751617,2.580494291628987
SNU-449,10427712,4.716616821408685,4.510366288648303
KYSE-70,11364421,-0.2598881855214042,-0.8595437329610448
SCC-9,46199207,3.715699147831311,3.30131662457143
OVISE,tretinoin-navitoclax (4-1 mol-mol),1.2267801901076945,2.554687874751069
SNU-81,selumetinib-navitoclax (8-1 mol-mol),-4.808792251277437,1.2956682776127681
NCI-H522,45279963,2.975445810656792,3.2788166233855014
NCI-H727,44137675,3.902640688581202,3.432135425744083
CAL-51,doxorubicin-navitoclax (2-1 mol-mol),-2.632738790580408,-1.5152910800619048
CAL-51,3854666,1.1494535123186709,2.058640013896164
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446,2.639276693372046
NCI-H2009,81146,6.16166931928307,4.900328639502164
LoVo,135440466,2.5900307411888357,2.0572798137931914
G-401,445455,4.8654155018395535,4.1621650304449
NCI-H1623,15547703,3.108106821400364,3.1964876302941914
SCC-9,322968,4.6886309532040435,3.9807090160079883
MDA-MB-157,23635314,-3.347178711973772,-1.052137531642673
CA46,49793307,-4.01311922110524,-4.813692160393904
CAL-51,53495165,0.3298774405260949,0.15097076582000274
SNU-449,54618164,4.194291334344069,4.184341928751192
LOU-NH91,11178236,-2.353397629942184,-3.040520441116201
A2780,5284616,-6.357248921927095,1.708183667637715
OVISE,11404337,1.793635825025173,-0.08778654901320752
HSC-4,216239,1.6239220207771676,2.6487872353738475
NCI-H1623,208908,0.8939149685214822,1.9389744402092715
NCI-H146,25161177,3.485806465133522,3.6118294304659577
YAPC,6918328,1.93910137978286,0.16632312503344274
EFO-27,3038522,3.6669358154068097,3.3961625580906527
DMS 273,25262965,-3.6359475061731534,-1.4463717835878116
SNU-81,9803433,4.184314019267332,4.468698458413768
SBC-5,5351362,3.2358684618056164,1.6292353247440392
NCI-H661,9826308,-0.3578866099027624,0.599628669676767
CA46,462382,0.6475442737717811,0.31187335419214196
SNU-449,168313200,1.9091128501610053,3.147662144876736
SBC-5,613753,3.3291324843640497,3.297018946832616
HCC1143,24797083,1.671403596818138,1.5209464629208704
NCI-H522,11625818,5.118334572164132,3.7165998750243214
Panc 04.03,446155,2.4976903608369994,2.818621198989189
NOMO-1,2733487,3.664178503465112,5.132978753741038
CA46,11494412,-0.1540181126177876,0.3234653724065414
KMRC-1,168313200,3.9547474801247455,3.0234846453614086
BT-549,12003241,-0.9663956127583828,-1.2216307677625395
MDA-MB-453,53232,4.528141583720988,2.9001538469128065
Panc 04.03,BRD-A02303741-carboplatin (1-1 mol-mol),4.551523048928573,4.346107337833995
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604,2.2140828570047217
BT-549,7251185,2.7032329014559555,2.721638726761235
YAPC,72734382,4.459010686131963,4.722453849212167
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345,0.3492092892078499
LoVo,10113978,1.9718639606113115,3.2395194788306303
G-401,9884685,-1.463173781220529,0.2265510110481798
NCI-H460,969516,4.1763077592827225,2.991945631261313
CAL-51,docetaxel-tanespimycin (2-1 mol-mol),-4.362144159711312,-3.5449923400363215
NCI-H522,10302451,3.5044820085806645,3.246027431313647
SNU-61,10127622,0.6703048084308344,2.897807932035844
DMS 273,216239,1.7826696655906364,2.030859290826539
NCI-H2171,24785538,-0.9958553447114444,0.28696209364124187
OPM-2,2945648,2.5610378238786367,2.3246616575192482
JM-1,5278396,3.0111139094733987,2.9770600160185103
A-673,11625818,4.166556040788123,4.003580011469597
MSTO-211H,23582824,0.616921606097025,0.7002131451567627
CAL-51,11977753,-3.094424679361229,-1.4772983801200845
OPM-2,55283,2.954343465689474,1.98576157164648
SCC-9,445091,4.9115801471194365,4.369979083458542
FTC-133,11609586,3.5175505098064113,3.1540312949015687
DMS 273,16065773,2.5819171284899873,2.244467325395211
NCI-H661,16725315,3.2574493912109315,4.161846742262222
ONS-76,3825829,4.014711164490238,3.7194761777688514
NCI-H2009,613753,3.3208706433892483,3.4293817542936167
OVISE,72376,-0.0680425204905225,-1.5317389265494241
Panc 04.03,1566236,3.6247050899799698,2.5492322960253735
KMRC-1,10385095,1.0697515150450725,1.4520209723340611
MDA-MB-157,6918638,0.523436976846598,0.780491040108735
SNU-61,10231331,-0.1396530061474971,1.6961412916433525
SBC-5,67156097,-2.1260485275267684,-0.31098879459958245
HCC1143,16720766,1.508740109375584,0.7996581153771778
SNU-449,5311281,1.2425771495660034,2.3465263209135356
EFO-27,15547703,3.36481674718985,3.4064506486173247
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683,4.071768875616669
HCC1143,71466445,2.406598865609875,4.042655550500771
HCC1143,11625818,4.1599423197543395,4.49907869627653
LoVo,67156097,-2.753278115102512,-0.7342187999894637
NOMO-1,3385,1.8227638422939128,2.1260525474274106
JM-1,11494412,0.2153546786296628,0.4639265766040115
SNU-449,3384730,4.130527031297823,3.347637142128032
KMRC-1,2871966,0.6996568641549454,0.625786492887392
MDA-MB-157,2126,3.382661447598077,4.749201780869172
SBC-5,444795,4.741830288065925,4.667264724991618
CAL-51,135398516,1.449392214756173,2.384985786066309
CAL-51,selumetinib-UNC0638 (4-1 mol-mol),4.646662024517227,3.6820022323415253
FTC-133,11626560,4.477282693511418,1.9594357702479885
NCI-H2171,135411,0.036573209368321,0.4135410528366624
NCI-H522,5479543,3.719555600198391,3.0129003681732014
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547,1.7260189697391382
SNU-81,44494148,1.061827805146114,3.24160799016383
OVISE,119607,5.735286818250817,5.216414478256095
CA46,4578,4.451375135730711,3.9146276882210764
FU-OV-1,navitoclax-piperlongumine (1-1 mol-mol),2.023653307095543,1.896261216884385
MDA-MB-453,148198,-6.384072425395857,-3.625048376371715
CAL-51,44491742,5.152478206660974,4.151397458534521
G-401,6438330,1.230579919692557,1.7776478307882542
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266,2.0662077346150842
KMRC-1,2746,4.901784458568857,2.821515368715046
SW1463,3025986,0.7137013515595916,-0.9174043803645229
NCI-H727,54618164,4.079418853402711,4.029091207289443
CA46,9907093,3.753589195065423,3.330960327026913
CA46,1750826,-4.755590130007624,-3.097224302698197
G-401,135411,0.5966957307940325,0.4641421964875107
NCI-H727,9825149,0.533141934304371,2.0664157745838856
NCI-H2009,168312962,3.455210391348572,2.249173666414095
NCI-H522,25154868,4.970187113391964,4.23430008575931
HSC-4,3503,2.6271988960037502,2.384138632723588
SNU-449,54619267,4.584813130836932,4.231816119770637
CAL-51,44507138,2.6477043136390637,2.455967137119731
CAL-51,24753719,3.9981702522006257,4.379684178930948
SBC-5,16725315,4.9617798252058165,4.133575063667056
CAL-51,123631,2.4616591372530605,2.4578509040286267
A2780,56963564,-1.0587892817911606,0.1695697465500068
LoVo,119182,-3.2827225124554804,-1.1496277280631373
A-498,3503,2.8872062971439436,2.6382863190302057
ONS-76,navitoclax-sorafenib (1-1 mol-mol),1.6529923050445217,1.742734870837497
FU-OV-1,9915743,0.5010130642537969,1.315411044924291
LOU-NH91,6917907,-5.4115573726076125,-5.179029474352843
A4/Fukuda,322968,1.909418940393303,2.1927245629942864
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936,2.1942730470784015
HSC-4,54618164,4.183236352259565,4.241194840802444
SNU-81,navitoclax-MST-312 (1-1 mol-mol),0.1255158725803597,0.6980239911049793
MSTO-211H,89928392,0.2675284607275224,1.7530962009546622
MSTO-211H,16741245,3.31564558456852,3.646118065919881
FU-OV-1,969516,2.7898134338200093,2.9105337941300977
FTC-133,9840324,5.72186430729165,5.746192760727427
FU-OV-1,2828334,6.23308188240882,6.278866898924421
JM-1,docetaxel-tanespimycin (2-1 mol-mol),-7.819980451052631,-4.7166660117510935
NCI-H146,25062766,0.9164062509537028,2.1186202654671136
MDA-MB-453,44197249,5.538441394278097,3.758973800678383
NCI-H292,25126798,3.8121795120859865,3.8540998595710843
NCI-H2009,49793307,-2.1832388254663746,-2.196283752202902
ONS-76,446155,1.9434822335598465,2.6959069726626295
NCI-H460,613753,5.368273372553464,3.3161946424087114
NCI-H1623,375860,-0.2497324332058591,0.23169364233776876
NCI-H292,135440466,1.1809367948500966,2.3434501752211134
DMS 273,24821094,3.2786522000090974,2.6749568070812795
CA46,1566236,0.9666867201201066,1.7349315550629998
LXF 289,6914657,-2.1957863105134474,-3.5015905601679136
BxPC-3,68056272,4.30573170491611,3.852487204670114
CA46,24856436,-0.7056093623802927,-0.5812949669899465
SCC-9,136227924,3.721677265331546,3.1573782821568437
BT-549,5281672,6.431065394953252,4.692745955689415
KMRC-1,136227924,2.9529226708788734,2.7308890955377625
A2780,46224516,3.0956757820489966,2.3680193276057624
OPM-2,2871966,-0.6940984937409527,0.18678954872530718
NCI-H522,44607530,1.256897748575463,1.7158580235863627
YAPC,135421197,1.6415717791988456,1.9583597751389765
Panc 04.03,11609586,3.1950022878003375,2.971590529871836
YAPC,285033,-1.734058118132599,-1.297348845511074
EFO-27,25161177,4.775691091389994,4.211461561028978
MDA-MB-453,285033,-3.584093663874095,-1.9404431181540844
YAPC,135398516,2.168624804585352,2.278391601867767
BT-549,10184653,2.4120945582019098,1.805877917633641
SNU-61,322968,3.1681402320576924,3.1988529642766483
CAL-51,9911463,4.251278022142156,3.8382327899584983
NCI-H661,119607,4.8407678671423975,5.253654263432436
Panc 04.03,navitoclax-pluripotin (1-1 mol-mol),0.6568791219760653,-0.5418829761073501
CA46,16720766,0.453567173389679,-0.8452297492706415
CAL-51,11404337,-1.4033364127444676,-0.3296278386233897
SBC-5,9911463,4.310936662946409,3.744711496277665
NCI-H727,2828334,5.890997909388885,6.2647085228495
JM-1,104842,-7.303088314363844,-4.537406481386736
NCI-H460,5335621,5.645903220513178,4.618507873882387
MDA-MB-157,ISOX-bortezomib (250-1 mol-mol),0.8277419655011916,0.43711614104300445
HSC-4,12003241,-0.0373048915881231,-1.1054938597495758
MDA-MB-157,53301938,4.15898814375023,2.4129245274089324
MDA-MB-453,25150857,2.1104930677980964,2.4358717662151865
HSC-4,25183872,-0.8460464512297751,-0.6978003021468556
CA46,46907787,-0.8110179268567884,-0.37345745388580703
LXF 289,5311,1.216776445363927,1.7828815192162608
NOMO-1,6610355,3.932739350210071,3.9937652905125156
CAL-51,11222830,1.6762547521470548,1.4447920168352177
HSC-4,9915743,0.765957034876682,0.5375317653371227
SBC-5,72193861,-0.1091418694351138,1.8256318360999828
NCI-H460,60700,-0.2314807684970784,-0.3084830987774822
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585,-0.5781510652074189
SNU-449,2729026,2.998695944617882,2.8453118547988954
A-673,6914657,-9.096845778146204,-4.640484476202827
EFO-27,64971,3.389505323176025,2.707294071515727
MDA-MB-157,44137675,2.4962707088889524,3.593987654703197
A-673,374536,-2.1767869041067462,1.2472797704743492
NCI-H522,24951314,1.0216385721244754,0.8792070987764585
JM-1,16038120,-0.8379540118722992,0.17644695959068352
SNU-449,25126798,3.9846076439311258,3.8905210615709933
JM-1,9444,3.0857992205099616,3.548325333451489
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408,2.223548913818752
A-673,327653,2.521292352419487,2.8158808714210504
MDA-MB-453,5470400,0.9814504444661803,-0.7759099903399295
KMRC-1,71751553,4.436686890494674,4.488775038738009
FU-OV-1,52947716,3.0881190342895626,-0.34620032315326854
A2780,selumetinib-piperlongumine (8-1 mol-mol),1.4682842142884078,2.5894341133025285
JM-1,3825829,3.3725964609251005,3.224695124445824
G-401,6918328,-1.3062418496747916,-0.632175912672761
OPM-2,136227331,3.7431952210756014,3.6085269791580883
OVISE,5281321,-1.443802792924895,-0.8233695520333657
CAL-51,6450551,1.9748462748620472,2.7090053281903903
DMS 273,387447,-5.016212668564022,-4.901999511782679
OPM-2,5278396,3.463635489570463,3.137075701870012
ONS-76,445643,3.769289821936489,3.9819535589349755
OVISE,676352,3.019558255819343,2.121055733315598
OPM-2,126941,-4.73900193491969,-2.880926721844048
MDA-MB-453,11404337,-0.3002498088297632,-0.5733231302101514
NOMO-1,24797083,1.0415171353084307,0.8078381374487043
NCI-H522,374536,3.894183139895475,1.8920726117677518
A-673,6252,-1.7615808961584718,-1.0466434230061752
LXF 289,9915743,1.5678711489122208,1.2298571492769437
DMS 273,72734382,4.203397510599988,3.6296115599502716
NCI-H522,selumetinib-tretinoin (2-1 mol-mol),5.363366003063694,3.4541352300099795
A4/Fukuda,BRD-K55473186,4.020373973875239,4.006874520806702
FU-OV-1,6505803,0.8019489696335256,0.029603852245447912
NCI-H292,10074640,3.1247192788252134,3.282929039965089
A-673,3854666,0.8608139997201792,0.9900147999896336
EFO-27,637858,1.802850970746332,2.1340533866040805
MSTO-211H,123631,1.7071024302486195,2.5452718756471207
OPM-2,54619267,3.38914180731132,3.571683807840724
SCC-9,11612883,3.4111633177056992,2.879679004799296
MSTO-211H,BRD-K55473186,4.0690738661382175,4.074717367256003
CA46,25154868,4.248651634430963,4.0047995254169715
LOU-NH91,6918837,-1.6936529516603684,-2.230113597312674
OPM-2,9911830,2.101419447334853,2.0764816639228822
BT-549,6438330,1.5528656655176645,2.5106151973001376
EFO-27,11647372,2.575313315468432,1.6911995056291778
SNU-61,568763,-0.2886838000487807,0.5855467792819522
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462,2.2589024319064537
Panc 04.03,5282054,4.5317440773242925,4.060575273460924
YAPC,53232,3.166937959197618,3.1012130599809935
SCC-9,44486219,3.972056382599232,4.292319703402083
NCI-H460,104842,-2.7771726159534773,-2.697922950093719
BxPC-3,4788,5.831531206482249,5.811948804574672
KMRC-1,753704,4.9867166993089365,4.709500277927211
MDA-MB-157,71729975,1.9097389430207852,2.4230167871971506
MDA-MB-157,46398810,3.5828771462995666,2.525955345903691
ONS-76,42642645,1.3507577274785498,0.9368504982104922
EFO-27,9956119,4.364890218263242,3.8922506052252386
SNU-61,49850262,3.504538311157692,3.25161562296208
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322,3.7356164326721824
MDA-MB-453,9967941,2.180105496017499,3.2816800359569283
OPM-2,409805,3.1459770002319023,3.720596287972455
BxPC-3,11214940,1.4945762019529478,2.0161757378322194
CAL-51,71466445,4.7818956768695715,4.299709386405706
YAPC,44137675,4.160217990140765,3.5551951637359256
A2780,3465537,2.6217509140821247,2.146304427901322
SNU-449,135398744,6.632733291537939,6.437720480923234
A4/Fukuda,676352,1.592410759121419,1.7367432038454362
NCI-H522,5566,3.055916396278747,2.963577681391293
SBC-5,6252,1.1660150864515155,0.7989015962269298
NCI-H460,65064,5.803776096144955,5.104478899611039
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678,0.7536810538865168
KMRC-1,60700,1.5998244644110848,-0.12209499229296152
MDA-MB-453,72734382,3.580352840578633,4.428803208896485
FTC-133,BRD-K55473186,4.331616686106064,4.15212630948899
NCI-H661,3062316,-1.6378145648450078,1.0986208249765472
NCI-H661,11977753,-1.2976183269776842,-1.5401170043174117
KYSE-70,4477,1.3887255745641551,0.24708394535996445
A2780,15953870,2.2934332620703457,3.3774344906544034
SBC-5,44589607,3.2873586375678627,2.8739303760818036
NCI-H2009,3634881,3.6058977960867233,3.495795416878322
A2780,5951923,4.306994873236267,3.8599888615016185
HSC-4,11152667,-1.532358108136572,-0.4208722019583125
OVISE,3543504,4.513312782724499,4.224709822205419
CAL-51,676352,2.3367523995253454,1.9544078398999085
LXF 289,100016,7.121965810949268,6.38430628679472
OVISE,JQ-1-vorinostat (2-1 mol-mol),2.753881285057562,1.2195697202786646
KMRC-1,4096211,2.4789291220770053,2.091930976995556
NCI-H522,2949965,1.5154466163896825,2.3691975008362136
G-401,613000,2.0341288465268397,2.5848211646713786
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745,3.4869906731234153
FU-OV-1,46907787,-0.0188806347407138,2.5141976302823674
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331,1.494535743656491
NCI-H522,9926054,1.815484319665427,1.8551115110543401
EFO-27,9866186,1.214213380462077,1.0516803090126594
DMS 273,446155,1.3230843960440628,2.480380569633585
EFO-27,136227924,3.515702384882397,3.1978669302406697
NCI-H522,25161177,5.347457629837048,3.4388600610498674
BT-549,107985,-4.157404914346088,-3.3693504916335986
CA46,vorinostat-carboplatin (1-1 mol-mol),1.5433198119850344,1.8555836456184298
CAL-51,984333,0.1261860025273146,0.6100018459969023
NCI-H2009,60700,0.1880080174398503,-0.019583639360028972
CAL-51,135421197,1.6266864976107616,1.8185082777869743
MDA-MB-453,54619267,4.30313846005301,3.7333780594999335
NCI-H727,72376,-1.9917966726836325,-1.6593009943370125
A4/Fukuda,54618771,0.259551202975953,0.0446778341789637
HCC1143,5280436,2.2824596389444567,3.3882736749303883
FTC-133,168313200,3.883948141330694,2.901577470158862
LOU-NH91,11427553,1.5999683226177923,2.9709597840554887
LoVo,5287620,-2.196691557023958,-2.083111463546613
LOU-NH91,11222830,1.619786635706389,1.699718206756874
SNU-81,ISOX-bortezomib (250-1 mol-mol),0.4477556870323437,0.8171593033644432
ONS-76,44507138,2.3475098717107685,2.477085130052341
EFO-27,12001922,2.6878207164132517,2.001645774543224
HSC-4,25102847,2.881629074853979,2.7033141071438904
A-673,4477,0.9527863024115504,0.3522892562637063
YAPC,119607,5.457421403002251,5.311789150490858
SNU-449,11364421,1.172419453845969,-1.6077534944900878
FTC-133,1566236,2.958331107997485,2.4529178819623327
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068,2.8015878264794987
A2780,9956119,3.341179703016576,3.2699617157237046
A2780,421610,3.3194399172740296,2.7938837289634364
MSTO-211H,11656518,-2.9147381038014095,1.9030877633556436
YAPC,carboplatin-etoposide (40-17 mol-mol),3.290819811015708,3.235290331738179
ONS-76,5282054,3.726244399490591,3.8146955344408155
BT-549,JQ-1-vorinostat (2-1 mol-mol),2.606631722875188,1.440938570895683
SNU-449,1750826,-2.5268598200751504,-1.2145217005797055
HSC-4,56949517,4.34052816497715,4.294072648478614
BxPC-3,alisertib-navitoclax (2-1 mol-mol),-2.4786410081497223,1.0421014491120004
LXF 289,11175137,1.607203821415342,2.6962957096929507
LoVo,400769,-0.9988261077541156,-0.5805919606425278
SNU-449,9823820,4.446865909721317,3.9925773807459084
A2780,23582824,-1.3073183780043152,0.8441564472692294
LOU-NH91,24821094,3.1074025746804854,3.339740991356113
NCI-H2171,1566236,1.862945078393334,1.8428794320361368
SBC-5,alisertib-navitoclax (2-1 mol-mol),-0.5027212648938616,0.5098125748774802
SNU-81,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.6771468011681286,3.0280243038599677
LXF 289,3815108,3.5075214319549683,3.1634739632470117
SCC-9,6918638,0.4192666549800527,0.511422422710051
LoVo,54626689,4.759845357486115,4.597338344410972
HSC-4,9956119,3.775946121479013,3.6297969371991763
Panc 04.03,carboplatin-UNC0638 (2-1 mol-mol),4.7376936577432405,3.719563114353831
JM-1,2708,2.6994993672471774,2.9104651906613306
A2780,151289,-0.0035192392559562,0.7423506550981587
JM-1,135440466,2.1821804764998785,1.9545174884018344
SNU-449,JQ-1-vorinostat (2-1 mol-mol),1.642225062280099,1.3778429475901373
SCC-9,100016,6.423023301160456,6.2915935247743775
MDA-MB-453,24180125,2.9500133631526477,2.9155080456958724
MDA-MB-157,6610216,4.481014218943506,4.347855630813532
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758,-0.6768382116768551
MDA-MB-157,216239,2.048111671637324,2.5991446583593567
ONS-76,72376,-2.745447792813742,-1.7596538246044897
YAPC,56946209,-4.683971162846982,-4.0216503629803055
LXF 289,11977753,-2.1467130480879217,-1.4983367479859766
A-673,46926350,-6.171938943197618,-4.461865399147575
SNU-81,44490293,1.2258782245734428,3.318216804768326
A-673,3384730,1.4382839107098095,1.8775440393862488
HSC-4,5328940,0.4436918358674775,1.6886254011277781
MDA-MB-453,15953870,2.92470748098227,3.1694871286845347
ONS-76,44487061,4.494085272908884,3.3910961300746036
MSTO-211H,656346,1.1626228980727835,1.0657311489833505
NCI-H522,72376,-2.490005030905514,-2.5886894252817068
A2780,2945648,2.954770875487345,2.506632578284305
OPM-2,49867926,3.883283056469906,3.1759187467329792
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078,-1.406371005028645
FU-OV-1,2729026,1.7636424043101242,2.8726306242306006
A-673,5351362,0.6290025594893434,1.2993457901026344
NCI-H727,crizotinib-PLX-4032 (2-1 mol-mol),1.979940863489789,1.8045241947146908
NOMO-1,3384730,0.781590014898287,1.373367600137577
A2780,753704,5.064252843259393,4.370747785292437
LOU-NH91,104842,-1.007764649763801,-2.0770884070604354
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884,3.0881698422193415
NCI-H661,135398738,5.197398941249139,4.492896793463595
OPM-2,11213558,0.5330056992590615,1.0465238999849797
SCC-9,216345,4.596520649168519,4.070611227721538
LXF 289,73707398,1.5723760999376108,1.44599307062273
KYSE-70,148198,-2.193158047226166,-3.267210396827751
LoVo,5281672,4.34355838965171,4.581832644556198
NCI-H292,3081361,1.6323755734101046,2.4846313263039734
NCI-H292,969516,2.7034021602074207,2.817296076849937
BxPC-3,carboplatin-UNC0638 (2-1 mol-mol),3.4079462645676815,3.4045384852805345
DMS 273,56963564,0.2331753873879126,-0.1959950846568804
CAL-51,168313047,1.9592520089902103,2.4344797602605164
CA46,2949965,2.263314804434843,2.106577349596773
G-401,135423438,1.541142645334712,1.5890014189274166
OVISE,16741245,2.37455837119256,3.677559326754767
CA46,3634881,2.7183374991781903,2.388938056102649
HSC-4,11427553,3.1625220487182193,2.881970490932156
BT-549,selumetinib-UNC0638 (4-1 mol-mol),5.0457009484631365,3.699368012599357
G-401,168313200,3.793890782777564,2.751766356639773
A-673,3689413,-2.493408888485536,-0.9800709085334804
OVISE,JQ-1-navitoclax (2-1 mol-mol),0.6695486858757606,0.27634590391720604
A-673,3062316,1.882423163055416,1.1681971712592036
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045,2.5031220133077814
FU-OV-1,49766530,-1.0180111021842635,-0.47008578714862814
NCI-H1623,4259181,0.7011384719609343,0.32676476100054513
NOMO-1,11427553,1.1686106553832942,1.1645152670930425
JM-1,25102847,1.7356230100982195,1.929568522629292
A2780,219104,2.8403974518726938,3.136369699807891
SBC-5,2113511,4.3346082595960045,5.35918526617791
BxPC-3,navitoclax-birinapant (1-1 mol-mol),-2.5138239615221907,1.6107313155831462
A-498,JQ-1-vorinostat (2-1 mol-mol),1.7562292819472516,1.4027394197946874
BT-549,44607530,1.0072782741331217,2.0236932652673563
FTC-133,56946209,-2.082875590070058,-3.8136683149477837
SBC-5,49766530,2.674414744921775,-0.237009694307791
NCI-H727,1750826,-0.0055354600789778,-0.8296922800102873
SNU-449,2749,2.680740017346485,2.183735225324932
YAPC,46843906,3.8406256643083214,3.475066986642501
OVISE,3503,3.051689922997692,2.6824965779320173
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903,-0.8495518769877569
A4/Fukuda,24901704,2.035809268681581,2.6890500258707744
SNU-449,2949965,2.551789087127138,3.0545694037616937
MSTO-211H,65064,5.509158922836103,4.968579663945563
NCI-H460,753704,5.635234970240753,4.992376140199674
BT-549,9907093,5.687861442777729,4.261401160990823
SNU-449,89928392,1.7008506784074908,1.641395167753282
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506,1.9876123044911702
LOU-NH91,675434,4.5447066201437325,4.646011302664398
CA46,5351362,0.7524287969492447,0.8873174178369112
BT-549,3025944,4.080638158593822,4.438194522632209
SW1463,57330099,3.693611547578868,4.081631840292719
HSC-4,16722836,1.7684769334825834,1.782624735856571
G-401,4096211,1.4243357241965535,1.5037456656124766
Panc 04.03,6610216,4.328711123736605,4.358010063497782
KMRC-1,5287620,-2.779883294896464,-2.1111436135489976
BxPC-3,119182,-1.1309049402050737,-0.4395230135193327
G-401,135999136,2.1711954992798987,2.8165669944748863
KYSE-70,285033,-2.195981319752621,-1.5590102280804603
NCI-H1623,selumetinib-decitabine (4-1 mol-mol),5.307511276565798,3.359711462287737
KYSE-70,44607531,3.0404164934883733,1.685151116271403
SCC-9,6918878,3.402250236896725,2.9892783695055742
MDA-MB-453,5282054,2.7696083041072237,3.6924372383034783
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563,2.535439980389132
BxPC-3,57519531,2.3630144255947045,2.623367504317754
NCI-H2171,56949517,4.289308734480345,4.130324528023101
Panc 04.03,54619267,4.1321899610425215,4.227335568529564
G-401,11485656,1.708547873036538,1.9720269880577082
A-673,6917907,-5.646852280462545,-5.268355199127131
NOMO-1,71304818,2.372593058500035,1.8800670264993096
MSTO-211H,11214940,0.3292815706978371,2.0651384638427097
HSC-4,1750826,0.4564084690350189,-0.5575726335148321
HSC-4,426756,6.131320111521982,4.407993248346833
SCC-9,12001922,2.463166865850559,1.9683880636141895
CAL-51,656346,0.8466306406200714,0.9929537097808084
NCI-H661,49793307,-1.6947898398784864,-2.6202903833814686
MSTO-211H,6450551,1.5186693992042568,2.9394621799981753
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005,2.061883780614929
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277,0.9979355298730898
NCI-H460,73707398,3.251551904382877,1.5624101938086126
CAL-51,168313016,5.819136604546001,4.943242673526496
NCI-H292,119607,5.8072644572840915,5.4213550894457345
SNU-81,31703,-2.2099083949209715,-1.2475251484342185
A-673,11719255,3.0296971336672627,2.869449316173654
HSC-4,9911830,2.7717739782698563,2.752988186146396
CAL-51,44589607,2.4963130908502107,2.840543380922033
FU-OV-1,24180125,2.037807307003979,3.114353914043355
EFO-27,3634881,3.530057446917586,3.4855590767393534
MSTO-211H,25262965,-3.426128826799908,-1.4992252629788978
LOU-NH91,3543504,4.266458043071255,4.5166275574932095
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961,0.5916297639010146
NCI-H2171,23582824,0.048802245172864,0.9185754900714633
SCC-9,11507802,1.3688807961315366,1.8901347801530204
MDA-MB-453,selumetinib-BRD-A02303741 (4-1 mol-mol),6.9656310639147305,3.6132133439974274
CAL-51,65628,4.560195683913681,4.486075411168395
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256,3.0434804859127786
CA46,6505803,0.7805822725654986,-1.2485622571751172
KYSE-70,327653,3.7336437717951103,3.035663675580456
NCI-H2171,11494412,-0.1110474347644453,0.7666013310761507
LXF 289,6918328,-0.239589445073231,0.19117090378138357
CAL-51,24951314,1.3730048574034712,1.3475817205476963
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878,3.4564927476568124
A4/Fukuda,2858523,2.415383768636832,2.7869890778708655
NCI-H522,753704,4.098243268802601,4.6249327532259255
A4/Fukuda,11625818,2.700159842549232,3.611861067696659
MDA-MB-157,2949965,2.5406478696331587,2.72114129913064
ONS-76,409805,3.962852167855045,4.663483396655396
NCI-H146,439501,-3.5641402563292393,-2.404043211320686
CAL-51,24856436,-0.3083697359271743,0.5019823173921183
SBC-5,31703,-1.5086983052531706,-0.8316812653409735
NCI-H522,10184653,0.5663226513641079,1.0755667250961742
NCI-H522,135421197,1.9700795220087195,1.5577811433868236
A-673,alisertib-navitoclax (2-1 mol-mol),-1.8576644604152912,-0.7341767058945641
NCI-H1623,46398810,3.5623335184860196,2.6045468354058996
A-673,216468,-1.1121166448103192,1.6306045546733525
BxPC-3,2708,4.650566781622339,4.993069597368011
SNU-81,6184667,-0.6614889419446587,2.7131449392586138
NOMO-1,168312962,2.6221164331885003,0.41734088881588766
MDA-MB-453,16720766,-0.5495005772629474,0.5297852713339721
NCI-H522,9956119,4.024745164263863,3.3198473670813256
NCI-H1623,135440466,0.8012621152288821,2.2785491328311607
CA46,3025944,4.264528242833472,3.8646540593836427
CAL-51,71466380,3.802692276073616,4.609882544101848
Panc 04.03,11656518,3.295682085422899,2.22801340364734
SNU-61,JQ-1-MK-0752 (1-1 mol-mol),2.077081766151821,1.1659100409011918
LOU-NH91,16720766,0.888730139062919,0.6407835362712578
HCC1143,selumetinib-MK-2206 (8-1 mol-mol),0.0669797287296957,2.337114293919173
JM-1,57519531,1.1574190263295916,1.5944336081644201
CAL-51,vorinostat-navitoclax (4-1 mol-mol),1.6210592416983378,1.447049506015454
MSTO-211H,148198,-2.180219295506665,-3.244985105277094
SCC-9,4521392,4.43257578464979,4.386899419804412
FTC-133,2746,3.487652314498242,3.4526825528578353
LoVo,44819697,3.398153390084315,-0.28484782948575516
Panc 04.03,122327,5.490637645011104,4.748804745425371
BxPC-3,25154868,5.007679584209566,4.481265978459756
NCI-H661,3503,2.324538290067321,2.216022110046785
NCI-H727,54618771,2.7901712320729333,1.3535319078955528
A2780,10302451,4.067201499125142,3.358949557241962
A4/Fukuda,5281321,-4.090150251628595,-2.1023198359488684
Panc 04.03,24771867,4.398084543376112,3.1857178478573434
CA46,241158,1.6221144264981358,2.4305036181134914
SBC-5,26596,-2.1907470722084414,-0.8412561862731026
A-498,11625818,3.6553151033235904,4.635406825710121
G-401,9911830,0.6760173642929876,2.17882143548989
CA46,123631,1.9024335998312112,1.8535456704703162
LoVo,104842,-3.39586805089817,-2.3973580294977324
OPM-2,5479543,3.226492982806864,2.8230367911463525
HCC1143,6623618,3.4930934009716226,2.405315846381385
NCI-H2009,46199207,3.041674504763304,3.116334974360944
NCI-H661,49766530,1.1318827683023138,-0.24867061163960463
CAL-51,1641662,3.5457804017420744,3.5312936820526204
ONS-76,44819697,-0.7397391051726983,-0.2474165494418597
BxPC-3,57330099,4.21152658046839,4.499904978400825
MSTO-211H,3038522,3.865174160499475,3.0541777314423166
LXF 289,71466380,3.888647536265504,4.578301602116474
CA46,5479543,2.004846411807367,2.6915969683725525
OPM-2,9907093,3.786753386665246,3.6780295835847308
NCI-H522,54613361,-1.014694822148615,-0.1145730017095847
NCI-H2171,25195348,2.4042641753284872,3.2452381264233496
LOU-NH91,9911463,4.226439837654448,3.889094615815409
JM-1,6918736,-2.112176013423493,-2.540871322577986
OPM-2,89183176,2.1177805080987633,2.8562444379083973
OPM-2,135875424,2.796643273298537,3.1367008054040673
HCC1143,24964624,2.836653438175677,2.424040580042916
DMS 273,44566777,1.254196350489733,0.555256607427891
NCI-H522,49867926,4.17523654199276,3.7688770183725553
LoVo,72193861,-0.0557430791680942,1.4615371246908102
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856,1.5514509260120588
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008,1.8423600996902507
SNU-61,374536,-1.8297483787291275,1.7678069927550584
CA46,44566777,-1.0409480025289963,-0.2995614133818383
JM-1,54613361,-0.7111924625528845,-0.8755670444262604
LoVo,25154868,3.829103546750207,4.3818065124959
A4/Fukuda,15547703,2.4441609561923547,2.7409870260326725
KMRC-1,10074640,3.6694615069556886,3.199215628162618
NCI-H2171,2729026,2.1337054337121466,2.396287249337106
CA46,JQ-1-vorinostat (2-1 mol-mol),-0.7880767442206768,-0.37727955990943235
HCC1143,68056272,4.744387863321378,4.127049279055333
CAL-51,navitoclax-MST-312 (1-1 mol-mol),1.7959249408216948,0.9289889074698597
NCI-H2009,44607531,0.9822487023795796,1.733370507957885
KYSE-70,89183176,4.766828638924323,4.449126549410404
SBC-5,25154868,3.0138435145006155,4.339680752856299
A-498,11719255,3.5352993104723245,3.8279114431905725
SCC-9,208908,2.838235608451249,1.8669417148374916
SW1463,2126,3.781949624288532,4.311140934866297
SBC-5,5311,0.7694897344457827,1.5443188403576593
BxPC-3,11609586,2.766108761160721,2.969997024840714
CA46,71466380,3.212448709653588,3.750214405010043
FTC-133,25126798,4.495223588633032,3.728715779757487
JM-1,44632017,0.8586744690995054,0.8255794929497461
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598,0.925554903115762
SNU-449,4917,3.4001304631059965,3.1781430045994497
JM-1,135984461,1.552881480804892,2.45378418222334
NCI-H2009,969516,2.7623608328977314,3.0123135719774323
SCC-9,104842,-1.437225086828998,-2.4963380943158855
CAL-51,73707398,0.7053044464230985,1.2069691691110007
KMRC-1,67156097,2.0694443843024173,-0.3467114067587982
SNU-449,135411,1.1071215925884743,0.9368623308528277
A4/Fukuda,72376,-3.4342601152101473,-3.0942596927833796
CAL-51,54619238,5.308906879487735,4.824111736463969
SBC-5,5282054,4.370273963099393,3.6638803066436645
SNU-81,vorinostat-carboplatin (1-1 mol-mol),3.3031492334396977,2.661538433293865
OVISE,5328940,2.3935755372069676,1.8248220498735768
SNU-449,BRD-A02303741-carboplatin (1-1 mol-mol),6.10453045453208,4.40206071855888
A2780,24779724,4.3340331177123765,3.2397918864703024
A-673,400769,-0.9976419565742564,-0.9869268082653286
MDA-MB-453,3081361,2.1431734647577496,2.1716225245628427
A4/Fukuda,123631,1.573225246333458,2.4464515704370893
A-498,46224516,5.193995490382977,2.903729490150843
CA46,5738263,2.2696720462337456,2.4321440160538828
DMS 273,16722836,2.1308156944151833,1.2951864434557465
KYSE-70,119607,5.065055719995064,5.282633009831296
MDA-MB-157,637858,0.0650158223638603,2.149095256091068
KMRC-1,24180125,3.3952911821821052,2.8688122188531735
A4/Fukuda,9935249,-4.132944592984893,1.5756491719196684
A4/Fukuda,9915743,-0.3554458205966057,0.8242047810287241
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143,-4.008041501993346
FU-OV-1,11222830,1.8946229471337992,1.5323686198624051
SNU-81,BRD-K27188169-navitoclax (2-1 mol-mol),2.560233422856499,1.8616731044150172
NCI-H522,24775005,3.057250054087749,3.5776520652604797
NCI-H522,15983966,4.053677978120726,-1.7510778245778147
DMS 273,25102847,1.54508352242066,2.5764021350069983
A4/Fukuda,44543605,3.1271044447490235,3.7678765141995485
CAL-51,44507138,2.6477043136390637,2.455967137119731
SNU-61,16725315,5.215969195263621,4.085325740186883
EFO-27,448949,1.7491267397814168,2.0568060105962633
A-673,5280436,1.8974559090481808,3.039506162162835
MDA-MB-453,24779724,5.606505141806212,4.2219369781839555
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092,3.022942692496158
G-401,alisertib-navitoclax (2-1 mol-mol),-1.5256164798687666,-0.5809400520329707
NCI-H522,216345,3.499198551341706,3.4461232552129912
BT-549,25022340,3.398199457605664,3.1037516989102993
SCC-9,23725625,6.300420686237622,5.119427134951635
MSTO-211H,54619267,2.133098694540018,3.8677419911946824
NCI-H146,JQ-1-UNC0638 (2-1 mol-mol),-1.369706115362065,0.8731498586311962
A-498,148198,-1.0809020747576437,-3.175331383664799
SNU-449,10127622,5.039458046327855,3.943564278922377
CAL-51,1641662,3.5457804017420744,3.5312936820526204
MDA-MB-453,5291,3.622613892398656,3.373387454327043
A-673,168312962,-0.712468254461992,1.4174813770337353
SNU-61,52912189,0.4386789975034979,1.2469427809036358
LXF 289,2828334,5.402872149224608,6.33413048554187
BxPC-3,374536,3.0351492595764347,2.709688431848935
EFO-27,9825149,3.71226874457915,2.4828188115445995
NCI-H727,216345,4.166745514794161,4.018951817741534
CAL-51,selumetinib-JQ-1 (4-1 mol-mol),2.755778227929117,1.641466976183809
A2780,156414,1.0391092981452308,1.2002498033403959
BxPC-3,11647372,-0.5523773269560157,1.2933256490746123
NOMO-1,10296883,3.647443685498321,2.991645154257837
LOU-NH91,60750,2.5426597160889823,-1.942240333666403
NCI-H460,16038120,2.547350732010626,1.25099289816843
ONS-76,123631,2.7486777230854176,2.28252972448378
OVISE,9903786,4.69480560533159,3.1625857426879858
HSC-4,168312962,-1.5337410071263893,2.440468520540571
NOMO-1,421610,4.35383474826381,2.4669130420906615
NCI-H661,4917,2.840246866325883,3.110710719644447
LXF 289,3634881,3.11935208210029,3.1522437976317237
EFO-27,9911830,3.273850069923984,2.6497773263555953
A2780,46215462,1.4920420325768875,1.4455604840186833
MSTO-211H,11234052,3.0252233847843515,4.334832299652769
NCI-H522,2842253,4.095670069869479,4.049524549505611
A-673,3385,3.2869772752619033,3.2967701336622492
MSTO-211H,46398810,1.7478948810000858,2.6063816901921877
ONS-76,49850262,3.849158291733923,3.566810471076101
MDA-MB-157,11507802,-0.5781039838427031,1.8404546383095433
A2780,24978538,0.9309197302054482,1.092051657716324
BxPC-3,24180719,3.164671730334926,3.516371957582189
NCI-H146,676352,1.7139908333138,1.9258344636120663
A-673,82146,3.820966427179324,3.3041586653832784
NCI-H2009,46174525,3.5250507211438107,4.693409145624346
EFO-27,10302451,6.465018307145316,3.4830181515411733
A-673,135984461,3.9402009784769745,3.1530582035421837
HCC1143,4521392,4.180219407268625,4.461731118323755
A2780,5351362,1.3372825777001471,1.2172982238381367
EFO-27,10296883,4.235346466258499,4.039368379999525
SNU-61,25150857,2.1451887473522295,2.190269554889809
LXF 289,25150857,2.4132050810476,2.5844148141182637
KYSE-70,135440466,2.892957215680813,2.351360219576157
MDA-MB-453,11222830,1.1155100991132725,1.5070002244720602
A2780,6918289,-5.622064624678881,1.7572342729196198
OPM-2,445455,3.93427157933256,3.7444009385152555
EFO-27,15953870,3.8448280803188233,3.5593219903282187
A4/Fukuda,4917,1.915641979161103,2.9782997227850463
YAPC,44185566,2.6271326170179248,2.5644928688758695
SNU-449,3634881,3.3285371967859128,3.505973569634529
OPM-2,44566777,-0.9514063433103236,0.1748960059238434
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593,-3.411199444332052
MDA-MB-157,4259181,-0.4671059045276012,0.18414976087823895
SNU-81,11656518,-0.0512259493867009,1.2313428685496193
NCI-H522,11494412,-0.7022253688217924,1.5365610552801876
A2780,selumetinib-decitabine (4-1 mol-mol),1.5025491201295178,2.6379481915663106
CA46,24180719,4.114109141176105,3.1963564944757143
MDA-MB-157,82146,3.0360891700929984,4.1440260085196
G-401,23635314,-3.865618451368766,-2.226671549974904
LoVo,42642645,0.0146125142547242,0.7749855939793397
HSC-4,9826308,3.3704185574061456,0.5799576738962872
NCI-H292,176870,4.643600229240446,3.291243310042944
ONS-76,44202524,1.6130278410730936,2.0841718292242217
KYSE-70,9911463,3.4914249269651307,3.7347861930449433
NCI-H146,24779724,4.32606530761132,3.7983706595181848
LoVo,44493528,4.114958638118981,4.2884812724474175
CAL-51,44486219,4.943814728636009,4.346895919241316
HCC1143,serdemetan-SCH-529074 (1-1 mol-mol),1.8750312876622353,2.0819441518433943
MDA-MB-453,8515,4.14044832994183,3.7410924432411945
A-498,tanespimycin-gemcitabine (1-1 mol-mol),3.605685519475067,0.46628662986912117
FTC-133,56963564,0.7376209226585526,0.08814966704628326
MDA-MB-157,11494412,-1.4760508995443156,1.6883191647228428
SNU-449,4261,2.5462586921108197,1.8163485893923978
MSTO-211H,984333,0.926178476056404,0.9971032415488429
SCC-9,1641662,3.777884166860496,3.547272784025094
HSC-4,2949965,3.8536489984175097,2.860996886723145
NCI-H2009,5566,2.98031688083636,3.084125706191904
HCC1143,16741245,3.781249389530293,4.08200510300867
CA46,67156097,-2.616833441535583,-2.4043095486840285
SNU-449,vorinostat-carboplatin (1-1 mol-mol),4.005391500954191,3.3277574002279366
G-401,55283,4.120501166008349,2.257777457010661
A-673,11977753,-4.8378783477247875,-1.8261457331275202
BT-549,637858,2.0216713295762614,2.052925757791732
MDA-MB-453,5287620,-1.4808110009700917,-2.0192271920955394
BxPC-3,46907787,0.03250860780982,2.2213924555989912
NCI-H661,44819697,-3.610310878099198,-1.0046159808190802
Panc 04.03,vorinostat-carboplatin (1-1 mol-mol),3.8664916709741792,3.3644083176562214
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492,2.3829014585133215
BxPC-3,46191454,0.7426288337003383,1.3864214674349058
MDA-MB-453,322968,3.088283756332906,3.6121738996981647
NCI-H1623,16736978,1.234327001570643,1.9151539743130508
KYSE-70,1641662,3.490090790744947,3.2540907520459386
A2780,5470400,5.365026906170319,-0.09360630894835477
NCI-H522,23582824,0.9084599252004664,0.7935747740786617
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824,4.138044007231719
MDA-MB-157,23725625,0.2462467633250468,5.090809623233758
SNU-61,44632017,1.0979359106396418,1.3153992748419927
ONS-76,8515,4.109060881613791,3.9570623010047075
BT-549,erlotinib-PLX-4032 (2-1 mol-mol),4.9890831311831665,3.313275038024796
HSC-4,54626689,4.284935050666877,4.669673320263066
SCC-9,42642645,1.380036396261508,1.1016849003067972
LOU-NH91,9866186,2.5706791809917258,1.1195696251262783
MDA-MB-453,3552672,1.8646445353613752,2.826353558895305
LXF 289,11507802,1.7765111516543377,1.879259238622276
KYSE-70,107985,-3.298359335305578,-3.4906711357744395
G-401,53325874,4.831157164763357,4.096009184745647
NCI-H460,5746,0.0249012606464236,1.3122663258938878
MSTO-211H,11213558,-0.8326933060339966,1.781262298544752
KYSE-70,56963564,0.3897414986371327,1.156305371451939
FU-OV-1,11485656,3.4521578130267336,2.4230666757560697
A4/Fukuda,56963564,-0.5107551488404702,-0.23062379456112547
A-498,51039095,3.6847311434926535,2.901003176915802
BxPC-3,44486219,3.8860987116797703,4.148526480610609
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696,0.2740434492919426
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524,1.274055765845457
HSC-4,44819697,-1.3561318696958864,-0.4917127355335749
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973,3.734026893336028
A2780,148198,-4.120801514793353,-3.8209377910450213
YAPC,36462,2.246335150310725,2.427737324128911
NCI-H460,10184653,3.574651577310896,1.5558497114016574
CAL-51,navitoclax-gemcitabine (1-1 mol-mol),-3.0464623098161256,-1.2890672162084065
LOU-NH91,54678924,3.1162234647683205,2.299837831516841
ONS-76,11214940,1.2536021206371053,1.8834359593578847
SCC-9,9907093,4.490912734248418,4.2649856076459205
NCI-H661,11964036,1.3116184134954847,1.5466770768888716
CAL-51,135411,0.595745817277345,0.630148061697358
EFO-27,613753,3.260816470325069,3.334336119879731
A-673,73707398,-0.4228078892765429,0.8360189426322624
YAPC,25262965,-0.9761970914901598,-1.2253759880098605
LXF 289,31703,0.1888440469000175,-0.9720873293805598
A-673,44486219,3.969252294689724,4.121526977436949
HCC1143,135875424,3.1375636080090925,3.7578977418178083
NCI-H661,241158,4.406370209729512,3.735134404607478
A-673,17755052,1.3895683648511998,1.6491000076068267
LXF 289,4788,5.213081732847737,5.699029274938908
NCI-H522,5738263,2.340773324031017,3.302610149869227
SCC-9,4788,5.928282303581182,5.659089395733872
JM-1,46843906,0.1108259550663182,1.3758117154141325
CAL-51,9967941,3.511576456928413,3.6416336932445232
Panc 04.03,5746,1.7282227653726634,1.5009382106135345
JM-1,444795,2.4559914793227597,3.0511592720931393
A2780,25183872,-0.9660294253312856,-1.1805583902853631
NCI-H460,ISOX-bortezomib (250-1 mol-mol),1.7631943110451136,0.8765687476733
A-498,12001922,2.3665933531109564,2.1695130132350045
NCI-H522,selumetinib-decitabine (4-1 mol-mol),5.680021227414058,2.3991326115838576
NCI-H460,3384730,3.247736649900264,3.1105530553114376
NCI-H292,9884685,1.805947993429832,0.961631610776452
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456,4.027112510966545
NCI-H2009,25126798,3.423512143516965,3.9883603782832155
A-673,67156097,-2.6530750558799268,-1.5939393478296822
A-673,selumetinib-JQ-1 (4-1 mol-mol),0.7422634242763538,1.002630081522445
NCI-H1623,11364421,1.5638784569997608,-1.645794890522638
OVISE,65064,5.3042455172619345,5.071146788711799
CAL-51,11485656,2.6541256228973773,2.303392523435677
EFO-27,navitoclax-MST-312 (1-1 mol-mol),1.1101378003165483,0.970806700453061
G-401,135984461,4.271777659576195,3.533591033629642
A2780,11960529,3.87105656281655,3.6611316015886746
OVISE,168312962,-1.1497759256084987,2.3127621060212697
SNU-449,25062766,2.0173338536366776,2.1714931488680866
CA46,44462760,4.878030903037556,2.3792411839141163
SNU-449,126941,-4.267074342641938,-2.9323794321245367
BxPC-3,55283,0.3092833280624811,3.0101824288576737
MDA-MB-453,2708,5.180783048838842,4.988893015808936
EFO-27,441298,3.357031616162376,2.5867466546451756
A-673,25195348,4.457358631051988,3.020986653904966
OPM-2,285033,-4.309653599496783,-3.471969206121788
FTC-133,156414,2.701071854154092,1.2410325517706173
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065,0.12279225323113209
A-673,vorinostat-navitoclax (4-1 mol-mol),0.758498532756487,0.42065324983922425
SNU-449,219104,4.193064059209751,3.986496918703764
SNU-61,387447,-3.847354855280633,-4.442502276765758
ONS-76,89928392,2.125505613903981,1.3506659705772677
DMS 273,10296883,4.130929131041443,3.2486593784679343
SCC-9,71466380,4.753733846444339,4.4478029514149675
CAL-51,11234052,5.18044926966805,4.230121771199316
FTC-133,135875424,4.265925786122884,4.272561797402288
NCI-H292,135398738,5.91070825601545,4.529736977236753
NCI-H2009,24785538,-2.0037312151285462,1.8456257701304526
KMRC-1,5281321,-2.040334048066586,-1.3205737026994695
OPM-2,9926054,1.8132463747821628,1.5670413706036859
NOMO-1,44607530,2.1799605259844914,1.3218179151868084
BxPC-3,104842,-2.6661298782325265,-2.6261384343828458
JM-1,decitabine-carboplatin (1-1 mol-mol),-2.2469818975584004,-0.0030124571033488846
A-498,1716436,3.6890609174990057,3.1959461196579055
NCI-H522,252682,6.061888172888063,6.537140067074301
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908,3.8015879437080247
CAL-51,409805,3.8515087112009656,5.0551596460620365
SNU-449,676352,1.7938896042567478,2.2079449010330565
NOMO-1,72193861,0.7304873005319745,-0.014427314862338534
FU-OV-1,5566,3.32118213388136,3.13188111692975
YAPC,piperlongumine-MST-312 (1-1 mol-mol),2.5050103055031356,1.9305156601053561
CAL-51,5291,4.8235616489491635,3.7286895212886177
NCI-H1623,73707398,1.8898657972875643,1.6694830613111538
G-401,navitoclax-PLX-4032 (1-1 mol-mol),3.453832495837289,0.7246041806003006
A2780,54619267,2.083839750794981,3.8303978969676717
A4/Fukuda,25150857,1.0832866246256998,1.8508173524137148
SCC-9,25195348,3.9019221273063858,3.516003223524367
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705,4.292735942759567
NCI-H2009,20959075,-3.4439076637996076,-2.8167278611886895
HSC-4,navitoclax-birinapant (1-1 mol-mol),2.9615241748083907,1.6448514121598778
YAPC,135875424,4.215334227700636,3.9803284584584917
NCI-H522,vorinostat-carboplatin (1-1 mol-mol),3.5371010286521827,2.5661486457178517
LOU-NH91,2708,7.798658787946165,4.934730555643722
MDA-MB-157,54613361,-1.9100924648361528,0.09540424515508195
YAPC,613753,3.436227254149273,3.4199349692746965
G-401,26596,-1.5666727843222663,-1.7567502768798247
A2780,124202324,1.685811695923782,2.012969586999672
BT-549,52912189,4.655826026030035,2.5672399635559433
OPM-2,6438330,0.5735051923287856,1.2371809582939892
ONS-76,49766530,-0.8397126534273769,-0.5457556947834962
A-673,24180719,3.918829940752815,3.4207833640843277
A-673,72734382,3.862779655203366,3.9757049945511755
JM-1,46926350,-6.131969810114727,-4.721740631716368
A-498,216239,2.9738940537308203,2.6320412137901563
NOMO-1,54618771,-0.7336388686704796,-0.08297864006662808
A4/Fukuda,25126798,3.529395374343333,3.444104679462299
NCI-H522,16013152,4.870026952980287,3.5851161038640114
NCI-H1623,JQ-1-vorinostat (2-1 mol-mol),1.274501215342979,1.2651811499466787
ONS-76,6918328,0.1573953751573411,-0.06377954176253167
LOU-NH91,1566236,3.241690914019502,2.7369538182189683
HCC1143,2858523,3.0390361797055276,2.9889290293878066
BT-549,71304818,3.5849392152335713,2.6039265107120655
MDA-MB-453,49867930,4.991198207309722,4.7536148243393335
LOU-NH91,4261,2.7247094190978007,1.9274303609218573
NCI-H522,52947716,2.6251827866590385,-1.1898003947767213
NCI-H661,6852167,3.3441449371697205,3.033009428590214
NCI-H292,16736978,2.16203795839555,1.937309731893947
SNU-449,637858,2.172600125936458,2.131040771131921
SBC-5,16720766,-1.9276845300945755,0.6168026630520942
ONS-76,piperlongumine-MST-312 (1-1 mol-mol),1.8657254357935973,1.9346979483074578
NCI-H661,2828334,5.966055284777512,6.19523483876986
EFO-27,9884685,1.4230112837032636,0.883190965359174
OPM-2,25227462,-6.0467342682230445,-1.7917048205379995
A-673,3038522,2.0400506341720237,2.6674119057927044
HSC-4,54686904,4.85379149564711,3.798298965062372
A4/Fukuda,969516,2.117405484631732,2.399287260054994
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573,1.8725192127710901
LOU-NH91,6610216,4.701575628194421,4.434173846742628
NCI-H661,24856436,-1.6135015308236011,0.7006446052413056
LoVo,6252,1.008875569338637,0.8755891958056639
CAL-51,5281672,3.9430830045045857,4.49530041944791
YAPC,25183872,-0.4840811687838853,-0.6743294101695902
NCI-H2171,11222830,1.3474519729527985,1.3803957208377091
SBC-5,16722836,3.112579400078665,1.6392668161480353
FU-OV-1,3689413,-2.180005064661593,-0.42438997568160985
JM-1,6914657,-7.803103466538306,-5.6399189740512075
A4/Fukuda,11222830,1.361211164053787,1.1841536570417959
OPM-2,24180719,3.7347961717129383,3.1011348366057883
A2780,50905018,3.503420862443992,4.0523183785787875
LXF 289,168313016,5.746715572468322,4.8370566543804
MDA-MB-453,2874250,4.390759253530558,4.348109883635599
NCI-H146,3543504,3.2112662755133616,3.8786646855453153
MSTO-211H,9956119,3.2798548332341246,3.685031787772525
NOMO-1,11152667,-1.8753376491976492,-2.1646943247805335
NCI-H292,241158,3.585722962787503,4.09139268628324
SCC-9,52912189,3.371588298050412,2.6306508338459356
A-673,15983966,-8.138595470092604,-2.7631274439830866
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695,-0.30318389819743463
NCI-H146,5287969,-2.632266530811145,-1.9465458969939968
A4/Fukuda,44632017,0.3391160528514481,0.7581915528444498
CA46,1242560,2.637858421223904,2.8900632858720403
CAL-51,serdemetan-SCH-529074 (1-1 mol-mol),1.9102886426753127,1.9556231688998311
NCI-H727,10184653,0.8809089143232124,1.6143272417250196
MSTO-211H,6918736,-4.031815262851263,-1.4965332731311234
Panc 04.03,54454,4.748257983656133,2.9281360716497598
BxPC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.8536024337573052,-0.9139127971112461
SNU-449,6918328,2.053547134624907,0.5132801713736764
A4/Fukuda,262093,3.0357368226896178,1.8873656169022737
ONS-76,6918837,-2.636307015456442,-2.7836648209192405
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525,-2.535813419908738
ONS-76,107985,-3.307412021608342,-3.751877867306827
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383,2.933506426208093
OPM-2,42642645,-0.4905470491794313,0.01255903465057496
FTC-133,16722836,3.262117509304611,1.810197289473572
SNU-449,123631,2.9179285945779183,2.547283193910798
OPM-2,644241,1.6900050339542656,0.09882151021348154
HSC-4,1242560,3.572222416741055,3.7041328112625598
NCI-H292,123631,3.5457837677726833,2.164582834961293
HSC-4,2842253,4.76622062087716,5.433998563144885
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908,3.6955104510160113
Panc 04.03,3689413,0.3957464459941977,0.5193997166563629
NCI-H460,135398516,4.13019906717736,1.8809045732025285
NCI-H460,5311,2.161812802665503,1.6194982583318351
SNU-61,11238147,3.2212717665721375,2.8425474828807773
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242,0.8991541652680326
HCC1143,44607531,1.4024247683472026,1.6350148077593667
NCI-H727,5351362,1.1476230363651536,1.6826184320495363
KMRC-1,6852167,3.0099217565414693,2.724793046842966
MDA-MB-157,5311,0.9088479539093504,1.6314064504484511
CA46,BRD-A02303741-carboplatin (1-1 mol-mol),6.48045136918117,4.269936453466382
HCC1143,crizotinib-PLX-4032 (2-1 mol-mol),1.506008388614785,2.09976311601838
SNU-449,3025944,4.153676005178765,4.3129297896401395
A-673,23635314,-4.460908555858267,-2.323176130420662
JM-1,5351362,0.3312371174067021,0.8058605994696759
DMS 273,24901704,3.9468378622372264,2.7261496562983796
MDA-MB-453,9911463,3.8683390626627454,3.7526578830052144
OVISE,60700,1.357326318980797,0.12534788143444764
FTC-133,448949,3.317946341403347,1.9657529435812249
LoVo,5566,2.507145044552918,2.8311398531293612
DMS 273,9967941,3.979035067958665,3.159878322460953
LOU-NH91,16038120,-0.2213795856096394,1.2658750298652666
NCI-H1623,11977753,-1.4500330036408269,-1.5760541891934494
NCI-H522,JQ-1-navitoclax (2-1 mol-mol),0.228465095222191,0.5425928746725679
NCI-H460,31703,-0.6563705559837907,-0.5771960707781764
A-673,9866186,-0.4052980916556575,0.6099033837812724
OVISE,31703,0.0982732174518241,-0.4157966108070304
HCC1143,124202324,1.6321362493528402,2.6749731420822007
G-401,4705,3.1032512954578415,3.133994130524045
NOMO-1,3025986,-1.4139862297409005,-1.7584243494865257
CAL-51,navitoclax-pluripotin (1-1 mol-mol),-0.5264654943286647,-0.8955618472132252
NOMO-1,148198,-5.33573798573566,-4.160016617753013
A2780,9907093,2.8643649893432106,3.6530139575437786
HSC-4,44607531,1.5153971496977892,1.5364887159947136
LXF 289,2746,3.190299829163617,3.434336612021344
MDA-MB-453,4261,0.3032353935433951,1.3625647625197883
BxPC-3,656346,-0.1234429100103727,0.7099062592057073
Panc 04.03,BRD-K55473186,5.259619810258457,4.3707921790568545
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966,0.7393983383216849
CAL-51,3385,3.064238699960593,4.035363659981511
BT-549,675434,4.287026263227802,4.623622687017451
LOU-NH91,9868037,3.6278868560603574,3.587908433003109
G-401,400769,-0.955062013548762,-0.8636152427675792
SNU-449,44185566,2.80206906512974,2.7846886640151274
DMS 273,613753,3.2268993277161524,2.9709088231661234
FTC-133,9911830,2.8814152307979946,2.6044959437523745
KMRC-1,selumetinib-navitoclax (8-1 mol-mol),3.760872598946533,2.2866983633336777
FTC-133,462382,1.2436445575195818,0.6832079149933692
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276,2.583024085642143
NOMO-1,9884685,0.4754269892492985,-0.22548461146308302
FU-OV-1,44589607,2.6910555486326397,3.0103560494314845
CA46,11228183,3.2150932794291975,0.26610232372742515
G-401,24797083,1.4378353960151609,1.4782475412905156
OPM-2,4705,3.10353547990691,2.9986860989444195
SCC-9,49766530,0.4117706354329887,-0.21147596682372227
DMS 273,44819697,-0.9932488797546292,-0.9792141741080671
NCI-H661,56963564,-1.1338494929069671,0.7527245402834865
NCI-H727,25154868,4.680199730171404,4.348230487058088
MDA-MB-453,56649450,1.3470223737131497,2.6525395745336953
CAL-51,54678924,3.225490994604415,2.1102849870294533
NCI-H292,vorinostat-navitoclax (4-1 mol-mol),3.14329221790471,1.4058535731641078
NCI-H522,56963564,-0.3134921987801757,0.1374036323150341
JM-1,10322450,2.576608882705072,3.091183479114232
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433,0.4125791958063341
A-673,24748573,1.962021648564739,1.648706163008913
LoVo,24785538,0.3940436885335026,1.4918170746690098
NCI-H292,135421197,1.1571557888211337,2.0608965202906298
SCC-9,19582717,4.601399638975327,4.258953429517142
NCI-H2009,5311281,-0.1357038590739554,2.39274567556329
BT-549,24951314,1.7605147679012945,1.7524077664502957
CAL-51,10302451,1.350542324147247,3.3426395340701744
HCC1143,10127622,3.54698748679943,4.335092763346634
NCI-H460,44589607,4.73035444754351,3.126696444268859
LXF 289,10113978,1.6721223719755247,3.3644739869798377
YAPC,5566,3.1204203259985044,3.0437255879025553
NCI-H522,135423438,2.202740699610144,1.2575509571645451
MDA-MB-453,5280436,1.8692407341233208,3.307168110941606
BxPC-3,400769,-1.094495387384235,-0.3986032395579107
MDA-MB-453,57330099,4.336922942952946,4.27062784310077
DMS 273,24964624,-0.4885915334424611,1.8826358402511882
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546,1.9774248908505794
A2780,11964036,-0.2399638951327319,0.9711239051419714
BxPC-3,56963564,-0.5407215297938537,0.32412668808671796
A-673,9907093,4.212541297476806,3.7062962258830225
EFO-27,11427553,3.591439679350591,3.0783720454148846
MDA-MB-453,439501,-3.002845657836036,-2.1054215141761023
LOU-NH91,11485656,3.2972382499502935,2.7328234489867578
MDA-MB-453,25161177,4.057301598200359,3.7707606384525327
NCI-H460,54143018,2.5592633032091956,0.4400198286727581
MDA-MB-453,53325874,4.468628295310174,4.288195702034515
CAL-51,71466380,3.802692276073616,4.609882544101848
NCI-H1623,4788,5.98570816019398,5.740982531151541
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446,2.0971016364959723
Panc 04.03,11707110,4.882480457753906,0.07709297041012338
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181,2.9109499048041436
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196,2.096972393356358
SNU-61,285033,-2.2323165928541746,-1.9735504027214994
A2780,25150857,2.724824774969284,2.0557071818897565
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825,-0.3786827081885153
SW1463,36314,3.0951531870893523,-1.211166360653621
A2780,2858523,2.134868506415456,2.897652180726374
NCI-H460,3825829,4.446795399525052,4.064847650881539
A2780,1750826,-0.9954774428329844,-2.095995984287386
NCI-H661,carboplatin-UNC0638 (2-1 mol-mol),4.544203960519617,3.311436584079811
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748,2.323674369979509
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606,1.2788195617637357
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552,0.11086599303446537
MSTO-211H,107985,-3.699787970340743,-3.5263226350384285
SNU-81,navitoclax-birinapant (1-1 mol-mol),-3.02925999333472,1.2058092412319312
DMS 273,10302451,4.121656528900648,3.1287252622873014
CAL-51,262093,2.862241975448649,2.9375601050700317
DMS 273,4261,-0.2104746005525494,1.0575463497182809
MDA-MB-453,148124,-4.8335014079709975,-1.0676039756588913
G-401,11178236,-6.653209761704985,-3.0961691663013546
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312,2.3379358441301927
MDA-MB-157,262093,2.565616950913742,2.9142052811161125
MSTO-211H,9868037,1.9157833543052896,3.271973712715834
HSC-4,5280436,3.1415705358429884,3.455114747393859
MSTO-211H,10231331,1.7809441814393978,2.3346704544264605
NCI-H2171,969516,2.758162928931276,2.3726388665262417
HCC1143,10184653,0.277782870066905,1.0858627763217217
A-673,4788,5.851137286094999,5.095520177479371
OVISE,11364421,1.999223974612241,-0.655757495863369
NCI-H661,44202524,1.2385989199848235,2.231823951274479
NCI-H460,3062316,3.704520183651484,1.547176613868254
NCI-H1623,44607531,0.8047036576600745,1.5343830179827822
OPM-2,9956119,3.674575368535915,2.679036577790713
OVISE,carboplatin-UNC0638 (2-1 mol-mol),3.0965224412296743,3.4022643755195356
NCI-H146,54618305,4.054654997899016,3.959185675345156
OPM-2,11507802,0.0988268127526858,0.9557798664876387
CAL-51,10385095,1.0305027810027567,1.351134554602969
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.504164226892268
A-673,71466380,3.8107210551169577,4.30365513607629
A-673,10427712,3.6867963290416346,3.928006112590056
DMS 273,56946209,-5.704769625352934,-4.5947277987679955
A2780,53301938,-5.924783673466769,1.387461649783083
MDA-MB-453,3025944,3.940846865776467,4.235875307086481
NCI-H146,9840324,5.546223512080725,5.598916137742552
HCC1143,3815108,2.289037887638348,3.0292925962218242
NCI-H460,11625818,5.428588497019925,4.502584737784317
HSC-4,salermide-PLX-4032 (12-1 mol-mol),5.175495928614886,4.785606354958837
SNU-61,123631,1.7897165257078365,2.1408384211982114
HCC1143,73707398,0.6963565440176983,1.3951284584114936
FU-OV-1,24964624,0.6948307959675745,2.5897960786263696
BxPC-3,89928392,1.339609071089843,1.849996824455978
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681,3.0541917150528892
NCI-H661,46398810,2.545394900571619,2.588688181152896
NCI-H661,17755052,1.4228000150725233,1.803319459344217
CAL-51,10427712,4.2973287072996085,4.341030193005624
NCI-H661,208908,1.9265593878348335,2.3698601518970457
LXF 289,71466578,4.726723075051965,4.7507560289822015
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549,1.9536630833417137
KMRC-1,46224516,3.1277122869876064,2.4756034418402426
JM-1,2113511,3.632981632735763,4.4547355334966
LOU-NH91,2113511,6.175446639496144,5.552828758488539
A4/Fukuda,6918837,-6.1208599704470865,-4.037138715694404
FU-OV-1,11640390,5.4167064390474335,3.7123633046608258
SBC-5,44607531,2.697205944866836,1.6432663351178698
OVISE,71304818,3.3064642565645572,2.604160533573025
OPM-2,11152667,-1.3080541002664456,-1.6769211837226685
NCI-H146,3552672,1.604439194031644,2.5910405928081093
CAL-51,12001922,2.008779489179369,1.8132586851236747
SBC-5,969516,3.68635139774897,2.9042939591454897
KMRC-1,alisertib-navitoclax (2-1 mol-mol),1.4545717666785216,0.5964972971312976
CA46,53495165,-3.0280125025934495,-1.751894699709795
SW1463,60750,0.1610513612263897,-1.8881312688022645
FU-OV-1,46215462,1.830231092617303,1.9182160893952138
ONS-76,49793307,-2.5280436252167733,-2.5275372167693377
NOMO-1,11404337,-0.1001889231988697,-1.4335978359938928
SW1463,123631,0.5150504925697384,2.4005341598389323
A2780,44819697,-3.3662473846109333,-1.234496747648094
A-673,44491742,3.844993574977925,4.105273175179693
NOMO-1,5280436,3.413613220161409,2.6067895987857175
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034,3.747387129886353
BxPC-3,2858523,2.8297817429760945,3.1233831805015653
A2780,445091,3.798794327077476,4.022413802018187
OPM-2,11647372,1.2733466761832082,0.32299076252124564
CA46,71751553,4.222934016329145,3.554105702473756
G-401,44486219,4.1772416968228505,4.0188352201277935
NCI-H522,9826308,0.3930789830124517,0.09258826053715279
CAL-51,5566,3.271951139375183,3.0387312284188135
G-401,89183176,4.003742825914683,3.382413626649852
NOMO-1,12003241,-0.5951695723430065,-1.549183485778741
MDA-MB-157,2708,2.34132544783096,4.957678805567811
YAPC,10410894,3.466680540940763,3.2009042708004087
HCC1143,65064,3.71051637258464,4.654125455154187
EFO-27,2746,3.149760082978987,3.5049292946321025
LoVo,216468,2.992200557668688,2.7420025367096215
DMS 273,3025944,4.590997145359233,4.126527097596694
NCI-H661,15983966,-5.492856258402122,-0.7062738931704378
BxPC-3,selumetinib-tretinoin (2-1 mol-mol),-1.7965498046170116,2.927590888316322
CAL-51,2708,4.939881356462198,4.974292044146339
HCC1143,11175137,3.393081010308343,2.558699115510195
CA46,42611257,2.680269393096826,2.9941819016083793
ONS-76,68056272,2.9147642388168675,3.3804110286361038
Panc 04.03,2871966,2.8539977368648275,0.7165093528102251
CAL-51,25062766,1.9168321284868295,2.107559023119767
FU-OV-1,52912189,0.1271866873311006,2.368478181076434
EFO-27,73707371,4.965139584704115,4.962182363693116
SNU-449,24951314,2.758293516562198,1.6205713399234118
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691,0.33687636595992243
A4/Fukuda,135999136,4.178898868342667,2.6825271458093853
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716,1.0280057547103312
HSC-4,119182,0.0150561689419209,-0.747004075256855
LXF 289,68056272,4.660756431297166,3.944713274062686
LoVo,selumetinib-navitoclax (8-1 mol-mol),1.0965034655670265,2.0450269094537195
SNU-61,31703,0.3335579072308824,-0.6040017516852734
SCC-9,9915743,1.0040050158500469,0.8179499077787328
NCI-H460,446155,3.79922347841428,2.7592887627387888
MSTO-211H,51037431,1.7350128995421004,3.140448609013841
OPM-2,73707438,4.146852269482474,3.958871087293598
MDA-MB-453,9926054,1.6596725660557576,2.0107306511964826
FU-OV-1,selumetinib-decitabine (4-1 mol-mol),7.280025082931535,4.441727905263241
MDA-MB-157,126941,-4.13859012935224,-2.7771722158950296
NCI-H522,doxorubicin-navitoclax (2-1 mol-mol),-0.6296252861358815,-1.4664666713844396
MDA-MB-453,24785538,3.5897722779252383,1.7599684222391108
JM-1,24978538,0.0218307924501431,-0.3446747368204224
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434,3.7808876707423997
DMS 273,3503,1.4004718919159695,2.0931238854438563
NCI-H460,JQ-1-vorinostat (2-1 mol-mol),2.751902354538612,1.1728813429939284
NCI-H2009,9926054,2.181635437582939,2.11643737083159
KYSE-70,23725625,6.518030965677853,5.0746310938002726
CA46,2729026,2.6315261399645755,2.1939443226147746
OPM-2,135398516,1.2750707316498222,1.2649820218758787
SNU-449,42642645,1.3579889941817174,1.0136887341616383
HCC1143,25126798,4.15297730422149,3.770076876034977
KMRC-1,9933475,1.7755712843428362,1.8627453594919252
G-401,12003241,-2.103305079214356,-0.8077034084396689
A-498,5113032,5.384850868352965,4.992080966156944
NCI-H2009,6918736,-2.2815319513344896,-1.3175650647777397
NCI-H292,11455910,1.285235050416197,1.2411790875705722
NOMO-1,24889392,4.281820029392572,3.0418186003766907
HSC-4,4259181,1.301377168384764,0.463631449792877
NCI-H2171,73707371,5.940029655461802,3.604199940252879
A-498,5329102,2.2449182254359843,2.278132189226678
JM-1,51037431,4.238886241129638,2.7648260448848765
A-673,56973724,1.675633920325915,2.341982738562741
MDA-MB-157,BRD9876-MK-1775 (4-1 mol-mol),0.1874852527806031,0.868127811867421
MDA-MB-157,136227331,3.870321503168366,4.046062581401144
A-673,navitoclax-gemcitabine (1-1 mol-mol),-4.77481524796036,-1.9320970881923378
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128,1.5689793531385507
OPM-2,7326481,2.643641332780412,2.7744272147962072
NCI-H146,135423438,2.8528911509997137,1.9810915996848937
BT-549,36314,1.6954100357352504,-0.6018330019944446
A2780,11717001,3.193837101204412,4.236201005894197
NCI-H2171,136227924,2.167829841056951,2.46053516169968
NCI-H292,selumetinib-navitoclax (8-1 mol-mol),1.0361315723218127,2.5231939216013526
NCI-H460,11152667,1.2005763717636435,-0.8637275487397618
JM-1,462382,-0.3688196944858197,0.27414919314115316
SNU-61,262093,2.836545473910542,2.563950571929995
FU-OV-1,10385095,1.480245925499038,1.3983428463710954
SCC-9,72193861,2.3270498811162508,1.8439802272078003
NCI-H661,1242560,4.217168015363727,3.5899072084739947
CAL-51,984333,0.1261860025273146,0.6100018459969023
NCI-H522,navitoclax-pluripotin (1-1 mol-mol),-0.4896519907045426,-0.8594500783352834
MDA-MB-157,SNX-2112-bortezomib (250-1 mol-mol),-2.8250293733048615,-1.0220341809987854
BT-549,374536,3.1184462544943363,2.901203752930972
NCI-H1623,11640390,0.1271923003977441,3.505712247823121
HSC-4,387447,-4.060952426407354,-3.9221532927328138
MDA-MB-157,5311037,2.9595373739718087,3.9069541187247836
MDA-MB-453,navitoclax-sorafenib (1-1 mol-mol),1.523284542572191,1.4717150415543512
YAPC,3543504,4.3832051547821855,4.568202784928746
SNU-449,tanespimycin-gemcitabine (1-1 mol-mol),2.625273627898756,-0.7388637022635355
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006,1.579468191618783
NCI-H1623,9866186,-0.0100221274837169,1.1718047021540077
SNU-449,4788,5.842775682236554,5.757426407751837
Panc 04.03,5287620,-2.39349186702993,-1.62966162049007
MDA-MB-157,11717001,3.389932991765854,3.8202701157039822
NCI-H2009,216468,1.7077485468094884,3.776799597996222
HSC-4,24821094,3.2038955653523713,3.001628195809927
A-673,4578,4.214026417190043,4.109857613305184
KMRC-1,135875424,5.075329697898493,3.8571315300709146
G-401,11612883,1.6387860096052431,2.138354585037905
HSC-4,156422,5.249929789072156,4.13674801628167
NCI-H522,2742550,2.7952007563166203,3.601352096210299
NCI-H522,400769,-0.9806645547005408,-0.8239952109561295
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055,3.219320395917447
NCI-H661,46199207,2.8133245189521054,3.1872247789586536
A2780,10184653,1.3482388837291208,1.2718594802353562
SCC-9,24856436,1.519847806890015,0.6193604442735969
NCI-H460,2729026,3.0609463870825926,2.8218637562756133
LXF 289,11222830,2.2114905387790755,1.5893490510422914
KMRC-1,46215462,1.6205494448376236,1.9103196889053065
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549,-0.8840678206860584
OPM-2,421610,2.2409150931042072,2.6710338434957905
KMRC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.70640431324625,1.8607963625302404
CAL-51,119607,5.291790266428237,5.153600576508238
CAL-51,24753719,3.9981702522006257,4.379684178930948
KMRC-1,25154868,5.3943697684741805,4.4889014954060125
Panc 04.03,89928392,1.6805018731496522,1.8609033311868486
SNU-61,25126798,4.129245799651812,3.6727435882085127
NCI-H522,UNC0638-navitoclax (1-1 mol-mol),4.115450321285854,1.5633818634115977
HSC-4,11977753,4.574500022269399,-0.70354169326068
NCI-H727,4477,0.5438785176620984,0.6790208602805943
CA46,5335621,3.676802077981384,3.99713023335004
JM-1,322968,1.8634300837521185,2.138575917882711
CAL-51,46907787,3.297361866649883,2.3283633608899
OVISE,doxorubicin-navitoclax (2-1 mol-mol),-1.2556065332393784,-0.5021347782484391
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629,4.893641754850596
NCI-H522,53495165,-1.820766752755188,-0.9098338896205986
MSTO-211H,11626560,1.3885064506517848,2.056816122102125
SBC-5,262093,2.1741934315953726,2.9350423955059197
MSTO-211H,52912189,3.1066961080068123,1.9914712139855704
HSC-4,568763,1.3764913265299208,0.7433477252011638
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626,0.920325729107594
DMS 273,25195348,3.734209419300899,3.1375576671251424
Panc 04.03,5951923,4.37213064077745,4.8409172323596055
FU-OV-1,439501,-0.5556149973103641,-2.010983749555982
A2780,BRD-A02303741-navitoclax (2-1 mol-mol),1.977156193717172,2.1399992430297132
LXF 289,168313047,4.113002678801054,2.437915624158796
SCC-9,67291369,5.015060977849177,2.787228216355766
OPM-2,5351362,0.2459388559982981,1.1033523068217725
FTC-133,11485656,4.087051585535102,2.609355251781013
HSC-4,46843906,4.814917111969106,3.101524194386885
CA46,51039095,1.651262767418978,2.06939460862554
NCI-H522,2945648,3.0823392214986343,2.5100222960026595
MDA-MB-453,selumetinib-piperlongumine (8-1 mol-mol),3.1080333616625713,2.675711877289912
YAPC,9911463,3.901904463732921,4.030134626627682
DMS 273,11977753,-2.475673354763999,-2.116784090332336
SNU-449,46191454,5.774811831739998,2.222077870292402
NCI-H661,25062766,2.1967321973268294,2.098771458305514
A-498,53301938,4.241910990361246,2.6756732522573907
Panc 04.03,10302451,3.874200048588579,3.2653878025184238
A-673,16065773,1.4559751864460968,2.1302825694282417
NCI-H1623,135398516,1.607867961646436,1.8118913632174727
FTC-133,60700,-2.7194012548196,-0.1145007079356175
NCI-H661,3384730,1.2254103498827775,3.0033544446038074
SCC-9,168313200,4.072126418899639,2.9767514304197276
OPM-2,25150857,1.3601106429565517,1.847205825414416
NCI-H292,3385,4.509781783210997,4.05380652841166
NOMO-1,227681,3.177880686522457,2.592732159577766
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947,2.3212599943675127
OPM-2,46191454,-0.9534482392265864,0.004839892670403556
NCI-H522,3081361,1.6470006965888542,2.32011496829961
CA46,374536,0.6029387131655304,0.6771456384488335
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538,3.1026404048279037
DMS 273,4705,3.496116762813734,2.9040027391336425
A4/Fukuda,17755052,-0.6813796549781841,1.2558043623388044
SNU-81,24180125,-1.7131691030529954,2.3029679857500076
Panc 04.03,969516,3.706271998961216,3.1107426241285663
CAL-51,15547703,3.503799403292956,3.2765851070822047
NCI-H460,24951314,1.96669984187411,1.4914131407393298
SBC-5,446155,1.3486611419477716,2.5360435902562415
Panc 04.03,6184667,3.768891848670565,3.1422250601593027
MDA-MB-157,4096211,2.1957324566584715,2.47562671338064
CAL-51,15983966,-4.387912760170627,-1.7191856765966582
NCI-H2171,49793307,-5.547674326636965,-4.07930481329575
MDA-MB-453,31703,-1.1483878700266144,-1.0963473661481558
KMRC-1,24785538,2.687509195601708,1.8311249111539494
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615,0.8532500444514838
FU-OV-1,54618164,4.603510021761196,4.10786646664367
YAPC,5287620,-1.8729921135671632,-1.8234377267830535
NCI-H661,16065773,2.6852778174065435,2.6845138173182725
CA46,5329102,1.3169898780971163,1.1305009120927998
OVISE,66577038,3.7859124338920065,2.934243440057931
LOU-NH91,57519531,4.764819520424852,2.508133469942561
LOU-NH91,448949,2.461672905148464,2.3835110654825407
LXF 289,10427712,4.0701965709145504,4.619345389687785
CAL-51,9915743,1.1260994347217144,1.3243514010241457
NCI-H2009,11609586,4.059888202416809,2.839971599056649
SBC-5,60700,-1.8327808511007615,-0.521610897395503
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576,-1.1568131511621984
OVISE,24951314,2.5954730551837386,1.4750126181201066
KMRC-1,66577038,2.9827052655036206,2.6048894166893577
LXF 289,36314,1.2391029615263165,-1.8325014363469558
NCI-H292,44607531,0.4181911293940362,1.446862742539279
KYSE-70,219104,3.9271840577372705,3.7364960304762844
NCI-H460,71304818,2.359856693071434,2.402819898975459
SNU-81,4477,1.0310003158688126,0.6200446072710699
A2780,1716436,1.933630716197044,2.8300112262917385
LOU-NH91,11964036,1.2476019563081622,1.745339112170699
SBC-5,9936388,-5.234314033557506,-0.3054520382254706
KMRC-1,24964624,2.351358467802262,2.4601702963428527
MSTO-211H,73707438,4.334782721865043,3.9137830988649607
MDA-MB-453,73707438,3.778137609083601,3.982715896992195
EFO-27,49793307,-1.9052761294403429,-2.4389000841038384
G-401,71680916,4.434691555895244,4.375163319882447
MSTO-211H,3634881,2.531877742135044,3.6024461589069703
NCI-H292,42642645,0.8145779285410705,1.1127646839628516
OPM-2,168313200,1.8002020874491595,2.7572496249269487
NCI-H2009,53232,2.115043522086945,2.7194784954582842
SNU-449,9825149,2.659052538489635,2.316311915242851
CAL-51,25105715,4.077363851334658,3.4004469341332113
MDA-MB-157,53232,1.9030895496471385,2.675547376989621
NCI-H727,2708,6.607150814967448,4.6875269350034126
A-673,carboplatin-etoposide (40-17 mol-mol),0.9497431982903584,1.483047240478203
NCI-H1623,44632017,1.5464636141196502,1.6687744608635546
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478,1.030421507638391
FTC-133,selumetinib-tretinoin (2-1 mol-mol),5.415389433541197,3.3179829791593813
SCC-9,3689413,-0.5284639903905319,-0.05197154330458188
NCI-H460,23725625,5.666756485817308,4.968482126891117
NCI-H460,100016,5.855223104671776,6.3509961137721564
NCI-H2009,24771867,-1.6305331500245923,2.745002268431569
SBC-5,9952709,3.0525329755213466,3.262431943046735
SNU-449,5566,3.0151612646695822,3.1781051829228444
NOMO-1,9926054,1.6113291347040215,1.6094588857317793
EFO-27,11404337,1.0583908830182924,-0.40059171757737494
A2780,54626689,3.943205764450006,4.433322035688067
A4/Fukuda,168313200,2.9572494196719723,2.800709319940911
LoVo,5460769,-2.1468642890382412,2.623061865118587
NCI-H661,25102847,2.378632231655901,2.537994786447476
A4/Fukuda,9866186,-0.2462641713744652,0.5612474084076572
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455,3.2607638812901087
KYSE-70,36314,1.2189527676950276,-1.141457518882348
BT-549,2828334,6.061535937537666,6.223093795540948
NOMO-1,25262965,-2.043358942198166,-2.0875073757216778
LXF 289,25195348,5.284501520866742,3.1957416574103297
CA46,451668,2.285623139838705,-0.431020183973246
SNU-61,24856436,-0.371488374536367,0.3662105788041221
NCI-H460,crizotinib-PLX-4032 (2-1 mol-mol),2.8016371489501593,1.8344387028979239
SCC-9,44137675,3.491154886377157,3.5873116854571014
BT-549,151289,0.9825598768305964,1.286904313480977
JM-1,49836020,4.6064946369246025,3.0116608935725098
YAPC,54618771,0.5686030675412354,1.2621375865265398
SCC-9,24772860,-2.0717241396099473,-1.7785459266816657
A-673,10385095,1.0544598585596625,1.1224294598842774
SNU-449,216468,4.54901774756382,3.768572720255778
SNU-61,67291369,4.2845115751683736,1.6660535479539351
FU-OV-1,5291,4.051520848138153,3.8617852793312966
LoVo,12001922,1.64420677630862,1.9223178192289998
NCI-H661,3815108,3.885074716587427,2.9887208833424483
JM-1,374536,-1.2279479926310035,1.2621718821352672
LoVo,tretinoin-carboplatin (2-1 mol-mol),5.63935886980119,4.875012453914744
NOMO-1,4788,5.067002306940809,5.168828297951601
SNU-61,24748573,1.6967337473161408,1.9552912840452605
BxPC-3,16720766,0.4925277259578197,0.5542319549990079
EFO-27,46215462,2.714023108610326,1.9852664410986518
SNU-61,selumetinib-JQ-1 (4-1 mol-mol),-2.0822040932557564,0.5121909439967405
SCC-9,31703,-1.2436349312067534,-0.6007538661545708
A2780,5335621,4.014990109441054,4.136464438536979
EFO-27,4917,3.7917867214450096,3.1843330909794787
A2780,9926054,1.5482217772077662,1.7937870333033845
A4/Fukuda,3689413,-1.7998697854540155,-1.6519214718144712
OPM-2,6610216,3.8953919440086575,3.9430652793176524
NCI-H522,6918328,0.2751454024017333,-0.27054921895724815
LoVo,60750,-4.161283305326802,-1.5626763813879143
LXF 289,15547703,4.3915240757493565,3.3220443559051995
HSC-4,55283,3.529343210540244,2.8422319146250925
MDA-MB-453,6436223,-6.0469700747965325,-3.854828739907365
OVISE,54619267,4.300185321056238,4.255224732324498
CA46,12001922,1.4868064190708767,1.533970402017163
SNU-61,53392493,2.2959575452819543,2.2566604157797223
CA46,alisertib-navitoclax (2-1 mol-mol),-0.3203128616100632,-1.227459803729393
G-401,44137675,2.141460704144857,3.2111564577187464
NOMO-1,9825149,1.4944850939332062,1.5416608619369263
CAL-51,4788,6.061217822513647,5.422423848457054
HSC-4,119607,3.948608575005578,5.314897474508921
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645,-0.31010479144282904
LXF 289,4477,1.125394938272502,0.44619837708262766
JM-1,11657048,4.676495506604394,2.766969397448724
G-401,10302451,3.1015289114526774,3.233293426026509
HCC1143,31703,-0.2055424786168501,-0.9753186977251264
HCC1143,374536,1.384467639208202,2.523758788817885
Panc 04.03,10184653,2.983159460505767,1.5361268605492997
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844,1.7689581615678662
MDA-MB-453,9915743,0.2126089191242519,-0.7066102679935683
HCC1143,4477,1.746819852748151,0.48612383415587845
LoVo,44486219,3.9526381308541025,4.3520734894016195
ONS-76,135875424,3.856833286433643,4.063538588676507
SCC-9,24797083,1.144476664186746,1.6714639287137112
OPM-2,4096211,1.0315429789467454,1.082222787592832
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306,2.126941902817656
SNU-81,25262965,-1.8265758424412304,-1.4029878628017287
KYSE-70,44137675,3.4677446622108925,3.4702521555811194
NCI-H1623,3854666,1.505587442259218,2.2436055527044187
HSC-4,10385095,0.4573663196580717,1.4979168719663318
EFO-27,107985,-2.474640150808475,-3.46989551226922
NCI-H2009,6610216,3.953101400309774,4.401040358879351
SNU-61,135421197,1.1046098427392648,1.6789072587590526
HCC1143,4259181,-0.4991941409006941,0.2086699363742413
BxPC-3,16038120,0.5924635925282854,1.1340567875541427
NCI-H661,135875424,2.4725937826628006,3.861957910152947
SCC-9,9866186,1.319539660579235,0.9108433197809744
LXF 289,24964624,1.3940062455599875,2.6762903602407415
HCC1143,vorinostat-navitoclax (4-1 mol-mol),1.2828606463085703,1.2237510374501268
HCC1143,6610216,3.638345017281011,4.190377904883673
G-401,2949965,1.5385484234582818,2.3839705094855184
BxPC-3,49793307,-3.2953922214008697,-2.698014517969142
A4/Fukuda,5287969,-2.571307610380136,-2.192193404414937
A-673,6184667,1.935989865778159,2.7201607500075187
NCI-H2171,24821094,2.9775477594317743,2.765896009134822
NCI-H2009,67156097,-1.7347724318553324,-0.612820377623629
A4/Fukuda,409805,3.596796639089143,3.9049074126809318
JM-1,5738263,2.278112606764228,2.2677850094540606
SBC-5,2828334,5.980106592077389,6.085366959913095
BxPC-3,107985,-2.51349631829315,-3.668180143415
G-401,11427553,1.555705840809683,1.8050952273656427
G-401,10113978,1.710663554595952,2.760201099904738
NCI-H661,16013152,4.678017706607999,4.058784544808066
A4/Fukuda,11497983,-1.0595923666648657,1.122257724250266
NCI-H522,10296883,3.751667506317718,3.7264575359931005
HCC1143,6610355,4.569348514461763,4.57079261976712
SCC-9,56946209,-4.978704692275232,-3.8770866119386325
LOU-NH91,54613361,0.2217026048603205,0.45485553022050984
Panc 04.03,ISOX-bortezomib (250-1 mol-mol),0.266400908707645,0.9836627473424212
G-401,42642645,-0.5846467586678221,0.607886882575053
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289,1.9680389696669676
NCI-H727,5287620,-1.579053209750056,-2.053795502038754
FTC-133,16038120,2.9212616737408896,1.3655450419323243
SCC-9,11626560,2.4253223939520976,1.7712577497825504
Panc 04.03,2742550,4.347188786942969,4.050520938227009
OPM-2,15547703,2.634316496996711,2.683537092570191
NCI-H522,10074640,3.1231046963753686,2.81872316197681
HSC-4,2945648,2.59041604505869,3.0153371551238024
NCI-H661,vorinostat-navitoclax (4-1 mol-mol),1.2789358142207048,1.1658092944894292
MSTO-211H,10127622,2.776094640706434,4.190589001648402
FTC-133,serdemetan-SCH-529074 (1-1 mol-mol),3.1500157786176777,2.0116829771614486
NCI-H661,2858523,3.1395656938248124,2.976613321998735
A-673,56946209,-5.889509916794497,-4.563580530758958
CAL-51,44185566,1.8630594392382311,2.5663340365896206
YAPC,51039095,2.046611375354791,2.7914929806927926
OPM-2,4261,-0.9911458583810344,0.3874301748387221
BT-549,969516,2.601131538014171,2.9122336627343812
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637,2.6203183929952036
A-498,55508,4.21947279006693,3.546802800128715
SNU-449,71466380,4.63195087543953,4.726008904808766
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363,4.3050726504598895
A-673,11707110,3.906892758790242,0.6909507390130333
NCI-H460,54649381,4.173104904963283,4.00504288182631
KYSE-70,5282054,4.279196842795529,3.677124917106558
G-401,119607,4.5837417334889885,4.820087117887554
YAPC,24856436,1.898811352025064,0.6658983147745703
CAL-51,5460769,1.3780575552768597,2.637232710803222
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787,-2.5447973035637417
CA46,400769,-1.5476292313826252,-1.3476595604119972
SNU-449,19582717,4.423938746946012,4.5720397035309
KMRC-1,46191454,1.86757619496812,1.8485764917873044
MDA-MB-453,45279963,3.011106079512325,3.327247452023193
BT-549,25150857,2.011062957026122,2.6108916950762637
BxPC-3,navitoclax-pluripotin (1-1 mol-mol),-1.3920803089523777,-0.874425012452426
NCI-H2009,135999136,4.285465393980956,4.095906791774746
LXF 289,984333,0.880488465949386,0.8844139406081386
NCI-H146,11238147,0.964491846183422,2.6124949880279917
Panc 04.03,5287969,-1.8253556910298991,-1.769799982494523
NCI-H292,654092,0.1209701484650686,-0.20781060298334178
MDA-MB-453,9927531,3.885109165752666,4.3053769013038785
NCI-H522,44819697,-2.38793523497331,-0.9105518431102106
LOU-NH91,11364421,-1.522672653311712,-1.0952802375822248
NOMO-1,4477,1.0767445259598296,0.6173450612792921
LoVo,148198,-1.1147075342847712,-3.3046472624746985
SBC-5,54619267,3.782844847718682,4.047732776424277
BxPC-3,vorinostat-carboplatin (1-1 mol-mol),1.8300641490410745,3.2428067877942346
NCI-H2171,46224516,1.006764214935909,2.0914208670278107
SNU-61,55283,2.411692675664504,2.7001335793885812
ONS-76,navitoclax-birinapant (1-1 mol-mol),1.131765862858429,1.6713429979307433
BxPC-3,vorinostat-navitoclax (4-1 mol-mol),1.2956332154746788,1.1953361007081689
G-401,135398738,4.751845538055463,3.477144477636393
A2780,24889392,2.5877097444926265,3.57360685773914
CAL-51,3081361,1.780158758130264,2.1319850967271456
MSTO-211H,3025986,-0.6925850648320051,-0.5249247467353202
NCI-H1623,10231331,4.737119210946733,1.9732637813259453
LXF 289,60750,-4.482846219959503,-1.2741208815083915
JM-1,19582717,1.6871405928140415,2.9058517989456165
MDA-MB-453,24775005,1.4926368241852035,3.6234750865778738
JM-1,10074640,2.5195149680920657,2.5726172858351304
A-673,2749,0.4791921848862392,1.3404811143183253
ONS-76,9911463,3.87028315643254,3.889618773660914
A2780,3136844,3.626688956130205,3.771936377717674
LOU-NH91,2945648,3.130856585594597,3.127228057575696
NCI-H146,52912189,0.5266703058361273,1.4041737920539408
A2780,156422,3.602973007130472,3.2871488008542578
LXF 289,969516,2.6399649875984355,2.907250072633819
NCI-H146,25154868,-1.0719819424572428,4.0687851274704805
YAPC,1641662,3.645861677961698,3.5158084072018734
LOU-NH91,136227331,3.865245001267085,4.13736651085007
YAPC,46224516,2.408657893134071,2.6761433472222724
JM-1,46199207,1.915427322474508,2.655004964520803
G-401,54618164,3.8592700204433807,3.809897526250809
A-673,53232,1.7702469915903785,2.7914308311590053
SBC-5,6918289,2.991753308414544,2.117099236706494
MDA-MB-453,selumetinib-MK-2206 (8-1 mol-mol),2.1996282854374303,2.198809849324769
NCI-H522,24797083,1.396487413816628,1.533752411038095
YAPC,11238147,2.574935183805209,2.9397607510854358
BT-549,9444,3.939814284899288,4.091900910570885
NCI-H460,11364421,0.3566052665939138,-2.0381260356605186
LXF 289,23582824,0.8647594683412683,0.792995885089744
FTC-133,89928392,1.8077600838169707,1.812062486334866
NCI-H661,15547703,3.600649740500543,3.338601685315267
JM-1,8515,3.19981027650634,2.940987868091098
LXF 289,25102847,1.656353256373218,2.5801788239766092
NCI-H1623,11626560,2.1087636260711333,1.8036114530251985
NOMO-1,2729026,1.9247353379999697,2.1987804909606736
A2780,carboplatin-etoposide (40-17 mol-mol),-0.855870041276873,1.6843291250812973
OPM-2,60700,-1.448416790812607,-1.6177742337116823
NCI-H292,9825149,1.7347241761388297,2.4712496849385626
KMRC-1,6918878,5.2070030404450485,2.669788228344882
SBC-5,4259181,0.3536055110585087,0.1685374479098887
KMRC-1,71466578,5.804397104747809,3.987965545537474
JM-1,selumetinib-MK-2206 (8-1 mol-mol),3.384959636780238,1.9634773269759522
SCC-9,54596490,5.620994411748341,4.047835847285733
MSTO-211H,42642645,-0.4763575861779333,1.0986723664478226
DMS 273,4378219,3.0463884183789336,2.392649305270065
FTC-133,SNX-2112-bortezomib (250-1 mol-mol),2.186622613691835,-1.3355788387164464
MDA-MB-453,11626560,2.2881538301476696,1.9337071192001212
BT-549,46215462,1.7261150757919093,1.9437226002475867
SNU-449,45279963,4.011305658965759,3.958312484813909
HSC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.233119251645935,3.5764272077073813
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605,2.3170288768590845
A-673,10302451,3.0176041071951345,3.190427814688748
CAL-51,5280436,3.749440064194485,3.3980941697465634
OPM-2,23582824,0.3145394278485406,0.3683820563312459
JM-1,5287620,-0.1298713463901946,-2.375000381683297
MDA-MB-157,3503,1.1658051797362206,2.2220203600874227
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757,1.8265151664623511
SNU-61,16741245,4.568608723382813,3.882771676308841
SNU-449,54626689,4.585589968636992,4.772320346011021
G-401,49867930,6.047675909857249,3.9178173759905595
HCC1143,46199207,3.122692827276537,3.1463517179349396
OPM-2,445643,3.4082912819673536,3.5839464900867397
DMS 273,54618771,0.8675837195237585,0.9790571924622187
NCI-H1623,71304818,2.8160491805212615,2.4891819098641337
MDA-MB-157,16659841,3.727147143419768,3.7692236970547284
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146,0.5135987288156876
MDA-MB-453,1750826,0.6003684780059517,-0.7755673403916943
NCI-H1623,5281321,-0.5392861044239732,-1.1300619093284463
MDA-MB-453,613753,2.5060803116052357,3.165044849159782
MDA-MB-453,2871966,-0.7610622755396385,0.15250413885689845
MSTO-211H,5281321,-2.386258436411726,-1.1999328766818143
KMRC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.854846859119752,3.365534375166872
FU-OV-1,44137675,3.1043101525841377,3.646763933205818
NCI-H2171,285033,-3.2427052076981693,-2.8017058218055753
FTC-133,alisertib-navitoclax (2-1 mol-mol),-1.780189218062184,0.6718557600148526
NCI-H727,5311,2.2708816030438816,1.4709247693430965
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859,-0.7121541032042025
A2780,5746,0.8697095475366516,0.45579626133653256
NCI-H2171,53232,2.7429596689347875,3.035286755562521
EFO-27,5291,4.106816055599409,3.7471436209681177
MDA-MB-453,9933475,1.6213532539721074,1.738489457810429
OPM-2,5281321,-3.721370442971226,-2.0854735382384475
SBC-5,25183872,-1.21590268467039,-0.849018287667059
SBC-5,452548,-1.978558467437607,0.09707750481814977
NCI-H522,5351362,1.1598735323390523,1.2773859865885007
MSTO-211H,3552672,1.7334798735784387,2.6467121196868084
A2780,10427712,3.0744297357135557,3.968696229962311
LOU-NH91,409805,5.248055334811583,5.017159434441179
JM-1,5460769,0.6255065324989537,2.0735220144088893
NCI-H292,9967941,4.033073764451828,3.784341099756931
NCI-H727,16038120,-0.1646423801756905,1.0108522634358308
NCI-H460,16038120,2.547350732010626,1.25099289816843
LXF 289,241158,4.717778097263283,3.940290906095764
OPM-2,46398810,1.9487214127979129,1.889845157553295
A2780,selumetinib-JQ-1 (4-1 mol-mol),-1.37978583005038,1.0551897056688129
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738,2.3461689081350827
CAL-51,9884685,-0.2528326244590672,0.6965478755175338
LoVo,44607531,1.302221694572025,1.3346182982193093
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434,0.5644155308039651
MSTO-211H,56963564,1.234327129960966,0.38243586996134477
MDA-MB-453,73707398,1.1537227860078607,1.2500027535996503
BxPC-3,5329102,1.9407746673909456,2.2240869816426763
HSC-4,5287620,-1.917371788332746,-1.9795188687345584
FTC-133,11152667,-0.4786534736280033,-0.2960779659308019
NCI-H146,9935249,1.0600603569941576,2.4759764059781912
YAPC,2729026,2.7496252904978293,2.943900167725735
SNU-449,71751553,4.402646349497825,4.585551615549736
HCC1143,9926054,1.808099247882512,2.099286903736427
Panc 04.03,448949,2.534760210414342,2.0866124262258476
NCI-H661,5566,3.151274839096282,3.0187363754026215
FTC-133,6610355,5.440540243356366,4.558726747180603
JM-1,16741245,4.187666128361383,3.428619094892304
SBC-5,navitoclax-birinapant (1-1 mol-mol),2.2573957245834246,1.3710720829413225
LXF 289,107970,2.2922723928752307,2.4570790058750793
Panc 04.03,54626689,4.659724899973851,4.725719763959223
MSTO-211H,16736978,0.1439838744803616,2.030576913710362
MDA-MB-453,151289,1.613318506724072,1.2534907094299286
CAL-51,carboplatin-etoposide (40-17 mol-mol),1.6376184164581593,2.504164226892268
CA46,6918638,-2.155597959241919,-0.9649115530546246
ONS-76,selumetinib-UNC0638 (4-1 mol-mol),0.4414887098860544,3.1759738893625955
A4/Fukuda,53495165,-3.058270414187161,-1.7771245621058425
DMS 273,135984461,4.327877942465965,2.854451088609636
OPM-2,89928392,0.3187576395153793,0.4906071702074678
NCI-H1623,10385095,1.1256497169747182,1.3798356067313122
ONS-76,11717001,3.327449083785458,3.7081961814586366
LoVo,6610216,4.332472846182503,4.25423959034518
NCI-H292,16722836,1.3558361632896196,1.6607396749266936
MSTO-211H,135440466,1.110539790918092,2.293405060779304
BxPC-3,9868037,2.7194108471732243,3.364805197360418
CA46,2874250,4.668483912698598,4.371200078626859
MSTO-211H,11238147,2.1702387480753393,2.913287105522031
JM-1,44607530,1.0639194271383936,1.2046060246681616
NCI-H460,navitoclax-sorafenib (1-1 mol-mol),2.697352012962362,1.8524012440452142
ONS-76,2749,5.1102698724547375,1.8111387227787334
CAL-51,36462,0.7338920585832341,1.7936824570410008
CAL-51,6610216,4.7761200098267365,4.271859305689512
KYSE-70,3062316,0.8461927752800795,1.1946344697210336
LOU-NH91,285033,0.7293222441785373,-1.5710027261486106
A2780,11485656,1.5628347007454235,1.9056639828300643
A-673,26596,-3.820628112159822,-1.8559809362954867
KYSE-70,44632017,1.4611535882953923,1.450831683010775
NCI-H2171,702558,3.801125308495619,4.433021536390081
MSTO-211H,23635314,-1.96294908215212,-1.3014996298410453
SNU-81,5746,1.2061469752663514,0.6708239147076861
KMRC-1,4788,5.9167994505540475,5.607633971572978
CAL-51,15983966,-4.387912760170627,-1.7191856765966582
CA46,49867930,4.292641096024632,3.134893667190834
HSC-4,11455910,0.337268703123225,1.1644070540776519
YAPC,5281672,4.680001258160183,4.720968970502036
SBC-5,5978,-3.632907311761228,-2.2600575675692802
NCI-H460,3825829,4.446795399525052,4.064847650881539
MDA-MB-157,9444,2.0478202605503206,4.258688046969048
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207,0.012212407998446648
SBC-5,46191454,2.9096163569547,1.9200786616434868
CA46,644241,2.374325583681648,-0.15714651178032216
EFO-27,erlotinib-PLX-4032 (2-1 mol-mol),3.67875442693599,3.152532042909286
FTC-133,252682,6.679184103041344,6.566777674177748
SCC-9,56649450,2.7319907342568275,3.3043480767210673
CA46,5311,-0.1889513685103653,0.4194003934623264
OVISE,9967941,3.747669270164806,3.579365824953615
KMRC-1,5328940,2.3844062156656256,1.8443191281310467
NCI-H146,9825149,1.1795040286889695,1.9884972358281912
SNU-81,445091,-0.9408785363266468,3.9537681885764453
FU-OV-1,6610216,4.742914927321441,4.283293575664346
A2780,56949517,4.37203598237815,4.2488892011576365
EFO-27,119607,5.664089470896734,5.272199069660915
ONS-76,57519531,2.0495811593793105,2.4277510881448943
MDA-MB-157,42642645,0.4106458170856017,1.0607037318873989
CA46,135421197,1.13174100448049,1.3488628296470992
LOU-NH91,11719255,2.9529273796726394,3.7686158520720414
A-673,9967941,2.0264988474191377,3.22910113115024
A-673,23582824,0.2073680927392712,0.9484526730663001
CAL-51,374536,3.1977545561189347,2.569166337821826
SNU-449,5311,2.373513113952619,1.6166588434797566
SCC-9,11178236,-3.8920346249942264,-3.0494121949847552
SNU-61,71680916,4.248107596602719,4.471066120490943
BT-549,4578,4.840393866327907,4.517350879677431
JM-1,56973724,1.572059771180543,1.7785790078844723
BT-549,6184667,4.320802676068414,3.1145722719903977
OPM-2,6918878,0.2719026340750923,0.610975334994698
HSC-4,9967941,3.0274642479334215,3.9017782477522798
G-401,6610355,3.5029306645068696,4.129154992880464
Panc 04.03,1750826,0.308709425359425,-0.7505867221507236
KYSE-70,6610355,4.961596413135767,4.6145516192301095
A-673,24775005,3.310963685757038,3.78004045571773
SNU-81,208908,2.232815974371363,1.8734024283368143
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772,0.8346924199437499
NCI-H727,3543504,4.299187359877464,4.3114293824161125
SCC-9,11152667,-0.1233430086603879,-0.7158594365182701
A2780,208908,2.5004436475537974,2.0990051894339428
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678,-0.9793263298337618
A4/Fukuda,44607531,1.1783204907000706,1.1227495528693168
ONS-76,54649381,4.0197495944656465,3.757473595464885
A4/Fukuda,31703,-2.1013190360416147,-2.1488967504419434
EFO-27,46398810,2.9967281863964867,2.6619572047885214
JM-1,119182,-5.01139227406357,-2.79141362577342
NCI-H2171,25183872,-2.065345244597309,-1.1008530386890758
SCC-9,53392493,3.3396857977581917,2.7730548311443806
ONS-76,44259,0.6373390659589321,1.0372113448245344
NCI-H661,72376,-3.040643961037913,-1.6991221372652499
KYSE-70,11609586,2.827625452517046,2.851685516442514
NCI-H727,3025944,4.64192894764355,4.166212472146006
NCI-H460,262093,3.3627537421549314,3.062937365710293
MDA-MB-157,tretinoin-navitoclax (4-1 mol-mol),4.215736518135254,2.5832876357537202
NCI-H292,11396600,3.7365966834404225,3.841110361912881
OPM-2,11626560,0.8852338363333486,0.7544566801490319
MDA-MB-453,24772860,-3.354356853525474,-1.4906094896268562
BxPC-3,168312962,2.7485538585474547,2.4048524335821275
KMRC-1,46199207,3.449143967158838,3.1688843151215305
MDA-MB-157,2729026,3.2437974205657816,2.6306094691904383
LoVo,4259181,0.2045859597859785,0.22507622343736045
KYSE-70,5329102,1.9375891375175784,2.1625631454211693
EFO-27,3025944,4.337116030950391,4.267784471186746
EFO-27,2742550,4.50908635993052,4.037563563046819
A2780,6610216,3.3472253004646593,4.0634152604991405
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625,-2.4178556476320723
EFO-27,24856436,4.205894943099943,0.42504142826193403
Panc 04.03,9444,4.565679465533194,4.286342027548951
ONS-76,72193861,2.0006819721723197,1.5180310568952182
MSTO-211H,445643,1.8400808237063873,4.042542290045376
CAL-51,8515,3.5852991976047863,3.964966869144921
OVISE,25150857,3.4132003431569524,2.6059329984572197
KMRC-1,tanespimycin-gemcitabine (1-1 mol-mol),2.381825597611343,-1.0231231295414136
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442,-0.44915990642380277
OVISE,5746,2.6308159153246047,1.0433061795343965
A4/Fukuda,168313016,2.0147776130358253,3.8923079448337483
LOU-NH91,54686904,4.160622905506427,3.64677587187454
LOU-NH91,8515,5.2113767400480775,3.8658662127280183
NCI-H727,73707398,1.5620380856857303,1.3529644498851778
OPM-2,16722836,0.349034656527362,0.9700168275512969
NCI-H2009,119607,5.663513162505294,5.404323056303799
G-401,11707110,-1.5866495763270043,1.69120598254268
SCC-9,439501,-2.6581193485563737,-1.9129236777362275
NCI-H2171,4259181,0.2390230285316857,-0.09903384495631279
MDA-MB-157,45279963,1.9862312593637983,3.7175820080803215
LXF 289,6610216,3.700752852024682,4.395160599287055
NCI-H2009,9936388,-6.076047204085024,-0.2867071772452614
ONS-76,11612883,3.1090836160489417,2.645748230520449
SNU-61,969516,2.346236032939849,2.738515262251478
HCC1143,3025986,-1.3091092061734078,-0.9842068256032508
NCI-H146,46398810,1.4219775291726766,2.3025597636335564
HSC-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.4165254570204953,2.425444479523899
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336,-1.7377003859123676
HSC-4,9887053,4.087399127765092,4.3870067935152814
JM-1,11178236,-8.647638887964375,-3.9999155825453077
LOU-NH91,24856436,2.045063798311017,0.9664739466983877
JM-1,4477,0.6485766089343484,0.35684384393405894
MDA-MB-157,31703,-2.5361356877609142,-0.5491073257223241
NCI-H1623,carboplatin-UNC0638 (2-1 mol-mol),3.4805064241678627,3.510941220317989
NCI-H661,54619267,3.8937949591354486,4.06119252182572
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452,1.1570501928519188
CAL-51,135398516,1.449392214756173,2.384985786066309
CA46,4917,3.2539126844885757,2.61469637546246
A-673,4705,3.2416788332737454,3.173168533991748
CA46,carboplatin-UNC0638 (2-1 mol-mol),3.486985389348746,2.499542290763175
NCI-H661,107985,-3.0533673433660393,-3.2804182674387845
G-401,navitoclax-gemcitabine (1-1 mol-mol),-3.419368467159671,-1.9777578858911646
NCI-H727,322968,3.201201930682186,3.7934545826129824
MDA-MB-453,9823820,3.844639760703811,3.839046480838633
CAL-51,44202524,1.5528850010053556,2.1782255868651377
MDA-MB-157,BRD-A02303741-navitoclax (2-1 mol-mol),-1.256832531766744,2.3225661191713938
NCI-H522,216468,3.814024876197808,1.9969006509605898
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244,1.8403161190945234
FTC-133,46191454,4.521976640758756,1.9571598893214708
A-673,tanespimycin-gemcitabine (1-1 mol-mol),-3.600781620367816,-1.7908367556052598
NCI-H460,3385,3.2657114863965573,4.041979671878836
SBC-5,4917,3.6947166304022465,3.0577632894806537
SNU-449,241158,4.010766929552104,4.204339719736251
SBC-5,676352,1.191452976157089,2.0791979747130838
FU-OV-1,11626560,1.6217924510760422,2.0739608183617917
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608,2.0620504985036248
JM-1,23635314,-4.012358401321602,-2.9960316951251422
MSTO-211H,24978538,-1.489482683206989,1.7925617677206702
A-673,6438330,1.8412388803722883,1.5276571891448147
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088,2.8310217022811632
SNU-449,11719255,4.899085715446655,3.8247447435975346
SBC-5,3025986,0.415316224839701,-1.0609992280006528
YAPC,439501,-1.3344819600707327,-1.7610602991804012
NCI-H292,25262965,-1.3774761624707286,-1.0956850327111705
OVISE,4261,2.633875372862392,1.8116722501762073
SCC-9,24951314,2.365472705935838,1.3771392258716977
CAL-51,57519531,1.893237876741888,2.4126420561341675
SNU-449,4521392,4.287622659497221,4.280702943665369
SNU-61,136227924,2.341371828887226,2.864280118864576
HCC1143,24772860,-1.4749293698634824,-1.3689815854329175
BT-549,11178236,-2.7962989267365828,-3.408145807055492
G-401,322968,2.2957138552590264,2.9810674200186287
DMS 273,322968,3.714238246037839,2.7103854004134114
NCI-H460,135875424,3.211754300989152,3.9402728426688425
SNU-449,8515,3.796953450261519,4.135543875702644
EFO-27,3689413,-2.375877948841856,0.013465780735624367
SBC-5,46224516,4.445568719663603,2.2773061118313893
SCC-9,285033,-1.0227924755741569,-1.6393268199699986
MDA-MB-157,vorinostat-navitoclax (4-1 mol-mol),-2.302516692171374,1.315449891593678
YAPC,6610216,4.2275333940091215,4.456589820521076
DMS 273,26596,-2.1961333269229173,-2.3083913578870763
NCI-H460,15953870,5.00315267734786,3.561525522470801
JM-1,16065773,2.0826903108024646,1.769028590682109
CA46,5280436,1.6785665289286047,2.4312209662409012
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884,0.4984720458269507
JM-1,navitoclax-piperlongumine (1-1 mol-mol),-0.2702753374722612,0.18299488803537353
NCI-H522,40482356,5.076444098213918,4.326918403650984
SNU-449,72193861,2.670314458690751,2.182798865085029
A-673,44185566,1.862123250313604,1.9878123788820075
MSTO-211H,6623618,1.8328237574963773,2.4439407143044996
NCI-H661,9868037,2.6835007144938032,3.6329380217944345
NCI-H522,9903786,3.9217135447784783,2.564882562068981
A2780,2828334,5.5086207374667175,5.76584321601615
FTC-133,9887053,4.335569761437092,4.515283017309947
Panc 04.03,3503,2.292907505320521,2.5685595178973846
A-498,126941,-2.1438583463370495,-2.094784286271026
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268,0.4647317317244589
OPM-2,2130404,2.9720984033823896,2.367423583710136
HCC1143,10427712,3.6655746579836497,4.3120338340505455
EFO-27,148198,-4.612142049540045,-3.425294106014844
MSTO-211H,25195348,2.7607409792089186,3.376995492074414
NCI-H460,11455910,1.4134750909778395,0.8872450346684911
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233,3.7739294440026696
NCI-H727,11640390,0.8742840152576016,3.4530981439970545
EFO-27,51039095,3.8168650627357903,2.9663694985691107
OPM-2,148198,-4.827513159673032,-4.389125994099712
CAL-51,10113978,3.4506321601115397,3.3797587006926864
NCI-H2009,71304818,2.93523377765095,2.4023057076552905
A4/Fukuda,24772860,-3.4983689572797307,-2.707819817890142
NCI-H460,6918837,-0.9355989207233988,-2.490971076286326
MDA-MB-453,3503,1.4691071846699333,1.8220537026783221
EFO-27,135398516,1.6834680726831996,2.2088321194869023
A2780,19582717,2.5113952618702102,3.4073173479191685
SNU-61,6918289,4.130324820008196,2.283710424393309
SNU-81,navitoclax-pluripotin (1-1 mol-mol),-1.399520137964588,-0.8492816745178574
MDA-MB-157,448949,1.9498713128669924,2.171436782995963
NCI-H727,675434,4.719754403481023,4.5413915689266515
KMRC-1,11152667,-0.0604913513883814,-1.0576313758749574
ONS-76,9926054,2.5108803232151304,2.019677759524042
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566,-0.48065767008671445
CAL-51,44491742,5.152478206660974,4.151397458534521
NCI-H1623,5278396,3.5068270087169022,3.5481734869587056
DMS 273,3634881,3.2856933751991844,2.8256174862171064
NCI-H146,23582824,-0.1302486758765051,0.712942147813527
NCI-H522,salermide-PLX-4032 (12-1 mol-mol),5.39637133830604,4.560653592758674
A-673,11175137,1.5552265537901524,2.112201304446231
A-673,4378219,1.9880690032317576,2.160000031801222
NCI-H661,5460769,1.0320957244219937,2.962113558034052
NCI-H522,selumetinib-BRD-A02303741 (4-1 mol-mol),6.687730464329683,3.858372350960539
NCI-H146,2746,0.8652413173737366,2.518772588969593
NCI-H1623,11955716,5.690110889982477,-1.168824733643161
JM-1,46224516,0.3128269384104456,1.7396284718523234
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989,-1.9157998308925173
A2780,11317348,0.9115498056774632,2.0773638967205765
NCI-H661,9911830,2.711917815790479,2.3800778807874834
CAL-51,44202524,1.5528850010053556,2.1782255868651377
BT-549,4096211,1.216432091282546,2.346659076569378
FTC-133,6918328,0.7944971797491694,0.2871497189868237
CAL-51,9911830,2.6702149728757343,2.4383258489621435
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482,1.3557498100429695
NCI-H146,BRD-K55473186,3.591565624419444,3.7550800180231763
ONS-76,doxorubicin-navitoclax (2-1 mol-mol),-1.5086467428383314,-1.0248030528642085
SNU-81,16720766,0.0913844680975832,0.2698205196807214
LOU-NH91,46215462,2.06389335978863,1.915584589872431
MDA-MB-453,navitoclax-PLX-4032 (1-1 mol-mol),2.982075726164247,1.737208904821271
CAL-51,5978,-2.6819752982341463,-2.339554427289995
CAL-51,5278396,3.885366261927898,3.5696720499720884
HSC-4,4477,1.1301199037714704,0.4760569373303528
HSC-4,25195348,4.125902627491381,3.26319713841956
NCI-H661,227681,4.255095664751994,3.217376244797539
NCI-H292,24951314,1.8411912809473163,1.698434347785438
NCI-H522,3543504,4.389197316233122,4.03799141878579
NCI-H460,452548,0.6919333948360032,0.39682693626447696
SNU-61,25105715,3.603411279706935,3.4311464571769377
NCI-H727,navitoclax-pluripotin (1-1 mol-mol),-0.0549082702470221,-0.6953512241254662
SW1463,11175137,3.4916395483032256,2.5791043850438156
SBC-5,6914657,-3.351925471283153,-3.302895750268978
JM-1,65064,5.210865559450395,3.763184227141868
OPM-2,9967941,3.958466181768741,3.3648815624301482
KMRC-1,969516,2.336566526495707,2.717470569154327
MSTO-211H,15983966,-3.5322347663594016,-1.4326735704177451
OPM-2,9952709,2.422518614873216,2.282406004646174
NOMO-1,16741245,4.369418152152245,3.304421919570714
DMS 273,16659841,4.479005871158747,2.9571549460321838
CAL-51,selumetinib-decitabine (4-1 mol-mol),5.605446855061176,3.808898676901501
JM-1,46398810,2.06860116520361,1.8112050515221163
NCI-H661,12003241,-1.8871798966926587,-0.9682648195731548
CA46,docetaxel-tanespimycin (2-1 mol-mol),-7.203765496579748,-4.884240510894318
FU-OV-1,10184653,3.943218547538411,1.5394197312667814
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402,3.8144474735775464
OPM-2,156422,3.8836640353636382,2.9750091232461533
BxPC-3,JQ-1-vorinostat (2-1 mol-mol),0.8253599744929256,1.0484639621463645
SNU-449,56649450,3.812927022122559,3.2212774750850715
CAL-51,119607,5.291790266428237,5.153600576508238
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549,3.5314918977591123
BT-549,148124,3.591112191677911,-2.064390416338655
A2780,216468,0.3493873836888674,1.6575856635305908
MDA-MB-453,176870,4.531738011413092,3.2839004807550287
FTC-133,docetaxel-tanespimycin (2-1 mol-mol),-1.4229742664151317,-2.678773290084706
LXF 289,24180125,2.8590757937383517,3.224848761430216
G-401,4259181,0.5796012369716917,-0.2653788638095322
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044,4.594382812409041
SNU-81,alisertib-navitoclax (2-1 mol-mol),-2.6757706059542445,0.2649562698486105
JM-1,54618305,4.117087010604098,3.945487544885783
NCI-H522,16736978,1.523319728114192,1.6008558745577002
NCI-H522,36462,3.1215227661343925,1.5394781693597508
HSC-4,400769,-0.948607557046086,-0.5022296241570179
FU-OV-1,piperlongumine-MST-312 (1-1 mol-mol),2.3913949476666243,1.9072537378614127
YAPC,20959075,1.1991758721406616,-2.784835039406703
A-498,5328940,1.8314953095149151,1.9587615173555404
YAPC,9915743,1.8269757962027744,0.880254567376941
SNU-81,54613361,-2.01246069716893,-0.06518012170237117
CA46,navitoclax-pluripotin (1-1 mol-mol),-1.6931023620468224,-1.9522555644348376
OPM-2,1716436,2.6292767753294437,2.506013695052171
Panc 04.03,3025986,-1.5275729109481309,-0.9540425888635798
NCI-H661,25150857,2.764254958619497,2.1901949643183034
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544,2.377240792327701
LOU-NH91,5746,1.403252091596802,1.537514432888261
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391,2.033894944986734
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698,2.823818919158366
NCI-H146,135398738,5.0513404057578155,3.8563916225098507
MDA-MB-453,25227462,0.3575965628816619,-0.34036813775699243
NCI-H460,2858523,3.1665522277325575,3.123700256264357
SNU-449,9866186,1.4050575476777012,1.011477775818495
CAL-51,54686904,4.850424917483252,3.3484677350036884
LoVo,53392493,2.4765619401689154,2.551374812586857
LXF 289,24951314,1.0119406639366386,1.5326653719105736
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992,2.437427143606024
NCI-H1623,5329102,1.790138577011996,2.203052878201945
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017,2.585662130135758
NCI-H292,3815108,3.432884993584308,3.1939573747803887
OPM-2,400769,-3.2268127368380215,-1.2585300039765965
MDA-MB-157,9823820,1.002295209558588,4.105733021866191
MDA-MB-453,vorinostat-carboplatin (1-1 mol-mol),1.132828187068375,3.071484879068376
YAPC,135999136,4.461108174764027,3.9745414290383554
A-498,71680916,6.416494665581045,4.958902052285796
BT-549,252682,5.865498031558929,6.609447607779165
NCI-H522,2130404,2.4549438882602463,2.525204163176075
BT-549,60750,3.345812478570961,-2.018120652893891
A2780,55508,1.942124594025635,3.1633862170977602
BT-549,3136844,5.53345832245052,4.369005035835712
A-673,SNX-2112-bortezomib (250-1 mol-mol),-3.639662214518592,-1.8535368455407033
NCI-H522,135398516,2.766899162932887,1.7736785018434074
Panc 04.03,45279963,4.427260741974604,4.041740692294903
MDA-MB-157,107970,2.1200224507121868,2.4011431176170075
DMS 273,24180719,3.915275581303962,3.554495285245105
Panc 04.03,71680916,5.172010716636655,4.843913094397016
DMS 273,44632017,0.8019003224742934,1.1733012437506987
NCI-H292,5311281,4.174884455345005,2.751483409014909
NCI-H2171,9549297,1.2348443580878434,2.1334072604371745
NCI-H661,135398516,2.0112722508641525,2.3362691356391543
A4/Fukuda,6918328,-3.9252329494253586,-1.2179899072414375
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603,2.4254940735262327
A-673,5284616,-2.8220877865693996,1.765506726526419
A-498,11222830,1.898532346529896,1.882694357502252
SNU-81,44589607,-1.0723208776906596,2.361092661576129
SCC-9,54596558,4.378159430294897,4.25064228145972
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617,-0.2573533555702845
OPM-2,56649450,1.6365959554779024,2.4234990070327087
JM-1,2945648,1.8231052373320176,2.1812296201069317
Panc 04.03,6852167,3.6951209581653743,2.994671375513371
OPM-2,5311281,1.024044758253736,2.0884068791979713
SCC-9,9967941,4.677287493278682,3.739648042089004
CAL-51,11609586,1.5077859423552509,2.9370573705538954
SNU-61,9911463,3.407728451470452,3.547133913221022
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893,2.7567680671342116
KMRC-1,72193861,2.923138623905541,1.9035472739315336
SCC-9,168313016,4.940700460648117,4.868773585793109
NCI-H1623,46215462,1.70222177248337,1.8831694073322867
MDA-MB-157,6505803,-0.678815881739905,-0.710374212924004
A-673,25062766,1.5933001652207863,2.1551282121167548
NCI-H522,148198,-5.538025476960186,-3.487540379126383
KMRC-1,11625818,4.222506706272698,4.185093675833164
LoVo,10074640,2.9851259451828476,3.182783093887458
NCI-H1623,12001922,2.89915315578861,1.9417760093468501
NCI-H460,107970,2.752075604137296,2.4551440913814147
HSC-4,10322450,4.749470049467763,3.844599070203383
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982,-0.3532343504398054
CAL-51,65628,4.560195683913681,4.486075411168395
LoVo,selumetinib-tretinoin (2-1 mol-mol),0.1717915474841797,2.950256899663533
SCC-9,2746,3.644005246156997,3.3702722978816144
JM-1,107985,-4.195149425063274,-3.8643715642663734
NCI-H146,119607,3.9951566487227823,4.933064796852034
JM-1,44566777,-1.1129943275867182,-0.15232178867613103
SBC-5,11167602,1.6319389998554443,2.4975232648364463
LOU-NH91,9936388,-6.294191236399446,0.16872584690917042
SNU-61,135875424,3.609444893060012,3.636082340473676
NCI-H292,6917907,-6.008612763335491,-4.584633819721987
G-401,19582717,3.4233639988307623,3.3525356269949316
LXF 289,46174525,4.3838011857350585,4.642692154690177
SW1463,10184653,-0.9517511422842978,0.9973389838179371
SCC-9,7251185,3.4755501931610486,2.6250786123604293
OPM-2,4788,3.799883557086963,5.169954701280192
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758,3.1019861218753495
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917,0.7752920174974862
DMS 273,JQ-1-navitoclax (2-1 mol-mol),1.419130204387569,0.38946831996493925
NCI-H460,387447,-2.436463262555682,-4.055833076086757
NCI-H522,3465537,1.2201304719285595,2.2479445532150586
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637,2.2820205183640736
OVISE,11228183,1.089434907795814,2.211217386074073
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958,0.8434019590336425
NOMO-1,10410894,2.884775843935945,2.8471558200827336
NCI-H522,3062316,1.3416096793720445,1.1349682113091817
NCI-H522,5328940,1.3898569828081493,1.6087559698795604
OVISE,6917907,-2.8614664806523975,-3.698381019962219
DMS 273,53392493,1.951320459884087,2.0221172709620867
BxPC-3,44259,0.1590720374324279,1.0564446222203447
CAL-51,17755052,0.5283491907817935,1.7751161221455043
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112,2.527070186461434
NCI-H661,676352,2.2217693895783115,1.9546803594140731
LXF 289,452548,0.2436004430663324,0.13684738236488475
LoVo,6438330,1.2087527750724023,2.3654479250631333
OPM-2,16736978,1.1906517256258733,0.7178649443960806
DMS 273,89928392,1.202164769006387,0.760026613159157
CA46,3543504,2.8823298921776717,3.2782590326892342
SBC-5,11427553,4.187017651849035,2.697054888439876
CAL-51,67156097,-2.385254348530768,-0.8563961613235145
FTC-133,23725625,5.526585624025884,5.194379065962164
BT-549,25227462,1.1552638438270102,0.7015688069811741
SNU-81,374536,-2.2172994025671877,1.9331398006907863
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317,-1.0729901715718078
BT-549,65064,5.372588334008338,4.899749216578844
NOMO-1,135398738,0.7085728369009435,2.0946918338017633
A-673,44566777,0.6818018070798556,0.5129558986366569
OVISE,42642645,1.7980918591344808,1.103016494160281
CA46,637858,0.8997823848237061,0.8970294375216716
NCI-H292,9877608,5.923265260718527,3.0900240060173316
DMS 273,11964036,0.5570994002779035,0.7703159911574899
FTC-133,44137675,6.176024086140045,3.5891150945653347
BxPC-3,9926054,1.7603137158224154,1.9425294439274732
DMS 273,5311,0.3077166337368,0.9500090885889905
SNU-61,36314,2.631499046696298,-1.4859623205868915
EFO-27,6917907,-5.745836009999857,-4.9491069994847665
OPM-2,11455910,0.7503761469114726,0.3755436202771151
NCI-H1623,24785538,-1.341558176424811,1.832507594089386
SNU-449,462382,1.3667681892704822,0.6959404784261488
G-401,8515,3.316277000480566,3.349498733943453
SNU-449,25102847,2.813788740655036,2.8326710697641215
BT-549,JQ-1-UNC0638 (2-1 mol-mol),2.8120688111855845,1.921832884893162
ONS-76,11404337,-0.4259392266769182,-0.19913089128342384
KMRC-1,49766530,-0.1675164065777726,-0.5526711605277755
HSC-4,24785538,3.772420906085344,1.917145940491165
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447,5.404006777095054
KYSE-70,73707398,2.029692143461395,1.4754211752495598
NCI-H1623,2729026,3.210868522276231,2.7122024620804113
ONS-76,selumetinib-MK-2206 (8-1 mol-mol),-0.5692436577416031,2.1138259844487064
FTC-133,56649450,4.4227260509908275,3.240439185251304
NCI-H727,3815108,3.498449156165097,2.9261053124177585
FU-OV-1,448949,2.8154029654914137,2.0070618972898675
FU-OV-1,168313200,1.721890351327649,3.228588568325896
HSC-4,107985,-2.2656284906222144,-3.4947117451247243
NCI-H2009,44241473,6.22803294537171,4.87976892637438
CAL-51,46843906,2.776329873296567,3.0669736849982128
NCI-H1623,56946209,-3.1229213094171895,-3.834495412719653
FU-OV-1,3825829,3.720797122696784,4.03133241266482
LXF 289,10385095,0.5776298837700374,1.425130237458579
KMRC-1,4259181,1.968851453570829,0.1193897186343966
G-401,11494412,0.2825252149996007,0.9818316032973776
KYSE-70,6918878,2.8589087884624673,2.691764287143858
CA46,44185566,1.786162700750641,1.657985493050134
LoVo,54618164,3.038824107117225,4.113992928868487
NOMO-1,16722836,0.125485002235246,0.8220430089597964
A4/Fukuda,44486219,1.5854911698245977,3.9945393612601108
LOU-NH91,10127622,4.686411868973226,4.112941715942032
KMRC-1,387447,-4.945508167403058,-3.678861326886077
NCI-H146,54618164,3.6762408834701423,3.9342475788224185
KMRC-1,5351362,3.133883590343709,1.7392322501407405
NCI-H2171,54765302,2.983840848305476,3.7167014978915853
KMRC-1,16013152,4.7431155582488325,4.049020412870703
SNU-61,71304818,2.3861681407496125,2.4350155566854577
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046,1.78845672173598
SW1463,2708,3.597321448088185,4.2552368262942455
CA46,vorinostat-navitoclax (4-1 mol-mol),0.373580583037546,0.18709555911521597
FTC-133,piperlongumine-MST-312 (1-1 mol-mol),3.9575841468826383,1.8945149352157813
SBC-5,445643,4.051401497201939,3.969490204699602
A4/Fukuda,241158,1.407426277414268,2.5816933957864916
NOMO-1,6852167,1.234836949550939,1.4962559406410525
A-673,9887053,2.3565868011684956,2.9528208000711786
SNU-61,6450551,3.0035817833604783,2.2263563762385816
OPM-2,24771867,-0.0082042750480303,-0.9850442612238637
NOMO-1,11507802,1.1250810428603863,0.7876814624866197
CAL-51,2828334,6.190580852669228,6.124517524197959
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847,3.1293438708782024
KMRC-1,44489675,3.6404436921550607,4.046153468771945
FU-OV-1,23725625,5.156277829802871,5.119269441341329
NCI-H1623,navitoclax-gemcitabine (1-1 mol-mol),-5.01790230865627,-0.4792825028966085
OVISE,439501,-2.343202219776273,-1.7484104129550098
CAL-51,5281321,-0.4656602142962174,-1.3189931263068793
DMS 273,151289,0.7083247440682101,0.6004661667932105
MSTO-211H,9903786,1.212702371904443,2.8864449126367218
LXF 289,135421197,2.6553019911408056,2.0256208293282993
NCI-H146,24771867,1.252264036368602,1.6863472260056342
CAL-51,136227924,2.079284078064279,3.129975976442895
NCI-H522,3689413,-4.273368850016072,-0.4325211435893666
NCI-H460,46907787,4.3372157131836255,2.512983389765001
NCI-H146,25183872,-1.3449770735764903,-1.2330235407088335
CAL-51,selumetinib-MK-2206 (8-1 mol-mol),3.019475754284589,2.3604404782991097
CAL-51,9887053,4.486783389261201,3.9317953498530973
NCI-H460,107985,-2.632533954936978,-3.351841133068893
YAPC,65064,4.247853222703643,4.947482517246209
SCC-9,9884685,0.522968392230544,0.7641202641056979
SNU-61,6852167,3.859693430343892,2.5818595411065264
NCI-H292,400769,-0.4441855968341354,-0.42008211761362907
EFO-27,24748573,3.2354879524418347,2.346348400180865
CA46,65628,4.372814936384242,2.8851478777447155
NOMO-1,1750826,-5.797741098147838,-3.0049902247666416
LOU-NH91,135440466,0.9387697781897782,2.1997520072888057
MSTO-211H,11427553,1.7459714847796464,2.9329632138473762
SNU-61,9903786,2.1391845181717373,2.3883052956627098
JM-1,9952709,2.333856130884211,2.360639403788927
YAPC,44507138,4.423761616669373,2.5699794234902407
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152,1.5690572120863968
NCI-H727,10231331,-2.105430518957453,1.9736964618959276
NCI-H661,navitoclax-gemcitabine (1-1 mol-mol),-0.9367360763965996,-1.2949668770388558
LoVo,6610355,3.962139785065475,4.408184583736509
LOU-NH91,16065773,1.5129164046929433,2.7936824297505027
NCI-H292,51039095,2.62578521626359,3.074500833244432
NCI-H2009,135398516,3.792403018557381,2.577430499275295
Panc 04.03,44566777,0.5187219827219705,0.7012240378672802
NOMO-1,285033,-2.4289999699368923,-3.0928776363603947
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621,-0.912845570432709
KYSE-70,51039095,3.5490987853947247,2.639718325334375
NCI-H460,36462,3.103581216464206,2.360442342119469
MDA-MB-157,216345,3.882260039310166,4.055286279331988
NCI-H522,104842,-1.8805759610000512,-3.454065600714308
FU-OV-1,72376,-3.2802123060842283,-1.3641911886160083
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302,1.3788258059794476
NCI-H661,5978,-4.21717720873681,-1.9487483830953038
A-498,54619267,3.764771843303345,4.230078968666437
SCC-9,53495165,0.7472636588137463,0.6799804594634463
MSTO-211H,9823820,1.3460489687603958,4.175647319137997
EFO-27,11222830,1.8018026478898377,1.6756525003995995
JM-1,11612883,1.345048153552996,1.9438859881212562
NCI-H146,carboplatin-etoposide (40-17 mol-mol),0.3222331814864832,1.845077409354761
EFO-27,12003241,-1.7336155023360622,-0.8057078634540353
SNU-449,969516,2.7263398794742972,2.9396787555174733
NCI-H146,4259181,0.4591034911128469,0.08977292030003714
NOMO-1,24901704,1.738276567126731,1.9009333618757083
BxPC-3,54619238,5.160880582862859,4.768308025182506
SBC-5,654092,0.9915803206550192,-0.2580785508225388
MDA-MB-453,71751553,4.5545018888168185,4.328765952334888
MDA-MB-157,5978,-4.802538048228265,-1.482254320901575
CAL-51,24964624,1.6704816041215405,2.581001245217389
LOU-NH91,5280436,5.173335280456015,3.683533346520926
EFO-27,53481919,4.175905541374054,4.03242155480235
ONS-76,6610216,4.821554065133985,4.2454381451675
JM-1,53495165,-3.850144918627292,-2.266310734779272
YAPC,16065773,2.864044457230109,2.432847827830833
SNU-449,51039095,3.650396552732121,2.9656244604442157
NCI-H661,71466445,2.1620252686029646,4.255272382108804
A4/Fukuda,984333,-0.4165614363108865,-0.04006323584317247
JM-1,4096211,0.9764948319580444,1.076927182669227
SNU-449,44197249,4.950419501644914,3.965174455458572
NCI-H460,11178236,-2.300904923417752,-3.159272018357043
MDA-MB-453,12001922,1.470906003655458,1.7032534593654864
NCI-H460,44620216,3.8133491956675902,3.7683201131030386
A-673,119182,-1.0392852637873304,-1.4922735881513853
NCI-H727,11178236,-2.542459533585497,-3.02230359906419
NCI-H1623,erlotinib-PLX-4032 (2-1 mol-mol),-0.1422885712238643,2.620189595318864
A4/Fukuda,753704,3.7176461109746897,4.085744819831948
SW1463,168312962,2.678519281942756,1.8124631664572128
KMRC-1,SNX-2112-bortezomib (250-1 mol-mol),0.0767950067042666,-1.4155212082611828
OPM-2,227681,1.827584998281281,2.672784343872237
HCC1143,3081361,2.3254724072420316,2.3390449301903278
CAL-51,44607531,1.640429423812436,1.551665242571687
HCC1143,322968,3.187805633465504,3.907279137514444
FTC-133,9911463,4.36756965003986,3.918954515276778
SNU-61,159324,1.5880493113453718,2.416242825822858
NCI-H2171,5738263,2.6832104272478188,2.82777258085146
CA46,49867926,4.142181337076857,3.121530830915196
SNU-81,BRD-A02303741-navitoclax (2-1 mol-mol),0.8522567387086551,1.8585423439396223
HSC-4,44589607,3.345116081225748,2.9187587228487892
EFO-27,11485656,3.240498776862908,2.416501988655798
SNU-81,23725625,1.2739024793065858,4.490008913522224
A4/Fukuda,9911830,0.8865121451383732,2.0191391711297864
NCI-H1623,JQ-1-UNC0638 (2-1 mol-mol),2.6843347454635604,1.3984990280595495
NCI-H292,9866186,0.3072921576740348,0.7962682221596938
NCI-H460,54143018,2.5592633032091956,0.4400198286727581
A2780,4378219,4.7769256594107254,2.1142544152272804
NCI-H1623,44566777,3.7111231324950102,0.7030775687776799
CAL-51,10074640,3.192334769578339,3.2311518540267663
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452,4.574743805970451
CAL-51,60700,-0.6497243984818711,-0.3147256658777052
HCC1143,12001922,1.8011931254041345,1.8954369362209977
NCI-H727,638278,3.5555642892396744,3.2768004565727433
LOU-NH91,72376,-0.6247816475402558,-1.172523881357108
EFO-27,4578,4.426476303141277,4.55762343235777
HCC1143,119607,4.074424413991316,5.163992757167844
JM-1,selumetinib-decitabine (4-1 mol-mol),-2.432451496880968,0.26187331516034495
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878,0.7960191160195238
NCI-H727,159324,3.364651085509472,3.161931249864024
NCI-H1623,5287620,-2.020641279124402,-2.2324288085144546
CAL-51,4261,2.4552246887350417,1.701428966721831
JM-1,3543504,2.821603823672808,3.448520020549264
SNU-81,11497983,2.4691665919847514,1.1953651167727135
G-401,5113032,4.898905985161468,4.695195066615973
MDA-MB-157,52912189,4.238554807379722,2.5831458062441843
G-401,selumetinib-navitoclax (8-1 mol-mol),2.1097176548583407,1.4972678963100021
KYSE-70,10410894,6.372300696648814,3.218816696752809
LXF 289,54618164,3.0378434141224617,4.300876815445867
SNU-61,11214940,-0.337645985307237,1.8727483685121549
ONS-76,11364421,-0.3098764345335473,-1.7883126479700935
KYSE-70,5978,-0.772629381148284,-1.193926982041262
Panc 04.03,53232,3.444660782403792,3.3109999434748643
FTC-133,46926350,-4.117104249862265,-3.9629180129127857
